text,drug1,drug2,ddi,ddi_type
in a study of 11 hiv-infected patients receiving drug1-maintenance therapy ( 40 mg and 90 mg daily ) with 600 mg of drug2 twice daily ( twice the currently recommended dose )  oral drug0 clearance increased 22 % ( 90 % ci 6 % to 42 % ) .,methadone,ziagen,TRUE,mechanism
in a study of 11 hiv-infected patients receiving drug2-maintenance therapy ( 40 mg and 90 mg daily ) with 600 mg of drug1 twice daily ( twice the currently recommended dose )  oral drug0 clearance increased 22 % ( 90 % ci 6 % to 42 % ) .,ziagen,methadone,FALSE,none
drug1 : concomitant drug0 administration decreased the mean auc of total drug2 approximately 55 % .,cholestyramine,ezetimibe,FALSE,none
drug1 : concomitant drug0 administration decreased the mean auc of total drug2 approximately 55 % .,cholestyramine,ezetimibe,TRUE,mechanism
the incremental ldl-c reduction due to adding drug1 to drug2 may be reduced by this interaction .,ezetimibe,cholestyramine,TRUE,effect
co-administration of drug1 with drug2 is not recommended until use in patients is studied .,zetia,fibrates,TRUE,advise
drug1 : in a pharmacokinetic study  concomitant drug0 administration increased total drug2 concentrations approximately 1.5-fold .,fenofibrate,ezetimibe,FALSE,none
drug1 : in a pharmacokinetic study  concomitant drug0 administration increased total drug2 concentrations approximately 1.5-fold .,fenofibrate,ezetimibe,TRUE,mechanism
drug1 : in a pharmacokinetic study  concomitant drug0 administration increased total drug2 concentrations approximately 1.7-fold .,gemfibrozil,ezetimibe,FALSE,none
drug1 : in a pharmacokinetic study  concomitant drug0 administration increased total drug2 concentrations approximately 1.7-fold .,gemfibrozil,ezetimibe,FALSE,none
drug1 : the total drug2 level increased 12-fold in one renal transplant patient receiving multiple medications  including drug0 .,cyclosporine,ezetimibe,FALSE,none
drug2 : the total drug1 level increased 12-fold in one renal transplant patient receiving multiple medications  including drug0 .,ezetimibe,cyclosporine,TRUE,mechanism
patients who take both drug1 and drug2 should be carefully monitored .,ezetimibe,cyclosporine,TRUE,advise
multiple dose studies of drug1 given in combination with drug2 ( drug0 ) in rats and rabbits during organogenesis result in higher drug0 and statin exposures .,ezetimibe,hmg-coa reductase inhibitors,FALSE,none
multiple dose studies of drug1 given in combination with drug0 ( drug2 ) in rats and rabbits during organogenesis result in higher drug0 and statin exposures .,ezetimibe,statins,FALSE,none
multiple dose studies of drug2 given in combination with drug1 ( drug0 ) in rats and rabbits during organogenesis result in higher drug0 and statin exposures .,hmg-coa reductase inhibitors,ezetimibe,FALSE,none
multiple dose studies of drug2 given in combination with drug0 ( drug1 ) in rats and rabbits during organogenesis result in higher drug0 and statin exposures .,statins,ezetimibe,FALSE,none
when drug1 is administered with an drug2 in a woman of childbearing potential  refer to the pregnancy category and package labeling for the drug0 .,zetia,hmg-coa reductase inhibitor,FALSE,none
when drug1 is administered with an drug2 in a woman of childbearing potential  refer to the pregnancy category and package labeling for the drug0 .,zetia,hmg-coa reductase inhibitor,FALSE,none
these are described in greater detail below : oral drug1  drug0-type drug0  drug2  drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0  short-acting drug0  oral drug0 : clinically significant hypoglycemia may be precipitated by the use of drug0 with oral drug0 agents ;,hypoglycemics,phenytoin,FALSE,none
these are described in greater detail below : oral drug1  drug0-type drug0  drug0  drug2  drug0  drug0  drug0  drug0  drug0  drug0  drug0  short-acting drug0  oral drug0 : clinically significant hypoglycemia may be precipitated by the use of drug0 with oral drug0 agents ;,hypoglycemics,cyclosporine,FALSE,none
these are described in greater detail below : oral drug1  drug0-type drug0  drug0  drug0  drug2  drug0  drug0  drug0  drug0  drug0  drug0  short-acting drug0  oral drug0 : clinically significant hypoglycemia may be precipitated by the use of drug0 with oral drug0 agents ;,hypoglycemics,rifampin,FALSE,none
these are described in greater detail below : oral drug1  drug0-type drug0  drug0  drug0  drug0  drug2  drug0  drug0  drug0  drug0  drug0  short-acting drug0  oral drug0 : clinically significant hypoglycemia may be precipitated by the use of drug0 with oral drug0 agents ;,hypoglycemics,theophylline,FALSE,none
these are described in greater detail below : oral drug1  drug0-type drug0  drug0  drug0  drug0  drug0  drug2  drug0  drug0  drug0  drug0  short-acting drug0  oral drug0 : clinically significant hypoglycemia may be precipitated by the use of drug0 with oral drug0 agents ;,hypoglycemics,terfenadine,FALSE,none
these are described in greater detail below : oral drug1  drug0-type drug0  drug0  drug0  drug0  drug0  drug0  drug2  drug0  drug0  drug0  short-acting drug0  oral drug0 : clinically significant hypoglycemia may be precipitated by the use of drug0 with oral drug0 agents ;,hypoglycemics,cisapride,FALSE,none
these are described in greater detail below : oral drug1  drug0-type drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug2  drug0  drug0  short-acting drug0  oral drug0 : clinically significant hypoglycemia may be precipitated by the use of drug0 with oral drug0 agents ;,hypoglycemics,astemizole,FALSE,none
these are described in greater detail below : oral drug1  drug0-type drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug2  drug0  short-acting drug0  oral drug0 : clinically significant hypoglycemia may be precipitated by the use of drug0 with oral drug0 agents ;,hypoglycemics,rifabutin,FALSE,none
these are described in greater detail below : oral drug1  drug0-type drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug2  short-acting drug0  oral drug0 : clinically significant hypoglycemia may be precipitated by the use of drug0 with oral drug0 agents ;,hypoglycemics,tacrolimus,FALSE,none
these are described in greater detail below : oral drug1  drug0-type drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug2  oral drug0 : clinically significant hypoglycemia may be precipitated by the use of drug0 with oral drug0 agents ;,hypoglycemics,short-acting benzodiazepines,FALSE,none
these are described in greater detail below : oral drug1  drug0-type drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0  short-acting drug0  oral drug0 : clinically significant hypoglycemia may be precipitated by the use of drug2 with oral drug0 agents ;,hypoglycemics,diflucan,FALSE,none
these are described in greater detail below : oral drug1  drug0-type drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0  short-acting drug0  oral drug0 : clinically significant hypoglycemia may be precipitated by the use of drug0 with oral drug2 ;,hypoglycemics,hypoglycemic agents,FALSE,none
these are described in greater detail below : oral drug0  drug1  drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0  short-acting drug0  oral drug0 : clinically significant hypoglycemia may be precipitated by the use of drug2 with oral drug0 agents ;,coumarin-type anticoagulants,diflucan,FALSE,none
these are described in greater detail below : oral drug0  drug1  drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0  short-acting drug0  oral drug0 : clinically significant hypoglycemia may be precipitated by the use of drug0 with oral drug2 ;,coumarin-type anticoagulants,hypoglycemic agents,FALSE,none
these are described in greater detail below : oral drug2  drug0-type drug0  drug1  drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0  short-acting drug0  oral drug0 : clinically significant hypoglycemia may be precipitated by the use of drug0 with oral drug0 agents ;,phenytoin,hypoglycemics,FALSE,none
these are described in greater detail below : oral drug0  drug0-type drug0  drug1  drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0  short-acting drug0  oral drug0 : clinically significant hypoglycemia may be precipitated by the use of drug2 with oral drug0 agents ;,phenytoin,diflucan,FALSE,none
these are described in greater detail below : oral drug0  drug0-type drug0  drug1  drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0  short-acting drug0  oral drug0 : clinically significant hypoglycemia may be precipitated by the use of drug0 with oral drug2 ;,phenytoin,hypoglycemic agents,FALSE,none
these are described in greater detail below : oral drug2  drug0-type drug0  drug0  drug1  drug0  drug0  drug0  drug0  drug0  drug0  drug0  short-acting drug0  oral drug0 : clinically significant hypoglycemia may be precipitated by the use of drug0 with oral drug0 agents ;,cyclosporine,hypoglycemics,FALSE,none
these are described in greater detail below : oral drug0  drug0-type drug0  drug0  drug1  drug0  drug0  drug0  drug0  drug0  drug0  drug0  short-acting drug0  oral drug0 : clinically significant hypoglycemia may be precipitated by the use of drug2 with oral drug0 agents ;,cyclosporine,diflucan,FALSE,none
these are described in greater detail below : oral drug0  drug0-type drug0  drug0  drug1  drug0  drug0  drug0  drug0  drug0  drug0  drug0  short-acting drug0  oral drug0 : clinically significant hypoglycemia may be precipitated by the use of drug0 with oral drug2 ;,cyclosporine,hypoglycemic agents,FALSE,none
these are described in greater detail below : oral drug2  drug0-type drug0  drug0  drug0  drug1  drug0  drug0  drug0  drug0  drug0  drug0  short-acting drug0  oral drug0 : clinically significant hypoglycemia may be precipitated by the use of drug0 with oral drug0 agents ;,rifampin,hypoglycemics,FALSE,none
these are described in greater detail below : oral drug0  drug0-type drug0  drug0  drug0  drug1  drug0  drug0  drug0  drug0  drug0  drug0  short-acting drug0  oral drug0 : clinically significant hypoglycemia may be precipitated by the use of drug2 with oral drug0 agents ;,rifampin,diflucan,FALSE,none
these are described in greater detail below : oral drug0  drug0-type drug0  drug0  drug0  drug1  drug0  drug0  drug0  drug0  drug0  drug0  short-acting drug0  oral drug0 : clinically significant hypoglycemia may be precipitated by the use of drug0 with oral drug2 ;,rifampin,hypoglycemic agents,FALSE,none
these are described in greater detail below : oral drug2  drug0-type drug0  drug0  drug0  drug0  drug1  drug0  drug0  drug0  drug0  drug0  short-acting drug0  oral drug0 : clinically significant hypoglycemia may be precipitated by the use of drug0 with oral drug0 agents ;,theophylline,hypoglycemics,FALSE,none
these are described in greater detail below : oral drug0  drug0-type drug0  drug0  drug0  drug0  drug1  drug0  drug0  drug0  drug0  drug0  short-acting drug0  oral drug0 : clinically significant hypoglycemia may be precipitated by the use of drug2 with oral drug0 agents ;,theophylline,diflucan,FALSE,none
these are described in greater detail below : oral drug0  drug0-type drug0  drug0  drug0  drug0  drug1  drug0  drug0  drug0  drug0  drug0  short-acting drug0  oral drug0 : clinically significant hypoglycemia may be precipitated by the use of drug0 with oral drug2 ;,theophylline,hypoglycemic agents,FALSE,none
these are described in greater detail below : oral drug2  drug0-type drug0  drug0  drug0  drug0  drug0  drug1  drug0  drug0  drug0  drug0  short-acting drug0  oral drug0 : clinically significant hypoglycemia may be precipitated by the use of drug0 with oral drug0 agents ;,terfenadine,hypoglycemics,FALSE,none
these are described in greater detail below : oral drug0  drug0-type drug0  drug0  drug0  drug0  drug0  drug1  drug0  drug0  drug0  drug0  short-acting drug0  oral drug0 : clinically significant hypoglycemia may be precipitated by the use of drug2 with oral drug0 agents ;,terfenadine,diflucan,FALSE,none
these are described in greater detail below : oral drug0  drug0-type drug0  drug0  drug0  drug0  drug0  drug1  drug0  drug0  drug0  drug0  short-acting drug0  oral drug0 : clinically significant hypoglycemia may be precipitated by the use of drug0 with oral drug2 ;,terfenadine,hypoglycemic agents,FALSE,none
these are described in greater detail below : oral drug2  drug0-type drug0  drug0  drug0  drug0  drug0  drug0  drug1  drug0  drug0  drug0  short-acting drug0  oral drug0 : clinically significant hypoglycemia may be precipitated by the use of drug0 with oral drug0 agents ;,cisapride,hypoglycemics,FALSE,none
these are described in greater detail below : oral drug0  drug0-type drug0  drug0  drug0  drug0  drug0  drug0  drug1  drug0  drug0  drug0  short-acting drug0  oral drug0 : clinically significant hypoglycemia may be precipitated by the use of drug2 with oral drug0 agents ;,cisapride,diflucan,FALSE,none
these are described in greater detail below : oral drug0  drug0-type drug0  drug0  drug0  drug0  drug0  drug0  drug1  drug0  drug0  drug0  short-acting drug0  oral drug0 : clinically significant hypoglycemia may be precipitated by the use of drug0 with oral drug2 ;,cisapride,hypoglycemic agents,FALSE,none
these are described in greater detail below : oral drug2  drug0-type drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug1  drug0  drug0  short-acting drug0  oral drug0 : clinically significant hypoglycemia may be precipitated by the use of drug0 with oral drug0 agents ;,astemizole,hypoglycemics,FALSE,none
these are described in greater detail below : oral drug0  drug0-type drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug1  drug0  drug0  short-acting drug0  oral drug0 : clinically significant hypoglycemia may be precipitated by the use of drug2 with oral drug0 agents ;,astemizole,diflucan,FALSE,none
these are described in greater detail below : oral drug0  drug0-type drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug1  drug0  drug0  short-acting drug0  oral drug0 : clinically significant hypoglycemia may be precipitated by the use of drug0 with oral drug2 ;,astemizole,hypoglycemic agents,FALSE,none
these are described in greater detail below : oral drug2  drug0-type drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug1  drug0  short-acting drug0  oral drug0 : clinically significant hypoglycemia may be precipitated by the use of drug0 with oral drug0 agents ;,rifabutin,hypoglycemics,FALSE,none
these are described in greater detail below : oral drug0  drug0-type drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug1  drug0  short-acting drug0  oral drug0 : clinically significant hypoglycemia may be precipitated by the use of drug2 with oral drug0 agents ;,rifabutin,diflucan,FALSE,none
these are described in greater detail below : oral drug0  drug0-type drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug1  drug0  short-acting drug0  oral drug0 : clinically significant hypoglycemia may be precipitated by the use of drug0 with oral drug2 ;,rifabutin,hypoglycemic agents,FALSE,none
these are described in greater detail below : oral drug2  drug0-type drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug1  short-acting drug0  oral drug0 : clinically significant hypoglycemia may be precipitated by the use of drug0 with oral drug0 agents ;,tacrolimus,hypoglycemics,FALSE,none
these are described in greater detail below : oral drug0  drug0-type drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug1  short-acting drug0  oral drug0 : clinically significant hypoglycemia may be precipitated by the use of drug2 with oral drug0 agents ;,tacrolimus,diflucan,FALSE,none
these are described in greater detail below : oral drug0  drug0-type drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug1  short-acting drug0  oral drug0 : clinically significant hypoglycemia may be precipitated by the use of drug0 with oral drug2 ;,tacrolimus,hypoglycemic agents,FALSE,none
these are described in greater detail below : oral drug2  drug0-type drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug1  oral drug0 : clinically significant hypoglycemia may be precipitated by the use of drug0 with oral drug0 agents ;,short-acting benzodiazepines,hypoglycemics,FALSE,none
these are described in greater detail below : oral drug0  drug0-type drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug1  oral drug0 : clinically significant hypoglycemia may be precipitated by the use of drug2 with oral drug0 agents ;,short-acting benzodiazepines,diflucan,FALSE,none
these are described in greater detail below : oral drug0  drug0-type drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug1  oral drug0 : clinically significant hypoglycemia may be precipitated by the use of drug0 with oral drug2 ;,short-acting benzodiazepines,hypoglycemic agents,FALSE,none
these are described in greater detail below : oral drug1  drug0-type drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0  short-acting drug0  oral drug0 : clinically significant hypoglycemia may be precipitated by the use of drug2 with oral drug0 agents ;,hypoglycemics,diflucan,FALSE,none
these are described in greater detail below : oral drug1  drug0-type drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0  short-acting drug0  oral drug0 : clinically significant hypoglycemia may be precipitated by the use of drug0 with oral drug2 ;,hypoglycemics,hypoglycemic agents,FALSE,none
these are described in greater detail below : oral drug0  drug0-type drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0  short-acting drug0  oral drug0 : clinically significant hypoglycemia may be precipitated by the use of drug1 with oral drug2 ;,diflucan,hypoglycemic agents,TRUE,effect
one fatality has been reported from hypoglycemia in association with combined drug1 and drug2 use .,diflucan,glyburide,TRUE,effect
drug1 reduces the metabolism of drug2  drug0  and drug0 and increases the plasma concentration of these agents .,diflucan,tolbutamide,TRUE,mechanism
drug1 reduces the metabolism of drug0  drug2  and drug0 and increases the plasma concentration of these agents .,diflucan,glyburide,TRUE,mechanism
drug1 reduces the metabolism of drug0  drug0  and drug2 and increases the plasma concentration of these agents .,diflucan,glipizide,TRUE,mechanism
drug0 reduces the metabolism of drug0  drug1  and drug2 and increases the plasma concentration of these agents .,glyburide,glipizide,FALSE,none
when drug1 is used concomitantly with these or other drug2  blood glucose concentrations should be carefully monitored and the dose of the drug0 should be adjusted as necessary .,diflucan,sulfonylurea oral hypoglycemic agents,TRUE,advise
when drug1 is used concomitantly with these or other drug2 oral drug0 agents  blood glucose concentrations should be carefully monitored and the dose of the drug0 should be adjusted as necessary .,diflucan,sulfonylurea,FALSE,none
when drug0 is used concomitantly with these or other drug1  blood glucose concentrations should be carefully monitored and the dose of the drug2 should be adjusted as necessary .,sulfonylurea oral hypoglycemic agents,sulfonylurea,FALSE,none
drug1 : prothrombin time may be increased in patients receiving concomitant drug2 and drug0-type drug0 .,coumarin-type anticoagulants,diflucan,FALSE,none
drug2 : prothrombin time may be increased in patients receiving concomitant drug1 and drug0-type drug0 .,diflucan,coumarin-type anticoagulants,TRUE,effect
in post-marketing experience  as with other drug1  bleeding events ( bruising  epistaxis  gastrointestinal bleeding  hematuria  and melena ) have been reported in association with increases in prothrombin time in patients receiving drug2 concurrently with drug0 .,azole antifungals,fluconazole,FALSE,none
in post-marketing experience  as with other drug1  bleeding events ( bruising  epistaxis  gastrointestinal bleeding  hematuria  and melena ) have been reported in association with increases in prothrombin time in patients receiving drug0 concurrently with drug2 .,azole antifungals,warfarin,FALSE,none
in post-marketing experience  as with other drug0  bleeding events ( bruising  epistaxis  gastrointestinal bleeding  hematuria  and melena ) have been reported in association with increases in prothrombin time in patients receiving drug1 concurrently with drug2 .,fluconazole,warfarin,TRUE,effect
careful monitoring of prothrombin time in patients receiving drug1 and drug2 is recommended .,diflucan,coumarin-type anticoagulants,TRUE,advise
drug1 : drug2 increases the plasma concentrations of drug0 .,phenytoin,diflucan,FALSE,none
drug2 : drug1 increases the plasma concentrations of drug0 .,diflucan,phenytoin,TRUE,mechanism
careful monitoring of drug1 concentrations in patients receiving drug2 and drug0 is recommended .,phenytoin,diflucan,FALSE,none
careful monitoring of drug2 concentrations in patients receiving drug1 and drug0 is recommended .,diflucan,phenytoin,TRUE,advise
drug1 : drug2 may significantly increase drug0 levels in renal transplant patients with or without renal impairment .,cyclosporine,diflucan,FALSE,none
drug2 : drug1 may significantly increase drug0 levels in renal transplant patients with or without renal impairment .,diflucan,cyclosporine,TRUE,mechanism
careful monitoring of drug1 concentrations and serum creatinine is recommended in patients receiving drug2 and drug0 .,cyclosporine,diflucan,FALSE,none
careful monitoring of drug2 concentrations and serum creatinine is recommended in patients receiving drug1 and drug0 .,diflucan,cyclosporine,TRUE,advise
drug1 : drug0 enhances the metabolism of concurrently administered drug2 .,rifampin,diflucan,FALSE,none
drug1 : drug0 enhances the metabolism of concurrently administered drug2 .,rifampin,diflucan,TRUE,mechanism
depending on clinical circumstances  consideration should be given to increasing the dose of drug1 when it is administered with drug2 .,diflucan,rifampin,TRUE,advise
drug1 : drug2 increases the serum concentrations of drug0 .,theophylline,diflucan,FALSE,none
drug2 : drug1 increases the serum concentrations of drug0 .,diflucan,theophylline,TRUE,mechanism
careful monitoring of serum drug1 concentrations in patients receiving drug2 and drug0 is recommended .,theophylline,diflucan,FALSE,none
careful monitoring of serum drug2 concentrations in patients receiving drug1 and drug0 is recommended .,diflucan,theophylline,TRUE,advise
drug1 : because of the occurrence of serious cardiac dysrhythmias secondary to prolongation of the qtc interval in patients receiving drug2 in conjunction with drug0  interaction studies have been performed .,terfenadine,azole antifungals,FALSE,none
drug2 : because of the occurrence of serious cardiac dysrhythmias secondary to prolongation of the qtc interval in patients receiving drug1 in conjunction with drug0  interaction studies have been performed .,azole antifungals,terfenadine,TRUE,effect
another study at a 400-mg and 800-mg daily dose of drug1 demonstrated that drug2 taken in doses of 400 mg per day or greater significantly increases plasma levels of drug0 when taken concomitantly .,fluconazole,diflucan,FALSE,none
another study at a 400-mg and 800-mg daily dose of drug1 demonstrated that drug0 taken in doses of 400 mg per day or greater significantly increases plasma levels of drug2 when taken concomitantly .,fluconazole,terfenadine,FALSE,none
another study at a 400-mg and 800-mg daily dose of drug0 demonstrated that drug1 taken in doses of 400 mg per day or greater significantly increases plasma levels of drug2 when taken concomitantly .,diflucan,terfenadine,TRUE,mechanism
the combined use of drug1 at doses of 400 mg or greater with drug2 is contraindicated .,fluconazole,terfenadine,TRUE,advise
the coadministration of drug1 at doses lower than 400 mg/day with drug2 should be carefully monitored .,fluconazole,terfenadine,TRUE,advise
drug1 : there have been reports of cardiac events  including torsade de pointes in patients to whom drug2 and drug0 were coadministered .,cisapride,fluconazole,FALSE,none
drug2 : there have been reports of cardiac events  including torsade de pointes in patients to whom drug1 and drug0 were coadministered .,fluconazole,cisapride,TRUE,effect
a controlled study found that concomitant drug1 200 mg once daily and drug2 20 mg four times a day yielded a significant increase in drug0 plasma levels and prolongation of qtc interval .,fluconazole,cisapride,TRUE,mechanism
a controlled study found that concomitant drug1 200 mg once daily and drug2 20 mg four times a day yielded a significant increase in drug0 plasma levels and prolongation of qtc interval .,fluconazole,cisapride,FALSE,none
the combined use of drug1 with drug2 is contraindicated .,fluconazole,cisapride,TRUE,advise
drug1 : the use of drug2 in patients concurrently taking drug0 or other drugs metabolized by the cytochrome p450 system may be associated with elevations in serum levels of these drugs .,astemizole,fluconazole,FALSE,none
drug2 : the use of drug1 in patients concurrently taking drug0 or other drugs metabolized by the cytochrome p450 system may be associated with elevations in serum levels of these drugs .,fluconazole,astemizole,TRUE,mechanism
drug1 : there have been reports of uveitis in patients to whom drug2 and drug0 were coadministered .,rifabutin,fluconazole,FALSE,none
drug2 : there have been reports of uveitis in patients to whom drug1 and drug0 were coadministered .,fluconazole,rifabutin,TRUE,effect
patients receiving drug1 and drug2 concomitantly should be carefully monitored .,rifabutin,fluconazole,TRUE,advise
drug1 : there have been reports of nephrotoxicity in patients to whom drug2 and drug0 were coadministered .,tacrolimus,fluconazole,FALSE,none
drug2 : there have been reports of nephrotoxicity in patients to whom drug1 and drug0 were coadministered .,fluconazole,tacrolimus,TRUE,effect
patients receiving drug1 and drug2 concomitantly should be carefully monitored .,tacrolimus,fluconazole,TRUE,advise
drug1 : following oral administration of drug2  drug0 resulted in substantial increases in drug0 concentrations and psychomotor effects .,short-acting benzodiazepines,midazolam,FALSE,none
drug1 : following oral administration of drug0  drug2 resulted in substantial increases in drug0 concentrations and psychomotor effects .,short-acting benzodiazepines,fluconazole,FALSE,none
drug1 : following oral administration of drug2  drug0 resulted in substantial increases in drug0 concentrations and psychomotor effects .,short-acting benzodiazepines,midazolam,FALSE,none
this effect on drug1 appears to be more pronounced following oral administration of drug2 than with drug0 administered intravenously .,midazolam,fluconazole,TRUE,effect
this effect on drug1 appears to be more pronounced following oral administration of drug2 than with drug0 administered intravenously .,midazolam,fluconazole,FALSE,none
if drug1  which are metabolized by the cytochrome p450 system  are concomitantly administered with drug2  consideration should be given to decreasing the drug0 dosage  and the patients should be appropriately monitored .,short-acting benzodiazepines,fluconazole,TRUE,advise
if drug1  which are metabolized by the cytochrome p450 system  are concomitantly administered with drug0  consideration should be given to decreasing the drug2 dosage  and the patients should be appropriately monitored .,short-acting benzodiazepines,benzodiazepine,FALSE,none
if short-acting drug0  which are metabolized by the cytochrome p450 system  are concomitantly administered with drug1  consideration should be given to decreasing the drug2 dosage  and the patients should be appropriately monitored .,fluconazole,benzodiazepine,FALSE,none
drug1 tablets coadministered with drug2- and drug0-containing oral drug0 produced an overall mean increase in ethinyl drug0 and drug0 levels ;,fluconazole,ethinyl estradiol,TRUE,mechanism
drug1 tablets coadministered with ethinyl drug0- and drug2-containing oral drug0 produced an overall mean increase in ethinyl drug0 and drug0 levels ;,fluconazole,levonorgestrel,TRUE,mechanism
drug1 tablets coadministered with ethinyl drug0- and drug0-containing oral drug2 produced an overall mean increase in ethinyl drug0 and drug0 levels ;,fluconazole,contraceptives,FALSE,none
drug1 tablets coadministered with drug2- and drug0-containing oral drug0 produced an overall mean increase in ethinyl drug0 and drug0 levels ;,fluconazole,ethinyl estradiol,FALSE,none
drug1 tablets coadministered with ethinyl drug0- and drug2-containing oral drug0 produced an overall mean increase in ethinyl drug0 and drug0 levels ;,fluconazole,levonorgestrel,FALSE,none
drug0 tablets coadministered with drug1- and drug2-containing oral drug0 produced an overall mean increase in ethinyl drug0 and drug0 levels ;,ethinyl estradiol,levonorgestrel,FALSE,none
drug0 tablets coadministered with drug1- and drug0-containing oral drug2 produced an overall mean increase in ethinyl drug0 and drug0 levels ;,ethinyl estradiol,contraceptives,FALSE,none
drug0 tablets coadministered with drug1- and drug2-containing oral drug0 produced an overall mean increase in ethinyl drug0 and drug0 levels ;,ethinyl estradiol,levonorgestrel,FALSE,none
drug0 tablets coadministered with ethinyl drug0- and drug1-containing oral drug2 produced an overall mean increase in ethinyl drug0 and drug0 levels ;,levonorgestrel,contraceptives,FALSE,none
drug0 tablets coadministered with drug2- and drug1-containing oral drug0 produced an overall mean increase in ethinyl drug0 and drug0 levels ;,levonorgestrel,ethinyl estradiol,FALSE,none
drug0 tablets coadministered with drug2- and drug0-containing oral drug1 produced an overall mean increase in ethinyl drug0 and drug0 levels ;,contraceptives,ethinyl estradiol,FALSE,none
drug0 tablets coadministered with ethinyl drug0- and drug2-containing oral drug1 produced an overall mean increase in ethinyl drug0 and drug0 levels ;,contraceptives,levonorgestrel,FALSE,none
drug0 tablets coadministered with drug1- and drug2-containing oral drug0 produced an overall mean increase in ethinyl drug0 and drug0 levels ;,ethinyl estradiol,levonorgestrel,FALSE,none
however  in some patients there were decreases up to 47 % and 33 % of drug1 and drug2 levels .,ethinyl estradiol,levonorgestrel,FALSE,none
the data presently available indicate that the decreases in some individual drug1 and drug2 auc values with drug0 treatment are likely the result of random variation .,ethinyl estradiol,levonorgestrel,FALSE,none
the data presently available indicate that the decreases in some individual drug1 and drug0 auc values with drug2 treatment are likely the result of random variation .,ethinyl estradiol,fluconazole,FALSE,none
the data presently available indicate that the decreases in some individual ethinyl drug0 and drug1 auc values with drug2 treatment are likely the result of random variation .,levonorgestrel,fluconazole,FALSE,none
you can not take drug1 if you have taken a drug2 ( drug0 ) such as drug0 ( drug0 )  drug0 ( drug0 )  or drug0 ( drug0 ) in the last 14 days .,mazindol,monoamine oxidase inhibitor,TRUE,advise
you can not take drug1 if you have taken a drug0 ( drug2 ) such as drug0 ( drug0 )  drug0 ( drug0 )  or drug0 ( drug0 ) in the last 14 days .,mazindol,maoi,TRUE,advise
you can not take drug1 if you have taken a drug0 ( drug0 ) such as drug2 ( drug0 )  drug0 ( drug0 )  or drug0 ( drug0 ) in the last 14 days .,mazindol,isocarboxazid,TRUE,advise
you can not take drug1 if you have taken a drug0 ( drug0 ) such as drug0 ( drug2 )  drug0 ( drug0 )  or drug0 ( drug0 ) in the last 14 days .,mazindol,marplan,TRUE,advise
you can not take drug1 if you have taken a drug0 ( drug0 ) such as drug0 ( drug0 )  drug2 ( drug0 )  or drug0 ( drug0 ) in the last 14 days .,mazindol,tranylcypromine,TRUE,advise
you can not take drug1 if you have taken a drug0 ( drug0 ) such as drug0 ( drug0 )  drug0 ( drug2 )  or drug0 ( drug0 ) in the last 14 days .,mazindol,parnate,TRUE,advise
you can not take drug1 if you have taken a drug0 ( drug0 ) such as drug0 ( drug0 )  drug0 ( drug0 )  or drug2 ( drug0 ) in the last 14 days .,mazindol,phenelzine,TRUE,advise
you can not take drug1 if you have taken a drug0 ( drug0 ) such as drug0 ( drug0 )  drug0 ( drug0 )  or drug0 ( drug2 ) in the last 14 days .,mazindol,nardil,TRUE,advise
you can not take drug0 if you have taken a drug1 ( drug0 ) such as drug2 ( drug0 )  drug0 ( drug0 )  or drug0 ( drug0 ) in the last 14 days .,monoamine oxidase inhibitor,isocarboxazid,FALSE,none
you can not take drug0 if you have taken a drug1 ( drug0 ) such as drug0 ( drug2 )  drug0 ( drug0 )  or drug0 ( drug0 ) in the last 14 days .,monoamine oxidase inhibitor,marplan,FALSE,none
you can not take drug0 if you have taken a drug1 ( drug0 ) such as drug0 ( drug0 )  drug2 ( drug0 )  or drug0 ( drug0 ) in the last 14 days .,monoamine oxidase inhibitor,tranylcypromine,FALSE,none
you can not take drug0 if you have taken a drug1 ( drug0 ) such as drug0 ( drug0 )  drug0 ( drug2 )  or drug0 ( drug0 ) in the last 14 days .,monoamine oxidase inhibitor,parnate,FALSE,none
you can not take drug0 if you have taken a drug1 ( drug0 ) such as drug0 ( drug0 )  drug0 ( drug0 )  or drug2 ( drug0 ) in the last 14 days .,monoamine oxidase inhibitor,phenelzine,FALSE,none
you can not take drug0 if you have taken a drug1 ( drug0 ) such as drug0 ( drug0 )  drug0 ( drug0 )  or drug0 ( drug2 ) in the last 14 days .,monoamine oxidase inhibitor,nardil,FALSE,none
you can not take drug0 if you have taken a drug0 ( drug1 ) such as drug2 ( drug0 )  drug0 ( drug0 )  or drug0 ( drug0 ) in the last 14 days .,maoi,isocarboxazid,FALSE,none
you can not take drug0 if you have taken a drug0 ( drug1 ) such as drug0 ( drug2 )  drug0 ( drug0 )  or drug0 ( drug0 ) in the last 14 days .,maoi,marplan,FALSE,none
you can not take drug0 if you have taken a drug0 ( drug1 ) such as drug0 ( drug0 )  drug2 ( drug0 )  or drug0 ( drug0 ) in the last 14 days .,maoi,tranylcypromine,FALSE,none
you can not take drug0 if you have taken a drug0 ( drug1 ) such as drug0 ( drug0 )  drug0 ( drug2 )  or drug0 ( drug0 ) in the last 14 days .,maoi,parnate,FALSE,none
you can not take drug0 if you have taken a drug0 ( drug1 ) such as drug0 ( drug0 )  drug0 ( drug0 )  or drug2 ( drug0 ) in the last 14 days .,maoi,phenelzine,FALSE,none
you can not take drug0 if you have taken a drug0 ( drug1 ) such as drug0 ( drug0 )  drug0 ( drug0 )  or drug0 ( drug2 ) in the last 14 days .,maoi,nardil,FALSE,none
you can not take drug0 if you have taken a drug0 ( drug0 ) such as drug1 ( drug0 )  drug2 ( drug0 )  or drug0 ( drug0 ) in the last 14 days .,isocarboxazid,tranylcypromine,FALSE,none
you can not take drug0 if you have taken a drug0 ( drug0 ) such as drug1 ( drug0 )  drug0 ( drug2 )  or drug0 ( drug0 ) in the last 14 days .,isocarboxazid,parnate,FALSE,none
you can not take drug0 if you have taken a drug0 ( drug0 ) such as drug1 ( drug0 )  drug0 ( drug0 )  or drug2 ( drug0 ) in the last 14 days .,isocarboxazid,phenelzine,FALSE,none
you can not take drug0 if you have taken a drug0 ( drug0 ) such as drug1 ( drug0 )  drug0 ( drug0 )  or drug0 ( drug2 ) in the last 14 days .,isocarboxazid,nardil,FALSE,none
you can not take drug0 if you have taken a drug0 ( drug0 ) such as drug0 ( drug1 )  drug2 ( drug0 )  or drug0 ( drug0 ) in the last 14 days .,marplan,tranylcypromine,FALSE,none
you can not take drug0 if you have taken a drug0 ( drug0 ) such as drug0 ( drug1 )  drug0 ( drug2 )  or drug0 ( drug0 ) in the last 14 days .,marplan,parnate,FALSE,none
you can not take drug0 if you have taken a drug0 ( drug0 ) such as drug0 ( drug1 )  drug0 ( drug0 )  or drug2 ( drug0 ) in the last 14 days .,marplan,phenelzine,FALSE,none
you can not take drug0 if you have taken a drug0 ( drug0 ) such as drug0 ( drug1 )  drug0 ( drug0 )  or drug0 ( drug2 ) in the last 14 days .,marplan,nardil,FALSE,none
you can not take drug0 if you have taken a drug0 ( drug0 ) such as drug0 ( drug0 )  drug1 ( drug0 )  or drug2 ( drug0 ) in the last 14 days .,tranylcypromine,phenelzine,FALSE,none
you can not take drug0 if you have taken a drug0 ( drug0 ) such as drug0 ( drug0 )  drug1 ( drug0 )  or drug0 ( drug2 ) in the last 14 days .,tranylcypromine,nardil,FALSE,none
you can not take drug0 if you have taken a drug0 ( drug0 ) such as drug0 ( drug0 )  drug0 ( drug1 )  or drug2 ( drug0 ) in the last 14 days .,parnate,phenelzine,FALSE,none
you can not take drug0 if you have taken a drug0 ( drug0 ) such as drug0 ( drug0 )  drug0 ( drug1 )  or drug0 ( drug2 ) in the last 14 days .,parnate,nardil,FALSE,none
changes in drug1 and other diabetes drug therapies may be necessary during treatment with drug2 .,insulin,mazindol,TRUE,advise
drug1 may reduce the effects of drug2 ( drug0 ) .,mazindol,guanethidine,TRUE,effect
drug1 may reduce the effects of drug0 ( drug2 ) .,mazindol,ismelin,TRUE,effect
before taking this medication  tell your doctor if you are taking a drug1 such as drug0 ( drug2 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  or drug0 ( drug0 ) .,tricyclic antidepressant,elavil,FALSE,none
before taking this medication  tell your doctor if you are taking a drug1 such as drug0 ( drug0 )  drug2 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  or drug0 ( drug0 ) .,tricyclic antidepressant,amoxapine,FALSE,none
before taking this medication  tell your doctor if you are taking a drug1 such as drug0 ( drug0 )  drug0 ( drug2 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  or drug0 ( drug0 ) .,tricyclic antidepressant,asendin,FALSE,none
before taking this medication  tell your doctor if you are taking a drug1 such as drug0 ( drug0 )  drug0 ( drug0 )  drug2 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  or drug0 ( drug0 ) .,tricyclic antidepressant,doxepin,FALSE,none
before taking this medication  tell your doctor if you are taking a drug1 such as drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug2 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  or drug0 ( drug0 ) .,tricyclic antidepressant,sinequan,FALSE,none
before taking this medication  tell your doctor if you are taking a drug1 such as drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug2 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  or drug0 ( drug0 ) .,tricyclic antidepressant,nortriptyline,FALSE,none
before taking this medication  tell your doctor if you are taking a drug1 such as drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug2 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  or drug0 ( drug0 ) .,tricyclic antidepressant,pamelor,FALSE,none
before taking this medication  tell your doctor if you are taking a drug1 such as drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug2 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  or drug0 ( drug0 ) .,tricyclic antidepressant,imipramine,FALSE,none
before taking this medication  tell your doctor if you are taking a drug1 such as drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug2 )  drug0 ( drug0 )  drug0 ( drug0 )  or drug0 ( drug0 ) .,tricyclic antidepressant,tofranil,FALSE,none
before taking this medication  tell your doctor if you are taking a drug1 such as drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug2 ( drug0 )  drug0 ( drug0 )  or drug0 ( drug0 ) .,tricyclic antidepressant,clomipramine,FALSE,none
before taking this medication  tell your doctor if you are taking a drug1 such as drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug2 )  drug0 ( drug0 )  or drug0 ( drug0 ) .,tricyclic antidepressant,anafranil,FALSE,none
before taking this medication  tell your doctor if you are taking a drug1 such as drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug2 ( drug0 )  or drug0 ( drug0 ) .,tricyclic antidepressant,protriptyline,FALSE,none
before taking this medication  tell your doctor if you are taking a drug1 such as drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug2 )  or drug0 ( drug0 ) .,tricyclic antidepressant,vivactil,FALSE,none
before taking this medication  tell your doctor if you are taking a drug1 such as drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  or drug2 ( drug0 ) .,tricyclic antidepressant,desipramine,FALSE,none
before taking this medication  tell your doctor if you are taking a drug1 such as drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  or drug0 ( drug2 ) .,tricyclic antidepressant,norpramin,FALSE,none
before taking this medication  tell your doctor if you are taking a drug0 drug0 such as drug1 ( drug0 )  drug2 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  or drug0 ( drug0 ) .,amitriptyline,amoxapine,FALSE,none
before taking this medication  tell your doctor if you are taking a drug0 drug0 such as drug1 ( drug0 )  drug0 ( drug2 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  or drug0 ( drug0 ) .,amitriptyline,asendin,FALSE,none
before taking this medication  tell your doctor if you are taking a drug0 drug0 such as drug1 ( drug0 )  drug0 ( drug0 )  drug2 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  or drug0 ( drug0 ) .,amitriptyline,doxepin,FALSE,none
before taking this medication  tell your doctor if you are taking a drug0 drug0 such as drug1 ( drug0 )  drug0 ( drug0 )  drug0 ( drug2 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  or drug0 ( drug0 ) .,amitriptyline,sinequan,FALSE,none
before taking this medication  tell your doctor if you are taking a drug0 drug0 such as drug1 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug2 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  or drug0 ( drug0 ) .,amitriptyline,nortriptyline,FALSE,none
before taking this medication  tell your doctor if you are taking a drug0 drug0 such as drug1 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug2 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  or drug0 ( drug0 ) .,amitriptyline,pamelor,FALSE,none
before taking this medication  tell your doctor if you are taking a drug0 drug0 such as drug1 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug2 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  or drug0 ( drug0 ) .,amitriptyline,imipramine,FALSE,none
before taking this medication  tell your doctor if you are taking a drug0 drug0 such as drug1 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug2 )  drug0 ( drug0 )  drug0 ( drug0 )  or drug0 ( drug0 ) .,amitriptyline,tofranil,FALSE,none
before taking this medication  tell your doctor if you are taking a drug0 drug0 such as drug1 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug2 ( drug0 )  drug0 ( drug0 )  or drug0 ( drug0 ) .,amitriptyline,clomipramine,FALSE,none
before taking this medication  tell your doctor if you are taking a drug0 drug0 such as drug1 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug2 )  drug0 ( drug0 )  or drug0 ( drug0 ) .,amitriptyline,anafranil,FALSE,none
before taking this medication  tell your doctor if you are taking a drug0 drug0 such as drug1 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug2 ( drug0 )  or drug0 ( drug0 ) .,amitriptyline,protriptyline,FALSE,none
before taking this medication  tell your doctor if you are taking a drug0 drug0 such as drug1 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug2 )  or drug0 ( drug0 ) .,amitriptyline,vivactil,FALSE,none
before taking this medication  tell your doctor if you are taking a drug0 drug0 such as drug1 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  or drug2 ( drug0 ) .,amitriptyline,desipramine,FALSE,none
before taking this medication  tell your doctor if you are taking a drug0 drug0 such as drug1 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  or drug0 ( drug2 ) .,amitriptyline,norpramin,FALSE,none
before taking this medication  tell your doctor if you are taking a drug0 drug0 such as drug0 ( drug1 )  drug2 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  or drug0 ( drug0 ) .,elavil,amoxapine,FALSE,none
before taking this medication  tell your doctor if you are taking a drug0 drug0 such as drug0 ( drug1 )  drug0 ( drug2 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  or drug0 ( drug0 ) .,elavil,asendin,FALSE,none
before taking this medication  tell your doctor if you are taking a drug0 drug0 such as drug0 ( drug1 )  drug0 ( drug0 )  drug2 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  or drug0 ( drug0 ) .,elavil,doxepin,FALSE,none
before taking this medication  tell your doctor if you are taking a drug0 drug0 such as drug0 ( drug1 )  drug0 ( drug0 )  drug0 ( drug2 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  or drug0 ( drug0 ) .,elavil,sinequan,FALSE,none
before taking this medication  tell your doctor if you are taking a drug0 drug0 such as drug0 ( drug1 )  drug0 ( drug0 )  drug0 ( drug0 )  drug2 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  or drug0 ( drug0 ) .,elavil,nortriptyline,FALSE,none
before taking this medication  tell your doctor if you are taking a drug0 drug0 such as drug0 ( drug1 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug2 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  or drug0 ( drug0 ) .,elavil,pamelor,FALSE,none
before taking this medication  tell your doctor if you are taking a drug0 drug0 such as drug0 ( drug1 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug2 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  or drug0 ( drug0 ) .,elavil,imipramine,FALSE,none
before taking this medication  tell your doctor if you are taking a drug0 drug0 such as drug0 ( drug1 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug2 )  drug0 ( drug0 )  drug0 ( drug0 )  or drug0 ( drug0 ) .,elavil,tofranil,FALSE,none
before taking this medication  tell your doctor if you are taking a drug0 drug0 such as drug0 ( drug1 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug2 ( drug0 )  drug0 ( drug0 )  or drug0 ( drug0 ) .,elavil,clomipramine,FALSE,none
before taking this medication  tell your doctor if you are taking a drug0 drug0 such as drug0 ( drug1 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug2 )  drug0 ( drug0 )  or drug0 ( drug0 ) .,elavil,anafranil,FALSE,none
before taking this medication  tell your doctor if you are taking a drug0 drug0 such as drug0 ( drug1 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug2 ( drug0 )  or drug0 ( drug0 ) .,elavil,protriptyline,FALSE,none
before taking this medication  tell your doctor if you are taking a drug0 drug0 such as drug0 ( drug1 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug2 )  or drug0 ( drug0 ) .,elavil,vivactil,FALSE,none
before taking this medication  tell your doctor if you are taking a drug0 drug0 such as drug0 ( drug1 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  or drug2 ( drug0 ) .,elavil,desipramine,FALSE,none
before taking this medication  tell your doctor if you are taking a drug0 drug0 such as drug0 ( drug1 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  or drug0 ( drug2 ) .,elavil,norpramin,FALSE,none
before taking this medication  tell your doctor if you are taking a drug0 drug0 such as drug0 ( drug0 )  drug1 ( drug0 )  drug2 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  or drug0 ( drug0 ) .,amoxapine,doxepin,FALSE,none
before taking this medication  tell your doctor if you are taking a drug0 drug0 such as drug0 ( drug0 )  drug1 ( drug0 )  drug0 ( drug2 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  or drug0 ( drug0 ) .,amoxapine,sinequan,FALSE,none
before taking this medication  tell your doctor if you are taking a drug0 drug0 such as drug0 ( drug0 )  drug1 ( drug0 )  drug0 ( drug0 )  drug2 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  or drug0 ( drug0 ) .,amoxapine,nortriptyline,FALSE,none
before taking this medication  tell your doctor if you are taking a drug0 drug0 such as drug0 ( drug0 )  drug1 ( drug0 )  drug0 ( drug0 )  drug0 ( drug2 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  or drug0 ( drug0 ) .,amoxapine,pamelor,FALSE,none
before taking this medication  tell your doctor if you are taking a drug0 drug0 such as drug0 ( drug0 )  drug1 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug2 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  or drug0 ( drug0 ) .,amoxapine,imipramine,FALSE,none
before taking this medication  tell your doctor if you are taking a drug0 drug0 such as drug0 ( drug0 )  drug1 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug2 )  drug0 ( drug0 )  drug0 ( drug0 )  or drug0 ( drug0 ) .,amoxapine,tofranil,FALSE,none
before taking this medication  tell your doctor if you are taking a drug0 drug0 such as drug0 ( drug0 )  drug1 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug2 ( drug0 )  drug0 ( drug0 )  or drug0 ( drug0 ) .,amoxapine,clomipramine,FALSE,none
before taking this medication  tell your doctor if you are taking a drug0 drug0 such as drug0 ( drug0 )  drug1 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug2 )  drug0 ( drug0 )  or drug0 ( drug0 ) .,amoxapine,anafranil,FALSE,none
before taking this medication  tell your doctor if you are taking a drug0 drug0 such as drug0 ( drug0 )  drug1 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug2 ( drug0 )  or drug0 ( drug0 ) .,amoxapine,protriptyline,FALSE,none
before taking this medication  tell your doctor if you are taking a drug0 drug0 such as drug0 ( drug0 )  drug1 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug2 )  or drug0 ( drug0 ) .,amoxapine,vivactil,FALSE,none
before taking this medication  tell your doctor if you are taking a drug0 drug0 such as drug0 ( drug0 )  drug1 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  or drug2 ( drug0 ) .,amoxapine,desipramine,FALSE,none
before taking this medication  tell your doctor if you are taking a drug0 drug0 such as drug0 ( drug0 )  drug1 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  or drug0 ( drug2 ) .,amoxapine,norpramin,FALSE,none
before taking this medication  tell your doctor if you are taking a drug0 drug0 such as drug0 ( drug0 )  drug0 ( drug1 )  drug2 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  or drug0 ( drug0 ) .,asendin,doxepin,FALSE,none
before taking this medication  tell your doctor if you are taking a drug0 drug0 such as drug0 ( drug0 )  drug0 ( drug1 )  drug0 ( drug2 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  or drug0 ( drug0 ) .,asendin,sinequan,FALSE,none
before taking this medication  tell your doctor if you are taking a drug0 drug0 such as drug0 ( drug0 )  drug0 ( drug1 )  drug0 ( drug0 )  drug2 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  or drug0 ( drug0 ) .,asendin,nortriptyline,FALSE,none
before taking this medication  tell your doctor if you are taking a drug0 drug0 such as drug0 ( drug0 )  drug0 ( drug1 )  drug0 ( drug0 )  drug0 ( drug2 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  or drug0 ( drug0 ) .,asendin,pamelor,FALSE,none
before taking this medication  tell your doctor if you are taking a drug0 drug0 such as drug0 ( drug0 )  drug0 ( drug1 )  drug0 ( drug0 )  drug0 ( drug0 )  drug2 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  or drug0 ( drug0 ) .,asendin,imipramine,FALSE,none
before taking this medication  tell your doctor if you are taking a drug0 drug0 such as drug0 ( drug0 )  drug0 ( drug1 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug2 )  drug0 ( drug0 )  drug0 ( drug0 )  or drug0 ( drug0 ) .,asendin,tofranil,FALSE,none
before taking this medication  tell your doctor if you are taking a drug0 drug0 such as drug0 ( drug0 )  drug0 ( drug1 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug2 ( drug0 )  drug0 ( drug0 )  or drug0 ( drug0 ) .,asendin,clomipramine,FALSE,none
before taking this medication  tell your doctor if you are taking a drug0 drug0 such as drug0 ( drug0 )  drug0 ( drug1 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug2 )  drug0 ( drug0 )  or drug0 ( drug0 ) .,asendin,anafranil,FALSE,none
before taking this medication  tell your doctor if you are taking a drug0 drug0 such as drug0 ( drug0 )  drug0 ( drug1 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug2 ( drug0 )  or drug0 ( drug0 ) .,asendin,protriptyline,FALSE,none
before taking this medication  tell your doctor if you are taking a drug0 drug0 such as drug0 ( drug0 )  drug0 ( drug1 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug2 )  or drug0 ( drug0 ) .,asendin,vivactil,FALSE,none
before taking this medication  tell your doctor if you are taking a drug0 drug0 such as drug0 ( drug0 )  drug0 ( drug1 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  or drug2 ( drug0 ) .,asendin,desipramine,FALSE,none
before taking this medication  tell your doctor if you are taking a drug0 drug0 such as drug0 ( drug0 )  drug0 ( drug1 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  or drug0 ( drug2 ) .,asendin,norpramin,FALSE,none
before taking this medication  tell your doctor if you are taking a drug0 drug0 such as drug0 ( drug0 )  drug0 ( drug0 )  drug1 ( drug0 )  drug2 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  or drug0 ( drug0 ) .,doxepin,nortriptyline,FALSE,none
before taking this medication  tell your doctor if you are taking a drug0 drug0 such as drug0 ( drug0 )  drug0 ( drug0 )  drug1 ( drug0 )  drug0 ( drug2 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  or drug0 ( drug0 ) .,doxepin,pamelor,FALSE,none
before taking this medication  tell your doctor if you are taking a drug0 drug0 such as drug0 ( drug0 )  drug0 ( drug0 )  drug1 ( drug0 )  drug0 ( drug0 )  drug2 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  or drug0 ( drug0 ) .,doxepin,imipramine,FALSE,none
before taking this medication  tell your doctor if you are taking a drug0 drug0 such as drug0 ( drug0 )  drug0 ( drug0 )  drug1 ( drug0 )  drug0 ( drug0 )  drug0 ( drug2 )  drug0 ( drug0 )  drug0 ( drug0 )  or drug0 ( drug0 ) .,doxepin,tofranil,FALSE,none
before taking this medication  tell your doctor if you are taking a drug0 drug0 such as drug0 ( drug0 )  drug0 ( drug0 )  drug1 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug2 ( drug0 )  drug0 ( drug0 )  or drug0 ( drug0 ) .,doxepin,clomipramine,FALSE,none
before taking this medication  tell your doctor if you are taking a drug0 drug0 such as drug0 ( drug0 )  drug0 ( drug0 )  drug1 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug2 )  drug0 ( drug0 )  or drug0 ( drug0 ) .,doxepin,anafranil,FALSE,none
before taking this medication  tell your doctor if you are taking a drug0 drug0 such as drug0 ( drug0 )  drug0 ( drug0 )  drug1 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug2 ( drug0 )  or drug0 ( drug0 ) .,doxepin,protriptyline,FALSE,none
before taking this medication  tell your doctor if you are taking a drug0 drug0 such as drug0 ( drug0 )  drug0 ( drug0 )  drug1 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug2 )  or drug0 ( drug0 ) .,doxepin,vivactil,FALSE,none
before taking this medication  tell your doctor if you are taking a drug0 drug0 such as drug0 ( drug0 )  drug0 ( drug0 )  drug1 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  or drug2 ( drug0 ) .,doxepin,desipramine,FALSE,none
before taking this medication  tell your doctor if you are taking a drug0 drug0 such as drug0 ( drug0 )  drug0 ( drug0 )  drug1 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  or drug0 ( drug2 ) .,doxepin,norpramin,FALSE,none
before taking this medication  tell your doctor if you are taking a drug0 drug0 such as drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug1 )  drug2 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  or drug0 ( drug0 ) .,sinequan,nortriptyline,FALSE,none
before taking this medication  tell your doctor if you are taking a drug0 drug0 such as drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug1 )  drug0 ( drug2 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  or drug0 ( drug0 ) .,sinequan,pamelor,FALSE,none
before taking this medication  tell your doctor if you are taking a drug0 drug0 such as drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug1 )  drug0 ( drug0 )  drug2 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  or drug0 ( drug0 ) .,sinequan,imipramine,FALSE,none
before taking this medication  tell your doctor if you are taking a drug0 drug0 such as drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug1 )  drug0 ( drug0 )  drug0 ( drug2 )  drug0 ( drug0 )  drug0 ( drug0 )  or drug0 ( drug0 ) .,sinequan,tofranil,FALSE,none
before taking this medication  tell your doctor if you are taking a drug0 drug0 such as drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug1 )  drug0 ( drug0 )  drug0 ( drug0 )  drug2 ( drug0 )  drug0 ( drug0 )  or drug0 ( drug0 ) .,sinequan,clomipramine,FALSE,none
before taking this medication  tell your doctor if you are taking a drug0 drug0 such as drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug1 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug2 )  drug0 ( drug0 )  or drug0 ( drug0 ) .,sinequan,anafranil,FALSE,none
before taking this medication  tell your doctor if you are taking a drug0 drug0 such as drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug1 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug2 ( drug0 )  or drug0 ( drug0 ) .,sinequan,protriptyline,FALSE,none
before taking this medication  tell your doctor if you are taking a drug0 drug0 such as drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug1 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug2 )  or drug0 ( drug0 ) .,sinequan,vivactil,FALSE,none
before taking this medication  tell your doctor if you are taking a drug0 drug0 such as drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug1 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  or drug2 ( drug0 ) .,sinequan,desipramine,FALSE,none
before taking this medication  tell your doctor if you are taking a drug0 drug0 such as drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug1 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  or drug0 ( drug2 ) .,sinequan,norpramin,FALSE,none
before taking this medication  tell your doctor if you are taking a drug0 drug0 such as drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug1 ( drug0 )  drug2 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  or drug0 ( drug0 ) .,nortriptyline,imipramine,FALSE,none
before taking this medication  tell your doctor if you are taking a drug0 drug0 such as drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug1 ( drug0 )  drug0 ( drug2 )  drug0 ( drug0 )  drug0 ( drug0 )  or drug0 ( drug0 ) .,nortriptyline,tofranil,FALSE,none
before taking this medication  tell your doctor if you are taking a drug0 drug0 such as drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug1 ( drug0 )  drug0 ( drug0 )  drug2 ( drug0 )  drug0 ( drug0 )  or drug0 ( drug0 ) .,nortriptyline,clomipramine,FALSE,none
before taking this medication  tell your doctor if you are taking a drug0 drug0 such as drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug1 ( drug0 )  drug0 ( drug0 )  drug0 ( drug2 )  drug0 ( drug0 )  or drug0 ( drug0 ) .,nortriptyline,anafranil,FALSE,none
before taking this medication  tell your doctor if you are taking a drug0 drug0 such as drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug1 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug2 ( drug0 )  or drug0 ( drug0 ) .,nortriptyline,protriptyline,FALSE,none
before taking this medication  tell your doctor if you are taking a drug0 drug0 such as drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug1 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug2 )  or drug0 ( drug0 ) .,nortriptyline,vivactil,FALSE,none
before taking this medication  tell your doctor if you are taking a drug0 drug0 such as drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug1 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  or drug2 ( drug0 ) .,nortriptyline,desipramine,FALSE,none
before taking this medication  tell your doctor if you are taking a drug0 drug0 such as drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug1 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  or drug0 ( drug2 ) .,nortriptyline,norpramin,FALSE,none
before taking this medication  tell your doctor if you are taking a drug0 drug0 such as drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug1 )  drug2 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  or drug0 ( drug0 ) .,pamelor,imipramine,FALSE,none
before taking this medication  tell your doctor if you are taking a drug0 drug0 such as drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug1 )  drug0 ( drug2 )  drug0 ( drug0 )  drug0 ( drug0 )  or drug0 ( drug0 ) .,pamelor,tofranil,FALSE,none
before taking this medication  tell your doctor if you are taking a drug0 drug0 such as drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug1 )  drug0 ( drug0 )  drug2 ( drug0 )  drug0 ( drug0 )  or drug0 ( drug0 ) .,pamelor,clomipramine,FALSE,none
before taking this medication  tell your doctor if you are taking a drug0 drug0 such as drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug1 )  drug0 ( drug0 )  drug0 ( drug2 )  drug0 ( drug0 )  or drug0 ( drug0 ) .,pamelor,anafranil,FALSE,none
before taking this medication  tell your doctor if you are taking a drug0 drug0 such as drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug1 )  drug0 ( drug0 )  drug0 ( drug0 )  drug2 ( drug0 )  or drug0 ( drug0 ) .,pamelor,protriptyline,FALSE,none
before taking this medication  tell your doctor if you are taking a drug0 drug0 such as drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug1 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug2 )  or drug0 ( drug0 ) .,pamelor,vivactil,FALSE,none
before taking this medication  tell your doctor if you are taking a drug0 drug0 such as drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug1 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  or drug2 ( drug0 ) .,pamelor,desipramine,FALSE,none
before taking this medication  tell your doctor if you are taking a drug0 drug0 such as drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug1 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  or drug0 ( drug2 ) .,pamelor,norpramin,FALSE,none
before taking this medication  tell your doctor if you are taking a drug0 drug0 such as drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug1 ( drug0 )  drug2 ( drug0 )  drug0 ( drug0 )  or drug0 ( drug0 ) .,imipramine,clomipramine,FALSE,none
before taking this medication  tell your doctor if you are taking a drug0 drug0 such as drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug1 ( drug0 )  drug0 ( drug2 )  drug0 ( drug0 )  or drug0 ( drug0 ) .,imipramine,anafranil,FALSE,none
before taking this medication  tell your doctor if you are taking a drug0 drug0 such as drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug1 ( drug0 )  drug0 ( drug0 )  drug2 ( drug0 )  or drug0 ( drug0 ) .,imipramine,protriptyline,FALSE,none
before taking this medication  tell your doctor if you are taking a drug0 drug0 such as drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug1 ( drug0 )  drug0 ( drug0 )  drug0 ( drug2 )  or drug0 ( drug0 ) .,imipramine,vivactil,FALSE,none
before taking this medication  tell your doctor if you are taking a drug0 drug0 such as drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug1 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  or drug2 ( drug0 ) .,imipramine,desipramine,FALSE,none
before taking this medication  tell your doctor if you are taking a drug0 drug0 such as drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug1 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  or drug0 ( drug2 ) .,imipramine,norpramin,FALSE,none
before taking this medication  tell your doctor if you are taking a drug0 drug0 such as drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug1 )  drug2 ( drug0 )  drug0 ( drug0 )  or drug0 ( drug0 ) .,tofranil,clomipramine,FALSE,none
before taking this medication  tell your doctor if you are taking a drug0 drug0 such as drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug1 )  drug0 ( drug2 )  drug0 ( drug0 )  or drug0 ( drug0 ) .,tofranil,anafranil,FALSE,none
before taking this medication  tell your doctor if you are taking a drug0 drug0 such as drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug1 )  drug0 ( drug0 )  drug2 ( drug0 )  or drug0 ( drug0 ) .,tofranil,protriptyline,FALSE,none
before taking this medication  tell your doctor if you are taking a drug0 drug0 such as drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug1 )  drug0 ( drug0 )  drug0 ( drug2 )  or drug0 ( drug0 ) .,tofranil,vivactil,FALSE,none
before taking this medication  tell your doctor if you are taking a drug0 drug0 such as drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug1 )  drug0 ( drug0 )  drug0 ( drug0 )  or drug2 ( drug0 ) .,tofranil,desipramine,FALSE,none
before taking this medication  tell your doctor if you are taking a drug0 drug0 such as drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug1 )  drug0 ( drug0 )  drug0 ( drug0 )  or drug0 ( drug2 ) .,tofranil,norpramin,FALSE,none
before taking this medication  tell your doctor if you are taking a drug0 drug0 such as drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug1 ( drug0 )  drug2 ( drug0 )  or drug0 ( drug0 ) .,clomipramine,protriptyline,FALSE,none
before taking this medication  tell your doctor if you are taking a drug0 drug0 such as drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug1 ( drug0 )  drug0 ( drug2 )  or drug0 ( drug0 ) .,clomipramine,vivactil,FALSE,none
before taking this medication  tell your doctor if you are taking a drug0 drug0 such as drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug1 ( drug0 )  drug0 ( drug0 )  or drug2 ( drug0 ) .,clomipramine,desipramine,FALSE,none
before taking this medication  tell your doctor if you are taking a drug0 drug0 such as drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug1 ( drug0 )  drug0 ( drug0 )  or drug0 ( drug2 ) .,clomipramine,norpramin,FALSE,none
before taking this medication  tell your doctor if you are taking a drug0 drug0 such as drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug1 )  drug2 ( drug0 )  or drug0 ( drug0 ) .,anafranil,protriptyline,FALSE,none
before taking this medication  tell your doctor if you are taking a drug0 drug0 such as drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug1 )  drug0 ( drug2 )  or drug0 ( drug0 ) .,anafranil,vivactil,FALSE,none
before taking this medication  tell your doctor if you are taking a drug0 drug0 such as drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug1 )  drug0 ( drug0 )  or drug2 ( drug0 ) .,anafranil,desipramine,FALSE,none
before taking this medication  tell your doctor if you are taking a drug0 drug0 such as drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug1 )  drug0 ( drug0 )  or drug0 ( drug2 ) .,anafranil,norpramin,FALSE,none
before taking this medication  tell your doctor if you are taking a drug0 drug0 such as drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug1 ( drug0 )  or drug2 ( drug0 ) .,protriptyline,desipramine,FALSE,none
before taking this medication  tell your doctor if you are taking a drug0 drug0 such as drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug1 ( drug0 )  or drug0 ( drug2 ) .,protriptyline,norpramin,FALSE,none
before taking this medication  tell your doctor if you are taking a drug0 drug0 such as drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug1 )  or drug2 ( drug0 ) .,vivactil,desipramine,FALSE,none
before taking this medication  tell your doctor if you are taking a drug0 drug0 such as drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug0 )  drug0 ( drug1 )  or drug0 ( drug2 ) .,vivactil,norpramin,FALSE,none
preliminary evidence suggests that drug1 inhibits drug2 metabolism and may result in an increase in plasma concentrations of drug0 .,cimetidine,mebendazole,TRUE,mechanism
preliminary evidence suggests that drug1 inhibits drug2 metabolism and may result in an increase in plasma concentrations of drug0 .,cimetidine,mebendazole,FALSE,none
patients receiving drug1 and drug2 generally should not be treated with drug0 .,antibiotics,sulfonamides,FALSE,none
patients receiving drug1 and drug0 generally should not be treated with drug2 .,antibiotics,ganglion blockers,TRUE,advise
patients receiving drug0 and drug1 generally should not be treated with drug2 .,sulfonamides,ganglion blockers,TRUE,advise
the action of drug1 may be potentiated by anesthesia  other drug2 and drug0 .,mecamylamine,antihypertensive drugs,TRUE,effect
the action of drug1 may be potentiated by anesthesia  other drug0 drugs and drug2 .,mecamylamine,alcohol,TRUE,effect
the action of drug0 may be potentiated by anesthesia  other drug1 and drug2 .,antihypertensive drugs,alcohol,FALSE,none
drug1 administered concomitantly with drug2 may significantly decrease the serum concentrations of drug0 .,aminoglutethimide,depo-subq provera 104,TRUE,mechanism
drug1 administered concomitantly with drug0 may significantly decrease the serum concentrations of drug2 .,aminoglutethimide,mpa,FALSE,none
drug0 administered concomitantly with drug1 may significantly decrease the serum concentrations of drug2 .,depo-subq provera 104,mpa,FALSE,none
a pharmacokinetic study demonstrated that coadministration of drug1 and drug2 results in a significant decrease in the pharmacokinetic parameters ( ~36 % for cmax and ~28 % for auc ) of drug0 .,megestrol acetate,indinavir,TRUE,mechanism
a pharmacokinetic study demonstrated that coadministration of drug1 and drug2 results in a significant decrease in the pharmacokinetic parameters ( ~36 % for cmax and ~28 % for auc ) of drug0 .,megestrol acetate,indinavir,FALSE,none
administration of a higher dose of drug1 should be considered when coadministering with drug2 .,indinavir,megestrol acetate,TRUE,advise
the effects of drug1  drug0 or drug2 on the pharmacokinetics of drug0 were not studied .,indinavir,rifabutin,FALSE,none
the effects of drug1  drug0 or drug0 on the pharmacokinetics of drug2 were not studied .,indinavir,megestrol acetate,FALSE,none
the effects of drug0  drug1 or drug2 on the pharmacokinetics of drug0 were not studied .,zidovudine,rifabutin,FALSE,none
the effects of drug0  drug1 or drug0 on the pharmacokinetics of drug2 were not studied .,zidovudine,megestrol acetate,FALSE,none
the effects of drug0  drug0 or drug1 on the pharmacokinetics of drug2 were not studied .,rifabutin,megestrol acetate,FALSE,none
drug1 may interact with the following drugs : drug2 and other drug0 ( may lower drug0 levels )  drug0 ( bioavailability of oral drug0 is increased with coadministration )  drug0 ( may decrease drug0 levels )  drug0 ( reports of psychotic episodes when coadministered )  drug0 ( coadministration of drug0 with drug0 can inhibit ovarian function in women )  drug0 and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects )  and drug0 ( coadministration of drug0 and drug0 may interfere with the efficacy of the drug0 ) .,melatonin,aspirin,TRUE,int
drug1 may interact with the following drugs : drug0 and other drug2 ( may lower drug0 levels )  drug0 ( bioavailability of oral drug0 is increased with coadministration )  drug0 ( may decrease drug0 levels )  drug0 ( reports of psychotic episodes when coadministered )  drug0 ( coadministration of drug0 with drug0 can inhibit ovarian function in women )  drug0 and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects )  and drug0 ( coadministration of drug0 and drug0 may interfere with the efficacy of the drug0 ) .,melatonin,nsaids,TRUE,int
drug1 may interact with the following drugs : drug0 and other drug0 ( may lower drug0 levels )  drug2 ( bioavailability of oral drug0 is increased with coadministration )  drug0 ( may decrease drug0 levels )  drug0 ( reports of psychotic episodes when coadministered )  drug0 ( coadministration of drug0 with drug0 can inhibit ovarian function in women )  drug0 and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects )  and drug0 ( coadministration of drug0 and drug0 may interfere with the efficacy of the drug0 ) .,melatonin,fluvoxamine,TRUE,int
drug1 may interact with the following drugs : drug0 and other drug0 ( may lower drug0 levels )  drug0 ( bioavailability of oral drug0 is increased with coadministration )  drug2 ( may decrease drug0 levels )  drug0 ( reports of psychotic episodes when coadministered )  drug0 ( coadministration of drug0 with drug0 can inhibit ovarian function in women )  drug0 and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects )  and drug0 ( coadministration of drug0 and drug0 may interfere with the efficacy of the drug0 ) .,melatonin,beta blockers,TRUE,int
drug1 may interact with the following drugs : drug0 and other drug0 ( may lower drug0 levels )  drug0 ( bioavailability of oral drug0 is increased with coadministration )  drug0 ( may decrease drug0 levels )  drug2 ( reports of psychotic episodes when coadministered )  drug0 ( coadministration of drug0 with drug0 can inhibit ovarian function in women )  drug0 and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects )  and drug0 ( coadministration of drug0 and drug0 may interfere with the efficacy of the drug0 ) .,melatonin,fluoxetine,TRUE,int
drug1 may interact with the following drugs : drug0 and other drug0 ( may lower drug0 levels )  drug0 ( bioavailability of oral drug0 is increased with coadministration )  drug0 ( may decrease drug0 levels )  drug0 ( reports of psychotic episodes when coadministered )  drug2 ( coadministration of drug0 with drug0 can inhibit ovarian function in women )  drug0 and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects )  and drug0 ( coadministration of drug0 and drug0 may interfere with the efficacy of the drug0 ) .,melatonin,progestin,TRUE,int
drug1 may interact with the following drugs : drug0 and other drug0 ( may lower drug0 levels )  drug0 ( bioavailability of oral drug0 is increased with coadministration )  drug0 ( may decrease drug0 levels )  drug0 ( reports of psychotic episodes when coadministered )  drug2 ( coadministration of drug0 with drug0 can inhibit ovarian function in women )  drug0 and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects )  and drug0 ( coadministration of drug0 and drug0 may interfere with the efficacy of the drug0 ) .,melatonin,progestin,FALSE,none
drug1 may interact with the following drugs : drug0 and other drug0 ( may lower drug0 levels )  drug0 ( bioavailability of oral drug0 is increased with coadministration )  drug0 ( may decrease drug0 levels )  drug0 ( reports of psychotic episodes when coadministered )  drug0 ( coadministration of drug0 with drug0 can inhibit ovarian function in women )  drug2 and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects )  and drug0 ( coadministration of drug0 and drug0 may interfere with the efficacy of the drug0 ) .,melatonin,benzodiazepenes,TRUE,int
drug1 may interact with the following drugs : drug0 and other drug0 ( may lower drug0 levels )  drug0 ( bioavailability of oral drug0 is increased with coadministration )  drug0 ( may decrease drug0 levels )  drug0 ( reports of psychotic episodes when coadministered )  drug0 ( coadministration of drug0 with drug0 can inhibit ovarian function in women )  drug0 and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects )  and drug2 ( coadministration of drug0 and drug0 may interfere with the efficacy of the drug0 ) .,melatonin,corticosteroids,TRUE,int
drug1 may interact with the following drugs : drug0 and other drug0 ( may lower drug0 levels )  drug0 ( bioavailability of oral drug0 is increased with coadministration )  drug0 ( may decrease drug0 levels )  drug0 ( reports of psychotic episodes when coadministered )  drug0 ( coadministration of drug0 with drug0 can inhibit ovarian function in women )  drug0 and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects )  and drug2 ( coadministration of drug0 and drug0 may interfere with the efficacy of the drug0 ) .,melatonin,corticosteroids,FALSE,none
drug1 may interact with the following drugs : drug0 and other drug0 ( may lower drug0 levels )  drug0 ( bioavailability of oral drug0 is increased with coadministration )  drug0 ( may decrease drug0 levels )  drug0 ( reports of psychotic episodes when coadministered )  drug0 ( coadministration of drug0 with drug0 can inhibit ovarian function in women )  drug0 and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects )  and drug2 ( coadministration of drug0 and drug0 may interfere with the efficacy of the drug0 ) .,melatonin,corticosteroids,FALSE,none
drug0 may interact with the following drugs : drug1 and other drug2 ( may lower drug0 levels )  drug0 ( bioavailability of oral drug0 is increased with coadministration )  drug0 ( may decrease drug0 levels )  drug0 ( reports of psychotic episodes when coadministered )  drug0 ( coadministration of drug0 with drug0 can inhibit ovarian function in women )  drug0 and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects )  and drug0 ( coadministration of drug0 and drug0 may interfere with the efficacy of the drug0 ) .,aspirin,nsaids,FALSE,none
drug2 may interact with the following drugs : drug1 and other drug0 ( may lower drug0 levels )  drug0 ( bioavailability of oral drug0 is increased with coadministration )  drug0 ( may decrease drug0 levels )  drug0 ( reports of psychotic episodes when coadministered )  drug0 ( coadministration of drug0 with drug0 can inhibit ovarian function in women )  drug0 and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects )  and drug0 ( coadministration of drug0 and drug0 may interfere with the efficacy of the drug0 ) .,aspirin,melatonin,FALSE,none
drug0 may interact with the following drugs : drug1 and other drug0 ( may lower drug0 levels )  drug2 ( bioavailability of oral drug0 is increased with coadministration )  drug0 ( may decrease drug0 levels )  drug0 ( reports of psychotic episodes when coadministered )  drug0 ( coadministration of drug0 with drug0 can inhibit ovarian function in women )  drug0 and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects )  and drug0 ( coadministration of drug0 and drug0 may interfere with the efficacy of the drug0 ) .,aspirin,fluvoxamine,FALSE,none
drug2 may interact with the following drugs : drug1 and other drug0 ( may lower drug0 levels )  drug0 ( bioavailability of oral drug0 is increased with coadministration )  drug0 ( may decrease drug0 levels )  drug0 ( reports of psychotic episodes when coadministered )  drug0 ( coadministration of drug0 with drug0 can inhibit ovarian function in women )  drug0 and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects )  and drug0 ( coadministration of drug0 and drug0 may interfere with the efficacy of the drug0 ) .,aspirin,melatonin,FALSE,none
drug0 may interact with the following drugs : drug1 and other drug0 ( may lower drug0 levels )  drug0 ( bioavailability of oral drug0 is increased with coadministration )  drug2 ( may decrease drug0 levels )  drug0 ( reports of psychotic episodes when coadministered )  drug0 ( coadministration of drug0 with drug0 can inhibit ovarian function in women )  drug0 and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects )  and drug0 ( coadministration of drug0 and drug0 may interfere with the efficacy of the drug0 ) .,aspirin,beta blockers,FALSE,none
drug2 may interact with the following drugs : drug1 and other drug0 ( may lower drug0 levels )  drug0 ( bioavailability of oral drug0 is increased with coadministration )  drug0 ( may decrease drug0 levels )  drug0 ( reports of psychotic episodes when coadministered )  drug0 ( coadministration of drug0 with drug0 can inhibit ovarian function in women )  drug0 and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects )  and drug0 ( coadministration of drug0 and drug0 may interfere with the efficacy of the drug0 ) .,aspirin,melatonin,FALSE,none
drug0 may interact with the following drugs : drug1 and other drug0 ( may lower drug0 levels )  drug0 ( bioavailability of oral drug0 is increased with coadministration )  drug0 ( may decrease drug0 levels )  drug2 ( reports of psychotic episodes when coadministered )  drug0 ( coadministration of drug0 with drug0 can inhibit ovarian function in women )  drug0 and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects )  and drug0 ( coadministration of drug0 and drug0 may interfere with the efficacy of the drug0 ) .,aspirin,fluoxetine,FALSE,none
drug0 may interact with the following drugs : drug1 and other drug0 ( may lower drug0 levels )  drug0 ( bioavailability of oral drug0 is increased with coadministration )  drug0 ( may decrease drug0 levels )  drug0 ( reports of psychotic episodes when coadministered )  drug2 ( coadministration of drug0 with drug0 can inhibit ovarian function in women )  drug0 and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects )  and drug0 ( coadministration of drug0 and drug0 may interfere with the efficacy of the drug0 ) .,aspirin,progestin,FALSE,none
drug2 may interact with the following drugs : drug1 and other drug0 ( may lower drug0 levels )  drug0 ( bioavailability of oral drug0 is increased with coadministration )  drug0 ( may decrease drug0 levels )  drug0 ( reports of psychotic episodes when coadministered )  drug0 ( coadministration of drug0 with drug0 can inhibit ovarian function in women )  drug0 and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects )  and drug0 ( coadministration of drug0 and drug0 may interfere with the efficacy of the drug0 ) .,aspirin,melatonin,FALSE,none
drug0 may interact with the following drugs : drug1 and other drug0 ( may lower drug0 levels )  drug0 ( bioavailability of oral drug0 is increased with coadministration )  drug0 ( may decrease drug0 levels )  drug0 ( reports of psychotic episodes when coadministered )  drug2 ( coadministration of drug0 with drug0 can inhibit ovarian function in women )  drug0 and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects )  and drug0 ( coadministration of drug0 and drug0 may interfere with the efficacy of the drug0 ) .,aspirin,progestin,FALSE,none
drug0 may interact with the following drugs : drug1 and other drug0 ( may lower drug0 levels )  drug0 ( bioavailability of oral drug0 is increased with coadministration )  drug0 ( may decrease drug0 levels )  drug0 ( reports of psychotic episodes when coadministered )  drug0 ( coadministration of drug0 with drug0 can inhibit ovarian function in women )  drug2 and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects )  and drug0 ( coadministration of drug0 and drug0 may interfere with the efficacy of the drug0 ) .,aspirin,benzodiazepenes,FALSE,none
drug0 may interact with the following drugs : drug1 and other drug0 ( may lower drug0 levels )  drug0 ( bioavailability of oral drug0 is increased with coadministration )  drug0 ( may decrease drug0 levels )  drug0 ( reports of psychotic episodes when coadministered )  drug0 ( coadministration of drug0 with drug0 can inhibit ovarian function in women )  drug0 and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects )  and drug2 ( coadministration of drug0 and drug0 may interfere with the efficacy of the drug0 ) .,aspirin,corticosteroids,FALSE,none
drug2 may interact with the following drugs : drug1 and other drug0 ( may lower drug0 levels )  drug0 ( bioavailability of oral drug0 is increased with coadministration )  drug0 ( may decrease drug0 levels )  drug0 ( reports of psychotic episodes when coadministered )  drug0 ( coadministration of drug0 with drug0 can inhibit ovarian function in women )  drug0 and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects )  and drug0 ( coadministration of drug0 and drug0 may interfere with the efficacy of the drug0 ) .,aspirin,melatonin,FALSE,none
drug0 may interact with the following drugs : drug1 and other drug0 ( may lower drug0 levels )  drug0 ( bioavailability of oral drug0 is increased with coadministration )  drug0 ( may decrease drug0 levels )  drug0 ( reports of psychotic episodes when coadministered )  drug0 ( coadministration of drug0 with drug0 can inhibit ovarian function in women )  drug0 and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects )  and drug2 ( coadministration of drug0 and drug0 may interfere with the efficacy of the drug0 ) .,aspirin,corticosteroids,FALSE,none
drug0 may interact with the following drugs : drug1 and other drug0 ( may lower drug0 levels )  drug0 ( bioavailability of oral drug0 is increased with coadministration )  drug0 ( may decrease drug0 levels )  drug0 ( reports of psychotic episodes when coadministered )  drug0 ( coadministration of drug0 with drug0 can inhibit ovarian function in women )  drug0 and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects )  and drug2 ( coadministration of drug0 and drug0 may interfere with the efficacy of the drug0 ) .,aspirin,corticosteroids,FALSE,none
drug2 may interact with the following drugs : drug0 and other drug1 ( may lower drug0 levels )  drug0 ( bioavailability of oral drug0 is increased with coadministration )  drug0 ( may decrease drug0 levels )  drug0 ( reports of psychotic episodes when coadministered )  drug0 ( coadministration of drug0 with drug0 can inhibit ovarian function in women )  drug0 and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects )  and drug0 ( coadministration of drug0 and drug0 may interfere with the efficacy of the drug0 ) .,nsaids,melatonin,FALSE,none
drug0 may interact with the following drugs : drug0 and other drug1 ( may lower drug0 levels )  drug2 ( bioavailability of oral drug0 is increased with coadministration )  drug0 ( may decrease drug0 levels )  drug0 ( reports of psychotic episodes when coadministered )  drug0 ( coadministration of drug0 with drug0 can inhibit ovarian function in women )  drug0 and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects )  and drug0 ( coadministration of drug0 and drug0 may interfere with the efficacy of the drug0 ) .,nsaids,fluvoxamine,FALSE,none
drug2 may interact with the following drugs : drug0 and other drug1 ( may lower drug0 levels )  drug0 ( bioavailability of oral drug0 is increased with coadministration )  drug0 ( may decrease drug0 levels )  drug0 ( reports of psychotic episodes when coadministered )  drug0 ( coadministration of drug0 with drug0 can inhibit ovarian function in women )  drug0 and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects )  and drug0 ( coadministration of drug0 and drug0 may interfere with the efficacy of the drug0 ) .,nsaids,melatonin,FALSE,none
drug0 may interact with the following drugs : drug0 and other drug1 ( may lower drug0 levels )  drug0 ( bioavailability of oral drug0 is increased with coadministration )  drug2 ( may decrease drug0 levels )  drug0 ( reports of psychotic episodes when coadministered )  drug0 ( coadministration of drug0 with drug0 can inhibit ovarian function in women )  drug0 and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects )  and drug0 ( coadministration of drug0 and drug0 may interfere with the efficacy of the drug0 ) .,nsaids,beta blockers,FALSE,none
drug2 may interact with the following drugs : drug0 and other drug1 ( may lower drug0 levels )  drug0 ( bioavailability of oral drug0 is increased with coadministration )  drug0 ( may decrease drug0 levels )  drug0 ( reports of psychotic episodes when coadministered )  drug0 ( coadministration of drug0 with drug0 can inhibit ovarian function in women )  drug0 and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects )  and drug0 ( coadministration of drug0 and drug0 may interfere with the efficacy of the drug0 ) .,nsaids,melatonin,FALSE,none
drug0 may interact with the following drugs : drug0 and other drug1 ( may lower drug0 levels )  drug0 ( bioavailability of oral drug0 is increased with coadministration )  drug0 ( may decrease drug0 levels )  drug2 ( reports of psychotic episodes when coadministered )  drug0 ( coadministration of drug0 with drug0 can inhibit ovarian function in women )  drug0 and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects )  and drug0 ( coadministration of drug0 and drug0 may interfere with the efficacy of the drug0 ) .,nsaids,fluoxetine,FALSE,none
drug0 may interact with the following drugs : drug0 and other drug1 ( may lower drug0 levels )  drug0 ( bioavailability of oral drug0 is increased with coadministration )  drug0 ( may decrease drug0 levels )  drug0 ( reports of psychotic episodes when coadministered )  drug2 ( coadministration of drug0 with drug0 can inhibit ovarian function in women )  drug0 and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects )  and drug0 ( coadministration of drug0 and drug0 may interfere with the efficacy of the drug0 ) .,nsaids,progestin,FALSE,none
drug2 may interact with the following drugs : drug0 and other drug1 ( may lower drug0 levels )  drug0 ( bioavailability of oral drug0 is increased with coadministration )  drug0 ( may decrease drug0 levels )  drug0 ( reports of psychotic episodes when coadministered )  drug0 ( coadministration of drug0 with drug0 can inhibit ovarian function in women )  drug0 and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects )  and drug0 ( coadministration of drug0 and drug0 may interfere with the efficacy of the drug0 ) .,nsaids,melatonin,FALSE,none
drug0 may interact with the following drugs : drug0 and other drug1 ( may lower drug0 levels )  drug0 ( bioavailability of oral drug0 is increased with coadministration )  drug0 ( may decrease drug0 levels )  drug0 ( reports of psychotic episodes when coadministered )  drug2 ( coadministration of drug0 with drug0 can inhibit ovarian function in women )  drug0 and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects )  and drug0 ( coadministration of drug0 and drug0 may interfere with the efficacy of the drug0 ) .,nsaids,progestin,FALSE,none
drug0 may interact with the following drugs : drug0 and other drug1 ( may lower drug0 levels )  drug0 ( bioavailability of oral drug0 is increased with coadministration )  drug0 ( may decrease drug0 levels )  drug0 ( reports of psychotic episodes when coadministered )  drug0 ( coadministration of drug0 with drug0 can inhibit ovarian function in women )  drug2 and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects )  and drug0 ( coadministration of drug0 and drug0 may interfere with the efficacy of the drug0 ) .,nsaids,benzodiazepenes,FALSE,none
drug0 may interact with the following drugs : drug0 and other drug1 ( may lower drug0 levels )  drug0 ( bioavailability of oral drug0 is increased with coadministration )  drug0 ( may decrease drug0 levels )  drug0 ( reports of psychotic episodes when coadministered )  drug0 ( coadministration of drug0 with drug0 can inhibit ovarian function in women )  drug0 and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects )  and drug2 ( coadministration of drug0 and drug0 may interfere with the efficacy of the drug0 ) .,nsaids,corticosteroids,FALSE,none
drug2 may interact with the following drugs : drug0 and other drug1 ( may lower drug0 levels )  drug0 ( bioavailability of oral drug0 is increased with coadministration )  drug0 ( may decrease drug0 levels )  drug0 ( reports of psychotic episodes when coadministered )  drug0 ( coadministration of drug0 with drug0 can inhibit ovarian function in women )  drug0 and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects )  and drug0 ( coadministration of drug0 and drug0 may interfere with the efficacy of the drug0 ) .,nsaids,melatonin,FALSE,none
drug0 may interact with the following drugs : drug0 and other drug1 ( may lower drug0 levels )  drug0 ( bioavailability of oral drug0 is increased with coadministration )  drug0 ( may decrease drug0 levels )  drug0 ( reports of psychotic episodes when coadministered )  drug0 ( coadministration of drug0 with drug0 can inhibit ovarian function in women )  drug0 and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects )  and drug2 ( coadministration of drug0 and drug0 may interfere with the efficacy of the drug0 ) .,nsaids,corticosteroids,FALSE,none
drug0 may interact with the following drugs : drug0 and other drug1 ( may lower drug0 levels )  drug0 ( bioavailability of oral drug0 is increased with coadministration )  drug0 ( may decrease drug0 levels )  drug0 ( reports of psychotic episodes when coadministered )  drug0 ( coadministration of drug0 with drug0 can inhibit ovarian function in women )  drug0 and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects )  and drug2 ( coadministration of drug0 and drug0 may interfere with the efficacy of the drug0 ) .,nsaids,corticosteroids,FALSE,none
drug1 may interact with the following drugs : drug0 and other drug0 ( may lower drug0 levels )  drug2 ( bioavailability of oral drug0 is increased with coadministration )  drug0 ( may decrease drug0 levels )  drug0 ( reports of psychotic episodes when coadministered )  drug0 ( coadministration of drug0 with drug0 can inhibit ovarian function in women )  drug0 and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects )  and drug0 ( coadministration of drug0 and drug0 may interfere with the efficacy of the drug0 ) .,melatonin,fluvoxamine,FALSE,none
drug1 may interact with the following drugs : drug0 and other drug0 ( may lower drug0 levels )  drug0 ( bioavailability of oral drug0 is increased with coadministration )  drug2 ( may decrease drug0 levels )  drug0 ( reports of psychotic episodes when coadministered )  drug0 ( coadministration of drug0 with drug0 can inhibit ovarian function in women )  drug0 and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects )  and drug0 ( coadministration of drug0 and drug0 may interfere with the efficacy of the drug0 ) .,melatonin,beta blockers,FALSE,none
drug1 may interact with the following drugs : drug0 and other drug0 ( may lower drug0 levels )  drug0 ( bioavailability of oral drug0 is increased with coadministration )  drug0 ( may decrease drug0 levels )  drug2 ( reports of psychotic episodes when coadministered )  drug0 ( coadministration of drug0 with drug0 can inhibit ovarian function in women )  drug0 and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects )  and drug0 ( coadministration of drug0 and drug0 may interfere with the efficacy of the drug0 ) .,melatonin,fluoxetine,FALSE,none
drug1 may interact with the following drugs : drug0 and other drug0 ( may lower drug0 levels )  drug0 ( bioavailability of oral drug0 is increased with coadministration )  drug0 ( may decrease drug0 levels )  drug0 ( reports of psychotic episodes when coadministered )  drug2 ( coadministration of drug0 with drug0 can inhibit ovarian function in women )  drug0 and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects )  and drug0 ( coadministration of drug0 and drug0 may interfere with the efficacy of the drug0 ) .,melatonin,progestin,FALSE,none
drug1 may interact with the following drugs : drug0 and other drug0 ( may lower drug0 levels )  drug0 ( bioavailability of oral drug0 is increased with coadministration )  drug0 ( may decrease drug0 levels )  drug0 ( reports of psychotic episodes when coadministered )  drug2 ( coadministration of drug0 with drug0 can inhibit ovarian function in women )  drug0 and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects )  and drug0 ( coadministration of drug0 and drug0 may interfere with the efficacy of the drug0 ) .,melatonin,progestin,FALSE,none
drug1 may interact with the following drugs : drug0 and other drug0 ( may lower drug0 levels )  drug0 ( bioavailability of oral drug0 is increased with coadministration )  drug0 ( may decrease drug0 levels )  drug0 ( reports of psychotic episodes when coadministered )  drug0 ( coadministration of drug0 with drug0 can inhibit ovarian function in women )  drug2 and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects )  and drug0 ( coadministration of drug0 and drug0 may interfere with the efficacy of the drug0 ) .,melatonin,benzodiazepenes,FALSE,none
drug1 may interact with the following drugs : drug0 and other drug0 ( may lower drug0 levels )  drug0 ( bioavailability of oral drug0 is increased with coadministration )  drug0 ( may decrease drug0 levels )  drug0 ( reports of psychotic episodes when coadministered )  drug0 ( coadministration of drug0 with drug0 can inhibit ovarian function in women )  drug0 and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects )  and drug2 ( coadministration of drug0 and drug0 may interfere with the efficacy of the drug0 ) .,melatonin,corticosteroids,FALSE,none
drug1 may interact with the following drugs : drug0 and other drug0 ( may lower drug0 levels )  drug0 ( bioavailability of oral drug0 is increased with coadministration )  drug0 ( may decrease drug0 levels )  drug0 ( reports of psychotic episodes when coadministered )  drug0 ( coadministration of drug0 with drug0 can inhibit ovarian function in women )  drug0 and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects )  and drug2 ( coadministration of drug0 and drug0 may interfere with the efficacy of the drug0 ) .,melatonin,corticosteroids,FALSE,none
drug1 may interact with the following drugs : drug0 and other drug0 ( may lower drug0 levels )  drug0 ( bioavailability of oral drug0 is increased with coadministration )  drug0 ( may decrease drug0 levels )  drug0 ( reports of psychotic episodes when coadministered )  drug0 ( coadministration of drug0 with drug0 can inhibit ovarian function in women )  drug0 and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects )  and drug2 ( coadministration of drug0 and drug0 may interfere with the efficacy of the drug0 ) .,melatonin,corticosteroids,FALSE,none
drug2 may interact with the following drugs : drug0 and other drug0 ( may lower drug0 levels )  drug1 ( bioavailability of oral drug0 is increased with coadministration )  drug0 ( may decrease drug0 levels )  drug0 ( reports of psychotic episodes when coadministered )  drug0 ( coadministration of drug0 with drug0 can inhibit ovarian function in women )  drug0 and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects )  and drug0 ( coadministration of drug0 and drug0 may interfere with the efficacy of the drug0 ) .,fluvoxamine,melatonin,FALSE,none
drug0 may interact with the following drugs : drug0 and other drug0 ( may lower drug0 levels )  drug1 ( bioavailability of oral drug0 is increased with coadministration )  drug2 ( may decrease drug0 levels )  drug0 ( reports of psychotic episodes when coadministered )  drug0 ( coadministration of drug0 with drug0 can inhibit ovarian function in women )  drug0 and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects )  and drug0 ( coadministration of drug0 and drug0 may interfere with the efficacy of the drug0 ) .,fluvoxamine,beta blockers,FALSE,none
drug2 may interact with the following drugs : drug0 and other drug0 ( may lower drug0 levels )  drug1 ( bioavailability of oral drug0 is increased with coadministration )  drug0 ( may decrease drug0 levels )  drug0 ( reports of psychotic episodes when coadministered )  drug0 ( coadministration of drug0 with drug0 can inhibit ovarian function in women )  drug0 and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects )  and drug0 ( coadministration of drug0 and drug0 may interfere with the efficacy of the drug0 ) .,fluvoxamine,melatonin,FALSE,none
drug0 may interact with the following drugs : drug0 and other drug0 ( may lower drug0 levels )  drug1 ( bioavailability of oral drug0 is increased with coadministration )  drug0 ( may decrease drug0 levels )  drug2 ( reports of psychotic episodes when coadministered )  drug0 ( coadministration of drug0 with drug0 can inhibit ovarian function in women )  drug0 and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects )  and drug0 ( coadministration of drug0 and drug0 may interfere with the efficacy of the drug0 ) .,fluvoxamine,fluoxetine,FALSE,none
drug0 may interact with the following drugs : drug0 and other drug0 ( may lower drug0 levels )  drug1 ( bioavailability of oral drug0 is increased with coadministration )  drug0 ( may decrease drug0 levels )  drug0 ( reports of psychotic episodes when coadministered )  drug2 ( coadministration of drug0 with drug0 can inhibit ovarian function in women )  drug0 and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects )  and drug0 ( coadministration of drug0 and drug0 may interfere with the efficacy of the drug0 ) .,fluvoxamine,progestin,FALSE,none
drug2 may interact with the following drugs : drug0 and other drug0 ( may lower drug0 levels )  drug1 ( bioavailability of oral drug0 is increased with coadministration )  drug0 ( may decrease drug0 levels )  drug0 ( reports of psychotic episodes when coadministered )  drug0 ( coadministration of drug0 with drug0 can inhibit ovarian function in women )  drug0 and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects )  and drug0 ( coadministration of drug0 and drug0 may interfere with the efficacy of the drug0 ) .,fluvoxamine,melatonin,FALSE,none
drug0 may interact with the following drugs : drug0 and other drug0 ( may lower drug0 levels )  drug1 ( bioavailability of oral drug0 is increased with coadministration )  drug0 ( may decrease drug0 levels )  drug0 ( reports of psychotic episodes when coadministered )  drug2 ( coadministration of drug0 with drug0 can inhibit ovarian function in women )  drug0 and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects )  and drug0 ( coadministration of drug0 and drug0 may interfere with the efficacy of the drug0 ) .,fluvoxamine,progestin,FALSE,none
drug0 may interact with the following drugs : drug0 and other drug0 ( may lower drug0 levels )  drug1 ( bioavailability of oral drug0 is increased with coadministration )  drug0 ( may decrease drug0 levels )  drug0 ( reports of psychotic episodes when coadministered )  drug0 ( coadministration of drug0 with drug0 can inhibit ovarian function in women )  drug2 and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects )  and drug0 ( coadministration of drug0 and drug0 may interfere with the efficacy of the drug0 ) .,fluvoxamine,benzodiazepenes,FALSE,none
drug0 may interact with the following drugs : drug0 and other drug0 ( may lower drug0 levels )  drug1 ( bioavailability of oral drug0 is increased with coadministration )  drug0 ( may decrease drug0 levels )  drug0 ( reports of psychotic episodes when coadministered )  drug0 ( coadministration of drug0 with drug0 can inhibit ovarian function in women )  drug0 and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects )  and drug2 ( coadministration of drug0 and drug0 may interfere with the efficacy of the drug0 ) .,fluvoxamine,corticosteroids,FALSE,none
drug2 may interact with the following drugs : drug0 and other drug0 ( may lower drug0 levels )  drug1 ( bioavailability of oral drug0 is increased with coadministration )  drug0 ( may decrease drug0 levels )  drug0 ( reports of psychotic episodes when coadministered )  drug0 ( coadministration of drug0 with drug0 can inhibit ovarian function in women )  drug0 and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects )  and drug0 ( coadministration of drug0 and drug0 may interfere with the efficacy of the drug0 ) .,fluvoxamine,melatonin,FALSE,none
drug0 may interact with the following drugs : drug0 and other drug0 ( may lower drug0 levels )  drug1 ( bioavailability of oral drug0 is increased with coadministration )  drug0 ( may decrease drug0 levels )  drug0 ( reports of psychotic episodes when coadministered )  drug0 ( coadministration of drug0 with drug0 can inhibit ovarian function in women )  drug0 and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects )  and drug2 ( coadministration of drug0 and drug0 may interfere with the efficacy of the drug0 ) .,fluvoxamine,corticosteroids,FALSE,none
drug0 may interact with the following drugs : drug0 and other drug0 ( may lower drug0 levels )  drug1 ( bioavailability of oral drug0 is increased with coadministration )  drug0 ( may decrease drug0 levels )  drug0 ( reports of psychotic episodes when coadministered )  drug0 ( coadministration of drug0 with drug0 can inhibit ovarian function in women )  drug0 and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects )  and drug2 ( coadministration of drug0 and drug0 may interfere with the efficacy of the drug0 ) .,fluvoxamine,corticosteroids,FALSE,none
drug1 may interact with the following drugs : drug0 and other drug0 ( may lower drug0 levels )  drug0 ( bioavailability of oral drug0 is increased with coadministration )  drug2 ( may decrease drug0 levels )  drug0 ( reports of psychotic episodes when coadministered )  drug0 ( coadministration of drug0 with drug0 can inhibit ovarian function in women )  drug0 and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects )  and drug0 ( coadministration of drug0 and drug0 may interfere with the efficacy of the drug0 ) .,melatonin,beta blockers,FALSE,none
drug1 may interact with the following drugs : drug0 and other drug0 ( may lower drug0 levels )  drug0 ( bioavailability of oral drug0 is increased with coadministration )  drug0 ( may decrease drug0 levels )  drug2 ( reports of psychotic episodes when coadministered )  drug0 ( coadministration of drug0 with drug0 can inhibit ovarian function in women )  drug0 and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects )  and drug0 ( coadministration of drug0 and drug0 may interfere with the efficacy of the drug0 ) .,melatonin,fluoxetine,FALSE,none
drug1 may interact with the following drugs : drug0 and other drug0 ( may lower drug0 levels )  drug0 ( bioavailability of oral drug0 is increased with coadministration )  drug0 ( may decrease drug0 levels )  drug0 ( reports of psychotic episodes when coadministered )  drug2 ( coadministration of drug0 with drug0 can inhibit ovarian function in women )  drug0 and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects )  and drug0 ( coadministration of drug0 and drug0 may interfere with the efficacy of the drug0 ) .,melatonin,progestin,FALSE,none
drug1 may interact with the following drugs : drug0 and other drug0 ( may lower drug0 levels )  drug0 ( bioavailability of oral drug0 is increased with coadministration )  drug0 ( may decrease drug0 levels )  drug0 ( reports of psychotic episodes when coadministered )  drug2 ( coadministration of drug0 with drug0 can inhibit ovarian function in women )  drug0 and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects )  and drug0 ( coadministration of drug0 and drug0 may interfere with the efficacy of the drug0 ) .,melatonin,progestin,FALSE,none
drug1 may interact with the following drugs : drug0 and other drug0 ( may lower drug0 levels )  drug0 ( bioavailability of oral drug0 is increased with coadministration )  drug0 ( may decrease drug0 levels )  drug0 ( reports of psychotic episodes when coadministered )  drug0 ( coadministration of drug0 with drug0 can inhibit ovarian function in women )  drug2 and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects )  and drug0 ( coadministration of drug0 and drug0 may interfere with the efficacy of the drug0 ) .,melatonin,benzodiazepenes,FALSE,none
drug1 may interact with the following drugs : drug0 and other drug0 ( may lower drug0 levels )  drug0 ( bioavailability of oral drug0 is increased with coadministration )  drug0 ( may decrease drug0 levels )  drug0 ( reports of psychotic episodes when coadministered )  drug0 ( coadministration of drug0 with drug0 can inhibit ovarian function in women )  drug0 and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects )  and drug2 ( coadministration of drug0 and drug0 may interfere with the efficacy of the drug0 ) .,melatonin,corticosteroids,FALSE,none
drug1 may interact with the following drugs : drug0 and other drug0 ( may lower drug0 levels )  drug0 ( bioavailability of oral drug0 is increased with coadministration )  drug0 ( may decrease drug0 levels )  drug0 ( reports of psychotic episodes when coadministered )  drug0 ( coadministration of drug0 with drug0 can inhibit ovarian function in women )  drug0 and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects )  and drug2 ( coadministration of drug0 and drug0 may interfere with the efficacy of the drug0 ) .,melatonin,corticosteroids,FALSE,none
drug1 may interact with the following drugs : drug0 and other drug0 ( may lower drug0 levels )  drug0 ( bioavailability of oral drug0 is increased with coadministration )  drug0 ( may decrease drug0 levels )  drug0 ( reports of psychotic episodes when coadministered )  drug0 ( coadministration of drug0 with drug0 can inhibit ovarian function in women )  drug0 and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects )  and drug2 ( coadministration of drug0 and drug0 may interfere with the efficacy of the drug0 ) .,melatonin,corticosteroids,FALSE,none
drug2 may interact with the following drugs : drug0 and other drug0 ( may lower drug0 levels )  drug0 ( bioavailability of oral drug0 is increased with coadministration )  drug1 ( may decrease drug0 levels )  drug0 ( reports of psychotic episodes when coadministered )  drug0 ( coadministration of drug0 with drug0 can inhibit ovarian function in women )  drug0 and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects )  and drug0 ( coadministration of drug0 and drug0 may interfere with the efficacy of the drug0 ) .,beta blockers,melatonin,FALSE,none
drug0 may interact with the following drugs : drug0 and other drug0 ( may lower drug0 levels )  drug0 ( bioavailability of oral drug0 is increased with coadministration )  drug1 ( may decrease drug0 levels )  drug2 ( reports of psychotic episodes when coadministered )  drug0 ( coadministration of drug0 with drug0 can inhibit ovarian function in women )  drug0 and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects )  and drug0 ( coadministration of drug0 and drug0 may interfere with the efficacy of the drug0 ) .,beta blockers,fluoxetine,FALSE,none
drug0 may interact with the following drugs : drug0 and other drug0 ( may lower drug0 levels )  drug0 ( bioavailability of oral drug0 is increased with coadministration )  drug1 ( may decrease drug0 levels )  drug0 ( reports of psychotic episodes when coadministered )  drug2 ( coadministration of drug0 with drug0 can inhibit ovarian function in women )  drug0 and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects )  and drug0 ( coadministration of drug0 and drug0 may interfere with the efficacy of the drug0 ) .,beta blockers,progestin,FALSE,none
drug2 may interact with the following drugs : drug0 and other drug0 ( may lower drug0 levels )  drug0 ( bioavailability of oral drug0 is increased with coadministration )  drug1 ( may decrease drug0 levels )  drug0 ( reports of psychotic episodes when coadministered )  drug0 ( coadministration of drug0 with drug0 can inhibit ovarian function in women )  drug0 and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects )  and drug0 ( coadministration of drug0 and drug0 may interfere with the efficacy of the drug0 ) .,beta blockers,melatonin,FALSE,none
drug0 may interact with the following drugs : drug0 and other drug0 ( may lower drug0 levels )  drug0 ( bioavailability of oral drug0 is increased with coadministration )  drug1 ( may decrease drug0 levels )  drug0 ( reports of psychotic episodes when coadministered )  drug2 ( coadministration of drug0 with drug0 can inhibit ovarian function in women )  drug0 and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects )  and drug0 ( coadministration of drug0 and drug0 may interfere with the efficacy of the drug0 ) .,beta blockers,progestin,FALSE,none
drug0 may interact with the following drugs : drug0 and other drug0 ( may lower drug0 levels )  drug0 ( bioavailability of oral drug0 is increased with coadministration )  drug1 ( may decrease drug0 levels )  drug0 ( reports of psychotic episodes when coadministered )  drug0 ( coadministration of drug0 with drug0 can inhibit ovarian function in women )  drug2 and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects )  and drug0 ( coadministration of drug0 and drug0 may interfere with the efficacy of the drug0 ) .,beta blockers,benzodiazepenes,FALSE,none
drug0 may interact with the following drugs : drug0 and other drug0 ( may lower drug0 levels )  drug0 ( bioavailability of oral drug0 is increased with coadministration )  drug1 ( may decrease drug0 levels )  drug0 ( reports of psychotic episodes when coadministered )  drug0 ( coadministration of drug0 with drug0 can inhibit ovarian function in women )  drug0 and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects )  and drug2 ( coadministration of drug0 and drug0 may interfere with the efficacy of the drug0 ) .,beta blockers,corticosteroids,FALSE,none
drug2 may interact with the following drugs : drug0 and other drug0 ( may lower drug0 levels )  drug0 ( bioavailability of oral drug0 is increased with coadministration )  drug1 ( may decrease drug0 levels )  drug0 ( reports of psychotic episodes when coadministered )  drug0 ( coadministration of drug0 with drug0 can inhibit ovarian function in women )  drug0 and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects )  and drug0 ( coadministration of drug0 and drug0 may interfere with the efficacy of the drug0 ) .,beta blockers,melatonin,FALSE,none
drug0 may interact with the following drugs : drug0 and other drug0 ( may lower drug0 levels )  drug0 ( bioavailability of oral drug0 is increased with coadministration )  drug1 ( may decrease drug0 levels )  drug0 ( reports of psychotic episodes when coadministered )  drug0 ( coadministration of drug0 with drug0 can inhibit ovarian function in women )  drug0 and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects )  and drug2 ( coadministration of drug0 and drug0 may interfere with the efficacy of the drug0 ) .,beta blockers,corticosteroids,FALSE,none
drug0 may interact with the following drugs : drug0 and other drug0 ( may lower drug0 levels )  drug0 ( bioavailability of oral drug0 is increased with coadministration )  drug1 ( may decrease drug0 levels )  drug0 ( reports of psychotic episodes when coadministered )  drug0 ( coadministration of drug0 with drug0 can inhibit ovarian function in women )  drug0 and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects )  and drug2 ( coadministration of drug0 and drug0 may interfere with the efficacy of the drug0 ) .,beta blockers,corticosteroids,FALSE,none
drug1 may interact with the following drugs : drug0 and other drug0 ( may lower drug0 levels )  drug0 ( bioavailability of oral drug0 is increased with coadministration )  drug0 ( may decrease drug0 levels )  drug2 ( reports of psychotic episodes when coadministered )  drug0 ( coadministration of drug0 with drug0 can inhibit ovarian function in women )  drug0 and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects )  and drug0 ( coadministration of drug0 and drug0 may interfere with the efficacy of the drug0 ) .,melatonin,fluoxetine,FALSE,none
drug1 may interact with the following drugs : drug0 and other drug0 ( may lower drug0 levels )  drug0 ( bioavailability of oral drug0 is increased with coadministration )  drug0 ( may decrease drug0 levels )  drug0 ( reports of psychotic episodes when coadministered )  drug2 ( coadministration of drug0 with drug0 can inhibit ovarian function in women )  drug0 and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects )  and drug0 ( coadministration of drug0 and drug0 may interfere with the efficacy of the drug0 ) .,melatonin,progestin,FALSE,none
drug1 may interact with the following drugs : drug0 and other drug0 ( may lower drug0 levels )  drug0 ( bioavailability of oral drug0 is increased with coadministration )  drug0 ( may decrease drug0 levels )  drug0 ( reports of psychotic episodes when coadministered )  drug2 ( coadministration of drug0 with drug0 can inhibit ovarian function in women )  drug0 and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects )  and drug0 ( coadministration of drug0 and drug0 may interfere with the efficacy of the drug0 ) .,melatonin,progestin,FALSE,none
drug1 may interact with the following drugs : drug0 and other drug0 ( may lower drug0 levels )  drug0 ( bioavailability of oral drug0 is increased with coadministration )  drug0 ( may decrease drug0 levels )  drug0 ( reports of psychotic episodes when coadministered )  drug0 ( coadministration of drug0 with drug0 can inhibit ovarian function in women )  drug2 and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects )  and drug0 ( coadministration of drug0 and drug0 may interfere with the efficacy of the drug0 ) .,melatonin,benzodiazepenes,FALSE,none
drug1 may interact with the following drugs : drug0 and other drug0 ( may lower drug0 levels )  drug0 ( bioavailability of oral drug0 is increased with coadministration )  drug0 ( may decrease drug0 levels )  drug0 ( reports of psychotic episodes when coadministered )  drug0 ( coadministration of drug0 with drug0 can inhibit ovarian function in women )  drug0 and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects )  and drug2 ( coadministration of drug0 and drug0 may interfere with the efficacy of the drug0 ) .,melatonin,corticosteroids,FALSE,none
drug1 may interact with the following drugs : drug0 and other drug0 ( may lower drug0 levels )  drug0 ( bioavailability of oral drug0 is increased with coadministration )  drug0 ( may decrease drug0 levels )  drug0 ( reports of psychotic episodes when coadministered )  drug0 ( coadministration of drug0 with drug0 can inhibit ovarian function in women )  drug0 and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects )  and drug2 ( coadministration of drug0 and drug0 may interfere with the efficacy of the drug0 ) .,melatonin,corticosteroids,FALSE,none
drug1 may interact with the following drugs : drug0 and other drug0 ( may lower drug0 levels )  drug0 ( bioavailability of oral drug0 is increased with coadministration )  drug0 ( may decrease drug0 levels )  drug0 ( reports of psychotic episodes when coadministered )  drug0 ( coadministration of drug0 with drug0 can inhibit ovarian function in women )  drug0 and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects )  and drug2 ( coadministration of drug0 and drug0 may interfere with the efficacy of the drug0 ) .,melatonin,corticosteroids,FALSE,none
drug0 may interact with the following drugs : drug0 and other drug0 ( may lower drug0 levels )  drug0 ( bioavailability of oral drug0 is increased with coadministration )  drug0 ( may decrease drug0 levels )  drug1 ( reports of psychotic episodes when coadministered )  drug2 ( coadministration of drug0 with drug0 can inhibit ovarian function in women )  drug0 and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects )  and drug0 ( coadministration of drug0 and drug0 may interfere with the efficacy of the drug0 ) .,fluoxetine,progestin,FALSE,none
drug2 may interact with the following drugs : drug0 and other drug0 ( may lower drug0 levels )  drug0 ( bioavailability of oral drug0 is increased with coadministration )  drug0 ( may decrease drug0 levels )  drug1 ( reports of psychotic episodes when coadministered )  drug0 ( coadministration of drug0 with drug0 can inhibit ovarian function in women )  drug0 and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects )  and drug0 ( coadministration of drug0 and drug0 may interfere with the efficacy of the drug0 ) .,fluoxetine,melatonin,FALSE,none
drug0 may interact with the following drugs : drug0 and other drug0 ( may lower drug0 levels )  drug0 ( bioavailability of oral drug0 is increased with coadministration )  drug0 ( may decrease drug0 levels )  drug1 ( reports of psychotic episodes when coadministered )  drug2 ( coadministration of drug0 with drug0 can inhibit ovarian function in women )  drug0 and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects )  and drug0 ( coadministration of drug0 and drug0 may interfere with the efficacy of the drug0 ) .,fluoxetine,progestin,FALSE,none
drug0 may interact with the following drugs : drug0 and other drug0 ( may lower drug0 levels )  drug0 ( bioavailability of oral drug0 is increased with coadministration )  drug0 ( may decrease drug0 levels )  drug1 ( reports of psychotic episodes when coadministered )  drug0 ( coadministration of drug0 with drug0 can inhibit ovarian function in women )  drug2 and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects )  and drug0 ( coadministration of drug0 and drug0 may interfere with the efficacy of the drug0 ) .,fluoxetine,benzodiazepenes,FALSE,none
drug0 may interact with the following drugs : drug0 and other drug0 ( may lower drug0 levels )  drug0 ( bioavailability of oral drug0 is increased with coadministration )  drug0 ( may decrease drug0 levels )  drug1 ( reports of psychotic episodes when coadministered )  drug0 ( coadministration of drug0 with drug0 can inhibit ovarian function in women )  drug0 and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects )  and drug2 ( coadministration of drug0 and drug0 may interfere with the efficacy of the drug0 ) .,fluoxetine,corticosteroids,FALSE,none
drug2 may interact with the following drugs : drug0 and other drug0 ( may lower drug0 levels )  drug0 ( bioavailability of oral drug0 is increased with coadministration )  drug0 ( may decrease drug0 levels )  drug1 ( reports of psychotic episodes when coadministered )  drug0 ( coadministration of drug0 with drug0 can inhibit ovarian function in women )  drug0 and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects )  and drug0 ( coadministration of drug0 and drug0 may interfere with the efficacy of the drug0 ) .,fluoxetine,melatonin,FALSE,none
drug0 may interact with the following drugs : drug0 and other drug0 ( may lower drug0 levels )  drug0 ( bioavailability of oral drug0 is increased with coadministration )  drug0 ( may decrease drug0 levels )  drug1 ( reports of psychotic episodes when coadministered )  drug0 ( coadministration of drug0 with drug0 can inhibit ovarian function in women )  drug0 and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects )  and drug2 ( coadministration of drug0 and drug0 may interfere with the efficacy of the drug0 ) .,fluoxetine,corticosteroids,FALSE,none
drug0 may interact with the following drugs : drug0 and other drug0 ( may lower drug0 levels )  drug0 ( bioavailability of oral drug0 is increased with coadministration )  drug0 ( may decrease drug0 levels )  drug1 ( reports of psychotic episodes when coadministered )  drug0 ( coadministration of drug0 with drug0 can inhibit ovarian function in women )  drug0 and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects )  and drug2 ( coadministration of drug0 and drug0 may interfere with the efficacy of the drug0 ) .,fluoxetine,corticosteroids,FALSE,none
drug2 may interact with the following drugs : drug0 and other drug0 ( may lower drug0 levels )  drug0 ( bioavailability of oral drug0 is increased with coadministration )  drug0 ( may decrease drug0 levels )  drug0 ( reports of psychotic episodes when coadministered )  drug1 ( coadministration of drug0 with drug0 can inhibit ovarian function in women )  drug0 and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects )  and drug0 ( coadministration of drug0 and drug0 may interfere with the efficacy of the drug0 ) .,progestin,melatonin,FALSE,none
drug0 may interact with the following drugs : drug0 and other drug0 ( may lower drug0 levels )  drug0 ( bioavailability of oral drug0 is increased with coadministration )  drug0 ( may decrease drug0 levels )  drug0 ( reports of psychotic episodes when coadministered )  drug1 ( coadministration of drug0 with drug0 can inhibit ovarian function in women )  drug2 and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects )  and drug0 ( coadministration of drug0 and drug0 may interfere with the efficacy of the drug0 ) .,progestin,benzodiazepenes,FALSE,none
drug0 may interact with the following drugs : drug0 and other drug0 ( may lower drug0 levels )  drug0 ( bioavailability of oral drug0 is increased with coadministration )  drug0 ( may decrease drug0 levels )  drug0 ( reports of psychotic episodes when coadministered )  drug1 ( coadministration of drug0 with drug0 can inhibit ovarian function in women )  drug0 and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects )  and drug2 ( coadministration of drug0 and drug0 may interfere with the efficacy of the drug0 ) .,progestin,corticosteroids,FALSE,none
drug2 may interact with the following drugs : drug0 and other drug0 ( may lower drug0 levels )  drug0 ( bioavailability of oral drug0 is increased with coadministration )  drug0 ( may decrease drug0 levels )  drug0 ( reports of psychotic episodes when coadministered )  drug1 ( coadministration of drug0 with drug0 can inhibit ovarian function in women )  drug0 and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects )  and drug0 ( coadministration of drug0 and drug0 may interfere with the efficacy of the drug0 ) .,progestin,melatonin,FALSE,none
drug0 may interact with the following drugs : drug0 and other drug0 ( may lower drug0 levels )  drug0 ( bioavailability of oral drug0 is increased with coadministration )  drug0 ( may decrease drug0 levels )  drug0 ( reports of psychotic episodes when coadministered )  drug1 ( coadministration of drug0 with drug0 can inhibit ovarian function in women )  drug0 and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects )  and drug2 ( coadministration of drug0 and drug0 may interfere with the efficacy of the drug0 ) .,progestin,corticosteroids,FALSE,none
drug0 may interact with the following drugs : drug0 and other drug0 ( may lower drug0 levels )  drug0 ( bioavailability of oral drug0 is increased with coadministration )  drug0 ( may decrease drug0 levels )  drug0 ( reports of psychotic episodes when coadministered )  drug1 ( coadministration of drug0 with drug0 can inhibit ovarian function in women )  drug0 and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects )  and drug2 ( coadministration of drug0 and drug0 may interfere with the efficacy of the drug0 ) .,progestin,corticosteroids,FALSE,none
drug1 may interact with the following drugs : drug0 and other drug0 ( may lower drug0 levels )  drug0 ( bioavailability of oral drug0 is increased with coadministration )  drug0 ( may decrease drug0 levels )  drug0 ( reports of psychotic episodes when coadministered )  drug2 ( coadministration of drug0 with drug0 can inhibit ovarian function in women )  drug0 and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects )  and drug0 ( coadministration of drug0 and drug0 may interfere with the efficacy of the drug0 ) .,melatonin,progestin,TRUE,effect
drug1 may interact with the following drugs : drug0 and other drug0 ( may lower drug0 levels )  drug0 ( bioavailability of oral drug0 is increased with coadministration )  drug0 ( may decrease drug0 levels )  drug0 ( reports of psychotic episodes when coadministered )  drug0 ( coadministration of drug0 with drug0 can inhibit ovarian function in women )  drug2 and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects )  and drug0 ( coadministration of drug0 and drug0 may interfere with the efficacy of the drug0 ) .,melatonin,benzodiazepenes,FALSE,none
drug1 may interact with the following drugs : drug0 and other drug0 ( may lower drug0 levels )  drug0 ( bioavailability of oral drug0 is increased with coadministration )  drug0 ( may decrease drug0 levels )  drug0 ( reports of psychotic episodes when coadministered )  drug0 ( coadministration of drug0 with drug0 can inhibit ovarian function in women )  drug0 and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects )  and drug2 ( coadministration of drug0 and drug0 may interfere with the efficacy of the drug0 ) .,melatonin,corticosteroids,FALSE,none
drug1 may interact with the following drugs : drug0 and other drug0 ( may lower drug0 levels )  drug0 ( bioavailability of oral drug0 is increased with coadministration )  drug0 ( may decrease drug0 levels )  drug0 ( reports of psychotic episodes when coadministered )  drug0 ( coadministration of drug0 with drug0 can inhibit ovarian function in women )  drug0 and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects )  and drug2 ( coadministration of drug0 and drug0 may interfere with the efficacy of the drug0 ) .,melatonin,corticosteroids,FALSE,none
drug1 may interact with the following drugs : drug0 and other drug0 ( may lower drug0 levels )  drug0 ( bioavailability of oral drug0 is increased with coadministration )  drug0 ( may decrease drug0 levels )  drug0 ( reports of psychotic episodes when coadministered )  drug0 ( coadministration of drug0 with drug0 can inhibit ovarian function in women )  drug0 and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects )  and drug2 ( coadministration of drug0 and drug0 may interfere with the efficacy of the drug0 ) .,melatonin,corticosteroids,FALSE,none
drug0 may interact with the following drugs : drug0 and other drug0 ( may lower drug0 levels )  drug0 ( bioavailability of oral drug0 is increased with coadministration )  drug0 ( may decrease drug0 levels )  drug0 ( reports of psychotic episodes when coadministered )  drug1 ( coadministration of drug0 with drug0 can inhibit ovarian function in women )  drug2 and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects )  and drug0 ( coadministration of drug0 and drug0 may interfere with the efficacy of the drug0 ) .,progestin,benzodiazepenes,FALSE,none
drug0 may interact with the following drugs : drug0 and other drug0 ( may lower drug0 levels )  drug0 ( bioavailability of oral drug0 is increased with coadministration )  drug0 ( may decrease drug0 levels )  drug0 ( reports of psychotic episodes when coadministered )  drug1 ( coadministration of drug0 with drug0 can inhibit ovarian function in women )  drug0 and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects )  and drug2 ( coadministration of drug0 and drug0 may interfere with the efficacy of the drug0 ) .,progestin,corticosteroids,FALSE,none
drug2 may interact with the following drugs : drug0 and other drug0 ( may lower drug0 levels )  drug0 ( bioavailability of oral drug0 is increased with coadministration )  drug0 ( may decrease drug0 levels )  drug0 ( reports of psychotic episodes when coadministered )  drug1 ( coadministration of drug0 with drug0 can inhibit ovarian function in women )  drug0 and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects )  and drug0 ( coadministration of drug0 and drug0 may interfere with the efficacy of the drug0 ) .,progestin,melatonin,FALSE,none
drug0 may interact with the following drugs : drug0 and other drug0 ( may lower drug0 levels )  drug0 ( bioavailability of oral drug0 is increased with coadministration )  drug0 ( may decrease drug0 levels )  drug0 ( reports of psychotic episodes when coadministered )  drug1 ( coadministration of drug0 with drug0 can inhibit ovarian function in women )  drug0 and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects )  and drug2 ( coadministration of drug0 and drug0 may interfere with the efficacy of the drug0 ) .,progestin,corticosteroids,FALSE,none
drug0 may interact with the following drugs : drug0 and other drug0 ( may lower drug0 levels )  drug0 ( bioavailability of oral drug0 is increased with coadministration )  drug0 ( may decrease drug0 levels )  drug0 ( reports of psychotic episodes when coadministered )  drug1 ( coadministration of drug0 with drug0 can inhibit ovarian function in women )  drug0 and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects )  and drug2 ( coadministration of drug0 and drug0 may interfere with the efficacy of the drug0 ) .,progestin,corticosteroids,FALSE,none
drug0 may interact with the following drugs : drug0 and other drug0 ( may lower drug0 levels )  drug0 ( bioavailability of oral drug0 is increased with coadministration )  drug0 ( may decrease drug0 levels )  drug0 ( reports of psychotic episodes when coadministered )  drug0 ( coadministration of drug0 with drug0 can inhibit ovarian function in women )  drug1 and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects )  and drug2 ( coadministration of drug0 and drug0 may interfere with the efficacy of the drug0 ) .,benzodiazepenes,corticosteroids,FALSE,none
drug2 may interact with the following drugs : drug0 and other drug0 ( may lower drug0 levels )  drug0 ( bioavailability of oral drug0 is increased with coadministration )  drug0 ( may decrease drug0 levels )  drug0 ( reports of psychotic episodes when coadministered )  drug0 ( coadministration of drug0 with drug0 can inhibit ovarian function in women )  drug1 and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects )  and drug0 ( coadministration of drug0 and drug0 may interfere with the efficacy of the drug0 ) .,benzodiazepenes,melatonin,FALSE,none
drug0 may interact with the following drugs : drug0 and other drug0 ( may lower drug0 levels )  drug0 ( bioavailability of oral drug0 is increased with coadministration )  drug0 ( may decrease drug0 levels )  drug0 ( reports of psychotic episodes when coadministered )  drug0 ( coadministration of drug0 with drug0 can inhibit ovarian function in women )  drug1 and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects )  and drug2 ( coadministration of drug0 and drug0 may interfere with the efficacy of the drug0 ) .,benzodiazepenes,corticosteroids,FALSE,none
drug0 may interact with the following drugs : drug0 and other drug0 ( may lower drug0 levels )  drug0 ( bioavailability of oral drug0 is increased with coadministration )  drug0 ( may decrease drug0 levels )  drug0 ( reports of psychotic episodes when coadministered )  drug0 ( coadministration of drug0 with drug0 can inhibit ovarian function in women )  drug1 and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects )  and drug2 ( coadministration of drug0 and drug0 may interfere with the efficacy of the drug0 ) .,benzodiazepenes,corticosteroids,FALSE,none
drug2 may interact with the following drugs : drug0 and other drug0 ( may lower drug0 levels )  drug0 ( bioavailability of oral drug0 is increased with coadministration )  drug0 ( may decrease drug0 levels )  drug0 ( reports of psychotic episodes when coadministered )  drug0 ( coadministration of drug0 with drug0 can inhibit ovarian function in women )  drug0 and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects )  and drug1 ( coadministration of drug0 and drug0 may interfere with the efficacy of the drug0 ) .,corticosteroids,melatonin,FALSE,none
drug1 may interact with the following drugs : drug0 and other drug0 ( may lower drug0 levels )  drug0 ( bioavailability of oral drug0 is increased with coadministration )  drug0 ( may decrease drug0 levels )  drug0 ( reports of psychotic episodes when coadministered )  drug0 ( coadministration of drug0 with drug0 can inhibit ovarian function in women )  drug0 and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects )  and drug2 ( coadministration of drug0 and drug0 may interfere with the efficacy of the drug0 ) .,melatonin,corticosteroids,TRUE,effect
drug1 may interact with the following drugs : drug0 and other drug0 ( may lower drug0 levels )  drug0 ( bioavailability of oral drug0 is increased with coadministration )  drug0 ( may decrease drug0 levels )  drug0 ( reports of psychotic episodes when coadministered )  drug0 ( coadministration of drug0 with drug0 can inhibit ovarian function in women )  drug0 and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects )  and drug2 ( coadministration of drug0 and drug0 may interfere with the efficacy of the drug0 ) .,melatonin,corticosteroids,FALSE,none
drug1 reports suggest that drug2 may diminish the drug0 effect of angiotensin-converting enzyme ( ace ) inhibitors .,ace inhibitors,nsaids,FALSE,none
drug1 reports suggest that drug0 may diminish the drug0 effect of angiotensin-converting enzyme ( ace ) inhibitors .,ace inhibitors,angiotensin-converting enzyme (ace) inhibitors,FALSE,none
drug0 reports suggest that drug1 may diminish the drug0 effect of angiotensin-converting enzyme ( ace ) inhibitors .,nsaids,angiotensin-converting enzyme (ace) inhibitors,TRUE,effect
this interaction should be given consideration in patients taking drug1 concomitantly with drug2 .,nsaids,ace inhibitors,TRUE,advise
drug1 : concomitant administration of drug0 ( 1000 mg tid ) to healthy volunteers tended to increase the auc ( 10 % ) and cmax ( 24 % ) of drug2 .,aspirin,meloxicam,FALSE,none
drug1 : concomitant administration of drug0 ( 1000 mg tid ) to healthy volunteers tended to increase the auc ( 10 % ) and cmax ( 24 % ) of drug2 .,aspirin,meloxicam,TRUE,mechanism
however  as with other drug1  concomitant administration of drug2 and drug0 is not generally recommended because of the potential for increased adverse effects .,nsaids,meloxicam,FALSE,none
however  as with other drug1  concomitant administration of drug0 and drug2 is not generally recommended because of the potential for increased adverse effects .,nsaids,aspirin,TRUE,advise
however  as with other drug0  concomitant administration of drug1 and drug2 is not generally recommended because of the potential for increased adverse effects .,meloxicam,aspirin,TRUE,advise
concomitant administration of low-dose drug1 with drug2 may result in an increased rate of gi ulceration or other complications  compared to use of drug0 alone .,aspirin,mobic,TRUE,effect
concomitant administration of low-dose drug1 with drug2 may result in an increased rate of gi ulceration or other complications  compared to use of drug0 alone .,aspirin,mobic,FALSE,none
drug1 : pretreatment for four days with drug0 significantly increased the clearance of drug2 by 50 % .,cholestyramine,meloxicam,FALSE,none
drug1 : pretreatment for four days with drug0 significantly increased the clearance of drug2 by 50 % .,cholestyramine,meloxicam,TRUE,mechanism
in vitro testing found no protein binding drug interaction between drug1 and drug2 .,digoxin,meloxicam,FALSE,none
drug1 : clinical studies  as well as post-marketing observations  have shown that drug2 can reduce the natriuretic effect of drug0 and thiazide drug0 in some patients .,furosemide,nsaids,FALSE,none
drug1 : clinical studies  as well as post-marketing observations  have shown that drug0 can reduce the natriuretic effect of drug0 and drug2 in some patients .,furosemide,thiazide diuretics,FALSE,none
drug2 : clinical studies  as well as post-marketing observations  have shown that drug1 can reduce the natriuretic effect of drug0 and thiazide drug0 in some patients .,nsaids,furosemide,TRUE,effect
drug0 : clinical studies  as well as post-marketing observations  have shown that drug1 can reduce the natriuretic effect of drug0 and drug2 in some patients .,nsaids,thiazide diuretics,TRUE,effect
drug1 : clinical studies  as well as post-marketing observations  have shown that drug0 can reduce the natriuretic effect of drug0 and drug2 in some patients .,furosemide,thiazide diuretics,FALSE,none
studies with drug1 agents and drug2 have not demonstrated a reduction in natriuretic effect .,furosemide,meloxicam,FALSE,none
nevertheless  during concomitant therapy with drug1 and drug2  patients should be observed closely for signs of declining renal function  as well as to assure drug0 efficacy .,furosemide,mobic,TRUE,advise
drug1 : in clinical trials  drug2 have produced an elevation of plasma drug0 levels and a reduction in renal drug0 clearance .,lithium,nsaids,FALSE,none
drug2 : in clinical trials  drug1 have produced an elevation of plasma drug0 levels and a reduction in renal drug0 clearance .,nsaids,lithium,TRUE,mechanism
drug2 : in clinical trials  drug1 have produced an elevation of plasma drug0 levels and a reduction in renal drug0 clearance .,nsaids,lithium,FALSE,none
in a study conducted in healthy subjects  mean pre-dose drug1 concentration and auc were increased by 21 % in subjects receiving drug0 doses ranging from 804 to 1072 mg bid with drug2 15 mg qd as compared to subjects receiving drug0 alone .,lithium,meloxicam,FALSE,none
in a study conducted in healthy subjects  mean pre-dose drug1 concentration and auc were increased by 21 % in subjects receiving drug0 doses ranging from 804 to 1072 mg bid with drug2 15 mg qd as compared to subjects receiving drug0 alone .,lithium,meloxicam,TRUE,mechanism
in a study conducted in healthy subjects  mean pre-dose drug2 concentration and auc were increased by 21 % in subjects receiving drug0 doses ranging from 804 to 1072 mg bid with drug1 15 mg qd as compared to subjects receiving drug0 alone .,meloxicam,lithium,FALSE,none
patients on drug1 treatment should be closely monitored when drug2 is introduced or withdrawn .,lithium,mobic,TRUE,advise
drug1 : a study in 13 rheumatoid arthritis ( ra ) patients evaluated the effects of multiple doses of drug2 on the pharmacokinetics of drug0 taken once weekly .,methotrexate,meloxicam,FALSE,none
drug2 : a study in 13 rheumatoid arthritis ( ra ) patients evaluated the effects of multiple doses of drug1 on the pharmacokinetics of drug0 taken once weekly .,meloxicam,methotrexate,FALSE,none
in vitro  drug1 did not displace drug2 from its human serum binding sites .,methotrexate,meloxicam,FALSE,none
drug1 : drug0 activity should be monitored  particularly in the first few days after initiating or changing drug2 therapy in patients receiving drug0 or similar agents  since these patients are at an increased risk of bleeding .,warfarin,mobic,FALSE,none
drug2 : drug0 activity should be monitored  particularly in the first few days after initiating or changing drug1 therapy in patients receiving drug0 or similar agents  since these patients are at an increased risk of bleeding .,mobic,warfarin,TRUE,advise
the effect of drug1 on the drug0 effect of drug2 was studied in a group of healthy subjects receiving daily doses of drug0 that produced an inr ( international normalized ratio ) between 1.2 and 1.8 .,meloxicam,warfarin,FALSE,none
the effect of drug1 on the drug0 effect of drug2 was studied in a group of healthy subjects receiving daily doses of drug0 that produced an inr ( international normalized ratio ) between 1.2 and 1.8 .,meloxicam,warfarin,FALSE,none
caution should be used when administering drug1 with drug2 since patients on drug0 may experience changes in inr and an increased risk of bleeding complications when a new medication is introduced .,mobic,warfarin,TRUE,advise
caution should be used when administering drug1 with drug2 since patients on drug0 may experience changes in inr and an increased risk of bleeding complications when a new medication is introduced .,mobic,warfarin,FALSE,none
drug interactions there are no known drug/drug interactions with oral drug1 vaccinations with drug2 are not recommended in immunocompromised individuals drug0 together with hidrug0-dose intravenous drug0 has caused deaths in children due to haemorrhagic enterocolitis .,alkeran,live organism vaccines,FALSE,none
drug interactions there are no known drug/drug interactions with oral drug1 vaccinations with drug0 are not recommended in immunocompromised individuals drug2 together with hidrug0-dose intravenous drug0 has caused deaths in children due to haemorrhagic enterocolitis .,alkeran,nalidixic acid,FALSE,none
drug interactions there are no known drug/drug interactions with oral drug1 vaccinations with drug0 are not recommended in immunocompromised individuals drug0 together with hidrug0-dose intravenous drug2 has caused deaths in children due to haemorrhagic enterocolitis .,alkeran,melphalan,FALSE,none
drug interactions there are no known drug/drug interactions with oral drug0 vaccinations with drug1 are not recommended in immunocompromised individuals drug2 together with hidrug0-dose intravenous drug0 has caused deaths in children due to haemorrhagic enterocolitis .,live organism vaccines,nalidixic acid,FALSE,none
drug interactions there are no known drug/drug interactions with oral drug0 vaccinations with drug1 are not recommended in immunocompromised individuals drug0 together with hidrug0-dose intravenous drug2 has caused deaths in children due to haemorrhagic enterocolitis .,live organism vaccines,melphalan,FALSE,none
drug interactions there are no known drug/drug interactions with oral drug0 vaccinations with drug0 are not recommended in immunocompromised individuals drug1 together with hidrug0-dose intravenous drug2 has caused deaths in children due to haemorrhagic enterocolitis .,nalidixic acid,melphalan,TRUE,effect
impaired renal function has been described in bone marrow transplant patients who were conditioned with hidrug0-dose intravenous drug1 and who subsequently received drug2 to prevent graft-versus-host disease,melphalan,cyclosporin,TRUE,effect
the following agents may increase certain actions or side effects of drug1 : drug2  drug0 ( e.g.  drug0 )  drug0  drug0 ( e.g.  drug0 )  drug0  drug0  narcotic drug0 ( e.g.  drug0 )  drug0 and drug0  drug0  drug0 drug0  and other drugs having drug0 activity .,anticholinergic drugs,amantadine,TRUE,effect
the following agents may increase certain actions or side effects of drug1 : drug0  drug2 ( e.g.  drug0 )  drug0  drug0 ( e.g.  drug0 )  drug0  drug0  narcotic drug0 ( e.g.  drug0 )  drug0 and drug0  drug0  drug0 drug0  and other drugs having drug0 activity .,anticholinergic drugs,antiarrhythmic agents of class i,TRUE,effect
the following agents may increase certain actions or side effects of drug1 : drug0  drug0 ( e.g.  drug2 )  drug0  drug0 ( e.g.  drug0 )  drug0  drug0  narcotic drug0 ( e.g.  drug0 )  drug0 and drug0  drug0  drug0 drug0  and other drugs having drug0 activity .,anticholinergic drugs,quinidine,TRUE,effect
the following agents may increase certain actions or side effects of drug1 : drug0  drug0 ( e.g.  drug0 )  drug2  drug0 ( e.g.  drug0 )  drug0  drug0  narcotic drug0 ( e.g.  drug0 )  drug0 and drug0  drug0  drug0 drug0  and other drugs having drug0 activity .,anticholinergic drugs,antihistamines,TRUE,effect
the following agents may increase certain actions or side effects of drug1 : drug0  drug0 ( e.g.  drug0 )  drug0  drug2 ( e.g.  drug0 )  drug0  drug0  narcotic drug0 ( e.g.  drug0 )  drug0 and drug0  drug0  drug0 drug0  and other drugs having drug0 activity .,anticholinergic drugs,antipsychotic agents,TRUE,effect
the following agents may increase certain actions or side effects of drug1 : drug0  drug0 ( e.g.  drug0 )  drug0  drug0 ( e.g.  drug2 )  drug0  drug0  narcotic drug0 ( e.g.  drug0 )  drug0 and drug0  drug0  drug0 drug0  and other drugs having drug0 activity .,anticholinergic drugs,phenothiazines,TRUE,effect
the following agents may increase certain actions or side effects of drug1 : drug0  drug0 ( e.g.  drug0 )  drug0  drug0 ( e.g.  drug0 )  drug2  drug0  narcotic drug0 ( e.g.  drug0 )  drug0 and drug0  drug0  drug0 drug0  and other drugs having drug0 activity .,anticholinergic drugs,benzodiazepines,TRUE,effect
the following agents may increase certain actions or side effects of drug1 : drug0  drug0 ( e.g.  drug0 )  drug0  drug0 ( e.g.  drug0 )  drug0  drug2  narcotic drug0 ( e.g.  drug0 )  drug0 and drug0  drug0  drug0 drug0  and other drugs having drug0 activity .,anticholinergic drugs,mao inhibitors,TRUE,effect
the following agents may increase certain actions or side effects of drug1 : drug0  drug0 ( e.g.  drug0 )  drug0  drug0 ( e.g.  drug0 )  drug0  drug0  drug2 ( e.g.  drug0 )  drug0 and drug0  drug0  drug0 drug0  and other drugs having drug0 activity .,anticholinergic drugs,narcotic analgesics,TRUE,effect
the following agents may increase certain actions or side effects of drug1 : drug0  drug0 ( e.g.  drug0 )  drug0  drug0 ( e.g.  drug0 )  drug0  drug0  narcotic drug0 ( e.g.  drug2 )  drug0 and drug0  drug0  drug0 drug0  and other drugs having drug0 activity .,anticholinergic drugs,meperidine,TRUE,effect
the following agents may increase certain actions or side effects of drug1 : drug0  drug0 ( e.g.  drug0 )  drug0  drug0 ( e.g.  drug0 )  drug0  drug0  narcotic drug0 ( e.g.  drug0 )  drug2 and drug0  drug0  drug0 drug0  and other drugs having drug0 activity .,anticholinergic drugs,nitrates,TRUE,effect
the following agents may increase certain actions or side effects of drug1 : drug0  drug0 ( e.g.  drug0 )  drug0  drug0 ( e.g.  drug0 )  drug0  drug0  narcotic drug0 ( e.g.  drug0 )  drug0 and drug2  drug0  drug0 drug0  and other drugs having drug0 activity .,anticholinergic drugs,nitrites,TRUE,effect
the following agents may increase certain actions or side effects of drug1 : drug0  drug0 ( e.g.  drug0 )  drug0  drug0 ( e.g.  drug0 )  drug0  drug0  narcotic drug0 ( e.g.  drug0 )  drug0 and drug0  drug2  drug0 drug0  and other drugs having drug0 activity .,anticholinergic drugs,sympathomimetic agents,TRUE,effect
the following agents may increase certain actions or side effects of drug1 : drug0  drug0 ( e.g.  drug0 )  drug0  drug0 ( e.g.  drug0 )  drug0  drug0  narcotic drug0 ( e.g.  drug0 )  drug0 and drug0  drug0  drug2  and other drugs having drug0 activity .,anticholinergic drugs,tricyclic antidepressants,TRUE,effect
the following agents may increase certain actions or side effects of drug0 drugs : drug1  drug0 ( e.g.  drug2 )  drug0  drug0 ( e.g.  drug0 )  drug0  drug0  narcotic drug0 ( e.g.  drug0 )  drug0 and drug0  drug0  drug0 drug0  and other drugs having drug0 activity .,amantadine,quinidine,FALSE,none
the following agents may increase certain actions or side effects of drug0 drugs : drug1  drug0 ( e.g.  drug0 )  drug2  drug0 ( e.g.  drug0 )  drug0  drug0  narcotic drug0 ( e.g.  drug0 )  drug0 and drug0  drug0  drug0 drug0  and other drugs having drug0 activity .,amantadine,antihistamines,FALSE,none
the following agents may increase certain actions or side effects of drug0 drugs : drug1  drug0 ( e.g.  drug0 )  drug0  drug2 ( e.g.  drug0 )  drug0  drug0  narcotic drug0 ( e.g.  drug0 )  drug0 and drug0  drug0  drug0 drug0  and other drugs having drug0 activity .,amantadine,antipsychotic agents,FALSE,none
the following agents may increase certain actions or side effects of drug0 drugs : drug1  drug0 ( e.g.  drug0 )  drug0  drug0 ( e.g.  drug2 )  drug0  drug0  narcotic drug0 ( e.g.  drug0 )  drug0 and drug0  drug0  drug0 drug0  and other drugs having drug0 activity .,amantadine,phenothiazines,FALSE,none
the following agents may increase certain actions or side effects of drug0 drugs : drug1  drug0 ( e.g.  drug0 )  drug0  drug0 ( e.g.  drug0 )  drug2  drug0  narcotic drug0 ( e.g.  drug0 )  drug0 and drug0  drug0  drug0 drug0  and other drugs having drug0 activity .,amantadine,benzodiazepines,FALSE,none
the following agents may increase certain actions or side effects of drug0 drugs : drug1  drug0 ( e.g.  drug0 )  drug0  drug0 ( e.g.  drug0 )  drug0  drug2  narcotic drug0 ( e.g.  drug0 )  drug0 and drug0  drug0  drug0 drug0  and other drugs having drug0 activity .,amantadine,mao inhibitors,FALSE,none
the following agents may increase certain actions or side effects of drug0 drugs : drug1  drug0 ( e.g.  drug0 )  drug0  drug0 ( e.g.  drug0 )  drug0  drug0  drug2 ( e.g.  drug0 )  drug0 and drug0  drug0  drug0 drug0  and other drugs having drug0 activity .,amantadine,narcotic analgesics,FALSE,none
the following agents may increase certain actions or side effects of drug0 drugs : drug1  drug0 ( e.g.  drug0 )  drug0  drug0 ( e.g.  drug0 )  drug0  drug0  narcotic drug0 ( e.g.  drug2 )  drug0 and drug0  drug0  drug0 drug0  and other drugs having drug0 activity .,amantadine,meperidine,FALSE,none
the following agents may increase certain actions or side effects of drug0 drugs : drug1  drug0 ( e.g.  drug0 )  drug0  drug0 ( e.g.  drug0 )  drug0  drug0  narcotic drug0 ( e.g.  drug0 )  drug2 and drug0  drug0  drug0 drug0  and other drugs having drug0 activity .,amantadine,nitrates,FALSE,none
the following agents may increase certain actions or side effects of drug0 drugs : drug1  drug0 ( e.g.  drug0 )  drug0  drug0 ( e.g.  drug0 )  drug0  drug0  narcotic drug0 ( e.g.  drug0 )  drug0 and drug2  drug0  drug0 drug0  and other drugs having drug0 activity .,amantadine,nitrites,FALSE,none
the following agents may increase certain actions or side effects of drug0 drugs : drug1  drug0 ( e.g.  drug0 )  drug0  drug0 ( e.g.  drug0 )  drug0  drug0  narcotic drug0 ( e.g.  drug0 )  drug0 and drug0  drug2  drug0 drug0  and other drugs having drug0 activity .,amantadine,sympathomimetic agents,FALSE,none
the following agents may increase certain actions or side effects of drug0 drugs : drug1  drug0 ( e.g.  drug0 )  drug0  drug0 ( e.g.  drug0 )  drug0  drug0  narcotic drug0 ( e.g.  drug0 )  drug0 and drug0  drug0  drug2  and other drugs having drug0 activity .,amantadine,tricyclic antidepressants,FALSE,none
the following agents may increase certain actions or side effects of drug0 drugs : drug0  drug1 ( e.g.  drug2 )  drug0  drug0 ( e.g.  drug0 )  drug0  drug0  narcotic drug0 ( e.g.  drug0 )  drug0 and drug0  drug0  drug0 drug0  and other drugs having drug0 activity .,antiarrhythmic agents of class i,quinidine,FALSE,none
the following agents may increase certain actions or side effects of drug0 drugs : drug0  drug1 ( e.g.  drug0 )  drug2  drug0 ( e.g.  drug0 )  drug0  drug0  narcotic drug0 ( e.g.  drug0 )  drug0 and drug0  drug0  drug0 drug0  and other drugs having drug0 activity .,antiarrhythmic agents of class i,antihistamines,FALSE,none
the following agents may increase certain actions or side effects of drug0 drugs : drug0  drug1 ( e.g.  drug0 )  drug0  drug2 ( e.g.  drug0 )  drug0  drug0  narcotic drug0 ( e.g.  drug0 )  drug0 and drug0  drug0  drug0 drug0  and other drugs having drug0 activity .,antiarrhythmic agents of class i,antipsychotic agents,FALSE,none
the following agents may increase certain actions or side effects of drug0 drugs : drug0  drug1 ( e.g.  drug0 )  drug0  drug0 ( e.g.  drug2 )  drug0  drug0  narcotic drug0 ( e.g.  drug0 )  drug0 and drug0  drug0  drug0 drug0  and other drugs having drug0 activity .,antiarrhythmic agents of class i,phenothiazines,FALSE,none
the following agents may increase certain actions or side effects of drug0 drugs : drug0  drug1 ( e.g.  drug0 )  drug0  drug0 ( e.g.  drug0 )  drug2  drug0  narcotic drug0 ( e.g.  drug0 )  drug0 and drug0  drug0  drug0 drug0  and other drugs having drug0 activity .,antiarrhythmic agents of class i,benzodiazepines,FALSE,none
the following agents may increase certain actions or side effects of drug0 drugs : drug0  drug1 ( e.g.  drug0 )  drug0  drug0 ( e.g.  drug0 )  drug0  drug2  narcotic drug0 ( e.g.  drug0 )  drug0 and drug0  drug0  drug0 drug0  and other drugs having drug0 activity .,antiarrhythmic agents of class i,mao inhibitors,FALSE,none
the following agents may increase certain actions or side effects of drug0 drugs : drug0  drug1 ( e.g.  drug0 )  drug0  drug0 ( e.g.  drug0 )  drug0  drug0  drug2 ( e.g.  drug0 )  drug0 and drug0  drug0  drug0 drug0  and other drugs having drug0 activity .,antiarrhythmic agents of class i,narcotic analgesics,FALSE,none
the following agents may increase certain actions or side effects of drug0 drugs : drug0  drug1 ( e.g.  drug0 )  drug0  drug0 ( e.g.  drug0 )  drug0  drug0  narcotic drug0 ( e.g.  drug2 )  drug0 and drug0  drug0  drug0 drug0  and other drugs having drug0 activity .,antiarrhythmic agents of class i,meperidine,FALSE,none
the following agents may increase certain actions or side effects of drug0 drugs : drug0  drug1 ( e.g.  drug0 )  drug0  drug0 ( e.g.  drug0 )  drug0  drug0  narcotic drug0 ( e.g.  drug0 )  drug2 and drug0  drug0  drug0 drug0  and other drugs having drug0 activity .,antiarrhythmic agents of class i,nitrates,FALSE,none
the following agents may increase certain actions or side effects of drug0 drugs : drug0  drug1 ( e.g.  drug0 )  drug0  drug0 ( e.g.  drug0 )  drug0  drug0  narcotic drug0 ( e.g.  drug0 )  drug0 and drug2  drug0  drug0 drug0  and other drugs having drug0 activity .,antiarrhythmic agents of class i,nitrites,FALSE,none
the following agents may increase certain actions or side effects of drug0 drugs : drug0  drug1 ( e.g.  drug0 )  drug0  drug0 ( e.g.  drug0 )  drug0  drug0  narcotic drug0 ( e.g.  drug0 )  drug0 and drug0  drug2  drug0 drug0  and other drugs having drug0 activity .,antiarrhythmic agents of class i,sympathomimetic agents,FALSE,none
the following agents may increase certain actions or side effects of drug0 drugs : drug0  drug1 ( e.g.  drug0 )  drug0  drug0 ( e.g.  drug0 )  drug0  drug0  narcotic drug0 ( e.g.  drug0 )  drug0 and drug0  drug0  drug2  and other drugs having drug0 activity .,antiarrhythmic agents of class i,tricyclic antidepressants,FALSE,none
the following agents may increase certain actions or side effects of drug0 drugs : drug0  drug0 ( e.g.  drug1 )  drug2  drug0 ( e.g.  drug0 )  drug0  drug0  narcotic drug0 ( e.g.  drug0 )  drug0 and drug0  drug0  drug0 drug0  and other drugs having drug0 activity .,quinidine,antihistamines,FALSE,none
the following agents may increase certain actions or side effects of drug0 drugs : drug0  drug0 ( e.g.  drug1 )  drug0  drug2 ( e.g.  drug0 )  drug0  drug0  narcotic drug0 ( e.g.  drug0 )  drug0 and drug0  drug0  drug0 drug0  and other drugs having drug0 activity .,quinidine,antipsychotic agents,FALSE,none
the following agents may increase certain actions or side effects of drug0 drugs : drug0  drug0 ( e.g.  drug1 )  drug0  drug0 ( e.g.  drug2 )  drug0  drug0  narcotic drug0 ( e.g.  drug0 )  drug0 and drug0  drug0  drug0 drug0  and other drugs having drug0 activity .,quinidine,phenothiazines,FALSE,none
the following agents may increase certain actions or side effects of drug0 drugs : drug0  drug0 ( e.g.  drug1 )  drug0  drug0 ( e.g.  drug0 )  drug2  drug0  narcotic drug0 ( e.g.  drug0 )  drug0 and drug0  drug0  drug0 drug0  and other drugs having drug0 activity .,quinidine,benzodiazepines,FALSE,none
the following agents may increase certain actions or side effects of drug0 drugs : drug0  drug0 ( e.g.  drug1 )  drug0  drug0 ( e.g.  drug0 )  drug0  drug2  narcotic drug0 ( e.g.  drug0 )  drug0 and drug0  drug0  drug0 drug0  and other drugs having drug0 activity .,quinidine,mao inhibitors,FALSE,none
the following agents may increase certain actions or side effects of drug0 drugs : drug0  drug0 ( e.g.  drug1 )  drug0  drug0 ( e.g.  drug0 )  drug0  drug0  drug2 ( e.g.  drug0 )  drug0 and drug0  drug0  drug0 drug0  and other drugs having drug0 activity .,quinidine,narcotic analgesics,FALSE,none
the following agents may increase certain actions or side effects of drug0 drugs : drug0  drug0 ( e.g.  drug1 )  drug0  drug0 ( e.g.  drug0 )  drug0  drug0  narcotic drug0 ( e.g.  drug2 )  drug0 and drug0  drug0  drug0 drug0  and other drugs having drug0 activity .,quinidine,meperidine,FALSE,none
the following agents may increase certain actions or side effects of drug0 drugs : drug0  drug0 ( e.g.  drug1 )  drug0  drug0 ( e.g.  drug0 )  drug0  drug0  narcotic drug0 ( e.g.  drug0 )  drug2 and drug0  drug0  drug0 drug0  and other drugs having drug0 activity .,quinidine,nitrates,FALSE,none
the following agents may increase certain actions or side effects of drug0 drugs : drug0  drug0 ( e.g.  drug1 )  drug0  drug0 ( e.g.  drug0 )  drug0  drug0  narcotic drug0 ( e.g.  drug0 )  drug0 and drug2  drug0  drug0 drug0  and other drugs having drug0 activity .,quinidine,nitrites,FALSE,none
the following agents may increase certain actions or side effects of drug0 drugs : drug0  drug0 ( e.g.  drug1 )  drug0  drug0 ( e.g.  drug0 )  drug0  drug0  narcotic drug0 ( e.g.  drug0 )  drug0 and drug0  drug2  drug0 drug0  and other drugs having drug0 activity .,quinidine,sympathomimetic agents,FALSE,none
the following agents may increase certain actions or side effects of drug0 drugs : drug0  drug0 ( e.g.  drug1 )  drug0  drug0 ( e.g.  drug0 )  drug0  drug0  narcotic drug0 ( e.g.  drug0 )  drug0 and drug0  drug0  drug2  and other drugs having drug0 activity .,quinidine,tricyclic antidepressants,FALSE,none
the following agents may increase certain actions or side effects of drug0 drugs : drug0  drug0 ( e.g.  drug0 )  drug1  drug0 ( e.g.  drug2 )  drug0  drug0  narcotic drug0 ( e.g.  drug0 )  drug0 and drug0  drug0  drug0 drug0  and other drugs having drug0 activity .,antihistamines,phenothiazines,FALSE,none
the following agents may increase certain actions or side effects of drug0 drugs : drug0  drug0 ( e.g.  drug0 )  drug1  drug0 ( e.g.  drug0 )  drug2  drug0  narcotic drug0 ( e.g.  drug0 )  drug0 and drug0  drug0  drug0 drug0  and other drugs having drug0 activity .,antihistamines,benzodiazepines,FALSE,none
the following agents may increase certain actions or side effects of drug0 drugs : drug0  drug0 ( e.g.  drug0 )  drug1  drug0 ( e.g.  drug0 )  drug0  drug2  narcotic drug0 ( e.g.  drug0 )  drug0 and drug0  drug0  drug0 drug0  and other drugs having drug0 activity .,antihistamines,mao inhibitors,FALSE,none
the following agents may increase certain actions or side effects of drug0 drugs : drug0  drug0 ( e.g.  drug0 )  drug1  drug0 ( e.g.  drug0 )  drug0  drug0  drug2 ( e.g.  drug0 )  drug0 and drug0  drug0  drug0 drug0  and other drugs having drug0 activity .,antihistamines,narcotic analgesics,FALSE,none
the following agents may increase certain actions or side effects of drug0 drugs : drug0  drug0 ( e.g.  drug0 )  drug1  drug0 ( e.g.  drug0 )  drug0  drug0  narcotic drug0 ( e.g.  drug2 )  drug0 and drug0  drug0  drug0 drug0  and other drugs having drug0 activity .,antihistamines,meperidine,FALSE,none
the following agents may increase certain actions or side effects of drug0 drugs : drug0  drug0 ( e.g.  drug0 )  drug1  drug0 ( e.g.  drug0 )  drug0  drug0  narcotic drug0 ( e.g.  drug0 )  drug2 and drug0  drug0  drug0 drug0  and other drugs having drug0 activity .,antihistamines,nitrates,FALSE,none
the following agents may increase certain actions or side effects of drug0 drugs : drug0  drug0 ( e.g.  drug0 )  drug1  drug0 ( e.g.  drug0 )  drug0  drug0  narcotic drug0 ( e.g.  drug0 )  drug0 and drug2  drug0  drug0 drug0  and other drugs having drug0 activity .,antihistamines,nitrites,FALSE,none
the following agents may increase certain actions or side effects of drug0 drugs : drug0  drug0 ( e.g.  drug0 )  drug1  drug0 ( e.g.  drug0 )  drug0  drug0  narcotic drug0 ( e.g.  drug0 )  drug0 and drug0  drug2  drug0 drug0  and other drugs having drug0 activity .,antihistamines,sympathomimetic agents,FALSE,none
the following agents may increase certain actions or side effects of drug0 drugs : drug0  drug0 ( e.g.  drug0 )  drug1  drug0 ( e.g.  drug0 )  drug0  drug0  narcotic drug0 ( e.g.  drug0 )  drug0 and drug0  drug0  drug2  and other drugs having drug0 activity .,antihistamines,tricyclic antidepressants,FALSE,none
the following agents may increase certain actions or side effects of drug0 drugs : drug0  drug0 ( e.g.  drug0 )  drug0  drug1 ( e.g.  drug2 )  drug0  drug0  narcotic drug0 ( e.g.  drug0 )  drug0 and drug0  drug0  drug0 drug0  and other drugs having drug0 activity .,antipsychotic agents,phenothiazines,FALSE,none
the following agents may increase certain actions or side effects of drug0 drugs : drug0  drug0 ( e.g.  drug0 )  drug0  drug1 ( e.g.  drug0 )  drug2  drug0  narcotic drug0 ( e.g.  drug0 )  drug0 and drug0  drug0  drug0 drug0  and other drugs having drug0 activity .,antipsychotic agents,benzodiazepines,FALSE,none
the following agents may increase certain actions or side effects of drug0 drugs : drug0  drug0 ( e.g.  drug0 )  drug0  drug1 ( e.g.  drug0 )  drug0  drug2  narcotic drug0 ( e.g.  drug0 )  drug0 and drug0  drug0  drug0 drug0  and other drugs having drug0 activity .,antipsychotic agents,mao inhibitors,FALSE,none
the following agents may increase certain actions or side effects of drug0 drugs : drug0  drug0 ( e.g.  drug0 )  drug0  drug1 ( e.g.  drug0 )  drug0  drug0  drug2 ( e.g.  drug0 )  drug0 and drug0  drug0  drug0 drug0  and other drugs having drug0 activity .,antipsychotic agents,narcotic analgesics,FALSE,none
the following agents may increase certain actions or side effects of drug0 drugs : drug0  drug0 ( e.g.  drug0 )  drug0  drug1 ( e.g.  drug0 )  drug0  drug0  narcotic drug0 ( e.g.  drug2 )  drug0 and drug0  drug0  drug0 drug0  and other drugs having drug0 activity .,antipsychotic agents,meperidine,FALSE,none
the following agents may increase certain actions or side effects of drug0 drugs : drug0  drug0 ( e.g.  drug0 )  drug0  drug1 ( e.g.  drug0 )  drug0  drug0  narcotic drug0 ( e.g.  drug0 )  drug2 and drug0  drug0  drug0 drug0  and other drugs having drug0 activity .,antipsychotic agents,nitrates,FALSE,none
the following agents may increase certain actions or side effects of drug0 drugs : drug0  drug0 ( e.g.  drug0 )  drug0  drug1 ( e.g.  drug0 )  drug0  drug0  narcotic drug0 ( e.g.  drug0 )  drug0 and drug2  drug0  drug0 drug0  and other drugs having drug0 activity .,antipsychotic agents,nitrites,FALSE,none
the following agents may increase certain actions or side effects of drug0 drugs : drug0  drug0 ( e.g.  drug0 )  drug0  drug1 ( e.g.  drug0 )  drug0  drug0  narcotic drug0 ( e.g.  drug0 )  drug0 and drug0  drug2  drug0 drug0  and other drugs having drug0 activity .,antipsychotic agents,sympathomimetic agents,FALSE,none
the following agents may increase certain actions or side effects of drug0 drugs : drug0  drug0 ( e.g.  drug0 )  drug0  drug1 ( e.g.  drug0 )  drug0  drug0  narcotic drug0 ( e.g.  drug0 )  drug0 and drug0  drug0  drug2  and other drugs having drug0 activity .,antipsychotic agents,tricyclic antidepressants,FALSE,none
the following agents may increase certain actions or side effects of drug0 drugs : drug0  drug0 ( e.g.  drug0 )  drug0  drug0 ( e.g.  drug1 )  drug2  drug0  narcotic drug0 ( e.g.  drug0 )  drug0 and drug0  drug0  drug0 drug0  and other drugs having drug0 activity .,phenothiazines,benzodiazepines,FALSE,none
the following agents may increase certain actions or side effects of drug0 drugs : drug0  drug0 ( e.g.  drug0 )  drug0  drug0 ( e.g.  drug1 )  drug0  drug2  narcotic drug0 ( e.g.  drug0 )  drug0 and drug0  drug0  drug0 drug0  and other drugs having drug0 activity .,phenothiazines,mao inhibitors,FALSE,none
the following agents may increase certain actions or side effects of drug0 drugs : drug0  drug0 ( e.g.  drug0 )  drug0  drug0 ( e.g.  drug1 )  drug0  drug0  drug2 ( e.g.  drug0 )  drug0 and drug0  drug0  drug0 drug0  and other drugs having drug0 activity .,phenothiazines,narcotic analgesics,FALSE,none
the following agents may increase certain actions or side effects of drug0 drugs : drug0  drug0 ( e.g.  drug0 )  drug0  drug0 ( e.g.  drug1 )  drug0  drug0  narcotic drug0 ( e.g.  drug2 )  drug0 and drug0  drug0  drug0 drug0  and other drugs having drug0 activity .,phenothiazines,meperidine,FALSE,none
the following agents may increase certain actions or side effects of drug0 drugs : drug0  drug0 ( e.g.  drug0 )  drug0  drug0 ( e.g.  drug1 )  drug0  drug0  narcotic drug0 ( e.g.  drug0 )  drug2 and drug0  drug0  drug0 drug0  and other drugs having drug0 activity .,phenothiazines,nitrates,FALSE,none
the following agents may increase certain actions or side effects of drug0 drugs : drug0  drug0 ( e.g.  drug0 )  drug0  drug0 ( e.g.  drug1 )  drug0  drug0  narcotic drug0 ( e.g.  drug0 )  drug0 and drug2  drug0  drug0 drug0  and other drugs having drug0 activity .,phenothiazines,nitrites,FALSE,none
the following agents may increase certain actions or side effects of drug0 drugs : drug0  drug0 ( e.g.  drug0 )  drug0  drug0 ( e.g.  drug1 )  drug0  drug0  narcotic drug0 ( e.g.  drug0 )  drug0 and drug0  drug2  drug0 drug0  and other drugs having drug0 activity .,phenothiazines,sympathomimetic agents,FALSE,none
the following agents may increase certain actions or side effects of drug0 drugs : drug0  drug0 ( e.g.  drug0 )  drug0  drug0 ( e.g.  drug1 )  drug0  drug0  narcotic drug0 ( e.g.  drug0 )  drug0 and drug0  drug0  drug2  and other drugs having drug0 activity .,phenothiazines,tricyclic antidepressants,FALSE,none
the following agents may increase certain actions or side effects of drug0 drugs : drug0  drug0 ( e.g.  drug0 )  drug0  drug0 ( e.g.  drug0 )  drug1  drug0  narcotic drug0 ( e.g.  drug2 )  drug0 and drug0  drug0  drug0 drug0  and other drugs having drug0 activity .,benzodiazepines,meperidine,FALSE,none
the following agents may increase certain actions or side effects of drug0 drugs : drug0  drug0 ( e.g.  drug0 )  drug0  drug0 ( e.g.  drug0 )  drug1  drug0  narcotic drug0 ( e.g.  drug0 )  drug2 and drug0  drug0  drug0 drug0  and other drugs having drug0 activity .,benzodiazepines,nitrates,FALSE,none
the following agents may increase certain actions or side effects of drug0 drugs : drug0  drug0 ( e.g.  drug0 )  drug0  drug0 ( e.g.  drug0 )  drug1  drug0  narcotic drug0 ( e.g.  drug0 )  drug0 and drug2  drug0  drug0 drug0  and other drugs having drug0 activity .,benzodiazepines,nitrites,FALSE,none
the following agents may increase certain actions or side effects of drug0 drugs : drug0  drug0 ( e.g.  drug0 )  drug0  drug0 ( e.g.  drug0 )  drug1  drug0  narcotic drug0 ( e.g.  drug0 )  drug0 and drug0  drug2  drug0 drug0  and other drugs having drug0 activity .,benzodiazepines,sympathomimetic agents,FALSE,none
the following agents may increase certain actions or side effects of drug0 drugs : drug0  drug0 ( e.g.  drug0 )  drug0  drug0 ( e.g.  drug0 )  drug1  drug0  narcotic drug0 ( e.g.  drug0 )  drug0 and drug0  drug0  drug2  and other drugs having drug0 activity .,benzodiazepines,tricyclic antidepressants,FALSE,none
the following agents may increase certain actions or side effects of drug0 drugs : drug0  drug0 ( e.g.  drug0 )  drug0  drug0 ( e.g.  drug0 )  drug0  drug1  narcotic drug0 ( e.g.  drug2 )  drug0 and drug0  drug0  drug0 drug0  and other drugs having drug0 activity .,mao inhibitors,meperidine,FALSE,none
the following agents may increase certain actions or side effects of drug0 drugs : drug0  drug0 ( e.g.  drug0 )  drug0  drug0 ( e.g.  drug0 )  drug0  drug1  narcotic drug0 ( e.g.  drug0 )  drug2 and drug0  drug0  drug0 drug0  and other drugs having drug0 activity .,mao inhibitors,nitrates,FALSE,none
the following agents may increase certain actions or side effects of drug0 drugs : drug0  drug0 ( e.g.  drug0 )  drug0  drug0 ( e.g.  drug0 )  drug0  drug1  narcotic drug0 ( e.g.  drug0 )  drug0 and drug2  drug0  drug0 drug0  and other drugs having drug0 activity .,mao inhibitors,nitrites,FALSE,none
the following agents may increase certain actions or side effects of drug0 drugs : drug0  drug0 ( e.g.  drug0 )  drug0  drug0 ( e.g.  drug0 )  drug0  drug1  narcotic drug0 ( e.g.  drug0 )  drug0 and drug0  drug2  drug0 drug0  and other drugs having drug0 activity .,mao inhibitors,sympathomimetic agents,FALSE,none
the following agents may increase certain actions or side effects of drug0 drugs : drug0  drug0 ( e.g.  drug0 )  drug0  drug0 ( e.g.  drug0 )  drug0  drug1  narcotic drug0 ( e.g.  drug0 )  drug0 and drug0  drug0  drug2  and other drugs having drug0 activity .,mao inhibitors,tricyclic antidepressants,FALSE,none
the following agents may increase certain actions or side effects of drug0 drugs : drug0  drug0 ( e.g.  drug0 )  drug0  drug0 ( e.g.  drug0 )  drug0  drug0  drug1 ( e.g.  drug2 )  drug0 and drug0  drug0  drug0 drug0  and other drugs having drug0 activity .,narcotic analgesics,meperidine,FALSE,none
the following agents may increase certain actions or side effects of drug0 drugs : drug0  drug0 ( e.g.  drug0 )  drug0  drug0 ( e.g.  drug0 )  drug0  drug0  drug1 ( e.g.  drug0 )  drug2 and drug0  drug0  drug0 drug0  and other drugs having drug0 activity .,narcotic analgesics,nitrates,FALSE,none
the following agents may increase certain actions or side effects of drug0 drugs : drug0  drug0 ( e.g.  drug0 )  drug0  drug0 ( e.g.  drug0 )  drug0  drug0  drug1 ( e.g.  drug0 )  drug0 and drug2  drug0  drug0 drug0  and other drugs having drug0 activity .,narcotic analgesics,nitrites,FALSE,none
the following agents may increase certain actions or side effects of drug0 drugs : drug0  drug0 ( e.g.  drug0 )  drug0  drug0 ( e.g.  drug0 )  drug0  drug0  drug1 ( e.g.  drug0 )  drug0 and drug0  drug2  drug0 drug0  and other drugs having drug0 activity .,narcotic analgesics,sympathomimetic agents,FALSE,none
the following agents may increase certain actions or side effects of drug0 drugs : drug0  drug0 ( e.g.  drug0 )  drug0  drug0 ( e.g.  drug0 )  drug0  drug0  drug1 ( e.g.  drug0 )  drug0 and drug0  drug0  drug2  and other drugs having drug0 activity .,narcotic analgesics,tricyclic antidepressants,FALSE,none
the following agents may increase certain actions or side effects of drug0 drugs : drug0  drug0 ( e.g.  drug0 )  drug0  drug0 ( e.g.  drug0 )  drug0  drug0  narcotic drug0 ( e.g.  drug1 )  drug2 and drug0  drug0  drug0 drug0  and other drugs having drug0 activity .,meperidine,nitrates,FALSE,none
the following agents may increase certain actions or side effects of drug0 drugs : drug0  drug0 ( e.g.  drug0 )  drug0  drug0 ( e.g.  drug0 )  drug0  drug0  narcotic drug0 ( e.g.  drug1 )  drug0 and drug2  drug0  drug0 drug0  and other drugs having drug0 activity .,meperidine,nitrites,FALSE,none
the following agents may increase certain actions or side effects of drug0 drugs : drug0  drug0 ( e.g.  drug0 )  drug0  drug0 ( e.g.  drug0 )  drug0  drug0  narcotic drug0 ( e.g.  drug1 )  drug0 and drug0  drug2  drug0 drug0  and other drugs having drug0 activity .,meperidine,sympathomimetic agents,FALSE,none
the following agents may increase certain actions or side effects of drug0 drugs : drug0  drug0 ( e.g.  drug0 )  drug0  drug0 ( e.g.  drug0 )  drug0  drug0  narcotic drug0 ( e.g.  drug1 )  drug0 and drug0  drug0  drug2  and other drugs having drug0 activity .,meperidine,tricyclic antidepressants,FALSE,none
the following agents may increase certain actions or side effects of drug0 drugs : drug0  drug0 ( e.g.  drug0 )  drug0  drug0 ( e.g.  drug0 )  drug0  drug0  narcotic drug0 ( e.g.  drug0 )  drug1 and drug2  drug0  drug0 drug0  and other drugs having drug0 activity .,nitrates,nitrites,FALSE,none
the following agents may increase certain actions or side effects of drug0 drugs : drug0  drug0 ( e.g.  drug0 )  drug0  drug0 ( e.g.  drug0 )  drug0  drug0  narcotic drug0 ( e.g.  drug0 )  drug1 and drug0  drug2  drug0 drug0  and other drugs having drug0 activity .,nitrates,sympathomimetic agents,FALSE,none
the following agents may increase certain actions or side effects of drug0 drugs : drug0  drug0 ( e.g.  drug0 )  drug0  drug0 ( e.g.  drug0 )  drug0  drug0  narcotic drug0 ( e.g.  drug0 )  drug1 and drug0  drug0  drug2  and other drugs having drug0 activity .,nitrates,tricyclic antidepressants,FALSE,none
drug1 antagonize the effects of drug2 .,anticholinergics,antiglaucoma agents,TRUE,effect
drug1 in the presence of increased intraocular pressure may be hazardous when taken concurrently with agents such as drug2 .,anticholinergic drugs,corticosteroids,TRUE,effect
drug1 may affect gastrointestinal absorption of various drugs  such as slowly dissolving dosage forms of drug2 ;,anticholinergic agents,digoxin,TRUE,mechanism
drug1 may antagonize the effects of drugs that alter gastrointestinal motility  such as drug2 .,anticholinergic drugs,metoclopramide,TRUE,effect
because drug1 may interfere with the absorption of drug2  simultaneous use of these drugs should be avoided .,antacids,anticholinergic agents,TRUE,mechanism
interaction with other drug1 : drug2 should be used with great caution and in reduced dosage in patients who are concurrently receiving other narcotic drug0  general drug0  drug0  other drug0  sedative-drug0 ( including drug0 )  drug0 drug0 and other drug0 ( including drug0 ) .,central nervous system depressants,meperidine,FALSE,none
interaction with other drug1 : drug0 should be used with great caution and in reduced dosage in patients who are concurrently receiving other drug2  general drug0  drug0  other drug0  sedative-drug0 ( including drug0 )  drug0 drug0 and other drug0 ( including drug0 ) .,central nervous system depressants,narcotic analgesics,FALSE,none
interaction with other drug1 : drug0 should be used with great caution and in reduced dosage in patients who are concurrently receiving other narcotic drug0  general drug2  drug0  other drug0  sedative-drug0 ( including drug0 )  drug0 drug0 and other drug0 ( including drug0 ) .,central nervous system depressants,anesthetics,FALSE,none
interaction with other drug1 : drug0 should be used with great caution and in reduced dosage in patients who are concurrently receiving other narcotic drug0  general drug0  drug2  other drug0  sedative-drug0 ( including drug0 )  drug0 drug0 and other drug0 ( including drug0 ) .,central nervous system depressants,phenothiazines,FALSE,none
interaction with other drug1 : drug0 should be used with great caution and in reduced dosage in patients who are concurrently receiving other narcotic drug0  general drug0  drug0  other drug2  sedative-drug0 ( including drug0 )  drug0 drug0 and other drug0 ( including drug0 ) .,central nervous system depressants,tranquilizers,FALSE,none
interaction with other drug1 : drug0 should be used with great caution and in reduced dosage in patients who are concurrently receiving other narcotic drug0  general drug0  drug0  other drug0  drug2 ( including drug0 )  drug0 drug0 and other drug0 ( including drug0 ) .,central nervous system depressants,sedative-hypnotics,FALSE,none
interaction with other drug1 : drug0 should be used with great caution and in reduced dosage in patients who are concurrently receiving other narcotic drug0  general drug0  drug0  other drug0  sedative-drug0 ( including drug2 )  drug0 drug0 and other drug0 ( including drug0 ) .,central nervous system depressants,barbiturates,FALSE,none
interaction with other drug1 : drug0 should be used with great caution and in reduced dosage in patients who are concurrently receiving other narcotic drug0  general drug0  drug0  other drug0  sedative-drug0 ( including drug0 )  drug2 and other drug0 ( including drug0 ) .,central nervous system depressants,tricyclic antidepressants,FALSE,none
interaction with other drug1 : drug0 should be used with great caution and in reduced dosage in patients who are concurrently receiving other narcotic drug0  general drug0  drug0  other drug0  sedative-drug0 ( including drug0 )  drug0 drug0 and other drug2 ( including drug0 ) .,central nervous system depressants,cns depressants,FALSE,none
interaction with other drug1 : drug0 should be used with great caution and in reduced dosage in patients who are concurrently receiving other narcotic drug0  general drug0  drug0  other drug0  sedative-drug0 ( including drug0 )  drug0 drug0 and other drug0 ( including drug2 ) .,central nervous system depressants,alcohol,FALSE,none
interaction with other drug0 : drug1 should be used with great caution and in reduced dosage in patients who are concurrently receiving other drug2  general drug0  drug0  other drug0  sedative-drug0 ( including drug0 )  drug0 drug0 and other drug0 ( including drug0 ) .,meperidine,narcotic analgesics,TRUE,advise
interaction with other drug0 : drug1 should be used with great caution and in reduced dosage in patients who are concurrently receiving other narcotic drug0  general drug2  drug0  other drug0  sedative-drug0 ( including drug0 )  drug0 drug0 and other drug0 ( including drug0 ) .,meperidine,anesthetics,TRUE,advise
interaction with other drug0 : drug1 should be used with great caution and in reduced dosage in patients who are concurrently receiving other narcotic drug0  general drug0  drug2  other drug0  sedative-drug0 ( including drug0 )  drug0 drug0 and other drug0 ( including drug0 ) .,meperidine,phenothiazines,TRUE,advise
interaction with other drug0 : drug1 should be used with great caution and in reduced dosage in patients who are concurrently receiving other narcotic drug0  general drug0  drug0  other drug2  sedative-drug0 ( including drug0 )  drug0 drug0 and other drug0 ( including drug0 ) .,meperidine,tranquilizers,TRUE,advise
interaction with other drug0 : drug1 should be used with great caution and in reduced dosage in patients who are concurrently receiving other narcotic drug0  general drug0  drug0  other drug0  drug2 ( including drug0 )  drug0 drug0 and other drug0 ( including drug0 ) .,meperidine,sedative-hypnotics,TRUE,advise
interaction with other drug0 : drug1 should be used with great caution and in reduced dosage in patients who are concurrently receiving other narcotic drug0  general drug0  drug0  other drug0  sedative-drug0 ( including drug2 )  drug0 drug0 and other drug0 ( including drug0 ) .,meperidine,barbiturates,TRUE,advise
interaction with other drug0 : drug1 should be used with great caution and in reduced dosage in patients who are concurrently receiving other narcotic drug0  general drug0  drug0  other drug0  sedative-drug0 ( including drug0 )  drug2 and other drug0 ( including drug0 ) .,meperidine,tricyclic antidepressants,TRUE,advise
interaction with other drug0 : drug1 should be used with great caution and in reduced dosage in patients who are concurrently receiving other narcotic drug0  general drug0  drug0  other drug0  sedative-drug0 ( including drug0 )  drug0 drug0 and other drug2 ( including drug0 ) .,meperidine,cns depressants,TRUE,advise
interaction with other drug0 : drug1 should be used with great caution and in reduced dosage in patients who are concurrently receiving other narcotic drug0  general drug0  drug0  other drug0  sedative-drug0 ( including drug0 )  drug0 drug0 and other drug0 ( including drug2 ) .,meperidine,alcohol,TRUE,advise
interaction with other drug0 : drug0 should be used with great caution and in reduced dosage in patients who are concurrently receiving other drug1  general drug2  drug0  other drug0  sedative-drug0 ( including drug0 )  drug0 drug0 and other drug0 ( including drug0 ) .,narcotic analgesics,anesthetics,FALSE,none
interaction with other drug0 : drug0 should be used with great caution and in reduced dosage in patients who are concurrently receiving other drug1  general drug0  drug0  other drug2  sedative-drug0 ( including drug0 )  drug0 drug0 and other drug0 ( including drug0 ) .,narcotic analgesics,tranquilizers,FALSE,none
interaction with other drug0 : drug0 should be used with great caution and in reduced dosage in patients who are concurrently receiving other drug1  general drug0  drug0  other drug0  sedative-drug0 ( including drug2 )  drug0 drug0 and other drug0 ( including drug0 ) .,narcotic analgesics,barbiturates,FALSE,none
interaction with other drug0 : drug0 should be used with great caution and in reduced dosage in patients who are concurrently receiving other drug1  general drug0  drug0  other drug0  sedative-drug0 ( including drug0 )  drug2 and other drug0 ( including drug0 ) .,narcotic analgesics,tricyclic antidepressants,FALSE,none
interaction with other drug0 : drug0 should be used with great caution and in reduced dosage in patients who are concurrently receiving other drug1  general drug0  drug0  other drug0  sedative-drug0 ( including drug0 )  drug0 drug0 and other drug2 ( including drug0 ) .,narcotic analgesics,cns depressants,FALSE,none
interaction with other drug0 : drug0 should be used with great caution and in reduced dosage in patients who are concurrently receiving other drug1  general drug0  drug0  other drug0  sedative-drug0 ( including drug0 )  drug0 drug0 and other drug0 ( including drug2 ) .,narcotic analgesics,alcohol,FALSE,none
interaction with other drug0 : drug0 should be used with great caution and in reduced dosage in patients who are concurrently receiving other narcotic drug0  general drug1  drug0  other drug2  sedative-drug0 ( including drug0 )  drug0 drug0 and other drug0 ( including drug0 ) .,anesthetics,tranquilizers,FALSE,none
interaction with other drug0 : drug0 should be used with great caution and in reduced dosage in patients who are concurrently receiving other narcotic drug0  general drug1  drug0  other drug0  sedative-drug0 ( including drug2 )  drug0 drug0 and other drug0 ( including drug0 ) .,anesthetics,barbiturates,FALSE,none
interaction with other drug0 : drug0 should be used with great caution and in reduced dosage in patients who are concurrently receiving other narcotic drug0  general drug1  drug0  other drug0  sedative-drug0 ( including drug0 )  drug2 and other drug0 ( including drug0 ) .,anesthetics,tricyclic antidepressants,FALSE,none
interaction with other drug0 : drug0 should be used with great caution and in reduced dosage in patients who are concurrently receiving other narcotic drug0  general drug1  drug0  other drug0  sedative-drug0 ( including drug0 )  drug0 drug0 and other drug2 ( including drug0 ) .,anesthetics,cns depressants,FALSE,none
interaction with other drug0 : drug0 should be used with great caution and in reduced dosage in patients who are concurrently receiving other narcotic drug0  general drug1  drug0  other drug0  sedative-drug0 ( including drug0 )  drug0 drug0 and other drug0 ( including drug2 ) .,anesthetics,alcohol,FALSE,none
interaction with other drug0 : drug0 should be used with great caution and in reduced dosage in patients who are concurrently receiving other narcotic drug0  general drug0  drug1  other drug2  sedative-drug0 ( including drug0 )  drug0 drug0 and other drug0 ( including drug0 ) .,phenothiazines,tranquilizers,FALSE,none
interaction with other drug0 : drug0 should be used with great caution and in reduced dosage in patients who are concurrently receiving other narcotic drug0  general drug0  drug1  other drug0  sedative-drug0 ( including drug2 )  drug0 drug0 and other drug0 ( including drug0 ) .,phenothiazines,barbiturates,FALSE,none
interaction with other drug0 : drug0 should be used with great caution and in reduced dosage in patients who are concurrently receiving other narcotic drug0  general drug0  drug1  other drug0  sedative-drug0 ( including drug0 )  drug2 and other drug0 ( including drug0 ) .,phenothiazines,tricyclic antidepressants,FALSE,none
interaction with other drug0 : drug0 should be used with great caution and in reduced dosage in patients who are concurrently receiving other narcotic drug0  general drug0  drug1  other drug0  sedative-drug0 ( including drug0 )  drug0 drug0 and other drug2 ( including drug0 ) .,phenothiazines,cns depressants,FALSE,none
interaction with other drug0 : drug0 should be used with great caution and in reduced dosage in patients who are concurrently receiving other narcotic drug0  general drug0  drug1  other drug0  sedative-drug0 ( including drug0 )  drug0 drug0 and other drug0 ( including drug2 ) .,phenothiazines,alcohol,FALSE,none
interaction with other drug0 : drug0 should be used with great caution and in reduced dosage in patients who are concurrently receiving other narcotic drug0  general drug0  drug0  other drug1  sedative-drug0 ( including drug2 )  drug0 drug0 and other drug0 ( including drug0 ) .,tranquilizers,barbiturates,FALSE,none
interaction with other drug0 : drug0 should be used with great caution and in reduced dosage in patients who are concurrently receiving other narcotic drug0  general drug0  drug0  other drug1  sedative-drug0 ( including drug0 )  drug2 and other drug0 ( including drug0 ) .,tranquilizers,tricyclic antidepressants,FALSE,none
interaction with other drug0 : drug0 should be used with great caution and in reduced dosage in patients who are concurrently receiving other narcotic drug0  general drug0  drug0  other drug1  sedative-drug0 ( including drug0 )  drug0 drug0 and other drug2 ( including drug0 ) .,tranquilizers,cns depressants,FALSE,none
interaction with other drug0 : drug0 should be used with great caution and in reduced dosage in patients who are concurrently receiving other narcotic drug0  general drug0  drug0  other drug1  sedative-drug0 ( including drug0 )  drug0 drug0 and other drug0 ( including drug2 ) .,tranquilizers,alcohol,FALSE,none
interaction with other drug0 : drug0 should be used with great caution and in reduced dosage in patients who are concurrently receiving other narcotic drug0  general drug0  drug0  other drug0  drug1 ( including drug2 )  drug0 drug0 and other drug0 ( including drug0 ) .,sedative-hypnotics,barbiturates,FALSE,none
interaction with other drug0 : drug0 should be used with great caution and in reduced dosage in patients who are concurrently receiving other narcotic drug0  general drug0  drug0  other drug0  drug1 ( including drug0 )  drug2 and other drug0 ( including drug0 ) .,sedative-hypnotics,tricyclic antidepressants,FALSE,none
interaction with other drug0 : drug0 should be used with great caution and in reduced dosage in patients who are concurrently receiving other narcotic drug0  general drug0  drug0  other drug0  drug1 ( including drug0 )  drug0 drug0 and other drug2 ( including drug0 ) .,sedative-hypnotics,cns depressants,FALSE,none
interaction with other drug0 : drug0 should be used with great caution and in reduced dosage in patients who are concurrently receiving other narcotic drug0  general drug0  drug0  other drug0  drug1 ( including drug0 )  drug0 drug0 and other drug0 ( including drug2 ) .,sedative-hypnotics,alcohol,FALSE,none
interaction with other drug0 : drug0 should be used with great caution and in reduced dosage in patients who are concurrently receiving other narcotic drug0  general drug0  drug0  other drug0  sedative-drug0 ( including drug1 )  drug2 and other drug0 ( including drug0 ) .,barbiturates,tricyclic antidepressants,FALSE,none
interaction with other drug0 : drug0 should be used with great caution and in reduced dosage in patients who are concurrently receiving other narcotic drug0  general drug0  drug0  other drug0  sedative-drug0 ( including drug1 )  drug0 drug0 and other drug2 ( including drug0 ) .,barbiturates,cns depressants,FALSE,none
interaction with other drug0 : drug0 should be used with great caution and in reduced dosage in patients who are concurrently receiving other narcotic drug0  general drug0  drug0  other drug0  sedative-drug0 ( including drug1 )  drug0 drug0 and other drug0 ( including drug2 ) .,barbiturates,alcohol,FALSE,none
interaction with other drug0 : drug0 should be used with great caution and in reduced dosage in patients who are concurrently receiving other narcotic drug0  general drug0  drug0  other drug0  sedative-drug0 ( including drug0 )  drug1 and other drug2 ( including drug0 ) .,tricyclic antidepressants,cns depressants,FALSE,none
interaction with other drug0 : drug0 should be used with great caution and in reduced dosage in patients who are concurrently receiving other narcotic drug0  general drug0  drug0  other drug0  sedative-drug0 ( including drug0 )  drug1 and other drug0 ( including drug2 ) .,tricyclic antidepressants,alcohol,FALSE,none
interaction with other drug0 : drug0 should be used with great caution and in reduced dosage in patients who are concurrently receiving other narcotic drug0  general drug0  drug0  other drug0  sedative-drug0 ( including drug0 )  drug0 drug0 and other drug1 ( including drug2 ) .,cns depressants,alcohol,FALSE,none
some drug1 may interact with drug2 .,anticonvulsants,mephenytoin,TRUE,int
those drug1 include drug2  drug0  and drug0 .,anticonvulsants,divalproex sodium,FALSE,none
those drug1 include drug0  drug2  and drug0 .,anticonvulsants,valproic acid,FALSE,none
those drug1 include drug0  drug0  and drug2 .,anticonvulsants,phenobarbital,FALSE,none
those drug0 include drug0  drug1  and drug2 .,valproic acid,phenobarbital,FALSE,none
drug1 may also affect the effects of other drugs  which include some drug2  drug0  certain heart medicines  birth control pills  drug0  drug0 and drug0 please note that drug0 may interact with other drugs that are not listed here .,mephenytoin,steroid medications,TRUE,effect
drug1 may also affect the effects of other drugs  which include some drug0  drug2  certain heart medicines  birth control pills  drug0  drug0 and drug0 please note that drug0 may interact with other drugs that are not listed here .,mephenytoin,warfarin,TRUE,effect
drug1 may also affect the effects of other drugs  which include some drug0  drug0  certain heart medicines  birth control pills  drug2  drug0 and drug0 please note that drug0 may interact with other drugs that are not listed here .,mephenytoin,anti-infective medicines,TRUE,effect
drug1 may also affect the effects of other drugs  which include some drug0  drug0  certain heart medicines  birth control pills  drug0  drug2 and drug0 please note that drug0 may interact with other drugs that are not listed here .,mephenytoin,furosemide,TRUE,effect
drug1 may also affect the effects of other drugs  which include some drug0  drug0  certain heart medicines  birth control pills  drug0  drug0 and drug2 please note that drug0 may interact with other drugs that are not listed here .,mephenytoin,theophylline,TRUE,effect
drug0 may also affect the effects of other drugs  which include some drug1  drug0  certain heart medicines  birth control pills  drug0  drug0 and drug2 please note that drug0 may interact with other drugs that are not listed here .,steroid medications,theophylline,FALSE,none
drug2 may also affect the effects of other drugs  which include some drug1  drug0  certain heart medicines  birth control pills  drug0  drug0 and drug0 please note that drug0 may interact with other drugs that are not listed here .,steroid medications,mephenytoin,FALSE,none
drug0 may also affect the effects of other drugs  which include some drug0  drug1  certain heart medicines  birth control pills  drug0  drug0 and drug2 please note that drug0 may interact with other drugs that are not listed here .,warfarin,theophylline,FALSE,none
drug2 may also affect the effects of other drugs  which include some drug0  drug1  certain heart medicines  birth control pills  drug0  drug0 and drug0 please note that drug0 may interact with other drugs that are not listed here .,warfarin,mephenytoin,FALSE,none
drug0 may also affect the effects of other drugs  which include some drug0  drug0  certain heart medicines  birth control pills  drug1  drug0 and drug2 please note that drug0 may interact with other drugs that are not listed here .,anti-infective medicines,theophylline,FALSE,none
drug2 may also affect the effects of other drugs  which include some drug0  drug0  certain heart medicines  birth control pills  drug1  drug0 and drug0 please note that drug0 may interact with other drugs that are not listed here .,anti-infective medicines,mephenytoin,FALSE,none
drug0 may also affect the effects of other drugs  which include some drug0  drug0  certain heart medicines  birth control pills  drug0  drug1 and drug2 please note that drug0 may interact with other drugs that are not listed here .,furosemide,theophylline,FALSE,none
drug2 may also affect the effects of other drugs  which include some drug0  drug0  certain heart medicines  birth control pills  drug0  drug1 and drug0 please note that drug0 may interact with other drugs that are not listed here .,furosemide,mephenytoin,FALSE,none
drug2 may also affect the effects of other drugs  which include some drug0  drug0  certain heart medicines  birth control pills  drug0  drug0 and drug1 please note that drug0 may interact with other drugs that are not listed here .,theophylline,mephenytoin,FALSE,none
drug1 can interact with drug2  drug0  drug0  drug0  and drug0 .,mequitazine,cns depressant,TRUE,int
drug1 can interact with drug0  drug2  drug0  drug0  and drug0 .,mequitazine,antichlolinergic,TRUE,int
drug1 can interact with drug0  drug0  drug2  drug0  and drug0 .,mequitazine,tca,TRUE,int
drug1 can interact with drug0  drug0  drug0  drug2  and drug0 .,mequitazine,maois,TRUE,int
drug1 can interact with drug0  drug0  drug0  drug0  and drug2 .,mequitazine,alcohol,TRUE,int
drug0 can interact with drug0  drug0  drug0  drug1  and drug2 .,maois,alcohol,FALSE,none
drug1 competes with drug2 for active tubular secretion and thus inhibits the renal excretion of drug0 .,probenecid,meropenem,TRUE,mechanism
drug1 competes with drug2 for active tubular secretion and thus inhibits the renal excretion of drug0 .,probenecid,meropenem,FALSE,none
therefore  the coadministration of drug1 with drug2 is not recommended .,probenecid,meropenem,TRUE,advise
there is evidence that drug1 may reduce serum levels of drug2 to subtherapeutic levels ( therapeutic range considered to be 50 to 100 g/ml total drug0 ) .,meropenem,valproic acid,TRUE,mechanism
there is evidence that drug1 may reduce serum levels of drug0 to subtherapeutic levels ( therapeutic range considered to be 50 to 100 g/ml total drug2 ) .,meropenem,valproate,FALSE,none
there is evidence that drug0 may reduce serum levels of drug1 to subtherapeutic levels ( therapeutic range considered to be 50 to 100 g/ml total drug2 ) .,valproic acid,valproate,FALSE,none
drug1 should be used with caution in digitalized patients  since the combination of drug2 and drug0 may cause ectopic arrhythmias .,aramine,digitalis,FALSE,none
drug1 should be used with caution in digitalized patients  since the combination of drug0 and drug2 may cause ectopic arrhythmias .,aramine,sympathomimetic amines,FALSE,none
drug0 should be used with caution in digitalized patients  since the combination of drug1 and drug2 may cause ectopic arrhythmias .,digitalis,sympathomimetic amines,TRUE,effect
drug1 or drug2 may potentiate the action of drug0 .,monoamine oxidase inhibitors,tricyclic antidepressants,FALSE,none
drug1 or drug0 drug0 may potentiate the action of drug2 .,monoamine oxidase inhibitors,sympathomimetic amines,TRUE,effect
drug0 or drug1 may potentiate the action of drug2 .,tricyclic antidepressants,sympathomimetic amines,TRUE,effect
drug1 may enhance the effects of drug2  drug0 and other drug0 .,skelaxin,alcohol,TRUE,effect
drug1 may enhance the effects of drug0  drug2 and other drug0 .,skelaxin,barbiturates,TRUE,effect
drug1 may enhance the effects of drug0  drug0 and other drug2 .,skelaxin,cns depressants,TRUE,effect
drug0 may enhance the effects of drug1  drug0 and other drug2 .,alcohol,cns depressants,FALSE,none
drug0 may enhance the effects of drug0  drug1 and other drug2 .,barbiturates,cns depressants,FALSE,none
caution is advised for patients receiving hidrug0-dose drug1 and drug2 concomitantly  as anorexia  tachypnea  lethargy  coma and death have been reported with concomitant use of hidrug0-dose drug0 and drug0 .,aspirin,methazolamide,TRUE,advise
caution is advised for patients receiving hidrug0-dose drug1 and drug0 concomitantly  as anorexia  tachypnea  lethargy  coma and death have been reported with concomitant use of hidrug0-dose drug0 and drug2 .,aspirin,carbonic anhydrase inhibitors,FALSE,none
caution is advised for patients receiving hidrug0-dose drug2 and drug1 concomitantly  as anorexia  tachypnea  lethargy  coma and death have been reported with concomitant use of hidrug0-dose drug0 and drug0 .,methazolamide,aspirin,FALSE,none
caution is advised for patients receiving hidrug0-dose drug0 and drug1 concomitantly  as anorexia  tachypnea  lethargy  coma and death have been reported with concomitant use of hidrug0-dose drug0 and drug2 .,methazolamide,carbonic anhydrase inhibitors,FALSE,none
caution is advised for patients receiving hidrug0-dose drug1 and drug0 concomitantly  as anorexia  tachypnea  lethargy  coma and death have been reported with concomitant use of hidrug0-dose drug0 and drug2 .,aspirin,carbonic anhydrase inhibitors,TRUE,effect
drug1 ( oral ) : the activity of oral drug0 may be potentiated by anti-vitamin-k activity attributed to drug2 .,anticoagulants,methimazole,FALSE,none
drug1 ( oral ) : the activity of oral drug0 may be potentiated by anti-vitamin-k activity attributed to drug2 .,anticoagulants,methimazole,TRUE,effect
drug1 : serum drug0 levels may be increased when hyperthyroid patients on a stable drug2 regimen become euthyroid ;,digitalis glycosides,digitalis glycoside,FALSE,none
dosages of concomitantly administered drug1 should be reduced by approximately half  because drug2 amplifies the therapeutic actions and side-effects of drug0 .,opioids,levomepromazine,TRUE,effect
dosages of concomitantly administered drug2 should be reduced by approximately half  because drug1 amplifies the therapeutic actions and side-effects of drug0 .,levomepromazine,opioids,TRUE,effect
additive sedative effects and confusional states may emerge if drug1 is given with drug2 or drug0 .,levomepromazine,benzodiazepines,TRUE,effect
additive sedative effects and confusional states may emerge if drug1 is given with drug0 or drug2 .,levomepromazine,barbiturates,TRUE,effect
additive sedative effects and confusional states may emerge if drug0 is given with drug1 or drug2 .,benzodiazepines,barbiturates,FALSE,none
exert particular caution in combining drug1 with other drug2 ( drug0 drug0 and drug0 ) : particularly the elderly may develop delirium  hidrug0 fever  severe obstipation  even ileus and glaucoma .,levomepromazine,anticholinergic drugs,TRUE,advise
exert particular caution in combining drug1 with other drug0 drugs ( drug2 and drug0 ) : particularly the elderly may develop delirium  hidrug0 fever  severe obstipation  even ileus and glaucoma .,levomepromazine,tricyclic antidepressants,TRUE,advise
exert particular caution in combining drug1 with other drug0 drugs ( drug0 drug0 and drug2 ) : particularly the elderly may develop delirium  hidrug0 fever  severe obstipation  even ileus and glaucoma .,levomepromazine,antiparkinsonian-agents,TRUE,advise
exert particular caution in combining drug0 with other drug1 ( drug2 and drug0 ) : particularly the elderly may develop delirium  hidrug0 fever  severe obstipation  even ileus and glaucoma .,anticholinergic drugs,tricyclic antidepressants,FALSE,none
exert particular caution in combining drug0 with other drug1 ( drug0 drug0 and drug2 ) : particularly the elderly may develop delirium  hidrug0 fever  severe obstipation  even ileus and glaucoma .,anticholinergic drugs,antiparkinsonian-agents,FALSE,none
exert particular caution in combining drug0 with other drug0 drugs ( drug1 and drug2 ) : particularly the elderly may develop delirium  hidrug0 fever  severe obstipation  even ileus and glaucoma .,tricyclic antidepressants,antiparkinsonian-agents,FALSE,none
drug1 and/or stimulantes of the drug2/drug0 type may counteract the specific actions of drug0 .,caffeine,ephedrine,FALSE,none
drug1 and/or stimulantes of the drug0/drug2 type may counteract the specific actions of drug0 .,caffeine,amphetamine,FALSE,none
drug1 and/or stimulantes of the drug0/drug0 type may counteract the specific actions of drug2 .,caffeine,levomepromazine,TRUE,effect
drug0 and/or stimulantes of the drug1/drug2 type may counteract the specific actions of drug0 .,ephedrine,amphetamine,FALSE,none
drug0 and/or stimulantes of the drug1/drug0 type may counteract the specific actions of drug2 .,ephedrine,levomepromazine,TRUE,effect
drug0 and/or stimulantes of the drug0/drug1 type may counteract the specific actions of drug2 .,amphetamine,levomepromazine,TRUE,effect
since drug1 ( drug0 ) may interact with concurrently administered drug2  periodic serum level determinations of these drugs may be necessary ( eg drug0 may increase the plasma concentrations of drug0 and drug0 ) .,celontin,antiepileptic drugs,TRUE,advise
since drug1 ( drug0 ) may interact with concurrently administered drug0  periodic serum level determinations of these drugs may be necessary ( eg drug0 may increase the plasma concentrations of drug2 and drug0 ) .,celontin,phenytoin,FALSE,none
since drug1 ( drug0 ) may interact with concurrently administered drug0  periodic serum level determinations of these drugs may be necessary ( eg drug0 may increase the plasma concentrations of drug0 and drug2 ) .,celontin,phenobarbital,FALSE,none
since drug0 ( drug1 ) may interact with concurrently administered drug2  periodic serum level determinations of these drugs may be necessary ( eg drug0 may increase the plasma concentrations of drug0 and drug0 ) .,methsuximide,antiepileptic drugs,TRUE,advise
since drug0 ( drug1 ) may interact with concurrently administered drug0  periodic serum level determinations of these drugs may be necessary ( eg drug0 may increase the plasma concentrations of drug2 and drug0 ) .,methsuximide,phenytoin,FALSE,none
since drug0 ( drug1 ) may interact with concurrently administered drug0  periodic serum level determinations of these drugs may be necessary ( eg drug0 may increase the plasma concentrations of drug0 and drug2 ) .,methsuximide,phenobarbital,FALSE,none
since drug0 ( drug2 ) may interact with concurrently administered drug1  periodic serum level determinations of these drugs may be necessary ( eg drug0 may increase the plasma concentrations of drug0 and drug0 ) .,antiepileptic drugs,methsuximide,FALSE,none
since drug0 ( drug0 ) may interact with concurrently administered drug1  periodic serum level determinations of these drugs may be necessary ( eg drug0 may increase the plasma concentrations of drug2 and drug0 ) .,antiepileptic drugs,phenytoin,FALSE,none
since drug0 ( drug0 ) may interact with concurrently administered drug1  periodic serum level determinations of these drugs may be necessary ( eg drug0 may increase the plasma concentrations of drug0 and drug2 ) .,antiepileptic drugs,phenobarbital,FALSE,none
since drug0 ( drug1 ) may interact with concurrently administered drug0  periodic serum level determinations of these drugs may be necessary ( eg drug0 may increase the plasma concentrations of drug2 and drug0 ) .,methsuximide,phenytoin,TRUE,mechanism
since drug0 ( drug1 ) may interact with concurrently administered drug0  periodic serum level determinations of these drugs may be necessary ( eg drug0 may increase the plasma concentrations of drug0 and drug2 ) .,methsuximide,phenobarbital,TRUE,mechanism
since drug0 ( drug0 ) may interact with concurrently administered drug0  periodic serum level determinations of these drugs may be necessary ( eg drug0 may increase the plasma concentrations of drug1 and drug2 ) .,phenytoin,phenobarbital,FALSE,none
hypokalemia may develop during concomitant use of drug1 or drug2 .,steroids,acth,FALSE,none
drug1 may decrease arterial responsiveness to drug2 .,thiazides,norepinephrine,TRUE,effect
drug1 may increase the responsiveness of drug2 .,thiazide drugs,tubocurarine,TRUE,effect
drug1 renal clearance is reduced by drug2  increasing the risk of drug0 toxicity .,lithium,thiazides,TRUE,mechanism
drug2 renal clearance is reduced by drug1  increasing the risk of drug0 toxicity .,thiazides,lithium,FALSE,none
drug1 may add to or potentiate the action of other drug2 .,thiazides,antihypertensive drugs,TRUE,effect
potentiation occurs with ganglionic or drug2 .,ganglionic adrenergic blocking drugs,peripheral adrenergic blocking drugs,FALSE,none
when drug1 is used with other drug2  potentiation of drug0 effect may occur .,methyldopa,antihypertensive drugs,TRUE,effect
patients may require reduced doses of drug1 when on drug2 .,anesthetics,methyldopa,TRUE,advise
when drug1 and drug2 are given concomitantly the patient should be carefully monitored for symptoms of drug0 toxicity .,methyldopa,lithium,TRUE,advise
when drug1 and drug2 are given concomitantly the patient should be carefully monitored for symptoms of drug0 toxicity .,methyldopa,lithium,FALSE,none
several studies demonstrate a decrease in the bioavailability of drug1 when it is ingested with drug2 or drug0 .,methyldopa,ferrous sulfate,TRUE,mechanism
several studies demonstrate a decrease in the bioavailability of drug1 when it is ingested with drug0 or drug2 .,methyldopa,ferrous gluconate,TRUE,mechanism
several studies demonstrate a decrease in the bioavailability of drug0 when it is ingested with drug1 or drug2 .,ferrous sulfate,ferrous gluconate,FALSE,none
coadministration of drug1 with drug2 or drug0 is not recommended .,methyldopa,ferrous sulfate,TRUE,advise
coadministration of drug1 with drug0 or drug2 is not recommended .,methyldopa,ferrous gluconate,TRUE,advise
coadministration of drug0 with drug1 or drug2 is not recommended .,ferrous sulfate,ferrous gluconate,FALSE,none
drug1 does not interfere with measurement of drug2 ( drug0 )  a test for pheochromocytoma  by those methods which convert drug0 to drug0 .,methyldopa,vma,FALSE,none
drug1 does not interfere with measurement of drug0 ( drug2 )  a test for pheochromocytoma  by those methods which convert drug0 to drug0 .,methyldopa,vanillylmandelic acid,FALSE,none
drug1 does not interfere with measurement of drug2 ( drug0 )  a test for pheochromocytoma  by those methods which convert drug0 to drug0 .,methyldopa,vma,FALSE,none
drug1 does not interfere with measurement of drug0 ( drug0 )  a test for pheochromocytoma  by those methods which convert drug0 to drug2 .,methyldopa,vanillin,FALSE,none
drug0 does not interfere with measurement of drug1 ( drug0 )  a test for pheochromocytoma  by those methods which convert drug0 to drug2 .,vma,vanillin,FALSE,none
drug0 does not interfere with measurement of drug0 ( drug1 )  a test for pheochromocytoma  by those methods which convert drug0 to drug2 .,vanillylmandelic acid,vanillin,FALSE,none
drug0 does not interfere with measurement of drug1 ( drug0 )  a test for pheochromocytoma  by those methods which convert drug0 to drug2 .,vma,vanillin,FALSE,none
cyp 3a4 inhibitors ( e.g . drug1 and drug2 ) there have been rare reports of serious adverse events in connection with the coadministration of certain drug0 ( e.g . drug0 and drug0 ) and potent cyp 3a4 inhibitors  resulting in vasospasm leading to cerebral ischemia and/or ischemia of the extremities .,macrolide antibiotics,protease inhibitors,FALSE,none
cyp 3a4 inhibitors ( e.g . drug1 and drug0 ) there have been rare reports of serious adverse events in connection with the coadministration of certain drug2 ( e.g . drug0 and drug0 ) and potent cyp 3a4 inhibitors  resulting in vasospasm leading to cerebral ischemia and/or ischemia of the extremities .,macrolide antibiotics,ergot alkaloid drugs,FALSE,none
cyp 3a4 inhibitors ( e.g . drug1 and drug0 ) there have been rare reports of serious adverse events in connection with the coadministration of certain drug0 ( e.g . drug2 and drug0 ) and potent cyp 3a4 inhibitors  resulting in vasospasm leading to cerebral ischemia and/or ischemia of the extremities .,macrolide antibiotics,dihydroergotamine,FALSE,none
cyp 3a4 inhibitors ( e.g . drug1 and drug0 ) there have been rare reports of serious adverse events in connection with the coadministration of certain drug0 ( e.g . dihydrodrug2 and drug0 ) and potent cyp 3a4 inhibitors  resulting in vasospasm leading to cerebral ischemia and/or ischemia of the extremities .,macrolide antibiotics,ergotamine,FALSE,none
cyp 3a4 inhibitors ( e.g . macrolide drug0 and drug1 ) there have been rare reports of serious adverse events in connection with the coadministration of certain drug2 ( e.g . drug0 and drug0 ) and potent cyp 3a4 inhibitors  resulting in vasospasm leading to cerebral ischemia and/or ischemia of the extremities .,protease inhibitors,ergot alkaloid drugs,FALSE,none
cyp 3a4 inhibitors ( e.g . macrolide drug0 and drug1 ) there have been rare reports of serious adverse events in connection with the coadministration of certain drug0 ( e.g . drug2 and drug0 ) and potent cyp 3a4 inhibitors  resulting in vasospasm leading to cerebral ischemia and/or ischemia of the extremities .,protease inhibitors,dihydroergotamine,FALSE,none
cyp 3a4 inhibitors ( e.g . macrolide drug0 and drug1 ) there have been rare reports of serious adverse events in connection with the coadministration of certain drug0 ( e.g . dihydrodrug2 and drug0 ) and potent cyp 3a4 inhibitors  resulting in vasospasm leading to cerebral ischemia and/or ischemia of the extremities .,protease inhibitors,ergotamine,FALSE,none
cyp 3a4 inhibitors ( e.g . macrolide drug0 and drug0 ) there have been rare reports of serious adverse events in connection with the coadministration of certain drug1 ( e.g . drug2 and drug0 ) and potent cyp 3a4 inhibitors  resulting in vasospasm leading to cerebral ischemia and/or ischemia of the extremities .,ergot alkaloid drugs,dihydroergotamine,FALSE,none
cyp 3a4 inhibitors ( e.g . macrolide drug0 and drug0 ) there have been rare reports of serious adverse events in connection with the coadministration of certain drug1 ( e.g . dihydrodrug2 and drug0 ) and potent cyp 3a4 inhibitors  resulting in vasospasm leading to cerebral ischemia and/or ischemia of the extremities .,ergot alkaloid drugs,ergotamine,FALSE,none
cyp 3a4 inhibitors ( e.g . macrolide drug0 and drug0 ) there have been rare reports of serious adverse events in connection with the coadministration of certain drug0 ( e.g . drug1 and drug2 ) and potent cyp 3a4 inhibitors  resulting in vasospasm leading to cerebral ischemia and/or ischemia of the extremities .,dihydroergotamine,ergotamine,FALSE,none
examples of some of the more potent cyp 3a4 inhibitors include drug1 ( e.g.  drug2  drug0  drug0 )  hiv protease or drug0 ( e.g.  drug0  drug0  drug0  drug0 ) or drug0 ( e.g.  drug0  drug0  drug0 ) .,macrolide antibiotics,erythromycin,FALSE,none
examples of some of the more potent cyp 3a4 inhibitors include drug1 ( e.g.  drug0  drug2  drug0 )  hiv protease or drug0 ( e.g.  drug0  drug0  drug0  drug0 ) or drug0 ( e.g.  drug0  drug0  drug0 ) .,macrolide antibiotics,troleandomycin,FALSE,none
examples of some of the more potent cyp 3a4 inhibitors include drug1 ( e.g.  drug0  drug0  drug2 )  hiv protease or drug0 ( e.g.  drug0  drug0  drug0  drug0 ) or drug0 ( e.g.  drug0  drug0  drug0 ) .,macrolide antibiotics,clarithromycin,FALSE,none
examples of some of the more potent cyp 3a4 inhibitors include drug1 ( e.g.  drug0  drug0  drug0 )  hiv protease or drug0 ( e.g.  drug0  drug0  drug0  drug0 ) or drug0 ( e.g.  drug0  drug0  drug0 ) .,macrolide antibiotics,hiv protease inhibitors,FALSE,none
examples of some of the more potent cyp 3a4 inhibitors include drug1 ( e.g.  drug0  drug0  drug0 )  hiv protease or drug2 ( e.g.  drug0  drug0  drug0  drug0 ) or drug0 ( e.g.  drug0  drug0  drug0 ) .,macrolide antibiotics,reverse transcriptase inhibitors,FALSE,none
examples of some of the more potent cyp 3a4 inhibitors include drug1 ( e.g.  drug0  drug0  drug0 )  hiv protease or drug0 ( e.g.  drug2  drug0  drug0  drug0 ) or drug0 ( e.g.  drug0  drug0  drug0 ) .,macrolide antibiotics,ritonavir,FALSE,none
examples of some of the more potent cyp 3a4 inhibitors include drug1 ( e.g.  drug0  drug0  drug0 )  hiv protease or drug0 ( e.g.  drug0  drug2  drug0  drug0 ) or drug0 ( e.g.  drug0  drug0  drug0 ) .,macrolide antibiotics,indinavir,FALSE,none
examples of some of the more potent cyp 3a4 inhibitors include drug1 ( e.g.  drug0  drug0  drug0 )  hiv protease or drug0 ( e.g.  drug0  drug0  drug2  drug0 ) or drug0 ( e.g.  drug0  drug0  drug0 ) .,macrolide antibiotics,nelfinavir,FALSE,none
examples of some of the more potent cyp 3a4 inhibitors include drug1 ( e.g.  drug0  drug0  drug0 )  hiv protease or drug0 ( e.g.  drug0  drug0  drug0  drug2 ) or drug0 ( e.g.  drug0  drug0  drug0 ) .,macrolide antibiotics,delavirdine,FALSE,none
examples of some of the more potent cyp 3a4 inhibitors include drug1 ( e.g.  drug0  drug0  drug0 )  hiv protease or drug0 ( e.g.  drug0  drug0  drug0  drug0 ) or drug2 ( e.g.  drug0  drug0  drug0 ) .,macrolide antibiotics,azole antifungals,FALSE,none
examples of some of the more potent cyp 3a4 inhibitors include drug1 ( e.g.  drug0  drug0  drug0 )  hiv protease or drug0 ( e.g.  drug0  drug0  drug0  drug0 ) or drug0 ( e.g.  drug2  drug0  drug0 ) .,macrolide antibiotics,ketoconazole,FALSE,none
examples of some of the more potent cyp 3a4 inhibitors include drug1 ( e.g.  drug0  drug0  drug0 )  hiv protease or drug0 ( e.g.  drug0  drug0  drug0  drug0 ) or drug0 ( e.g.  drug0  drug2  drug0 ) .,macrolide antibiotics,itraconazole,FALSE,none
examples of some of the more potent cyp 3a4 inhibitors include drug1 ( e.g.  drug0  drug0  drug0 )  hiv protease or drug0 ( e.g.  drug0  drug0  drug0  drug0 ) or drug0 ( e.g.  drug0  drug0  drug2 ) .,macrolide antibiotics,voriconazole,FALSE,none
examples of some of the more potent cyp 3a4 inhibitors include macrolide drug0 ( e.g.  drug1  drug0  drug0 )  hiv protease or drug0 ( e.g.  drug0  drug0  drug0  drug0 ) or drug0 ( e.g.  drug0  drug0  drug0 ) .,erythromycin,hiv protease inhibitors,FALSE,none
examples of some of the more potent cyp 3a4 inhibitors include macrolide drug0 ( e.g.  drug1  drug0  drug0 )  hiv protease or drug2 ( e.g.  drug0  drug0  drug0  drug0 ) or drug0 ( e.g.  drug0  drug0  drug0 ) .,erythromycin,reverse transcriptase inhibitors,FALSE,none
examples of some of the more potent cyp 3a4 inhibitors include macrolide drug0 ( e.g.  drug1  drug0  drug0 )  hiv protease or drug0 ( e.g.  drug2  drug0  drug0  drug0 ) or drug0 ( e.g.  drug0  drug0  drug0 ) .,erythromycin,ritonavir,FALSE,none
examples of some of the more potent cyp 3a4 inhibitors include macrolide drug0 ( e.g.  drug1  drug0  drug0 )  hiv protease or drug0 ( e.g.  drug0  drug2  drug0  drug0 ) or drug0 ( e.g.  drug0  drug0  drug0 ) .,erythromycin,indinavir,FALSE,none
examples of some of the more potent cyp 3a4 inhibitors include macrolide drug0 ( e.g.  drug1  drug0  drug0 )  hiv protease or drug0 ( e.g.  drug0  drug0  drug2  drug0 ) or drug0 ( e.g.  drug0  drug0  drug0 ) .,erythromycin,nelfinavir,FALSE,none
examples of some of the more potent cyp 3a4 inhibitors include macrolide drug0 ( e.g.  drug1  drug0  drug0 )  hiv protease or drug0 ( e.g.  drug0  drug0  drug0  drug2 ) or drug0 ( e.g.  drug0  drug0  drug0 ) .,erythromycin,delavirdine,FALSE,none
examples of some of the more potent cyp 3a4 inhibitors include macrolide drug0 ( e.g.  drug1  drug0  drug0 )  hiv protease or drug0 ( e.g.  drug0  drug0  drug0  drug0 ) or drug2 ( e.g.  drug0  drug0  drug0 ) .,erythromycin,azole antifungals,FALSE,none
examples of some of the more potent cyp 3a4 inhibitors include macrolide drug0 ( e.g.  drug1  drug0  drug0 )  hiv protease or drug0 ( e.g.  drug0  drug0  drug0  drug0 ) or drug0 ( e.g.  drug2  drug0  drug0 ) .,erythromycin,ketoconazole,FALSE,none
examples of some of the more potent cyp 3a4 inhibitors include macrolide drug0 ( e.g.  drug1  drug0  drug0 )  hiv protease or drug0 ( e.g.  drug0  drug0  drug0  drug0 ) or drug0 ( e.g.  drug0  drug2  drug0 ) .,erythromycin,itraconazole,FALSE,none
examples of some of the more potent cyp 3a4 inhibitors include macrolide drug0 ( e.g.  drug1  drug0  drug0 )  hiv protease or drug0 ( e.g.  drug0  drug0  drug0  drug0 ) or drug0 ( e.g.  drug0  drug0  drug2 ) .,erythromycin,voriconazole,FALSE,none
examples of some of the more potent cyp 3a4 inhibitors include macrolide drug0 ( e.g.  drug0  drug1  drug0 )  hiv protease or drug0 ( e.g.  drug0  drug0  drug0  drug0 ) or drug0 ( e.g.  drug0  drug0  drug0 ) .,troleandomycin,hiv protease inhibitors,FALSE,none
examples of some of the more potent cyp 3a4 inhibitors include macrolide drug0 ( e.g.  drug0  drug1  drug0 )  hiv protease or drug2 ( e.g.  drug0  drug0  drug0  drug0 ) or drug0 ( e.g.  drug0  drug0  drug0 ) .,troleandomycin,reverse transcriptase inhibitors,FALSE,none
examples of some of the more potent cyp 3a4 inhibitors include macrolide drug0 ( e.g.  drug0  drug1  drug0 )  hiv protease or drug0 ( e.g.  drug2  drug0  drug0  drug0 ) or drug0 ( e.g.  drug0  drug0  drug0 ) .,troleandomycin,ritonavir,FALSE,none
examples of some of the more potent cyp 3a4 inhibitors include macrolide drug0 ( e.g.  drug0  drug1  drug0 )  hiv protease or drug0 ( e.g.  drug0  drug2  drug0  drug0 ) or drug0 ( e.g.  drug0  drug0  drug0 ) .,troleandomycin,indinavir,FALSE,none
examples of some of the more potent cyp 3a4 inhibitors include macrolide drug0 ( e.g.  drug0  drug1  drug0 )  hiv protease or drug0 ( e.g.  drug0  drug0  drug2  drug0 ) or drug0 ( e.g.  drug0  drug0  drug0 ) .,troleandomycin,nelfinavir,FALSE,none
examples of some of the more potent cyp 3a4 inhibitors include macrolide drug0 ( e.g.  drug0  drug1  drug0 )  hiv protease or drug0 ( e.g.  drug0  drug0  drug0  drug2 ) or drug0 ( e.g.  drug0  drug0  drug0 ) .,troleandomycin,delavirdine,FALSE,none
examples of some of the more potent cyp 3a4 inhibitors include macrolide drug0 ( e.g.  drug0  drug1  drug0 )  hiv protease or drug0 ( e.g.  drug0  drug0  drug0  drug0 ) or drug2 ( e.g.  drug0  drug0  drug0 ) .,troleandomycin,azole antifungals,FALSE,none
examples of some of the more potent cyp 3a4 inhibitors include macrolide drug0 ( e.g.  drug0  drug1  drug0 )  hiv protease or drug0 ( e.g.  drug0  drug0  drug0  drug0 ) or drug0 ( e.g.  drug2  drug0  drug0 ) .,troleandomycin,ketoconazole,FALSE,none
examples of some of the more potent cyp 3a4 inhibitors include macrolide drug0 ( e.g.  drug0  drug1  drug0 )  hiv protease or drug0 ( e.g.  drug0  drug0  drug0  drug0 ) or drug0 ( e.g.  drug0  drug2  drug0 ) .,troleandomycin,itraconazole,FALSE,none
examples of some of the more potent cyp 3a4 inhibitors include macrolide drug0 ( e.g.  drug0  drug1  drug0 )  hiv protease or drug0 ( e.g.  drug0  drug0  drug0  drug0 ) or drug0 ( e.g.  drug0  drug0  drug2 ) .,troleandomycin,voriconazole,FALSE,none
examples of some of the more potent cyp 3a4 inhibitors include macrolide drug0 ( e.g.  drug0  drug0  drug1 )  hiv protease or drug0 ( e.g.  drug0  drug0  drug0  drug0 ) or drug0 ( e.g.  drug0  drug0  drug0 ) .,clarithromycin,hiv protease inhibitors,FALSE,none
examples of some of the more potent cyp 3a4 inhibitors include macrolide drug0 ( e.g.  drug0  drug0  drug1 )  hiv protease or drug2 ( e.g.  drug0  drug0  drug0  drug0 ) or drug0 ( e.g.  drug0  drug0  drug0 ) .,clarithromycin,reverse transcriptase inhibitors,FALSE,none
examples of some of the more potent cyp 3a4 inhibitors include macrolide drug0 ( e.g.  drug0  drug0  drug1 )  hiv protease or drug0 ( e.g.  drug2  drug0  drug0  drug0 ) or drug0 ( e.g.  drug0  drug0  drug0 ) .,clarithromycin,ritonavir,FALSE,none
examples of some of the more potent cyp 3a4 inhibitors include macrolide drug0 ( e.g.  drug0  drug0  drug1 )  hiv protease or drug0 ( e.g.  drug0  drug2  drug0  drug0 ) or drug0 ( e.g.  drug0  drug0  drug0 ) .,clarithromycin,indinavir,FALSE,none
examples of some of the more potent cyp 3a4 inhibitors include macrolide drug0 ( e.g.  drug0  drug0  drug1 )  hiv protease or drug0 ( e.g.  drug0  drug0  drug2  drug0 ) or drug0 ( e.g.  drug0  drug0  drug0 ) .,clarithromycin,nelfinavir,FALSE,none
examples of some of the more potent cyp 3a4 inhibitors include macrolide drug0 ( e.g.  drug0  drug0  drug1 )  hiv protease or drug0 ( e.g.  drug0  drug0  drug0  drug2 ) or drug0 ( e.g.  drug0  drug0  drug0 ) .,clarithromycin,delavirdine,FALSE,none
examples of some of the more potent cyp 3a4 inhibitors include macrolide drug0 ( e.g.  drug0  drug0  drug1 )  hiv protease or drug0 ( e.g.  drug0  drug0  drug0  drug0 ) or drug2 ( e.g.  drug0  drug0  drug0 ) .,clarithromycin,azole antifungals,FALSE,none
examples of some of the more potent cyp 3a4 inhibitors include macrolide drug0 ( e.g.  drug0  drug0  drug1 )  hiv protease or drug0 ( e.g.  drug0  drug0  drug0  drug0 ) or drug0 ( e.g.  drug2  drug0  drug0 ) .,clarithromycin,ketoconazole,FALSE,none
examples of some of the more potent cyp 3a4 inhibitors include macrolide drug0 ( e.g.  drug0  drug0  drug1 )  hiv protease or drug0 ( e.g.  drug0  drug0  drug0  drug0 ) or drug0 ( e.g.  drug0  drug2  drug0 ) .,clarithromycin,itraconazole,FALSE,none
examples of some of the more potent cyp 3a4 inhibitors include macrolide drug0 ( e.g.  drug0  drug0  drug1 )  hiv protease or drug0 ( e.g.  drug0  drug0  drug0  drug0 ) or drug0 ( e.g.  drug0  drug0  drug2 ) .,clarithromycin,voriconazole,FALSE,none
examples of some of the more potent cyp 3a4 inhibitors include macrolide drug0 ( e.g.  drug0  drug0  drug0 )  hiv protease or drug2 ( e.g.  drug0  drug0  drug0  drug0 ) or drug0 ( e.g.  drug0  drug0  drug0 ) .,hiv protease inhibitors,reverse transcriptase inhibitors,FALSE,none
examples of some of the more potent cyp 3a4 inhibitors include macrolide drug0 ( e.g.  drug0  drug0  drug0 )  hiv protease or drug0 ( e.g.  drug2  drug0  drug0  drug0 ) or drug0 ( e.g.  drug0  drug0  drug0 ) .,hiv protease inhibitors,ritonavir,FALSE,none
examples of some of the more potent cyp 3a4 inhibitors include macrolide drug0 ( e.g.  drug0  drug0  drug0 )  hiv protease or drug0 ( e.g.  drug0  drug2  drug0  drug0 ) or drug0 ( e.g.  drug0  drug0  drug0 ) .,hiv protease inhibitors,indinavir,FALSE,none
examples of some of the more potent cyp 3a4 inhibitors include macrolide drug0 ( e.g.  drug0  drug0  drug0 )  hiv protease or drug0 ( e.g.  drug0  drug0  drug2  drug0 ) or drug0 ( e.g.  drug0  drug0  drug0 ) .,hiv protease inhibitors,nelfinavir,FALSE,none
examples of some of the more potent cyp 3a4 inhibitors include macrolide drug0 ( e.g.  drug0  drug0  drug0 )  hiv protease or drug0 ( e.g.  drug0  drug0  drug0  drug2 ) or drug0 ( e.g.  drug0  drug0  drug0 ) .,hiv protease inhibitors,delavirdine,FALSE,none
examples of some of the more potent cyp 3a4 inhibitors include macrolide drug0 ( e.g.  drug0  drug0  drug0 )  hiv protease or drug0 ( e.g.  drug0  drug0  drug0  drug0 ) or drug2 ( e.g.  drug0  drug0  drug0 ) .,hiv protease inhibitors,azole antifungals,FALSE,none
examples of some of the more potent cyp 3a4 inhibitors include macrolide drug0 ( e.g.  drug0  drug0  drug0 )  hiv protease or drug0 ( e.g.  drug0  drug0  drug0  drug0 ) or drug0 ( e.g.  drug2  drug0  drug0 ) .,hiv protease inhibitors,ketoconazole,FALSE,none
examples of some of the more potent cyp 3a4 inhibitors include macrolide drug0 ( e.g.  drug0  drug0  drug0 )  hiv protease or drug0 ( e.g.  drug0  drug0  drug0  drug0 ) or drug0 ( e.g.  drug0  drug2  drug0 ) .,hiv protease inhibitors,itraconazole,FALSE,none
examples of some of the more potent cyp 3a4 inhibitors include macrolide drug0 ( e.g.  drug0  drug0  drug0 )  hiv protease or drug0 ( e.g.  drug0  drug0  drug0  drug0 ) or drug0 ( e.g.  drug0  drug0  drug2 ) .,hiv protease inhibitors,voriconazole,FALSE,none
examples of some of the more potent cyp 3a4 inhibitors include macrolide drug0 ( e.g.  drug0  drug0  drug0 )  hiv protease or drug1 ( e.g.  drug2  drug0  drug0  drug0 ) or drug0 ( e.g.  drug0  drug0  drug0 ) .,reverse transcriptase inhibitors,ritonavir,FALSE,none
examples of some of the more potent cyp 3a4 inhibitors include macrolide drug0 ( e.g.  drug0  drug0  drug0 )  hiv protease or drug1 ( e.g.  drug0  drug2  drug0  drug0 ) or drug0 ( e.g.  drug0  drug0  drug0 ) .,reverse transcriptase inhibitors,indinavir,FALSE,none
examples of some of the more potent cyp 3a4 inhibitors include macrolide drug0 ( e.g.  drug0  drug0  drug0 )  hiv protease or drug1 ( e.g.  drug0  drug0  drug2  drug0 ) or drug0 ( e.g.  drug0  drug0  drug0 ) .,reverse transcriptase inhibitors,nelfinavir,FALSE,none
examples of some of the more potent cyp 3a4 inhibitors include macrolide drug0 ( e.g.  drug0  drug0  drug0 )  hiv protease or drug1 ( e.g.  drug0  drug0  drug0  drug2 ) or drug0 ( e.g.  drug0  drug0  drug0 ) .,reverse transcriptase inhibitors,delavirdine,FALSE,none
examples of some of the more potent cyp 3a4 inhibitors include macrolide drug0 ( e.g.  drug0  drug0  drug0 )  hiv protease or drug1 ( e.g.  drug0  drug0  drug0  drug0 ) or drug2 ( e.g.  drug0  drug0  drug0 ) .,reverse transcriptase inhibitors,azole antifungals,FALSE,none
examples of some of the more potent cyp 3a4 inhibitors include macrolide drug0 ( e.g.  drug0  drug0  drug0 )  hiv protease or drug1 ( e.g.  drug0  drug0  drug0  drug0 ) or drug0 ( e.g.  drug2  drug0  drug0 ) .,reverse transcriptase inhibitors,ketoconazole,FALSE,none
examples of some of the more potent cyp 3a4 inhibitors include macrolide drug0 ( e.g.  drug0  drug0  drug0 )  hiv protease or drug1 ( e.g.  drug0  drug0  drug0  drug0 ) or drug0 ( e.g.  drug0  drug2  drug0 ) .,reverse transcriptase inhibitors,itraconazole,FALSE,none
examples of some of the more potent cyp 3a4 inhibitors include macrolide drug0 ( e.g.  drug0  drug0  drug0 )  hiv protease or drug1 ( e.g.  drug0  drug0  drug0  drug0 ) or drug0 ( e.g.  drug0  drug0  drug2 ) .,reverse transcriptase inhibitors,voriconazole,FALSE,none
examples of some of the more potent cyp 3a4 inhibitors include macrolide drug0 ( e.g.  drug0  drug0  drug0 )  hiv protease or drug0 ( e.g.  drug1  drug0  drug0  drug0 ) or drug2 ( e.g.  drug0  drug0  drug0 ) .,ritonavir,azole antifungals,FALSE,none
examples of some of the more potent cyp 3a4 inhibitors include macrolide drug0 ( e.g.  drug0  drug0  drug0 )  hiv protease or drug0 ( e.g.  drug1  drug0  drug0  drug0 ) or drug0 ( e.g.  drug2  drug0  drug0 ) .,ritonavir,ketoconazole,FALSE,none
examples of some of the more potent cyp 3a4 inhibitors include macrolide drug0 ( e.g.  drug0  drug0  drug0 )  hiv protease or drug0 ( e.g.  drug1  drug0  drug0  drug0 ) or drug0 ( e.g.  drug0  drug2  drug0 ) .,ritonavir,itraconazole,FALSE,none
examples of some of the more potent cyp 3a4 inhibitors include macrolide drug0 ( e.g.  drug0  drug0  drug0 )  hiv protease or drug0 ( e.g.  drug1  drug0  drug0  drug0 ) or drug0 ( e.g.  drug0  drug0  drug2 ) .,ritonavir,voriconazole,FALSE,none
examples of some of the more potent cyp 3a4 inhibitors include macrolide drug0 ( e.g.  drug0  drug0  drug0 )  hiv protease or drug0 ( e.g.  drug0  drug1  drug0  drug0 ) or drug2 ( e.g.  drug0  drug0  drug0 ) .,indinavir,azole antifungals,FALSE,none
examples of some of the more potent cyp 3a4 inhibitors include macrolide drug0 ( e.g.  drug0  drug0  drug0 )  hiv protease or drug0 ( e.g.  drug0  drug1  drug0  drug0 ) or drug0 ( e.g.  drug2  drug0  drug0 ) .,indinavir,ketoconazole,FALSE,none
examples of some of the more potent cyp 3a4 inhibitors include macrolide drug0 ( e.g.  drug0  drug0  drug0 )  hiv protease or drug0 ( e.g.  drug0  drug1  drug0  drug0 ) or drug0 ( e.g.  drug0  drug2  drug0 ) .,indinavir,itraconazole,FALSE,none
examples of some of the more potent cyp 3a4 inhibitors include macrolide drug0 ( e.g.  drug0  drug0  drug0 )  hiv protease or drug0 ( e.g.  drug0  drug1  drug0  drug0 ) or drug0 ( e.g.  drug0  drug0  drug2 ) .,indinavir,voriconazole,FALSE,none
examples of some of the more potent cyp 3a4 inhibitors include macrolide drug0 ( e.g.  drug0  drug0  drug0 )  hiv protease or drug0 ( e.g.  drug0  drug0  drug1  drug0 ) or drug2 ( e.g.  drug0  drug0  drug0 ) .,nelfinavir,azole antifungals,FALSE,none
examples of some of the more potent cyp 3a4 inhibitors include macrolide drug0 ( e.g.  drug0  drug0  drug0 )  hiv protease or drug0 ( e.g.  drug0  drug0  drug1  drug0 ) or drug0 ( e.g.  drug2  drug0  drug0 ) .,nelfinavir,ketoconazole,FALSE,none
examples of some of the more potent cyp 3a4 inhibitors include macrolide drug0 ( e.g.  drug0  drug0  drug0 )  hiv protease or drug0 ( e.g.  drug0  drug0  drug1  drug0 ) or drug0 ( e.g.  drug0  drug2  drug0 ) .,nelfinavir,itraconazole,FALSE,none
examples of some of the more potent cyp 3a4 inhibitors include macrolide drug0 ( e.g.  drug0  drug0  drug0 )  hiv protease or drug0 ( e.g.  drug0  drug0  drug1  drug0 ) or drug0 ( e.g.  drug0  drug0  drug2 ) .,nelfinavir,voriconazole,FALSE,none
examples of some of the more potent cyp 3a4 inhibitors include macrolide drug0 ( e.g.  drug0  drug0  drug0 )  hiv protease or drug0 ( e.g.  drug0  drug0  drug0  drug1 ) or drug2 ( e.g.  drug0  drug0  drug0 ) .,delavirdine,azole antifungals,FALSE,none
examples of some of the more potent cyp 3a4 inhibitors include macrolide drug0 ( e.g.  drug0  drug0  drug0 )  hiv protease or drug0 ( e.g.  drug0  drug0  drug0  drug1 ) or drug0 ( e.g.  drug2  drug0  drug0 ) .,delavirdine,ketoconazole,FALSE,none
examples of some of the more potent cyp 3a4 inhibitors include macrolide drug0 ( e.g.  drug0  drug0  drug0 )  hiv protease or drug0 ( e.g.  drug0  drug0  drug0  drug1 ) or drug0 ( e.g.  drug0  drug2  drug0 ) .,delavirdine,itraconazole,FALSE,none
examples of some of the more potent cyp 3a4 inhibitors include macrolide drug0 ( e.g.  drug0  drug0  drug0 )  hiv protease or drug0 ( e.g.  drug0  drug0  drug0  drug1 ) or drug0 ( e.g.  drug0  drug0  drug2 ) .,delavirdine,voriconazole,FALSE,none
examples of some of the more potent cyp 3a4 inhibitors include macrolide drug0 ( e.g.  drug0  drug0  drug0 )  hiv protease or drug0 ( e.g.  drug0  drug0  drug0  drug0 ) or drug1 ( e.g.  drug2  drug0  drug0 ) .,azole antifungals,ketoconazole,FALSE,none
examples of some of the more potent cyp 3a4 inhibitors include macrolide drug0 ( e.g.  drug0  drug0  drug0 )  hiv protease or drug0 ( e.g.  drug0  drug0  drug0  drug0 ) or drug1 ( e.g.  drug0  drug2  drug0 ) .,azole antifungals,itraconazole,FALSE,none
examples of some of the more potent cyp 3a4 inhibitors include macrolide drug0 ( e.g.  drug0  drug0  drug0 )  hiv protease or drug0 ( e.g.  drug0  drug0  drug0  drug0 ) or drug1 ( e.g.  drug0  drug0  drug2 ) .,azole antifungals,voriconazole,FALSE,none
less potent inhibitors include drug1  drug0  drug0  grapefruit juice  drug0  drug0  drug0  and drug2 .,saquinavir,clotrimazole,FALSE,none
less potent inhibitors include drug0  drug1  drug0  grapefruit juice  drug0  drug0  drug0  and drug2 .,nefazodone,clotrimazole,FALSE,none
less potent inhibitors include drug0  drug0  drug1  grapefruit juice  drug0  drug0  drug0  and drug2 .,fluconazole,clotrimazole,FALSE,none
less potent inhibitors include drug0  drug0  drug0  grapefruit juice  drug0  drug0  drug1  and drug2 .,zileuton,clotrimazole,FALSE,none
caution should be exercised when drug1 ( drug2 ) is used concurrently with other drug0 or drug0 .,methergine,methylergonovine maleate,FALSE,none
caution should be exercised when drug1 ( drug0 ) is used concurrently with other drug2 or drug0 .,methergine,vasoconstrictors,TRUE,advise
caution should be exercised when drug1 ( drug0 ) is used concurrently with other drug0 or drug2 .,methergine,ergot alkaloids,TRUE,advise
caution should be exercised when drug0 ( drug1 ) is used concurrently with other drug2 or drug0 .,methylergonovine maleate,vasoconstrictors,TRUE,advise
caution should be exercised when drug0 ( drug1 ) is used concurrently with other drug0 or drug2 .,methylergonovine maleate,ergot alkaloids,FALSE,none
caution should be exercised when drug0 ( drug0 ) is used concurrently with other drug1 or drug2 .,vasoconstrictors,ergot alkaloids,FALSE,none
drug1 may decrease the hypotensive effect of drug2 .,ritalin,guanethidine,TRUE,effect
human pharmacologic studies have shown that drug1 may inhibit the metabolism of drug2  drug0 ( drug0  drug0  drug0 )  drug0  and drug0 drugs ( drug0  drug0  drug0 ) .,ritalin,coumarin anticoagulants,TRUE,mechanism
human pharmacologic studies have shown that drug1 may inhibit the metabolism of drug0 drug0  drug2 ( drug0  drug0  drug0 )  drug0  and drug0 drugs ( drug0  drug0  drug0 ) .,ritalin,anticonvulsants,TRUE,mechanism
human pharmacologic studies have shown that drug1 may inhibit the metabolism of drug0 drug0  drug0 ( drug2  drug0  drug0 )  drug0  and drug0 drugs ( drug0  drug0  drug0 ) .,ritalin,phenobarbital,TRUE,mechanism
human pharmacologic studies have shown that drug1 may inhibit the metabolism of drug0 drug0  drug0 ( drug0  drug2  drug0 )  drug0  and drug0 drugs ( drug0  drug0  drug0 ) .,ritalin,diphenylhydantoin,TRUE,mechanism
human pharmacologic studies have shown that drug1 may inhibit the metabolism of drug0 drug0  drug0 ( drug0  drug0  drug2 )  drug0  and drug0 drugs ( drug0  drug0  drug0 ) .,ritalin,primidone,TRUE,mechanism
human pharmacologic studies have shown that drug1 may inhibit the metabolism of drug0 drug0  drug0 ( drug0  drug0  drug0 )  drug2  and drug0 drugs ( drug0  drug0  drug0 ) .,ritalin,phenylbutazone,TRUE,mechanism
human pharmacologic studies have shown that drug1 may inhibit the metabolism of drug0 drug0  drug0 ( drug0  drug0  drug0 )  drug0  and drug2 ( drug0  drug0  drug0 ) .,ritalin,tricyclic drugs,TRUE,mechanism
human pharmacologic studies have shown that drug1 may inhibit the metabolism of drug0 drug0  drug0 ( drug0  drug0  drug0 )  drug0  and drug0 drugs ( drug2  drug0  drug0 ) .,ritalin,imipramine,TRUE,mechanism
human pharmacologic studies have shown that drug1 may inhibit the metabolism of drug0 drug0  drug0 ( drug0  drug0  drug0 )  drug0  and drug0 drugs ( drug0  drug2  drug0 ) .,ritalin,clomipramine,TRUE,mechanism
human pharmacologic studies have shown that drug1 may inhibit the metabolism of drug0 drug0  drug0 ( drug0  drug0  drug0 )  drug0  and drug0 drugs ( drug0  drug0  drug2 ) .,ritalin,desipramine,TRUE,mechanism
human pharmacologic studies have shown that drug0 may inhibit the metabolism of drug1  drug0 ( drug2  drug0  drug0 )  drug0  and drug0 drugs ( drug0  drug0  drug0 ) .,coumarin anticoagulants,phenobarbital,FALSE,none
human pharmacologic studies have shown that drug0 may inhibit the metabolism of drug1  drug0 ( drug0  drug2  drug0 )  drug0  and drug0 drugs ( drug0  drug0  drug0 ) .,coumarin anticoagulants,diphenylhydantoin,FALSE,none
human pharmacologic studies have shown that drug0 may inhibit the metabolism of drug1  drug0 ( drug0  drug0  drug2 )  drug0  and drug0 drugs ( drug0  drug0  drug0 ) .,coumarin anticoagulants,primidone,FALSE,none
human pharmacologic studies have shown that drug0 may inhibit the metabolism of drug1  drug0 ( drug0  drug0  drug0 )  drug2  and drug0 drugs ( drug0  drug0  drug0 ) .,coumarin anticoagulants,phenylbutazone,FALSE,none
human pharmacologic studies have shown that drug0 may inhibit the metabolism of drug1  drug0 ( drug0  drug0  drug0 )  drug0  and drug2 ( drug0  drug0  drug0 ) .,coumarin anticoagulants,tricyclic drugs,FALSE,none
human pharmacologic studies have shown that drug0 may inhibit the metabolism of drug1  drug0 ( drug0  drug0  drug0 )  drug0  and drug0 drugs ( drug2  drug0  drug0 ) .,coumarin anticoagulants,imipramine,FALSE,none
human pharmacologic studies have shown that drug0 may inhibit the metabolism of drug1  drug0 ( drug0  drug0  drug0 )  drug0  and drug0 drugs ( drug0  drug2  drug0 ) .,coumarin anticoagulants,clomipramine,FALSE,none
human pharmacologic studies have shown that drug0 may inhibit the metabolism of drug1  drug0 ( drug0  drug0  drug0 )  drug0  and drug0 drugs ( drug0  drug0  drug2 ) .,coumarin anticoagulants,desipramine,FALSE,none
human pharmacologic studies have shown that drug0 may inhibit the metabolism of drug0 drug0  drug1 ( drug2  drug0  drug0 )  drug0  and drug0 drugs ( drug0  drug0  drug0 ) .,anticonvulsants,phenobarbital,FALSE,none
human pharmacologic studies have shown that drug0 may inhibit the metabolism of drug0 drug0  drug1 ( drug0  drug2  drug0 )  drug0  and drug0 drugs ( drug0  drug0  drug0 ) .,anticonvulsants,diphenylhydantoin,FALSE,none
human pharmacologic studies have shown that drug0 may inhibit the metabolism of drug0 drug0  drug1 ( drug0  drug0  drug2 )  drug0  and drug0 drugs ( drug0  drug0  drug0 ) .,anticonvulsants,primidone,FALSE,none
human pharmacologic studies have shown that drug0 may inhibit the metabolism of drug0 drug0  drug1 ( drug0  drug0  drug0 )  drug2  and drug0 drugs ( drug0  drug0  drug0 ) .,anticonvulsants,phenylbutazone,FALSE,none
human pharmacologic studies have shown that drug0 may inhibit the metabolism of drug0 drug0  drug1 ( drug0  drug0  drug0 )  drug0  and drug2 ( drug0  drug0  drug0 ) .,anticonvulsants,tricyclic drugs,FALSE,none
human pharmacologic studies have shown that drug0 may inhibit the metabolism of drug0 drug0  drug1 ( drug0  drug0  drug0 )  drug0  and drug0 drugs ( drug2  drug0  drug0 ) .,anticonvulsants,imipramine,FALSE,none
human pharmacologic studies have shown that drug0 may inhibit the metabolism of drug0 drug0  drug1 ( drug0  drug0  drug0 )  drug0  and drug0 drugs ( drug0  drug2  drug0 ) .,anticonvulsants,clomipramine,FALSE,none
human pharmacologic studies have shown that drug0 may inhibit the metabolism of drug0 drug0  drug1 ( drug0  drug0  drug0 )  drug0  and drug0 drugs ( drug0  drug0  drug2 ) .,anticonvulsants,desipramine,FALSE,none
human pharmacologic studies have shown that drug0 may inhibit the metabolism of drug0 drug0  drug0 ( drug1  drug0  drug0 )  drug2  and drug0 drugs ( drug0  drug0  drug0 ) .,phenobarbital,phenylbutazone,FALSE,none
human pharmacologic studies have shown that drug0 may inhibit the metabolism of drug0 drug0  drug0 ( drug1  drug0  drug0 )  drug0  and drug2 ( drug0  drug0  drug0 ) .,phenobarbital,tricyclic drugs,FALSE,none
human pharmacologic studies have shown that drug0 may inhibit the metabolism of drug0 drug0  drug0 ( drug1  drug0  drug0 )  drug0  and drug0 drugs ( drug2  drug0  drug0 ) .,phenobarbital,imipramine,FALSE,none
human pharmacologic studies have shown that drug0 may inhibit the metabolism of drug0 drug0  drug0 ( drug1  drug0  drug0 )  drug0  and drug0 drugs ( drug0  drug2  drug0 ) .,phenobarbital,clomipramine,FALSE,none
human pharmacologic studies have shown that drug0 may inhibit the metabolism of drug0 drug0  drug0 ( drug1  drug0  drug0 )  drug0  and drug0 drugs ( drug0  drug0  drug2 ) .,phenobarbital,desipramine,FALSE,none
human pharmacologic studies have shown that drug0 may inhibit the metabolism of drug0 drug0  drug0 ( drug0  drug1  drug0 )  drug2  and drug0 drugs ( drug0  drug0  drug0 ) .,diphenylhydantoin,phenylbutazone,FALSE,none
human pharmacologic studies have shown that drug0 may inhibit the metabolism of drug0 drug0  drug0 ( drug0  drug1  drug0 )  drug0  and drug2 ( drug0  drug0  drug0 ) .,diphenylhydantoin,tricyclic drugs,FALSE,none
human pharmacologic studies have shown that drug0 may inhibit the metabolism of drug0 drug0  drug0 ( drug0  drug1  drug0 )  drug0  and drug0 drugs ( drug2  drug0  drug0 ) .,diphenylhydantoin,imipramine,FALSE,none
human pharmacologic studies have shown that drug0 may inhibit the metabolism of drug0 drug0  drug0 ( drug0  drug1  drug0 )  drug0  and drug0 drugs ( drug0  drug2  drug0 ) .,diphenylhydantoin,clomipramine,FALSE,none
human pharmacologic studies have shown that drug0 may inhibit the metabolism of drug0 drug0  drug0 ( drug0  drug1  drug0 )  drug0  and drug0 drugs ( drug0  drug0  drug2 ) .,diphenylhydantoin,desipramine,FALSE,none
human pharmacologic studies have shown that drug0 may inhibit the metabolism of drug0 drug0  drug0 ( drug0  drug0  drug1 )  drug2  and drug0 drugs ( drug0  drug0  drug0 ) .,primidone,phenylbutazone,FALSE,none
human pharmacologic studies have shown that drug0 may inhibit the metabolism of drug0 drug0  drug0 ( drug0  drug0  drug1 )  drug0  and drug2 ( drug0  drug0  drug0 ) .,primidone,tricyclic drugs,FALSE,none
human pharmacologic studies have shown that drug0 may inhibit the metabolism of drug0 drug0  drug0 ( drug0  drug0  drug1 )  drug0  and drug0 drugs ( drug2  drug0  drug0 ) .,primidone,imipramine,FALSE,none
human pharmacologic studies have shown that drug0 may inhibit the metabolism of drug0 drug0  drug0 ( drug0  drug0  drug1 )  drug0  and drug0 drugs ( drug0  drug2  drug0 ) .,primidone,clomipramine,FALSE,none
human pharmacologic studies have shown that drug0 may inhibit the metabolism of drug0 drug0  drug0 ( drug0  drug0  drug1 )  drug0  and drug0 drugs ( drug0  drug0  drug2 ) .,primidone,desipramine,FALSE,none
human pharmacologic studies have shown that drug0 may inhibit the metabolism of drug0 drug0  drug0 ( drug0  drug0  drug0 )  drug1  and drug2 ( drug0  drug0  drug0 ) .,phenylbutazone,tricyclic drugs,FALSE,none
human pharmacologic studies have shown that drug0 may inhibit the metabolism of drug0 drug0  drug0 ( drug0  drug0  drug0 )  drug1  and drug0 drugs ( drug2  drug0  drug0 ) .,phenylbutazone,imipramine,FALSE,none
human pharmacologic studies have shown that drug0 may inhibit the metabolism of drug0 drug0  drug0 ( drug0  drug0  drug0 )  drug1  and drug0 drugs ( drug0  drug2  drug0 ) .,phenylbutazone,clomipramine,FALSE,none
human pharmacologic studies have shown that drug0 may inhibit the metabolism of drug0 drug0  drug0 ( drug0  drug0  drug0 )  drug1  and drug0 drugs ( drug0  drug0  drug2 ) .,phenylbutazone,desipramine,FALSE,none
human pharmacologic studies have shown that drug0 may inhibit the metabolism of drug0 drug0  drug0 ( drug0  drug0  drug0 )  drug0  and drug1 ( drug2  drug0  drug0 ) .,tricyclic drugs,imipramine,FALSE,none
human pharmacologic studies have shown that drug0 may inhibit the metabolism of drug0 drug0  drug0 ( drug0  drug0  drug0 )  drug0  and drug1 ( drug0  drug2  drug0 ) .,tricyclic drugs,clomipramine,FALSE,none
human pharmacologic studies have shown that drug0 may inhibit the metabolism of drug0 drug0  drug0 ( drug0  drug0  drug0 )  drug0  and drug1 ( drug0  drug0  drug2 ) .,tricyclic drugs,desipramine,FALSE,none
mutual inhibition of metabolism occurs with concurrent use of drug1 and drug2 ;,cyclosporin,methylprednisolone,TRUE,mechanism
convulsions have been reported with concurrent use of drug1 and drug2 .,methylprednisolone,cyclosporin,TRUE,effect
drugs that induce hepatic enzymes such as drug1  drug0  and drug0 may increase the clearance of drug2 and may require increased in drug0 dose to achieve the desired response .,phenobarbital,methylprednisolone,TRUE,mechanism
drugs that induce hepatic enzymes such as drug1  drug0  and drug0 may increase the clearance of drug2 and may require increased in drug0 dose to achieve the desired response .,phenobarbital,methylprednisolone,TRUE,advise
drugs that induce hepatic enzymes such as drug0  drug1  and drug2 may increase the clearance of drug0 and may require increased in drug0 dose to achieve the desired response .,phenytoin,rifampin,FALSE,none
drugs that induce hepatic enzymes such as drug0  drug1  and drug0 may increase the clearance of drug2 and may require increased in drug0 dose to achieve the desired response .,phenytoin,methylprednisolone,TRUE,mechanism
drugs that induce hepatic enzymes such as drug0  drug1  and drug0 may increase the clearance of drug2 and may require increased in drug0 dose to achieve the desired response .,phenytoin,methylprednisolone,TRUE,advise
drugs that induce hepatic enzymes such as drug0  drug0  and drug1 may increase the clearance of drug2 and may require increased in drug0 dose to achieve the desired response .,rifampin,methylprednisolone,TRUE,mechanism
drugs that induce hepatic enzymes such as drug0  drug0  and drug1 may increase the clearance of drug2 and may require increased in drug0 dose to achieve the desired response .,rifampin,methylprednisolone,TRUE,advise
drugs such as drug1 and drug2 may inhibit the metabolism of drug0 and thus decrease its clearance .,troleandomycin,ketoconazole,FALSE,none
drugs such as drug1 and drug0 may inhibit the metabolism of drug2 and thus decrease its clearance .,troleandomycin,methylprednisolone,TRUE,mechanism
drugs such as drug0 and drug1 may inhibit the metabolism of drug2 and thus decrease its clearance .,ketoconazole,methylprednisolone,TRUE,mechanism
drug1 may increase the clearance of chronic hidrug0 dose drug2 .,methylprednisolone,aspirin,TRUE,mechanism
this could lead to decreased drug1 serum levels or increase the risk of drug0 toxicity when drug2 is withdrawn .,salicylate,methylprednisolone,FALSE,none
this could lead to decreased drug1 serum levels or increase the risk of drug0 toxicity when drug2 is withdrawn .,salicylate,methylprednisolone,TRUE,effect
drug1 should be used cautiously in conjunction with drug2 in patients suffering from hypoprothrombinemia .,aspirin,corticosteroids,TRUE,advise
the effect of drug1 on oral drug2 is variable .,methylprednisolone,anticoagulants,FALSE,none
there are reports of enhanced as well as diminished effects of drug1 when given concurrently with drug2 .,anticoagulant,corticosteroids,TRUE,effect
drug1 may interact with drug2 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,methscopolamine,antidepressants,FALSE,none
drug1 may interact with drug0 ( drug2 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,methscopolamine,tricyclic,TRUE,int
drug1 may interact with drug0 ( drug0 type )  drug2 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,methscopolamine,mao inhibitors,TRUE,int
drug1 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug2  drug0  drug0  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,methscopolamine,phenelzine,TRUE,int
drug1 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug2  drug0  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,methscopolamine,linezolid,TRUE,int
drug1 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug2  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,methscopolamine,tranylcypromine,TRUE,int
drug1 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug2  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,methscopolamine,isocarboxazid,TRUE,int
drug1 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug2  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,methscopolamine,selegiline,TRUE,int
drug1 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug2 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,methscopolamine,furazolidone,TRUE,int
drug1 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug2  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,methscopolamine,quinidine,TRUE,int
drug1 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug0  drug2  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,methscopolamine,amantadine,TRUE,int
drug1 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug0  drug0  drug2 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,methscopolamine,antihistamines,TRUE,int
drug1 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug2 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,methscopolamine,diphenhydramine,TRUE,int
drug1 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug2  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,methscopolamine,anticholinergics,TRUE,int
drug1 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug2 supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,methscopolamine,potassium chloride,TRUE,int
drug1 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug2  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,methscopolamine,antacids,TRUE,int
drug1 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug2 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,methscopolamine,absorbent-type anti-diarrhea medicines,TRUE,int
drug1 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug2-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,methscopolamine,kaolin,TRUE,int
drug1 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug2 )  drug0 ( e.g.  drug0  drug0 ) .,methscopolamine,pectin,TRUE,int
drug1 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug2 ( e.g.  drug0  drug0 ) .,methscopolamine,phenothiazines,TRUE,int
drug1 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug2  drug0 ) .,methscopolamine,chlorpromazine,TRUE,int
drug1 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug2 ) .,methscopolamine,promethazine,TRUE,int
drug0 may interact with drug1 ( drug2 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,antidepressants,tricyclic,FALSE,none
drug0 may interact with drug1 ( drug0 type )  drug2 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,antidepressants,mao inhibitors,FALSE,none
drug0 may interact with drug1 ( drug0 type )  drug0 ( e.g.  drug2  drug0  drug0  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,antidepressants,phenelzine,FALSE,none
drug0 may interact with drug1 ( drug0 type )  drug0 ( e.g.  drug0  drug2  drug0  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,antidepressants,linezolid,FALSE,none
drug0 may interact with drug1 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug2  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,antidepressants,tranylcypromine,FALSE,none
drug0 may interact with drug1 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug2  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,antidepressants,isocarboxazid,FALSE,none
drug0 may interact with drug1 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug2  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,antidepressants,selegiline,FALSE,none
drug0 may interact with drug1 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug2 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,antidepressants,furazolidone,FALSE,none
drug0 may interact with drug1 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug2  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,antidepressants,quinidine,FALSE,none
drug0 may interact with drug1 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug0  drug2  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,antidepressants,amantadine,FALSE,none
drug0 may interact with drug1 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug0  drug0  drug2 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,antidepressants,antihistamines,FALSE,none
drug0 may interact with drug1 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug2 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,antidepressants,diphenhydramine,FALSE,none
drug0 may interact with drug1 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug2  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,antidepressants,anticholinergics,FALSE,none
drug0 may interact with drug1 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug2 supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,antidepressants,potassium chloride,FALSE,none
drug0 may interact with drug1 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug2  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,antidepressants,antacids,FALSE,none
drug0 may interact with drug1 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug2 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,antidepressants,absorbent-type anti-diarrhea medicines,FALSE,none
drug0 may interact with drug1 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug2-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,antidepressants,kaolin,FALSE,none
drug0 may interact with drug1 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug2 )  drug0 ( e.g.  drug0  drug0 ) .,antidepressants,pectin,FALSE,none
drug0 may interact with drug1 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug2 ( e.g.  drug0  drug0 ) .,antidepressants,phenothiazines,FALSE,none
drug0 may interact with drug1 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug2  drug0 ) .,antidepressants,chlorpromazine,FALSE,none
drug0 may interact with drug1 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug2 ) .,antidepressants,promethazine,FALSE,none
drug0 may interact with drug0 ( drug1 type )  drug2 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,tricyclic,mao inhibitors,FALSE,none
drug0 may interact with drug0 ( drug1 type )  drug0 ( e.g.  drug2  drug0  drug0  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,tricyclic,phenelzine,FALSE,none
drug0 may interact with drug0 ( drug1 type )  drug0 ( e.g.  drug0  drug2  drug0  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,tricyclic,linezolid,FALSE,none
drug0 may interact with drug0 ( drug1 type )  drug0 ( e.g.  drug0  drug0  drug2  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,tricyclic,tranylcypromine,FALSE,none
drug0 may interact with drug0 ( drug1 type )  drug0 ( e.g.  drug0  drug0  drug0  drug2  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,tricyclic,isocarboxazid,FALSE,none
drug0 may interact with drug0 ( drug1 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug2  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,tricyclic,selegiline,FALSE,none
drug0 may interact with drug0 ( drug1 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug2 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,tricyclic,furazolidone,FALSE,none
drug0 may interact with drug0 ( drug1 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug2  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,tricyclic,quinidine,FALSE,none
drug0 may interact with drug0 ( drug1 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug0  drug2  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,tricyclic,amantadine,FALSE,none
drug0 may interact with drug0 ( drug1 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug0  drug0  drug2 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,tricyclic,antihistamines,FALSE,none
drug0 may interact with drug0 ( drug1 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug2 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,tricyclic,diphenhydramine,FALSE,none
drug0 may interact with drug0 ( drug1 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug2  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,tricyclic,anticholinergics,FALSE,none
drug0 may interact with drug0 ( drug1 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug2 supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,tricyclic,potassium chloride,FALSE,none
drug0 may interact with drug0 ( drug1 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug2  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,tricyclic,antacids,FALSE,none
drug0 may interact with drug0 ( drug1 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug2 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,tricyclic,absorbent-type anti-diarrhea medicines,FALSE,none
drug0 may interact with drug0 ( drug1 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug2-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,tricyclic,kaolin,FALSE,none
drug0 may interact with drug0 ( drug1 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug2 )  drug0 ( e.g.  drug0  drug0 ) .,tricyclic,pectin,FALSE,none
drug0 may interact with drug0 ( drug1 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug2 ( e.g.  drug0  drug0 ) .,tricyclic,phenothiazines,FALSE,none
drug0 may interact with drug0 ( drug1 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug2  drug0 ) .,tricyclic,chlorpromazine,FALSE,none
drug0 may interact with drug0 ( drug1 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug2 ) .,tricyclic,promethazine,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug1 ( e.g.  drug2  drug0  drug0  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,mao inhibitors,phenelzine,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug1 ( e.g.  drug0  drug2  drug0  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,mao inhibitors,linezolid,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug1 ( e.g.  drug0  drug0  drug2  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,mao inhibitors,tranylcypromine,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug1 ( e.g.  drug0  drug0  drug0  drug2  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,mao inhibitors,isocarboxazid,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug1 ( e.g.  drug0  drug0  drug0  drug0  drug2  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,mao inhibitors,selegiline,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug1 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug2 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,mao inhibitors,furazolidone,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug1 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug2  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,mao inhibitors,quinidine,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug1 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug0  drug2  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,mao inhibitors,amantadine,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug1 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug0  drug0  drug2 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,mao inhibitors,antihistamines,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug1 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug2 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,mao inhibitors,diphenhydramine,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug1 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug2  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,mao inhibitors,anticholinergics,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug1 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug2 supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,mao inhibitors,potassium chloride,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug1 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug2  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,mao inhibitors,antacids,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug1 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug2 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,mao inhibitors,absorbent-type anti-diarrhea medicines,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug1 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug2-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,mao inhibitors,kaolin,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug1 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug2 )  drug0 ( e.g.  drug0  drug0 ) .,mao inhibitors,pectin,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug1 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug2 ( e.g.  drug0  drug0 ) .,mao inhibitors,phenothiazines,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug1 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug2  drug0 ) .,mao inhibitors,chlorpromazine,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug1 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug2 ) .,mao inhibitors,promethazine,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug1  drug0  drug0  drug0  drug0  drug0 )  drug2  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,phenelzine,quinidine,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug1  drug0  drug0  drug0  drug0  drug0 )  drug0  drug2  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,phenelzine,amantadine,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug1  drug0  drug0  drug0  drug0  drug0 )  drug0  drug0  drug2 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,phenelzine,antihistamines,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug1  drug0  drug0  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug2 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,phenelzine,diphenhydramine,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug1  drug0  drug0  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug2  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,phenelzine,anticholinergics,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug1  drug0  drug0  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug2 supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,phenelzine,potassium chloride,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug1  drug0  drug0  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug2  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,phenelzine,antacids,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug1  drug0  drug0  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug2 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,phenelzine,absorbent-type anti-diarrhea medicines,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug1  drug0  drug0  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug2-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,phenelzine,kaolin,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug1  drug0  drug0  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug2 )  drug0 ( e.g.  drug0  drug0 ) .,phenelzine,pectin,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug1  drug0  drug0  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug2 ( e.g.  drug0  drug0 ) .,phenelzine,phenothiazines,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug1  drug0  drug0  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug2  drug0 ) .,phenelzine,chlorpromazine,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug1  drug0  drug0  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug2 ) .,phenelzine,promethazine,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug1  drug0  drug0  drug0  drug0 )  drug2  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,linezolid,quinidine,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug1  drug0  drug0  drug0  drug0 )  drug0  drug2  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,linezolid,amantadine,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug1  drug0  drug0  drug0  drug0 )  drug0  drug0  drug2 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,linezolid,antihistamines,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug1  drug0  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug2 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,linezolid,diphenhydramine,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug1  drug0  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug2  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,linezolid,anticholinergics,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug1  drug0  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug2 supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,linezolid,potassium chloride,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug1  drug0  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug2  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,linezolid,antacids,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug1  drug0  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug2 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,linezolid,absorbent-type anti-diarrhea medicines,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug1  drug0  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug2-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,linezolid,kaolin,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug1  drug0  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug2 )  drug0 ( e.g.  drug0  drug0 ) .,linezolid,pectin,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug1  drug0  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug2 ( e.g.  drug0  drug0 ) .,linezolid,phenothiazines,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug1  drug0  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug2  drug0 ) .,linezolid,chlorpromazine,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug1  drug0  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug2 ) .,linezolid,promethazine,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug1  drug0  drug0  drug0 )  drug2  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,tranylcypromine,quinidine,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug1  drug0  drug0  drug0 )  drug0  drug2  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,tranylcypromine,amantadine,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug1  drug0  drug0  drug0 )  drug0  drug0  drug2 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,tranylcypromine,antihistamines,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug1  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug2 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,tranylcypromine,diphenhydramine,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug1  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug2  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,tranylcypromine,anticholinergics,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug1  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug2 supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,tranylcypromine,potassium chloride,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug1  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug2  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,tranylcypromine,antacids,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug1  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug2 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,tranylcypromine,absorbent-type anti-diarrhea medicines,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug1  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug2-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,tranylcypromine,kaolin,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug1  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug2 )  drug0 ( e.g.  drug0  drug0 ) .,tranylcypromine,pectin,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug1  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug2 ( e.g.  drug0  drug0 ) .,tranylcypromine,phenothiazines,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug1  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug2  drug0 ) .,tranylcypromine,chlorpromazine,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug1  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug2 ) .,tranylcypromine,promethazine,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug1  drug0  drug0 )  drug2  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,isocarboxazid,quinidine,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug1  drug0  drug0 )  drug0  drug2  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,isocarboxazid,amantadine,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug1  drug0  drug0 )  drug0  drug0  drug2 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,isocarboxazid,antihistamines,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug1  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug2 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,isocarboxazid,diphenhydramine,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug1  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug2  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,isocarboxazid,anticholinergics,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug1  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug2 supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,isocarboxazid,potassium chloride,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug1  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug2  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,isocarboxazid,antacids,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug1  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug2 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,isocarboxazid,absorbent-type anti-diarrhea medicines,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug1  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug2-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,isocarboxazid,kaolin,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug1  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug2 )  drug0 ( e.g.  drug0  drug0 ) .,isocarboxazid,pectin,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug1  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug2 ( e.g.  drug0  drug0 ) .,isocarboxazid,phenothiazines,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug1  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug2  drug0 ) .,isocarboxazid,chlorpromazine,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug1  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug2 ) .,isocarboxazid,promethazine,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug1  drug0 )  drug2  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,selegiline,quinidine,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug1  drug0 )  drug0  drug2  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,selegiline,amantadine,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug1  drug0 )  drug0  drug0  drug2 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,selegiline,antihistamines,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug1  drug0 )  drug0  drug0  drug0 ( e.g.  drug2 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,selegiline,diphenhydramine,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug1  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug2  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,selegiline,anticholinergics,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug1  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug2 supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,selegiline,potassium chloride,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug1  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug2  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,selegiline,antacids,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug1  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug2 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,selegiline,absorbent-type anti-diarrhea medicines,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug1  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug2-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,selegiline,kaolin,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug1  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug2 )  drug0 ( e.g.  drug0  drug0 ) .,selegiline,pectin,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug1  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug2 ( e.g.  drug0  drug0 ) .,selegiline,phenothiazines,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug1  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug2  drug0 ) .,selegiline,chlorpromazine,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug1  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug2 ) .,selegiline,promethazine,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug1 )  drug2  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,furazolidone,quinidine,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug1 )  drug0  drug2  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,furazolidone,amantadine,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug1 )  drug0  drug0  drug2 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,furazolidone,antihistamines,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug1 )  drug0  drug0  drug0 ( e.g.  drug2 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,furazolidone,diphenhydramine,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug1 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug2  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,furazolidone,anticholinergics,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug1 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug2 supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,furazolidone,potassium chloride,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug1 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug2  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,furazolidone,antacids,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug1 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug2 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,furazolidone,absorbent-type anti-diarrhea medicines,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug1 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug2-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,furazolidone,kaolin,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug1 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug2 )  drug0 ( e.g.  drug0  drug0 ) .,furazolidone,pectin,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug1 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug2 ( e.g.  drug0  drug0 ) .,furazolidone,phenothiazines,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug1 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug2  drug0 ) .,furazolidone,chlorpromazine,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug1 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug2 ) .,furazolidone,promethazine,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug1  drug0  drug0 ( e.g.  drug2 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,quinidine,diphenhydramine,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug1  drug0  drug0 ( e.g.  drug0 )  other drug2  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,quinidine,anticholinergics,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug1  drug0  drug0 ( e.g.  drug0 )  other drug0  drug2 supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,quinidine,potassium chloride,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug1  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug2  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,quinidine,antacids,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug1  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug2 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,quinidine,absorbent-type anti-diarrhea medicines,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug1  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug2-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,quinidine,kaolin,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug1  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug2 )  drug0 ( e.g.  drug0  drug0 ) .,quinidine,pectin,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug1  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug2 ( e.g.  drug0  drug0 ) .,quinidine,phenothiazines,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug1  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug2  drug0 ) .,quinidine,chlorpromazine,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug1  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug2 ) .,quinidine,promethazine,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug0  drug1  drug0 ( e.g.  drug2 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,amantadine,diphenhydramine,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug0  drug1  drug0 ( e.g.  drug0 )  other drug2  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,amantadine,anticholinergics,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug0  drug1  drug0 ( e.g.  drug0 )  other drug0  drug2 supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,amantadine,potassium chloride,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug0  drug1  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug2  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,amantadine,antacids,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug0  drug1  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug2 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,amantadine,absorbent-type anti-diarrhea medicines,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug0  drug1  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug2-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,amantadine,kaolin,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug0  drug1  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug2 )  drug0 ( e.g.  drug0  drug0 ) .,amantadine,pectin,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug0  drug1  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug2 ( e.g.  drug0  drug0 ) .,amantadine,phenothiazines,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug0  drug1  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug2  drug0 ) .,amantadine,chlorpromazine,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug0  drug1  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug2 ) .,amantadine,promethazine,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug0  drug0  drug1 ( e.g.  drug2 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,antihistamines,diphenhydramine,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug0  drug0  drug1 ( e.g.  drug0 )  other drug2  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,antihistamines,anticholinergics,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug0  drug0  drug1 ( e.g.  drug0 )  other drug0  drug2 supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,antihistamines,potassium chloride,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug0  drug0  drug1 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug2  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,antihistamines,antacids,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug0  drug0  drug1 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug2 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,antihistamines,absorbent-type anti-diarrhea medicines,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug0  drug0  drug1 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug2-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,antihistamines,kaolin,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug0  drug0  drug1 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug2 )  drug0 ( e.g.  drug0  drug0 ) .,antihistamines,pectin,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug0  drug0  drug1 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug2 ( e.g.  drug0  drug0 ) .,antihistamines,phenothiazines,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug0  drug0  drug1 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug2  drug0 ) .,antihistamines,chlorpromazine,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug0  drug0  drug1 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug2 ) .,antihistamines,promethazine,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug1 )  other drug2  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,diphenhydramine,anticholinergics,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug1 )  other drug0  drug2 supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,diphenhydramine,potassium chloride,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug1 )  other drug0  drug0 chloride supplements  drug2  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,diphenhydramine,antacids,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug1 )  other drug0  drug0 chloride supplements  drug0  drug2 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,diphenhydramine,absorbent-type anti-diarrhea medicines,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug1 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug2-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,diphenhydramine,kaolin,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug1 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug2 )  drug0 ( e.g.  drug0  drug0 ) .,diphenhydramine,pectin,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug1 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug2 ( e.g.  drug0  drug0 ) .,diphenhydramine,phenothiazines,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug1 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug2  drug0 ) .,diphenhydramine,chlorpromazine,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug1 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug2 ) .,diphenhydramine,promethazine,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug1  drug0 chloride supplements  drug0  drug0 ( e.g.  drug2-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,anticholinergics,kaolin,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug1  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug2 )  drug0 ( e.g.  drug0  drug0 ) .,anticholinergics,pectin,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug1  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug2 ( e.g.  drug0  drug0 ) .,anticholinergics,phenothiazines,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug1  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug2  drug0 ) .,anticholinergics,chlorpromazine,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug1  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug2 ) .,anticholinergics,promethazine,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug1 supplements  drug2  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,potassium chloride,antacids,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug1 supplements  drug0  drug2 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,potassium chloride,absorbent-type anti-diarrhea medicines,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug1 supplements  drug0  drug0 ( e.g.  drug2-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,potassium chloride,kaolin,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug1 supplements  drug0  drug0 ( e.g.  drug0-drug2 )  drug0 ( e.g.  drug0  drug0 ) .,potassium chloride,pectin,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug1 supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug2 ( e.g.  drug0  drug0 ) .,potassium chloride,phenothiazines,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug1 supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug2  drug0 ) .,potassium chloride,chlorpromazine,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug1 supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug2 ) .,potassium chloride,promethazine,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug1  drug0 ( e.g.  drug2-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,antacids,kaolin,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug1  drug0 ( e.g.  drug0-drug2 )  drug0 ( e.g.  drug0  drug0 ) .,antacids,pectin,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug1  drug0 ( e.g.  drug0-drug0 )  drug2 ( e.g.  drug0  drug0 ) .,antacids,phenothiazines,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug1  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug2  drug0 ) .,antacids,chlorpromazine,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug1  drug0 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug2 ) .,antacids,promethazine,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug1 ( e.g.  drug2-drug0 )  drug0 ( e.g.  drug0  drug0 ) .,absorbent-type anti-diarrhea medicines,kaolin,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug1 ( e.g.  drug0-drug2 )  drug0 ( e.g.  drug0  drug0 ) .,absorbent-type anti-diarrhea medicines,pectin,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug1 ( e.g.  drug0-drug0 )  drug2 ( e.g.  drug0  drug0 ) .,absorbent-type anti-diarrhea medicines,phenothiazines,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug1 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug2  drug0 ) .,absorbent-type anti-diarrhea medicines,chlorpromazine,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug1 ( e.g.  drug0-drug0 )  drug0 ( e.g.  drug0  drug2 ) .,absorbent-type anti-diarrhea medicines,promethazine,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug1-drug2 )  drug0 ( e.g.  drug0  drug0 ) .,kaolin,pectin,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug1-drug0 )  drug2 ( e.g.  drug0  drug0 ) .,kaolin,phenothiazines,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug1-drug0 )  drug0 ( e.g.  drug2  drug0 ) .,kaolin,chlorpromazine,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug1-drug0 )  drug0 ( e.g.  drug0  drug2 ) .,kaolin,promethazine,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug1 )  drug2 ( e.g.  drug0  drug0 ) .,pectin,phenothiazines,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug1 )  drug0 ( e.g.  drug2  drug0 ) .,pectin,chlorpromazine,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug1 )  drug0 ( e.g.  drug0  drug2 ) .,pectin,promethazine,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug1 ( e.g.  drug2  drug0 ) .,phenothiazines,chlorpromazine,FALSE,none
drug0 may interact with drug0 ( drug0 type )  drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0 )  drug0  drug0  drug0 ( e.g.  drug0 )  other drug0  drug0 chloride supplements  drug0  drug0 ( e.g.  drug0-drug0 )  drug1 ( e.g.  drug0  drug2 ) .,phenothiazines,promethazine,FALSE,none
concurrent use of drug1 and other drug2 may increase the drug0 effects of drug0 or these other medications .,alcohol,cns depression-producing drugs,FALSE,none
concurrent use of drug1 and other drug0 may increase the drug0 effects of drug2 or these other medications .,alcohol,methyprylon,TRUE,effect
concurrent use of drug0 and other drug1 may increase the drug0 effects of drug2 or these other medications .,cns depression-producing drugs,methyprylon,TRUE,effect
drug1 may reverse the drug0 activity of drug2 .,methysergide,narcotic analgesics,TRUE,effect
concurrent use with drug1 including drug2  drug0  and drug0 ( e.g . smoking ) may result in enhanced vasoconstriction .,vasoconstrictor agents,ergot alkaloids,FALSE,none
concurrent use with drug1 including drug0  drug2  and drug0 ( e.g . smoking ) may result in enhanced vasoconstriction .,vasoconstrictor agents,sumatriptan,FALSE,none
concurrent use with drug1 including drug0  drug0  and drug2 ( e.g . smoking ) may result in enhanced vasoconstriction .,vasoconstrictor agents,nicotine,FALSE,none
concurrent use with drug0 including drug0  drug1  and drug2 ( e.g . smoking ) may result in enhanced vasoconstriction .,sumatriptan,nicotine,FALSE,none
the effects of drug1 on gastrointestinal motility are antagonized by drug2 and narcotic drug0 .,metoclopramide,anticholinergic drugs,TRUE,effect
the effects of drug1 on gastrointestinal motility are antagonized by drug0 drugs and drug2 .,metoclopramide,narcotic analgesics,TRUE,effect
the effects of drug0 on gastrointestinal motility are antagonized by drug1 and drug2 .,anticholinergic drugs,narcotic analgesics,FALSE,none
additive sedative effects can occur when drug1 is given with drug2  drug0  drug0  drug0  or drug0 .,metoclopramide,alcohol,TRUE,effect
additive sedative effects can occur when drug1 is given with drug0  drug2  drug0  drug0  or drug0 .,metoclopramide,sedatives,TRUE,effect
additive sedative effects can occur when drug1 is given with drug0  drug0  drug2  drug0  or drug0 .,metoclopramide,hypnotics,TRUE,effect
additive sedative effects can occur when drug1 is given with drug0  drug0  drug0  drug2  or drug0 .,metoclopramide,narcotics,TRUE,effect
additive sedative effects can occur when drug1 is given with drug0  drug0  drug0  drug0  or drug2 .,metoclopramide,tranquilizers,TRUE,effect
additive sedative effects can occur when drug0 is given with drug0  drug0  drug0  drug1  or drug2 .,narcotics,tranquilizers,FALSE,none
the finding that drug1 releases catecholamines in patients with essential hypertension suggests that it should be used cautiously  if at all  in patients receiving drug2 .,metoclopramide,monoamine oxi-dase inhibitors,TRUE,advise
absorption of drugs from the stomach may be diminished ( e.g.  drug1 ) by drug2  whereas the rate and/or extent of absorption of drugs from the small bowel may be increased ( e.g.  drug0  drug0  drug0  drug0  drug0 ) .,digoxin,metoclopramide,TRUE,mechanism
absorption of drugs from the stomach may be diminished ( e.g.  drug1 ) by drug0  whereas the rate and/or extent of absorption of drugs from the small bowel may be increased ( e.g.  drug2  drug0  drug0  drug0  drug0 ) .,digoxin,acetaminophen,FALSE,none
absorption of drugs from the stomach may be diminished ( e.g.  drug1 ) by drug0  whereas the rate and/or extent of absorption of drugs from the small bowel may be increased ( e.g.  drug0  drug2  drug0  drug0  drug0 ) .,digoxin,tetracycline,FALSE,none
absorption of drugs from the stomach may be diminished ( e.g.  drug1 ) by drug0  whereas the rate and/or extent of absorption of drugs from the small bowel may be increased ( e.g.  drug0  drug0  drug2  drug0  drug0 ) .,digoxin,levodopa,FALSE,none
absorption of drugs from the stomach may be diminished ( e.g.  drug1 ) by drug0  whereas the rate and/or extent of absorption of drugs from the small bowel may be increased ( e.g.  drug0  drug0  drug0  drug2  drug0 ) .,digoxin,ethanol,FALSE,none
absorption of drugs from the stomach may be diminished ( e.g.  drug1 ) by drug0  whereas the rate and/or extent of absorption of drugs from the small bowel may be increased ( e.g.  drug0  drug0  drug0  drug0  drug2 ) .,digoxin,cyclosporine,FALSE,none
absorption of drugs from the stomach may be diminished ( e.g.  drug0 ) by drug1  whereas the rate and/or extent of absorption of drugs from the small bowel may be increased ( e.g.  drug2  drug0  drug0  drug0  drug0 ) .,metoclopramide,acetaminophen,TRUE,mechanism
absorption of drugs from the stomach may be diminished ( e.g.  drug0 ) by drug1  whereas the rate and/or extent of absorption of drugs from the small bowel may be increased ( e.g.  drug0  drug2  drug0  drug0  drug0 ) .,metoclopramide,tetracycline,FALSE,none
absorption of drugs from the stomach may be diminished ( e.g.  drug0 ) by drug1  whereas the rate and/or extent of absorption of drugs from the small bowel may be increased ( e.g.  drug0  drug0  drug2  drug0  drug0 ) .,metoclopramide,levodopa,FALSE,none
absorption of drugs from the stomach may be diminished ( e.g.  drug0 ) by drug1  whereas the rate and/or extent of absorption of drugs from the small bowel may be increased ( e.g.  drug0  drug0  drug0  drug2  drug0 ) .,metoclopramide,ethanol,FALSE,none
absorption of drugs from the stomach may be diminished ( e.g.  drug0 ) by drug1  whereas the rate and/or extent of absorption of drugs from the small bowel may be increased ( e.g.  drug0  drug0  drug0  drug0  drug2 ) .,metoclopramide,cyclosporine,FALSE,none
because the action of drug1 will influence the delivery of food to the intestines and thus the rate of absorption  drug2 dosage or timing of dosage may require adjustment .,metoclopramide,insulin,TRUE,advise
drug1 : drug2 and probably other loop drug0 given concomitantly with drug0 can cause unusually large or prolonged losses of fluid and electrolytes .,diuretics,furosemide,FALSE,none
drug1 : drug0 and probably other drug2 given concomitantly with drug0 can cause unusually large or prolonged losses of fluid and electrolytes .,diuretics,loop diuretics,FALSE,none
drug1 : drug0 and probably other loop drug0 given concomitantly with drug2 can cause unusually large or prolonged losses of fluid and electrolytes .,diuretics,metolazone,FALSE,none
drug0 : drug1 and probably other drug2 given concomitantly with drug0 can cause unusually large or prolonged losses of fluid and electrolytes .,furosemide,loop diuretics,FALSE,none
drug0 : drug1 and probably other loop drug0 given concomitantly with drug2 can cause unusually large or prolonged losses of fluid and electrolytes .,furosemide,metolazone,TRUE,effect
drug0 : drug0 and probably other drug1 given concomitantly with drug2 can cause unusually large or prolonged losses of fluid and electrolytes .,loop diuretics,metolazone,TRUE,effect
other drug1 : when drug2 tablets are used with other drug0 drugs  care must be taken  especially during initial therapy .,antihypertensives,mykrox,FALSE,none
other drug1 : when drug0 tablets are used with other drug2  care must be taken  especially during initial therapy .,antihypertensives,antihypertensive drugs,FALSE,none
other drug0 : when drug1 tablets are used with other drug2  care must be taken  especially during initial therapy .,mykrox,antihypertensive drugs,TRUE,advise
drug1  drug0  and drug0 : the hypotensive effects of these drugs may be potentiated by the volume contraction that may be associated with drug2 therapy .,alcohol,metolazone,FALSE,none
drug0  drug1  and drug2 : the hypotensive effects of these drugs may be potentiated by the volume contraction that may be associated with drug0 therapy .,barbiturates,narcotics,FALSE,none
drug0  drug1  and drug0 : the hypotensive effects of these drugs may be potentiated by the volume contraction that may be associated with drug2 therapy .,barbiturates,metolazone,FALSE,none
drug0  drug0  and drug1 : the hypotensive effects of these drugs may be potentiated by the volume contraction that may be associated with drug2 therapy .,narcotics,metolazone,FALSE,none
drug1 : drug2-induced hypokalemia can increase the sensitivity of the myocardium to drug0 .,digitalis glycosides,diuretic,FALSE,none
drug1 : drug0-induced hypokalemia can increase the sensitivity of the myocardium to drug2 .,digitalis glycosides,digitalis,FALSE,none
drug2 glycosides : drug1-induced hypokalemia can increase the sensitivity of the myocardium to drug0 .,diuretic,digitalis,TRUE,effect
drug1 or drug2 : may increase the risk of hypokalemia and increase salt and water retention .,corticosteroids,acth,FALSE,none
drug1 : drug2-induced hypokalemia may enhance neuromuscular blocking effects of drug0 ( such as drug0 ) the most serious effect would be respiratory depression which could proceed to apnea .,curariform drugs,diuretic,FALSE,none
drug1 : drug0-induced hypokalemia may enhance neuromuscular blocking effects of drug0 ( such as drug2 ) the most serious effect would be respiratory depression which could proceed to apnea .,curariform drugs,tubocurarine,FALSE,none
drug2 : drug1-induced hypokalemia may enhance neuromuscular blocking effects of drug0 ( such as drug0 ) the most serious effect would be respiratory depression which could proceed to apnea .,diuretic,curariform drugs,TRUE,effect
drug0 : drug1-induced hypokalemia may enhance neuromuscular blocking effects of drug0 ( such as drug2 ) the most serious effect would be respiratory depression which could proceed to apnea .,diuretic,tubocurarine,TRUE,effect
drug1 : drug0-induced hypokalemia may enhance neuromuscular blocking effects of drug0 ( such as drug2 ) the most serious effect would be respiratory depression which could proceed to apnea .,curariform drugs,tubocurarine,FALSE,none
drug1 and other drug2 : may decrease the drug0 effects of drug0 tablets .,salicylates,non-steroidal anti-inflammatory drugs,FALSE,none
drug1 and other drug0 : may decrease the drug0 effects of drug2 tablets .,salicylates,mykrox,TRUE,effect
drug0 and other drug1 : may decrease the drug0 effects of drug2 tablets .,non-steroidal anti-inflammatory drugs,mykrox,TRUE,effect
drug1 : drug2 may decrease arterial responsiveness to drug0  but this diminution is not sufficient to preclude effectiveness of the pressor agent for therapeutic use .,sympathomimetics,metolazone,FALSE,none
drug1 : drug0 may decrease arterial responsiveness to drug2  but this diminution is not sufficient to preclude effectiveness of the pressor agent for therapeutic use .,sympathomimetics,norepinephrine,FALSE,none
drug0 : drug1 may decrease arterial responsiveness to drug2  but this diminution is not sufficient to preclude effectiveness of the pressor agent for therapeutic use .,metolazone,norepinephrine,TRUE,effect
drug1 : efficacy may be decreased due to urinary alkalizing effect of drug2 .,methenamine,metolazone,TRUE,effect
drug1 : drug2  as well as other thiazide-like drug0  may affect the hypoprothrombinemic response to drug0 ;,anticoagulants,metolazone,FALSE,none
drug1 : drug0  as well as other drug2  may affect the hypoprothrombinemic response to drug0 ;,anticoagulants,thiazide-like diuretics,FALSE,none
drug0 : drug1  as well as other drug2  may affect the hypoprothrombinemic response to drug0 ;,metolazone,thiazide-like diuretics,FALSE,none
drug2 : drug1  as well as other thiazide-like drug0  may affect the hypoprothrombinemic response to drug0 ;,metolazone,anticoagulants,TRUE,effect
drug2 : drug0  as well as other drug1  may affect the hypoprothrombinemic response to drug0 ;,thiazide-like diuretics,anticoagulants,FALSE,none
catecholamine-depleting drugs ( e.g.  drug1 ) may have an additive effect when given with drug2 .,reserpine,beta-blocking agents,TRUE,effect
oral drug1 has been reported to potentiate the drug0 effect of drug2 and drug0  resulting in a prolongation of prothrombin time .,metronidazole,coumarin,TRUE,effect
oral drug1 has been reported to potentiate the drug0 effect of drug0 and drug2  resulting in a prolongation of prothrombin time .,metronidazole,warfarin,TRUE,effect
oral drug0 has been reported to potentiate the drug0 effect of drug1 and drug2  resulting in a prolongation of prothrombin time .,coumarin,warfarin,FALSE,none
drug interactions should be kept in mind when drug1 ( drug2 gel )  1 % is prescribed for patients who are receiving drug0 treatment  althoudrug0 they are less likely to occur with topical drug0 administration because of low absorption .,metrogel,metronidazole,FALSE,none
drug interactions should be kept in mind when drug1 ( drug2 gel )  1 % is prescribed for patients who are receiving drug0 treatment  althoudrug0 they are less likely to occur with topical drug0 administration because of low absorption .,metrogel,metronidazole,FALSE,none
the metabolism of drug1 is accelerated by drug2 ;,metopirone,phenytoin,TRUE,mechanism
drug1 inhibits the glucuronidation of drug2 and could possibly potentiate drug0 toxicity .,metopirone,acetaminophen,TRUE,mechanism
drug1 inhibits the glucuronidation of drug2 and could possibly potentiate drug0 toxicity .,metopirone,acetaminophen,TRUE,effect
caution should be observed in administering drug1 to patients receiving drug2 or drug0 because the extrapyramidal effects of these drugs can be expected to be potentiated by inhibition of catecholamine synthesis .,demser,phenothiazines,TRUE,advise
caution should be observed in administering drug1 to patients receiving drug0 or drug2 because the extrapyramidal effects of these drugs can be expected to be potentiated by inhibition of catecholamine synthesis .,demser,haloperidol,TRUE,advise
caution should be observed in administering drug0 to patients receiving drug1 or drug2 because the extrapyramidal effects of these drugs can be expected to be potentiated by inhibition of catecholamine synthesis .,phenothiazines,haloperidol,FALSE,none
concurrent use of drug1 with drug2 or other drug0 can increase their sedative effects .,demser,alcohol,TRUE,effect
concurrent use of drug1 with drug0 or other drug2 can increase their sedative effects .,demser,cns depressants,TRUE,effect
concurrent use of drug0 with drug1 or other drug2 can increase their sedative effects .,alcohol,cns depressants,FALSE,none
since drug1 is a substrate for the metabolic pathways involving cyp2d6 and cyp1a2 enzymes  inhibition or induction of either of these enzymes would be expected to alter drug2 plasma concentrations .,mexitil,mexiletine,FALSE,none
in a formal  single-dose interaction study ( n = 6 males ) the clearance of drug1 was decreased by 38 % following the coadministration of drug2  an inhibitor of cyp1a2 .,mexiletine,fluvoxamine,TRUE,mechanism
in this crossover steady state study  the pharmacokinetics of drug1 were unaffected in either phenotype by the coadministration of drug2 .,propafenone,mexiletine,FALSE,none
addition of drug1 to drug2 did not lead to further electrocardiographic parameters changes of qrs  qtc  rr  and pr intervals than drug0 alone .,mexiletine,propafenone,FALSE,none
addition of drug1 to drug2 did not lead to further electrocardiographic parameters changes of qrs  qtc  rr  and pr intervals than drug0 alone .,mexiletine,propafenone,FALSE,none
in a large compassionate use program drug1 has been used concurrently with commonly employed antianginal  drug2  and drug0 drugs without observed interactions .,mexitil,antihypertensive,FALSE,none
in a large compassionate use program drug1 has been used concurrently with commonly employed antianginal  drug0  and drug2 without observed interactions .,mexitil,anticoagulant drugs,FALSE,none
in a large compassionate use program drug0 has been used concurrently with commonly employed antianginal  drug1  and drug2 without observed interactions .,antihypertensive,anticoagulant drugs,FALSE,none
a variety of drug1 such as drug0 or drug2 were also added  sometimes with improved control of ventricular ectopy .,antiarrhythmics,propranolol,FALSE,none
a variety of drug0 such as drug1 or drug2 were also added  sometimes with improved control of ventricular ectopy .,quinidine,propranolol,FALSE,none
when drug1 or other hepatic enzyme inducers such as drug2 and drug0 have been taken concurrently with drug0  lowered drug0 plasma levels have been reported .,phenytoin,rifampin,FALSE,none
when drug1 or other hepatic enzyme inducers such as drug0 and drug2 have been taken concurrently with drug0  lowered drug0 plasma levels have been reported .,phenytoin,phenobarbital,FALSE,none
when drug1 or other hepatic enzyme inducers such as drug0 and drug0 have been taken concurrently with drug2  lowered drug0 plasma levels have been reported .,phenytoin,mexitil,TRUE,mechanism
when drug1 or other hepatic enzyme inducers such as drug0 and drug0 have been taken concurrently with drug2  lowered drug0 plasma levels have been reported .,phenytoin,mexitil,FALSE,none
when drug0 or other hepatic enzyme inducers such as drug1 and drug2 have been taken concurrently with drug0  lowered drug0 plasma levels have been reported .,rifampin,phenobarbital,FALSE,none
when drug0 or other hepatic enzyme inducers such as drug1 and drug0 have been taken concurrently with drug2  lowered drug0 plasma levels have been reported .,rifampin,mexitil,TRUE,mechanism
when drug0 or other hepatic enzyme inducers such as drug1 and drug0 have been taken concurrently with drug2  lowered drug0 plasma levels have been reported .,rifampin,mexitil,FALSE,none
when drug0 or other hepatic enzyme inducers such as drug0 and drug1 have been taken concurrently with drug2  lowered drug0 plasma levels have been reported .,phenobarbital,mexitil,TRUE,mechanism
when drug0 or other hepatic enzyme inducers such as drug0 and drug1 have been taken concurrently with drug2  lowered drug0 plasma levels have been reported .,phenobarbital,mexitil,FALSE,none
in a formal study  drug1 were shown not to affect drug2 plasma concentrations .,benzodiazepines,mexitil,FALSE,none
concurrent administration of drug1 and drug2 has been reported to increase  decrease  or leave unchanged drug0 plasma levels ;,cimetidine,mexitil,TRUE,mechanism
concurrent administration of drug1 and drug2 has been reported to increase  decrease  or leave unchanged drug0 plasma levels ;,cimetidine,mexitil,FALSE,none
concurrent use of drug1 and drug2 may lead to increased plasma drug0 levels .,mexitil,theophylline,TRUE,mechanism
concurrent use of drug1 and drug2 may lead to increased plasma drug0 levels .,mexitil,theophylline,FALSE,none
this increase was observed at the first test point which was the second day after starting drug1 . drug2 plasma levels returned to pre-drug0 values within 48 hours after discontinuing drug0 . if drug0 and drug0 are to be used concurrently  drug0 blood levels should be monitored  particularly when the drug0 dose is changed .,mexitil,theophylline,FALSE,none
this increase was observed at the first test point which was the second day after starting drug1 . drug2 plasma levels returned to pre-drug0 values within 48 hours after discontinuing drug0 . if drug0 and drug0 are to be used concurrently  drug0 blood levels should be monitored  particularly when the drug0 dose is changed .,mexitil,theophylline,FALSE,none
this increase was observed at the first test point which was the second day after starting drug1 . drug2 plasma levels returned to pre-drug0 values within 48 hours after discontinuing drug0 . if drug0 and drug0 are to be used concurrently  drug0 blood levels should be monitored  particularly when the drug0 dose is changed .,mexitil,theophylline,FALSE,none
this increase was observed at the first test point which was the second day after starting drug2 . drug1 plasma levels returned to pre-drug0 values within 48 hours after discontinuing drug0 . if drug0 and drug0 are to be used concurrently  drug0 blood levels should be monitored  particularly when the drug0 dose is changed .,theophylline,mexitil,FALSE,none
this increase was observed at the first test point which was the second day after starting drug2 . drug1 plasma levels returned to pre-drug0 values within 48 hours after discontinuing drug0 . if drug0 and drug0 are to be used concurrently  drug0 blood levels should be monitored  particularly when the drug0 dose is changed .,theophylline,mexitil,TRUE,mechanism
this increase was observed at the first test point which was the second day after starting drug2 . drug1 plasma levels returned to pre-drug0 values within 48 hours after discontinuing drug0 . if drug0 and drug0 are to be used concurrently  drug0 blood levels should be monitored  particularly when the drug0 dose is changed .,theophylline,mexitil,FALSE,none
this increase was observed at the first test point which was the second day after starting drug2 . drug1 plasma levels returned to pre-drug0 values within 48 hours after discontinuing drug0 . if drug0 and drug0 are to be used concurrently  drug0 blood levels should be monitored  particularly when the drug0 dose is changed .,theophylline,mexitil,FALSE,none
this increase was observed at the first test point which was the second day after starting drug1 . drug2 plasma levels returned to pre-drug0 values within 48 hours after discontinuing drug0 . if drug0 and drug0 are to be used concurrently  drug0 blood levels should be monitored  particularly when the drug0 dose is changed .,mexitil,theophylline,FALSE,none
this increase was observed at the first test point which was the second day after starting drug1 . drug2 plasma levels returned to pre-drug0 values within 48 hours after discontinuing drug0 . if drug0 and drug0 are to be used concurrently  drug0 blood levels should be monitored  particularly when the drug0 dose is changed .,mexitil,theophylline,FALSE,none
this increase was observed at the first test point which was the second day after starting drug1 . drug2 plasma levels returned to pre-drug0 values within 48 hours after discontinuing drug0 . if drug0 and drug0 are to be used concurrently  drug0 blood levels should be monitored  particularly when the drug0 dose is changed .,mexitil,theophylline,FALSE,none
this increase was observed at the first test point which was the second day after starting drug1 . drug2 plasma levels returned to pre-drug0 values within 48 hours after discontinuing drug0 . if drug0 and drug0 are to be used concurrently  drug0 blood levels should be monitored  particularly when the drug0 dose is changed .,mexitil,theophylline,FALSE,none
this increase was observed at the first test point which was the second day after starting drug1 . drug2 plasma levels returned to pre-drug0 values within 48 hours after discontinuing drug0 . if drug0 and drug0 are to be used concurrently  drug0 blood levels should be monitored  particularly when the drug0 dose is changed .,mexitil,theophylline,TRUE,advise
this increase was observed at the first test point which was the second day after starting drug1 . drug2 plasma levels returned to pre-drug0 values within 48 hours after discontinuing drug0 . if drug0 and drug0 are to be used concurrently  drug0 blood levels should be monitored  particularly when the drug0 dose is changed .,mexitil,theophylline,FALSE,none
this increase was observed at the first test point which was the second day after starting drug2 . drug1 plasma levels returned to pre-drug0 values within 48 hours after discontinuing drug0 . if drug0 and drug0 are to be used concurrently  drug0 blood levels should be monitored  particularly when the drug0 dose is changed .,theophylline,mexitil,FALSE,none
this increase was observed at the first test point which was the second day after starting drug2 . drug1 plasma levels returned to pre-drug0 values within 48 hours after discontinuing drug0 . if drug0 and drug0 are to be used concurrently  drug0 blood levels should be monitored  particularly when the drug0 dose is changed .,theophylline,mexitil,FALSE,none
additionally  in one controlled study in five normal subjects and seven patients  the clearance of drug1 was decreased 50 % following the administration of drug2 .,caffeine,mexitil,TRUE,mechanism
drug1 inhibits some of the liver 's ability to metabolize some other drugs - drug2  drug0  drug0  drug0  and drug0 drug0 .,posicor,terfenadine,TRUE,mechanism
drug1 inhibits some of the liver 's ability to metabolize some other drugs - drug0  drug2  drug0  drug0  and drug0 drug0 .,posicor,astemizole,TRUE,mechanism
drug1 inhibits some of the liver 's ability to metabolize some other drugs - drug0  drug0  drug2  drug0  and drug0 drug0 .,posicor,cisapride,TRUE,mechanism
drug1 inhibits some of the liver 's ability to metabolize some other drugs - drug0  drug0  drug0  drug2  and drug0 drug0 .,posicor,cyclosporine,TRUE,mechanism
drug1 inhibits some of the liver 's ability to metabolize some other drugs - drug0  drug0  drug0  drug0  and drug2 .,posicor,tricyclic antidepressants,TRUE,mechanism
drug0 inhibits some of the liver 's ability to metabolize some other drugs - drug0  drug0  drug0  drug1  and drug2 .,cyclosporine,tricyclic antidepressants,FALSE,none
a total of 11 clinical drug-drug interaction studies were conducted in healthy volunteers to evaluate the potential for interaction between drug1 and drug2  drug0  drug0  drug0  drug0  drug0  drug0  drug0  and drug0 .,mycamine,mycophenolate mofetil,FALSE,none
a total of 11 clinical drug-drug interaction studies were conducted in healthy volunteers to evaluate the potential for interaction between drug1 and drug0  drug2  drug0  drug0  drug0  drug0  drug0  drug0  and drug0 .,mycamine,cyclosporine,FALSE,none
a total of 11 clinical drug-drug interaction studies were conducted in healthy volunteers to evaluate the potential for interaction between drug1 and drug0  drug0  drug2  drug0  drug0  drug0  drug0  drug0  and drug0 .,mycamine,tacrolimus,FALSE,none
a total of 11 clinical drug-drug interaction studies were conducted in healthy volunteers to evaluate the potential for interaction between drug1 and drug0  drug0  drug0  drug2  drug0  drug0  drug0  drug0  and drug0 .,mycamine,prednisolone,FALSE,none
a total of 11 clinical drug-drug interaction studies were conducted in healthy volunteers to evaluate the potential for interaction between drug1 and drug0  drug0  drug0  drug0  drug2  drug0  drug0  drug0  and drug0 .,mycamine,sirolimus,FALSE,none
a total of 11 clinical drug-drug interaction studies were conducted in healthy volunteers to evaluate the potential for interaction between drug1 and drug0  drug0  drug0  drug0  drug0  drug2  drug0  drug0  and drug0 .,mycamine,nifedipine,FALSE,none
a total of 11 clinical drug-drug interaction studies were conducted in healthy volunteers to evaluate the potential for interaction between drug1 and drug0  drug0  drug0  drug0  drug0  drug0  drug2  drug0  and drug0 .,mycamine,fluconazole,FALSE,none
a total of 11 clinical drug-drug interaction studies were conducted in healthy volunteers to evaluate the potential for interaction between drug1 and drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug2  and drug0 .,mycamine,ritonavir,FALSE,none
a total of 11 clinical drug-drug interaction studies were conducted in healthy volunteers to evaluate the potential for interaction between drug1 and drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0  and drug2 .,mycamine,rifampin,FALSE,none
a total of 11 clinical drug-drug interaction studies were conducted in healthy volunteers to evaluate the potential for interaction between drug0 and drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug1  and drug2 .,ritonavir,rifampin,FALSE,none
drug1 auc and cmax were increased by 18 % and 42 %  respectively  in the presence of steady-state drug2 compared with drug0 alone .,nifedipine,mycamine,TRUE,mechanism
drug2 auc and cmax were increased by 18 % and 42 %  respectively  in the presence of steady-state drug1 compared with drug0 alone .,mycamine,nifedipine,FALSE,none
patients receiving drug1 or drug2 in combination with drug0 should be monitored for drug0 or drug0 toxicity and drug0 or drug0 dosage should be reduced if necessary .,sirolimus,nifedipine,FALSE,none
patients receiving drug1 or drug0 in combination with drug2 should be monitored for drug0 or drug0 toxicity and drug0 or drug0 dosage should be reduced if necessary .,sirolimus,mycamine,TRUE,advise
patients receiving drug1 or drug2 in combination with drug0 should be monitored for drug0 or drug0 toxicity and drug0 or drug0 dosage should be reduced if necessary .,sirolimus,nifedipine,FALSE,none
patients receiving drug1 or drug2 in combination with drug0 should be monitored for drug0 or drug0 toxicity and drug0 or drug0 dosage should be reduced if necessary .,sirolimus,nifedipine,FALSE,none
patients receiving drug0 or drug1 in combination with drug2 should be monitored for drug0 or drug0 toxicity and drug0 or drug0 dosage should be reduced if necessary .,nifedipine,mycamine,TRUE,advise
patients receiving drug2 or drug1 in combination with drug0 should be monitored for drug0 or drug0 toxicity and drug0 or drug0 dosage should be reduced if necessary .,nifedipine,sirolimus,FALSE,none
patients receiving drug2 or drug1 in combination with drug0 should be monitored for drug0 or drug0 toxicity and drug0 or drug0 dosage should be reduced if necessary .,nifedipine,sirolimus,FALSE,none
patients receiving drug2 or drug0 in combination with drug1 should be monitored for drug0 or drug0 toxicity and drug0 or drug0 dosage should be reduced if necessary .,mycamine,sirolimus,FALSE,none
patients receiving drug0 or drug2 in combination with drug1 should be monitored for drug0 or drug0 toxicity and drug0 or drug0 dosage should be reduced if necessary .,mycamine,nifedipine,FALSE,none
patients receiving drug2 or drug0 in combination with drug1 should be monitored for drug0 or drug0 toxicity and drug0 or drug0 dosage should be reduced if necessary .,mycamine,sirolimus,FALSE,none
patients receiving drug0 or drug2 in combination with drug1 should be monitored for drug0 or drug0 toxicity and drug0 or drug0 dosage should be reduced if necessary .,mycamine,nifedipine,FALSE,none
patients receiving drug1 or drug2 in combination with drug0 should be monitored for drug0 or drug0 toxicity and drug0 or drug0 dosage should be reduced if necessary .,sirolimus,nifedipine,FALSE,none
patients receiving drug1 or drug2 in combination with drug0 should be monitored for drug0 or drug0 toxicity and drug0 or drug0 dosage should be reduced if necessary .,sirolimus,nifedipine,FALSE,none
patients receiving drug2 or drug1 in combination with drug0 should be monitored for drug0 or drug0 toxicity and drug0 or drug0 dosage should be reduced if necessary .,nifedipine,sirolimus,FALSE,none
patients receiving drug1 or drug2 in combination with drug0 should be monitored for drug0 or drug0 toxicity and drug0 or drug0 dosage should be reduced if necessary .,sirolimus,nifedipine,FALSE,none
drug interactions : inhibitors of cyp3a4 isozymes : caution is advised when drug1 is administered concomitantly with drugs that are known to inhibit the cytochrome p450 3a4 enzyme system ( ie  some drugs in the drug classes of drug2  drug0  drug0 channel antagonists  and macrolide drug0 ) .,midazolam,azole antimycotics,TRUE,advise
drug interactions : inhibitors of cyp3a4 isozymes : caution is advised when drug1 is administered concomitantly with drugs that are known to inhibit the cytochrome p450 3a4 enzyme system ( ie  some drugs in the drug classes of drug0  drug2  drug0 channel antagonists  and macrolide drug0 ) .,midazolam,protease inhibitors,TRUE,advise
drug interactions : inhibitors of cyp3a4 isozymes : caution is advised when drug1 is administered concomitantly with drugs that are known to inhibit the cytochrome p450 3a4 enzyme system ( ie  some drugs in the drug classes of drug0  drug0  drug2  and macrolide drug0 ) .,midazolam,calcium channel antagonists,TRUE,advise
drug interactions : inhibitors of cyp3a4 isozymes : caution is advised when drug1 is administered concomitantly with drugs that are known to inhibit the cytochrome p450 3a4 enzyme system ( ie  some drugs in the drug classes of drug0  drug0  drug0 channel antagonists  and drug2 ) .,midazolam,macrolide antibiotics,TRUE,advise
drug interactions : inhibitors of cyp3a4 isozymes : caution is advised when drug0 is administered concomitantly with drugs that are known to inhibit the cytochrome p450 3a4 enzyme system ( ie  some drugs in the drug classes of drug1  drug0  drug0 channel antagonists  and drug2 ) .,azole antimycotics,macrolide antibiotics,FALSE,none
drug interactions : inhibitors of cyp3a4 isozymes : caution is advised when drug0 is administered concomitantly with drugs that are known to inhibit the cytochrome p450 3a4 enzyme system ( ie  some drugs in the drug classes of drug0  drug1  drug0 channel antagonists  and drug2 ) .,protease inhibitors,macrolide antibiotics,FALSE,none
drug interactions : inhibitors of cyp3a4 isozymes : caution is advised when drug0 is administered concomitantly with drugs that are known to inhibit the cytochrome p450 3a4 enzyme system ( ie  some drugs in the drug classes of drug0  drug0  drug1  and drug2 ) .,calcium channel antagonists,macrolide antibiotics,FALSE,none
drugs such as drug1  drug0  drug0  drug0  drug0 and drug2 were shown to significantly increase the c max and auc of orally administered drug0 .,erythromycin,itraconazole,FALSE,none
drugs such as drug1  drug0  drug0  drug0  drug0 and drug0 were shown to significantly increase the c max and auc of orally administered drug2 .,erythromycin,midazolam,TRUE,mechanism
drugs such as drug0  drug1  drug0  drug0  drug0 and drug2 were shown to significantly increase the c max and auc of orally administered drug0 .,diltiazem,itraconazole,FALSE,none
drugs such as drug0  drug1  drug0  drug0  drug0 and drug0 were shown to significantly increase the c max and auc of orally administered drug2 .,diltiazem,midazolam,TRUE,mechanism
drugs such as drug0  drug0  drug1  drug0  drug0 and drug2 were shown to significantly increase the c max and auc of orally administered drug0 .,verapamil,itraconazole,FALSE,none
drugs such as drug0  drug0  drug1  drug0  drug0 and drug0 were shown to significantly increase the c max and auc of orally administered drug2 .,verapamil,midazolam,TRUE,mechanism
drugs such as drug0  drug0  drug0  drug1  drug0 and drug2 were shown to significantly increase the c max and auc of orally administered drug0 .,ketoconazole,itraconazole,FALSE,none
drugs such as drug0  drug0  drug0  drug1  drug0 and drug0 were shown to significantly increase the c max and auc of orally administered drug2 .,ketoconazole,midazolam,TRUE,mechanism
drugs such as drug0  drug0  drug0  drug0  drug1 and drug2 were shown to significantly increase the c max and auc of orally administered drug0 .,fluconazole,itraconazole,FALSE,none
drugs such as drug0  drug0  drug0  drug0  drug1 and drug0 were shown to significantly increase the c max and auc of orally administered drug2 .,fluconazole,midazolam,TRUE,mechanism
drugs such as drug0  drug0  drug0  drug0  drug0 and drug1 were shown to significantly increase the c max and auc of orally administered drug2 .,itraconazole,midazolam,TRUE,mechanism
althoudrug0 not studied  the potent cytochrome p450 3a4 inhibitors drug1 and drug2 may cause intense and prolonged sedation and respiratory depression due to a decrease in plasma clearance of drug0 .,ritonavir,nelfinavir,FALSE,none
althoudrug0 not studied  the potent cytochrome p450 3a4 inhibitors drug1 and drug0 may cause intense and prolonged sedation and respiratory depression due to a decrease in plasma clearance of drug2 .,ritonavir,midazolam,TRUE,mechanism
althoudrug0 not studied  the potent cytochrome p450 3a4 inhibitors drug0 and drug1 may cause intense and prolonged sedation and respiratory depression due to a decrease in plasma clearance of drug2 .,nelfinavir,midazolam,TRUE,mechanism
inducers of cyp3a4 isozymes : cytochrome p450 inducers  such as drug1  drug0  and drug0  induce metabolism and caused a markedly decreased c max and auc of oral drug2 in adult studies .,rifampin,midazolam,TRUE,mechanism
inducers of cyp3a4 isozymes : cytochrome p450 inducers  such as drug0  drug1  and drug2  induce metabolism and caused a markedly decreased c max and auc of oral drug0 in adult studies .,carbamazepine,phenytoin,FALSE,none
inducers of cyp3a4 isozymes : cytochrome p450 inducers  such as drug0  drug1  and drug0  induce metabolism and caused a markedly decreased c max and auc of oral drug2 in adult studies .,carbamazepine,midazolam,TRUE,mechanism
inducers of cyp3a4 isozymes : cytochrome p450 inducers  such as drug0  drug0  and drug1  induce metabolism and caused a markedly decreased c max and auc of oral drug2 in adult studies .,phenytoin,midazolam,TRUE,mechanism
the difficulty in achieving adequate sedation may have been the result of decreased absorption of the drug1 due to both the gastrointestinal effects and stimulant effects of drug2 .,sedatives,methylphenidate,FALSE,none
the sedative effect of drug1 is accentuated by any concomitantly administered medication which depresses the central nervous system  particularly drug2 ( eg  drug0  drug0 and drug0 )  drug0  drug0  drug0  drug0 and drug0 .,versed syrup,narcotics,TRUE,effect
the sedative effect of drug1 is accentuated by any concomitantly administered medication which depresses the central nervous system  particularly drug0 ( eg  drug2  drug0 and drug0 )  drug0  drug0  drug0  drug0 and drug0 .,versed syrup,morphine,TRUE,effect
the sedative effect of drug1 is accentuated by any concomitantly administered medication which depresses the central nervous system  particularly drug0 ( eg  drug0  drug2 and drug0 )  drug0  drug0  drug0  drug0 and drug0 .,versed syrup,meperidine,TRUE,effect
the sedative effect of drug1 is accentuated by any concomitantly administered medication which depresses the central nervous system  particularly drug0 ( eg  drug0  drug0 and drug2 )  drug0  drug0  drug0  drug0 and drug0 .,versed syrup,fentanyl,TRUE,effect
the sedative effect of drug1 is accentuated by any concomitantly administered medication which depresses the central nervous system  particularly drug0 ( eg  drug0  drug0 and drug0 )  drug2  drug0  drug0  drug0 and drug0 .,versed syrup,propofol,TRUE,effect
the sedative effect of drug1 is accentuated by any concomitantly administered medication which depresses the central nervous system  particularly drug0 ( eg  drug0  drug0 and drug0 )  drug0  drug2  drug0  drug0 and drug0 .,versed syrup,ketamine,TRUE,effect
the sedative effect of drug1 is accentuated by any concomitantly administered medication which depresses the central nervous system  particularly drug0 ( eg  drug0  drug0 and drug0 )  drug0  drug0  drug2  drug0 and drug0 .,versed syrup,nitrous oxide,TRUE,effect
the sedative effect of drug1 is accentuated by any concomitantly administered medication which depresses the central nervous system  particularly drug0 ( eg  drug0  drug0 and drug0 )  drug0  drug0  drug0  drug2 and drug0 .,versed syrup,secobarbital,TRUE,effect
the sedative effect of drug1 is accentuated by any concomitantly administered medication which depresses the central nervous system  particularly drug0 ( eg  drug0  drug0 and drug0 )  drug0  drug0  drug0  drug0 and drug2 .,versed syrup,droperidol,TRUE,effect
the sedative effect of drug0 is accentuated by any concomitantly administered medication which depresses the central nervous system  particularly drug1 ( eg  drug2  drug0 and drug0 )  drug0  drug0  drug0  drug0 and drug0 .,narcotics,morphine,FALSE,none
the sedative effect of drug0 is accentuated by any concomitantly administered medication which depresses the central nervous system  particularly drug1 ( eg  drug0  drug2 and drug0 )  drug0  drug0  drug0  drug0 and drug0 .,narcotics,meperidine,FALSE,none
the sedative effect of drug0 is accentuated by any concomitantly administered medication which depresses the central nervous system  particularly drug1 ( eg  drug0  drug0 and drug2 )  drug0  drug0  drug0  drug0 and drug0 .,narcotics,fentanyl,FALSE,none
the sedative effect of drug0 is accentuated by any concomitantly administered medication which depresses the central nervous system  particularly drug1 ( eg  drug0  drug0 and drug0 )  drug2  drug0  drug0  drug0 and drug0 .,narcotics,propofol,FALSE,none
the sedative effect of drug0 is accentuated by any concomitantly administered medication which depresses the central nervous system  particularly drug1 ( eg  drug0  drug0 and drug0 )  drug0  drug2  drug0  drug0 and drug0 .,narcotics,ketamine,FALSE,none
the sedative effect of drug0 is accentuated by any concomitantly administered medication which depresses the central nervous system  particularly drug1 ( eg  drug0  drug0 and drug0 )  drug0  drug0  drug2  drug0 and drug0 .,narcotics,nitrous oxide,FALSE,none
the sedative effect of drug0 is accentuated by any concomitantly administered medication which depresses the central nervous system  particularly drug1 ( eg  drug0  drug0 and drug0 )  drug0  drug0  drug0  drug2 and drug0 .,narcotics,secobarbital,FALSE,none
the sedative effect of drug0 is accentuated by any concomitantly administered medication which depresses the central nervous system  particularly drug1 ( eg  drug0  drug0 and drug0 )  drug0  drug0  drug0  drug0 and drug2 .,narcotics,droperidol,FALSE,none
the sedative effect of drug0 is accentuated by any concomitantly administered medication which depresses the central nervous system  particularly drug0 ( eg  drug1  drug0 and drug2 )  drug0  drug0  drug0  drug0 and drug0 .,morphine,fentanyl,FALSE,none
the sedative effect of drug0 is accentuated by any concomitantly administered medication which depresses the central nervous system  particularly drug0 ( eg  drug1  drug0 and drug0 )  drug2  drug0  drug0  drug0 and drug0 .,morphine,propofol,FALSE,none
the sedative effect of drug0 is accentuated by any concomitantly administered medication which depresses the central nervous system  particularly drug0 ( eg  drug1  drug0 and drug0 )  drug0  drug2  drug0  drug0 and drug0 .,morphine,ketamine,FALSE,none
the sedative effect of drug0 is accentuated by any concomitantly administered medication which depresses the central nervous system  particularly drug0 ( eg  drug1  drug0 and drug0 )  drug0  drug0  drug2  drug0 and drug0 .,morphine,nitrous oxide,FALSE,none
the sedative effect of drug0 is accentuated by any concomitantly administered medication which depresses the central nervous system  particularly drug0 ( eg  drug1  drug0 and drug0 )  drug0  drug0  drug0  drug2 and drug0 .,morphine,secobarbital,FALSE,none
the sedative effect of drug0 is accentuated by any concomitantly administered medication which depresses the central nervous system  particularly drug0 ( eg  drug1  drug0 and drug0 )  drug0  drug0  drug0  drug0 and drug2 .,morphine,droperidol,FALSE,none
the sedative effect of drug0 is accentuated by any concomitantly administered medication which depresses the central nervous system  particularly drug0 ( eg  drug0  drug1 and drug2 )  drug0  drug0  drug0  drug0 and drug0 .,meperidine,fentanyl,FALSE,none
the sedative effect of drug0 is accentuated by any concomitantly administered medication which depresses the central nervous system  particularly drug0 ( eg  drug0  drug1 and drug0 )  drug2  drug0  drug0  drug0 and drug0 .,meperidine,propofol,FALSE,none
the sedative effect of drug0 is accentuated by any concomitantly administered medication which depresses the central nervous system  particularly drug0 ( eg  drug0  drug1 and drug0 )  drug0  drug2  drug0  drug0 and drug0 .,meperidine,ketamine,FALSE,none
the sedative effect of drug0 is accentuated by any concomitantly administered medication which depresses the central nervous system  particularly drug0 ( eg  drug0  drug1 and drug0 )  drug0  drug0  drug2  drug0 and drug0 .,meperidine,nitrous oxide,FALSE,none
the sedative effect of drug0 is accentuated by any concomitantly administered medication which depresses the central nervous system  particularly drug0 ( eg  drug0  drug1 and drug0 )  drug0  drug0  drug0  drug2 and drug0 .,meperidine,secobarbital,FALSE,none
the sedative effect of drug0 is accentuated by any concomitantly administered medication which depresses the central nervous system  particularly drug0 ( eg  drug0  drug1 and drug0 )  drug0  drug0  drug0  drug0 and drug2 .,meperidine,droperidol,FALSE,none
the sedative effect of drug0 is accentuated by any concomitantly administered medication which depresses the central nervous system  particularly drug0 ( eg  drug0  drug0 and drug1 )  drug2  drug0  drug0  drug0 and drug0 .,fentanyl,propofol,FALSE,none
the sedative effect of drug0 is accentuated by any concomitantly administered medication which depresses the central nervous system  particularly drug0 ( eg  drug0  drug0 and drug1 )  drug0  drug2  drug0  drug0 and drug0 .,fentanyl,ketamine,FALSE,none
the sedative effect of drug0 is accentuated by any concomitantly administered medication which depresses the central nervous system  particularly drug0 ( eg  drug0  drug0 and drug1 )  drug0  drug0  drug2  drug0 and drug0 .,fentanyl,nitrous oxide,FALSE,none
the sedative effect of drug0 is accentuated by any concomitantly administered medication which depresses the central nervous system  particularly drug0 ( eg  drug0  drug0 and drug1 )  drug0  drug0  drug0  drug2 and drug0 .,fentanyl,secobarbital,FALSE,none
the sedative effect of drug0 is accentuated by any concomitantly administered medication which depresses the central nervous system  particularly drug0 ( eg  drug0  drug0 and drug1 )  drug0  drug0  drug0  drug0 and drug2 .,fentanyl,droperidol,FALSE,none
the sedative effect of drug0 is accentuated by any concomitantly administered medication which depresses the central nervous system  particularly drug0 ( eg  drug0  drug0 and drug0 )  drug1  drug0  drug0  drug0 and drug2 .,propofol,droperidol,FALSE,none
the sedative effect of drug0 is accentuated by any concomitantly administered medication which depresses the central nervous system  particularly drug0 ( eg  drug0  drug0 and drug0 )  drug0  drug1  drug0  drug0 and drug2 .,ketamine,droperidol,FALSE,none
the sedative effect of drug0 is accentuated by any concomitantly administered medication which depresses the central nervous system  particularly drug0 ( eg  drug0  drug0 and drug0 )  drug0  drug0  drug1  drug0 and drug2 .,nitrous oxide,droperidol,FALSE,none
the sedative effect of drug0 is accentuated by any concomitantly administered medication which depresses the central nervous system  particularly drug0 ( eg  drug0  drug0 and drug0 )  drug0  drug0  drug0  drug1 and drug2 .,secobarbital,droperidol,FALSE,none
when administered concomitantly with drug1  drug2 may enhance or precipitate bradycardia  a.v .,proamatine,cardiac glycosides,TRUE,effect
the use of drugs that stimulate alpha-adrenergic receptors ( e.g.  drug1  pseudodrug2  drug0  drug0 or drug0 ) may enhance or potentiate the pressor effects of drug0 . therefore  caution should be used when drug0 is administered concomitantly with agents that cause vasoconstriction .,phenylephrine,ephedrine,FALSE,none
the use of drugs that stimulate alpha-adrenergic receptors ( e.g.  drug1  pseudodrug0  drug0  drug0 or drug2 ) may enhance or potentiate the pressor effects of drug0 . therefore  caution should be used when drug0 is administered concomitantly with agents that cause vasoconstriction .,phenylephrine,dihydroergotamine,FALSE,none
the use of drugs that stimulate alpha-adrenergic receptors ( e.g.  drug1  pseudodrug0  drug0  drug0 or drug0 ) may enhance or potentiate the pressor effects of drug2 . therefore  caution should be used when drug0 is administered concomitantly with agents that cause vasoconstriction .,phenylephrine,proamatine,TRUE,effect
the use of drugs that stimulate alpha-adrenergic receptors ( e.g.  drug1  pseudodrug0  drug0  drug0 or drug0 ) may enhance or potentiate the pressor effects of drug2 . therefore  caution should be used when drug0 is administered concomitantly with agents that cause vasoconstriction .,phenylephrine,proamatine,FALSE,none
the use of drugs that stimulate alpha-adrenergic receptors ( e.g.  drug0  drug1  drug0  drug0 or drug2 ) may enhance or potentiate the pressor effects of drug0 . therefore  caution should be used when drug0 is administered concomitantly with agents that cause vasoconstriction .,pseudoephedrine,dihydroergotamine,FALSE,none
the use of drugs that stimulate alpha-adrenergic receptors ( e.g.  drug0  drug1  drug0  drug0 or drug0 ) may enhance or potentiate the pressor effects of drug2 . therefore  caution should be used when drug0 is administered concomitantly with agents that cause vasoconstriction .,pseudoephedrine,proamatine,TRUE,effect
the use of drugs that stimulate alpha-adrenergic receptors ( e.g.  drug0  drug1  drug0  drug0 or drug0 ) may enhance or potentiate the pressor effects of drug2 . therefore  caution should be used when drug0 is administered concomitantly with agents that cause vasoconstriction .,pseudoephedrine,proamatine,FALSE,none
the use of drugs that stimulate alpha-adrenergic receptors ( e.g.  drug0  pseudodrug1  drug0  drug0 or drug2 ) may enhance or potentiate the pressor effects of drug0 . therefore  caution should be used when drug0 is administered concomitantly with agents that cause vasoconstriction .,ephedrine,dihydroergotamine,FALSE,none
the use of drugs that stimulate alpha-adrenergic receptors ( e.g.  drug0  pseudodrug1  drug0  drug0 or drug0 ) may enhance or potentiate the pressor effects of drug2 . therefore  caution should be used when drug0 is administered concomitantly with agents that cause vasoconstriction .,ephedrine,proamatine,TRUE,effect
the use of drugs that stimulate alpha-adrenergic receptors ( e.g.  drug0  pseudodrug1  drug0  drug0 or drug0 ) may enhance or potentiate the pressor effects of drug2 . therefore  caution should be used when drug0 is administered concomitantly with agents that cause vasoconstriction .,ephedrine,proamatine,FALSE,none
the use of drugs that stimulate alpha-adrenergic receptors ( e.g.  drug0  pseudodrug0  drug0  drug1 or drug2 ) may enhance or potentiate the pressor effects of drug0 . therefore  caution should be used when drug0 is administered concomitantly with agents that cause vasoconstriction .,phenylpropanolamine,dihydroergotamine,FALSE,none
the use of drugs that stimulate alpha-adrenergic receptors ( e.g.  drug0  pseudodrug0  drug0  drug1 or drug0 ) may enhance or potentiate the pressor effects of drug2 . therefore  caution should be used when drug0 is administered concomitantly with agents that cause vasoconstriction .,phenylpropanolamine,proamatine,TRUE,effect
the use of drugs that stimulate alpha-adrenergic receptors ( e.g.  drug0  pseudodrug0  drug0  drug1 or drug0 ) may enhance or potentiate the pressor effects of drug2 . therefore  caution should be used when drug0 is administered concomitantly with agents that cause vasoconstriction .,phenylpropanolamine,proamatine,FALSE,none
the use of drugs that stimulate alpha-adrenergic receptors ( e.g.  drug0  pseudodrug0  drug0  drug0 or drug1 ) may enhance or potentiate the pressor effects of drug2 . therefore  caution should be used when drug0 is administered concomitantly with agents that cause vasoconstriction .,dihydroergotamine,proamatine,TRUE,effect
the use of drugs that stimulate alpha-adrenergic receptors ( e.g.  drug0  pseudodrug0  drug0  drug0 or drug1 ) may enhance or potentiate the pressor effects of drug2 . therefore  caution should be used when drug0 is administered concomitantly with agents that cause vasoconstriction .,dihydroergotamine,proamatine,FALSE,none
drug1 has been used in patients concomitantly treated with salt-retaining steroid therapy ( i.e.  drug2 )  with or without salt supplementation .,proamatine,fludrocortisone acetate,FALSE,none
drug1 . drug2  such as drug0  drug0  and drug0  can antagonize the effects of drug0 . potential for drug interactions : it appears possible  althoudrug0 there is no supporting experimental evidence  that the hidrug0 renal clearance of drug0 ( a base ) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as drug0  drug0  drug0  drug0  drug0  drug0  and drug0 .,proamatine,alpha-adrenergic blocking agents,FALSE,none
drug1 . drug0  such as drug2  drug0  and drug0  can antagonize the effects of drug0 . potential for drug interactions : it appears possible  althoudrug0 there is no supporting experimental evidence  that the hidrug0 renal clearance of drug0 ( a base ) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as drug0  drug0  drug0  drug0  drug0  drug0  and drug0 .,proamatine,prazosin,FALSE,none
drug1 . drug0  such as drug0  drug2  and drug0  can antagonize the effects of drug0 . potential for drug interactions : it appears possible  althoudrug0 there is no supporting experimental evidence  that the hidrug0 renal clearance of drug0 ( a base ) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as drug0  drug0  drug0  drug0  drug0  drug0  and drug0 .,proamatine,terazosin,FALSE,none
drug1 . drug0  such as drug0  drug0  and drug2  can antagonize the effects of drug0 . potential for drug interactions : it appears possible  althoudrug0 there is no supporting experimental evidence  that the hidrug0 renal clearance of drug0 ( a base ) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as drug0  drug0  drug0  drug0  drug0  drug0  and drug0 .,proamatine,doxazosin,FALSE,none
drug1 . drug0  such as drug0  drug0  and drug0  can antagonize the effects of drug0 . potential for drug interactions : it appears possible  althoudrug0 there is no supporting experimental evidence  that the hidrug0 renal clearance of drug2 ( a base ) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as drug0  drug0  drug0  drug0  drug0  drug0  and drug0 .,proamatine,desglymidodrine,FALSE,none
drug1 . drug0  such as drug0  drug0  and drug0  can antagonize the effects of drug0 . potential for drug interactions : it appears possible  althoudrug0 there is no supporting experimental evidence  that the hidrug0 renal clearance of drug0 ( a base ) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as drug2  drug0  drug0  drug0  drug0  drug0  and drug0 .,proamatine,metformin,FALSE,none
drug1 . drug0  such as drug0  drug0  and drug0  can antagonize the effects of drug0 . potential for drug interactions : it appears possible  althoudrug0 there is no supporting experimental evidence  that the hidrug0 renal clearance of drug0 ( a base ) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as drug0  drug2  drug0  drug0  drug0  drug0  and drug0 .,proamatine,cimetidine,FALSE,none
drug1 . drug0  such as drug0  drug0  and drug0  can antagonize the effects of drug0 . potential for drug interactions : it appears possible  althoudrug0 there is no supporting experimental evidence  that the hidrug0 renal clearance of drug0 ( a base ) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as drug0  drug0  drug2  drug0  drug0  drug0  and drug0 .,proamatine,ranitidine,FALSE,none
drug1 . drug0  such as drug0  drug0  and drug0  can antagonize the effects of drug0 . potential for drug interactions : it appears possible  althoudrug0 there is no supporting experimental evidence  that the hidrug0 renal clearance of drug0 ( a base ) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as drug0  drug0  drug0  drug2  drug0  drug0  and drug0 .,proamatine,procainamide,FALSE,none
drug1 . drug0  such as drug0  drug0  and drug0  can antagonize the effects of drug0 . potential for drug interactions : it appears possible  althoudrug0 there is no supporting experimental evidence  that the hidrug0 renal clearance of drug0 ( a base ) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as drug0  drug0  drug0  drug0  drug2  drug0  and drug0 .,proamatine,triamterene,FALSE,none
drug1 . drug0  such as drug0  drug0  and drug0  can antagonize the effects of drug0 . potential for drug interactions : it appears possible  althoudrug0 there is no supporting experimental evidence  that the hidrug0 renal clearance of drug0 ( a base ) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as drug0  drug0  drug0  drug0  drug0  drug2  and drug0 .,proamatine,flecainide,FALSE,none
drug1 . drug0  such as drug0  drug0  and drug0  can antagonize the effects of drug0 . potential for drug interactions : it appears possible  althoudrug0 there is no supporting experimental evidence  that the hidrug0 renal clearance of drug0 ( a base ) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as drug0  drug0  drug0  drug0  drug0  drug0  and drug2 .,proamatine,quinidine,FALSE,none
drug0 . drug1  such as drug2  drug0  and drug0  can antagonize the effects of drug0 . potential for drug interactions : it appears possible  althoudrug0 there is no supporting experimental evidence  that the hidrug0 renal clearance of drug0 ( a base ) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as drug0  drug0  drug0  drug0  drug0  drug0  and drug0 .,alpha-adrenergic blocking agents,prazosin,FALSE,none
drug0 . drug1  such as drug0  drug0  and drug2  can antagonize the effects of drug0 . potential for drug interactions : it appears possible  althoudrug0 there is no supporting experimental evidence  that the hidrug0 renal clearance of drug0 ( a base ) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as drug0  drug0  drug0  drug0  drug0  drug0  and drug0 .,alpha-adrenergic blocking agents,doxazosin,FALSE,none
drug2 . drug1  such as drug0  drug0  and drug0  can antagonize the effects of drug0 . potential for drug interactions : it appears possible  althoudrug0 there is no supporting experimental evidence  that the hidrug0 renal clearance of drug0 ( a base ) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as drug0  drug0  drug0  drug0  drug0  drug0  and drug0 .,alpha-adrenergic blocking agents,proamatine,TRUE,effect
drug0 . drug1  such as drug0  drug0  and drug0  can antagonize the effects of drug0 . potential for drug interactions : it appears possible  althoudrug0 there is no supporting experimental evidence  that the hidrug0 renal clearance of drug2 ( a base ) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as drug0  drug0  drug0  drug0  drug0  drug0  and drug0 .,alpha-adrenergic blocking agents,desglymidodrine,FALSE,none
drug0 . drug1  such as drug0  drug0  and drug0  can antagonize the effects of drug0 . potential for drug interactions : it appears possible  althoudrug0 there is no supporting experimental evidence  that the hidrug0 renal clearance of drug0 ( a base ) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as drug2  drug0  drug0  drug0  drug0  drug0  and drug0 .,alpha-adrenergic blocking agents,metformin,FALSE,none
drug0 . drug1  such as drug0  drug0  and drug0  can antagonize the effects of drug0 . potential for drug interactions : it appears possible  althoudrug0 there is no supporting experimental evidence  that the hidrug0 renal clearance of drug0 ( a base ) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as drug0  drug2  drug0  drug0  drug0  drug0  and drug0 .,alpha-adrenergic blocking agents,cimetidine,FALSE,none
drug0 . drug1  such as drug0  drug0  and drug0  can antagonize the effects of drug0 . potential for drug interactions : it appears possible  althoudrug0 there is no supporting experimental evidence  that the hidrug0 renal clearance of drug0 ( a base ) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as drug0  drug0  drug2  drug0  drug0  drug0  and drug0 .,alpha-adrenergic blocking agents,ranitidine,FALSE,none
drug0 . drug1  such as drug0  drug0  and drug0  can antagonize the effects of drug0 . potential for drug interactions : it appears possible  althoudrug0 there is no supporting experimental evidence  that the hidrug0 renal clearance of drug0 ( a base ) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as drug0  drug0  drug0  drug2  drug0  drug0  and drug0 .,alpha-adrenergic blocking agents,procainamide,FALSE,none
drug0 . drug1  such as drug0  drug0  and drug0  can antagonize the effects of drug0 . potential for drug interactions : it appears possible  althoudrug0 there is no supporting experimental evidence  that the hidrug0 renal clearance of drug0 ( a base ) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as drug0  drug0  drug0  drug0  drug2  drug0  and drug0 .,alpha-adrenergic blocking agents,triamterene,FALSE,none
drug0 . drug1  such as drug0  drug0  and drug0  can antagonize the effects of drug0 . potential for drug interactions : it appears possible  althoudrug0 there is no supporting experimental evidence  that the hidrug0 renal clearance of drug0 ( a base ) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as drug0  drug0  drug0  drug0  drug0  drug2  and drug0 .,alpha-adrenergic blocking agents,flecainide,FALSE,none
drug0 . drug1  such as drug0  drug0  and drug0  can antagonize the effects of drug0 . potential for drug interactions : it appears possible  althoudrug0 there is no supporting experimental evidence  that the hidrug0 renal clearance of drug0 ( a base ) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as drug0  drug0  drug0  drug0  drug0  drug0  and drug2 .,alpha-adrenergic blocking agents,quinidine,FALSE,none
drug2 . drug0  such as drug1  drug0  and drug0  can antagonize the effects of drug0 . potential for drug interactions : it appears possible  althoudrug0 there is no supporting experimental evidence  that the hidrug0 renal clearance of drug0 ( a base ) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as drug0  drug0  drug0  drug0  drug0  drug0  and drug0 .,prazosin,proamatine,TRUE,effect
drug0 . drug0  such as drug1  drug0  and drug0  can antagonize the effects of drug0 . potential for drug interactions : it appears possible  althoudrug0 there is no supporting experimental evidence  that the hidrug0 renal clearance of drug2 ( a base ) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as drug0  drug0  drug0  drug0  drug0  drug0  and drug0 .,prazosin,desglymidodrine,FALSE,none
drug0 . drug0  such as drug1  drug0  and drug0  can antagonize the effects of drug0 . potential for drug interactions : it appears possible  althoudrug0 there is no supporting experimental evidence  that the hidrug0 renal clearance of drug0 ( a base ) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as drug2  drug0  drug0  drug0  drug0  drug0  and drug0 .,prazosin,metformin,FALSE,none
drug0 . drug0  such as drug1  drug0  and drug0  can antagonize the effects of drug0 . potential for drug interactions : it appears possible  althoudrug0 there is no supporting experimental evidence  that the hidrug0 renal clearance of drug0 ( a base ) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as drug0  drug2  drug0  drug0  drug0  drug0  and drug0 .,prazosin,cimetidine,FALSE,none
drug0 . drug0  such as drug1  drug0  and drug0  can antagonize the effects of drug0 . potential for drug interactions : it appears possible  althoudrug0 there is no supporting experimental evidence  that the hidrug0 renal clearance of drug0 ( a base ) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as drug0  drug0  drug2  drug0  drug0  drug0  and drug0 .,prazosin,ranitidine,FALSE,none
drug0 . drug0  such as drug1  drug0  and drug0  can antagonize the effects of drug0 . potential for drug interactions : it appears possible  althoudrug0 there is no supporting experimental evidence  that the hidrug0 renal clearance of drug0 ( a base ) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as drug0  drug0  drug0  drug2  drug0  drug0  and drug0 .,prazosin,procainamide,FALSE,none
drug0 . drug0  such as drug1  drug0  and drug0  can antagonize the effects of drug0 . potential for drug interactions : it appears possible  althoudrug0 there is no supporting experimental evidence  that the hidrug0 renal clearance of drug0 ( a base ) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as drug0  drug0  drug0  drug0  drug2  drug0  and drug0 .,prazosin,triamterene,FALSE,none
drug0 . drug0  such as drug1  drug0  and drug0  can antagonize the effects of drug0 . potential for drug interactions : it appears possible  althoudrug0 there is no supporting experimental evidence  that the hidrug0 renal clearance of drug0 ( a base ) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as drug0  drug0  drug0  drug0  drug0  drug2  and drug0 .,prazosin,flecainide,FALSE,none
drug0 . drug0  such as drug1  drug0  and drug0  can antagonize the effects of drug0 . potential for drug interactions : it appears possible  althoudrug0 there is no supporting experimental evidence  that the hidrug0 renal clearance of drug0 ( a base ) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as drug0  drug0  drug0  drug0  drug0  drug0  and drug2 .,prazosin,quinidine,FALSE,none
drug0 . drug0  such as drug0  drug1  and drug2  can antagonize the effects of drug0 . potential for drug interactions : it appears possible  althoudrug0 there is no supporting experimental evidence  that the hidrug0 renal clearance of drug0 ( a base ) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as drug0  drug0  drug0  drug0  drug0  drug0  and drug0 .,terazosin,doxazosin,FALSE,none
drug2 . drug0  such as drug0  drug1  and drug0  can antagonize the effects of drug0 . potential for drug interactions : it appears possible  althoudrug0 there is no supporting experimental evidence  that the hidrug0 renal clearance of drug0 ( a base ) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as drug0  drug0  drug0  drug0  drug0  drug0  and drug0 .,terazosin,proamatine,TRUE,effect
drug0 . drug0  such as drug0  drug1  and drug0  can antagonize the effects of drug0 . potential for drug interactions : it appears possible  althoudrug0 there is no supporting experimental evidence  that the hidrug0 renal clearance of drug2 ( a base ) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as drug0  drug0  drug0  drug0  drug0  drug0  and drug0 .,terazosin,desglymidodrine,FALSE,none
drug0 . drug0  such as drug0  drug1  and drug0  can antagonize the effects of drug0 . potential for drug interactions : it appears possible  althoudrug0 there is no supporting experimental evidence  that the hidrug0 renal clearance of drug0 ( a base ) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as drug2  drug0  drug0  drug0  drug0  drug0  and drug0 .,terazosin,metformin,FALSE,none
drug0 . drug0  such as drug0  drug1  and drug0  can antagonize the effects of drug0 . potential for drug interactions : it appears possible  althoudrug0 there is no supporting experimental evidence  that the hidrug0 renal clearance of drug0 ( a base ) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as drug0  drug2  drug0  drug0  drug0  drug0  and drug0 .,terazosin,cimetidine,FALSE,none
drug0 . drug0  such as drug0  drug1  and drug0  can antagonize the effects of drug0 . potential for drug interactions : it appears possible  althoudrug0 there is no supporting experimental evidence  that the hidrug0 renal clearance of drug0 ( a base ) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as drug0  drug0  drug2  drug0  drug0  drug0  and drug0 .,terazosin,ranitidine,FALSE,none
drug0 . drug0  such as drug0  drug1  and drug0  can antagonize the effects of drug0 . potential for drug interactions : it appears possible  althoudrug0 there is no supporting experimental evidence  that the hidrug0 renal clearance of drug0 ( a base ) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as drug0  drug0  drug0  drug2  drug0  drug0  and drug0 .,terazosin,procainamide,FALSE,none
drug0 . drug0  such as drug0  drug1  and drug0  can antagonize the effects of drug0 . potential for drug interactions : it appears possible  althoudrug0 there is no supporting experimental evidence  that the hidrug0 renal clearance of drug0 ( a base ) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as drug0  drug0  drug0  drug0  drug2  drug0  and drug0 .,terazosin,triamterene,FALSE,none
drug0 . drug0  such as drug0  drug1  and drug0  can antagonize the effects of drug0 . potential for drug interactions : it appears possible  althoudrug0 there is no supporting experimental evidence  that the hidrug0 renal clearance of drug0 ( a base ) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as drug0  drug0  drug0  drug0  drug0  drug2  and drug0 .,terazosin,flecainide,FALSE,none
drug0 . drug0  such as drug0  drug1  and drug0  can antagonize the effects of drug0 . potential for drug interactions : it appears possible  althoudrug0 there is no supporting experimental evidence  that the hidrug0 renal clearance of drug0 ( a base ) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as drug0  drug0  drug0  drug0  drug0  drug0  and drug2 .,terazosin,quinidine,FALSE,none
drug2 . drug0  such as drug0  drug0  and drug1  can antagonize the effects of drug0 . potential for drug interactions : it appears possible  althoudrug0 there is no supporting experimental evidence  that the hidrug0 renal clearance of drug0 ( a base ) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as drug0  drug0  drug0  drug0  drug0  drug0  and drug0 .,doxazosin,proamatine,TRUE,effect
drug0 . drug0  such as drug0  drug0  and drug1  can antagonize the effects of drug0 . potential for drug interactions : it appears possible  althoudrug0 there is no supporting experimental evidence  that the hidrug0 renal clearance of drug2 ( a base ) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as drug0  drug0  drug0  drug0  drug0  drug0  and drug0 .,doxazosin,desglymidodrine,FALSE,none
drug0 . drug0  such as drug0  drug0  and drug1  can antagonize the effects of drug0 . potential for drug interactions : it appears possible  althoudrug0 there is no supporting experimental evidence  that the hidrug0 renal clearance of drug0 ( a base ) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as drug2  drug0  drug0  drug0  drug0  drug0  and drug0 .,doxazosin,metformin,FALSE,none
drug0 . drug0  such as drug0  drug0  and drug1  can antagonize the effects of drug0 . potential for drug interactions : it appears possible  althoudrug0 there is no supporting experimental evidence  that the hidrug0 renal clearance of drug0 ( a base ) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as drug0  drug2  drug0  drug0  drug0  drug0  and drug0 .,doxazosin,cimetidine,FALSE,none
drug0 . drug0  such as drug0  drug0  and drug1  can antagonize the effects of drug0 . potential for drug interactions : it appears possible  althoudrug0 there is no supporting experimental evidence  that the hidrug0 renal clearance of drug0 ( a base ) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as drug0  drug0  drug2  drug0  drug0  drug0  and drug0 .,doxazosin,ranitidine,FALSE,none
drug0 . drug0  such as drug0  drug0  and drug1  can antagonize the effects of drug0 . potential for drug interactions : it appears possible  althoudrug0 there is no supporting experimental evidence  that the hidrug0 renal clearance of drug0 ( a base ) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as drug0  drug0  drug0  drug2  drug0  drug0  and drug0 .,doxazosin,procainamide,FALSE,none
drug0 . drug0  such as drug0  drug0  and drug1  can antagonize the effects of drug0 . potential for drug interactions : it appears possible  althoudrug0 there is no supporting experimental evidence  that the hidrug0 renal clearance of drug0 ( a base ) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as drug0  drug0  drug0  drug0  drug2  drug0  and drug0 .,doxazosin,triamterene,FALSE,none
drug0 . drug0  such as drug0  drug0  and drug1  can antagonize the effects of drug0 . potential for drug interactions : it appears possible  althoudrug0 there is no supporting experimental evidence  that the hidrug0 renal clearance of drug0 ( a base ) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as drug0  drug0  drug0  drug0  drug0  drug2  and drug0 .,doxazosin,flecainide,FALSE,none
drug0 . drug0  such as drug0  drug0  and drug1  can antagonize the effects of drug0 . potential for drug interactions : it appears possible  althoudrug0 there is no supporting experimental evidence  that the hidrug0 renal clearance of drug0 ( a base ) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as drug0  drug0  drug0  drug0  drug0  drug0  and drug2 .,doxazosin,quinidine,FALSE,none
drug1 . drug0  such as drug0  drug0  and drug0  can antagonize the effects of drug0 . potential for drug interactions : it appears possible  althoudrug0 there is no supporting experimental evidence  that the hidrug0 renal clearance of drug2 ( a base ) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as drug0  drug0  drug0  drug0  drug0  drug0  and drug0 .,proamatine,desglymidodrine,FALSE,none
drug1 . drug0  such as drug0  drug0  and drug0  can antagonize the effects of drug0 . potential for drug interactions : it appears possible  althoudrug0 there is no supporting experimental evidence  that the hidrug0 renal clearance of drug0 ( a base ) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as drug2  drug0  drug0  drug0  drug0  drug0  and drug0 .,proamatine,metformin,FALSE,none
drug1 . drug0  such as drug0  drug0  and drug0  can antagonize the effects of drug0 . potential for drug interactions : it appears possible  althoudrug0 there is no supporting experimental evidence  that the hidrug0 renal clearance of drug0 ( a base ) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as drug0  drug2  drug0  drug0  drug0  drug0  and drug0 .,proamatine,cimetidine,FALSE,none
drug1 . drug0  such as drug0  drug0  and drug0  can antagonize the effects of drug0 . potential for drug interactions : it appears possible  althoudrug0 there is no supporting experimental evidence  that the hidrug0 renal clearance of drug0 ( a base ) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as drug0  drug0  drug2  drug0  drug0  drug0  and drug0 .,proamatine,ranitidine,FALSE,none
drug1 . drug0  such as drug0  drug0  and drug0  can antagonize the effects of drug0 . potential for drug interactions : it appears possible  althoudrug0 there is no supporting experimental evidence  that the hidrug0 renal clearance of drug0 ( a base ) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as drug0  drug0  drug0  drug2  drug0  drug0  and drug0 .,proamatine,procainamide,FALSE,none
drug1 . drug0  such as drug0  drug0  and drug0  can antagonize the effects of drug0 . potential for drug interactions : it appears possible  althoudrug0 there is no supporting experimental evidence  that the hidrug0 renal clearance of drug0 ( a base ) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as drug0  drug0  drug0  drug0  drug2  drug0  and drug0 .,proamatine,triamterene,FALSE,none
drug1 . drug0  such as drug0  drug0  and drug0  can antagonize the effects of drug0 . potential for drug interactions : it appears possible  althoudrug0 there is no supporting experimental evidence  that the hidrug0 renal clearance of drug0 ( a base ) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as drug0  drug0  drug0  drug0  drug0  drug2  and drug0 .,proamatine,flecainide,FALSE,none
drug1 . drug0  such as drug0  drug0  and drug0  can antagonize the effects of drug0 . potential for drug interactions : it appears possible  althoudrug0 there is no supporting experimental evidence  that the hidrug0 renal clearance of drug0 ( a base ) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as drug0  drug0  drug0  drug0  drug0  drug0  and drug2 .,proamatine,quinidine,FALSE,none
drug0 . drug0  such as drug0  drug0  and drug0  can antagonize the effects of drug0 . potential for drug interactions : it appears possible  althoudrug0 there is no supporting experimental evidence  that the hidrug0 renal clearance of drug1 ( a base ) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as drug2  drug0  drug0  drug0  drug0  drug0  and drug0 .,desglymidodrine,metformin,TRUE,mechanism
drug0 . drug0  such as drug0  drug0  and drug0  can antagonize the effects of drug0 . potential for drug interactions : it appears possible  althoudrug0 there is no supporting experimental evidence  that the hidrug0 renal clearance of drug1 ( a base ) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as drug0  drug2  drug0  drug0  drug0  drug0  and drug0 .,desglymidodrine,cimetidine,TRUE,mechanism
drug0 . drug0  such as drug0  drug0  and drug0  can antagonize the effects of drug0 . potential for drug interactions : it appears possible  althoudrug0 there is no supporting experimental evidence  that the hidrug0 renal clearance of drug1 ( a base ) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as drug0  drug0  drug2  drug0  drug0  drug0  and drug0 .,desglymidodrine,ranitidine,TRUE,mechanism
drug0 . drug0  such as drug0  drug0  and drug0  can antagonize the effects of drug0 . potential for drug interactions : it appears possible  althoudrug0 there is no supporting experimental evidence  that the hidrug0 renal clearance of drug1 ( a base ) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as drug0  drug0  drug0  drug2  drug0  drug0  and drug0 .,desglymidodrine,procainamide,TRUE,mechanism
drug0 . drug0  such as drug0  drug0  and drug0  can antagonize the effects of drug0 . potential for drug interactions : it appears possible  althoudrug0 there is no supporting experimental evidence  that the hidrug0 renal clearance of drug1 ( a base ) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as drug0  drug0  drug0  drug0  drug2  drug0  and drug0 .,desglymidodrine,triamterene,TRUE,mechanism
drug0 . drug0  such as drug0  drug0  and drug0  can antagonize the effects of drug0 . potential for drug interactions : it appears possible  althoudrug0 there is no supporting experimental evidence  that the hidrug0 renal clearance of drug1 ( a base ) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as drug0  drug0  drug0  drug0  drug0  drug2  and drug0 .,desglymidodrine,flecainide,TRUE,mechanism
drug0 . drug0  such as drug0  drug0  and drug0  can antagonize the effects of drug0 . potential for drug interactions : it appears possible  althoudrug0 there is no supporting experimental evidence  that the hidrug0 renal clearance of drug1 ( a base ) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as drug0  drug0  drug0  drug0  drug0  drug0  and drug2 .,desglymidodrine,quinidine,TRUE,mechanism
drug0 . drug0  such as drug0  drug0  and drug0  can antagonize the effects of drug0 . potential for drug interactions : it appears possible  althoudrug0 there is no supporting experimental evidence  that the hidrug0 renal clearance of drug0 ( a base ) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as drug0  drug0  drug0  drug0  drug0  drug1  and drug2 .,flecainide,quinidine,FALSE,none
john s wort  and certain drug1 ( drug2  drug0  drug0 ) may induce drug0 metabolism ( lowering serum levels of drug0 ) .,anticonvulsants,phenytoin,FALSE,none
john s wort  and certain drug1 ( drug0  drug2  drug0 ) may induce drug0 metabolism ( lowering serum levels of drug0 ) .,anticonvulsants,phenobarbital,FALSE,none
john s wort  and certain drug1 ( drug0  drug0  drug2 ) may induce drug0 metabolism ( lowering serum levels of drug0 ) .,anticonvulsants,carbamazepine,FALSE,none
john s wort  and certain drug1 ( drug0  drug0  drug0 ) may induce drug2 metabolism ( lowering serum levels of drug0 ) .,anticonvulsants,mifepristone,TRUE,mechanism
john s wort  and certain drug1 ( drug0  drug0  drug0 ) may induce drug2 metabolism ( lowering serum levels of drug0 ) .,anticonvulsants,mifepristone,FALSE,none
john s wort  and certain drug0 ( drug1  drug0  drug0 ) may induce drug2 metabolism ( lowering serum levels of drug0 ) .,phenytoin,mifepristone,TRUE,mechanism
john s wort  and certain drug0 ( drug1  drug0  drug0 ) may induce drug2 metabolism ( lowering serum levels of drug0 ) .,phenytoin,mifepristone,FALSE,none
john s wort  and certain drug0 ( drug0  drug1  drug0 ) may induce drug2 metabolism ( lowering serum levels of drug0 ) .,phenobarbital,mifepristone,TRUE,mechanism
john s wort  and certain drug0 ( drug0  drug1  drug0 ) may induce drug2 metabolism ( lowering serum levels of drug0 ) .,phenobarbital,mifepristone,FALSE,none
john s wort  and certain drug0 ( drug0  drug0  drug1 ) may induce drug2 metabolism ( lowering serum levels of drug0 ) .,carbamazepine,mifepristone,TRUE,mechanism
john s wort  and certain drug0 ( drug0  drug0  drug1 ) may induce drug2 metabolism ( lowering serum levels of drug0 ) .,carbamazepine,mifepristone,FALSE,none
while co-administration of drug1 appeared to increase the clearance of drug2 by 70 %  these results are not conclusive because of the small number of subjects studied and because patients took variable doses of drug0 .,zavesca,cerezyme,TRUE,mechanism
while co-administration of drug1 appeared to increase the clearance of drug2 by 70 %  these results are not conclusive because of the small number of subjects studied and because patients took variable doses of drug0 .,zavesca,cerezyme,FALSE,none
combination therapy with drug1 ( drug2 ) and drug0 is not indicated .,cerezyme,imiglucerase,FALSE,none
combination therapy with drug1 ( drug0 ) and drug2 is not indicated .,cerezyme,zavesca,TRUE,advise
combination therapy with drug0 ( drug1 ) and drug2 is not indicated .,imiglucerase,zavesca,TRUE,advise
because drug1 have been shown to depress plasma prothrombin activity  patients who are on drug2 therapy may require downward adjustment of their drug0 dosage .,tetracyclines,anticoagulant,TRUE,advise
because drug1 have been shown to depress plasma prothrombin activity  patients who are on drug2 therapy may require downward adjustment of their drug0 dosage .,tetracyclines,anticoagulant,FALSE,none
since bacteriostatic drugs may interfere with the bactericidal action of drug1  it is advisable to avoid giving drug2 in conjunction with drug0 .,penicillin,tetracycline class drugs,FALSE,none
since bacteriostatic drugs may interfere with the bactericidal action of drug2  it is advisable to avoid giving drug1 in conjunction with drug0 .,tetracycline class drugs,penicillin,TRUE,advise
absorption of drug1 is impaired by drug2 containing drug0  drug0 or drug0  and drug0-containing preparations .,tetracyclines,antacids,FALSE,none
absorption of drug1 is impaired by drug0 containing drug2  drug0 or drug0  and drug0-containing preparations .,tetracyclines,aluminum,TRUE,mechanism
absorption of drug1 is impaired by drug0 containing drug0  drug2 or drug0  and drug0-containing preparations .,tetracyclines,calcium,TRUE,mechanism
absorption of drug1 is impaired by drug0 containing drug0  drug0 or drug2  and drug0-containing preparations .,tetracyclines,magnesium,TRUE,mechanism
absorption of drug1 is impaired by drug0 containing drug0  drug0 or drug0  and drug2-containing preparations .,tetracyclines,iron,TRUE,mechanism
absorption of drug0 is impaired by drug1 containing drug2  drug0 or drug0  and drug0-containing preparations .,antacids,aluminum,FALSE,none
absorption of drug0 is impaired by drug1 containing drug0  drug2 or drug0  and drug0-containing preparations .,antacids,calcium,FALSE,none
absorption of drug0 is impaired by drug1 containing drug0  drug0 or drug2  and drug0-containing preparations .,antacids,magnesium,FALSE,none
absorption of drug0 is impaired by drug1 containing drug0  drug0 or drug0  and drug2-containing preparations .,antacids,iron,FALSE,none
absorption of drug0 is impaired by drug0 containing drug1  drug0 or drug2  and drug0-containing preparations .,aluminum,magnesium,FALSE,none
absorption of drug0 is impaired by drug0 containing drug1  drug0 or drug0  and drug2-containing preparations .,aluminum,iron,FALSE,none
absorption of drug0 is impaired by drug0 containing drug0  drug1 or drug2  and drug0-containing preparations .,calcium,magnesium,FALSE,none
absorption of drug0 is impaired by drug0 containing drug0  drug1 or drug0  and drug2-containing preparations .,calcium,iron,FALSE,none
absorption of drug0 is impaired by drug0 containing drug0  drug0 or drug1  and drug2-containing preparations .,magnesium,iron,FALSE,none
the concurrent use of drug1 and drug2 has been reported to result in fatal renal toxicity .,tetracycline,methoxyflurane,TRUE,effect
concurrent use of drug1 with oral drug2 may render oral drug0 less effective .,tetracyclines,contraceptives,TRUE,effect
concurrent use of drug1 with oral drug2 may render oral drug0 less effective .,tetracyclines,contraceptives,FALSE,none
interaction with drug1 : althoudrug0 drug2 does not itself cause orthostatic hypotension  its administration to patients already receiving drug0 can result in profound orthostatic effects .,guanethidine,minoxidil,FALSE,none
interaction with drug2 : althoudrug0 drug1 does not itself cause orthostatic hypotension  its administration to patients already receiving drug0 can result in profound orthostatic effects .,minoxidil,guanethidine,TRUE,effect
if at all possible drug1 should be discontinued well before drug2 is begun .,guanethidine,minoxidil,TRUE,advise
drugs affecting hepatic metabolism the metabolism and pharmacokinetics of drug1 ( drug2 ) orally disintegrating tablets may be affected by the induction or inhibition of drug-metab-olizing enzymes .,remeron soltab,mirtazapine,FALSE,none
drug1 : concomitant administration of drug0 ( equivalent to 60 g ) had a minimal effect on plasma levels of drug2 ( 15 mg ) in 6 healthy male subjects .,alcohol,mirtazapine,FALSE,none
drug1 : concomitant administration of drug0 ( equivalent to 60 g ) had a minimal effect on plasma levels of drug2 ( 15 mg ) in 6 healthy male subjects .,alcohol,mirtazapine,TRUE,mechanism
however  the impairment of cognitive and motor skills produced by drug1 were shown to be additive with those produced by drug2 .,remeron,alcohol,TRUE,effect
accordingly  patients should be advised to avoid drug1 while taking drug2 . drug0 : concomitant administration of drug0 ( 15 mg ) had a minimal effect on plasma levels of drug0 ( 15 mg ) in 12 healthy subjects .,alcohol,remeron soltab,TRUE,advise
accordingly  patients should be advised to avoid drug1 while taking drug0 soltab . drug2 : concomitant administration of drug0 ( 15 mg ) had a minimal effect on plasma levels of drug0 ( 15 mg ) in 12 healthy subjects .,alcohol,diazepam,FALSE,none
accordingly  patients should be advised to avoid drug1 while taking drug0 soltab . drug2 : concomitant administration of drug0 ( 15 mg ) had a minimal effect on plasma levels of drug0 ( 15 mg ) in 12 healthy subjects .,alcohol,diazepam,FALSE,none
accordingly  patients should be advised to avoid drug1 while taking drug0 soltab . drug0 : concomitant administration of drug0 ( 15 mg ) had a minimal effect on plasma levels of drug2 ( 15 mg ) in 12 healthy subjects .,alcohol,mirtazapine,FALSE,none
accordingly  patients should be advised to avoid drug0 while taking drug1 . drug2 : concomitant administration of drug0 ( 15 mg ) had a minimal effect on plasma levels of drug0 ( 15 mg ) in 12 healthy subjects .,remeron soltab,diazepam,FALSE,none
accordingly  patients should be advised to avoid drug0 while taking drug1 . drug2 : concomitant administration of drug0 ( 15 mg ) had a minimal effect on plasma levels of drug0 ( 15 mg ) in 12 healthy subjects .,remeron soltab,diazepam,FALSE,none
accordingly  patients should be advised to avoid drug0 while taking drug1 . drug0 : concomitant administration of drug0 ( 15 mg ) had a minimal effect on plasma levels of drug2 ( 15 mg ) in 12 healthy subjects .,remeron soltab,mirtazapine,FALSE,none
accordingly  patients should be advised to avoid drug0 while taking drug0 soltab . drug1 : concomitant administration of drug0 ( 15 mg ) had a minimal effect on plasma levels of drug2 ( 15 mg ) in 12 healthy subjects .,diazepam,mirtazapine,FALSE,none
accordingly  patients should be advised to avoid drug0 while taking drug0 soltab . drug1 : concomitant administration of drug0 ( 15 mg ) had a minimal effect on plasma levels of drug2 ( 15 mg ) in 12 healthy subjects .,diazepam,mirtazapine,TRUE,mechanism
however  the impairment of motor skills produced by drug1 has been shown to be additive with those caused by drug2 .,remeron,diazepam,TRUE,effect
accordingly  patients should be advised to avoid drug1 and other similar drugs while taking drug2 .,diazepam,remeron soltab,TRUE,advise
drug1 has been reported to accelerate the metabolism of drug2 by the mechanism of hepatic microsomal enzyme induction  leading to an increase in dosage requirements for drug0 .,mitotane,warfarin,TRUE,mechanism
drug1 has been reported to accelerate the metabolism of drug2 by the mechanism of hepatic microsomal enzyme induction  leading to an increase in dosage requirements for drug0 .,mitotane,warfarin,FALSE,none
therefore  physicians should closely monitor patients for a change in drug1 dosage requirements when administering drug2 to patients on drug0-type drug0 .,anticoagulant,mitotane,FALSE,none
therefore  physicians should closely monitor patients for a change in drug1 dosage requirements when administering drug0 to patients on drug2 .,anticoagulant,coumarin-type anticoagulants,FALSE,none
therefore  physicians should closely monitor patients for a change in drug0 dosage requirements when administering drug1 to patients on drug2 .,mitotane,coumarin-type anticoagulants,TRUE,advise
prior administration of drug1 can potentiate the neuromuscular blocking effects of drug2 .,succinylcholine,nondepolarizing agents,TRUE,effect
evidence of spontaneous recovery from drug1 should be observed before the administration of drug2 .,succinylcholine,mivacron,TRUE,advise
there are no clinical data on the use of drug1 with other drug2 .,mivacron,nondepolarizing neuromuscular blocking agents,FALSE,none
drug1 and drug2 ( administered with drug0/drug0 to achieve 1.25 m.c .,isoflurane,enflurane,FALSE,none
drug1 and drug0 ( administered with drug2/drug0 to achieve 1.25 m.c .,isoflurane,nitrous oxide,FALSE,none
drug1 and drug0 ( administered with drug0/drug2 to achieve 1.25 m.c .,isoflurane,oxygen,FALSE,none
drug0 and drug1 ( administered with drug2/drug0 to achieve 1.25 m.c .,enflurane,nitrous oxide,FALSE,none
drug0 and drug1 ( administered with drug0/drug2 to achieve 1.25 m.c .,enflurane,oxygen,FALSE,none
drug0 and drug0 ( administered with drug1/drug2 to achieve 1.25 m.c .,nitrous oxide,oxygen,FALSE,none
a greater potentiation of the neuromuscular blocking effects of drug1 may be expected with higher concentrations of drug2 or drug0 .,mivacron,enflurane,FALSE,none
a greater potentiation of the neuromuscular blocking effects of drug1 may be expected with higher concentrations of drug0 or drug2 .,mivacron,isoflurane,FALSE,none
a greater potentiation of the neuromuscular blocking effects of drug0 may be expected with higher concentrations of drug1 or drug2 .,enflurane,isoflurane,FALSE,none
other drugs which may enhance the neuromuscular blocking action of drug1 such as drug0 include certain drug2 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0  drug0  and drug0 )  drug0 salts  drug0  local drug0  drug0  and drug0 .,nondepolarizing agents,antibiotics,TRUE,int
other drugs which may enhance the neuromuscular blocking action of drug1 such as drug0 include certain drug0 ( e.g.  drug2  drug0  drug0  drug0  drug0  drug0  drug0  and drug0 )  drug0 salts  drug0  local drug0  drug0  and drug0 .,nondepolarizing agents,aminoglycosides,TRUE,int
other drugs which may enhance the neuromuscular blocking action of drug1 such as drug0 include certain drug0 ( e.g.  drug0  drug2  drug0  drug0  drug0  drug0  drug0  and drug0 )  drug0 salts  drug0  local drug0  drug0  and drug0 .,nondepolarizing agents,tetracyclines,TRUE,int
other drugs which may enhance the neuromuscular blocking action of drug1 such as drug0 include certain drug0 ( e.g.  drug0  drug0  drug2  drug0  drug0  drug0  drug0  and drug0 )  drug0 salts  drug0  local drug0  drug0  and drug0 .,nondepolarizing agents,bacitracin,TRUE,int
other drugs which may enhance the neuromuscular blocking action of drug1 such as drug0 include certain drug0 ( e.g.  drug0  drug0  drug0  drug2  drug0  drug0  drug0  and drug0 )  drug0 salts  drug0  local drug0  drug0  and drug0 .,nondepolarizing agents,polymyxins,TRUE,int
other drugs which may enhance the neuromuscular blocking action of drug1 such as drug0 include certain drug0 ( e.g.  drug0  drug0  drug0  drug0  drug2  drug0  drug0  and drug0 )  drug0 salts  drug0  local drug0  drug0  and drug0 .,nondepolarizing agents,lincomycin,TRUE,int
other drugs which may enhance the neuromuscular blocking action of drug1 such as drug0 include certain drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug2  drug0  and drug0 )  drug0 salts  drug0  local drug0  drug0  and drug0 .,nondepolarizing agents,clindamycin,TRUE,int
other drugs which may enhance the neuromuscular blocking action of drug1 such as drug0 include certain drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0  drug2  and drug0 )  drug0 salts  drug0  local drug0  drug0  and drug0 .,nondepolarizing agents,colistin,TRUE,int
other drugs which may enhance the neuromuscular blocking action of drug1 such as drug0 include certain drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0  drug0  and drug2 )  drug0 salts  drug0  local drug0  drug0  and drug0 .,nondepolarizing agents,sodium colistimethate,TRUE,int
other drugs which may enhance the neuromuscular blocking action of drug1 such as drug0 include certain drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0  drug0  and drug0 )  drug2 salts  drug0  local drug0  drug0  and drug0 .,nondepolarizing agents,magnesium,TRUE,int
other drugs which may enhance the neuromuscular blocking action of drug1 such as drug0 include certain drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0  drug0  and drug0 )  drug0 salts  drug2  local drug0  drug0  and drug0 .,nondepolarizing agents,lithium,TRUE,int
other drugs which may enhance the neuromuscular blocking action of drug1 such as drug0 include certain drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0  drug0  and drug0 )  drug0 salts  drug0  local drug2  drug0  and drug0 .,nondepolarizing agents,anesthetics,TRUE,int
other drugs which may enhance the neuromuscular blocking action of drug1 such as drug0 include certain drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0  drug0  and drug0 )  drug0 salts  drug0  local drug0  drug2  and drug0 .,nondepolarizing agents,procainamide,TRUE,int
other drugs which may enhance the neuromuscular blocking action of drug1 such as drug0 include certain drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0  drug0  and drug0 )  drug0 salts  drug0  local drug0  drug0  and drug2 .,nondepolarizing agents,quinidine,TRUE,int
other drugs which may enhance the neuromuscular blocking action of drug0 such as drug1 include certain drug2 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0  drug0  and drug0 )  drug0 salts  drug0  local drug0  drug0  and drug0 .,mivacron,antibiotics,TRUE,int
other drugs which may enhance the neuromuscular blocking action of drug0 such as drug1 include certain drug0 ( e.g.  drug2  drug0  drug0  drug0  drug0  drug0  drug0  and drug0 )  drug0 salts  drug0  local drug0  drug0  and drug0 .,mivacron,aminoglycosides,TRUE,int
other drugs which may enhance the neuromuscular blocking action of drug0 such as drug1 include certain drug0 ( e.g.  drug0  drug2  drug0  drug0  drug0  drug0  drug0  and drug0 )  drug0 salts  drug0  local drug0  drug0  and drug0 .,mivacron,tetracyclines,TRUE,int
other drugs which may enhance the neuromuscular blocking action of drug0 such as drug1 include certain drug0 ( e.g.  drug0  drug0  drug2  drug0  drug0  drug0  drug0  and drug0 )  drug0 salts  drug0  local drug0  drug0  and drug0 .,mivacron,bacitracin,TRUE,int
other drugs which may enhance the neuromuscular blocking action of drug0 such as drug1 include certain drug0 ( e.g.  drug0  drug0  drug0  drug2  drug0  drug0  drug0  and drug0 )  drug0 salts  drug0  local drug0  drug0  and drug0 .,mivacron,polymyxins,TRUE,int
other drugs which may enhance the neuromuscular blocking action of drug0 such as drug1 include certain drug0 ( e.g.  drug0  drug0  drug0  drug0  drug2  drug0  drug0  and drug0 )  drug0 salts  drug0  local drug0  drug0  and drug0 .,mivacron,lincomycin,TRUE,int
other drugs which may enhance the neuromuscular blocking action of drug0 such as drug1 include certain drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug2  drug0  and drug0 )  drug0 salts  drug0  local drug0  drug0  and drug0 .,mivacron,clindamycin,TRUE,int
other drugs which may enhance the neuromuscular blocking action of drug0 such as drug1 include certain drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0  drug2  and drug0 )  drug0 salts  drug0  local drug0  drug0  and drug0 .,mivacron,colistin,TRUE,int
other drugs which may enhance the neuromuscular blocking action of drug0 such as drug1 include certain drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0  drug0  and drug2 )  drug0 salts  drug0  local drug0  drug0  and drug0 .,mivacron,sodium colistimethate,TRUE,int
other drugs which may enhance the neuromuscular blocking action of drug0 such as drug1 include certain drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0  drug0  and drug0 )  drug2 salts  drug0  local drug0  drug0  and drug0 .,mivacron,magnesium,TRUE,int
other drugs which may enhance the neuromuscular blocking action of drug0 such as drug1 include certain drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0  drug0  and drug0 )  drug0 salts  drug2  local drug0  drug0  and drug0 .,mivacron,lithium,TRUE,int
other drugs which may enhance the neuromuscular blocking action of drug0 such as drug1 include certain drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0  drug0  and drug0 )  drug0 salts  drug0  local drug2  drug0  and drug0 .,mivacron,anesthetics,TRUE,int
other drugs which may enhance the neuromuscular blocking action of drug0 such as drug1 include certain drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0  drug0  and drug0 )  drug0 salts  drug0  local drug0  drug2  and drug0 .,mivacron,procainamide,TRUE,int
other drugs which may enhance the neuromuscular blocking action of drug0 such as drug1 include certain drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0  drug0  and drug0 )  drug0 salts  drug0  local drug0  drug0  and drug2 .,mivacron,quinidine,TRUE,int
other drugs which may enhance the neuromuscular blocking action of drug0 such as drug0 include certain drug1 ( e.g.  drug2  drug0  drug0  drug0  drug0  drug0  drug0  and drug0 )  drug0 salts  drug0  local drug0  drug0  and drug0 .,antibiotics,aminoglycosides,FALSE,none
other drugs which may enhance the neuromuscular blocking action of drug0 such as drug0 include certain drug1 ( e.g.  drug0  drug2  drug0  drug0  drug0  drug0  drug0  and drug0 )  drug0 salts  drug0  local drug0  drug0  and drug0 .,antibiotics,tetracyclines,FALSE,none
other drugs which may enhance the neuromuscular blocking action of drug0 such as drug0 include certain drug1 ( e.g.  drug0  drug0  drug2  drug0  drug0  drug0  drug0  and drug0 )  drug0 salts  drug0  local drug0  drug0  and drug0 .,antibiotics,bacitracin,FALSE,none
other drugs which may enhance the neuromuscular blocking action of drug0 such as drug0 include certain drug1 ( e.g.  drug0  drug0  drug0  drug2  drug0  drug0  drug0  and drug0 )  drug0 salts  drug0  local drug0  drug0  and drug0 .,antibiotics,polymyxins,FALSE,none
other drugs which may enhance the neuromuscular blocking action of drug0 such as drug0 include certain drug1 ( e.g.  drug0  drug0  drug0  drug0  drug2  drug0  drug0  and drug0 )  drug0 salts  drug0  local drug0  drug0  and drug0 .,antibiotics,lincomycin,FALSE,none
other drugs which may enhance the neuromuscular blocking action of drug0 such as drug0 include certain drug1 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug2  drug0  and drug0 )  drug0 salts  drug0  local drug0  drug0  and drug0 .,antibiotics,clindamycin,FALSE,none
other drugs which may enhance the neuromuscular blocking action of drug0 such as drug0 include certain drug1 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0  drug2  and drug0 )  drug0 salts  drug0  local drug0  drug0  and drug0 .,antibiotics,colistin,FALSE,none
other drugs which may enhance the neuromuscular blocking action of drug0 such as drug0 include certain drug1 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0  drug0  and drug2 )  drug0 salts  drug0  local drug0  drug0  and drug0 .,antibiotics,sodium colistimethate,FALSE,none
other drugs which may enhance the neuromuscular blocking action of drug0 such as drug0 include certain drug1 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0  drug0  and drug0 )  drug2 salts  drug0  local drug0  drug0  and drug0 .,antibiotics,magnesium,FALSE,none
other drugs which may enhance the neuromuscular blocking action of drug0 such as drug0 include certain drug1 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0  drug0  and drug0 )  drug0 salts  drug2  local drug0  drug0  and drug0 .,antibiotics,lithium,FALSE,none
other drugs which may enhance the neuromuscular blocking action of drug0 such as drug0 include certain drug1 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0  drug0  and drug0 )  drug0 salts  drug0  local drug2  drug0  and drug0 .,antibiotics,anesthetics,FALSE,none
other drugs which may enhance the neuromuscular blocking action of drug0 such as drug0 include certain drug1 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0  drug0  and drug0 )  drug0 salts  drug0  local drug0  drug2  and drug0 .,antibiotics,procainamide,FALSE,none
other drugs which may enhance the neuromuscular blocking action of drug0 such as drug0 include certain drug1 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0  drug0  and drug0 )  drug0 salts  drug0  local drug0  drug0  and drug2 .,antibiotics,quinidine,FALSE,none
other drugs which may enhance the neuromuscular blocking action of drug0 such as drug0 include certain drug0 ( e.g.  drug1  drug0  drug0  drug0  drug0  drug0  drug0  and drug0 )  drug2 salts  drug0  local drug0  drug0  and drug0 .,aminoglycosides,magnesium,FALSE,none
other drugs which may enhance the neuromuscular blocking action of drug0 such as drug0 include certain drug0 ( e.g.  drug1  drug0  drug0  drug0  drug0  drug0  drug0  and drug0 )  drug0 salts  drug2  local drug0  drug0  and drug0 .,aminoglycosides,lithium,FALSE,none
other drugs which may enhance the neuromuscular blocking action of drug0 such as drug0 include certain drug0 ( e.g.  drug1  drug0  drug0  drug0  drug0  drug0  drug0  and drug0 )  drug0 salts  drug0  local drug2  drug0  and drug0 .,aminoglycosides,anesthetics,FALSE,none
other drugs which may enhance the neuromuscular blocking action of drug0 such as drug0 include certain drug0 ( e.g.  drug1  drug0  drug0  drug0  drug0  drug0  drug0  and drug0 )  drug0 salts  drug0  local drug0  drug2  and drug0 .,aminoglycosides,procainamide,FALSE,none
other drugs which may enhance the neuromuscular blocking action of drug0 such as drug0 include certain drug0 ( e.g.  drug1  drug0  drug0  drug0  drug0  drug0  drug0  and drug0 )  drug0 salts  drug0  local drug0  drug0  and drug2 .,aminoglycosides,quinidine,FALSE,none
other drugs which may enhance the neuromuscular blocking action of drug0 such as drug0 include certain drug0 ( e.g.  drug0  drug1  drug0  drug0  drug0  drug0  drug0  and drug0 )  drug2 salts  drug0  local drug0  drug0  and drug0 .,tetracyclines,magnesium,FALSE,none
other drugs which may enhance the neuromuscular blocking action of drug0 such as drug0 include certain drug0 ( e.g.  drug0  drug1  drug0  drug0  drug0  drug0  drug0  and drug0 )  drug0 salts  drug2  local drug0  drug0  and drug0 .,tetracyclines,lithium,FALSE,none
other drugs which may enhance the neuromuscular blocking action of drug0 such as drug0 include certain drug0 ( e.g.  drug0  drug1  drug0  drug0  drug0  drug0  drug0  and drug0 )  drug0 salts  drug0  local drug2  drug0  and drug0 .,tetracyclines,anesthetics,FALSE,none
other drugs which may enhance the neuromuscular blocking action of drug0 such as drug0 include certain drug0 ( e.g.  drug0  drug1  drug0  drug0  drug0  drug0  drug0  and drug0 )  drug0 salts  drug0  local drug0  drug2  and drug0 .,tetracyclines,procainamide,FALSE,none
other drugs which may enhance the neuromuscular blocking action of drug0 such as drug0 include certain drug0 ( e.g.  drug0  drug1  drug0  drug0  drug0  drug0  drug0  and drug0 )  drug0 salts  drug0  local drug0  drug0  and drug2 .,tetracyclines,quinidine,FALSE,none
other drugs which may enhance the neuromuscular blocking action of drug0 such as drug0 include certain drug0 ( e.g.  drug0  drug0  drug1  drug0  drug0  drug0  drug0  and drug0 )  drug2 salts  drug0  local drug0  drug0  and drug0 .,bacitracin,magnesium,FALSE,none
other drugs which may enhance the neuromuscular blocking action of drug0 such as drug0 include certain drug0 ( e.g.  drug0  drug0  drug1  drug0  drug0  drug0  drug0  and drug0 )  drug0 salts  drug2  local drug0  drug0  and drug0 .,bacitracin,lithium,FALSE,none
other drugs which may enhance the neuromuscular blocking action of drug0 such as drug0 include certain drug0 ( e.g.  drug0  drug0  drug1  drug0  drug0  drug0  drug0  and drug0 )  drug0 salts  drug0  local drug2  drug0  and drug0 .,bacitracin,anesthetics,FALSE,none
other drugs which may enhance the neuromuscular blocking action of drug0 such as drug0 include certain drug0 ( e.g.  drug0  drug0  drug1  drug0  drug0  drug0  drug0  and drug0 )  drug0 salts  drug0  local drug0  drug2  and drug0 .,bacitracin,procainamide,FALSE,none
other drugs which may enhance the neuromuscular blocking action of drug0 such as drug0 include certain drug0 ( e.g.  drug0  drug0  drug1  drug0  drug0  drug0  drug0  and drug0 )  drug0 salts  drug0  local drug0  drug0  and drug2 .,bacitracin,quinidine,FALSE,none
other drugs which may enhance the neuromuscular blocking action of drug0 such as drug0 include certain drug0 ( e.g.  drug0  drug0  drug0  drug1  drug0  drug0  drug0  and drug0 )  drug2 salts  drug0  local drug0  drug0  and drug0 .,polymyxins,magnesium,FALSE,none
other drugs which may enhance the neuromuscular blocking action of drug0 such as drug0 include certain drug0 ( e.g.  drug0  drug0  drug0  drug1  drug0  drug0  drug0  and drug0 )  drug0 salts  drug2  local drug0  drug0  and drug0 .,polymyxins,lithium,FALSE,none
other drugs which may enhance the neuromuscular blocking action of drug0 such as drug0 include certain drug0 ( e.g.  drug0  drug0  drug0  drug1  drug0  drug0  drug0  and drug0 )  drug0 salts  drug0  local drug2  drug0  and drug0 .,polymyxins,anesthetics,FALSE,none
other drugs which may enhance the neuromuscular blocking action of drug0 such as drug0 include certain drug0 ( e.g.  drug0  drug0  drug0  drug1  drug0  drug0  drug0  and drug0 )  drug0 salts  drug0  local drug0  drug2  and drug0 .,polymyxins,procainamide,FALSE,none
other drugs which may enhance the neuromuscular blocking action of drug0 such as drug0 include certain drug0 ( e.g.  drug0  drug0  drug0  drug1  drug0  drug0  drug0  and drug0 )  drug0 salts  drug0  local drug0  drug0  and drug2 .,polymyxins,quinidine,FALSE,none
other drugs which may enhance the neuromuscular blocking action of drug0 such as drug0 include certain drug0 ( e.g.  drug0  drug0  drug0  drug0  drug1  drug0  drug0  and drug0 )  drug2 salts  drug0  local drug0  drug0  and drug0 .,lincomycin,magnesium,FALSE,none
other drugs which may enhance the neuromuscular blocking action of drug0 such as drug0 include certain drug0 ( e.g.  drug0  drug0  drug0  drug0  drug1  drug0  drug0  and drug0 )  drug0 salts  drug2  local drug0  drug0  and drug0 .,lincomycin,lithium,FALSE,none
other drugs which may enhance the neuromuscular blocking action of drug0 such as drug0 include certain drug0 ( e.g.  drug0  drug0  drug0  drug0  drug1  drug0  drug0  and drug0 )  drug0 salts  drug0  local drug2  drug0  and drug0 .,lincomycin,anesthetics,FALSE,none
other drugs which may enhance the neuromuscular blocking action of drug0 such as drug0 include certain drug0 ( e.g.  drug0  drug0  drug0  drug0  drug1  drug0  drug0  and drug0 )  drug0 salts  drug0  local drug0  drug2  and drug0 .,lincomycin,procainamide,FALSE,none
other drugs which may enhance the neuromuscular blocking action of drug0 such as drug0 include certain drug0 ( e.g.  drug0  drug0  drug0  drug0  drug1  drug0  drug0  and drug0 )  drug0 salts  drug0  local drug0  drug0  and drug2 .,lincomycin,quinidine,FALSE,none
other drugs which may enhance the neuromuscular blocking action of drug0 such as drug0 include certain drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug1  drug0  and drug0 )  drug2 salts  drug0  local drug0  drug0  and drug0 .,clindamycin,magnesium,FALSE,none
other drugs which may enhance the neuromuscular blocking action of drug0 such as drug0 include certain drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug1  drug0  and drug0 )  drug0 salts  drug2  local drug0  drug0  and drug0 .,clindamycin,lithium,FALSE,none
other drugs which may enhance the neuromuscular blocking action of drug0 such as drug0 include certain drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug1  drug0  and drug0 )  drug0 salts  drug0  local drug2  drug0  and drug0 .,clindamycin,anesthetics,FALSE,none
other drugs which may enhance the neuromuscular blocking action of drug0 such as drug0 include certain drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug1  drug0  and drug0 )  drug0 salts  drug0  local drug0  drug2  and drug0 .,clindamycin,procainamide,FALSE,none
other drugs which may enhance the neuromuscular blocking action of drug0 such as drug0 include certain drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug1  drug0  and drug0 )  drug0 salts  drug0  local drug0  drug0  and drug2 .,clindamycin,quinidine,FALSE,none
other drugs which may enhance the neuromuscular blocking action of drug0 such as drug0 include certain drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0  drug1  and drug2 )  drug0 salts  drug0  local drug0  drug0  and drug0 .,colistin,sodium colistimethate,FALSE,none
other drugs which may enhance the neuromuscular blocking action of drug0 such as drug0 include certain drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0  drug1  and drug0 )  drug2 salts  drug0  local drug0  drug0  and drug0 .,colistin,magnesium,FALSE,none
other drugs which may enhance the neuromuscular blocking action of drug0 such as drug0 include certain drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0  drug1  and drug0 )  drug0 salts  drug2  local drug0  drug0  and drug0 .,colistin,lithium,FALSE,none
other drugs which may enhance the neuromuscular blocking action of drug0 such as drug0 include certain drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0  drug1  and drug0 )  drug0 salts  drug0  local drug2  drug0  and drug0 .,colistin,anesthetics,FALSE,none
other drugs which may enhance the neuromuscular blocking action of drug0 such as drug0 include certain drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0  drug1  and drug0 )  drug0 salts  drug0  local drug0  drug2  and drug0 .,colistin,procainamide,FALSE,none
other drugs which may enhance the neuromuscular blocking action of drug0 such as drug0 include certain drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0  drug1  and drug0 )  drug0 salts  drug0  local drug0  drug0  and drug2 .,colistin,quinidine,FALSE,none
other drugs which may enhance the neuromuscular blocking action of drug0 such as drug0 include certain drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0  drug0  and drug1 )  drug2 salts  drug0  local drug0  drug0  and drug0 .,sodium colistimethate,magnesium,FALSE,none
other drugs which may enhance the neuromuscular blocking action of drug0 such as drug0 include certain drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0  drug0  and drug1 )  drug0 salts  drug2  local drug0  drug0  and drug0 .,sodium colistimethate,lithium,FALSE,none
other drugs which may enhance the neuromuscular blocking action of drug0 such as drug0 include certain drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0  drug0  and drug1 )  drug0 salts  drug0  local drug2  drug0  and drug0 .,sodium colistimethate,anesthetics,FALSE,none
other drugs which may enhance the neuromuscular blocking action of drug0 such as drug0 include certain drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0  drug0  and drug1 )  drug0 salts  drug0  local drug0  drug2  and drug0 .,sodium colistimethate,procainamide,FALSE,none
other drugs which may enhance the neuromuscular blocking action of drug0 such as drug0 include certain drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0  drug0  and drug1 )  drug0 salts  drug0  local drug0  drug0  and drug2 .,sodium colistimethate,quinidine,FALSE,none
other drugs which may enhance the neuromuscular blocking action of drug0 such as drug0 include certain drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0  drug0  and drug0 )  drug1 salts  drug2  local drug0  drug0  and drug0 .,magnesium,lithium,FALSE,none
other drugs which may enhance the neuromuscular blocking action of drug0 such as drug0 include certain drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0  drug0  and drug0 )  drug1 salts  drug0  local drug2  drug0  and drug0 .,magnesium,anesthetics,FALSE,none
other drugs which may enhance the neuromuscular blocking action of drug0 such as drug0 include certain drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0  drug0  and drug0 )  drug1 salts  drug0  local drug0  drug2  and drug0 .,magnesium,procainamide,FALSE,none
other drugs which may enhance the neuromuscular blocking action of drug0 such as drug0 include certain drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0  drug0  and drug0 )  drug1 salts  drug0  local drug0  drug0  and drug2 .,magnesium,quinidine,FALSE,none
other drugs which may enhance the neuromuscular blocking action of drug0 such as drug0 include certain drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0  drug0  and drug0 )  drug0 salts  drug1  local drug2  drug0  and drug0 .,lithium,anesthetics,FALSE,none
other drugs which may enhance the neuromuscular blocking action of drug0 such as drug0 include certain drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0  drug0  and drug0 )  drug0 salts  drug1  local drug0  drug0  and drug2 .,lithium,quinidine,FALSE,none
other drugs which may enhance the neuromuscular blocking action of drug0 such as drug0 include certain drug0 ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0  drug0  and drug0 )  drug0 salts  drug0  local drug0  drug1  and drug2 .,procainamide,quinidine,FALSE,none
the neuromuscular blocking effect of drug1 may be enhanced by drugs that reduce plasma cholinesterase activity ( e.g.  chronically administered oral drug2  drug0  or certain drug0 ) or by drugs that irreversibly inhibit plasma cholinesterase . resistance to the neuromuscular blocking action of nondepolarizing drug0 has been demonstrated in patients chronically administered drug0 or drug0 .,mivacron,contraceptives,TRUE,effect
the neuromuscular blocking effect of drug1 may be enhanced by drugs that reduce plasma cholinesterase activity ( e.g.  chronically administered oral drug0  drug2  or certain drug0 ) or by drugs that irreversibly inhibit plasma cholinesterase . resistance to the neuromuscular blocking action of nondepolarizing drug0 has been demonstrated in patients chronically administered drug0 or drug0 .,mivacron,glucocorticoids,TRUE,effect
the neuromuscular blocking effect of drug1 may be enhanced by drugs that reduce plasma cholinesterase activity ( e.g.  chronically administered oral drug0  drug0  or certain drug2 ) or by drugs that irreversibly inhibit plasma cholinesterase . resistance to the neuromuscular blocking action of nondepolarizing drug0 has been demonstrated in patients chronically administered drug0 or drug0 .,mivacron,monoamine oxidase inhibitors,TRUE,effect
the neuromuscular blocking effect of drug1 may be enhanced by drugs that reduce plasma cholinesterase activity ( e.g.  chronically administered oral drug0  drug0  or certain drug0 ) or by drugs that irreversibly inhibit plasma cholinesterase . resistance to the neuromuscular blocking action of nondepolarizing drug2 has been demonstrated in patients chronically administered drug0 or drug0 .,mivacron,neuromuscular blocking agents,FALSE,none
the neuromuscular blocking effect of drug1 may be enhanced by drugs that reduce plasma cholinesterase activity ( e.g.  chronically administered oral drug0  drug0  or certain drug0 ) or by drugs that irreversibly inhibit plasma cholinesterase . resistance to the neuromuscular blocking action of nondepolarizing drug0 has been demonstrated in patients chronically administered drug2 or drug0 .,mivacron,phenytoin,FALSE,none
the neuromuscular blocking effect of drug1 may be enhanced by drugs that reduce plasma cholinesterase activity ( e.g.  chronically administered oral drug0  drug0  or certain drug0 ) or by drugs that irreversibly inhibit plasma cholinesterase . resistance to the neuromuscular blocking action of nondepolarizing drug0 has been demonstrated in patients chronically administered drug0 or drug2 .,mivacron,carbamazepine,FALSE,none
the neuromuscular blocking effect of drug0 may be enhanced by drugs that reduce plasma cholinesterase activity ( e.g.  chronically administered oral drug1  drug0  or certain drug2 ) or by drugs that irreversibly inhibit plasma cholinesterase . resistance to the neuromuscular blocking action of nondepolarizing drug0 has been demonstrated in patients chronically administered drug0 or drug0 .,contraceptives,monoamine oxidase inhibitors,FALSE,none
the neuromuscular blocking effect of drug0 may be enhanced by drugs that reduce plasma cholinesterase activity ( e.g.  chronically administered oral drug1  drug0  or certain drug0 ) or by drugs that irreversibly inhibit plasma cholinesterase . resistance to the neuromuscular blocking action of nondepolarizing drug2 has been demonstrated in patients chronically administered drug0 or drug0 .,contraceptives,neuromuscular blocking agents,FALSE,none
the neuromuscular blocking effect of drug0 may be enhanced by drugs that reduce plasma cholinesterase activity ( e.g.  chronically administered oral drug1  drug0  or certain drug0 ) or by drugs that irreversibly inhibit plasma cholinesterase . resistance to the neuromuscular blocking action of nondepolarizing drug0 has been demonstrated in patients chronically administered drug2 or drug0 .,contraceptives,phenytoin,FALSE,none
the neuromuscular blocking effect of drug0 may be enhanced by drugs that reduce plasma cholinesterase activity ( e.g.  chronically administered oral drug1  drug0  or certain drug0 ) or by drugs that irreversibly inhibit plasma cholinesterase . resistance to the neuromuscular blocking action of nondepolarizing drug0 has been demonstrated in patients chronically administered drug0 or drug2 .,contraceptives,carbamazepine,FALSE,none
the neuromuscular blocking effect of drug0 may be enhanced by drugs that reduce plasma cholinesterase activity ( e.g.  chronically administered oral drug0  drug1  or certain drug2 ) or by drugs that irreversibly inhibit plasma cholinesterase . resistance to the neuromuscular blocking action of nondepolarizing drug0 has been demonstrated in patients chronically administered drug0 or drug0 .,glucocorticoids,monoamine oxidase inhibitors,FALSE,none
the neuromuscular blocking effect of drug0 may be enhanced by drugs that reduce plasma cholinesterase activity ( e.g.  chronically administered oral drug0  drug1  or certain drug0 ) or by drugs that irreversibly inhibit plasma cholinesterase . resistance to the neuromuscular blocking action of nondepolarizing drug2 has been demonstrated in patients chronically administered drug0 or drug0 .,glucocorticoids,neuromuscular blocking agents,FALSE,none
the neuromuscular blocking effect of drug0 may be enhanced by drugs that reduce plasma cholinesterase activity ( e.g.  chronically administered oral drug0  drug1  or certain drug0 ) or by drugs that irreversibly inhibit plasma cholinesterase . resistance to the neuromuscular blocking action of nondepolarizing drug0 has been demonstrated in patients chronically administered drug2 or drug0 .,glucocorticoids,phenytoin,FALSE,none
the neuromuscular blocking effect of drug0 may be enhanced by drugs that reduce plasma cholinesterase activity ( e.g.  chronically administered oral drug0  drug1  or certain drug0 ) or by drugs that irreversibly inhibit plasma cholinesterase . resistance to the neuromuscular blocking action of nondepolarizing drug0 has been demonstrated in patients chronically administered drug0 or drug2 .,glucocorticoids,carbamazepine,FALSE,none
the neuromuscular blocking effect of drug0 may be enhanced by drugs that reduce plasma cholinesterase activity ( e.g.  chronically administered oral drug0  drug0  or certain drug1 ) or by drugs that irreversibly inhibit plasma cholinesterase . resistance to the neuromuscular blocking action of nondepolarizing drug2 has been demonstrated in patients chronically administered drug0 or drug0 .,monoamine oxidase inhibitors,neuromuscular blocking agents,FALSE,none
the neuromuscular blocking effect of drug0 may be enhanced by drugs that reduce plasma cholinesterase activity ( e.g.  chronically administered oral drug0  drug0  or certain drug1 ) or by drugs that irreversibly inhibit plasma cholinesterase . resistance to the neuromuscular blocking action of nondepolarizing drug0 has been demonstrated in patients chronically administered drug2 or drug0 .,monoamine oxidase inhibitors,phenytoin,FALSE,none
the neuromuscular blocking effect of drug0 may be enhanced by drugs that reduce plasma cholinesterase activity ( e.g.  chronically administered oral drug0  drug0  or certain drug1 ) or by drugs that irreversibly inhibit plasma cholinesterase . resistance to the neuromuscular blocking action of nondepolarizing drug0 has been demonstrated in patients chronically administered drug0 or drug2 .,monoamine oxidase inhibitors,carbamazepine,FALSE,none
the neuromuscular blocking effect of drug0 may be enhanced by drugs that reduce plasma cholinesterase activity ( e.g.  chronically administered oral drug0  drug0  or certain drug0 ) or by drugs that irreversibly inhibit plasma cholinesterase . resistance to the neuromuscular blocking action of nondepolarizing drug1 has been demonstrated in patients chronically administered drug2 or drug0 .,neuromuscular blocking agents,phenytoin,TRUE,effect
the neuromuscular blocking effect of drug0 may be enhanced by drugs that reduce plasma cholinesterase activity ( e.g.  chronically administered oral drug0  drug0  or certain drug0 ) or by drugs that irreversibly inhibit plasma cholinesterase . resistance to the neuromuscular blocking action of nondepolarizing drug1 has been demonstrated in patients chronically administered drug0 or drug2 .,neuromuscular blocking agents,carbamazepine,TRUE,effect
the neuromuscular blocking effect of drug0 may be enhanced by drugs that reduce plasma cholinesterase activity ( e.g.  chronically administered oral drug0  drug0  or certain drug0 ) or by drugs that irreversibly inhibit plasma cholinesterase . resistance to the neuromuscular blocking action of nondepolarizing drug0 has been demonstrated in patients chronically administered drug1 or drug2 .,phenytoin,carbamazepine,FALSE,none
while the effects of chronic drug1 or drug2 therapy on the action of drug0 are unknown  slightly shorter durations of neuromuscular block may be anticipated and infusion rate requirements may be higher .,phenytoin,carbamazepine,FALSE,none
while the effects of chronic drug1 or drug0 therapy on the action of drug2 are unknown  slightly shorter durations of neuromuscular block may be anticipated and infusion rate requirements may be higher .,phenytoin,mivacron,TRUE,effect
while the effects of chronic drug0 or drug1 therapy on the action of drug2 are unknown  slightly shorter durations of neuromuscular block may be anticipated and infusion rate requirements may be higher .,carbamazepine,mivacron,TRUE,effect
some drug interactions are : - birth control pills - drug1 - medicines for angina or hidrug0 blood pressure - medicines for pain - medicines to control seizures such as drug2 or drug0 - certain drug0 given by injection - drug0 - drug0 - drug0 - drug0 or drug0 - local drug0 such as drug0 - general drug0 - drug0 or other muscle relaxants,corticosteroids,phenytoin,FALSE,none
some drug interactions are : - birth control pills - drug1 - medicines for angina or hidrug0 blood pressure - medicines for pain - medicines to control seizures such as drug0 or drug2 - certain drug0 given by injection - drug0 - drug0 - drug0 - drug0 or drug0 - local drug0 such as drug0 - general drug0 - drug0 or other muscle relaxants,corticosteroids,carbamazepine,FALSE,none
some drug interactions are : - birth control pills - drug1 - medicines for angina or hidrug0 blood pressure - medicines for pain - medicines to control seizures such as drug0 or drug0 - certain drug2 given by injection - drug0 - drug0 - drug0 - drug0 or drug0 - local drug0 such as drug0 - general drug0 - drug0 or other muscle relaxants,corticosteroids,antibiotics,FALSE,none
some drug interactions are : - birth control pills - drug1 - medicines for angina or hidrug0 blood pressure - medicines for pain - medicines to control seizures such as drug0 or drug0 - certain drug0 given by injection - drug2 - drug0 - drug0 - drug0 or drug0 - local drug0 such as drug0 - general drug0 - drug0 or other muscle relaxants,corticosteroids,cisplatin,FALSE,none
some drug interactions are : - birth control pills - drug1 - medicines for angina or hidrug0 blood pressure - medicines for pain - medicines to control seizures such as drug0 or drug0 - certain drug0 given by injection - drug0 - drug2 - drug0 - drug0 or drug0 - local drug0 such as drug0 - general drug0 - drug0 or other muscle relaxants,corticosteroids,edrophonium,FALSE,none
some drug interactions are : - birth control pills - drug1 - medicines for angina or hidrug0 blood pressure - medicines for pain - medicines to control seizures such as drug0 or drug0 - certain drug0 given by injection - drug0 - drug0 - drug2 - drug0 or drug0 - local drug0 such as drug0 - general drug0 - drug0 or other muscle relaxants,corticosteroids,neostigmine,FALSE,none
some drug interactions are : - birth control pills - drug1 - medicines for angina or hidrug0 blood pressure - medicines for pain - medicines to control seizures such as drug0 or drug0 - certain drug0 given by injection - drug0 - drug0 - drug0 - drug2 or drug0 - local drug0 such as drug0 - general drug0 - drug0 or other muscle relaxants,corticosteroids,polymyxin b,FALSE,none
some drug interactions are : - birth control pills - drug1 - medicines for angina or hidrug0 blood pressure - medicines for pain - medicines to control seizures such as drug0 or drug0 - certain drug0 given by injection - drug0 - drug0 - drug0 - drug0 or drug2 - local drug0 such as drug0 - general drug0 - drug0 or other muscle relaxants,corticosteroids,bacitracin,FALSE,none
some drug interactions are : - birth control pills - drug1 - medicines for angina or hidrug0 blood pressure - medicines for pain - medicines to control seizures such as drug0 or drug0 - certain drug0 given by injection - drug0 - drug0 - drug0 - drug0 or drug0 - local drug2 such as drug0 - general drug0 - drug0 or other muscle relaxants,corticosteroids,anesthetics,FALSE,none
some drug interactions are : - birth control pills - drug1 - medicines for angina or hidrug0 blood pressure - medicines for pain - medicines to control seizures such as drug0 or drug0 - certain drug0 given by injection - drug0 - drug0 - drug0 - drug0 or drug0 - local drug0 such as drug2 - general drug0 - drug0 or other muscle relaxants,corticosteroids,procaine,FALSE,none
some drug interactions are : - birth control pills - drug1 - medicines for angina or hidrug0 blood pressure - medicines for pain - medicines to control seizures such as drug0 or drug0 - certain drug0 given by injection - drug0 - drug0 - drug0 - drug0 or drug0 - local drug2 such as drug0 - general drug0 - drug0 or other muscle relaxants,corticosteroids,anesthetics,FALSE,none
some drug interactions are : - birth control pills - drug1 - medicines for angina or hidrug0 blood pressure - medicines for pain - medicines to control seizures such as drug0 or drug0 - certain drug0 given by injection - drug0 - drug0 - drug0 - drug0 or drug0 - local drug0 such as drug0 - general drug0 - drug2 or other muscle relaxants,corticosteroids,succinylcholine,FALSE,none
some drug interactions are : - birth control pills - drug1 - medicines for angina or hidrug0 blood pressure - medicines for pain - medicines to control seizures such as drug0 or drug0 - certain drug0 given by injection - drug0 - drug0 - drug0 - drug0 or drug0 - local drug0 such as drug0 - general drug0 - drug0 or other muscle relaxants,corticosteroids,muscle relaxants,FALSE,none
some drug interactions are : - birth control pills - drug0 - medicines for angina or hidrug0 blood pressure - medicines for pain - medicines to control seizures such as drug1 or drug2 - certain drug0 given by injection - drug0 - drug0 - drug0 - drug0 or drug0 - local drug0 such as drug0 - general drug0 - drug0 or other muscle relaxants,phenytoin,carbamazepine,FALSE,none
some drug interactions are : - birth control pills - drug0 - medicines for angina or hidrug0 blood pressure - medicines for pain - medicines to control seizures such as drug1 or drug0 - certain drug2 given by injection - drug0 - drug0 - drug0 - drug0 or drug0 - local drug0 such as drug0 - general drug0 - drug0 or other muscle relaxants,phenytoin,antibiotics,FALSE,none
some drug interactions are : - birth control pills - drug0 - medicines for angina or hidrug0 blood pressure - medicines for pain - medicines to control seizures such as drug1 or drug0 - certain drug0 given by injection - drug2 - drug0 - drug0 - drug0 or drug0 - local drug0 such as drug0 - general drug0 - drug0 or other muscle relaxants,phenytoin,cisplatin,FALSE,none
some drug interactions are : - birth control pills - drug0 - medicines for angina or hidrug0 blood pressure - medicines for pain - medicines to control seizures such as drug1 or drug0 - certain drug0 given by injection - drug0 - drug2 - drug0 - drug0 or drug0 - local drug0 such as drug0 - general drug0 - drug0 or other muscle relaxants,phenytoin,edrophonium,FALSE,none
some drug interactions are : - birth control pills - drug0 - medicines for angina or hidrug0 blood pressure - medicines for pain - medicines to control seizures such as drug1 or drug0 - certain drug0 given by injection - drug0 - drug0 - drug2 - drug0 or drug0 - local drug0 such as drug0 - general drug0 - drug0 or other muscle relaxants,phenytoin,neostigmine,FALSE,none
some drug interactions are : - birth control pills - drug0 - medicines for angina or hidrug0 blood pressure - medicines for pain - medicines to control seizures such as drug1 or drug0 - certain drug0 given by injection - drug0 - drug0 - drug0 - drug2 or drug0 - local drug0 such as drug0 - general drug0 - drug0 or other muscle relaxants,phenytoin,polymyxin b,FALSE,none
some drug interactions are : - birth control pills - drug0 - medicines for angina or hidrug0 blood pressure - medicines for pain - medicines to control seizures such as drug1 or drug0 - certain drug0 given by injection - drug0 - drug0 - drug0 - drug0 or drug2 - local drug0 such as drug0 - general drug0 - drug0 or other muscle relaxants,phenytoin,bacitracin,FALSE,none
some drug interactions are : - birth control pills - drug0 - medicines for angina or hidrug0 blood pressure - medicines for pain - medicines to control seizures such as drug1 or drug0 - certain drug0 given by injection - drug0 - drug0 - drug0 - drug0 or drug0 - local drug2 such as drug0 - general drug0 - drug0 or other muscle relaxants,phenytoin,anesthetics,FALSE,none
some drug interactions are : - birth control pills - drug0 - medicines for angina or hidrug0 blood pressure - medicines for pain - medicines to control seizures such as drug1 or drug0 - certain drug0 given by injection - drug0 - drug0 - drug0 - drug0 or drug0 - local drug0 such as drug2 - general drug0 - drug0 or other muscle relaxants,phenytoin,procaine,FALSE,none
some drug interactions are : - birth control pills - drug0 - medicines for angina or hidrug0 blood pressure - medicines for pain - medicines to control seizures such as drug1 or drug0 - certain drug0 given by injection - drug0 - drug0 - drug0 - drug0 or drug0 - local drug2 such as drug0 - general drug0 - drug0 or other muscle relaxants,phenytoin,anesthetics,FALSE,none
some drug interactions are : - birth control pills - drug0 - medicines for angina or hidrug0 blood pressure - medicines for pain - medicines to control seizures such as drug1 or drug0 - certain drug0 given by injection - drug0 - drug0 - drug0 - drug0 or drug0 - local drug0 such as drug0 - general drug0 - drug2 or other muscle relaxants,phenytoin,succinylcholine,FALSE,none
some drug interactions are : - birth control pills - drug0 - medicines for angina or hidrug0 blood pressure - medicines for pain - medicines to control seizures such as drug1 or drug0 - certain drug0 given by injection - drug0 - drug0 - drug0 - drug0 or drug0 - local drug0 such as drug0 - general drug0 - drug0 or other muscle relaxants,phenytoin,muscle relaxants,FALSE,none
some drug interactions are : - birth control pills - drug0 - medicines for angina or hidrug0 blood pressure - medicines for pain - medicines to control seizures such as drug0 or drug1 - certain drug2 given by injection - drug0 - drug0 - drug0 - drug0 or drug0 - local drug0 such as drug0 - general drug0 - drug0 or other muscle relaxants,carbamazepine,antibiotics,FALSE,none
some drug interactions are : - birth control pills - drug0 - medicines for angina or hidrug0 blood pressure - medicines for pain - medicines to control seizures such as drug0 or drug1 - certain drug0 given by injection - drug2 - drug0 - drug0 - drug0 or drug0 - local drug0 such as drug0 - general drug0 - drug0 or other muscle relaxants,carbamazepine,cisplatin,FALSE,none
some drug interactions are : - birth control pills - drug0 - medicines for angina or hidrug0 blood pressure - medicines for pain - medicines to control seizures such as drug0 or drug1 - certain drug0 given by injection - drug0 - drug2 - drug0 - drug0 or drug0 - local drug0 such as drug0 - general drug0 - drug0 or other muscle relaxants,carbamazepine,edrophonium,FALSE,none
some drug interactions are : - birth control pills - drug0 - medicines for angina or hidrug0 blood pressure - medicines for pain - medicines to control seizures such as drug0 or drug1 - certain drug0 given by injection - drug0 - drug0 - drug2 - drug0 or drug0 - local drug0 such as drug0 - general drug0 - drug0 or other muscle relaxants,carbamazepine,neostigmine,FALSE,none
some drug interactions are : - birth control pills - drug0 - medicines for angina or hidrug0 blood pressure - medicines for pain - medicines to control seizures such as drug0 or drug1 - certain drug0 given by injection - drug0 - drug0 - drug0 - drug2 or drug0 - local drug0 such as drug0 - general drug0 - drug0 or other muscle relaxants,carbamazepine,polymyxin b,FALSE,none
some drug interactions are : - birth control pills - drug0 - medicines for angina or hidrug0 blood pressure - medicines for pain - medicines to control seizures such as drug0 or drug1 - certain drug0 given by injection - drug0 - drug0 - drug0 - drug0 or drug2 - local drug0 such as drug0 - general drug0 - drug0 or other muscle relaxants,carbamazepine,bacitracin,FALSE,none
some drug interactions are : - birth control pills - drug0 - medicines for angina or hidrug0 blood pressure - medicines for pain - medicines to control seizures such as drug0 or drug1 - certain drug0 given by injection - drug0 - drug0 - drug0 - drug0 or drug0 - local drug2 such as drug0 - general drug0 - drug0 or other muscle relaxants,carbamazepine,anesthetics,FALSE,none
some drug interactions are : - birth control pills - drug0 - medicines for angina or hidrug0 blood pressure - medicines for pain - medicines to control seizures such as drug0 or drug1 - certain drug0 given by injection - drug0 - drug0 - drug0 - drug0 or drug0 - local drug0 such as drug2 - general drug0 - drug0 or other muscle relaxants,carbamazepine,procaine,FALSE,none
some drug interactions are : - birth control pills - drug0 - medicines for angina or hidrug0 blood pressure - medicines for pain - medicines to control seizures such as drug0 or drug1 - certain drug0 given by injection - drug0 - drug0 - drug0 - drug0 or drug0 - local drug2 such as drug0 - general drug0 - drug0 or other muscle relaxants,carbamazepine,anesthetics,FALSE,none
some drug interactions are : - birth control pills - drug0 - medicines for angina or hidrug0 blood pressure - medicines for pain - medicines to control seizures such as drug0 or drug1 - certain drug0 given by injection - drug0 - drug0 - drug0 - drug0 or drug0 - local drug0 such as drug0 - general drug0 - drug2 or other muscle relaxants,carbamazepine,succinylcholine,FALSE,none
some drug interactions are : - birth control pills - drug0 - medicines for angina or hidrug0 blood pressure - medicines for pain - medicines to control seizures such as drug0 or drug1 - certain drug0 given by injection - drug0 - drug0 - drug0 - drug0 or drug0 - local drug0 such as drug0 - general drug0 - drug0 or other muscle relaxants,carbamazepine,muscle relaxants,FALSE,none
some drug interactions are : - birth control pills - drug0 - medicines for angina or hidrug0 blood pressure - medicines for pain - medicines to control seizures such as drug0 or drug0 - certain drug1 given by injection - drug2 - drug0 - drug0 - drug0 or drug0 - local drug0 such as drug0 - general drug0 - drug0 or other muscle relaxants,antibiotics,cisplatin,FALSE,none
some drug interactions are : - birth control pills - drug0 - medicines for angina or hidrug0 blood pressure - medicines for pain - medicines to control seizures such as drug0 or drug0 - certain drug1 given by injection - drug0 - drug2 - drug0 - drug0 or drug0 - local drug0 such as drug0 - general drug0 - drug0 or other muscle relaxants,antibiotics,edrophonium,FALSE,none
some drug interactions are : - birth control pills - drug0 - medicines for angina or hidrug0 blood pressure - medicines for pain - medicines to control seizures such as drug0 or drug0 - certain drug1 given by injection - drug0 - drug0 - drug2 - drug0 or drug0 - local drug0 such as drug0 - general drug0 - drug0 or other muscle relaxants,antibiotics,neostigmine,FALSE,none
some drug interactions are : - birth control pills - drug0 - medicines for angina or hidrug0 blood pressure - medicines for pain - medicines to control seizures such as drug0 or drug0 - certain drug1 given by injection - drug0 - drug0 - drug0 - drug2 or drug0 - local drug0 such as drug0 - general drug0 - drug0 or other muscle relaxants,antibiotics,polymyxin b,FALSE,none
some drug interactions are : - birth control pills - drug0 - medicines for angina or hidrug0 blood pressure - medicines for pain - medicines to control seizures such as drug0 or drug0 - certain drug1 given by injection - drug0 - drug0 - drug0 - drug0 or drug2 - local drug0 such as drug0 - general drug0 - drug0 or other muscle relaxants,antibiotics,bacitracin,FALSE,none
some drug interactions are : - birth control pills - drug0 - medicines for angina or hidrug0 blood pressure - medicines for pain - medicines to control seizures such as drug0 or drug0 - certain drug1 given by injection - drug0 - drug0 - drug0 - drug0 or drug0 - local drug2 such as drug0 - general drug0 - drug0 or other muscle relaxants,antibiotics,anesthetics,FALSE,none
some drug interactions are : - birth control pills - drug0 - medicines for angina or hidrug0 blood pressure - medicines for pain - medicines to control seizures such as drug0 or drug0 - certain drug1 given by injection - drug0 - drug0 - drug0 - drug0 or drug0 - local drug0 such as drug2 - general drug0 - drug0 or other muscle relaxants,antibiotics,procaine,FALSE,none
some drug interactions are : - birth control pills - drug0 - medicines for angina or hidrug0 blood pressure - medicines for pain - medicines to control seizures such as drug0 or drug0 - certain drug1 given by injection - drug0 - drug0 - drug0 - drug0 or drug0 - local drug2 such as drug0 - general drug0 - drug0 or other muscle relaxants,antibiotics,anesthetics,FALSE,none
some drug interactions are : - birth control pills - drug0 - medicines for angina or hidrug0 blood pressure - medicines for pain - medicines to control seizures such as drug0 or drug0 - certain drug1 given by injection - drug0 - drug0 - drug0 - drug0 or drug0 - local drug0 such as drug0 - general drug0 - drug2 or other muscle relaxants,antibiotics,succinylcholine,FALSE,none
some drug interactions are : - birth control pills - drug0 - medicines for angina or hidrug0 blood pressure - medicines for pain - medicines to control seizures such as drug0 or drug0 - certain drug1 given by injection - drug0 - drug0 - drug0 - drug0 or drug0 - local drug0 such as drug0 - general drug0 - drug0 or other muscle relaxants,antibiotics,muscle relaxants,FALSE,none
some drug interactions are : - birth control pills - drug0 - medicines for angina or hidrug0 blood pressure - medicines for pain - medicines to control seizures such as drug0 or drug0 - certain drug0 given by injection - drug1 - drug2 - drug0 - drug0 or drug0 - local drug0 such as drug0 - general drug0 - drug0 or other muscle relaxants,cisplatin,edrophonium,FALSE,none
some drug interactions are : - birth control pills - drug0 - medicines for angina or hidrug0 blood pressure - medicines for pain - medicines to control seizures such as drug0 or drug0 - certain drug0 given by injection - drug1 - drug0 - drug2 - drug0 or drug0 - local drug0 such as drug0 - general drug0 - drug0 or other muscle relaxants,cisplatin,neostigmine,FALSE,none
some drug interactions are : - birth control pills - drug0 - medicines for angina or hidrug0 blood pressure - medicines for pain - medicines to control seizures such as drug0 or drug0 - certain drug0 given by injection - drug1 - drug0 - drug0 - drug2 or drug0 - local drug0 such as drug0 - general drug0 - drug0 or other muscle relaxants,cisplatin,polymyxin b,FALSE,none
some drug interactions are : - birth control pills - drug0 - medicines for angina or hidrug0 blood pressure - medicines for pain - medicines to control seizures such as drug0 or drug0 - certain drug0 given by injection - drug1 - drug0 - drug0 - drug0 or drug2 - local drug0 such as drug0 - general drug0 - drug0 or other muscle relaxants,cisplatin,bacitracin,FALSE,none
some drug interactions are : - birth control pills - drug0 - medicines for angina or hidrug0 blood pressure - medicines for pain - medicines to control seizures such as drug0 or drug0 - certain drug0 given by injection - drug1 - drug0 - drug0 - drug0 or drug0 - local drug2 such as drug0 - general drug0 - drug0 or other muscle relaxants,cisplatin,anesthetics,FALSE,none
some drug interactions are : - birth control pills - drug0 - medicines for angina or hidrug0 blood pressure - medicines for pain - medicines to control seizures such as drug0 or drug0 - certain drug0 given by injection - drug1 - drug0 - drug0 - drug0 or drug0 - local drug0 such as drug2 - general drug0 - drug0 or other muscle relaxants,cisplatin,procaine,FALSE,none
some drug interactions are : - birth control pills - drug0 - medicines for angina or hidrug0 blood pressure - medicines for pain - medicines to control seizures such as drug0 or drug0 - certain drug0 given by injection - drug1 - drug0 - drug0 - drug0 or drug0 - local drug2 such as drug0 - general drug0 - drug0 or other muscle relaxants,cisplatin,anesthetics,FALSE,none
some drug interactions are : - birth control pills - drug0 - medicines for angina or hidrug0 blood pressure - medicines for pain - medicines to control seizures such as drug0 or drug0 - certain drug0 given by injection - drug1 - drug0 - drug0 - drug0 or drug0 - local drug0 such as drug0 - general drug0 - drug2 or other muscle relaxants,cisplatin,succinylcholine,FALSE,none
some drug interactions are : - birth control pills - drug0 - medicines for angina or hidrug0 blood pressure - medicines for pain - medicines to control seizures such as drug0 or drug0 - certain drug0 given by injection - drug1 - drug0 - drug0 - drug0 or drug0 - local drug0 such as drug0 - general drug0 - drug0 or other muscle relaxants,cisplatin,muscle relaxants,FALSE,none
some drug interactions are : - birth control pills - drug0 - medicines for angina or hidrug0 blood pressure - medicines for pain - medicines to control seizures such as drug0 or drug0 - certain drug0 given by injection - drug0 - drug1 - drug2 - drug0 or drug0 - local drug0 such as drug0 - general drug0 - drug0 or other muscle relaxants,edrophonium,neostigmine,FALSE,none
some drug interactions are : - birth control pills - drug0 - medicines for angina or hidrug0 blood pressure - medicines for pain - medicines to control seizures such as drug0 or drug0 - certain drug0 given by injection - drug0 - drug1 - drug0 - drug2 or drug0 - local drug0 such as drug0 - general drug0 - drug0 or other muscle relaxants,edrophonium,polymyxin b,FALSE,none
some drug interactions are : - birth control pills - drug0 - medicines for angina or hidrug0 blood pressure - medicines for pain - medicines to control seizures such as drug0 or drug0 - certain drug0 given by injection - drug0 - drug1 - drug0 - drug0 or drug2 - local drug0 such as drug0 - general drug0 - drug0 or other muscle relaxants,edrophonium,bacitracin,FALSE,none
some drug interactions are : - birth control pills - drug0 - medicines for angina or hidrug0 blood pressure - medicines for pain - medicines to control seizures such as drug0 or drug0 - certain drug0 given by injection - drug0 - drug1 - drug0 - drug0 or drug0 - local drug2 such as drug0 - general drug0 - drug0 or other muscle relaxants,edrophonium,anesthetics,FALSE,none
some drug interactions are : - birth control pills - drug0 - medicines for angina or hidrug0 blood pressure - medicines for pain - medicines to control seizures such as drug0 or drug0 - certain drug0 given by injection - drug0 - drug1 - drug0 - drug0 or drug0 - local drug0 such as drug2 - general drug0 - drug0 or other muscle relaxants,edrophonium,procaine,FALSE,none
some drug interactions are : - birth control pills - drug0 - medicines for angina or hidrug0 blood pressure - medicines for pain - medicines to control seizures such as drug0 or drug0 - certain drug0 given by injection - drug0 - drug1 - drug0 - drug0 or drug0 - local drug2 such as drug0 - general drug0 - drug0 or other muscle relaxants,edrophonium,anesthetics,FALSE,none
some drug interactions are : - birth control pills - drug0 - medicines for angina or hidrug0 blood pressure - medicines for pain - medicines to control seizures such as drug0 or drug0 - certain drug0 given by injection - drug0 - drug1 - drug0 - drug0 or drug0 - local drug0 such as drug0 - general drug0 - drug2 or other muscle relaxants,edrophonium,succinylcholine,FALSE,none
some drug interactions are : - birth control pills - drug0 - medicines for angina or hidrug0 blood pressure - medicines for pain - medicines to control seizures such as drug0 or drug0 - certain drug0 given by injection - drug0 - drug1 - drug0 - drug0 or drug0 - local drug0 such as drug0 - general drug0 - drug0 or other muscle relaxants,edrophonium,muscle relaxants,FALSE,none
some drug interactions are : - birth control pills - drug0 - medicines for angina or hidrug0 blood pressure - medicines for pain - medicines to control seizures such as drug0 or drug0 - certain drug0 given by injection - drug0 - drug0 - drug1 - drug2 or drug0 - local drug0 such as drug0 - general drug0 - drug0 or other muscle relaxants,neostigmine,polymyxin b,FALSE,none
some drug interactions are : - birth control pills - drug0 - medicines for angina or hidrug0 blood pressure - medicines for pain - medicines to control seizures such as drug0 or drug0 - certain drug0 given by injection - drug0 - drug0 - drug1 - drug0 or drug2 - local drug0 such as drug0 - general drug0 - drug0 or other muscle relaxants,neostigmine,bacitracin,FALSE,none
some drug interactions are : - birth control pills - drug0 - medicines for angina or hidrug0 blood pressure - medicines for pain - medicines to control seizures such as drug0 or drug0 - certain drug0 given by injection - drug0 - drug0 - drug1 - drug0 or drug0 - local drug2 such as drug0 - general drug0 - drug0 or other muscle relaxants,neostigmine,anesthetics,FALSE,none
some drug interactions are : - birth control pills - drug0 - medicines for angina or hidrug0 blood pressure - medicines for pain - medicines to control seizures such as drug0 or drug0 - certain drug0 given by injection - drug0 - drug0 - drug1 - drug0 or drug0 - local drug0 such as drug2 - general drug0 - drug0 or other muscle relaxants,neostigmine,procaine,FALSE,none
some drug interactions are : - birth control pills - drug0 - medicines for angina or hidrug0 blood pressure - medicines for pain - medicines to control seizures such as drug0 or drug0 - certain drug0 given by injection - drug0 - drug0 - drug1 - drug0 or drug0 - local drug2 such as drug0 - general drug0 - drug0 or other muscle relaxants,neostigmine,anesthetics,FALSE,none
some drug interactions are : - birth control pills - drug0 - medicines for angina or hidrug0 blood pressure - medicines for pain - medicines to control seizures such as drug0 or drug0 - certain drug0 given by injection - drug0 - drug0 - drug1 - drug0 or drug0 - local drug0 such as drug0 - general drug0 - drug2 or other muscle relaxants,neostigmine,succinylcholine,FALSE,none
some drug interactions are : - birth control pills - drug0 - medicines for angina or hidrug0 blood pressure - medicines for pain - medicines to control seizures such as drug0 or drug0 - certain drug0 given by injection - drug0 - drug0 - drug1 - drug0 or drug0 - local drug0 such as drug0 - general drug0 - drug0 or other muscle relaxants,neostigmine,muscle relaxants,FALSE,none
some drug interactions are : - birth control pills - drug0 - medicines for angina or hidrug0 blood pressure - medicines for pain - medicines to control seizures such as drug0 or drug0 - certain drug0 given by injection - drug0 - drug0 - drug0 - drug1 or drug2 - local drug0 such as drug0 - general drug0 - drug0 or other muscle relaxants,polymyxin b,bacitracin,FALSE,none
some drug interactions are : - birth control pills - drug0 - medicines for angina or hidrug0 blood pressure - medicines for pain - medicines to control seizures such as drug0 or drug0 - certain drug0 given by injection - drug0 - drug0 - drug0 - drug1 or drug0 - local drug2 such as drug0 - general drug0 - drug0 or other muscle relaxants,polymyxin b,anesthetics,FALSE,none
some drug interactions are : - birth control pills - drug0 - medicines for angina or hidrug0 blood pressure - medicines for pain - medicines to control seizures such as drug0 or drug0 - certain drug0 given by injection - drug0 - drug0 - drug0 - drug1 or drug0 - local drug0 such as drug2 - general drug0 - drug0 or other muscle relaxants,polymyxin b,procaine,FALSE,none
some drug interactions are : - birth control pills - drug0 - medicines for angina or hidrug0 blood pressure - medicines for pain - medicines to control seizures such as drug0 or drug0 - certain drug0 given by injection - drug0 - drug0 - drug0 - drug1 or drug0 - local drug2 such as drug0 - general drug0 - drug0 or other muscle relaxants,polymyxin b,anesthetics,FALSE,none
some drug interactions are : - birth control pills - drug0 - medicines for angina or hidrug0 blood pressure - medicines for pain - medicines to control seizures such as drug0 or drug0 - certain drug0 given by injection - drug0 - drug0 - drug0 - drug1 or drug0 - local drug0 such as drug0 - general drug0 - drug2 or other muscle relaxants,polymyxin b,succinylcholine,FALSE,none
some drug interactions are : - birth control pills - drug0 - medicines for angina or hidrug0 blood pressure - medicines for pain - medicines to control seizures such as drug0 or drug0 - certain drug0 given by injection - drug0 - drug0 - drug0 - drug1 or drug0 - local drug0 such as drug0 - general drug0 - drug0 or other muscle relaxants,polymyxin b,muscle relaxants,FALSE,none
some drug interactions are : - birth control pills - drug0 - medicines for angina or hidrug0 blood pressure - medicines for pain - medicines to control seizures such as drug0 or drug0 - certain drug0 given by injection - drug0 - drug0 - drug0 - drug0 or drug1 - local drug2 such as drug0 - general drug0 - drug0 or other muscle relaxants,bacitracin,anesthetics,FALSE,none
some drug interactions are : - birth control pills - drug0 - medicines for angina or hidrug0 blood pressure - medicines for pain - medicines to control seizures such as drug0 or drug0 - certain drug0 given by injection - drug0 - drug0 - drug0 - drug0 or drug1 - local drug0 such as drug2 - general drug0 - drug0 or other muscle relaxants,bacitracin,procaine,FALSE,none
some drug interactions are : - birth control pills - drug0 - medicines for angina or hidrug0 blood pressure - medicines for pain - medicines to control seizures such as drug0 or drug0 - certain drug0 given by injection - drug0 - drug0 - drug0 - drug0 or drug1 - local drug2 such as drug0 - general drug0 - drug0 or other muscle relaxants,bacitracin,anesthetics,FALSE,none
some drug interactions are : - birth control pills - drug0 - medicines for angina or hidrug0 blood pressure - medicines for pain - medicines to control seizures such as drug0 or drug0 - certain drug0 given by injection - drug0 - drug0 - drug0 - drug0 or drug1 - local drug0 such as drug0 - general drug0 - drug2 or other muscle relaxants,bacitracin,succinylcholine,FALSE,none
some drug interactions are : - birth control pills - drug0 - medicines for angina or hidrug0 blood pressure - medicines for pain - medicines to control seizures such as drug0 or drug0 - certain drug0 given by injection - drug0 - drug0 - drug0 - drug0 or drug1 - local drug0 such as drug0 - general drug0 - drug0 or other muscle relaxants,bacitracin,muscle relaxants,FALSE,none
some drug interactions are : - birth control pills - drug0 - medicines for angina or hidrug0 blood pressure - medicines for pain - medicines to control seizures such as drug0 or drug0 - certain drug0 given by injection - drug0 - drug0 - drug0 - drug0 or drug0 - local drug1 such as drug0 - general drug0 - drug2 or other muscle relaxants,anesthetics,succinylcholine,FALSE,none
some drug interactions are : - birth control pills - drug0 - medicines for angina or hidrug0 blood pressure - medicines for pain - medicines to control seizures such as drug0 or drug0 - certain drug0 given by injection - drug0 - drug0 - drug0 - drug0 or drug0 - local drug1 such as drug0 - general drug0 - drug0 or other muscle relaxants,anesthetics,muscle relaxants,FALSE,none
some drug interactions are : - birth control pills - drug0 - medicines for angina or hidrug0 blood pressure - medicines for pain - medicines to control seizures such as drug0 or drug0 - certain drug0 given by injection - drug0 - drug0 - drug0 - drug0 or drug0 - local drug0 such as drug1 - general drug0 - drug2 or other muscle relaxants,procaine,succinylcholine,FALSE,none
some drug interactions are : - birth control pills - drug0 - medicines for angina or hidrug0 blood pressure - medicines for pain - medicines to control seizures such as drug0 or drug0 - certain drug0 given by injection - drug0 - drug0 - drug0 - drug0 or drug0 - local drug0 such as drug1 - general drug0 - drug0 or other muscle relaxants,procaine,muscle relaxants,FALSE,none
some drug interactions are : - birth control pills - drug0 - medicines for angina or hidrug0 blood pressure - medicines for pain - medicines to control seizures such as drug0 or drug0 - certain drug0 given by injection - drug0 - drug0 - drug0 - drug0 or drug0 - local drug1 such as drug0 - general drug0 - drug2 or other muscle relaxants,anesthetics,succinylcholine,FALSE,none
some drug interactions are : - birth control pills - drug0 - medicines for angina or hidrug0 blood pressure - medicines for pain - medicines to control seizures such as drug0 or drug0 - certain drug0 given by injection - drug0 - drug0 - drug0 - drug0 or drug0 - local drug1 such as drug0 - general drug0 - drug0 or other muscle relaxants,anesthetics,muscle relaxants,FALSE,none
some drug interactions are : - birth control pills - drug0 - medicines for angina or hidrug0 blood pressure - medicines for pain - medicines to control seizures such as drug0 or drug0 - certain drug0 given by injection - drug0 - drug0 - drug0 - drug0 or drug0 - local drug0 such as drug0 - general drug0 - drug1 or other muscle relaxants,succinylcholine,muscle relaxants,FALSE,none
drug1 : excessive reductions in blood pressure may occur in patients on drug0 therapy when drug2 are started .,diuretics,ace inhibitors,FALSE,none
the possibility of hypotensive effects with drug1 can be minimized by discontinuing drug0 therapy for several days or cautiously increasing salt intake before initiation of treatment with drug0 . if this is not possible  the starting dose of drug2 should be reduced..,univasc,moexpril,FALSE,none
the possibility of hypotensive effects with drug1 can be minimized by discontinuing drug0 therapy for several days or cautiously increasing salt intake before initiation of treatment with drug0 . if this is not possible  the starting dose of drug2 should be reduced..,univasc,moexpril,FALSE,none
drug1 supplements and drug2 : drug0 can increase serum drug0 because it decreases aldosterone secretion .,potassium,potassium-sparing diuretics,FALSE,none
drug1 supplements and drug0-sparing drug0 : drug2 can increase serum drug0 because it decreases aldosterone secretion .,potassium,univasc,FALSE,none
drug0 supplements and drug1 : drug2 can increase serum drug0 because it decreases aldosterone secretion .,potassium-sparing diuretics,univasc,FALSE,none
use of drug1 ( drug2  drug0  drug0 ) or drug0 supplements concomitantly with drug0 can increase the risk of hyperkalemia .,potassium-sparing diuretics,spironolactone,FALSE,none
use of drug1 ( drug0  drug2  drug0 ) or drug0 supplements concomitantly with drug0 can increase the risk of hyperkalemia .,potassium-sparing diuretics,triamterene,FALSE,none
use of drug1 ( drug0  drug0  drug2 ) or drug0 supplements concomitantly with drug0 can increase the risk of hyperkalemia .,potassium-sparing diuretics,amiloride,FALSE,none
use of drug1 ( drug0  drug0  drug0 ) or drug2 supplements concomitantly with drug0 can increase the risk of hyperkalemia .,potassium-sparing diuretics,potassium,FALSE,none
use of drug1 ( drug0  drug0  drug0 ) or drug0 supplements concomitantly with drug2 can increase the risk of hyperkalemia .,potassium-sparing diuretics,ace inhibitors,TRUE,effect
use of drug2-sparing drug0 ( drug1  drug0  drug0 ) or drug0 supplements concomitantly with drug0 can increase the risk of hyperkalemia .,spironolactone,potassium,FALSE,none
use of drug0-sparing drug0 ( drug1  drug0  drug0 ) or drug0 supplements concomitantly with drug2 can increase the risk of hyperkalemia .,spironolactone,ace inhibitors,TRUE,effect
use of drug2-sparing drug0 ( drug0  drug1  drug0 ) or drug0 supplements concomitantly with drug0 can increase the risk of hyperkalemia .,triamterene,potassium,FALSE,none
use of drug0-sparing drug0 ( drug0  drug1  drug0 ) or drug0 supplements concomitantly with drug2 can increase the risk of hyperkalemia .,triamterene,ace inhibitors,TRUE,effect
use of drug2-sparing drug0 ( drug0  drug0  drug1 ) or drug0 supplements concomitantly with drug0 can increase the risk of hyperkalemia .,amiloride,potassium,FALSE,none
use of drug0-sparing drug0 ( drug0  drug0  drug1 ) or drug0 supplements concomitantly with drug2 can increase the risk of hyperkalemia .,amiloride,ace inhibitors,TRUE,effect
use of drug1-sparing drug0 ( drug0  drug0  drug0 ) or drug0 supplements concomitantly with drug2 can increase the risk of hyperkalemia .,potassium,ace inhibitors,TRUE,effect
oral drug1 : interaction studies with drug2 failed to identify any clinically important effect on the serum concentrations of the drug0 or on its drug0 effect .,anticoagulants,warfarin,FALSE,none
oral drug1 : interaction studies with drug0 failed to identify any clinically important effect on the serum concentrations of the drug2 or on its drug0 effect .,anticoagulants,anticoagulant,FALSE,none
oral drug0 : interaction studies with drug1 failed to identify any clinically important effect on the serum concentrations of the drug2 or on its drug0 effect .,warfarin,anticoagulant,FALSE,none
drug1 : increased serum drug0 levels and symptoms of drug0 toxicity have been reported in patients receiving drug2 during therapy with drug0 .,lithium,ace inhibitors,FALSE,none
drug1 : increased serum drug0 levels and symptoms of drug0 toxicity have been reported in patients receiving drug2 during therapy with drug0 .,lithium,ace inhibitors,FALSE,none
drug1 : increased serum drug0 levels and symptoms of drug0 toxicity have been reported in patients receiving drug2 during therapy with drug0 .,lithium,ace inhibitors,FALSE,none
drug2 : increased serum drug0 levels and symptoms of drug0 toxicity have been reported in patients receiving drug1 during therapy with drug0 .,ace inhibitors,lithium,TRUE,effect
if a drug1 is also used  the risk of drug2 toxicity may be increased .,diuretic,lithium,TRUE,effect
drug1 has been used in clinical trials concomitantly with drug2  drug0  drug0  drug0  oral drug0 agents  and cholesterol-lowering agents .,univasc,calcium-channel-blocking agents,FALSE,none
drug1 has been used in clinical trials concomitantly with drug0-channel-blocking agents  drug2  drug0  drug0  oral drug0 agents  and cholesterol-lowering agents .,univasc,diuretics,FALSE,none
drug1 has been used in clinical trials concomitantly with drug0-channel-blocking agents  drug0  drug2  drug0  oral drug0 agents  and cholesterol-lowering agents .,univasc,h2 blockers,FALSE,none
drug1 has been used in clinical trials concomitantly with drug0-channel-blocking agents  drug0  drug0  drug2  oral drug0 agents  and cholesterol-lowering agents .,univasc,digoxin,FALSE,none
drug1 has been used in clinical trials concomitantly with drug0-channel-blocking agents  drug0  drug0  drug0  oral drug2  and cholesterol-lowering agents .,univasc,hypoglycemic agents,FALSE,none
drug0 has been used in clinical trials concomitantly with drug1  drug0  drug0  drug0  oral drug2  and cholesterol-lowering agents .,calcium-channel-blocking agents,hypoglycemic agents,FALSE,none
drug0 has been used in clinical trials concomitantly with drug0-channel-blocking agents  drug1  drug0  drug0  oral drug2  and cholesterol-lowering agents .,diuretics,hypoglycemic agents,FALSE,none
drug0 has been used in clinical trials concomitantly with drug0-channel-blocking agents  drug0  drug1  drug0  oral drug2  and cholesterol-lowering agents .,h2 blockers,hypoglycemic agents,FALSE,none
drug0 has been used in clinical trials concomitantly with drug0-channel-blocking agents  drug0  drug0  drug1  oral drug2  and cholesterol-lowering agents .,digoxin,hypoglycemic agents,FALSE,none
however  drug1  a potent inhibitor of cytochrome p450 3a4  may increase plasma levels of drug2 during concomitant dosing .,ketoconazole,mometasone furoate,TRUE,mechanism
drug1 at a dose of 10 mg once daily dosed to pharmacokinetic steady state - did not cause clinically significant changes in the kinetics of a single intravenous dose of drug2 ( predominantly a cytochrome p450 1a2 substrate ) .,montelukast,theophylline,FALSE,none
- did not change the plasma concentration profile of drug1 ( a substrate of cytochrome p450 3a4 ) or drug2  its carboxylated metabolite  and did not prolong the qtc interval following co-administration with drug0 60 mg twice daily .,terfenadine,fexofenadine,FALSE,none
- did not change the plasma concentration profile of drug2 ( a substrate of cytochrome p450 3a4 ) or drug1  its carboxylated metabolite  and did not prolong the qtc interval following co-administration with drug0 60 mg twice daily .,fexofenadine,terfenadine,FALSE,none
- did not cause any clinically significant change in plasma profiles of drug1 or drug2 following administration of either oral drug0 or intravenous drug0 .,prednisone,prednisolone,FALSE,none
- did not cause any clinically significant change in plasma profiles of drug1 or drug2 following administration of either oral drug0 or intravenous drug0 .,prednisone,prednisolone,FALSE,none
- did not cause any clinically significant change in plasma profiles of drug2 or drug1 following administration of either oral drug0 or intravenous drug0 .,prednisolone,prednisone,FALSE,none
- did not cause any clinically significant change in plasma profiles of drug1 or drug2 following administration of either oral drug0 or intravenous drug0 .,prednisone,prednisolone,FALSE,none
drug1  which induces hepatic metabolism  decreased the auc of drug2 approximately 40 % following a single 10-mg dose of drug0 .,phenobarbital,montelukast,FALSE,none
drug1  which induces hepatic metabolism  decreased the auc of drug2 approximately 40 % following a single 10-mg dose of drug0 .,phenobarbital,montelukast,FALSE,none
it is reasonable to employ appropriate clinical monitoring when potent cytochrome p450 enzyme inducers  such as drug1 or drug2  are co-administered with drug0 .,phenobarbital,rifampin,FALSE,none
it is reasonable to employ appropriate clinical monitoring when potent cytochrome p450 enzyme inducers  such as drug1 or drug0  are co-administered with drug2 .,phenobarbital,montelukast,TRUE,advise
it is reasonable to employ appropriate clinical monitoring when potent cytochrome p450 enzyme inducers  such as drug0 or drug1  are co-administered with drug2 .,rifampin,montelukast,TRUE,advise
these medications included drug1  sedative drug0  drug0  drug0  and drug2 .,thyroid hormones,decongestants,FALSE,none
these medications included drug0  sedative drug0  drug0  drug1  and drug2 .,benzodiazepines,decongestants,FALSE,none
drug1  which induces hepatic metabolism  decreased the auc of drug2 approximately 40 % following a single 10-mg dose of drug0 .,phenobarbital,montelukast,FALSE,none
drug1  which induces hepatic metabolism  decreased the auc of drug2 approximately 40 % following a single 10-mg dose of drug0 .,phenobarbital,montelukast,FALSE,none
it is reasonable to employ appropriate clinical monitoring when potent cytochrome p450 enzyme inducers  such as drug1 or drug2  are co-administered with drug0 .,phenobarbital,rifampin,FALSE,none
it is reasonable to employ appropriate clinical monitoring when potent cytochrome p450 enzyme inducers  such as drug1 or drug0  are co-administered with drug2 .,phenobarbital,montelukast,TRUE,advise
it is reasonable to employ appropriate clinical monitoring when potent cytochrome p450 enzyme inducers  such as drug0 or drug1  are co-administered with drug2 .,rifampin,montelukast,TRUE,advise
use with other drug1 : the depressant effects of drug2 are potentiated by the presence of other drug0 such as drug0  drug0  drug0  or drug0 .,central nervous system depressants,morphine,FALSE,none
use with other drug1 : the depressant effects of drug0 are potentiated by the presence of other drug2 such as drug0  drug0  drug0  or drug0 .,central nervous system depressants,cns depressants,FALSE,none
use with other drug1 : the depressant effects of drug0 are potentiated by the presence of other drug0 such as drug2  drug0  drug0  or drug0 .,central nervous system depressants,alcohol,FALSE,none
use with other drug1 : the depressant effects of drug0 are potentiated by the presence of other drug0 such as drug0  drug2  drug0  or drug0 .,central nervous system depressants,sedatives,FALSE,none
use with other drug1 : the depressant effects of drug0 are potentiated by the presence of other drug0 such as drug0  drug0  drug2  or drug0 .,central nervous system depressants,antihistaminics,FALSE,none
use with other drug1 : the depressant effects of drug0 are potentiated by the presence of other drug0 such as drug0  drug0  drug0  or drug2 .,central nervous system depressants,psychotropic drugs,FALSE,none
use with other drug0 : the depressant effects of drug1 are potentiated by the presence of other drug2 such as drug0  drug0  drug0  or drug0 .,morphine,cns depressants,TRUE,effect
use with other drug0 : the depressant effects of drug1 are potentiated by the presence of other drug0 such as drug2  drug0  drug0  or drug0 .,morphine,alcohol,TRUE,effect
use with other drug0 : the depressant effects of drug1 are potentiated by the presence of other drug0 such as drug0  drug2  drug0  or drug0 .,morphine,sedatives,TRUE,effect
use with other drug0 : the depressant effects of drug1 are potentiated by the presence of other drug0 such as drug0  drug0  drug2  or drug0 .,morphine,antihistaminics,TRUE,effect
use with other drug0 : the depressant effects of drug1 are potentiated by the presence of other drug0 such as drug0  drug0  drug0  or drug2 .,morphine,psychotropic drugs,TRUE,effect
use with other drug0 : the depressant effects of drug0 are potentiated by the presence of other drug1 such as drug0  drug2  drug0  or drug0 .,cns depressants,sedatives,FALSE,none
use with other drug0 : the depressant effects of drug0 are potentiated by the presence of other drug1 such as drug0  drug0  drug2  or drug0 .,cns depressants,antihistaminics,FALSE,none
use with other drug0 : the depressant effects of drug0 are potentiated by the presence of other drug1 such as drug0  drug0  drug0  or drug2 .,cns depressants,psychotropic drugs,FALSE,none
use with other drug0 : the depressant effects of drug0 are potentiated by the presence of other drug0 such as drug0  drug0  drug1  or drug2 .,antihistaminics,psychotropic drugs,FALSE,none
use of drug1 in conjunction with oral drug2 may increase the risk of respiratory depression  hypotension and profound sedation or coma .,neuroleptics,morphine,TRUE,effect
interaction with drug1 : drug2 ( i.e.  drug0  drug0  drug0  or drug0 ) should not be administered to patients who have received or are receiving a course of therapy with a proof opioid agonist drug0 .,mixed agonist/antagonist opioid analgesics,agonist/antagonist analgesics,FALSE,none
interaction with drug1 : drug0 ( i.e.  drug2  drug0  drug0  or drug0 ) should not be administered to patients who have received or are receiving a course of therapy with a proof opioid agonist drug0 .,mixed agonist/antagonist opioid analgesics,pentazocine,FALSE,none
interaction with drug1 : drug0 ( i.e.  drug0  drug2  drug0  or drug0 ) should not be administered to patients who have received or are receiving a course of therapy with a proof opioid agonist drug0 .,mixed agonist/antagonist opioid analgesics,nalbuphine,FALSE,none
interaction with drug1 : drug0 ( i.e.  drug0  drug0  drug2  or drug0 ) should not be administered to patients who have received or are receiving a course of therapy with a proof opioid agonist drug0 .,mixed agonist/antagonist opioid analgesics,butorphanol,FALSE,none
interaction with drug1 : drug0 ( i.e.  drug0  drug0  drug0  or drug2 ) should not be administered to patients who have received or are receiving a course of therapy with a proof opioid agonist drug0 .,mixed agonist/antagonist opioid analgesics,buprenorphine,FALSE,none
interaction with drug1 : drug0 ( i.e.  drug0  drug0  drug0  or drug0 ) should not be administered to patients who have received or are receiving a course of therapy with a proof drug2 .,mixed agonist/antagonist opioid analgesics,opioid agonist analgesic,FALSE,none
interaction with mixed agonist/antagonist opioid drug0 : drug1 ( i.e.  drug2  drug0  drug0  or drug0 ) should not be administered to patients who have received or are receiving a course of therapy with a proof opioid agonist drug0 .,agonist/antagonist analgesics,pentazocine,FALSE,none
interaction with mixed agonist/antagonist opioid drug0 : drug1 ( i.e.  drug0  drug2  drug0  or drug0 ) should not be administered to patients who have received or are receiving a course of therapy with a proof opioid agonist drug0 .,agonist/antagonist analgesics,nalbuphine,FALSE,none
interaction with mixed agonist/antagonist opioid drug0 : drug1 ( i.e.  drug0  drug0  drug2  or drug0 ) should not be administered to patients who have received or are receiving a course of therapy with a proof opioid agonist drug0 .,agonist/antagonist analgesics,butorphanol,FALSE,none
interaction with mixed agonist/antagonist opioid drug0 : drug1 ( i.e.  drug0  drug0  drug0  or drug2 ) should not be administered to patients who have received or are receiving a course of therapy with a proof opioid agonist drug0 .,agonist/antagonist analgesics,buprenorphine,FALSE,none
interaction with mixed agonist/antagonist opioid drug0 : drug1 ( i.e.  drug0  drug0  drug0  or drug0 ) should not be administered to patients who have received or are receiving a course of therapy with a proof drug2 .,agonist/antagonist analgesics,opioid agonist analgesic,TRUE,advise
interaction with mixed agonist/antagonist opioid drug0 : drug0 ( i.e.  drug1  drug0  drug0  or drug0 ) should not be administered to patients who have received or are receiving a course of therapy with a proof drug2 .,pentazocine,opioid agonist analgesic,TRUE,advise
interaction with mixed agonist/antagonist opioid drug0 : drug0 ( i.e.  drug0  drug1  drug0  or drug0 ) should not be administered to patients who have received or are receiving a course of therapy with a proof drug2 .,nalbuphine,opioid agonist analgesic,TRUE,advise
interaction with mixed agonist/antagonist opioid drug0 : drug0 ( i.e.  drug0  drug0  drug1  or drug2 ) should not be administered to patients who have received or are receiving a course of therapy with a proof opioid agonist drug0 .,butorphanol,buprenorphine,FALSE,none
interaction with mixed agonist/antagonist opioid drug0 : drug0 ( i.e.  drug0  drug0  drug1  or drug0 ) should not be administered to patients who have received or are receiving a course of therapy with a proof drug2 .,butorphanol,opioid agonist analgesic,TRUE,advise
interaction with mixed agonist/antagonist opioid drug0 : drug0 ( i.e.  drug0  drug0  drug0  or drug1 ) should not be administered to patients who have received or are receiving a course of therapy with a proof drug2 .,buprenorphine,opioid agonist analgesic,TRUE,advise
drug1 : absorption of a single dose of drug2 was decreased when administered to 12 stable renal transplant patients also taking drug0-drug0 containing drug0 ( 30 ml ) : the mean cmax and auc ( 0-t ) values for drug0 were 25 % and 37 % lower  respectively  than when drug0 was administered alone under fasting conditions .,antacids,myfortic,FALSE,none
drug1 : absorption of a single dose of drug0 was decreased when administered to 12 stable renal transplant patients also taking drug2-drug0 containing drug0 ( 30 ml ) : the mean cmax and auc ( 0-t ) values for drug0 were 25 % and 37 % lower  respectively  than when drug0 was administered alone under fasting conditions .,antacids,magnesium,FALSE,none
drug1 : absorption of a single dose of drug0 was decreased when administered to 12 stable renal transplant patients also taking drug0-drug2 containing drug0 ( 30 ml ) : the mean cmax and auc ( 0-t ) values for drug0 were 25 % and 37 % lower  respectively  than when drug0 was administered alone under fasting conditions .,antacids,aluminum,FALSE,none
drug1 : absorption of a single dose of drug2 was decreased when administered to 12 stable renal transplant patients also taking drug0-drug0 containing drug0 ( 30 ml ) : the mean cmax and auc ( 0-t ) values for drug0 were 25 % and 37 % lower  respectively  than when drug0 was administered alone under fasting conditions .,antacids,myfortic,FALSE,none
drug0 : absorption of a single dose of drug1 was decreased when administered to 12 stable renal transplant patients also taking drug2-drug0 containing drug0 ( 30 ml ) : the mean cmax and auc ( 0-t ) values for drug0 were 25 % and 37 % lower  respectively  than when drug0 was administered alone under fasting conditions .,myfortic,magnesium,TRUE,mechanism
drug0 : absorption of a single dose of drug1 was decreased when administered to 12 stable renal transplant patients also taking drug0-drug2 containing drug0 ( 30 ml ) : the mean cmax and auc ( 0-t ) values for drug0 were 25 % and 37 % lower  respectively  than when drug0 was administered alone under fasting conditions .,myfortic,aluminum,TRUE,mechanism
drug2 : absorption of a single dose of drug1 was decreased when administered to 12 stable renal transplant patients also taking drug0-drug0 containing drug0 ( 30 ml ) : the mean cmax and auc ( 0-t ) values for drug0 were 25 % and 37 % lower  respectively  than when drug0 was administered alone under fasting conditions .,myfortic,antacids,FALSE,none
drug0 : absorption of a single dose of drug0 was decreased when administered to 12 stable renal transplant patients also taking drug1-drug2 containing drug0 ( 30 ml ) : the mean cmax and auc ( 0-t ) values for drug0 were 25 % and 37 % lower  respectively  than when drug0 was administered alone under fasting conditions .,magnesium,aluminum,FALSE,none
drug2 : absorption of a single dose of drug0 was decreased when administered to 12 stable renal transplant patients also taking drug1-drug0 containing drug0 ( 30 ml ) : the mean cmax and auc ( 0-t ) values for drug0 were 25 % and 37 % lower  respectively  than when drug0 was administered alone under fasting conditions .,magnesium,antacids,FALSE,none
drug0 : absorption of a single dose of drug2 was decreased when administered to 12 stable renal transplant patients also taking drug1-drug0 containing drug0 ( 30 ml ) : the mean cmax and auc ( 0-t ) values for drug0 were 25 % and 37 % lower  respectively  than when drug0 was administered alone under fasting conditions .,magnesium,myfortic,FALSE,none
drug2 : absorption of a single dose of drug0 was decreased when administered to 12 stable renal transplant patients also taking drug0-drug1 containing drug0 ( 30 ml ) : the mean cmax and auc ( 0-t ) values for drug0 were 25 % and 37 % lower  respectively  than when drug0 was administered alone under fasting conditions .,aluminum,antacids,FALSE,none
drug0 : absorption of a single dose of drug2 was decreased when administered to 12 stable renal transplant patients also taking drug0-drug1 containing drug0 ( 30 ml ) : the mean cmax and auc ( 0-t ) values for drug0 were 25 % and 37 % lower  respectively  than when drug0 was administered alone under fasting conditions .,aluminum,myfortic,FALSE,none
drug1 : absorption of a single dose of drug2 was decreased when administered to 12 stable renal transplant patients also taking drug0-drug0 containing drug0 ( 30 ml ) : the mean cmax and auc ( 0-t ) values for drug0 were 25 % and 37 % lower  respectively  than when drug0 was administered alone under fasting conditions .,antacids,myfortic,FALSE,none
it is recommended that drug1 and drug2 not be administered simultaneously .,myfortic,antacids,TRUE,advise
drug1 : when studied in stable renal transplant patients  drug0  usp ( modified ) pharmacokinetics were unaffected by steady state dosing of drug2 .,cyclosporine,myfortic,FALSE,none
drug1 : when studied in stable renal transplant patients  drug0  usp ( modified ) pharmacokinetics were unaffected by steady state dosing of drug2 .,cyclosporine,myfortic,FALSE,none
drug1/drug2 : may be taken with drug0 ;,acyclovir,ganciclovir,FALSE,none
drug1/drug0 : may be taken with drug2 ;,acyclovir,myfortic,FALSE,none
drug0/drug1 : may be taken with drug2 ;,ganciclovir,myfortic,FALSE,none
both drug1/drug2 and drug0 concentrations are increased in the presence of renal impairment  their coexistence may compete for tubular secretion and further increase in the concentrations of the two .,acyclovir,ganciclovir,FALSE,none
both drug1/drug0 and drug2 concentrations are increased in the presence of renal impairment  their coexistence may compete for tubular secretion and further increase in the concentrations of the two .,acyclovir,mpag,FALSE,none
both drug0/drug1 and drug2 concentrations are increased in the presence of renal impairment  their coexistence may compete for tubular secretion and further increase in the concentrations of the two .,ganciclovir,mpag,FALSE,none
drug1/drug2 : given that drug0 and drug0 inhibit purine metabolism  it is recommended that drug0 not be administered concomitantly with drug0 or drug0 .,azathioprine,mycophenolate mofetil,FALSE,none
drug1/drug2 : given that drug0 and drug0 inhibit purine metabolism  it is recommended that drug0 not be administered concomitantly with drug0 or drug0 .,azathioprine,mycophenolate mofetil,FALSE,none
drug1/drug0 : given that drug0 and drug0 inhibit purine metabolism  it is recommended that drug2 not be administered concomitantly with drug0 or drug0 .,azathioprine,myfortic,FALSE,none
drug1/drug2 : given that drug0 and drug0 inhibit purine metabolism  it is recommended that drug0 not be administered concomitantly with drug0 or drug0 .,azathioprine,mycophenolate mofetil,FALSE,none
drug2/drug1 : given that drug0 and drug0 inhibit purine metabolism  it is recommended that drug0 not be administered concomitantly with drug0 or drug0 .,mycophenolate mofetil,azathioprine,FALSE,none
drug0/drug1 : given that drug0 and drug0 inhibit purine metabolism  it is recommended that drug2 not be administered concomitantly with drug0 or drug0 .,mycophenolate mofetil,myfortic,FALSE,none
drug2/drug1 : given that drug0 and drug0 inhibit purine metabolism  it is recommended that drug0 not be administered concomitantly with drug0 or drug0 .,mycophenolate mofetil,azathioprine,FALSE,none
drug1/drug2 : given that drug0 and drug0 inhibit purine metabolism  it is recommended that drug0 not be administered concomitantly with drug0 or drug0 .,azathioprine,mycophenolate mofetil,FALSE,none
drug1/drug0 : given that drug0 and drug0 inhibit purine metabolism  it is recommended that drug2 not be administered concomitantly with drug0 or drug0 .,azathioprine,myfortic,FALSE,none
drug1/drug2 : given that drug0 and drug0 inhibit purine metabolism  it is recommended that drug0 not be administered concomitantly with drug0 or drug0 .,azathioprine,mycophenolate mofetil,FALSE,none
drug0/drug1 : given that drug0 and drug0 inhibit purine metabolism  it is recommended that drug2 not be administered concomitantly with drug0 or drug0 .,mycophenolate mofetil,myfortic,FALSE,none
drug2/drug1 : given that drug0 and drug0 inhibit purine metabolism  it is recommended that drug0 not be administered concomitantly with drug0 or drug0 .,mycophenolate mofetil,azathioprine,FALSE,none
drug2/drug0 : given that drug0 and drug0 inhibit purine metabolism  it is recommended that drug1 not be administered concomitantly with drug0 or drug0 .,myfortic,azathioprine,TRUE,advise
drug0/drug2 : given that drug0 and drug0 inhibit purine metabolism  it is recommended that drug1 not be administered concomitantly with drug0 or drug0 .,myfortic,mycophenolate mofetil,TRUE,advise
drug1/drug2 : given that drug0 and drug0 inhibit purine metabolism  it is recommended that drug0 not be administered concomitantly with drug0 or drug0 .,azathioprine,mycophenolate mofetil,FALSE,none
drug1 and drugs that bind bile acids : these drugs interrupt enterohepatic recirculation and reduce drug2 exposure when coadministered with drug0 .,cholestyramine,mpa,FALSE,none
drug1 and drugs that bind bile acids : these drugs interrupt enterohepatic recirculation and reduce drug0 exposure when coadministered with drug2 .,cholestyramine,mycophenolate mofetil,FALSE,none
drug0 and drugs that bind bile acids : these drugs interrupt enterohepatic recirculation and reduce drug1 exposure when coadministered with drug2 .,mpa,mycophenolate mofetil,FALSE,none
oral drug1 : given the different metabolism of drug2 and oral drug0  no drug interaction between these two classes of drug is expected .,contraceptives,myfortic,FALSE,none
oral drug2 : given the different metabolism of drug1 and oral drug0  no drug interaction between these two classes of drug is expected .,myfortic,contraceptives,FALSE,none
however  in a drug-drug interaction study  mean drug1 auc was decreased by 15 % when coadministered with drug2 .,levonorgesterol,mycophenolate mofetil,TRUE,mechanism
therefore  it is recommended that oral drug1 are co- administered with drug2 with caution and additional birth control methods be considered .,contraceptives,myfortic,TRUE,advise
drug1 : during treatment with drug2  the use of drug0 should be avoided and patients should be advised that vaccinations may be less effective .,live vaccines,myfortic,FALSE,none
drug1 : during treatment with drug0  the use of drug2 should be avoided and patients should be advised that vaccinations may be less effective .,live vaccines,live attenuated vaccines,FALSE,none
drug0 : during treatment with drug1  the use of drug2 should be avoided and patients should be advised that vaccinations may be less effective .,myfortic,live attenuated vaccines,TRUE,advise
interference of drug1 hydrolysis may lead to less drug2 available for absorption .,mpag,mpa,FALSE,none
drug1  drug0  and drug0 : in patients treated with potent inducers of cyp3a4 ( i.e.  drug0  drug0  and drug0 )  the clearance of drug2 was significantly increased and drug0 blood concentrations were decreased .,phenytoin,ondansetron,FALSE,none
drug1  drug0  and drug0 : in patients treated with potent inducers of cyp3a4 ( i.e.  drug0  drug0  and drug0 )  the clearance of drug2 was significantly increased and drug0 blood concentrations were decreased .,phenytoin,ondansetron,FALSE,none
drug0  drug1  and drug2 : in patients treated with potent inducers of cyp3a4 ( i.e.  drug0  drug0  and drug0 )  the clearance of drug0 was significantly increased and drug0 blood concentrations were decreased .,carbamazepine,rifampicin,FALSE,none
drug0  drug1  and drug2 : in patients treated with potent inducers of cyp3a4 ( i.e.  drug0  drug0  and drug0 )  the clearance of drug0 was significantly increased and drug0 blood concentrations were decreased .,carbamazepine,rifampicin,FALSE,none
drug0  drug1  and drug0 : in patients treated with potent inducers of cyp3a4 ( i.e.  drug0  drug0  and drug0 )  the clearance of drug2 was significantly increased and drug0 blood concentrations were decreased .,carbamazepine,ondansetron,FALSE,none
drug0  drug1  and drug0 : in patients treated with potent inducers of cyp3a4 ( i.e.  drug0  drug0  and drug0 )  the clearance of drug2 was significantly increased and drug0 blood concentrations were decreased .,carbamazepine,ondansetron,FALSE,none
drug0  drug2  and drug1 : in patients treated with potent inducers of cyp3a4 ( i.e.  drug0  drug0  and drug0 )  the clearance of drug0 was significantly increased and drug0 blood concentrations were decreased .,rifampicin,carbamazepine,FALSE,none
drug0  drug0  and drug1 : in patients treated with potent inducers of cyp3a4 ( i.e.  drug0  drug0  and drug0 )  the clearance of drug2 was significantly increased and drug0 blood concentrations were decreased .,rifampicin,ondansetron,FALSE,none
drug0  drug0  and drug1 : in patients treated with potent inducers of cyp3a4 ( i.e.  drug0  drug0  and drug0 )  the clearance of drug2 was significantly increased and drug0 blood concentrations were decreased .,rifampicin,ondansetron,FALSE,none
drug1  drug0  and drug0 : in patients treated with potent inducers of cyp3a4 ( i.e.  drug0  drug0  and drug0 )  the clearance of drug2 was significantly increased and drug0 blood concentrations were decreased .,phenytoin,ondansetron,TRUE,mechanism
drug1  drug0  and drug0 : in patients treated with potent inducers of cyp3a4 ( i.e.  drug0  drug0  and drug0 )  the clearance of drug2 was significantly increased and drug0 blood concentrations were decreased .,phenytoin,ondansetron,TRUE,mechanism
drug0  drug1  and drug2 : in patients treated with potent inducers of cyp3a4 ( i.e.  drug0  drug0  and drug0 )  the clearance of drug0 was significantly increased and drug0 blood concentrations were decreased .,carbamazepine,rifampicin,FALSE,none
drug0  drug1  and drug0 : in patients treated with potent inducers of cyp3a4 ( i.e.  drug0  drug0  and drug0 )  the clearance of drug2 was significantly increased and drug0 blood concentrations were decreased .,carbamazepine,ondansetron,TRUE,mechanism
drug0  drug1  and drug0 : in patients treated with potent inducers of cyp3a4 ( i.e.  drug0  drug0  and drug0 )  the clearance of drug2 was significantly increased and drug0 blood concentrations were decreased .,carbamazepine,ondansetron,TRUE,mechanism
drug0  drug0  and drug1 : in patients treated with potent inducers of cyp3a4 ( i.e.  drug0  drug0  and drug0 )  the clearance of drug2 was significantly increased and drug0 blood concentrations were decreased .,rifampicin,ondansetron,TRUE,mechanism
drug0  drug0  and drug1 : in patients treated with potent inducers of cyp3a4 ( i.e.  drug0  drug0  and drug0 )  the clearance of drug2 was significantly increased and drug0 blood concentrations were decreased .,rifampicin,ondansetron,TRUE,mechanism
drug1 did not increase blood levels of hidrug0-dose drug2 .,ondansetron,methotrexate,FALSE,none
other drug1 should not be used concomitantly with drug2 ( drug0 usp ) because they may have additive effects .,beta adrenergic aerosol bronchodilators,alupent,TRUE,advise
other drug1 should not be used concomitantly with drug0 ( drug2 usp ) because they may have additive effects .,beta adrenergic aerosol bronchodilators,metaproterenol sulfate,TRUE,advise
other drug0 should not be used concomitantly with drug1 ( drug2 usp ) because they may have additive effects .,alupent,metaproterenol sulfate,FALSE,none
drug1 should be administered with caution to patients being treated with drug2 or drug0 drug0  since the action of drug0 on the vascular system may be potentiated .,beta adrenergic agonists,monoamine oxidase inhibitors,TRUE,advise
drug1 should be administered with caution to patients being treated with drug0 or drug2  since the action of drug0 on the vascular system may be potentiated .,beta adrenergic agonists,tricyclic antidepressants,TRUE,advise
drug0 should be administered with caution to patients being treated with drug1 or drug2  since the action of drug0 on the vascular system may be potentiated .,monoamine oxidase inhibitors,tricyclic antidepressants,FALSE,none
drug2 should be administered with caution to patients being treated with drug1 or drug0 drug0  since the action of drug0 on the vascular system may be potentiated .,monoamine oxidase inhibitors,beta adrenergic agonists,FALSE,none
drug2 should be administered with caution to patients being treated with drug0 or drug1  since the action of drug0 on the vascular system may be potentiated .,tricyclic antidepressants,beta adrenergic agonists,FALSE,none
drug1 : preliminary data from a drug2 and drug0 drug interaction study indicate a reduction in drug0 plasma levels when drug0 was coadministered with drug0 .,cyclosporine,xenical,FALSE,none
drug1 : preliminary data from a drug2 and drug0 drug interaction study indicate a reduction in drug0 plasma levels when drug0 was coadministered with drug0 .,cyclosporine,xenical,FALSE,none
drug2 : preliminary data from a drug1 and drug0 drug interaction study indicate a reduction in drug0 plasma levels when drug0 was coadministered with drug0 .,xenical,cyclosporine,FALSE,none
drug2 : preliminary data from a drug1 and drug0 drug interaction study indicate a reduction in drug0 plasma levels when drug0 was coadministered with drug0 .,xenical,cyclosporine,FALSE,none
drug2 : preliminary data from a drug1 and drug0 drug interaction study indicate a reduction in drug0 plasma levels when drug0 was coadministered with drug0 .,xenical,cyclosporine,FALSE,none
drug1 : preliminary data from a drug2 and drug0 drug interaction study indicate a reduction in drug0 plasma levels when drug0 was coadministered with drug0 .,cyclosporine,xenical,FALSE,none
drug1 : preliminary data from a drug2 and drug0 drug interaction study indicate a reduction in drug0 plasma levels when drug0 was coadministered with drug0 .,cyclosporine,xenical,FALSE,none
drug2 : preliminary data from a drug1 and drug0 drug interaction study indicate a reduction in drug0 plasma levels when drug0 was coadministered with drug0 .,xenical,cyclosporine,TRUE,mechanism
drug1 and analogues : a pharmacokinetic interaction study showed a 30 % reduction in drug2 supplement absorption when concomitantly administered with drug0 .,fat-soluble vitamin supplements,beta-carotene,FALSE,none
drug1 and analogues : a pharmacokinetic interaction study showed a 30 % reduction in drug0 supplement absorption when concomitantly administered with drug2 .,fat-soluble vitamin supplements,xenical,FALSE,none
drug0 and analogues : a pharmacokinetic interaction study showed a 30 % reduction in drug1 supplement absorption when concomitantly administered with drug2 .,beta-carotene,xenical,TRUE,mechanism
drug1 inhibited absorption of a drug2 supplement by approximately 60 % .,xenical,vitamin e acetate,TRUE,mechanism
oral drug1 : in 20 normal-weight female subjects  the treatment of drug2 120 mg three times a day for 23 days resulted in no changes in the ovulation-suppressing action of oral drug0 .,contraceptives,xenical,FALSE,none
oral drug2 : in 20 normal-weight female subjects  the treatment of drug1 120 mg three times a day for 23 days resulted in no changes in the ovulation-suppressing action of oral drug0 .,xenical,contraceptives,FALSE,none
therefore  as drug1 absorption may be decreased with drug2  patients on chronic stable doses of drug0 who are prescribed drug0 should be monitored closely for changes in coagulation parameters .,vitamin k,xenical,TRUE,mechanism
therefore  as drug1 absorption may be decreased with drug0  patients on chronic stable doses of drug2 who are prescribed drug0 should be monitored closely for changes in coagulation parameters .,vitamin k,warfarin,FALSE,none
therefore  as drug1 absorption may be decreased with drug2  patients on chronic stable doses of drug0 who are prescribed drug0 should be monitored closely for changes in coagulation parameters .,vitamin k,xenical,FALSE,none
therefore  as drug0 absorption may be decreased with drug1  patients on chronic stable doses of drug2 who are prescribed drug0 should be monitored closely for changes in coagulation parameters .,xenical,warfarin,FALSE,none
therefore  as drug0 absorption may be decreased with drug2  patients on chronic stable doses of drug1 who are prescribed drug0 should be monitored closely for changes in coagulation parameters .,warfarin,xenical,TRUE,advise
drug1  a bacteriostatic drug2  may antagonize the bactericidal effect of drug0 and concurrent use of these drugs should be avoided .,tetracycline,antibiotic,FALSE,none
drug1  a bacteriostatic drug0  may antagonize the bactericidal effect of drug2 and concurrent use of these drugs should be avoided .,tetracycline,penicillin,TRUE,effect
drug0  a bacteriostatic drug1  may antagonize the bactericidal effect of drug2 and concurrent use of these drugs should be avoided .,antibiotic,penicillin,FALSE,none
increases of drug1 plasma concentrations by approximately 20 % have been observed with doses of 130 mg/m2 drug2 dosed every 3 weeks .,5-fu,eloxatin,TRUE,mechanism
drug1 drug2 may increase sensitivity to oral drug0 .,anticoagulants,anabolic steroids,FALSE,none
drug2 drug1 may increase sensitivity to oral drug0 .,anabolic steroids,anticoagulants,TRUE,effect
drug1 : a multidose study of drug2  given as 5 or 10 mg bid in 15 healthy subjects concurrently treated with drug0  resulted in a mean increase in drug0 half-life from 26 to 48 hours and auc from 4.55 to 12.08 ng*hr/ml : similar increases in drug0 half-life and auc were also detected .,warfarin,oxandrolone,FALSE,none
drug1 : a multidose study of drug0  given as 5 or 10 mg bid in 15 healthy subjects concurrently treated with drug0  resulted in a mean increase in drug2 half-life from 26 to 48 hours and auc from 4.55 to 12.08 ng*hr/ml : similar increases in drug0 half-life and auc were also detected .,warfarin,s-warfarin,FALSE,none
drug1 : a multidose study of drug0  given as 5 or 10 mg bid in 15 healthy subjects concurrently treated with drug0  resulted in a mean increase in drug0 half-life from 26 to 48 hours and auc from 4.55 to 12.08 ng*hr/ml : similar increases in drug2 half-life and auc were also detected .,warfarin,r-warfarin,FALSE,none
drug2 : a multidose study of drug1  given as 5 or 10 mg bid in 15 healthy subjects concurrently treated with drug0  resulted in a mean increase in drug0 half-life from 26 to 48 hours and auc from 4.55 to 12.08 ng*hr/ml : similar increases in drug0 half-life and auc were also detected .,oxandrolone,warfarin,TRUE,mechanism
drug0 : a multidose study of drug1  given as 5 or 10 mg bid in 15 healthy subjects concurrently treated with drug0  resulted in a mean increase in drug2 half-life from 26 to 48 hours and auc from 4.55 to 12.08 ng*hr/ml : similar increases in drug0 half-life and auc were also detected .,oxandrolone,s-warfarin,FALSE,none
drug0 : a multidose study of drug1  given as 5 or 10 mg bid in 15 healthy subjects concurrently treated with drug0  resulted in a mean increase in drug0 half-life from 26 to 48 hours and auc from 4.55 to 12.08 ng*hr/ml : similar increases in drug2 half-life and auc were also detected .,oxandrolone,r-warfarin,FALSE,none
drug1 : a multidose study of drug0  given as 5 or 10 mg bid in 15 healthy subjects concurrently treated with drug0  resulted in a mean increase in drug2 half-life from 26 to 48 hours and auc from 4.55 to 12.08 ng*hr/ml : similar increases in drug0 half-life and auc were also detected .,warfarin,s-warfarin,FALSE,none
drug1 : a multidose study of drug0  given as 5 or 10 mg bid in 15 healthy subjects concurrently treated with drug0  resulted in a mean increase in drug0 half-life from 26 to 48 hours and auc from 4.55 to 12.08 ng*hr/ml : similar increases in drug2 half-life and auc were also detected .,warfarin,r-warfarin,FALSE,none
drug0 : a multidose study of drug0  given as 5 or 10 mg bid in 15 healthy subjects concurrently treated with drug0  resulted in a mean increase in drug1 half-life from 26 to 48 hours and auc from 4.55 to 12.08 ng*hr/ml : similar increases in drug2 half-life and auc were also detected .,s-warfarin,r-warfarin,FALSE,none
when drug1 therapy is initiated in a patient already receiving treatment with drug2  the inr or prothrombin time ( pt ) should be monitored closely and the dose of drug0 adjusted as necessary until a stable target inr or pt has been achieved .,oxandrolone,warfarin,TRUE,advise
when drug1 therapy is initiated in a patient already receiving treatment with drug2  the inr or prothrombin time ( pt ) should be monitored closely and the dose of drug0 adjusted as necessary until a stable target inr or pt has been achieved .,oxandrolone,warfarin,FALSE,none
furthermore  in patients receiving both drugs  careful monitoring of the inr or pt  and adjustment of the drug1 dosage if indicated are recommended when the drug2 dose is changed or discontinued .,warfarin,oxandrolone,TRUE,advise
oral drug1 drug2 may inhibit the metabolism of oral drug0 agents .,hypoglycemic agents,oxandrolone,FALSE,none
oral drug2 drug1 may inhibit the metabolism of oral drug0 agents .,oxandrolone,hypoglycemic agents,TRUE,mechanism
drug1 or drug2 in patients with edema  concomitant administration with drug0 or drug0 may increase the edema .,adrenal steroids,acth,FALSE,none
drug1 or drug0 in patients with edema  concomitant administration with drug2 or drug0 may increase the edema .,adrenal steroids,adrenal cortical steroids,FALSE,none
drug1 or drug2 in patients with edema  concomitant administration with drug0 or drug0 may increase the edema .,adrenal steroids,acth,FALSE,none
drug0 or drug1 in patients with edema  concomitant administration with drug2 or drug0 may increase the edema .,acth,adrenal cortical steroids,FALSE,none
drug0 or drug2 in patients with edema  concomitant administration with drug1 or drug0 may increase the edema .,adrenal cortical steroids,acth,FALSE,none
the concomitant use of drug1 with other drug2 or with other agents which produce dry mouth  constipation  somnolence ( drowsiness )  and/or other drug0-like effects may increase the frequency and/or severity of such effects .,oxybutynin,anticholinergic drugs,TRUE,effect
mean drug1 plasma concentrations were approximately 2 fold higher when drug2 was administered with drug0  a potent cyp3a4 inhibitor .,oxybutynin chloride,ditropan xl,FALSE,none
mean drug1 plasma concentrations were approximately 2 fold higher when drug0 was administered with drug2  a potent cyp3a4 inhibitor .,oxybutynin chloride,ketoconazole,FALSE,none
mean drug0 chloride plasma concentrations were approximately 2 fold higher when drug1 was administered with drug2  a potent cyp3a4 inhibitor .,ditropan xl,ketoconazole,TRUE,mechanism
other inhibitors of the cytochrome p450 3a4 enzyme system  such as drug1 ( e.g.  drug2 and drug0 ) or macrolide drug0 ( e.g.  drug0 and drug0 )  may alter drug0 mean pharmacokinetic parameters ( i.e.  cmax and auc ) .,antimycotic agents,itraconazole,FALSE,none
other inhibitors of the cytochrome p450 3a4 enzyme system  such as drug1 ( e.g.  drug0 and drug2 ) or macrolide drug0 ( e.g.  drug0 and drug0 )  may alter drug0 mean pharmacokinetic parameters ( i.e.  cmax and auc ) .,antimycotic agents,miconazole,FALSE,none
other inhibitors of the cytochrome p450 3a4 enzyme system  such as drug1 ( e.g.  drug0 and drug0 ) or drug2 ( e.g.  drug0 and drug0 )  may alter drug0 mean pharmacokinetic parameters ( i.e.  cmax and auc ) .,antimycotic agents,macrolide antibiotics,FALSE,none
other inhibitors of the cytochrome p450 3a4 enzyme system  such as drug1 ( e.g.  drug0 and drug0 ) or macrolide drug0 ( e.g.  drug2 and drug0 )  may alter drug0 mean pharmacokinetic parameters ( i.e.  cmax and auc ) .,antimycotic agents,erythromycin,FALSE,none
other inhibitors of the cytochrome p450 3a4 enzyme system  such as drug1 ( e.g.  drug0 and drug0 ) or macrolide drug0 ( e.g.  drug0 and drug2 )  may alter drug0 mean pharmacokinetic parameters ( i.e.  cmax and auc ) .,antimycotic agents,clarithromycin,FALSE,none
other inhibitors of the cytochrome p450 3a4 enzyme system  such as drug1 ( e.g.  drug0 and drug0 ) or macrolide drug0 ( e.g.  drug0 and drug0 )  may alter drug2 mean pharmacokinetic parameters ( i.e.  cmax and auc ) .,antimycotic agents,oxybutynin,TRUE,mechanism
other inhibitors of the cytochrome p450 3a4 enzyme system  such as drug0 ( e.g.  drug1 and drug2 ) or macrolide drug0 ( e.g.  drug0 and drug0 )  may alter drug0 mean pharmacokinetic parameters ( i.e.  cmax and auc ) .,itraconazole,miconazole,FALSE,none
other inhibitors of the cytochrome p450 3a4 enzyme system  such as drug0 ( e.g.  drug1 and drug0 ) or drug2 ( e.g.  drug0 and drug0 )  may alter drug0 mean pharmacokinetic parameters ( i.e.  cmax and auc ) .,itraconazole,macrolide antibiotics,FALSE,none
other inhibitors of the cytochrome p450 3a4 enzyme system  such as drug0 ( e.g.  drug1 and drug0 ) or macrolide drug0 ( e.g.  drug2 and drug0 )  may alter drug0 mean pharmacokinetic parameters ( i.e.  cmax and auc ) .,itraconazole,erythromycin,FALSE,none
other inhibitors of the cytochrome p450 3a4 enzyme system  such as drug0 ( e.g.  drug1 and drug0 ) or macrolide drug0 ( e.g.  drug0 and drug2 )  may alter drug0 mean pharmacokinetic parameters ( i.e.  cmax and auc ) .,itraconazole,clarithromycin,FALSE,none
other inhibitors of the cytochrome p450 3a4 enzyme system  such as drug0 ( e.g.  drug1 and drug0 ) or macrolide drug0 ( e.g.  drug0 and drug0 )  may alter drug2 mean pharmacokinetic parameters ( i.e.  cmax and auc ) .,itraconazole,oxybutynin,TRUE,mechanism
other inhibitors of the cytochrome p450 3a4 enzyme system  such as drug0 ( e.g.  drug0 and drug1 ) or drug2 ( e.g.  drug0 and drug0 )  may alter drug0 mean pharmacokinetic parameters ( i.e.  cmax and auc ) .,miconazole,macrolide antibiotics,FALSE,none
other inhibitors of the cytochrome p450 3a4 enzyme system  such as drug0 ( e.g.  drug0 and drug1 ) or macrolide drug0 ( e.g.  drug2 and drug0 )  may alter drug0 mean pharmacokinetic parameters ( i.e.  cmax and auc ) .,miconazole,erythromycin,FALSE,none
other inhibitors of the cytochrome p450 3a4 enzyme system  such as drug0 ( e.g.  drug0 and drug1 ) or macrolide drug0 ( e.g.  drug0 and drug2 )  may alter drug0 mean pharmacokinetic parameters ( i.e.  cmax and auc ) .,miconazole,clarithromycin,FALSE,none
other inhibitors of the cytochrome p450 3a4 enzyme system  such as drug0 ( e.g.  drug0 and drug1 ) or macrolide drug0 ( e.g.  drug0 and drug0 )  may alter drug2 mean pharmacokinetic parameters ( i.e.  cmax and auc ) .,miconazole,oxybutynin,TRUE,mechanism
other inhibitors of the cytochrome p450 3a4 enzyme system  such as drug0 ( e.g.  drug0 and drug0 ) or drug1 ( e.g.  drug2 and drug0 )  may alter drug0 mean pharmacokinetic parameters ( i.e.  cmax and auc ) .,macrolide antibiotics,erythromycin,FALSE,none
other inhibitors of the cytochrome p450 3a4 enzyme system  such as drug0 ( e.g.  drug0 and drug0 ) or drug1 ( e.g.  drug0 and drug2 )  may alter drug0 mean pharmacokinetic parameters ( i.e.  cmax and auc ) .,macrolide antibiotics,clarithromycin,FALSE,none
other inhibitors of the cytochrome p450 3a4 enzyme system  such as drug0 ( e.g.  drug0 and drug0 ) or drug1 ( e.g.  drug0 and drug0 )  may alter drug2 mean pharmacokinetic parameters ( i.e.  cmax and auc ) .,macrolide antibiotics,oxybutynin,TRUE,mechanism
other inhibitors of the cytochrome p450 3a4 enzyme system  such as drug0 ( e.g.  drug0 and drug0 ) or macrolide drug0 ( e.g.  drug1 and drug2 )  may alter drug0 mean pharmacokinetic parameters ( i.e.  cmax and auc ) .,erythromycin,clarithromycin,FALSE,none
other inhibitors of the cytochrome p450 3a4 enzyme system  such as drug0 ( e.g.  drug0 and drug0 ) or macrolide drug0 ( e.g.  drug1 and drug0 )  may alter drug2 mean pharmacokinetic parameters ( i.e.  cmax and auc ) .,erythromycin,oxybutynin,TRUE,mechanism
other inhibitors of the cytochrome p450 3a4 enzyme system  such as drug0 ( e.g.  drug0 and drug0 ) or macrolide drug0 ( e.g.  drug0 and drug1 )  may alter drug2 mean pharmacokinetic parameters ( i.e.  cmax and auc ) .,clarithromycin,oxybutynin,TRUE,mechanism
the drug0 effects of drug1 may be additive with that of other drug2..,oxycodone hydrochloride,cns depressants,TRUE,effect
the concomitant use of other drug1 including drug2  drug0  drug0  general drug0  drug0  other drug0  drug0 drug0  monoamine oxidase ( mao ) inhibitors  and drug0 may produce additive drug0 effects .,cns depressants,sedatives,FALSE,none
the concomitant use of other drug1 including drug0  drug2  drug0  general drug0  drug0  other drug0  drug0 drug0  monoamine oxidase ( mao ) inhibitors  and drug0 may produce additive drug0 effects .,cns depressants,hypnotics,FALSE,none
the concomitant use of other drug1 including drug0  drug0  drug2  general drug0  drug0  other drug0  drug0 drug0  monoamine oxidase ( mao ) inhibitors  and drug0 may produce additive drug0 effects .,cns depressants,tranquilizers,FALSE,none
the concomitant use of other drug1 including drug0  drug0  drug0  general drug2  drug0  other drug0  drug0 drug0  monoamine oxidase ( mao ) inhibitors  and drug0 may produce additive drug0 effects .,cns depressants,anesthetics,FALSE,none
the concomitant use of other drug1 including drug0  drug0  drug0  general drug0  drug2  other drug0  drug0 drug0  monoamine oxidase ( mao ) inhibitors  and drug0 may produce additive drug0 effects .,cns depressants,phenothiazines,FALSE,none
the concomitant use of other drug1 including drug0  drug0  drug0  general drug0  drug0  other drug2  drug0 drug0  monoamine oxidase ( mao ) inhibitors  and drug0 may produce additive drug0 effects .,cns depressants,opioids,FALSE,none
the concomitant use of other drug1 including drug0  drug0  drug0  general drug0  drug0  other drug0  drug2  monoamine oxidase ( mao ) inhibitors  and drug0 may produce additive drug0 effects .,cns depressants,tricyclic antidepressants,FALSE,none
the concomitant use of other drug1 including drug0  drug0  drug0  general drug0  drug0  other drug0  drug0 drug0  monoamine oxidase ( mao ) inhibitors  and drug0 may produce additive drug0 effects .,cns depressants,monoamine oxidase (mao) inhibitors,FALSE,none
the concomitant use of other drug1 including drug0  drug0  drug0  general drug0  drug0  other drug0  drug0 drug0  monoamine oxidase ( mao ) inhibitors  and drug2 may produce additive drug0 effects .,cns depressants,alcohol,FALSE,none
the concomitant use of other drug0 including drug1  drug0  drug0  general drug2  drug0  other drug0  drug0 drug0  monoamine oxidase ( mao ) inhibitors  and drug0 may produce additive drug0 effects .,sedatives,anesthetics,FALSE,none
the concomitant use of other drug0 including drug1  drug0  drug0  general drug0  drug0  other drug2  drug0 drug0  monoamine oxidase ( mao ) inhibitors  and drug0 may produce additive drug0 effects .,sedatives,opioids,FALSE,none
the concomitant use of other drug0 including drug1  drug0  drug0  general drug0  drug0  other drug0  drug0 drug0  monoamine oxidase ( mao ) inhibitors  and drug0 may produce additive drug0 effects .,sedatives,monoamine oxidase (mao) inhibitors,FALSE,none
the concomitant use of other drug0 including drug1  drug0  drug0  general drug0  drug0  other drug0  drug0 drug0  monoamine oxidase ( mao ) inhibitors  and drug2 may produce additive drug0 effects .,sedatives,alcohol,FALSE,none
the concomitant use of other drug0 including drug0  drug1  drug0  general drug2  drug0  other drug0  drug0 drug0  monoamine oxidase ( mao ) inhibitors  and drug0 may produce additive drug0 effects .,hypnotics,anesthetics,FALSE,none
the concomitant use of other drug0 including drug0  drug1  drug0  general drug0  drug0  other drug2  drug0 drug0  monoamine oxidase ( mao ) inhibitors  and drug0 may produce additive drug0 effects .,hypnotics,opioids,FALSE,none
the concomitant use of other drug0 including drug0  drug1  drug0  general drug0  drug0  other drug0  drug0 drug0  monoamine oxidase ( mao ) inhibitors  and drug0 may produce additive drug0 effects .,hypnotics,monoamine oxidase (mao) inhibitors,FALSE,none
the concomitant use of other drug0 including drug0  drug1  drug0  general drug0  drug0  other drug0  drug0 drug0  monoamine oxidase ( mao ) inhibitors  and drug2 may produce additive drug0 effects .,hypnotics,alcohol,FALSE,none
the concomitant use of other drug0 including drug0  drug0  drug1  general drug2  drug0  other drug0  drug0 drug0  monoamine oxidase ( mao ) inhibitors  and drug0 may produce additive drug0 effects .,tranquilizers,anesthetics,FALSE,none
the concomitant use of other drug0 including drug0  drug0  drug1  general drug0  drug0  other drug2  drug0 drug0  monoamine oxidase ( mao ) inhibitors  and drug0 may produce additive drug0 effects .,tranquilizers,opioids,FALSE,none
the concomitant use of other drug0 including drug0  drug0  drug1  general drug0  drug0  other drug0  drug0 drug0  monoamine oxidase ( mao ) inhibitors  and drug0 may produce additive drug0 effects .,tranquilizers,monoamine oxidase (mao) inhibitors,FALSE,none
the concomitant use of other drug0 including drug0  drug0  drug1  general drug0  drug0  other drug0  drug0 drug0  monoamine oxidase ( mao ) inhibitors  and drug2 may produce additive drug0 effects .,tranquilizers,alcohol,FALSE,none
the concomitant use of other drug0 including drug0  drug0  drug0  general drug1  drug0  other drug2  drug0 drug0  monoamine oxidase ( mao ) inhibitors  and drug0 may produce additive drug0 effects .,anesthetics,opioids,FALSE,none
the concomitant use of other drug0 including drug0  drug0  drug0  general drug1  drug0  other drug0  drug0 drug0  monoamine oxidase ( mao ) inhibitors  and drug0 may produce additive drug0 effects .,anesthetics,monoamine oxidase (mao) inhibitors,FALSE,none
the concomitant use of other drug0 including drug0  drug0  drug0  general drug1  drug0  other drug0  drug0 drug0  monoamine oxidase ( mao ) inhibitors  and drug2 may produce additive drug0 effects .,anesthetics,alcohol,FALSE,none
the concomitant use of other drug0 including drug0  drug0  drug0  general drug0  drug1  other drug2  drug0 drug0  monoamine oxidase ( mao ) inhibitors  and drug0 may produce additive drug0 effects .,phenothiazines,opioids,FALSE,none
the concomitant use of other drug0 including drug0  drug0  drug0  general drug0  drug1  other drug0  drug0 drug0  monoamine oxidase ( mao ) inhibitors  and drug0 may produce additive drug0 effects .,phenothiazines,monoamine oxidase (mao) inhibitors,FALSE,none
the concomitant use of other drug0 including drug0  drug0  drug0  general drug0  drug1  other drug0  drug0 drug0  monoamine oxidase ( mao ) inhibitors  and drug2 may produce additive drug0 effects .,phenothiazines,alcohol,FALSE,none
the concomitant use of other drug0 including drug0  drug0  drug0  general drug0  drug0  other drug1  drug0 drug0  monoamine oxidase ( mao ) inhibitors  and drug0 may produce additive drug0 effects .,opioids,monoamine oxidase (mao) inhibitors,FALSE,none
the concomitant use of other drug0 including drug0  drug0  drug0  general drug0  drug0  other drug1  drug0 drug0  monoamine oxidase ( mao ) inhibitors  and drug2 may produce additive drug0 effects .,opioids,alcohol,FALSE,none
the concomitant use of other drug0 including drug0  drug0  drug0  general drug0  drug0  other drug0  drug1  monoamine oxidase ( mao ) inhibitors  and drug0 may produce additive drug0 effects .,tricyclic antidepressants,monoamine oxidase (mao) inhibitors,FALSE,none
the concomitant use of other drug0 including drug0  drug0  drug0  general drug0  drug0  other drug0  drug1  monoamine oxidase ( mao ) inhibitors  and drug2 may produce additive drug0 effects .,tricyclic antidepressants,alcohol,FALSE,none
the concomitant use of other drug0 including drug0  drug0  drug0  general drug0  drug0  other drug0  drug0 drug0  monoamine oxidase ( mao ) inhibitors  and drug2 may produce additive drug0 effects .,monoamine oxidase (mao) inhibitors,alcohol,FALSE,none
drug1 or other medications with drug0 activity when used concurrently with drug2 may result in increased risk of urinary retention and/or severe constipation  which may lead to paralytic ileus .,anticholinergics,opioid analgesics,TRUE,effect
it has been reported that the incidence of bradycardia was increased when drug1 was combined with drug2 for induction of anesthesia .,oxymorphone,propofol,TRUE,effect
in addition  cns toxicity has been reported ( confusion  disorientation  respiratory depression  apnea  seizures ) following coadministration of drug1 with drug2 ;,cimetidine,opioid analgesics,TRUE,effect
potential for drug1 to affect other drugs drug2 is not expected to cause clinically important pharmacokinetic interactions with drugs that are metabolized by cytochrome p450 isozymes .,invega,paliperidone,FALSE,none
given the primary cns effects of drug1  drug0 should be used with caution in combination with other drug2 and drug0 .,paliperidone,centrally acting drugs,TRUE,advise
given the primary cns effects of drug1  drug0 should be used with caution in combination with other drug0 and drug2 .,paliperidone,alcohol,TRUE,advise
given the primary cns effects of drug0  drug1 should be used with caution in combination with other drug2 and drug0 .,invega,centrally acting drugs,TRUE,advise
given the primary cns effects of drug0  drug1 should be used with caution in combination with other drug0 and drug2 .,invega,alcohol,TRUE,advise
given the primary cns effects of drug0  drug0 should be used with caution in combination with other drug1 and drug2 .,centrally acting drugs,alcohol,FALSE,none
drug1 may antagonize the effect of drug2 and other drug0 .,paliperidone,levodopa,TRUE,effect
drug1 may antagonize the effect of drug0 and other drug2 .,paliperidone,dopamine agonists,TRUE,effect
drug0 may antagonize the effect of drug1 and other drug2 .,levodopa,dopamine agonists,FALSE,none
based on studies evaluating possible interactions of drug1 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug2  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  drug0  or drug0 .,pantoprazole,theophylline,FALSE,none
based on studies evaluating possible interactions of drug1 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug2  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  drug0  or drug0 .,pantoprazole,cisapride,FALSE,none
based on studies evaluating possible interactions of drug1 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug2  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  drug0  or drug0 .,pantoprazole,antipyrine,FALSE,none
based on studies evaluating possible interactions of drug1 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug2  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  drug0  or drug0 .,pantoprazole,caffeine,FALSE,none
based on studies evaluating possible interactions of drug1 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug2  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  drug0  or drug0 .,pantoprazole,carbamazepine,FALSE,none
based on studies evaluating possible interactions of drug1 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug2 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  drug0  or drug0 .,pantoprazole,diazepam,FALSE,none
based on studies evaluating possible interactions of drug1 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug2 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  drug0  or drug0 .,pantoprazole,desmethyldiazepam,FALSE,none
based on studies evaluating possible interactions of drug1 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug2  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  drug0  or drug0 .,pantoprazole,diclofenac,FALSE,none
based on studies evaluating possible interactions of drug1 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug2  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  drug0  or drug0 .,pantoprazole,naproxen,FALSE,none
based on studies evaluating possible interactions of drug1 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug2  drug0  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  drug0  or drug0 .,pantoprazole,piroxicam,FALSE,none
based on studies evaluating possible interactions of drug1 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug2  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  drug0  or drug0 .,pantoprazole,digoxin,FALSE,none
based on studies evaluating possible interactions of drug1 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug2  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  drug0  or drug0 .,pantoprazole,ethanol,FALSE,none
based on studies evaluating possible interactions of drug1 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug2  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  drug0  or drug0 .,pantoprazole,glyburide,FALSE,none
based on studies evaluating possible interactions of drug1 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug2 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  drug0  or drug0 .,pantoprazole,contraceptive,FALSE,none
based on studies evaluating possible interactions of drug1 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug2/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  drug0  or drug0 .,pantoprazole,levonorgestrel,FALSE,none
based on studies evaluating possible interactions of drug1 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/drug2 )  drug0  drug0  drug0  drug0  drug0  drug0  drug0  or drug0 .,pantoprazole,ethinyl estradiol,FALSE,none
based on studies evaluating possible interactions of drug1 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug2  drug0  drug0  drug0  drug0  drug0  drug0  or drug0 .,pantoprazole,metoprolol,FALSE,none
based on studies evaluating possible interactions of drug1 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug2  drug0  drug0  drug0  drug0  drug0  or drug0 .,pantoprazole,nifedipine,FALSE,none
based on studies evaluating possible interactions of drug1 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug2  drug0  drug0  drug0  drug0  or drug0 .,pantoprazole,phenytoin,FALSE,none
based on studies evaluating possible interactions of drug1 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug2  drug0  drug0  drug0  or drug0 .,pantoprazole,warfarin,FALSE,none
based on studies evaluating possible interactions of drug1 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug2  drug0  drug0  or drug0 .,pantoprazole,midazolam,FALSE,none
based on studies evaluating possible interactions of drug1 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug2  drug0  or drug0 .,pantoprazole,clarithromycin,FALSE,none
based on studies evaluating possible interactions of drug1 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  drug2  or drug0 .,pantoprazole,metronidazole,FALSE,none
based on studies evaluating possible interactions of drug1 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  drug0  or drug2 .,pantoprazole,amoxicillin,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug1  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug2 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  drug0  or drug0 .,theophylline,desmethyldiazepam,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug1  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug2  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  drug0  or drug0 .,theophylline,diclofenac,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug1  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug2  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  drug0  or drug0 .,theophylline,naproxen,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug1  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug2  drug0  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  drug0  or drug0 .,theophylline,piroxicam,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug1  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug2  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  drug0  or drug0 .,theophylline,digoxin,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug1  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug2  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  drug0  or drug0 .,theophylline,ethanol,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug1  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug2  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  drug0  or drug0 .,theophylline,glyburide,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug1  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug2 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  drug0  or drug0 .,theophylline,contraceptive,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug1  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug2/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  drug0  or drug0 .,theophylline,levonorgestrel,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug1  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/drug2 )  drug0  drug0  drug0  drug0  drug0  drug0  drug0  or drug0 .,theophylline,ethinyl estradiol,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug1  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug2  drug0  drug0  drug0  drug0  drug0  drug0  or drug0 .,theophylline,metoprolol,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug1  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug2  drug0  drug0  drug0  drug0  drug0  or drug0 .,theophylline,nifedipine,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug1  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug2  drug0  drug0  drug0  drug0  or drug0 .,theophylline,phenytoin,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug1  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug2  drug0  drug0  drug0  or drug0 .,theophylline,warfarin,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug1  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug2  drug0  drug0  or drug0 .,theophylline,midazolam,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug1  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug2  drug0  or drug0 .,theophylline,clarithromycin,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug1  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  drug2  or drug0 .,theophylline,metronidazole,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug1  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  drug0  or drug2 .,theophylline,amoxicillin,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug1  drug0  drug0  drug0  drug0 ( and its active metabolite  drug2 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  drug0  or drug0 .,cisapride,desmethyldiazepam,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug1  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug2  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  drug0  or drug0 .,cisapride,diclofenac,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug1  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug2  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  drug0  or drug0 .,cisapride,naproxen,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug1  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug2  drug0  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  drug0  or drug0 .,cisapride,piroxicam,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug1  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug2  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  drug0  or drug0 .,cisapride,digoxin,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug1  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug2  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  drug0  or drug0 .,cisapride,ethanol,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug1  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug2  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  drug0  or drug0 .,cisapride,glyburide,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug1  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug2 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  drug0  or drug0 .,cisapride,contraceptive,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug1  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug2/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  drug0  or drug0 .,cisapride,levonorgestrel,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug1  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/drug2 )  drug0  drug0  drug0  drug0  drug0  drug0  drug0  or drug0 .,cisapride,ethinyl estradiol,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug1  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug2  drug0  drug0  drug0  drug0  drug0  drug0  or drug0 .,cisapride,metoprolol,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug1  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug2  drug0  drug0  drug0  drug0  drug0  or drug0 .,cisapride,nifedipine,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug1  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug2  drug0  drug0  drug0  drug0  or drug0 .,cisapride,phenytoin,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug1  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug2  drug0  drug0  drug0  or drug0 .,cisapride,warfarin,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug1  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug2  drug0  drug0  or drug0 .,cisapride,midazolam,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug1  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug2  drug0  or drug0 .,cisapride,clarithromycin,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug1  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  drug2  or drug0 .,cisapride,metronidazole,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug1  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  drug0  or drug2 .,cisapride,amoxicillin,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug1  drug0  drug0  drug0 ( and its active metabolite  drug2 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  drug0  or drug0 .,antipyrine,desmethyldiazepam,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug1  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug2  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  drug0  or drug0 .,antipyrine,diclofenac,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug1  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug2  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  drug0  or drug0 .,antipyrine,naproxen,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug1  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug2  drug0  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  drug0  or drug0 .,antipyrine,piroxicam,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug1  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug2  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  drug0  or drug0 .,antipyrine,digoxin,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug1  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug2  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  drug0  or drug0 .,antipyrine,ethanol,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug1  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug2  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  drug0  or drug0 .,antipyrine,glyburide,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug1  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug2 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  drug0  or drug0 .,antipyrine,contraceptive,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug1  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug2/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  drug0  or drug0 .,antipyrine,levonorgestrel,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug1  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/drug2 )  drug0  drug0  drug0  drug0  drug0  drug0  drug0  or drug0 .,antipyrine,ethinyl estradiol,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug1  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug2  drug0  drug0  drug0  drug0  drug0  drug0  or drug0 .,antipyrine,metoprolol,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug1  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug2  drug0  drug0  drug0  drug0  drug0  or drug0 .,antipyrine,nifedipine,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug1  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug2  drug0  drug0  drug0  drug0  or drug0 .,antipyrine,phenytoin,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug1  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug2  drug0  drug0  drug0  or drug0 .,antipyrine,warfarin,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug1  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug2  drug0  drug0  or drug0 .,antipyrine,midazolam,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug1  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug2  drug0  or drug0 .,antipyrine,clarithromycin,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug1  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  drug2  or drug0 .,antipyrine,metronidazole,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug1  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  drug0  or drug2 .,antipyrine,amoxicillin,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug1  drug0  drug0 ( and its active metabolite  drug2 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  drug0  or drug0 .,caffeine,desmethyldiazepam,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug1  drug0  drug0 ( and its active metabolite  drug0 )  drug2  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  drug0  or drug0 .,caffeine,diclofenac,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug1  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug2  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  drug0  or drug0 .,caffeine,naproxen,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug1  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug2  drug0  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  drug0  or drug0 .,caffeine,piroxicam,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug1  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug2  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  drug0  or drug0 .,caffeine,digoxin,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug1  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug2  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  drug0  or drug0 .,caffeine,ethanol,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug1  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug2  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  drug0  or drug0 .,caffeine,glyburide,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug1  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug2 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  drug0  or drug0 .,caffeine,contraceptive,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug1  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug2/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  drug0  or drug0 .,caffeine,levonorgestrel,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug1  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/drug2 )  drug0  drug0  drug0  drug0  drug0  drug0  drug0  or drug0 .,caffeine,ethinyl estradiol,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug1  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug2  drug0  drug0  drug0  drug0  drug0  drug0  or drug0 .,caffeine,metoprolol,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug1  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug2  drug0  drug0  drug0  drug0  drug0  or drug0 .,caffeine,nifedipine,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug1  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug2  drug0  drug0  drug0  drug0  or drug0 .,caffeine,phenytoin,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug1  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug2  drug0  drug0  drug0  or drug0 .,caffeine,warfarin,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug1  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug2  drug0  drug0  or drug0 .,caffeine,midazolam,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug1  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug2  drug0  or drug0 .,caffeine,clarithromycin,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug1  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  drug2  or drug0 .,caffeine,metronidazole,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug1  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  drug0  or drug2 .,caffeine,amoxicillin,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug1  drug0 ( and its active metabolite  drug2 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  drug0  or drug0 .,carbamazepine,desmethyldiazepam,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug1  drug0 ( and its active metabolite  drug0 )  drug2  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  drug0  or drug0 .,carbamazepine,diclofenac,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug1  drug0 ( and its active metabolite  drug0 )  drug0  drug2  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  drug0  or drug0 .,carbamazepine,naproxen,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug1  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug2  drug0  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  drug0  or drug0 .,carbamazepine,piroxicam,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug1  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug2  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  drug0  or drug0 .,carbamazepine,digoxin,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug1  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug2  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  drug0  or drug0 .,carbamazepine,ethanol,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug1  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug2  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  drug0  or drug0 .,carbamazepine,glyburide,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug1  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug2 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  drug0  or drug0 .,carbamazepine,contraceptive,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug1  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug2/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  drug0  or drug0 .,carbamazepine,levonorgestrel,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug1  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/drug2 )  drug0  drug0  drug0  drug0  drug0  drug0  drug0  or drug0 .,carbamazepine,ethinyl estradiol,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug1  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug2  drug0  drug0  drug0  drug0  drug0  drug0  or drug0 .,carbamazepine,metoprolol,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug1  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug2  drug0  drug0  drug0  drug0  drug0  or drug0 .,carbamazepine,nifedipine,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug1  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug2  drug0  drug0  drug0  drug0  or drug0 .,carbamazepine,phenytoin,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug1  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug2  drug0  drug0  drug0  or drug0 .,carbamazepine,warfarin,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug1  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug2  drug0  drug0  or drug0 .,carbamazepine,midazolam,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug1  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug2  drug0  or drug0 .,carbamazepine,clarithromycin,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug1  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  drug2  or drug0 .,carbamazepine,metronidazole,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug1  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  drug0  or drug2 .,carbamazepine,amoxicillin,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug1 ( and its active metabolite  drug2 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  drug0  or drug0 .,diazepam,desmethyldiazepam,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug1 ( and its active metabolite  drug0 )  drug2  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  drug0  or drug0 .,diazepam,diclofenac,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug1 ( and its active metabolite  drug0 )  drug0  drug2  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  drug0  or drug0 .,diazepam,naproxen,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug1 ( and its active metabolite  drug0 )  drug0  drug0  drug2  drug0  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  drug0  or drug0 .,diazepam,piroxicam,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug1 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug2  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  drug0  or drug0 .,diazepam,digoxin,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug1 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug2  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  drug0  or drug0 .,diazepam,ethanol,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug1 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug2  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  drug0  or drug0 .,diazepam,glyburide,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug1 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug2 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  drug0  or drug0 .,diazepam,contraceptive,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug1 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug2/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  drug0  or drug0 .,diazepam,levonorgestrel,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug1 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/drug2 )  drug0  drug0  drug0  drug0  drug0  drug0  drug0  or drug0 .,diazepam,ethinyl estradiol,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug1 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug2  drug0  drug0  drug0  drug0  drug0  drug0  or drug0 .,diazepam,metoprolol,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug1 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug2  drug0  drug0  drug0  drug0  drug0  or drug0 .,diazepam,nifedipine,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug1 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug2  drug0  drug0  drug0  drug0  or drug0 .,diazepam,phenytoin,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug1 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug2  drug0  drug0  drug0  or drug0 .,diazepam,warfarin,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug1 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug2  drug0  drug0  or drug0 .,diazepam,midazolam,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug1 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug2  drug0  or drug0 .,diazepam,clarithromycin,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug1 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  drug2  or drug0 .,diazepam,metronidazole,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug1 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  drug0  or drug2 .,diazepam,amoxicillin,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug1 )  drug2  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  drug0  or drug0 .,desmethyldiazepam,diclofenac,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug1 )  drug0  drug2  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  drug0  or drug0 .,desmethyldiazepam,naproxen,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug1 )  drug0  drug0  drug2  drug0  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  drug0  or drug0 .,desmethyldiazepam,piroxicam,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug1 )  drug0  drug0  drug0  drug2  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  drug0  or drug0 .,desmethyldiazepam,digoxin,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug1 )  drug0  drug0  drug0  drug0  drug2  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  drug0  or drug0 .,desmethyldiazepam,ethanol,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug1 )  drug0  drug0  drug0  drug0  drug0  drug2  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  drug0  or drug0 .,desmethyldiazepam,glyburide,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug1 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug2 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  drug0  or drug0 .,desmethyldiazepam,contraceptive,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug1 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug2/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  drug0  or drug0 .,desmethyldiazepam,levonorgestrel,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug1 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/drug2 )  drug0  drug0  drug0  drug0  drug0  drug0  drug0  or drug0 .,desmethyldiazepam,ethinyl estradiol,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug1 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug2  drug0  drug0  drug0  drug0  drug0  drug0  or drug0 .,desmethyldiazepam,metoprolol,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug1 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug2  drug0  drug0  drug0  drug0  drug0  or drug0 .,desmethyldiazepam,nifedipine,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug1 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug2  drug0  drug0  drug0  drug0  or drug0 .,desmethyldiazepam,phenytoin,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug1 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug2  drug0  drug0  drug0  or drug0 .,desmethyldiazepam,warfarin,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug1 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug2  drug0  drug0  or drug0 .,desmethyldiazepam,midazolam,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug1 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug2  drug0  or drug0 .,desmethyldiazepam,clarithromycin,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug1 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  drug2  or drug0 .,desmethyldiazepam,metronidazole,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug1 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  drug0  or drug2 .,desmethyldiazepam,amoxicillin,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug1  drug0  drug0  drug0  drug0  drug0  an oral drug2 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  drug0  or drug0 .,diclofenac,contraceptive,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug1  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug2/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  drug0  or drug0 .,diclofenac,levonorgestrel,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug1  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/drug2 )  drug0  drug0  drug0  drug0  drug0  drug0  drug0  or drug0 .,diclofenac,ethinyl estradiol,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug1  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug2  drug0  drug0  drug0  drug0  drug0  drug0  or drug0 .,diclofenac,metoprolol,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug1  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug2  drug0  drug0  drug0  drug0  drug0  or drug0 .,diclofenac,nifedipine,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug1  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug2  drug0  drug0  drug0  drug0  or drug0 .,diclofenac,phenytoin,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug1  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug2  drug0  drug0  drug0  or drug0 .,diclofenac,warfarin,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug1  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug2  drug0  drug0  or drug0 .,diclofenac,midazolam,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug1  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug2  drug0  or drug0 .,diclofenac,clarithromycin,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug1  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  drug2  or drug0 .,diclofenac,metronidazole,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug1  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  drug0  or drug2 .,diclofenac,amoxicillin,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug1  drug0  drug0  drug0  drug0  an oral drug2 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  drug0  or drug0 .,naproxen,contraceptive,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug1  drug0  drug0  drug0  drug0  an oral drug0 ( drug2/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  drug0  or drug0 .,naproxen,levonorgestrel,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug1  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/drug2 )  drug0  drug0  drug0  drug0  drug0  drug0  drug0  or drug0 .,naproxen,ethinyl estradiol,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug1  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug2  drug0  drug0  drug0  drug0  drug0  drug0  or drug0 .,naproxen,metoprolol,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug1  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug2  drug0  drug0  drug0  drug0  drug0  or drug0 .,naproxen,nifedipine,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug1  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug2  drug0  drug0  drug0  drug0  or drug0 .,naproxen,phenytoin,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug1  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug2  drug0  drug0  drug0  or drug0 .,naproxen,warfarin,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug1  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug2  drug0  drug0  or drug0 .,naproxen,midazolam,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug1  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug2  drug0  or drug0 .,naproxen,clarithromycin,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug1  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  drug2  or drug0 .,naproxen,metronidazole,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug1  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  drug0  or drug2 .,naproxen,amoxicillin,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug1  drug0  drug0  drug0  an oral drug2 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  drug0  or drug0 .,piroxicam,contraceptive,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug1  drug0  drug0  drug0  an oral drug0 ( drug2/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  drug0  or drug0 .,piroxicam,levonorgestrel,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug1  drug0  drug0  drug0  an oral drug0 ( drug0/drug2 )  drug0  drug0  drug0  drug0  drug0  drug0  drug0  or drug0 .,piroxicam,ethinyl estradiol,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug1  drug0  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug2  drug0  drug0  drug0  drug0  drug0  drug0  or drug0 .,piroxicam,metoprolol,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug1  drug0  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug2  drug0  drug0  drug0  drug0  drug0  or drug0 .,piroxicam,nifedipine,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug1  drug0  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug2  drug0  drug0  drug0  drug0  or drug0 .,piroxicam,phenytoin,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug1  drug0  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug2  drug0  drug0  drug0  or drug0 .,piroxicam,warfarin,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug1  drug0  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug2  drug0  drug0  or drug0 .,piroxicam,midazolam,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug1  drug0  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug2  drug0  or drug0 .,piroxicam,clarithromycin,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug1  drug0  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  drug2  or drug0 .,piroxicam,metronidazole,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug1  drug0  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  drug0  or drug2 .,piroxicam,amoxicillin,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug1  drug0  drug0  an oral drug2 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  drug0  or drug0 .,digoxin,contraceptive,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug1  drug0  drug0  an oral drug0 ( drug2/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  drug0  or drug0 .,digoxin,levonorgestrel,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug1  drug0  drug0  an oral drug0 ( drug0/drug2 )  drug0  drug0  drug0  drug0  drug0  drug0  drug0  or drug0 .,digoxin,ethinyl estradiol,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug1  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug2  drug0  drug0  drug0  drug0  drug0  drug0  or drug0 .,digoxin,metoprolol,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug1  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug2  drug0  drug0  drug0  drug0  drug0  or drug0 .,digoxin,nifedipine,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug1  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug2  drug0  drug0  drug0  drug0  or drug0 .,digoxin,phenytoin,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug1  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug2  drug0  drug0  drug0  or drug0 .,digoxin,warfarin,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug1  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug2  drug0  drug0  or drug0 .,digoxin,midazolam,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug1  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug2  drug0  or drug0 .,digoxin,clarithromycin,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug1  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  drug2  or drug0 .,digoxin,metronidazole,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug1  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  drug0  or drug2 .,digoxin,amoxicillin,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug1  drug0  an oral drug2 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  drug0  or drug0 .,ethanol,contraceptive,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug1  drug0  an oral drug0 ( drug2/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  drug0  or drug0 .,ethanol,levonorgestrel,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug1  drug0  an oral drug0 ( drug0/drug2 )  drug0  drug0  drug0  drug0  drug0  drug0  drug0  or drug0 .,ethanol,ethinyl estradiol,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug1  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug2  drug0  drug0  drug0  drug0  drug0  drug0  or drug0 .,ethanol,metoprolol,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug1  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug2  drug0  drug0  drug0  drug0  drug0  or drug0 .,ethanol,nifedipine,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug1  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug2  drug0  drug0  drug0  drug0  or drug0 .,ethanol,phenytoin,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug1  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug2  drug0  drug0  drug0  or drug0 .,ethanol,warfarin,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug1  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug2  drug0  drug0  or drug0 .,ethanol,midazolam,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug1  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug2  drug0  or drug0 .,ethanol,clarithromycin,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug1  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  drug2  or drug0 .,ethanol,metronidazole,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug1  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  drug0  or drug2 .,ethanol,amoxicillin,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug1  an oral drug2 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  drug0  or drug0 .,glyburide,contraceptive,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug1  an oral drug0 ( drug2/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  drug0  or drug0 .,glyburide,levonorgestrel,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug1  an oral drug0 ( drug0/drug2 )  drug0  drug0  drug0  drug0  drug0  drug0  drug0  or drug0 .,glyburide,ethinyl estradiol,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug1  an oral drug0 ( drug0/ethinyl drug0 )  drug2  drug0  drug0  drug0  drug0  drug0  drug0  or drug0 .,glyburide,metoprolol,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug1  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug2  drug0  drug0  drug0  drug0  drug0  or drug0 .,glyburide,nifedipine,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug1  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug2  drug0  drug0  drug0  drug0  or drug0 .,glyburide,phenytoin,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug1  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug2  drug0  drug0  drug0  or drug0 .,glyburide,warfarin,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug1  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug2  drug0  drug0  or drug0 .,glyburide,midazolam,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug1  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug2  drug0  or drug0 .,glyburide,clarithromycin,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug1  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  drug2  or drug0 .,glyburide,metronidazole,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug1  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  drug0  or drug2 .,glyburide,amoxicillin,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug1 ( drug2/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  drug0  or drug0 .,contraceptive,levonorgestrel,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug1 ( drug0/drug2 )  drug0  drug0  drug0  drug0  drug0  drug0  drug0  or drug0 .,contraceptive,ethinyl estradiol,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug1 ( drug0/ethinyl drug0 )  drug2  drug0  drug0  drug0  drug0  drug0  drug0  or drug0 .,contraceptive,metoprolol,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug1 ( drug0/ethinyl drug0 )  drug0  drug2  drug0  drug0  drug0  drug0  drug0  or drug0 .,contraceptive,nifedipine,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug1 ( drug0/ethinyl drug0 )  drug0  drug0  drug2  drug0  drug0  drug0  drug0  or drug0 .,contraceptive,phenytoin,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug1 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug2  drug0  drug0  drug0  or drug0 .,contraceptive,warfarin,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug1 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug2  drug0  drug0  or drug0 .,contraceptive,midazolam,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug1 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug2  drug0  or drug0 .,contraceptive,clarithromycin,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug1 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  drug2  or drug0 .,contraceptive,metronidazole,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug1 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  drug0  or drug2 .,contraceptive,amoxicillin,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug1/drug2 )  drug0  drug0  drug0  drug0  drug0  drug0  drug0  or drug0 .,levonorgestrel,ethinyl estradiol,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug1/ethinyl drug0 )  drug2  drug0  drug0  drug0  drug0  drug0  drug0  or drug0 .,levonorgestrel,metoprolol,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug1/ethinyl drug0 )  drug0  drug2  drug0  drug0  drug0  drug0  drug0  or drug0 .,levonorgestrel,nifedipine,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug1/ethinyl drug0 )  drug0  drug0  drug2  drug0  drug0  drug0  drug0  or drug0 .,levonorgestrel,phenytoin,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug1/ethinyl drug0 )  drug0  drug0  drug0  drug2  drug0  drug0  drug0  or drug0 .,levonorgestrel,warfarin,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug1/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug2  drug0  drug0  or drug0 .,levonorgestrel,midazolam,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug1/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug2  drug0  or drug0 .,levonorgestrel,clarithromycin,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug1/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  drug2  or drug0 .,levonorgestrel,metronidazole,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug1/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  drug0  or drug2 .,levonorgestrel,amoxicillin,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/drug1 )  drug2  drug0  drug0  drug0  drug0  drug0  drug0  or drug0 .,ethinyl estradiol,metoprolol,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/drug1 )  drug0  drug2  drug0  drug0  drug0  drug0  drug0  or drug0 .,ethinyl estradiol,nifedipine,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/drug1 )  drug0  drug0  drug2  drug0  drug0  drug0  drug0  or drug0 .,ethinyl estradiol,phenytoin,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/drug1 )  drug0  drug0  drug0  drug2  drug0  drug0  drug0  or drug0 .,ethinyl estradiol,warfarin,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/drug1 )  drug0  drug0  drug0  drug0  drug2  drug0  drug0  or drug0 .,ethinyl estradiol,midazolam,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/drug1 )  drug0  drug0  drug0  drug0  drug0  drug2  drug0  or drug0 .,ethinyl estradiol,clarithromycin,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/drug1 )  drug0  drug0  drug0  drug0  drug0  drug0  drug2  or drug0 .,ethinyl estradiol,metronidazole,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/drug1 )  drug0  drug0  drug0  drug0  drug0  drug0  drug0  or drug2 .,ethinyl estradiol,amoxicillin,FALSE,none
based on studies evaluating possible interactions of drug0 with other drugs  no dosage adjustment is needed with concomitant use of the following : drug0  drug0  drug0  drug0  drug0  drug0 ( and its active metabolite  drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  an oral drug0 ( drug0/ethinyl drug0 )  drug0  drug0  drug0  drug0  drug0  drug0  drug1  or drug2 .,metronidazole,amoxicillin,FALSE,none
there have been postmarketing reports of increased inr and prothrombin time in patients receiving drug1  including drug2  and drug0 concomitantly .,proton pump inhibitors,pantoprazole,FALSE,none
there have been postmarketing reports of increased inr and prothrombin time in patients receiving drug1  including drug0  and drug2 concomitantly .,proton pump inhibitors,warfarin,TRUE,effect
there have been postmarketing reports of increased inr and prothrombin time in patients receiving drug0  including drug1  and drug2 concomitantly .,pantoprazole,warfarin,TRUE,effect
patients treated with drug1 and drug2 concomitantly should be monitored for increases in inr and prothrombin time .,proton pump inhibitors,warfarin,TRUE,advise
because of profound and long lasting inhibition of gastric acid secretion  drug1 may interfere with absorption of drugs where gastric ph is an important determinant of their bioavailability ( eg  drug2  drug0 esters  and drug0 salts ) .,pantoprazole,ketoconazole,TRUE,mechanism
because of profound and long lasting inhibition of gastric acid secretion  drug1 may interfere with absorption of drugs where gastric ph is an important determinant of their bioavailability ( eg  drug0  drug2 esters  and drug0 salts ) .,pantoprazole,ampicillin,TRUE,mechanism
because of profound and long lasting inhibition of gastric acid secretion  drug1 may interfere with absorption of drugs where gastric ph is an important determinant of their bioavailability ( eg  drug0  drug0 esters  and drug2 salts ) .,pantoprazole,iron,TRUE,mechanism
because of profound and long lasting inhibition of gastric acid secretion  drug0 may interfere with absorption of drugs where gastric ph is an important determinant of their bioavailability ( eg  drug1  drug0 esters  and drug2 salts ) .,ketoconazole,iron,FALSE,none
because of profound and long lasting inhibition of gastric acid secretion  drug0 may interfere with absorption of drugs where gastric ph is an important determinant of their bioavailability ( eg  drug0  drug1 esters  and drug2 salts ) .,ampicillin,iron,FALSE,none
laboratory tests there have been reports of false-positive urine screening tests for drug1 ( drug0 ) in patients receiving most drug2  including drug0 .,tetrahydrocannabinol,proton pump inhibitors,FALSE,none
laboratory tests there have been reports of false-positive urine screening tests for drug1 ( drug0 ) in patients receiving most drug0  including drug2 .,tetrahydrocannabinol,pantoprazole,FALSE,none
laboratory tests there have been reports of false-positive urine screening tests for drug0 ( drug1 ) in patients receiving most drug2  including drug0 .,thc,proton pump inhibitors,FALSE,none
laboratory tests there have been reports of false-positive urine screening tests for drug0 ( drug1 ) in patients receiving most drug0  including drug2 .,thc,pantoprazole,FALSE,none
laboratory tests there have been reports of false-positive urine screening tests for drug0 ( drug0 ) in patients receiving most drug1  including drug2 .,proton pump inhibitors,pantoprazole,FALSE,none
a multiple dose drug-drug interaction study demonstrated that drug1 approximately doubled drug2 auc0- . since drug0 is partially metabolized by cyp3a and drug0 le is known to be a strong inhibitor of cytochrome p450 3a enzyme  care should be taken while dosing drug0 with drug0 and other strong p450 3a inhibitors including drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0 or drug0 .,ketoconazole,paricalcitol,TRUE,mechanism
a multiple dose drug-drug interaction study demonstrated that drug1 approximately doubled drug2 auc0- . since drug0 is partially metabolized by cyp3a and drug0 le is known to be a strong inhibitor of cytochrome p450 3a enzyme  care should be taken while dosing drug0 with drug0 and other strong p450 3a inhibitors including drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0 or drug0 .,ketoconazole,paricalcitol,FALSE,none
a multiple dose drug-drug interaction study demonstrated that drug1 approximately doubled drug2 auc0- . since drug0 is partially metabolized by cyp3a and drug0 le is known to be a strong inhibitor of cytochrome p450 3a enzyme  care should be taken while dosing drug0 with drug0 and other strong p450 3a inhibitors including drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0 or drug0 .,ketoconazole,paricalcitol,FALSE,none
a multiple dose drug-drug interaction study demonstrated that drug1 approximately doubled drug0 auc0- . since drug0 is partially metabolized by cyp3a and drug0 le is known to be a strong inhibitor of cytochrome p450 3a enzyme  care should be taken while dosing drug0 with drug0 and other strong p450 3a inhibitors including drug2  drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0 or drug0 .,ketoconazole,atazanavir,FALSE,none
a multiple dose drug-drug interaction study demonstrated that drug1 approximately doubled drug0 auc0- . since drug0 is partially metabolized by cyp3a and drug0 le is known to be a strong inhibitor of cytochrome p450 3a enzyme  care should be taken while dosing drug0 with drug0 and other strong p450 3a inhibitors including drug0  drug2  drug0  drug0  drug0  drug0  drug0  drug0  drug0 or drug0 .,ketoconazole,clarithromycin,FALSE,none
a multiple dose drug-drug interaction study demonstrated that drug1 approximately doubled drug0 auc0- . since drug0 is partially metabolized by cyp3a and drug0 le is known to be a strong inhibitor of cytochrome p450 3a enzyme  care should be taken while dosing drug0 with drug0 and other strong p450 3a inhibitors including drug0  drug0  drug2  drug0  drug0  drug0  drug0  drug0  drug0 or drug0 .,ketoconazole,indinavir,FALSE,none
a multiple dose drug-drug interaction study demonstrated that drug1 approximately doubled drug0 auc0- . since drug0 is partially metabolized by cyp3a and drug0 le is known to be a strong inhibitor of cytochrome p450 3a enzyme  care should be taken while dosing drug0 with drug0 and other strong p450 3a inhibitors including drug0  drug0  drug0  drug2  drug0  drug0  drug0  drug0  drug0 or drug0 .,ketoconazole,itraconazole,FALSE,none
a multiple dose drug-drug interaction study demonstrated that drug1 approximately doubled drug0 auc0- . since drug0 is partially metabolized by cyp3a and drug0 le is known to be a strong inhibitor of cytochrome p450 3a enzyme  care should be taken while dosing drug0 with drug0 and other strong p450 3a inhibitors including drug0  drug0  drug0  drug0  drug2  drug0  drug0  drug0  drug0 or drug0 .,ketoconazole,nefazodone,FALSE,none
a multiple dose drug-drug interaction study demonstrated that drug1 approximately doubled drug0 auc0- . since drug0 is partially metabolized by cyp3a and drug0 le is known to be a strong inhibitor of cytochrome p450 3a enzyme  care should be taken while dosing drug0 with drug0 and other strong p450 3a inhibitors including drug0  drug0  drug0  drug0  drug0  drug2  drug0  drug0  drug0 or drug0 .,ketoconazole,nelfinavir,FALSE,none
a multiple dose drug-drug interaction study demonstrated that drug1 approximately doubled drug0 auc0- . since drug0 is partially metabolized by cyp3a and drug0 le is known to be a strong inhibitor of cytochrome p450 3a enzyme  care should be taken while dosing drug0 with drug0 and other strong p450 3a inhibitors including drug0  drug0  drug0  drug0  drug0  drug0  drug2  drug0  drug0 or drug0 .,ketoconazole,ritonavir,FALSE,none
a multiple dose drug-drug interaction study demonstrated that drug1 approximately doubled drug0 auc0- . since drug0 is partially metabolized by cyp3a and drug0 le is known to be a strong inhibitor of cytochrome p450 3a enzyme  care should be taken while dosing drug0 with drug0 and other strong p450 3a inhibitors including drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug2  drug0 or drug0 .,ketoconazole,saquinavir,FALSE,none
a multiple dose drug-drug interaction study demonstrated that drug1 approximately doubled drug0 auc0- . since drug0 is partially metabolized by cyp3a and drug0 le is known to be a strong inhibitor of cytochrome p450 3a enzyme  care should be taken while dosing drug0 with drug0 and other strong p450 3a inhibitors including drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug2 or drug0 .,ketoconazole,telithromycin,FALSE,none
a multiple dose drug-drug interaction study demonstrated that drug1 approximately doubled drug0 auc0- . since drug0 is partially metabolized by cyp3a and drug0 le is known to be a strong inhibitor of cytochrome p450 3a enzyme  care should be taken while dosing drug0 with drug0 and other strong p450 3a inhibitors including drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0 or drug2 .,ketoconazole,voriconazole,FALSE,none
a multiple dose drug-drug interaction study demonstrated that drug2 approximately doubled drug1 auc0- . since drug0 is partially metabolized by cyp3a and drug0 le is known to be a strong inhibitor of cytochrome p450 3a enzyme  care should be taken while dosing drug0 with drug0 and other strong p450 3a inhibitors including drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0 or drug0 .,paricalcitol,ketoconazole,FALSE,none
a multiple dose drug-drug interaction study demonstrated that drug2 approximately doubled drug1 auc0- . since drug0 is partially metabolized by cyp3a and drug0 le is known to be a strong inhibitor of cytochrome p450 3a enzyme  care should be taken while dosing drug0 with drug0 and other strong p450 3a inhibitors including drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0 or drug0 .,paricalcitol,ketoconazole,FALSE,none
a multiple dose drug-drug interaction study demonstrated that drug0 approximately doubled drug1 auc0- . since drug0 is partially metabolized by cyp3a and drug0 le is known to be a strong inhibitor of cytochrome p450 3a enzyme  care should be taken while dosing drug0 with drug0 and other strong p450 3a inhibitors including drug2  drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0 or drug0 .,paricalcitol,atazanavir,FALSE,none
a multiple dose drug-drug interaction study demonstrated that drug0 approximately doubled drug1 auc0- . since drug0 is partially metabolized by cyp3a and drug0 le is known to be a strong inhibitor of cytochrome p450 3a enzyme  care should be taken while dosing drug0 with drug0 and other strong p450 3a inhibitors including drug0  drug2  drug0  drug0  drug0  drug0  drug0  drug0  drug0 or drug0 .,paricalcitol,clarithromycin,FALSE,none
a multiple dose drug-drug interaction study demonstrated that drug0 approximately doubled drug1 auc0- . since drug0 is partially metabolized by cyp3a and drug0 le is known to be a strong inhibitor of cytochrome p450 3a enzyme  care should be taken while dosing drug0 with drug0 and other strong p450 3a inhibitors including drug0  drug0  drug2  drug0  drug0  drug0  drug0  drug0  drug0 or drug0 .,paricalcitol,indinavir,FALSE,none
a multiple dose drug-drug interaction study demonstrated that drug0 approximately doubled drug1 auc0- . since drug0 is partially metabolized by cyp3a and drug0 le is known to be a strong inhibitor of cytochrome p450 3a enzyme  care should be taken while dosing drug0 with drug0 and other strong p450 3a inhibitors including drug0  drug0  drug0  drug2  drug0  drug0  drug0  drug0  drug0 or drug0 .,paricalcitol,itraconazole,FALSE,none
a multiple dose drug-drug interaction study demonstrated that drug0 approximately doubled drug1 auc0- . since drug0 is partially metabolized by cyp3a and drug0 le is known to be a strong inhibitor of cytochrome p450 3a enzyme  care should be taken while dosing drug0 with drug0 and other strong p450 3a inhibitors including drug0  drug0  drug0  drug0  drug2  drug0  drug0  drug0  drug0 or drug0 .,paricalcitol,nefazodone,FALSE,none
a multiple dose drug-drug interaction study demonstrated that drug0 approximately doubled drug1 auc0- . since drug0 is partially metabolized by cyp3a and drug0 le is known to be a strong inhibitor of cytochrome p450 3a enzyme  care should be taken while dosing drug0 with drug0 and other strong p450 3a inhibitors including drug0  drug0  drug0  drug0  drug0  drug2  drug0  drug0  drug0 or drug0 .,paricalcitol,nelfinavir,FALSE,none
a multiple dose drug-drug interaction study demonstrated that drug0 approximately doubled drug1 auc0- . since drug0 is partially metabolized by cyp3a and drug0 le is known to be a strong inhibitor of cytochrome p450 3a enzyme  care should be taken while dosing drug0 with drug0 and other strong p450 3a inhibitors including drug0  drug0  drug0  drug0  drug0  drug0  drug2  drug0  drug0 or drug0 .,paricalcitol,ritonavir,FALSE,none
a multiple dose drug-drug interaction study demonstrated that drug0 approximately doubled drug1 auc0- . since drug0 is partially metabolized by cyp3a and drug0 le is known to be a strong inhibitor of cytochrome p450 3a enzyme  care should be taken while dosing drug0 with drug0 and other strong p450 3a inhibitors including drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug2  drug0 or drug0 .,paricalcitol,saquinavir,FALSE,none
a multiple dose drug-drug interaction study demonstrated that drug0 approximately doubled drug1 auc0- . since drug0 is partially metabolized by cyp3a and drug0 le is known to be a strong inhibitor of cytochrome p450 3a enzyme  care should be taken while dosing drug0 with drug0 and other strong p450 3a inhibitors including drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug2 or drug0 .,paricalcitol,telithromycin,FALSE,none
a multiple dose drug-drug interaction study demonstrated that drug0 approximately doubled drug1 auc0- . since drug0 is partially metabolized by cyp3a and drug0 le is known to be a strong inhibitor of cytochrome p450 3a enzyme  care should be taken while dosing drug0 with drug0 and other strong p450 3a inhibitors including drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0 or drug2 .,paricalcitol,voriconazole,FALSE,none
a multiple dose drug-drug interaction study demonstrated that drug2 approximately doubled drug1 auc0- . since drug0 is partially metabolized by cyp3a and drug0 le is known to be a strong inhibitor of cytochrome p450 3a enzyme  care should be taken while dosing drug0 with drug0 and other strong p450 3a inhibitors including drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0 or drug0 .,paricalcitol,ketoconazole,FALSE,none
a multiple dose drug-drug interaction study demonstrated that drug2 approximately doubled drug1 auc0- . since drug0 is partially metabolized by cyp3a and drug0 le is known to be a strong inhibitor of cytochrome p450 3a enzyme  care should be taken while dosing drug0 with drug0 and other strong p450 3a inhibitors including drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0 or drug0 .,paricalcitol,ketoconazole,FALSE,none
a multiple dose drug-drug interaction study demonstrated that drug0 approximately doubled drug1 auc0- . since drug0 is partially metabolized by cyp3a and drug0 le is known to be a strong inhibitor of cytochrome p450 3a enzyme  care should be taken while dosing drug0 with drug0 and other strong p450 3a inhibitors including drug2  drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0 or drug0 .,paricalcitol,atazanavir,FALSE,none
a multiple dose drug-drug interaction study demonstrated that drug0 approximately doubled drug1 auc0- . since drug0 is partially metabolized by cyp3a and drug0 le is known to be a strong inhibitor of cytochrome p450 3a enzyme  care should be taken while dosing drug0 with drug0 and other strong p450 3a inhibitors including drug0  drug2  drug0  drug0  drug0  drug0  drug0  drug0  drug0 or drug0 .,paricalcitol,clarithromycin,FALSE,none
a multiple dose drug-drug interaction study demonstrated that drug0 approximately doubled drug1 auc0- . since drug0 is partially metabolized by cyp3a and drug0 le is known to be a strong inhibitor of cytochrome p450 3a enzyme  care should be taken while dosing drug0 with drug0 and other strong p450 3a inhibitors including drug0  drug0  drug2  drug0  drug0  drug0  drug0  drug0  drug0 or drug0 .,paricalcitol,indinavir,FALSE,none
a multiple dose drug-drug interaction study demonstrated that drug0 approximately doubled drug1 auc0- . since drug0 is partially metabolized by cyp3a and drug0 le is known to be a strong inhibitor of cytochrome p450 3a enzyme  care should be taken while dosing drug0 with drug0 and other strong p450 3a inhibitors including drug0  drug0  drug0  drug2  drug0  drug0  drug0  drug0  drug0 or drug0 .,paricalcitol,itraconazole,FALSE,none
a multiple dose drug-drug interaction study demonstrated that drug0 approximately doubled drug1 auc0- . since drug0 is partially metabolized by cyp3a and drug0 le is known to be a strong inhibitor of cytochrome p450 3a enzyme  care should be taken while dosing drug0 with drug0 and other strong p450 3a inhibitors including drug0  drug0  drug0  drug0  drug2  drug0  drug0  drug0  drug0 or drug0 .,paricalcitol,nefazodone,FALSE,none
a multiple dose drug-drug interaction study demonstrated that drug0 approximately doubled drug1 auc0- . since drug0 is partially metabolized by cyp3a and drug0 le is known to be a strong inhibitor of cytochrome p450 3a enzyme  care should be taken while dosing drug0 with drug0 and other strong p450 3a inhibitors including drug0  drug0  drug0  drug0  drug0  drug2  drug0  drug0  drug0 or drug0 .,paricalcitol,nelfinavir,FALSE,none
a multiple dose drug-drug interaction study demonstrated that drug0 approximately doubled drug1 auc0- . since drug0 is partially metabolized by cyp3a and drug0 le is known to be a strong inhibitor of cytochrome p450 3a enzyme  care should be taken while dosing drug0 with drug0 and other strong p450 3a inhibitors including drug0  drug0  drug0  drug0  drug0  drug0  drug2  drug0  drug0 or drug0 .,paricalcitol,ritonavir,FALSE,none
a multiple dose drug-drug interaction study demonstrated that drug0 approximately doubled drug1 auc0- . since drug0 is partially metabolized by cyp3a and drug0 le is known to be a strong inhibitor of cytochrome p450 3a enzyme  care should be taken while dosing drug0 with drug0 and other strong p450 3a inhibitors including drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug2  drug0 or drug0 .,paricalcitol,saquinavir,FALSE,none
a multiple dose drug-drug interaction study demonstrated that drug0 approximately doubled drug1 auc0- . since drug0 is partially metabolized by cyp3a and drug0 le is known to be a strong inhibitor of cytochrome p450 3a enzyme  care should be taken while dosing drug0 with drug0 and other strong p450 3a inhibitors including drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug2 or drug0 .,paricalcitol,telithromycin,FALSE,none
a multiple dose drug-drug interaction study demonstrated that drug0 approximately doubled drug1 auc0- . since drug0 is partially metabolized by cyp3a and drug0 le is known to be a strong inhibitor of cytochrome p450 3a enzyme  care should be taken while dosing drug0 with drug0 and other strong p450 3a inhibitors including drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0 or drug2 .,paricalcitol,voriconazole,FALSE,none
a multiple dose drug-drug interaction study demonstrated that drug1 approximately doubled drug2 auc0- . since drug0 is partially metabolized by cyp3a and drug0 le is known to be a strong inhibitor of cytochrome p450 3a enzyme  care should be taken while dosing drug0 with drug0 and other strong p450 3a inhibitors including drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0 or drug0 .,ketoconazole,paricalcitol,FALSE,none
a multiple dose drug-drug interaction study demonstrated that drug1 approximately doubled drug0 auc0- . since drug0 is partially metabolized by cyp3a and drug0 le is known to be a strong inhibitor of cytochrome p450 3a enzyme  care should be taken while dosing drug0 with drug0 and other strong p450 3a inhibitors including drug2  drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0 or drug0 .,ketoconazole,atazanavir,FALSE,none
a multiple dose drug-drug interaction study demonstrated that drug1 approximately doubled drug0 auc0- . since drug0 is partially metabolized by cyp3a and drug0 le is known to be a strong inhibitor of cytochrome p450 3a enzyme  care should be taken while dosing drug0 with drug0 and other strong p450 3a inhibitors including drug0  drug2  drug0  drug0  drug0  drug0  drug0  drug0  drug0 or drug0 .,ketoconazole,clarithromycin,FALSE,none
a multiple dose drug-drug interaction study demonstrated that drug1 approximately doubled drug0 auc0- . since drug0 is partially metabolized by cyp3a and drug0 le is known to be a strong inhibitor of cytochrome p450 3a enzyme  care should be taken while dosing drug0 with drug0 and other strong p450 3a inhibitors including drug0  drug0  drug2  drug0  drug0  drug0  drug0  drug0  drug0 or drug0 .,ketoconazole,indinavir,FALSE,none
a multiple dose drug-drug interaction study demonstrated that drug1 approximately doubled drug0 auc0- . since drug0 is partially metabolized by cyp3a and drug0 le is known to be a strong inhibitor of cytochrome p450 3a enzyme  care should be taken while dosing drug0 with drug0 and other strong p450 3a inhibitors including drug0  drug0  drug0  drug2  drug0  drug0  drug0  drug0  drug0 or drug0 .,ketoconazole,itraconazole,FALSE,none
a multiple dose drug-drug interaction study demonstrated that drug1 approximately doubled drug0 auc0- . since drug0 is partially metabolized by cyp3a and drug0 le is known to be a strong inhibitor of cytochrome p450 3a enzyme  care should be taken while dosing drug0 with drug0 and other strong p450 3a inhibitors including drug0  drug0  drug0  drug0  drug2  drug0  drug0  drug0  drug0 or drug0 .,ketoconazole,nefazodone,FALSE,none
a multiple dose drug-drug interaction study demonstrated that drug1 approximately doubled drug0 auc0- . since drug0 is partially metabolized by cyp3a and drug0 le is known to be a strong inhibitor of cytochrome p450 3a enzyme  care should be taken while dosing drug0 with drug0 and other strong p450 3a inhibitors including drug0  drug0  drug0  drug0  drug0  drug2  drug0  drug0  drug0 or drug0 .,ketoconazole,nelfinavir,FALSE,none
a multiple dose drug-drug interaction study demonstrated that drug1 approximately doubled drug0 auc0- . since drug0 is partially metabolized by cyp3a and drug0 le is known to be a strong inhibitor of cytochrome p450 3a enzyme  care should be taken while dosing drug0 with drug0 and other strong p450 3a inhibitors including drug0  drug0  drug0  drug0  drug0  drug0  drug2  drug0  drug0 or drug0 .,ketoconazole,ritonavir,FALSE,none
a multiple dose drug-drug interaction study demonstrated that drug1 approximately doubled drug0 auc0- . since drug0 is partially metabolized by cyp3a and drug0 le is known to be a strong inhibitor of cytochrome p450 3a enzyme  care should be taken while dosing drug0 with drug0 and other strong p450 3a inhibitors including drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug2  drug0 or drug0 .,ketoconazole,saquinavir,FALSE,none
a multiple dose drug-drug interaction study demonstrated that drug1 approximately doubled drug0 auc0- . since drug0 is partially metabolized by cyp3a and drug0 le is known to be a strong inhibitor of cytochrome p450 3a enzyme  care should be taken while dosing drug0 with drug0 and other strong p450 3a inhibitors including drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug2 or drug0 .,ketoconazole,telithromycin,FALSE,none
a multiple dose drug-drug interaction study demonstrated that drug1 approximately doubled drug0 auc0- . since drug0 is partially metabolized by cyp3a and drug0 le is known to be a strong inhibitor of cytochrome p450 3a enzyme  care should be taken while dosing drug0 with drug0 and other strong p450 3a inhibitors including drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0 or drug2 .,ketoconazole,voriconazole,FALSE,none
a multiple dose drug-drug interaction study demonstrated that drug2 approximately doubled drug1 auc0- . since drug0 is partially metabolized by cyp3a and drug0 le is known to be a strong inhibitor of cytochrome p450 3a enzyme  care should be taken while dosing drug0 with drug0 and other strong p450 3a inhibitors including drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0 or drug0 .,paricalcitol,ketoconazole,TRUE,advise
a multiple dose drug-drug interaction study demonstrated that drug0 approximately doubled drug1 auc0- . since drug0 is partially metabolized by cyp3a and drug0 le is known to be a strong inhibitor of cytochrome p450 3a enzyme  care should be taken while dosing drug0 with drug0 and other strong p450 3a inhibitors including drug2  drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0 or drug0 .,paricalcitol,atazanavir,TRUE,advise
a multiple dose drug-drug interaction study demonstrated that drug0 approximately doubled drug1 auc0- . since drug0 is partially metabolized by cyp3a and drug0 le is known to be a strong inhibitor of cytochrome p450 3a enzyme  care should be taken while dosing drug0 with drug0 and other strong p450 3a inhibitors including drug0  drug2  drug0  drug0  drug0  drug0  drug0  drug0  drug0 or drug0 .,paricalcitol,clarithromycin,TRUE,advise
a multiple dose drug-drug interaction study demonstrated that drug0 approximately doubled drug1 auc0- . since drug0 is partially metabolized by cyp3a and drug0 le is known to be a strong inhibitor of cytochrome p450 3a enzyme  care should be taken while dosing drug0 with drug0 and other strong p450 3a inhibitors including drug0  drug0  drug2  drug0  drug0  drug0  drug0  drug0  drug0 or drug0 .,paricalcitol,indinavir,TRUE,advise
a multiple dose drug-drug interaction study demonstrated that drug0 approximately doubled drug1 auc0- . since drug0 is partially metabolized by cyp3a and drug0 le is known to be a strong inhibitor of cytochrome p450 3a enzyme  care should be taken while dosing drug0 with drug0 and other strong p450 3a inhibitors including drug0  drug0  drug0  drug2  drug0  drug0  drug0  drug0  drug0 or drug0 .,paricalcitol,itraconazole,TRUE,advise
a multiple dose drug-drug interaction study demonstrated that drug0 approximately doubled drug1 auc0- . since drug0 is partially metabolized by cyp3a and drug0 le is known to be a strong inhibitor of cytochrome p450 3a enzyme  care should be taken while dosing drug0 with drug0 and other strong p450 3a inhibitors including drug0  drug0  drug0  drug0  drug2  drug0  drug0  drug0  drug0 or drug0 .,paricalcitol,nefazodone,TRUE,advise
a multiple dose drug-drug interaction study demonstrated that drug0 approximately doubled drug1 auc0- . since drug0 is partially metabolized by cyp3a and drug0 le is known to be a strong inhibitor of cytochrome p450 3a enzyme  care should be taken while dosing drug0 with drug0 and other strong p450 3a inhibitors including drug0  drug0  drug0  drug0  drug0  drug2  drug0  drug0  drug0 or drug0 .,paricalcitol,nelfinavir,TRUE,advise
a multiple dose drug-drug interaction study demonstrated that drug0 approximately doubled drug1 auc0- . since drug0 is partially metabolized by cyp3a and drug0 le is known to be a strong inhibitor of cytochrome p450 3a enzyme  care should be taken while dosing drug0 with drug0 and other strong p450 3a inhibitors including drug0  drug0  drug0  drug0  drug0  drug0  drug2  drug0  drug0 or drug0 .,paricalcitol,ritonavir,TRUE,advise
a multiple dose drug-drug interaction study demonstrated that drug0 approximately doubled drug1 auc0- . since drug0 is partially metabolized by cyp3a and drug0 le is known to be a strong inhibitor of cytochrome p450 3a enzyme  care should be taken while dosing drug0 with drug0 and other strong p450 3a inhibitors including drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug2  drug0 or drug0 .,paricalcitol,saquinavir,TRUE,advise
a multiple dose drug-drug interaction study demonstrated that drug0 approximately doubled drug1 auc0- . since drug0 is partially metabolized by cyp3a and drug0 le is known to be a strong inhibitor of cytochrome p450 3a enzyme  care should be taken while dosing drug0 with drug0 and other strong p450 3a inhibitors including drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug2 or drug0 .,paricalcitol,telithromycin,TRUE,advise
a multiple dose drug-drug interaction study demonstrated that drug0 approximately doubled drug1 auc0- . since drug0 is partially metabolized by cyp3a and drug0 le is known to be a strong inhibitor of cytochrome p450 3a enzyme  care should be taken while dosing drug0 with drug0 and other strong p450 3a inhibitors including drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0 or drug2 .,paricalcitol,voriconazole,TRUE,advise
a multiple dose drug-drug interaction study demonstrated that drug1 approximately doubled drug0 auc0- . since drug0 is partially metabolized by cyp3a and drug0 le is known to be a strong inhibitor of cytochrome p450 3a enzyme  care should be taken while dosing drug0 with drug0 and other strong p450 3a inhibitors including drug2  drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0 or drug0 .,ketoconazole,atazanavir,FALSE,none
a multiple dose drug-drug interaction study demonstrated that drug1 approximately doubled drug0 auc0- . since drug0 is partially metabolized by cyp3a and drug0 le is known to be a strong inhibitor of cytochrome p450 3a enzyme  care should be taken while dosing drug0 with drug0 and other strong p450 3a inhibitors including drug0  drug2  drug0  drug0  drug0  drug0  drug0  drug0  drug0 or drug0 .,ketoconazole,clarithromycin,FALSE,none
a multiple dose drug-drug interaction study demonstrated that drug1 approximately doubled drug0 auc0- . since drug0 is partially metabolized by cyp3a and drug0 le is known to be a strong inhibitor of cytochrome p450 3a enzyme  care should be taken while dosing drug0 with drug0 and other strong p450 3a inhibitors including drug0  drug0  drug2  drug0  drug0  drug0  drug0  drug0  drug0 or drug0 .,ketoconazole,indinavir,FALSE,none
a multiple dose drug-drug interaction study demonstrated that drug1 approximately doubled drug0 auc0- . since drug0 is partially metabolized by cyp3a and drug0 le is known to be a strong inhibitor of cytochrome p450 3a enzyme  care should be taken while dosing drug0 with drug0 and other strong p450 3a inhibitors including drug0  drug0  drug0  drug2  drug0  drug0  drug0  drug0  drug0 or drug0 .,ketoconazole,itraconazole,FALSE,none
a multiple dose drug-drug interaction study demonstrated that drug1 approximately doubled drug0 auc0- . since drug0 is partially metabolized by cyp3a and drug0 le is known to be a strong inhibitor of cytochrome p450 3a enzyme  care should be taken while dosing drug0 with drug0 and other strong p450 3a inhibitors including drug0  drug0  drug0  drug0  drug2  drug0  drug0  drug0  drug0 or drug0 .,ketoconazole,nefazodone,FALSE,none
a multiple dose drug-drug interaction study demonstrated that drug1 approximately doubled drug0 auc0- . since drug0 is partially metabolized by cyp3a and drug0 le is known to be a strong inhibitor of cytochrome p450 3a enzyme  care should be taken while dosing drug0 with drug0 and other strong p450 3a inhibitors including drug0  drug0  drug0  drug0  drug0  drug2  drug0  drug0  drug0 or drug0 .,ketoconazole,nelfinavir,FALSE,none
a multiple dose drug-drug interaction study demonstrated that drug1 approximately doubled drug0 auc0- . since drug0 is partially metabolized by cyp3a and drug0 le is known to be a strong inhibitor of cytochrome p450 3a enzyme  care should be taken while dosing drug0 with drug0 and other strong p450 3a inhibitors including drug0  drug0  drug0  drug0  drug0  drug0  drug2  drug0  drug0 or drug0 .,ketoconazole,ritonavir,FALSE,none
a multiple dose drug-drug interaction study demonstrated that drug1 approximately doubled drug0 auc0- . since drug0 is partially metabolized by cyp3a and drug0 le is known to be a strong inhibitor of cytochrome p450 3a enzyme  care should be taken while dosing drug0 with drug0 and other strong p450 3a inhibitors including drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug2  drug0 or drug0 .,ketoconazole,saquinavir,FALSE,none
a multiple dose drug-drug interaction study demonstrated that drug1 approximately doubled drug0 auc0- . since drug0 is partially metabolized by cyp3a and drug0 le is known to be a strong inhibitor of cytochrome p450 3a enzyme  care should be taken while dosing drug0 with drug0 and other strong p450 3a inhibitors including drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug2 or drug0 .,ketoconazole,telithromycin,FALSE,none
a multiple dose drug-drug interaction study demonstrated that drug1 approximately doubled drug0 auc0- . since drug0 is partially metabolized by cyp3a and drug0 le is known to be a strong inhibitor of cytochrome p450 3a enzyme  care should be taken while dosing drug0 with drug0 and other strong p450 3a inhibitors including drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0 or drug2 .,ketoconazole,voriconazole,FALSE,none
a multiple dose drug-drug interaction study demonstrated that drug0 approximately doubled drug0 auc0- . since drug0 is partially metabolized by cyp3a and drug0 le is known to be a strong inhibitor of cytochrome p450 3a enzyme  care should be taken while dosing drug0 with drug0 and other strong p450 3a inhibitors including drug1  drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0 or drug2 .,atazanavir,voriconazole,FALSE,none
a multiple dose drug-drug interaction study demonstrated that drug0 approximately doubled drug0 auc0- . since drug0 is partially metabolized by cyp3a and drug0 le is known to be a strong inhibitor of cytochrome p450 3a enzyme  care should be taken while dosing drug0 with drug0 and other strong p450 3a inhibitors including drug0  drug1  drug0  drug0  drug0  drug0  drug0  drug0  drug0 or drug2 .,clarithromycin,voriconazole,FALSE,none
a multiple dose drug-drug interaction study demonstrated that drug0 approximately doubled drug0 auc0- . since drug0 is partially metabolized by cyp3a and drug0 le is known to be a strong inhibitor of cytochrome p450 3a enzyme  care should be taken while dosing drug0 with drug0 and other strong p450 3a inhibitors including drug0  drug0  drug1  drug0  drug0  drug0  drug0  drug0  drug0 or drug2 .,indinavir,voriconazole,FALSE,none
a multiple dose drug-drug interaction study demonstrated that drug0 approximately doubled drug0 auc0- . since drug0 is partially metabolized by cyp3a and drug0 le is known to be a strong inhibitor of cytochrome p450 3a enzyme  care should be taken while dosing drug0 with drug0 and other strong p450 3a inhibitors including drug0  drug0  drug0  drug1  drug0  drug0  drug0  drug0  drug0 or drug2 .,itraconazole,voriconazole,FALSE,none
a multiple dose drug-drug interaction study demonstrated that drug0 approximately doubled drug0 auc0- . since drug0 is partially metabolized by cyp3a and drug0 le is known to be a strong inhibitor of cytochrome p450 3a enzyme  care should be taken while dosing drug0 with drug0 and other strong p450 3a inhibitors including drug0  drug0  drug0  drug0  drug1  drug0  drug0  drug0  drug0 or drug2 .,nefazodone,voriconazole,FALSE,none
a multiple dose drug-drug interaction study demonstrated that drug0 approximately doubled drug0 auc0- . since drug0 is partially metabolized by cyp3a and drug0 le is known to be a strong inhibitor of cytochrome p450 3a enzyme  care should be taken while dosing drug0 with drug0 and other strong p450 3a inhibitors including drug0  drug0  drug0  drug0  drug0  drug1  drug0  drug0  drug0 or drug2 .,nelfinavir,voriconazole,FALSE,none
a multiple dose drug-drug interaction study demonstrated that drug0 approximately doubled drug0 auc0- . since drug0 is partially metabolized by cyp3a and drug0 le is known to be a strong inhibitor of cytochrome p450 3a enzyme  care should be taken while dosing drug0 with drug0 and other strong p450 3a inhibitors including drug0  drug0  drug0  drug0  drug0  drug0  drug1  drug0  drug0 or drug2 .,ritonavir,voriconazole,FALSE,none
a multiple dose drug-drug interaction study demonstrated that drug0 approximately doubled drug0 auc0- . since drug0 is partially metabolized by cyp3a and drug0 le is known to be a strong inhibitor of cytochrome p450 3a enzyme  care should be taken while dosing drug0 with drug0 and other strong p450 3a inhibitors including drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug1  drug0 or drug2 .,saquinavir,voriconazole,FALSE,none
a multiple dose drug-drug interaction study demonstrated that drug0 approximately doubled drug0 auc0- . since drug0 is partially metabolized by cyp3a and drug0 le is known to be a strong inhibitor of cytochrome p450 3a enzyme  care should be taken while dosing drug0 with drug0 and other strong p450 3a inhibitors including drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug1 or drug2 .,telithromycin,voriconazole,FALSE,none
dose adjustment of drug1 capsules may be required  and ipth and serum drug0 concentrations should be closely monitored if a patient initiates or discontinues therapy with a strong cyp3a4 inhibitor such as drug2 .,zemplar,ketoconazole,TRUE,advise
drugs that impair intestinal absorption of drug1  such as drug2  may interfere with the absorption of drug0 capsules .,fat-soluble vitamins,cholestyramine,TRUE,mechanism
drugs that impair intestinal absorption of drug1  such as drug0  may interfere with the absorption of drug2 capsules .,fat-soluble vitamins,zemplar,FALSE,none
drugs that impair intestinal absorption of drug0  such as drug1  may interfere with the absorption of drug2 capsules .,cholestyramine,zemplar,TRUE,mechanism
patients receiving drug1 and drug2 should have more frequent monitoring of neutrophil counts .,lithium,neulasta,TRUE,advise
in a pharmacokinetic study of 18 chronic hepatitis c patients concomitantly receiving drug1  treatment with drug2 once weekly for 4 weeks was associated with a mean increase of 16 % in drug0 auc ;,methadone,peg-intron,TRUE,mechanism
in a pharmacokinetic study of 18 chronic hepatitis c patients concomitantly receiving drug2  treatment with drug1 once weekly for 4 weeks was associated with a mean increase of 16 % in drug0 auc ;,peg-intron,methadone,FALSE,none
acromegalic patients with diabetes mellitus being treated with drug1 and/or oral drug2 agents may require dose reductions of these therapeutic agents after the initiation of therapy with drug0 .,insulin,hypoglycemic,FALSE,none
acromegalic patients with diabetes mellitus being treated with drug1 and/or oral drug0 agents may require dose reductions of these therapeutic agents after the initiation of therapy with drug2 .,insulin,somavert,TRUE,advise
acromegalic patients with diabetes mellitus being treated with drug0 and/or oral drug1 agents may require dose reductions of these therapeutic agents after the initiation of therapy with drug2 .,hypoglycemic,somavert,TRUE,advise
in clinical studies  patients on drug1 often needed higher serum drug2 concentrations to achieve appropriate igf-i suppression compared with patients not receiving drug0 .,opioids,pegvisomant,TRUE,mechanism
in clinical studies  patients on drug2 often needed higher serum drug1 concentrations to achieve appropriate igf-i suppression compared with patients not receiving drug0 .,pegvisomant,opioids,FALSE,none
concomitant administration of substances that are also tubularly secreted ( e.g.  drug1 ) could potentially result in delayed clearance of drug2 .,probenecid,alimta,TRUE,mechanism
althoudrug0 drug1 ( 400 mg qid ) can be administered with drug2 in patients with normal renal function ( creatinine clearance 80 ml/min )  caution should be used when administering drug0 concurrently with drug0 to patients with mild to moderate renal insufficiency ( creatinine clearance from 45 to 79 ml/min ) .,ibuprofen,alimta,FALSE,none
althoudrug0 drug1 ( 400 mg qid ) can be administered with drug2 in patients with normal renal function ( creatinine clearance 80 ml/min )  caution should be used when administering drug0 concurrently with drug0 to patients with mild to moderate renal insufficiency ( creatinine clearance from 45 to 79 ml/min ) .,ibuprofen,alimta,FALSE,none
althoudrug0 drug2 ( 400 mg qid ) can be administered with drug1 in patients with normal renal function ( creatinine clearance 80 ml/min )  caution should be used when administering drug0 concurrently with drug0 to patients with mild to moderate renal insufficiency ( creatinine clearance from 45 to 79 ml/min ) .,alimta,ibuprofen,FALSE,none
althoudrug0 drug1 ( 400 mg qid ) can be administered with drug2 in patients with normal renal function ( creatinine clearance 80 ml/min )  caution should be used when administering drug0 concurrently with drug0 to patients with mild to moderate renal insufficiency ( creatinine clearance from 45 to 79 ml/min ) .,ibuprofen,alimta,TRUE,advise
patients with mild to moderate renal insufficiency should avoid taking drug1 with short elimination half-lives for a period of 2 days before  the day of  and 2 days following administration of drug2 .,nsaids,alimta,TRUE,advise
in the absence of data regarding potential interaction between drug1 and drug2 with longer half-lives  all patients taking these drug0 should interrupt dosing for at least 5 days before  the day of  and 2 days following drug0 administration .,alimta,nsaids,FALSE,none
in the absence of data regarding potential interaction between drug1 and drug2 with longer half-lives  all patients taking these drug0 should interrupt dosing for at least 5 days before  the day of  and 2 days following drug0 administration .,alimta,nsaids,FALSE,none
in the absence of data regarding potential interaction between drug2 and drug1 with longer half-lives  all patients taking these drug0 should interrupt dosing for at least 5 days before  the day of  and 2 days following drug0 administration .,nsaids,alimta,FALSE,none
in the absence of data regarding potential interaction between drug2 and drug1 with longer half-lives  all patients taking these drug0 should interrupt dosing for at least 5 days before  the day of  and 2 days following drug0 administration .,nsaids,alimta,TRUE,advise
decreased seizure threshold has been reported in patients receiving drug1 concomitantly with drug2 .,cylert,antiepileptic medications,TRUE,effect
concurrent administration of drug1 ( e.g.  drug2  drug0 ) may diminish the bactericidal effects of drug0 by slowing the rate of bacterial growth .,bacteriostatic antibiotics,erythromycin,FALSE,none
concurrent administration of drug1 ( e.g.  drug0  drug2 ) may diminish the bactericidal effects of drug0 by slowing the rate of bacterial growth .,bacteriostatic antibiotics,tetracycline,FALSE,none
concurrent administration of drug1 ( e.g.  drug0  drug0 ) may diminish the bactericidal effects of drug2 by slowing the rate of bacterial growth .,bacteriostatic antibiotics,penicillins,TRUE,effect
concurrent administration of bacteriostatic drug0 ( e.g.  drug1  drug0 ) may diminish the bactericidal effects of drug2 by slowing the rate of bacterial growth .,erythromycin,penicillins,TRUE,effect
concurrent administration of bacteriostatic drug0 ( e.g.  drug0  drug1 ) may diminish the bactericidal effects of drug2 by slowing the rate of bacterial growth .,tetracycline,penicillins,TRUE,effect
drug1 blood levels may be prolonged by concurrent administration of drug2 which blocks the renal tubular secretion of drug0 .,penicillin,probenecid,TRUE,mechanism
drug1 blood levels may be prolonged by concurrent administration of drug0 which blocks the renal tubular secretion of drug2 .,penicillin,penicillins,FALSE,none
drug0 blood levels may be prolonged by concurrent administration of drug1 which blocks the renal tubular secretion of drug2 .,probenecid,penicillins,FALSE,none
usage with drug1 : due to the potential for increased drug0 effects  drug0 should be used with caution in patients who are currently receiving drug2 .,alcohol,pentazocine,FALSE,none
usage with drug1 : due to the potential for increased drug0 effects  drug0 should be used with caution in patients who are currently receiving drug2 .,alcohol,pentazocine,TRUE,advise
concomitant administration of drug1 and drug2-containing drugs leads to increased drug0 levels and drug0 toxicity in some individuals .,trental,theophylline,TRUE,mechanism
concomitant administration of drug1 and drug2-containing drugs leads to increased drug0 levels and drug0 toxicity in some individuals .,trental,theophylline,FALSE,none
concomitant administration of drug1 and drug2-containing drugs leads to increased drug0 levels and drug0 toxicity in some individuals .,trental,theophylline,FALSE,none
drug1 has been used concurrently with drug2  drug0  drug0  drug0  drug0  and drug0  without observed problems .,trental,antihypertensive drugs,FALSE,none
drug1 has been used concurrently with drug0 drugs  drug2  drug0  drug0  drug0  and drug0  without observed problems .,trental,beta blockers,FALSE,none
drug1 has been used concurrently with drug0 drugs  drug0  drug2  drug0  drug0  and drug0  without observed problems .,trental,digitalis,FALSE,none
drug1 has been used concurrently with drug0 drugs  drug0  drug0  drug2  drug0  and drug0  without observed problems .,trental,diuretics,FALSE,none
drug1 has been used concurrently with drug0 drugs  drug0  drug0  drug0  drug2  and drug0  without observed problems .,trental,antidiabetic agents,FALSE,none
drug1 has been used concurrently with drug0 drugs  drug0  drug0  drug0  drug0  and drug2  without observed problems .,trental,antiarrhythmics,FALSE,none
drug0 has been used concurrently with drug0 drugs  drug0  drug0  drug0  drug1  and drug2  without observed problems .,antidiabetic agents,antiarrhythmics,FALSE,none
drug1  such as the drug2 ( drug0  drug0  drug0 ) or drug0  ordinarily should not be administered concurrently with drug0 ( a drug0 ) ;,dopamine antagonists,neuroleptics,FALSE,none
drug1  such as the drug0 ( drug2  drug0  drug0 ) or drug0  ordinarily should not be administered concurrently with drug0 ( a drug0 ) ;,dopamine antagonists,phenothiazines,FALSE,none
drug1  such as the drug0 ( drug0  drug2  drug0 ) or drug0  ordinarily should not be administered concurrently with drug0 ( a drug0 ) ;,dopamine antagonists,butyrophenones,FALSE,none
drug1  such as the drug0 ( drug0  drug0  drug2 ) or drug0  ordinarily should not be administered concurrently with drug0 ( a drug0 ) ;,dopamine antagonists,thioxanthines,FALSE,none
drug1  such as the drug0 ( drug0  drug0  drug0 ) or drug2  ordinarily should not be administered concurrently with drug0 ( a drug0 ) ;,dopamine antagonists,metoclopramide,FALSE,none
drug1  such as the drug0 ( drug0  drug0  drug0 ) or drug0  ordinarily should not be administered concurrently with drug2 ( a drug0 ) ;,dopamine antagonists,permax,TRUE,advise
drug1  such as the drug0 ( drug0  drug0  drug0 ) or drug0  ordinarily should not be administered concurrently with drug0 ( a drug2 ) ;,dopamine antagonists,dopamine agonist,FALSE,none
drug0  such as the drug1 ( drug2  drug0  drug0 ) or drug0  ordinarily should not be administered concurrently with drug0 ( a drug0 ) ;,neuroleptics,phenothiazines,FALSE,none
drug0  such as the drug1 ( drug0  drug2  drug0 ) or drug0  ordinarily should not be administered concurrently with drug0 ( a drug0 ) ;,neuroleptics,butyrophenones,FALSE,none
drug0  such as the drug1 ( drug0  drug0  drug2 ) or drug0  ordinarily should not be administered concurrently with drug0 ( a drug0 ) ;,neuroleptics,thioxanthines,FALSE,none
drug0  such as the drug1 ( drug0  drug0  drug0 ) or drug2  ordinarily should not be administered concurrently with drug0 ( a drug0 ) ;,neuroleptics,metoclopramide,FALSE,none
drug0  such as the drug1 ( drug0  drug0  drug0 ) or drug0  ordinarily should not be administered concurrently with drug2 ( a drug0 ) ;,neuroleptics,permax,TRUE,advise
drug0  such as the drug1 ( drug0  drug0  drug0 ) or drug0  ordinarily should not be administered concurrently with drug0 ( a drug2 ) ;,neuroleptics,dopamine agonist,FALSE,none
drug0  such as the drug0 ( drug1  drug0  drug0 ) or drug2  ordinarily should not be administered concurrently with drug0 ( a drug0 ) ;,phenothiazines,metoclopramide,FALSE,none
drug0  such as the drug0 ( drug1  drug0  drug0 ) or drug0  ordinarily should not be administered concurrently with drug2 ( a drug0 ) ;,phenothiazines,permax,TRUE,advise
drug0  such as the drug0 ( drug1  drug0  drug0 ) or drug0  ordinarily should not be administered concurrently with drug0 ( a drug2 ) ;,phenothiazines,dopamine agonist,FALSE,none
drug0  such as the drug0 ( drug0  drug1  drug0 ) or drug2  ordinarily should not be administered concurrently with drug0 ( a drug0 ) ;,butyrophenones,metoclopramide,FALSE,none
drug0  such as the drug0 ( drug0  drug1  drug0 ) or drug0  ordinarily should not be administered concurrently with drug2 ( a drug0 ) ;,butyrophenones,permax,TRUE,advise
drug0  such as the drug0 ( drug0  drug1  drug0 ) or drug0  ordinarily should not be administered concurrently with drug0 ( a drug2 ) ;,butyrophenones,dopamine agonist,FALSE,none
drug0  such as the drug0 ( drug0  drug0  drug1 ) or drug2  ordinarily should not be administered concurrently with drug0 ( a drug0 ) ;,thioxanthines,metoclopramide,FALSE,none
drug0  such as the drug0 ( drug0  drug0  drug1 ) or drug0  ordinarily should not be administered concurrently with drug2 ( a drug0 ) ;,thioxanthines,permax,TRUE,advise
drug0  such as the drug0 ( drug0  drug0  drug1 ) or drug0  ordinarily should not be administered concurrently with drug0 ( a drug2 ) ;,thioxanthines,dopamine agonist,FALSE,none
drug0  such as the drug0 ( drug0  drug0  drug0 ) or drug1  ordinarily should not be administered concurrently with drug2 ( a drug0 ) ;,metoclopramide,permax,TRUE,advise
drug0  such as the drug0 ( drug0  drug0  drug0 ) or drug1  ordinarily should not be administered concurrently with drug0 ( a drug2 ) ;,metoclopramide,dopamine agonist,FALSE,none
drug0  such as the drug0 ( drug0  drug0  drug0 ) or drug0  ordinarily should not be administered concurrently with drug1 ( a drug2 ) ;,permax,dopamine agonist,FALSE,none
drug1 : patients on drug0  and especially those started recently  may occasionally experience an excessive reduction of blood pressure after initiation of drug2 tablets therapy .,diuretics,aceon,FALSE,none
drug1 : patients on drug0  and especially those started recently  may occasionally experience an excessive reduction of blood pressure after initiation of drug2 tablets therapy .,diuretics,aceon,TRUE,effect
the possibility of hypotensive effects can be minimized by either discontinuing the drug1 or increasing the salt intake prior to initiation of treatment with drug2 .,diuretic,perindopril,TRUE,effect
if drug1 can not be interrupted  close medical supervision should be provided with the first dose of drug2 tablets  for at least two hours and until blood pressure has stabilized for another hour .,diuretics,aceon,TRUE,advise
the bioavailability of drug1 was reduced by drug2  however  and this was associated with a decrease in plasma ace inhibition .,perindoprilat,diuretics,FALSE,none
drug1 supplements and drug2 : drug0 tablets may increase serum drug0 because of its potential to decrease aldosterone production .,potassium,potassium-sparing diuretics,FALSE,none
drug1 supplements and drug0-sparing drug0 : drug2 tablets may increase serum drug0 because of its potential to decrease aldosterone production .,potassium,aceon,FALSE,none
drug0 supplements and drug1 : drug2 tablets may increase serum drug0 because of its potential to decrease aldosterone production .,potassium-sparing diuretics,aceon,FALSE,none
use of drug1 ( drug2  drug0  drug0 and others )  drug0 supplements or other drugs capable of increasing serum drug0 ( drug0  drug0  drug0 and others ) can increase the risk of hyperkalemia .,potassium-sparing diuretics,spironolactone,FALSE,none
use of drug1 ( drug0  drug2  drug0 and others )  drug0 supplements or other drugs capable of increasing serum drug0 ( drug0  drug0  drug0 and others ) can increase the risk of hyperkalemia .,potassium-sparing diuretics,amiloride,FALSE,none
use of drug1 ( drug0  drug0  drug2 and others )  drug0 supplements or other drugs capable of increasing serum drug0 ( drug0  drug0  drug0 and others ) can increase the risk of hyperkalemia .,potassium-sparing diuretics,triamterene,FALSE,none
use of drug1 ( drug0  drug0  drug0 and others )  drug2 supplements or other drugs capable of increasing serum drug0 ( drug0  drug0  drug0 and others ) can increase the risk of hyperkalemia .,potassium-sparing diuretics,potassium,FALSE,none
use of drug1 ( drug0  drug0  drug0 and others )  drug0 supplements or other drugs capable of increasing serum drug0 ( drug2  drug0  drug0 and others ) can increase the risk of hyperkalemia .,potassium-sparing diuretics,indomethacin,FALSE,none
use of drug1 ( drug0  drug0  drug0 and others )  drug0 supplements or other drugs capable of increasing serum drug0 ( drug0  drug2  drug0 and others ) can increase the risk of hyperkalemia .,potassium-sparing diuretics,heparin,FALSE,none
use of drug1 ( drug0  drug0  drug0 and others )  drug0 supplements or other drugs capable of increasing serum drug0 ( drug0  drug0  drug2 and others ) can increase the risk of hyperkalemia .,potassium-sparing diuretics,cyclosporine,FALSE,none
use of drug2-sparing drug0 ( drug1  drug0  drug0 and others )  drug0 supplements or other drugs capable of increasing serum drug0 ( drug0  drug0  drug0 and others ) can increase the risk of hyperkalemia .,spironolactone,potassium,FALSE,none
use of drug0-sparing drug0 ( drug1  drug0  drug0 and others )  drug0 supplements or other drugs capable of increasing serum drug0 ( drug2  drug0  drug0 and others ) can increase the risk of hyperkalemia .,spironolactone,indomethacin,FALSE,none
use of drug0-sparing drug0 ( drug1  drug0  drug0 and others )  drug0 supplements or other drugs capable of increasing serum drug0 ( drug0  drug2  drug0 and others ) can increase the risk of hyperkalemia .,spironolactone,heparin,FALSE,none
use of drug0-sparing drug0 ( drug1  drug0  drug0 and others )  drug0 supplements or other drugs capable of increasing serum drug0 ( drug0  drug0  drug2 and others ) can increase the risk of hyperkalemia .,spironolactone,cyclosporine,FALSE,none
use of drug2-sparing drug0 ( drug0  drug1  drug0 and others )  drug0 supplements or other drugs capable of increasing serum drug0 ( drug0  drug0  drug0 and others ) can increase the risk of hyperkalemia .,amiloride,potassium,FALSE,none
use of drug0-sparing drug0 ( drug0  drug1  drug0 and others )  drug0 supplements or other drugs capable of increasing serum drug0 ( drug2  drug0  drug0 and others ) can increase the risk of hyperkalemia .,amiloride,indomethacin,FALSE,none
use of drug0-sparing drug0 ( drug0  drug1  drug0 and others )  drug0 supplements or other drugs capable of increasing serum drug0 ( drug0  drug2  drug0 and others ) can increase the risk of hyperkalemia .,amiloride,heparin,FALSE,none
use of drug0-sparing drug0 ( drug0  drug1  drug0 and others )  drug0 supplements or other drugs capable of increasing serum drug0 ( drug0  drug0  drug2 and others ) can increase the risk of hyperkalemia .,amiloride,cyclosporine,FALSE,none
use of drug2-sparing drug0 ( drug0  drug0  drug1 and others )  drug0 supplements or other drugs capable of increasing serum drug0 ( drug0  drug0  drug0 and others ) can increase the risk of hyperkalemia .,triamterene,potassium,FALSE,none
use of drug0-sparing drug0 ( drug0  drug0  drug1 and others )  drug0 supplements or other drugs capable of increasing serum drug0 ( drug2  drug0  drug0 and others ) can increase the risk of hyperkalemia .,triamterene,indomethacin,FALSE,none
use of drug0-sparing drug0 ( drug0  drug0  drug1 and others )  drug0 supplements or other drugs capable of increasing serum drug0 ( drug0  drug2  drug0 and others ) can increase the risk of hyperkalemia .,triamterene,heparin,FALSE,none
use of drug0-sparing drug0 ( drug0  drug0  drug1 and others )  drug0 supplements or other drugs capable of increasing serum drug0 ( drug0  drug0  drug2 and others ) can increase the risk of hyperkalemia .,triamterene,cyclosporine,FALSE,none
use of drug1-sparing drug0 ( drug0  drug0  drug0 and others )  drug0 supplements or other drugs capable of increasing serum drug0 ( drug2  drug0  drug0 and others ) can increase the risk of hyperkalemia .,potassium,indomethacin,FALSE,none
use of drug1-sparing drug0 ( drug0  drug0  drug0 and others )  drug0 supplements or other drugs capable of increasing serum drug0 ( drug0  drug2  drug0 and others ) can increase the risk of hyperkalemia .,potassium,heparin,FALSE,none
use of drug1-sparing drug0 ( drug0  drug0  drug0 and others )  drug0 supplements or other drugs capable of increasing serum drug0 ( drug0  drug0  drug2 and others ) can increase the risk of hyperkalemia .,potassium,cyclosporine,FALSE,none
use of a drug1 may further increase the risk of drug2 toxicity .,diuretic,lithium,FALSE,none
drug1 : animal data have suggested the possibility of interaction between drug2 and drug0 .,gentamicin,perindopril,FALSE,none
drug2 : animal data have suggested the possibility of interaction between drug1 and drug0 .,perindopril,gentamicin,TRUE,int
however  the extent of biotransformation of drug1 to the active metabolite  drug2  is reduced approximately 43 %  resulting in a reduction in the plasma ace inhibition curve of approximately 20 %  probably clinically insignificant .,perindopril,perindoprilat,FALSE,none
concomitant use of drug1 with drug2 may result in an adverse drug interaction .,alcohol,phentermine hydrochloride,TRUE,int
drug1 : the pressor effect of drug2 is markedly potentiated in patients receiving drug0 ( drug0 ) .,mao inhibitors,sympathomimetic pressor amines,FALSE,none
drug1 : the pressor effect of drug0 is markedly potentiated in patients receiving drug2 ( drug0 ) .,mao inhibitors,monoamine oxidase inhibitors,FALSE,none
drug1 : the pressor effect of drug0 is markedly potentiated in patients receiving drug0 ( drug2 ) .,mao inhibitors,maoi,FALSE,none
drug0 : the pressor effect of drug1 is markedly potentiated in patients receiving drug2 ( drug0 ) .,sympathomimetic pressor amines,monoamine oxidase inhibitors,TRUE,effect
drug0 : the pressor effect of drug1 is markedly potentiated in patients receiving drug0 ( drug2 ) .,sympathomimetic pressor amines,maoi,TRUE,effect
the pressor response of drug1 may also be potentiated by drug2 .,adrenergic agents,tricyclic antidepressants,TRUE,effect
drug1 - the pressor effect of drug2 is markedly potentiated in patients receiving drug0 ( drug0 ) .,mao inhibitors,sympathomimetic pressor amines,FALSE,none
drug1 - the pressor effect of drug0 is markedly potentiated in patients receiving drug2 ( drug0 ) .,mao inhibitors,monoamine oxidase inhibitors,FALSE,none
drug1 - the pressor effect of drug0 is markedly potentiated in patients receiving drug0 ( drug2 ) .,mao inhibitors,maoi,FALSE,none
drug0 - the pressor effect of drug1 is markedly potentiated in patients receiving drug2 ( drug0 ) .,sympathomimetic pressor amines,monoamine oxidase inhibitors,TRUE,effect
drug0 - the pressor effect of drug1 is markedly potentiated in patients receiving drug0 ( drug2 ) .,sympathomimetic pressor amines,maoi,TRUE,effect
the pressor response of drug1 may also be potentiated by drug2 .,adrenergic agents,tricyclic antidepressants,TRUE,effect
drug1 should be administered with caution to patients taking drug2 because of the possibility of conduction disturbances .,pilocarpine,beta adrenergic antagonists,TRUE,advise
these effects should be considered when drug0 properties may be contributing to the therapeutic effect of concomitant medication ( e.g.  drug1  inhaled drug2 ) .,atropine,ipratropium,FALSE,none
catecholamine-depleting drugs ( e.g.  drug1 ) may have an additive effect when given with drug2 .,reserpine,beta-blocking agents,TRUE,effect
drug1 has been used with a variety of drug2  including drug0  drug0  and drug0 without unexpected adverse interactions .,pindolol,antihypertensive agents,FALSE,none
drug1 has been used with a variety of drug0 agents  including drug2  drug0  and drug0 without unexpected adverse interactions .,pindolol,hydrochlorothiazide,FALSE,none
drug1 has been used with a variety of drug0 agents  including drug0  drug2  and drug0 without unexpected adverse interactions .,pindolol,hydralazine,FALSE,none
drug1 has been used with a variety of drug0 agents  including drug0  drug0  and drug2 without unexpected adverse interactions .,pindolol,guanethidine,FALSE,none
drug0 has been used with a variety of drug1  including drug2  drug0  and drug0 without unexpected adverse interactions .,antihypertensive agents,hydrochlorothiazide,FALSE,none
drug0 has been used with a variety of drug1  including drug0  drug0  and drug2 without unexpected adverse interactions .,antihypertensive agents,guanethidine,FALSE,none
drug0 has been used with a variety of drug0 agents  including drug0  drug1  and drug2 without unexpected adverse interactions .,hydralazine,guanethidine,FALSE,none
drug1 has been shown to increase serum drug2 levels when both drugs are co-administered .,pindolol,thioridazine,TRUE,mechanism
other drug1 should not be used concomitantly with drug2 because they may have additive effects .,short-acting beta adrenergic aerosol bronchodilators,maxair autohaler,TRUE,advise
althoudrug0 this has not occurred in in vitro studies with drug1  interactions with drug0-type drug0 have been reported with drug2 since marketing  therefore  physicians should closely monitor patients for a change in dosage requirements when administering drug0 to patients on drug0-type drug0 and other highly protein-bound drugs .,coumarin-type anticoagulants,feldene,FALSE,none
althoudrug0 this has not occurred in in vitro studies with drug1  interactions with drug0-type drug0 have been reported with drug2 since marketing  therefore  physicians should closely monitor patients for a change in dosage requirements when administering drug0 to patients on drug0-type drug0 and other highly protein-bound drugs .,coumarin-type anticoagulants,feldene,FALSE,none
althoudrug0 this has not occurred in in vitro studies with drug1  interactions with drug0-type drug0 have been reported with drug2 since marketing  therefore  physicians should closely monitor patients for a change in dosage requirements when administering drug0 to patients on drug0-type drug0 and other highly protein-bound drugs .,coumarin-type anticoagulants,feldene,TRUE,int
althoudrug0 this has not occurred in in vitro studies with drug1  interactions with drug0-type drug0 have been reported with drug2 since marketing  therefore  physicians should closely monitor patients for a change in dosage requirements when administering drug0 to patients on drug0-type drug0 and other highly protein-bound drugs .,coumarin-type anticoagulants,feldene,FALSE,none
althoudrug0 this has not occurred in in vitro studies with drug2  interactions with drug0-type drug0 have been reported with drug1 since marketing  therefore  physicians should closely monitor patients for a change in dosage requirements when administering drug0 to patients on drug0-type drug0 and other highly protein-bound drugs .,feldene,coumarin-type anticoagulants,FALSE,none
althoudrug0 this has not occurred in in vitro studies with drug2  interactions with drug0-type drug0 have been reported with drug1 since marketing  therefore  physicians should closely monitor patients for a change in dosage requirements when administering drug0 to patients on drug0-type drug0 and other highly protein-bound drugs .,feldene,coumarin-type anticoagulants,TRUE,advise
it is recommended that plasma drug1 levels be monitored when initiating  adjusting and discontinuing drug2 .,lithium,feldene,TRUE,advise
when drug1 and drug2 are used together  the signs of atropinization ( flushing  mydriasis  tachycardia  dryness of the mouth and nose ) may occur earlier than might be expected when drug0 is used alone .,atropine,pralidoxime,TRUE,effect
when drug2 and drug1 are used together  the signs of atropinization ( flushing  mydriasis  tachycardia  dryness of the mouth and nose ) may occur earlier than might be expected when drug0 is used alone .,pralidoxime,atropine,FALSE,none
this is especially true if the total dose of drug1 has been large and the administration of drug2 has been delayed .,atropine,pralidoxime,FALSE,none
2 - 4 the following precautions should be kept in mind in the treatment of anticholinesterase poisoning  althoudrug0 they do not bear directly on the use of drug1 : since drug2 are potentiated by the drug0  they should be used cautiously in the treatment of convulsions ;,pralidoxime,barbiturates,FALSE,none
2 - 4 the following precautions should be kept in mind in the treatment of anticholinesterase poisoning  althoudrug0 they do not bear directly on the use of drug1 : since drug0 are potentiated by the drug2  they should be used cautiously in the treatment of convulsions ;,pralidoxime,anticholinesterases,FALSE,none
2 - 4 the following precautions should be kept in mind in the treatment of anticholinesterase poisoning  althoudrug0 they do not bear directly on the use of drug0 : since drug1 are potentiated by the drug2  they should be used cautiously in the treatment of convulsions ;,barbiturates,anticholinesterases,TRUE,effect
drug0  drug0  drug0  drug0  drug1  and drug2 should be avoided in patients with organophosphate poisoning .,reserpine,phenothiazine-type tranquilizers,FALSE,none
drug1 : population pharmacokinetic analysis suggests that drug0 is unlikely to alter the oral clearance of drug2 ( n= 54 ) .,amantadine,pramipexole,FALSE,none
drug1 : population pharmacokinetic analysis suggests that drug0 is unlikely to alter the oral clearance of drug2 ( n= 54 ) .,amantadine,pramipexole,FALSE,none
drug1 : drug0  a known inhibitor of renal tubular secretion of organic bases via the cationic transport system  caused a 50 % increase in drug2 auc and a 40 % increase in half-life ( n= 12 ) .,cimetidine,pramipexole,FALSE,none
drug1 : drug0  a known inhibitor of renal tubular secretion of organic bases via the cationic transport system  caused a 50 % increase in drug2 auc and a 40 % increase in half-life ( n= 12 ) .,cimetidine,pramipexole,TRUE,mechanism
drug1 : drug0  a known inhibitor of renal tubular secretion of organic acids via the aruonic transporter  did not noticeably influence drug2 pharmacokinetics ( n= 12 ) .,probenecid,pramipexole,FALSE,none
drug1 : drug0  a known inhibitor of renal tubular secretion of organic acids via the aruonic transporter  did not noticeably influence drug2 pharmacokinetics ( n= 12 ) .,probenecid,pramipexole,FALSE,none
other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system ( e.g.  drug1  drug0  drug0  drug0  drug0  drug0  and drug0 ) decreases the oral clearance of drug2 by about 20 %  while those secreted by the anionic transport system ( e.g.  drug0  drug0  drug0  drug0  and drug0 ) are likely to have little effect on the oral clearance of drug0 .,cimetidine,pramipexole,TRUE,mechanism
other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system ( e.g.  drug1  drug0  drug0  drug0  drug0  drug0  and drug0 ) decreases the oral clearance of drug0 by about 20 %  while those secreted by the anionic transport system ( e.g.  drug2  drug0  drug0  drug0  and drug0 ) are likely to have little effect on the oral clearance of drug0 .,cimetidine,cephalosporins,FALSE,none
other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system ( e.g.  drug1  drug0  drug0  drug0  drug0  drug0  and drug0 ) decreases the oral clearance of drug0 by about 20 %  while those secreted by the anionic transport system ( e.g.  drug0  drug2  drug0  drug0  and drug0 ) are likely to have little effect on the oral clearance of drug0 .,cimetidine,penicillins,FALSE,none
other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system ( e.g.  drug1  drug0  drug0  drug0  drug0  drug0  and drug0 ) decreases the oral clearance of drug0 by about 20 %  while those secreted by the anionic transport system ( e.g.  drug0  drug0  drug2  drug0  and drug0 ) are likely to have little effect on the oral clearance of drug0 .,cimetidine,indomethacin,FALSE,none
other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system ( e.g.  drug1  drug0  drug0  drug0  drug0  drug0  and drug0 ) decreases the oral clearance of drug0 by about 20 %  while those secreted by the anionic transport system ( e.g.  drug0  drug0  drug0  drug2  and drug0 ) are likely to have little effect on the oral clearance of drug0 .,cimetidine,hydrochlorothiazide,FALSE,none
other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system ( e.g.  drug1  drug0  drug0  drug0  drug0  drug0  and drug0 ) decreases the oral clearance of drug0 by about 20 %  while those secreted by the anionic transport system ( e.g.  drug0  drug0  drug0  drug0  and drug2 ) are likely to have little effect on the oral clearance of drug0 .,cimetidine,chlorpropamide,FALSE,none
other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system ( e.g.  drug1  drug0  drug0  drug0  drug0  drug0  and drug0 ) decreases the oral clearance of drug2 by about 20 %  while those secreted by the anionic transport system ( e.g.  drug0  drug0  drug0  drug0  and drug0 ) are likely to have little effect on the oral clearance of drug0 .,cimetidine,pramipexole,FALSE,none
other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system ( e.g.  drug0  drug1  drug0  drug0  drug0  drug0  and drug0 ) decreases the oral clearance of drug2 by about 20 %  while those secreted by the anionic transport system ( e.g.  drug0  drug0  drug0  drug0  and drug0 ) are likely to have little effect on the oral clearance of drug0 .,ranitidine,pramipexole,TRUE,mechanism
other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system ( e.g.  drug0  drug1  drug0  drug0  drug0  drug0  and drug0 ) decreases the oral clearance of drug0 by about 20 %  while those secreted by the anionic transport system ( e.g.  drug2  drug0  drug0  drug0  and drug0 ) are likely to have little effect on the oral clearance of drug0 .,ranitidine,cephalosporins,FALSE,none
other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system ( e.g.  drug0  drug1  drug0  drug0  drug0  drug0  and drug0 ) decreases the oral clearance of drug0 by about 20 %  while those secreted by the anionic transport system ( e.g.  drug0  drug2  drug0  drug0  and drug0 ) are likely to have little effect on the oral clearance of drug0 .,ranitidine,penicillins,FALSE,none
other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system ( e.g.  drug0  drug1  drug0  drug0  drug0  drug0  and drug0 ) decreases the oral clearance of drug0 by about 20 %  while those secreted by the anionic transport system ( e.g.  drug0  drug0  drug2  drug0  and drug0 ) are likely to have little effect on the oral clearance of drug0 .,ranitidine,indomethacin,FALSE,none
other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system ( e.g.  drug0  drug1  drug0  drug0  drug0  drug0  and drug0 ) decreases the oral clearance of drug0 by about 20 %  while those secreted by the anionic transport system ( e.g.  drug0  drug0  drug0  drug2  and drug0 ) are likely to have little effect on the oral clearance of drug0 .,ranitidine,hydrochlorothiazide,FALSE,none
other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system ( e.g.  drug0  drug1  drug0  drug0  drug0  drug0  and drug0 ) decreases the oral clearance of drug0 by about 20 %  while those secreted by the anionic transport system ( e.g.  drug0  drug0  drug0  drug0  and drug2 ) are likely to have little effect on the oral clearance of drug0 .,ranitidine,chlorpropamide,FALSE,none
other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system ( e.g.  drug0  drug1  drug0  drug0  drug0  drug0  and drug0 ) decreases the oral clearance of drug2 by about 20 %  while those secreted by the anionic transport system ( e.g.  drug0  drug0  drug0  drug0  and drug0 ) are likely to have little effect on the oral clearance of drug0 .,ranitidine,pramipexole,FALSE,none
other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system ( e.g.  drug0  drug0  drug1  drug0  drug0  drug0  and drug0 ) decreases the oral clearance of drug2 by about 20 %  while those secreted by the anionic transport system ( e.g.  drug0  drug0  drug0  drug0  and drug0 ) are likely to have little effect on the oral clearance of drug0 .,diltiazem,pramipexole,TRUE,mechanism
other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system ( e.g.  drug0  drug0  drug1  drug0  drug0  drug0  and drug0 ) decreases the oral clearance of drug0 by about 20 %  while those secreted by the anionic transport system ( e.g.  drug2  drug0  drug0  drug0  and drug0 ) are likely to have little effect on the oral clearance of drug0 .,diltiazem,cephalosporins,FALSE,none
other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system ( e.g.  drug0  drug0  drug1  drug0  drug0  drug0  and drug0 ) decreases the oral clearance of drug0 by about 20 %  while those secreted by the anionic transport system ( e.g.  drug0  drug2  drug0  drug0  and drug0 ) are likely to have little effect on the oral clearance of drug0 .,diltiazem,penicillins,FALSE,none
other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system ( e.g.  drug0  drug0  drug1  drug0  drug0  drug0  and drug0 ) decreases the oral clearance of drug0 by about 20 %  while those secreted by the anionic transport system ( e.g.  drug0  drug0  drug2  drug0  and drug0 ) are likely to have little effect on the oral clearance of drug0 .,diltiazem,indomethacin,FALSE,none
other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system ( e.g.  drug0  drug0  drug1  drug0  drug0  drug0  and drug0 ) decreases the oral clearance of drug0 by about 20 %  while those secreted by the anionic transport system ( e.g.  drug0  drug0  drug0  drug2  and drug0 ) are likely to have little effect on the oral clearance of drug0 .,diltiazem,hydrochlorothiazide,FALSE,none
other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system ( e.g.  drug0  drug0  drug1  drug0  drug0  drug0  and drug0 ) decreases the oral clearance of drug0 by about 20 %  while those secreted by the anionic transport system ( e.g.  drug0  drug0  drug0  drug0  and drug2 ) are likely to have little effect on the oral clearance of drug0 .,diltiazem,chlorpropamide,FALSE,none
other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system ( e.g.  drug0  drug0  drug1  drug0  drug0  drug0  and drug0 ) decreases the oral clearance of drug2 by about 20 %  while those secreted by the anionic transport system ( e.g.  drug0  drug0  drug0  drug0  and drug0 ) are likely to have little effect on the oral clearance of drug0 .,diltiazem,pramipexole,FALSE,none
other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system ( e.g.  drug0  drug0  drug0  drug1  drug0  drug0  and drug0 ) decreases the oral clearance of drug2 by about 20 %  while those secreted by the anionic transport system ( e.g.  drug0  drug0  drug0  drug0  and drug0 ) are likely to have little effect on the oral clearance of drug0 .,triamterene,pramipexole,TRUE,mechanism
other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system ( e.g.  drug0  drug0  drug0  drug1  drug0  drug0  and drug0 ) decreases the oral clearance of drug0 by about 20 %  while those secreted by the anionic transport system ( e.g.  drug2  drug0  drug0  drug0  and drug0 ) are likely to have little effect on the oral clearance of drug0 .,triamterene,cephalosporins,FALSE,none
other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system ( e.g.  drug0  drug0  drug0  drug1  drug0  drug0  and drug0 ) decreases the oral clearance of drug0 by about 20 %  while those secreted by the anionic transport system ( e.g.  drug0  drug2  drug0  drug0  and drug0 ) are likely to have little effect on the oral clearance of drug0 .,triamterene,penicillins,FALSE,none
other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system ( e.g.  drug0  drug0  drug0  drug1  drug0  drug0  and drug0 ) decreases the oral clearance of drug0 by about 20 %  while those secreted by the anionic transport system ( e.g.  drug0  drug0  drug2  drug0  and drug0 ) are likely to have little effect on the oral clearance of drug0 .,triamterene,indomethacin,FALSE,none
other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system ( e.g.  drug0  drug0  drug0  drug1  drug0  drug0  and drug0 ) decreases the oral clearance of drug0 by about 20 %  while those secreted by the anionic transport system ( e.g.  drug0  drug0  drug0  drug2  and drug0 ) are likely to have little effect on the oral clearance of drug0 .,triamterene,hydrochlorothiazide,FALSE,none
other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system ( e.g.  drug0  drug0  drug0  drug1  drug0  drug0  and drug0 ) decreases the oral clearance of drug0 by about 20 %  while those secreted by the anionic transport system ( e.g.  drug0  drug0  drug0  drug0  and drug2 ) are likely to have little effect on the oral clearance of drug0 .,triamterene,chlorpropamide,FALSE,none
other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system ( e.g.  drug0  drug0  drug0  drug1  drug0  drug0  and drug0 ) decreases the oral clearance of drug2 by about 20 %  while those secreted by the anionic transport system ( e.g.  drug0  drug0  drug0  drug0  and drug0 ) are likely to have little effect on the oral clearance of drug0 .,triamterene,pramipexole,FALSE,none
other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system ( e.g.  drug0  drug0  drug0  drug0  drug1  drug0  and drug0 ) decreases the oral clearance of drug2 by about 20 %  while those secreted by the anionic transport system ( e.g.  drug0  drug0  drug0  drug0  and drug0 ) are likely to have little effect on the oral clearance of drug0 .,verapamil,pramipexole,TRUE,mechanism
other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system ( e.g.  drug0  drug0  drug0  drug0  drug1  drug0  and drug0 ) decreases the oral clearance of drug0 by about 20 %  while those secreted by the anionic transport system ( e.g.  drug2  drug0  drug0  drug0  and drug0 ) are likely to have little effect on the oral clearance of drug0 .,verapamil,cephalosporins,FALSE,none
other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system ( e.g.  drug0  drug0  drug0  drug0  drug1  drug0  and drug0 ) decreases the oral clearance of drug0 by about 20 %  while those secreted by the anionic transport system ( e.g.  drug0  drug2  drug0  drug0  and drug0 ) are likely to have little effect on the oral clearance of drug0 .,verapamil,penicillins,FALSE,none
other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system ( e.g.  drug0  drug0  drug0  drug0  drug1  drug0  and drug0 ) decreases the oral clearance of drug0 by about 20 %  while those secreted by the anionic transport system ( e.g.  drug0  drug0  drug2  drug0  and drug0 ) are likely to have little effect on the oral clearance of drug0 .,verapamil,indomethacin,FALSE,none
other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system ( e.g.  drug0  drug0  drug0  drug0  drug1  drug0  and drug0 ) decreases the oral clearance of drug0 by about 20 %  while those secreted by the anionic transport system ( e.g.  drug0  drug0  drug0  drug2  and drug0 ) are likely to have little effect on the oral clearance of drug0 .,verapamil,hydrochlorothiazide,FALSE,none
other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system ( e.g.  drug0  drug0  drug0  drug0  drug1  drug0  and drug0 ) decreases the oral clearance of drug0 by about 20 %  while those secreted by the anionic transport system ( e.g.  drug0  drug0  drug0  drug0  and drug2 ) are likely to have little effect on the oral clearance of drug0 .,verapamil,chlorpropamide,FALSE,none
other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system ( e.g.  drug0  drug0  drug0  drug0  drug1  drug0  and drug0 ) decreases the oral clearance of drug2 by about 20 %  while those secreted by the anionic transport system ( e.g.  drug0  drug0  drug0  drug0  and drug0 ) are likely to have little effect on the oral clearance of drug0 .,verapamil,pramipexole,FALSE,none
other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system ( e.g.  drug0  drug0  drug0  drug0  drug0  drug1  and drug2 ) decreases the oral clearance of drug0 by about 20 %  while those secreted by the anionic transport system ( e.g.  drug0  drug0  drug0  drug0  and drug0 ) are likely to have little effect on the oral clearance of drug0 .,quinidine,quinine,FALSE,none
other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system ( e.g.  drug0  drug0  drug0  drug0  drug0  drug1  and drug0 ) decreases the oral clearance of drug2 by about 20 %  while those secreted by the anionic transport system ( e.g.  drug0  drug0  drug0  drug0  and drug0 ) are likely to have little effect on the oral clearance of drug0 .,quinidine,pramipexole,TRUE,mechanism
other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system ( e.g.  drug0  drug0  drug0  drug0  drug0  drug1  and drug0 ) decreases the oral clearance of drug0 by about 20 %  while those secreted by the anionic transport system ( e.g.  drug2  drug0  drug0  drug0  and drug0 ) are likely to have little effect on the oral clearance of drug0 .,quinidine,cephalosporins,FALSE,none
other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system ( e.g.  drug0  drug0  drug0  drug0  drug0  drug1  and drug0 ) decreases the oral clearance of drug0 by about 20 %  while those secreted by the anionic transport system ( e.g.  drug0  drug2  drug0  drug0  and drug0 ) are likely to have little effect on the oral clearance of drug0 .,quinidine,penicillins,FALSE,none
other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system ( e.g.  drug0  drug0  drug0  drug0  drug0  drug1  and drug0 ) decreases the oral clearance of drug0 by about 20 %  while those secreted by the anionic transport system ( e.g.  drug0  drug0  drug2  drug0  and drug0 ) are likely to have little effect on the oral clearance of drug0 .,quinidine,indomethacin,FALSE,none
other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system ( e.g.  drug0  drug0  drug0  drug0  drug0  drug1  and drug0 ) decreases the oral clearance of drug0 by about 20 %  while those secreted by the anionic transport system ( e.g.  drug0  drug0  drug0  drug2  and drug0 ) are likely to have little effect on the oral clearance of drug0 .,quinidine,hydrochlorothiazide,FALSE,none
other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system ( e.g.  drug0  drug0  drug0  drug0  drug0  drug1  and drug0 ) decreases the oral clearance of drug0 by about 20 %  while those secreted by the anionic transport system ( e.g.  drug0  drug0  drug0  drug0  and drug2 ) are likely to have little effect on the oral clearance of drug0 .,quinidine,chlorpropamide,FALSE,none
other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system ( e.g.  drug0  drug0  drug0  drug0  drug0  drug1  and drug0 ) decreases the oral clearance of drug2 by about 20 %  while those secreted by the anionic transport system ( e.g.  drug0  drug0  drug0  drug0  and drug0 ) are likely to have little effect on the oral clearance of drug0 .,quinidine,pramipexole,FALSE,none
other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0  and drug1 ) decreases the oral clearance of drug2 by about 20 %  while those secreted by the anionic transport system ( e.g.  drug0  drug0  drug0  drug0  and drug0 ) are likely to have little effect on the oral clearance of drug0 .,quinine,pramipexole,TRUE,mechanism
other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0  and drug1 ) decreases the oral clearance of drug0 by about 20 %  while those secreted by the anionic transport system ( e.g.  drug2  drug0  drug0  drug0  and drug0 ) are likely to have little effect on the oral clearance of drug0 .,quinine,cephalosporins,FALSE,none
other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0  and drug1 ) decreases the oral clearance of drug0 by about 20 %  while those secreted by the anionic transport system ( e.g.  drug0  drug2  drug0  drug0  and drug0 ) are likely to have little effect on the oral clearance of drug0 .,quinine,penicillins,FALSE,none
other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0  and drug1 ) decreases the oral clearance of drug0 by about 20 %  while those secreted by the anionic transport system ( e.g.  drug0  drug0  drug2  drug0  and drug0 ) are likely to have little effect on the oral clearance of drug0 .,quinine,indomethacin,FALSE,none
other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0  and drug1 ) decreases the oral clearance of drug0 by about 20 %  while those secreted by the anionic transport system ( e.g.  drug0  drug0  drug0  drug2  and drug0 ) are likely to have little effect on the oral clearance of drug0 .,quinine,hydrochlorothiazide,FALSE,none
other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0  and drug1 ) decreases the oral clearance of drug0 by about 20 %  while those secreted by the anionic transport system ( e.g.  drug0  drug0  drug0  drug0  and drug2 ) are likely to have little effect on the oral clearance of drug0 .,quinine,chlorpropamide,FALSE,none
other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0  and drug1 ) decreases the oral clearance of drug2 by about 20 %  while those secreted by the anionic transport system ( e.g.  drug0  drug0  drug0  drug0  and drug0 ) are likely to have little effect on the oral clearance of drug0 .,quinine,pramipexole,FALSE,none
other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0  and drug0 ) decreases the oral clearance of drug1 by about 20 %  while those secreted by the anionic transport system ( e.g.  drug2  drug0  drug0  drug0  and drug0 ) are likely to have little effect on the oral clearance of drug0 .,pramipexole,cephalosporins,FALSE,none
other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0  and drug0 ) decreases the oral clearance of drug1 by about 20 %  while those secreted by the anionic transport system ( e.g.  drug0  drug2  drug0  drug0  and drug0 ) are likely to have little effect on the oral clearance of drug0 .,pramipexole,penicillins,FALSE,none
other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0  and drug0 ) decreases the oral clearance of drug1 by about 20 %  while those secreted by the anionic transport system ( e.g.  drug0  drug0  drug2  drug0  and drug0 ) are likely to have little effect on the oral clearance of drug0 .,pramipexole,indomethacin,FALSE,none
other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0  and drug0 ) decreases the oral clearance of drug1 by about 20 %  while those secreted by the anionic transport system ( e.g.  drug0  drug0  drug0  drug2  and drug0 ) are likely to have little effect on the oral clearance of drug0 .,pramipexole,hydrochlorothiazide,FALSE,none
other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0  and drug0 ) decreases the oral clearance of drug1 by about 20 %  while those secreted by the anionic transport system ( e.g.  drug0  drug0  drug0  drug0  and drug2 ) are likely to have little effect on the oral clearance of drug0 .,pramipexole,chlorpropamide,FALSE,none
other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0  and drug0 ) decreases the oral clearance of drug2 by about 20 %  while those secreted by the anionic transport system ( e.g.  drug1  drug0  drug0  drug0  and drug0 ) are likely to have little effect on the oral clearance of drug0 .,cephalosporins,pramipexole,TRUE,mechanism
other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0  and drug0 ) decreases the oral clearance of drug2 by about 20 %  while those secreted by the anionic transport system ( e.g.  drug0  drug1  drug0  drug0  and drug0 ) are likely to have little effect on the oral clearance of drug0 .,penicillins,pramipexole,TRUE,mechanism
other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0  and drug0 ) decreases the oral clearance of drug2 by about 20 %  while those secreted by the anionic transport system ( e.g.  drug0  drug0  drug1  drug0  and drug0 ) are likely to have little effect on the oral clearance of drug0 .,indomethacin,pramipexole,TRUE,mechanism
other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0  and drug0 ) decreases the oral clearance of drug0 by about 20 %  while those secreted by the anionic transport system ( e.g.  drug0  drug0  drug0  drug1  and drug2 ) are likely to have little effect on the oral clearance of drug0 .,hydrochlorothiazide,chlorpropamide,FALSE,none
other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0  and drug0 ) decreases the oral clearance of drug2 by about 20 %  while those secreted by the anionic transport system ( e.g.  drug0  drug0  drug0  drug1  and drug0 ) are likely to have little effect on the oral clearance of drug0 .,hydrochlorothiazide,pramipexole,TRUE,mechanism
other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0  and drug0 ) decreases the oral clearance of drug2 by about 20 %  while those secreted by the anionic transport system ( e.g.  drug0  drug0  drug0  drug0  and drug1 ) are likely to have little effect on the oral clearance of drug0 .,chlorpropamide,pramipexole,TRUE,mechanism
drug1 : since drug2 is a drug0  it is possible that drug0  such as the drug0 ( drug0  drug0  drug0 ) or drug0  may diminish the effectiveness of drug0 .,dopamine antagonists,pramipexole,FALSE,none
drug1 : since drug0 is a drug2  it is possible that drug0  such as the drug0 ( drug0  drug0  drug0 ) or drug0  may diminish the effectiveness of drug0 .,dopamine antagonists,dopamine agonist,FALSE,none
drug1 : since drug0 is a drug0  it is possible that drug0  such as the drug2 ( drug0  drug0  drug0 ) or drug0  may diminish the effectiveness of drug0 .,dopamine antagonists,neuroleptics,FALSE,none
drug1 : since drug0 is a drug0  it is possible that drug0  such as the drug0 ( drug2  drug0  drug0 ) or drug0  may diminish the effectiveness of drug0 .,dopamine antagonists,phenothiazines,FALSE,none
drug1 : since drug0 is a drug0  it is possible that drug0  such as the drug0 ( drug0  drug2  drug0 ) or drug0  may diminish the effectiveness of drug0 .,dopamine antagonists,butyrophenones,FALSE,none
drug1 : since drug0 is a drug0  it is possible that drug0  such as the drug0 ( drug0  drug0  drug2 ) or drug0  may diminish the effectiveness of drug0 .,dopamine antagonists,thioxanthenes,FALSE,none
drug1 : since drug0 is a drug0  it is possible that drug0  such as the drug0 ( drug0  drug0  drug0 ) or drug2  may diminish the effectiveness of drug0 .,dopamine antagonists,metoclopramide,FALSE,none
drug1 : since drug0 is a drug0  it is possible that drug0  such as the drug0 ( drug0  drug0  drug0 ) or drug0  may diminish the effectiveness of drug2 .,dopamine antagonists,mirapex,FALSE,none
drug0 : since drug1 is a drug2  it is possible that drug0  such as the drug0 ( drug0  drug0  drug0 ) or drug0  may diminish the effectiveness of drug0 .,pramipexole,dopamine agonist,FALSE,none
drug2 : since drug1 is a drug0  it is possible that drug0  such as the drug0 ( drug0  drug0  drug0 ) or drug0  may diminish the effectiveness of drug0 .,pramipexole,dopamine antagonists,FALSE,none
drug0 : since drug1 is a drug0  it is possible that drug0  such as the drug2 ( drug0  drug0  drug0 ) or drug0  may diminish the effectiveness of drug0 .,pramipexole,neuroleptics,FALSE,none
drug0 : since drug1 is a drug0  it is possible that drug0  such as the drug0 ( drug2  drug0  drug0 ) or drug0  may diminish the effectiveness of drug0 .,pramipexole,phenothiazines,FALSE,none
drug0 : since drug1 is a drug0  it is possible that drug0  such as the drug0 ( drug0  drug2  drug0 ) or drug0  may diminish the effectiveness of drug0 .,pramipexole,butyrophenones,FALSE,none
drug0 : since drug1 is a drug0  it is possible that drug0  such as the drug0 ( drug0  drug0  drug2 ) or drug0  may diminish the effectiveness of drug0 .,pramipexole,thioxanthenes,FALSE,none
drug0 : since drug1 is a drug0  it is possible that drug0  such as the drug0 ( drug0  drug0  drug0 ) or drug2  may diminish the effectiveness of drug0 .,pramipexole,metoclopramide,FALSE,none
drug0 : since drug1 is a drug0  it is possible that drug0  such as the drug0 ( drug0  drug0  drug0 ) or drug0  may diminish the effectiveness of drug2 .,pramipexole,mirapex,FALSE,none
drug2 : since drug0 is a drug1  it is possible that drug0  such as the drug0 ( drug0  drug0  drug0 ) or drug0  may diminish the effectiveness of drug0 .,dopamine agonist,dopamine antagonists,FALSE,none
drug0 : since drug0 is a drug1  it is possible that drug0  such as the drug2 ( drug0  drug0  drug0 ) or drug0  may diminish the effectiveness of drug0 .,dopamine agonist,neuroleptics,FALSE,none
drug0 : since drug0 is a drug1  it is possible that drug0  such as the drug0 ( drug2  drug0  drug0 ) or drug0  may diminish the effectiveness of drug0 .,dopamine agonist,phenothiazines,FALSE,none
drug0 : since drug0 is a drug1  it is possible that drug0  such as the drug0 ( drug0  drug2  drug0 ) or drug0  may diminish the effectiveness of drug0 .,dopamine agonist,butyrophenones,FALSE,none
drug0 : since drug0 is a drug1  it is possible that drug0  such as the drug0 ( drug0  drug0  drug2 ) or drug0  may diminish the effectiveness of drug0 .,dopamine agonist,thioxanthenes,FALSE,none
drug0 : since drug0 is a drug1  it is possible that drug0  such as the drug0 ( drug0  drug0  drug0 ) or drug2  may diminish the effectiveness of drug0 .,dopamine agonist,metoclopramide,FALSE,none
drug0 : since drug0 is a drug1  it is possible that drug0  such as the drug0 ( drug0  drug0  drug0 ) or drug0  may diminish the effectiveness of drug2 .,dopamine agonist,mirapex,FALSE,none
drug1 : since drug0 is a drug0  it is possible that drug0  such as the drug2 ( drug0  drug0  drug0 ) or drug0  may diminish the effectiveness of drug0 .,dopamine antagonists,neuroleptics,FALSE,none
drug1 : since drug0 is a drug0  it is possible that drug0  such as the drug0 ( drug2  drug0  drug0 ) or drug0  may diminish the effectiveness of drug0 .,dopamine antagonists,phenothiazines,FALSE,none
drug1 : since drug0 is a drug0  it is possible that drug0  such as the drug0 ( drug0  drug2  drug0 ) or drug0  may diminish the effectiveness of drug0 .,dopamine antagonists,butyrophenones,FALSE,none
drug1 : since drug0 is a drug0  it is possible that drug0  such as the drug0 ( drug0  drug0  drug2 ) or drug0  may diminish the effectiveness of drug0 .,dopamine antagonists,thioxanthenes,FALSE,none
drug1 : since drug0 is a drug0  it is possible that drug0  such as the drug0 ( drug0  drug0  drug0 ) or drug2  may diminish the effectiveness of drug0 .,dopamine antagonists,metoclopramide,FALSE,none
drug1 : since drug0 is a drug0  it is possible that drug0  such as the drug0 ( drug0  drug0  drug0 ) or drug0  may diminish the effectiveness of drug2 .,dopamine antagonists,mirapex,TRUE,effect
drug0 : since drug0 is a drug0  it is possible that drug0  such as the drug1 ( drug2  drug0  drug0 ) or drug0  may diminish the effectiveness of drug0 .,neuroleptics,phenothiazines,FALSE,none
drug0 : since drug0 is a drug0  it is possible that drug0  such as the drug1 ( drug0  drug2  drug0 ) or drug0  may diminish the effectiveness of drug0 .,neuroleptics,butyrophenones,FALSE,none
drug0 : since drug0 is a drug0  it is possible that drug0  such as the drug1 ( drug0  drug0  drug2 ) or drug0  may diminish the effectiveness of drug0 .,neuroleptics,thioxanthenes,FALSE,none
drug0 : since drug0 is a drug0  it is possible that drug0  such as the drug1 ( drug0  drug0  drug0 ) or drug2  may diminish the effectiveness of drug0 .,neuroleptics,metoclopramide,FALSE,none
drug0 : since drug0 is a drug0  it is possible that drug0  such as the drug1 ( drug0  drug0  drug0 ) or drug0  may diminish the effectiveness of drug2 .,neuroleptics,mirapex,TRUE,effect
drug0 : since drug0 is a drug0  it is possible that drug0  such as the drug0 ( drug1  drug0  drug0 ) or drug2  may diminish the effectiveness of drug0 .,phenothiazines,metoclopramide,FALSE,none
drug0 : since drug0 is a drug0  it is possible that drug0  such as the drug0 ( drug1  drug0  drug0 ) or drug0  may diminish the effectiveness of drug2 .,phenothiazines,mirapex,TRUE,effect
drug0 : since drug0 is a drug0  it is possible that drug0  such as the drug0 ( drug0  drug1  drug0 ) or drug2  may diminish the effectiveness of drug0 .,butyrophenones,metoclopramide,FALSE,none
drug0 : since drug0 is a drug0  it is possible that drug0  such as the drug0 ( drug0  drug1  drug0 ) or drug0  may diminish the effectiveness of drug2 .,butyrophenones,mirapex,TRUE,effect
drug0 : since drug0 is a drug0  it is possible that drug0  such as the drug0 ( drug0  drug0  drug1 ) or drug2  may diminish the effectiveness of drug0 .,thioxanthenes,metoclopramide,FALSE,none
drug0 : since drug0 is a drug0  it is possible that drug0  such as the drug0 ( drug0  drug0  drug1 ) or drug0  may diminish the effectiveness of drug2 .,thioxanthenes,mirapex,TRUE,effect
drug0 : since drug0 is a drug0  it is possible that drug0  such as the drug0 ( drug0  drug0  drug0 ) or drug1  may diminish the effectiveness of drug2 .,metoclopramide,mirapex,TRUE,effect
due to its effects on gastric emptying  drug1 therapy should not be considered for patients taking drugs that alter gastrointestinal motility ( e.g.  drug2 such as drug0 ) and agents that slow the intestinal absorption of nutrients ( e.g.  drug0 ) .,symlin,anticholinergic agents,TRUE,advise
due to its effects on gastric emptying  drug1 therapy should not be considered for patients taking drugs that alter gastrointestinal motility ( e.g.  drug0 agents such as drug2 ) and agents that slow the intestinal absorption of nutrients ( e.g.  drug0 ) .,symlin,atropine,TRUE,advise
due to its effects on gastric emptying  drug1 therapy should not be considered for patients taking drugs that alter gastrointestinal motility ( e.g.  drug0 agents such as drug0 ) and agents that slow the intestinal absorption of nutrients ( e.g.  drug2 ) .,symlin,alpha glucosidase inhibitors,TRUE,advise
due to its effects on gastric emptying  drug0 therapy should not be considered for patients taking drugs that alter gastrointestinal motility ( e.g.  drug1 such as drug0 ) and agents that slow the intestinal absorption of nutrients ( e.g.  drug2 ) .,anticholinergic agents,alpha glucosidase inhibitors,FALSE,none
due to its effects on gastric emptying  drug0 therapy should not be considered for patients taking drugs that alter gastrointestinal motility ( e.g.  drug0 agents such as drug1 ) and agents that slow the intestinal absorption of nutrients ( e.g.  drug2 ) .,atropine,alpha glucosidase inhibitors,FALSE,none
when the rapid onset of a concomitant orally administered agent is a critical determinant of effectiveness ( such as drug1 )  the agent should be administered at least 1 hour prior to or 2 hours after drug2 injection .,analgesics,symlin,TRUE,advise
mixing drug1 and drug2 the pharmacokinetic parameters of drug0 were altered when mixed with regular  nph  and 70/30 premixed formulations of recombinant drug0 immediately prior to injection .,symlin,insulin,FALSE,none
mixing drug1 and drug0 the pharmacokinetic parameters of drug0 were altered when mixed with regular  nph  and 70/30 premixed formulations of recombinant drug2 immediately prior to injection .,symlin,human insulin,FALSE,none
mixing drug2 and drug1 the pharmacokinetic parameters of drug0 were altered when mixed with regular  nph  and 70/30 premixed formulations of recombinant drug0 immediately prior to injection .,insulin,symlin,FALSE,none
mixing drug0 and drug1 the pharmacokinetic parameters of drug0 were altered when mixed with regular  nph  and 70/30 premixed formulations of recombinant drug2 immediately prior to injection .,insulin,human insulin,FALSE,none
mixing drug1 and drug0 the pharmacokinetic parameters of drug0 were altered when mixed with regular  nph  and 70/30 premixed formulations of recombinant drug2 immediately prior to injection .,symlin,human insulin,TRUE,mechanism
thus  drug1 and drug2 should not be mixed and must be administered separately .,symlin,insulin,FALSE,none
drugs that induce hepatic enzymes such as drug1  drug0 and drug2 may increase the clearance of drug0 and may require increases in drug0 dose to achieve the desired response .,phenobarbital,rifampin,FALSE,none
drugs that induce hepatic enzymes such as drug1  drug0 and drug0 may increase the clearance of drug2 and may require increases in drug0 dose to achieve the desired response .,phenobarbital,corticosteroids,TRUE,mechanism
drugs that induce hepatic enzymes such as drug1  drug0 and drug0 may increase the clearance of drug0 and may require increases in drug2 dose to achieve the desired response .,phenobarbital,corticosteroid,TRUE,mechanism
drugs that induce hepatic enzymes such as drug0  drug1 and drug2 may increase the clearance of drug0 and may require increases in drug0 dose to achieve the desired response .,phenytoin,rifampin,FALSE,none
drugs that induce hepatic enzymes such as drug0  drug1 and drug0 may increase the clearance of drug2 and may require increases in drug0 dose to achieve the desired response .,phenytoin,corticosteroids,TRUE,mechanism
drugs that induce hepatic enzymes such as drug0  drug1 and drug0 may increase the clearance of drug0 and may require increases in drug2 dose to achieve the desired response .,phenytoin,corticosteroid,TRUE,mechanism
drugs that induce hepatic enzymes such as drug0  drug0 and drug1 may increase the clearance of drug2 and may require increases in drug0 dose to achieve the desired response .,rifampin,corticosteroids,TRUE,mechanism
drugs that induce hepatic enzymes such as drug0  drug0 and drug1 may increase the clearance of drug0 and may require increases in drug2 dose to achieve the desired response .,rifampin,corticosteroid,TRUE,mechanism
drugs that induce hepatic enzymes such as drug0  drug0 and drug0 may increase the clearance of drug1 and may require increases in drug2 dose to achieve the desired response .,corticosteroids,corticosteroid,FALSE,none
drugs such as drug1 and drug2 may inhibit the metabolism of drug0 and thus decrease their clearance .,troleandomycin,ketoconazole,FALSE,none
drugs such as drug1 and drug0 may inhibit the metabolism of drug2 and thus decrease their clearance .,troleandomycin,corticosteroids,TRUE,mechanism
drugs such as drug0 and drug1 may inhibit the metabolism of drug2 and thus decrease their clearance .,ketoconazole,corticosteroids,TRUE,mechanism
drug1 may increase the clearance of chronic hidrug0 dose drug2 .,corticosteroids,aspirin,TRUE,mechanism
this could lead to decreased drug1 serum levels or increase the risk of drug0 toxicity when drug2 is withdrawn .,salicylate,corticosteroid,FALSE,none
this could lead to decreased drug1 serum levels or increase the risk of drug0 toxicity when drug2 is withdrawn .,salicylate,corticosteroid,TRUE,effect
drug1 should be used cautiously in conjunction with drug2 in patients suffering from hypoprothrombinemia .,aspirin,corticosteroids,TRUE,advise
the effect of drug1 on oral drug2 is variable .,corticosteroids,anticoagulants,TRUE,effect
there are reports of enhanced as well as diminished effects of drug1 when given concurrently with drug2 .,anticoagulants,corticosteroids,TRUE,effect
drug1 : concurrent use of drug2 and drug0 may result in increased systemic toxicity since drug0 inhibit the breakdown of drug0 hydrochloride .,anticholinesterases,procaine hydrochloride,FALSE,none
drug1 : concurrent use of drug0 hydrochloride and drug2 may result in increased systemic toxicity since drug0 inhibit the breakdown of drug0 hydrochloride .,anticholinesterases,anticholinesterase agents,FALSE,none
drug1 : concurrent use of drug2 and drug0 may result in increased systemic toxicity since drug0 inhibit the breakdown of drug0 hydrochloride .,anticholinesterases,procaine hydrochloride,FALSE,none
drug0 : concurrent use of drug1 and drug2 may result in increased systemic toxicity since drug0 inhibit the breakdown of drug0 hydrochloride .,procaine hydrochloride,anticholinesterase agents,TRUE,effect
drug2 : concurrent use of drug1 and drug0 may result in increased systemic toxicity since drug0 inhibit the breakdown of drug0 hydrochloride .,procaine hydrochloride,anticholinesterases,FALSE,none
drug2 : concurrent use of drug0 hydrochloride and drug1 may result in increased systemic toxicity since drug0 inhibit the breakdown of drug0 hydrochloride .,anticholinesterase agents,anticholinesterases,FALSE,none
drug0 : concurrent use of drug2 and drug1 may result in increased systemic toxicity since drug0 inhibit the breakdown of drug0 hydrochloride .,anticholinesterase agents,procaine hydrochloride,FALSE,none
drug1 : concurrent use of drug2 and drug0 may result in increased systemic toxicity since drug0 inhibit the breakdown of drug0 hydrochloride .,anticholinesterases,procaine hydrochloride,TRUE,mechanism
drug1 medications : concurrent use of drug2 and drug0 medications may result in additive depressant effects .,cns depressant,procaine hydrochloride,FALSE,none
drug1 medications : concurrent use of drug0 hydrochloride and drug2 may result in additive depressant effects .,cns depressant,cns depressant medications,FALSE,none
drug2 : concurrent use of drug1 and drug0 medications may result in additive depressant effects .,procaine hydrochloride,cns depressant medications,TRUE,effect
drug1 : drug0 may increase the diffusion rate of drug2  resulting in a decreased time of onset  but an increase in systemic toxicity .,hyaluronidase,procaine hydrochloride,FALSE,none
drug1 : drug0 may increase the diffusion rate of drug2  resulting in a decreased time of onset  but an increase in systemic toxicity .,hyaluronidase,procaine hydrochloride,TRUE,mechanism
drug1 ( such as drug2 ) : concurrent use of drug0 hydrochloride and drug0 may result in prolongation or enhancement of the neuromuscular blockade .,neuromuscular blocking agents,suxamethonium chloride,FALSE,none
drug1 ( such as drug0 ) : concurrent use of drug2 and drug0 may result in prolongation or enhancement of the neuromuscular blockade .,neuromuscular blocking agents,procaine hydrochloride,FALSE,none
drug0 ( such as drug1 ) : concurrent use of drug2 and drug0 may result in prolongation or enhancement of the neuromuscular blockade .,suxamethonium chloride,procaine hydrochloride,FALSE,none
drug2 ( such as drug1 ) : concurrent use of drug0 hydrochloride and drug0 may result in prolongation or enhancement of the neuromuscular blockade .,suxamethonium chloride,neuromuscular blocking agents,FALSE,none
drug2 ( such as drug0 ) : concurrent use of drug1 and drug0 may result in prolongation or enhancement of the neuromuscular blockade .,procaine hydrochloride,neuromuscular blocking agents,TRUE,effect
drug1 : concurrent use of drug2 and drug0 may result in a reduction of the antibacterial action of the drug0 .,sulfonamides,procaine hydrochloride,FALSE,none
drug1 : concurrent use of drug0 hydrochloride and drug0 may result in a reduction of the antibacterial action of the drug2 .,sulfonamides,sulfonamide,FALSE,none
drug2 : concurrent use of drug1 and drug0 may result in a reduction of the antibacterial action of the drug0 .,procaine hydrochloride,sulfonamides,TRUE,effect
drug0 : concurrent use of drug1 and drug0 may result in a reduction of the antibacterial action of the drug2 .,procaine hydrochloride,sulfonamide,FALSE,none
drug1 : concurrent use of drug0 hydrochloride and drug0 may result in a reduction of the antibacterial action of the drug2 .,sulfonamides,sulfonamide,FALSE,none
drug1 : concurrent use of drug0 and drug2 may extend the plasma half-life of drug0 .,acetazolamide,procaine hydrochloride,FALSE,none
drug1 : concurrent use of drug0 and drug2 hydrochloride may extend the plasma half-life of drug0 .,acetazolamide,procaine,FALSE,none
drug1 : concurrent use of drug0 and drug2 may extend the plasma half-life of drug0 .,acetazolamide,procaine hydrochloride,TRUE,mechanism
drug1 : concurrent use of drug0 and drug2 hydrochloride may extend the plasma half-life of drug0 .,acetazolamide,procaine,FALSE,none
drug0 : concurrent use of drug0 and drug1 may extend the plasma half-life of drug2 .,procaine hydrochloride,procaine,FALSE,none
to minimize cns depression and possible potentiation  drug1  drug0  drug0  drug0 or drug2 should be used with caution .,barbiturates,phenothiazines,FALSE,none
to minimize cns depression and possible potentiation  drug0  drug1  drug0  drug0 or drug2 should be used with caution .,antihistamines,phenothiazines,FALSE,none
to minimize cns depression and possible potentiation  drug0  drug0  drug1  drug0 or drug2 should be used with caution .,narcotics,phenothiazines,FALSE,none
to minimize cns depression and possible potentiation  drug0  drug0  drug0  drug1 or drug2 should be used with caution .,hypotensive agents,phenothiazines,FALSE,none
because drug1 exhibits some monoamine oxidase inhibitory activity  drug2  drug0 drug0 drugs ( e.g.  drug0 hcl  drug0 hcl ) and other drugs and foods with known hidrug0 drug0 content  such as wine  yogurt  ripe cheese and bananas  should be avoided .,matulane,sympathomimetic drugs,TRUE,advise
because drug1 exhibits some monoamine oxidase inhibitory activity  drug0  drug2 drugs ( e.g.  drug0 hcl  drug0 hcl ) and other drugs and foods with known hidrug0 drug0 content  such as wine  yogurt  ripe cheese and bananas  should be avoided .,matulane,tricyclic antidepressant,TRUE,advise
because drug1 exhibits some monoamine oxidase inhibitory activity  drug0  drug0 drug0 drugs ( e.g.  drug2  drug0 hcl ) and other drugs and foods with known hidrug0 drug0 content  such as wine  yogurt  ripe cheese and bananas  should be avoided .,matulane,amitriptyline hcl,TRUE,advise
because drug1 exhibits some monoamine oxidase inhibitory activity  drug0  drug0 drug0 drugs ( e.g.  drug0 hcl  drug2 ) and other drugs and foods with known hidrug0 drug0 content  such as wine  yogurt  ripe cheese and bananas  should be avoided .,matulane,imipramine hcl,TRUE,advise
because drug1 exhibits some monoamine oxidase inhibitory activity  drug0  drug0 drug0 drugs ( e.g.  drug0 hcl  drug0 hcl ) and other drugs and foods with known hidrug0 drug2 content  such as wine  yogurt  ripe cheese and bananas  should be avoided .,matulane,tyramine,TRUE,advise
because drug0 exhibits some monoamine oxidase inhibitory activity  drug1  drug0 drug0 drugs ( e.g.  drug2  drug0 hcl ) and other drugs and foods with known hidrug0 drug0 content  such as wine  yogurt  ripe cheese and bananas  should be avoided .,sympathomimetic drugs,amitriptyline hcl,FALSE,none
because drug0 exhibits some monoamine oxidase inhibitory activity  drug1  drug0 drug0 drugs ( e.g.  drug0 hcl  drug2 ) and other drugs and foods with known hidrug0 drug0 content  such as wine  yogurt  ripe cheese and bananas  should be avoided .,sympathomimetic drugs,imipramine hcl,FALSE,none
because drug0 exhibits some monoamine oxidase inhibitory activity  drug1  drug0 drug0 drugs ( e.g.  drug0 hcl  drug0 hcl ) and other drugs and foods with known hidrug0 drug2 content  such as wine  yogurt  ripe cheese and bananas  should be avoided .,sympathomimetic drugs,tyramine,FALSE,none
because drug0 exhibits some monoamine oxidase inhibitory activity  drug0  drug1 drugs ( e.g.  drug2  drug0 hcl ) and other drugs and foods with known hidrug0 drug0 content  such as wine  yogurt  ripe cheese and bananas  should be avoided .,tricyclic antidepressant,amitriptyline hcl,FALSE,none
because drug0 exhibits some monoamine oxidase inhibitory activity  drug0  drug1 drugs ( e.g.  drug0 hcl  drug2 ) and other drugs and foods with known hidrug0 drug0 content  such as wine  yogurt  ripe cheese and bananas  should be avoided .,tricyclic antidepressant,imipramine hcl,FALSE,none
because drug0 exhibits some monoamine oxidase inhibitory activity  drug0  drug1 drugs ( e.g.  drug0 hcl  drug0 hcl ) and other drugs and foods with known hidrug0 drug2 content  such as wine  yogurt  ripe cheese and bananas  should be avoided .,tricyclic antidepressant,tyramine,FALSE,none
because drug0 exhibits some monoamine oxidase inhibitory activity  drug0  drug0 drug0 drugs ( e.g.  drug1  drug0 hcl ) and other drugs and foods with known hidrug0 drug2 content  such as wine  yogurt  ripe cheese and bananas  should be avoided .,amitriptyline hcl,tyramine,FALSE,none
because drug0 exhibits some monoamine oxidase inhibitory activity  drug0  drug0 drug0 drugs ( e.g.  drug0 hcl  drug1 ) and other drugs and foods with known hidrug0 drug2 content  such as wine  yogurt  ripe cheese and bananas  should be avoided .,imipramine hcl,tyramine,FALSE,none
no cross-resistance with other drug1  radiotherapy or drug2 has been demonstrated .,chemotherapeutic agents,steroids,FALSE,none
drug1 may accentuate the orthostatic hypotension that may occur with drug2 .,thiazide diuretics,phenothiazines,TRUE,effect
drug0 effects of drug1 and related compounds may be counteracted when drug2 are used concomitantly .,guanethidine,phenothiazines,TRUE,effect
concomitant administration of drug1 with drug2 results in increased plasma levels of both drugs .,propranolol,phenothiazines,TRUE,mechanism
the induction dose requirements of drug1 injectable emulsion may be reduced in patients with intramuscular or intravenous premedication  particularly with drug2 ( eg  drug0  drug0  and drug0  etc . ),diprivan,narcotics,TRUE,effect
the induction dose requirements of drug1 injectable emulsion may be reduced in patients with intramuscular or intravenous premedication  particularly with drug0 ( eg  drug2  drug0  and drug0  etc . ),diprivan,morphine,TRUE,effect
the induction dose requirements of drug1 injectable emulsion may be reduced in patients with intramuscular or intravenous premedication  particularly with drug0 ( eg  drug0  drug2  and drug0  etc . ),diprivan,meperidine,TRUE,effect
the induction dose requirements of drug1 injectable emulsion may be reduced in patients with intramuscular or intravenous premedication  particularly with drug0 ( eg  drug0  drug0  and drug2  etc . ),diprivan,fentanyl,TRUE,effect
the induction dose requirements of drug0 injectable emulsion may be reduced in patients with intramuscular or intravenous premedication  particularly with drug1 ( eg  drug2  drug0  and drug0  etc . ),narcotics,morphine,FALSE,none
the induction dose requirements of drug0 injectable emulsion may be reduced in patients with intramuscular or intravenous premedication  particularly with drug1 ( eg  drug0  drug2  and drug0  etc . ),narcotics,meperidine,FALSE,none
the induction dose requirements of drug0 injectable emulsion may be reduced in patients with intramuscular or intravenous premedication  particularly with drug1 ( eg  drug0  drug0  and drug2  etc . ),narcotics,fentanyl,FALSE,none
the induction dose requirements of drug0 injectable emulsion may be reduced in patients with intramuscular or intravenous premedication  particularly with drug0 ( eg  drug0  drug1  and drug2  etc . ),meperidine,fentanyl,FALSE,none
and combinations of drug1 and drug2 ( eg  drug0  drug0  drug0  drug0  etc . ) .,opioids,sedatives,FALSE,none
and combinations of drug1 and drug0 ( eg  drug2  drug0  drug0  drug0  etc . ) .,opioids,benzodiazepines,FALSE,none
and combinations of drug1 and drug0 ( eg  drug0  drug2  drug0  drug0  etc . ) .,opioids,barbiturates,FALSE,none
and combinations of drug1 and drug0 ( eg  drug0  drug0  drug2  drug0  etc . ) .,opioids,chloral hydrate,FALSE,none
and combinations of drug1 and drug0 ( eg  drug0  drug0  drug0  drug2  etc . ) .,opioids,droperidol,FALSE,none
and combinations of drug0 and drug1 ( eg  drug2  drug0  drug0  drug0  etc . ) .,sedatives,benzodiazepines,FALSE,none
and combinations of drug0 and drug1 ( eg  drug0  drug2  drug0  drug0  etc . ) .,sedatives,barbiturates,FALSE,none
and combinations of drug0 and drug1 ( eg  drug0  drug0  drug2  drug0  etc . ) .,sedatives,chloral hydrate,FALSE,none
and combinations of drug0 and drug1 ( eg  drug0  drug0  drug0  drug2  etc . ) .,sedatives,droperidol,FALSE,none
during maintenance of anesthesia or sedation  the rate of drug1 injectable emulsion administration should be adjusted according to the desired level of anesthesia or sedation and may be reduced in the presence of supplemental drug2 ( eg  drug0 or drug0 ) .,diprivan,analgesic agents,TRUE,advise
during maintenance of anesthesia or sedation  the rate of drug1 injectable emulsion administration should be adjusted according to the desired level of anesthesia or sedation and may be reduced in the presence of supplemental drug0 agents ( eg  drug2 or drug0 ) .,diprivan,nitrous oxide,TRUE,advise
during maintenance of anesthesia or sedation  the rate of drug1 injectable emulsion administration should be adjusted according to the desired level of anesthesia or sedation and may be reduced in the presence of supplemental drug0 agents ( eg  drug0 or drug2 ) .,diprivan,opioids,TRUE,advise
during maintenance of anesthesia or sedation  the rate of drug0 injectable emulsion administration should be adjusted according to the desired level of anesthesia or sedation and may be reduced in the presence of supplemental drug1 ( eg  drug2 or drug0 ) .,analgesic agents,nitrous oxide,FALSE,none
during maintenance of anesthesia or sedation  the rate of drug0 injectable emulsion administration should be adjusted according to the desired level of anesthesia or sedation and may be reduced in the presence of supplemental drug1 ( eg  drug0 or drug2 ) .,analgesic agents,opioids,FALSE,none
during maintenance of anesthesia or sedation  the rate of drug0 injectable emulsion administration should be adjusted according to the desired level of anesthesia or sedation and may be reduced in the presence of supplemental drug0 agents ( eg  drug1 or drug2 ) .,nitrous oxide,opioids,FALSE,none
drug1 injectable emulsion does not cause a clinically significant change in onset  intensity  or duration of action of the commonly used drug2 ( eg  drug0 and nondepolarizing drug0 ) .,diprivan,neuromuscular blocking agents,FALSE,none
drug1 injectable emulsion does not cause a clinically significant change in onset  intensity  or duration of action of the commonly used drug0 ( eg  drug2 and nondepolarizing drug0 ) .,diprivan,succinylcholine,FALSE,none
drug1 injectable emulsion does not cause a clinically significant change in onset  intensity  or duration of action of the commonly used drug0 ( eg  drug0 and drug2 ) .,diprivan,nondepolarizing muscle relaxants,FALSE,none
drug0 injectable emulsion does not cause a clinically significant change in onset  intensity  or duration of action of the commonly used drug1 ( eg  drug2 and nondepolarizing drug0 ) .,neuromuscular blocking agents,succinylcholine,FALSE,none
drug0 injectable emulsion does not cause a clinically significant change in onset  intensity  or duration of action of the commonly used drug1 ( eg  drug0 and drug2 ) .,neuromuscular blocking agents,nondepolarizing muscle relaxants,FALSE,none
drug0 injectable emulsion does not cause a clinically significant change in onset  intensity  or duration of action of the commonly used drug0 ( eg  drug1 and drug2 ) .,succinylcholine,nondepolarizing muscle relaxants,FALSE,none
the cns-depressant effect of drug1 is additive with that of other drug2  including drug0 .,propoxyphene,cns depressants,TRUE,effect
the cns-depressant effect of drug1 is additive with that of other drug0  including drug2 .,propoxyphene,alcohol,TRUE,effect
the cns-depressant effect of drug0 is additive with that of other drug1  including drug2 .,cns depressants,alcohol,FALSE,none
such occurrences have been reported when drug1 was administered to patients on drug2  drug0  or drug0-like drugs .,propoxyphene,antidepressants,FALSE,none
such occurrences have been reported when drug1 was administered to patients on drug0  drug2  or drug0-like drugs .,propoxyphene,anticonvulsants,FALSE,none
such occurrences have been reported when drug1 was administered to patients on drug0  drug0  or drug2-like drugs .,propoxyphene,warfarin,FALSE,none
such occurrences have been reported when drug0 was administered to patients on drug0  drug1  or drug2-like drugs .,anticonvulsants,warfarin,FALSE,none
drug1 and drug2 increase the effects of pseudodrug0 .,mao inhibitors,beta adrenergic blockers,FALSE,none
drug1 and drug0 increase the effects of drug2 .,mao inhibitors,pseudoephedrine,TRUE,effect
drug0 and drug1 increase the effects of drug2 .,beta adrenergic blockers,pseudoephedrine,TRUE,effect
drug1 may reduce the drug0 effects of drug2  drug0  drug0 and drug0 .,sympathomimetics,methyldopa,TRUE,effect
drug1 may reduce the drug0 effects of drug0  drug2  drug0 and drug0 .,sympathomimetics,mecamylamine,TRUE,effect
drug1 may reduce the drug0 effects of drug0  drug0  drug2 and drug0 .,sympathomimetics,reserpine,TRUE,effect
drug1 may reduce the drug0 effects of drug0  drug0  drug0 and drug2 .,sympathomimetics,veratrum alkaloids,TRUE,effect
drug0 may reduce the drug0 effects of drug1  drug0  drug0 and drug2 .,methyldopa,veratrum alkaloids,FALSE,none
drug0 may reduce the drug0 effects of drug0  drug1  drug0 and drug2 .,mecamylamine,veratrum alkaloids,FALSE,none
drug0 may reduce the drug0 effects of drug0  drug0  drug1 and drug2 .,reserpine,veratrum alkaloids,FALSE,none
drug1 may be used with drug2  drug0 and other drug0  and with other drug0 .,pyrimethamine,sulfonamides,FALSE,none
drug1 may be used with drug0  drug2 and other drug0  and with other drug0 .,pyrimethamine,quinine,FALSE,none
drug1 may be used with drug0  drug0 and other drug2  and with other drug0 .,pyrimethamine,antimalarials,FALSE,none
drug1 may be used with drug0  drug0 and other drug0  and with other drug2 .,pyrimethamine,antibiotics,FALSE,none
drug0 may be used with drug1  drug0 and other drug2  and with other drug0 .,sulfonamides,antimalarials,FALSE,none
drug0 may be used with drug1  drug0 and other drug0  and with other drug2 .,sulfonamides,antibiotics,FALSE,none
drug0 may be used with drug0  drug1 and other drug2  and with other drug0 .,quinine,antimalarials,FALSE,none
drug0 may be used with drug0  drug1 and other drug0  and with other drug2 .,quinine,antibiotics,FALSE,none
drug0 may be used with drug0  drug0 and other drug1  and with other drug2 .,antimalarials,antibiotics,FALSE,none
mild hepatotoxicity has been reported in some patients when drug1 and drug2 were administered concomitantly .,lorazepam,pyrimethamine,TRUE,effect
drug1 : drug0 causes a 60 % reduction in the absorption and enterohepatic cycling of drug2 and should not be coadministered with drug0 .,cholestyramine,raloxifene,FALSE,none
drug1 : drug0 causes a 60 % reduction in the absorption and enterohepatic cycling of drug0 and should not be coadministered with drug2 .,cholestyramine,evista,FALSE,none
drug1 : drug0 causes a 60 % reduction in the absorption and enterohepatic cycling of drug2 and should not be coadministered with drug0 .,cholestyramine,raloxifene,TRUE,mechanism
drug1 : drug0 causes a 60 % reduction in the absorption and enterohepatic cycling of drug0 and should not be coadministered with drug2 .,cholestyramine,evista,TRUE,advise
drug0 : drug0 causes a 60 % reduction in the absorption and enterohepatic cycling of drug1 and should not be coadministered with drug2 .,raloxifene,evista,FALSE,none
if drug1 is given concurrently with drug2  prothrombin time should be monitored .,evista,warfarin,TRUE,advise
caution should be used when drug1 is coadministered with other highly protein-bound drugs  such as drug2  drug0  drug0  drug0  drug0  and drug0 .,evista,clofibrate,TRUE,advise
caution should be used when drug1 is coadministered with other highly protein-bound drugs  such as drug0  drug2  drug0  drug0  drug0  and drug0 .,evista,indomethacin,TRUE,advise
caution should be used when drug1 is coadministered with other highly protein-bound drugs  such as drug0  drug0  drug2  drug0  drug0  and drug0 .,evista,naproxen,TRUE,advise
caution should be used when drug1 is coadministered with other highly protein-bound drugs  such as drug0  drug0  drug0  drug2  drug0  and drug0 .,evista,ibuprofen,TRUE,advise
caution should be used when drug1 is coadministered with other highly protein-bound drugs  such as drug0  drug0  drug0  drug0  drug2  and drug0 .,evista,diazepam,TRUE,advise
caution should be used when drug1 is coadministered with other highly protein-bound drugs  such as drug0  drug0  drug0  drug0  drug0  and drug2 .,evista,diazoxide,TRUE,advise
caution should be used when drug0 is coadministered with other highly protein-bound drugs  such as drug0  drug0  drug0  drug0  drug1  and drug2 .,diazepam,diazoxide,FALSE,none
coadministration of drug1 with drug2 resulted in increased plasma drug0 concentrations ( 57 % )  increased plasma bismuth troudrug0 concentrations ( 48 % )  and increased drug0 plasma concentrations ( 31 % ) .,tritec,clarithromycin,TRUE,mechanism
coadministration of drug1 with drug0 resulted in increased plasma drug2 concentrations ( 57 % )  increased plasma bismuth troudrug0 concentrations ( 48 % )  and increased drug0 plasma concentrations ( 31 % ) .,tritec,ranitidine,FALSE,none
coadministration of drug1 with drug0 resulted in increased plasma drug0 concentrations ( 57 % )  increased plasma bismuth troudrug0 concentrations ( 48 % )  and increased drug2 plasma concentrations ( 31 % ) .,tritec,14- hydroxy- clarithromycin,FALSE,none
coadministration of drug0 with drug1 resulted in increased plasma drug2 concentrations ( 57 % )  increased plasma bismuth troudrug0 concentrations ( 48 % )  and increased drug0 plasma concentrations ( 31 % ) .,clarithromycin,ranitidine,FALSE,none
coadministration of drug0 with drug1 resulted in increased plasma drug0 concentrations ( 57 % )  increased plasma bismuth troudrug0 concentrations ( 48 % )  and increased drug2 plasma concentrations ( 31 % ) .,clarithromycin,14- hydroxy- clarithromycin,FALSE,none
coadministration of drug0 with drug0 resulted in increased plasma drug1 concentrations ( 57 % )  increased plasma bismuth troudrug0 concentrations ( 48 % )  and increased drug2 plasma concentrations ( 31 % ) .,ranitidine,14- hydroxy- clarithromycin,FALSE,none
coadministration with drug1 results in a slight decrease in the rate of drug2 absorption that is clinically unimportant .,aspirin,salicylate,FALSE,none
coadministration with a hidrug0 dose of drug1 ( 170 meq ) results in a 28 % decrease in plasma concentrations of drug2 and may decrease plasma concentrations of bismuth from drug0 .,antacid,ranitidine,TRUE,mechanism
coadministration with a hidrug0 dose of drug1 ( 170 meq ) results in a 28 % decrease in plasma concentrations of drug0 and may decrease plasma concentrations of bismuth from drug2 .,antacid,tritec,TRUE,mechanism
coadministration with a hidrug0 dose of drug0 ( 170 meq ) results in a 28 % decrease in plasma concentrations of drug1 and may decrease plasma concentrations of bismuth from drug2 .,ranitidine,tritec,FALSE,none
for information on drug interactions associated with drug1  refer to the drug2 package insert .,ranitidine,zantac,FALSE,none
co-administration of oral drug1 200 mg twice daily increased drug2 geometric mean auc ( 0-24 ) and cmax by 81 % after topical application of drug0 ointment  1 % on the abraded skin of healthy adult males .,ketoconazole,retapamulin,FALSE,none
co-administration of oral drug1 200 mg twice daily increased drug2 geometric mean auc ( 0-24 ) and cmax by 81 % after topical application of drug0 ointment  1 % on the abraded skin of healthy adult males .,ketoconazole,retapamulin,TRUE,mechanism
due to low systemic exposure to drug1 following topical application in patients  dosage adjustments for drug0 are unnecessary when co-administered with cyp3a4 inhibitors  such as drug2 .,retapamulin,ketoconazole,FALSE,none
due to low systemic exposure to drug1 following topical application in patients  dosage adjustments for drug0 are unnecessary when co-administered with cyp3a4 inhibitors  such as drug2 .,retapamulin,ketoconazole,FALSE,none
in addition to bleeding associated with drug1 and drug2  drugs that alter platelet function ( such as drug0  drug0  and drug0 ) may increase the risk of bleeding if administered prior to or after drug0 therapy .,heparin,vitamin k antagonists,FALSE,none
in addition to bleeding associated with drug1 and drug0 antagonists  drugs that alter platelet function ( such as drug2  drug0  and drug0 ) may increase the risk of bleeding if administered prior to or after drug0 therapy .,heparin,aspirin,FALSE,none
in addition to bleeding associated with drug1 and drug0 antagonists  drugs that alter platelet function ( such as drug0  drug2  and drug0 ) may increase the risk of bleeding if administered prior to or after drug0 therapy .,heparin,dipyridamole,FALSE,none
in addition to bleeding associated with drug1 and drug0 antagonists  drugs that alter platelet function ( such as drug0  drug0  and drug2 ) may increase the risk of bleeding if administered prior to or after drug0 therapy .,heparin,abciximab,FALSE,none
in addition to bleeding associated with drug1 and drug0 antagonists  drugs that alter platelet function ( such as drug0  drug0  and drug0 ) may increase the risk of bleeding if administered prior to or after drug2 therapy .,heparin,retavase,TRUE,effect
in addition to bleeding associated with drug0 and drug1  drugs that alter platelet function ( such as drug2  drug0  and drug0 ) may increase the risk of bleeding if administered prior to or after drug0 therapy .,vitamin k antagonists,aspirin,FALSE,none
in addition to bleeding associated with drug0 and drug1  drugs that alter platelet function ( such as drug0  drug2  and drug0 ) may increase the risk of bleeding if administered prior to or after drug0 therapy .,vitamin k antagonists,dipyridamole,FALSE,none
in addition to bleeding associated with drug0 and drug1  drugs that alter platelet function ( such as drug0  drug0  and drug2 ) may increase the risk of bleeding if administered prior to or after drug0 therapy .,vitamin k antagonists,abciximab,FALSE,none
in addition to bleeding associated with drug0 and drug1  drugs that alter platelet function ( such as drug0  drug0  and drug0 ) may increase the risk of bleeding if administered prior to or after drug2 therapy .,vitamin k antagonists,retavase,TRUE,effect
in addition to bleeding associated with drug0 and drug0 antagonists  drugs that alter platelet function ( such as drug1  drug0  and drug0 ) may increase the risk of bleeding if administered prior to or after drug2 therapy .,aspirin,retavase,TRUE,effect
in addition to bleeding associated with drug0 and drug0 antagonists  drugs that alter platelet function ( such as drug0  drug1  and drug2 ) may increase the risk of bleeding if administered prior to or after drug0 therapy .,dipyridamole,abciximab,FALSE,none
in addition to bleeding associated with drug0 and drug0 antagonists  drugs that alter platelet function ( such as drug0  drug1  and drug0 ) may increase the risk of bleeding if administered prior to or after drug2 therapy .,dipyridamole,retavase,TRUE,effect
in addition to bleeding associated with drug0 and drug0 antagonists  drugs that alter platelet function ( such as drug0  drug0  and drug1 ) may increase the risk of bleeding if administered prior to or after drug2 therapy .,abciximab,retavase,TRUE,effect
interactions for drug1 ( drug0 ) : drug2 - impairs the intestinal absorption of riboflavin,vitamin b2,alcohol,FALSE,none
interactions for drug0 ( drug1 ) : drug2 - impairs the intestinal absorption of riboflavin,riboflavin,alcohol,FALSE,none
interactions for drug0 ( drug2 ) : drug1 - impairs the intestinal absorption of riboflavin,alcohol,riboflavin,TRUE,mechanism
drug1 - concurrent use decreases gastrointestinal absorption of drug2 ;,probenecid,riboflavin,TRUE,mechanism
requirements for drug1 may be increased in patients receiving drug2 .,riboflavin,probenecid,TRUE,effect
when a single 100 mg dose of drug1 was administered one hour after the initiation of drug2 ( 300 mg four times a day )  the apparent total drug0 clearance of this single dose in normal healthy adults was reduced by 18 % ( compared to the apparent total drug0 clearance in the same subjects in the absence of drug0 ) .,rimantadine hcl,cimetidine,TRUE,mechanism
when a single 100 mg dose of drug1 was administered one hour after the initiation of drug0 ( 300 mg four times a day )  the apparent total drug2 clearance of this single dose in normal healthy adults was reduced by 18 % ( compared to the apparent total drug0 clearance in the same subjects in the absence of drug0 ) .,rimantadine hcl,rimantadine,FALSE,none
when a single 100 mg dose of drug1 was administered one hour after the initiation of drug0 ( 300 mg four times a day )  the apparent total drug2 clearance of this single dose in normal healthy adults was reduced by 18 % ( compared to the apparent total drug0 clearance in the same subjects in the absence of drug0 ) .,rimantadine hcl,rimantadine,FALSE,none
when a single 100 mg dose of drug1 was administered one hour after the initiation of drug2 ( 300 mg four times a day )  the apparent total drug0 clearance of this single dose in normal healthy adults was reduced by 18 % ( compared to the apparent total drug0 clearance in the same subjects in the absence of drug0 ) .,rimantadine hcl,cimetidine,FALSE,none
when a single 100 mg dose of drug2 hcl was administered one hour after the initiation of drug1 ( 300 mg four times a day )  the apparent total drug0 clearance of this single dose in normal healthy adults was reduced by 18 % ( compared to the apparent total drug0 clearance in the same subjects in the absence of drug0 ) .,cimetidine,rimantadine,FALSE,none
when a single 100 mg dose of drug2 hcl was administered one hour after the initiation of drug1 ( 300 mg four times a day )  the apparent total drug0 clearance of this single dose in normal healthy adults was reduced by 18 % ( compared to the apparent total drug0 clearance in the same subjects in the absence of drug0 ) .,cimetidine,rimantadine,FALSE,none
when a single 100 mg dose of drug1 hcl was administered one hour after the initiation of drug2 ( 300 mg four times a day )  the apparent total drug0 clearance of this single dose in normal healthy adults was reduced by 18 % ( compared to the apparent total drug0 clearance in the same subjects in the absence of drug0 ) .,rimantadine,cimetidine,FALSE,none
when a single 100 mg dose of drug1 hcl was administered one hour after the initiation of drug2 ( 300 mg four times a day )  the apparent total drug0 clearance of this single dose in normal healthy adults was reduced by 18 % ( compared to the apparent total drug0 clearance in the same subjects in the absence of drug0 ) .,rimantadine,cimetidine,FALSE,none
drug1 : drug2  100 mg  was given twice daily for 13 days to 12 healthy volunteers .,acetaminophen,rimantadine hcl,FALSE,none
coadministration with drug1 reduced the peak concentration and auc values for drug2 by approximately 11 % .,acetaminophen,rimantadine,TRUE,mechanism
drug1 : drug2  100 mg  was given twice daily fro 13 days to 12 healthy volunteers .,aspirin,rimantadine hcl,FALSE,none
peak plasma concentrations and auc of drug1 were reduced approximately 10 % in the presence of drug2 .,rimantadine,aspirin,TRUE,mechanism
drug-drug interactions effect of drug1 ( drug2 ) on the metabolism of other drugs : drug0 is primarily metabolized throudrug0 hydrolysis by esterases .,exelon,rivastigmine tartrate,FALSE,none
drug-drug interactions effect of drug1 ( drug2 tartrate ) on the metabolism of other drugs : drug0 is primarily metabolized throudrug0 hydrolysis by esterases .,exelon,rivastigmine,FALSE,none
drug-drug interactions effect of drug0 ( drug1 ) on the metabolism of other drugs : drug2 is primarily metabolized throudrug0 hydrolysis by esterases .,rivastigmine tartrate,rivastigmine,FALSE,none
effect of other drugs on the metabolism of drug1 : drugs that induce or inhibit cyp450 metabolism are not expected to alter the metabolism of drug2 .,exelon,rivastigmine,FALSE,none
use with drug1 : because of their mechanism of action  drug2 have the potential to interfere with the activity of drug0 medications .,anticholinergics,cholinesterase inhibitors,FALSE,none
use with drug1 : because of their mechanism of action  drug0 have the potential to interfere with the activity of drug2 .,anticholinergics,anticholinergic medications,FALSE,none
use with drug0 : because of their mechanism of action  drug1 have the potential to interfere with the activity of drug2 .,cholinesterase inhibitors,anticholinergic medications,TRUE,int
use with drug1 and other drug2 : a synergistic effect may be expected when drug0 are given concurrently with drug0  similar drug0 or drug0 such as drug0 .,cholinomimetics,cholinesterase inhibitors,FALSE,none
use with drug1 and other drug2 : a synergistic effect may be expected when drug0 are given concurrently with drug0  similar drug0 or drug0 such as drug0 .,cholinomimetics,cholinesterase inhibitors,FALSE,none
use with drug1 and other drug0 : a synergistic effect may be expected when drug0 are given concurrently with drug2  similar drug0 or drug0 such as drug0 .,cholinomimetics,succinylcholine,FALSE,none
use with drug1 and other drug0 : a synergistic effect may be expected when drug0 are given concurrently with drug0  similar drug2 or drug0 such as drug0 .,cholinomimetics,neuromuscular blocking agents,FALSE,none
use with drug1 and other drug0 : a synergistic effect may be expected when drug0 are given concurrently with drug0  similar drug0 or drug2 such as drug0 .,cholinomimetics,cholinergic agonists,FALSE,none
use with drug1 and other drug0 : a synergistic effect may be expected when drug0 are given concurrently with drug0  similar drug0 or drug0 such as drug2 .,cholinomimetics,bethanechol,FALSE,none
use with drug0 and other drug1 : a synergistic effect may be expected when drug0 are given concurrently with drug2  similar drug0 or drug0 such as drug0 .,cholinesterase inhibitors,succinylcholine,FALSE,none
use with drug0 and other drug1 : a synergistic effect may be expected when drug0 are given concurrently with drug0  similar drug2 or drug0 such as drug0 .,cholinesterase inhibitors,neuromuscular blocking agents,FALSE,none
use with drug0 and other drug1 : a synergistic effect may be expected when drug0 are given concurrently with drug0  similar drug0 or drug2 such as drug0 .,cholinesterase inhibitors,cholinergic agonists,FALSE,none
use with drug0 and other drug1 : a synergistic effect may be expected when drug0 are given concurrently with drug0  similar drug0 or drug0 such as drug2 .,cholinesterase inhibitors,bethanechol,FALSE,none
use with drug0 and other drug1 : a synergistic effect may be expected when drug0 are given concurrently with drug2  similar drug0 or drug0 such as drug0 .,cholinesterase inhibitors,succinylcholine,TRUE,effect
use with drug0 and other drug1 : a synergistic effect may be expected when drug0 are given concurrently with drug0  similar drug2 or drug0 such as drug0 .,cholinesterase inhibitors,neuromuscular blocking agents,TRUE,effect
use with drug0 and other drug1 : a synergistic effect may be expected when drug0 are given concurrently with drug0  similar drug0 or drug2 such as drug0 .,cholinesterase inhibitors,cholinergic agonists,TRUE,effect
use with drug0 and other drug1 : a synergistic effect may be expected when drug0 are given concurrently with drug0  similar drug0 or drug0 such as drug2 .,cholinesterase inhibitors,bethanechol,TRUE,effect
use with drug0 and other drug0 : a synergistic effect may be expected when drug0 are given concurrently with drug1  similar drug2 or drug0 such as drug0 .,succinylcholine,neuromuscular blocking agents,FALSE,none
use with drug0 and other drug0 : a synergistic effect may be expected when drug0 are given concurrently with drug1  similar drug0 or drug2 such as drug0 .,succinylcholine,cholinergic agonists,FALSE,none
use with drug0 and other drug0 : a synergistic effect may be expected when drug0 are given concurrently with drug1  similar drug0 or drug0 such as drug2 .,succinylcholine,bethanechol,FALSE,none
use with drug0 and other drug0 : a synergistic effect may be expected when drug0 are given concurrently with drug0  similar drug1 or drug2 such as drug0 .,neuromuscular blocking agents,cholinergic agonists,FALSE,none
use with drug0 and other drug0 : a synergistic effect may be expected when drug0 are given concurrently with drug0  similar drug1 or drug0 such as drug2 .,neuromuscular blocking agents,bethanechol,FALSE,none
if drug1 is administered following administration of drug2  it should not be given until recovery from drug0 has been observed .,zemuron,succinylcholine,TRUE,advise
if drug1 is administered following administration of drug2  it should not be given until recovery from drug0 has been observed .,zemuron,succinylcholine,FALSE,none
the median duration of action of drug1 0.6 mg/kg administered after a 1 mg/kg dose of drug2 when t 1 returned to 75 % of control was 36 minutes ( range 14-57  n=12 ) vs .,zemuron,succinylcholine,FALSE,none
there are no controlled studies documenting the use of drug1 before or after other drug2 .,zemuron,nondepolarizing muscle relaxants,FALSE,none
drug1 should be used with caution in patients receiving other local drug2 or agents structurally related to drug0  since the toxic effects of these drugs are additive .,ropivacaine,anesthetics,TRUE,advise
drug1 should be used with caution in patients receiving other local drug0 or agents structurally related to drug2  since the toxic effects of these drugs are additive .,ropivacaine,amide-type local anesthetics,FALSE,none
drug0 should be used with caution in patients receiving other local drug1 or agents structurally related to drug2  since the toxic effects of these drugs are additive .,anesthetics,amide-type local anesthetics,FALSE,none
in vivo  the plasma clearance of drug1 was reduced by 70 % during coadministration of drug2 ( 25 mg bid for 2 days )  a selective and potent cyp1a2 inhibitor .,ropivacaine,fluvoxamine,TRUE,mechanism
thus strong inhibitors of cytochrome p4501a2  such as drug1  given concomitantly during administration of drug2  can interact with drug0 leading to increased drug0 plasma levels .,fluvoxamine,ropivacaine,TRUE,int
thus strong inhibitors of cytochrome p4501a2  such as drug1  given concomitantly during administration of drug2  can interact with drug0 leading to increased drug0 plasma levels .,fluvoxamine,ropivacaine,FALSE,none
thus strong inhibitors of cytochrome p4501a2  such as drug1  given concomitantly during administration of drug2  can interact with drug0 leading to increased drug0 plasma levels .,fluvoxamine,ropivacaine,FALSE,none
possible interactions with drugs known to be metabolized by cyp1a2 via competitive inhibition such as drug1 and drug2 may also occur .,theophylline,imipramine,FALSE,none
coadministration of a selective and potent inhibitor of cyp3a4  drug1 ( 100 mg bid for 2 days with drug2 infusion administered 1 hour after drug0 ) caused a 15 % reduction in in-vivo plasma clearance of drug0 .,ketoconazole,ropivacaine,FALSE,none
coadministration of a selective and potent inhibitor of cyp3a4  drug1 ( 100 mg bid for 2 days with drug2 infusion administered 1 hour after drug0 ) caused a 15 % reduction in in-vivo plasma clearance of drug0 .,ketoconazole,ropivacaine,TRUE,mechanism
coadministration of a selective and potent inhibitor of cyp3a4  drug2 ( 100 mg bid for 2 days with drug1 infusion administered 1 hour after drug0 ) caused a 15 % reduction in in-vivo plasma clearance of drug0 .,ropivacaine,ketoconazole,FALSE,none
coadministration of a selective and potent inhibitor of cyp3a4  drug1 ( 100 mg bid for 2 days with drug2 infusion administered 1 hour after drug0 ) caused a 15 % reduction in in-vivo plasma clearance of drug0 .,ketoconazole,ropivacaine,FALSE,none
an inhibitor of cyp2c8 ( such as drug1 ) may increase the auc of drug2 and an inducer of cyp2c8 ( such as drug0 ) may decrease the auc of drug0 .,gemfibrozil,rosiglitazone,TRUE,mechanism
an inhibitor of cyp2c8 ( such as drug1 ) may increase the auc of drug0 and an inducer of cyp2c8 ( such as drug2 ) may decrease the auc of drug0 .,gemfibrozil,rifampin,FALSE,none
an inhibitor of cyp2c8 ( such as drug1 ) may increase the auc of drug2 and an inducer of cyp2c8 ( such as drug0 ) may decrease the auc of drug0 .,gemfibrozil,rosiglitazone,FALSE,none
an inhibitor of cyp2c8 ( such as drug0 ) may increase the auc of drug1 and an inducer of cyp2c8 ( such as drug2 ) may decrease the auc of drug0 .,rosiglitazone,rifampin,FALSE,none
an inhibitor of cyp2c8 ( such as drug0 ) may increase the auc of drug2 and an inducer of cyp2c8 ( such as drug1 ) may decrease the auc of drug0 .,rifampin,rosiglitazone,TRUE,mechanism
concomitant administrations not recommended : - drug1 and drug2 : certain drug0 interact with drug0 and drug0 leading to increased serum concentrations of the latter .,terfenadine,astemizole,FALSE,none
concomitant administrations not recommended : - drug1 and drug0 : certain drug2 interact with drug0 and drug0 leading to increased serum concentrations of the latter .,terfenadine,macrolides,FALSE,none
concomitant administrations not recommended : - drug1 and drug2 : certain drug0 interact with drug0 and drug0 leading to increased serum concentrations of the latter .,terfenadine,astemizole,FALSE,none
concomitant administrations not recommended : - drug0 and drug1 : certain drug2 interact with drug0 and drug0 leading to increased serum concentrations of the latter .,astemizole,macrolides,FALSE,none
concomitant administrations not recommended : - drug2 and drug1 : certain drug0 interact with drug0 and drug0 leading to increased serum concentrations of the latter .,astemizole,terfenadine,FALSE,none
concomitant administrations not recommended : - drug2 and drug0 : certain drug1 interact with drug0 and drug0 leading to increased serum concentrations of the latter .,macrolides,terfenadine,TRUE,int
concomitant administrations not recommended : - drug0 and drug2 : certain drug1 interact with drug0 and drug0 leading to increased serum concentrations of the latter .,macrolides,astemizole,TRUE,int
concomitant administrations not recommended : - drug1 and drug2 : certain drug0 interact with drug0 and drug0 leading to increased serum concentrations of the latter .,terfenadine,astemizole,FALSE,none
- drug1  drug0 : other drugs such as drug0 or drug0  which are metabolised by hepatic cyp3a isozymes have been associated with qt interval prolongation and/or cardiac arrythmias ( typically torsades de pointe ) as a result of increase in their serum level subsequent to interaction with significant inhibitors of the isozyme  including some drug2 .,cisapride,macrolide antibacterials,FALSE,none
- drug0  drug1 : other drugs such as drug0 or drug0  which are metabolised by hepatic cyp3a isozymes have been associated with qt interval prolongation and/or cardiac arrythmias ( typically torsades de pointe ) as a result of increase in their serum level subsequent to interaction with significant inhibitors of the isozyme  including some drug2 .,pimozide,macrolide antibacterials,TRUE,mechanism
- drug1  drug0 : other drugs such as drug0 or drug0  which are metabolised by hepatic cyp3a isozymes have been associated with qt interval prolongation and/or cardiac arrythmias ( typically torsades de pointe ) as a result of increase in their serum level subsequent to interaction with significant inhibitors of the isozyme  including some drug2 .,cisapride,macrolide antibacterials,TRUE,mechanism
- drug0  drug1 : other drugs such as drug0 or drug0  which are metabolised by hepatic cyp3a isozymes have been associated with qt interval prolongation and/or cardiac arrythmias ( typically torsades de pointe ) as a result of increase in their serum level subsequent to interaction with significant inhibitors of the isozyme  including some drug2 .,pimozide,macrolide antibacterials,FALSE,none
however  in patients with paget 's disease prior drug1 use appears to reduce the anti-resorptive response to calcitonin ( salmon ) nasal spray .,diphosphonate,calcitonin (salmon),TRUE,effect
drug1 and other drug2 will be additive to drug0 and may increase plasma concentrations of drug0 to toxic levels .,aspirin,salicylate drugs,FALSE,none
drug1 and other drug0 drugs will be additive to drug2 and may increase plasma concentrations of drug0 to toxic levels .,aspirin,disalcid,TRUE,effect
drug1 and other drug0 drugs will be additive to drug0 and may increase plasma concentrations of drug2 to toxic levels .,aspirin,salicylic acid,FALSE,none
drug0 and other drug1 will be additive to drug2 and may increase plasma concentrations of drug0 to toxic levels .,salicylate drugs,disalcid,TRUE,effect
drug0 and other drug1 will be additive to drug0 and may increase plasma concentrations of drug2 to toxic levels .,salicylate drugs,salicylic acid,FALSE,none
drug0 and other drug0 drugs will be additive to drug1 and may increase plasma concentrations of drug2 to toxic levels .,disalcid,salicylic acid,FALSE,none
drug1 given concomitantly with drug2 may predispose to systemic bleeding .,salicylates,anticoagulant drugs,TRUE,effect
drug1 may enhance the drug0 effect of oral drug2 of the drug0 class .,salicylates,antidiabetic drugs,TRUE,effect
drug1 competes with a number of drugs for protein binding sites  notably drug2  drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0  and possibly drug0 .,salicylate,penicillin,TRUE,mechanism
drug1 competes with a number of drugs for protein binding sites  notably drug0  drug2  drug0  drug0  drug0  drug0  drug0  drug0  drug0  and possibly drug0 .,salicylate,thiopental,TRUE,mechanism
drug1 competes with a number of drugs for protein binding sites  notably drug0  drug0  drug2  drug0  drug0  drug0  drug0  drug0  drug0  and possibly drug0 .,salicylate,thyroxine,TRUE,mechanism
drug1 competes with a number of drugs for protein binding sites  notably drug0  drug0  drug0  drug2  drug0  drug0  drug0  drug0  drug0  and possibly drug0 .,salicylate,triiodothyronine,TRUE,mechanism
drug1 competes with a number of drugs for protein binding sites  notably drug0  drug0  drug0  drug0  drug2  drug0  drug0  drug0  drug0  and possibly drug0 .,salicylate,phenytoin,TRUE,mechanism
drug1 competes with a number of drugs for protein binding sites  notably drug0  drug0  drug0  drug0  drug0  drug2  drug0  drug0  drug0  and possibly drug0 .,salicylate,sulfinpyrazone,TRUE,mechanism
drug1 competes with a number of drugs for protein binding sites  notably drug0  drug0  drug0  drug0  drug0  drug0  drug2  drug0  drug0  and possibly drug0 .,salicylate,naproxen,TRUE,mechanism
drug1 competes with a number of drugs for protein binding sites  notably drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug2  drug0  and possibly drug0 .,salicylate,warfarin,TRUE,mechanism
drug1 competes with a number of drugs for protein binding sites  notably drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug2  and possibly drug0 .,salicylate,methotrexate,TRUE,mechanism
drug1 competes with a number of drugs for protein binding sites  notably drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0  and possibly drug2 .,salicylate,corticosteroids,TRUE,mechanism
drug0 competes with a number of drugs for protein binding sites  notably drug1  drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0  and possibly drug2 .,penicillin,corticosteroids,FALSE,none
drug0 competes with a number of drugs for protein binding sites  notably drug0  drug1  drug0  drug0  drug0  drug0  drug0  drug0  drug0  and possibly drug2 .,thiopental,corticosteroids,FALSE,none
drug0 competes with a number of drugs for protein binding sites  notably drug0  drug0  drug1  drug0  drug0  drug0  drug0  drug0  drug0  and possibly drug2 .,thyroxine,corticosteroids,FALSE,none
drug0 competes with a number of drugs for protein binding sites  notably drug0  drug0  drug0  drug1  drug0  drug0  drug0  drug0  drug0  and possibly drug2 .,triiodothyronine,corticosteroids,FALSE,none
drug0 competes with a number of drugs for protein binding sites  notably drug0  drug0  drug0  drug0  drug1  drug0  drug0  drug0  drug0  and possibly drug2 .,phenytoin,corticosteroids,FALSE,none
drug0 competes with a number of drugs for protein binding sites  notably drug0  drug0  drug0  drug0  drug0  drug1  drug0  drug0  drug0  and possibly drug2 .,sulfinpyrazone,corticosteroids,FALSE,none
drug0 competes with a number of drugs for protein binding sites  notably drug0  drug0  drug0  drug0  drug0  drug0  drug1  drug0  drug0  and possibly drug2 .,naproxen,corticosteroids,FALSE,none
drug0 competes with a number of drugs for protein binding sites  notably drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug1  drug0  and possibly drug2 .,warfarin,corticosteroids,FALSE,none
drug0 competes with a number of drugs for protein binding sites  notably drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug1  and possibly drug2 .,methotrexate,corticosteroids,FALSE,none
drugs which may potentiate the myeloproliferative effects of drug1  such as drug2 and drug0  should be used with caution .,leukine,lithium,TRUE,effect
drugs which may potentiate the myeloproliferative effects of drug1  such as drug0 and drug2  should be used with caution .,leukine,corticosteroids,TRUE,effect
drugs which may potentiate the myeloproliferative effects of drug0  such as drug1 and drug2  should be used with caution .,lithium,corticosteroids,FALSE,none
drug1 should be used with care in patients taking other drugs that are capable of causing cns effects such as drug2  drug0  or drug0 .,scopolamine,sedatives,TRUE,advise
drug1 should be used with care in patients taking other drugs that are capable of causing cns effects such as drug0  drug2  or drug0 .,scopolamine,tranquilizers,TRUE,advise
drug1 should be used with care in patients taking other drugs that are capable of causing cns effects such as drug0  drug0  or drug2 .,scopolamine,alcohol,TRUE,advise
drug0 should be used with care in patients taking other drugs that are capable of causing cns effects such as drug0  drug1  or drug2 .,tranquilizers,alcohol,FALSE,none
e.g.  other drug1  drug0 ( including drug2 )  drug0 drug0  and drug0 .,belladonna alkaloids,meclizine,FALSE,none
e.g.  other drug1  drug0 ( including drug0 )  drug2  and drug0 .,belladonna alkaloids,tricyclic antidepressants,FALSE,none
e.g.  other drug1  drug0 ( including drug0 )  drug0 drug0  and drug2 .,belladonna alkaloids,muscle relaxants,FALSE,none
e.g.  other drug0  drug1 ( including drug2 )  drug0 drug0  and drug0 .,antihistamines,meclizine,FALSE,none
e.g.  other drug0  drug1 ( including drug0 )  drug2  and drug0 .,antihistamines,tricyclic antidepressants,FALSE,none
e.g.  other drug0  drug1 ( including drug0 )  drug0 drug0  and drug2 .,antihistamines,muscle relaxants,FALSE,none
e.g.  other drug0  drug0 ( including drug1 )  drug2  and drug0 .,meclizine,tricyclic antidepressants,FALSE,none
e.g.  other drug0  drug0 ( including drug1 )  drug0 drug0  and drug2 .,meclizine,muscle relaxants,FALSE,none
e.g.  other drug0  drug0 ( including drug0 )  drug1  and drug2 .,tricyclic antidepressants,muscle relaxants,FALSE,none
drug1 may decrease the effectiveness of oral drug2  certain drug0  drug0  drug0  drug0  drug0  and drug0 .,barbiturates,contraceptives,TRUE,int
drug1 may decrease the effectiveness of oral drug0  certain drug2  drug0  drug0  drug0  drug0  and drug0 .,barbiturates,antibiotics,TRUE,int
drug1 may decrease the effectiveness of oral drug0  certain drug0  drug2  drug0  drug0  drug0  and drug0 .,barbiturates,quinidine,TRUE,int
drug1 may decrease the effectiveness of oral drug0  certain drug0  drug0  drug2  drug0  drug0  and drug0 .,barbiturates,theophylline,TRUE,int
drug1 may decrease the effectiveness of oral drug0  certain drug0  drug0  drug0  drug2  drug0  and drug0 .,barbiturates,corticosteroids,TRUE,int
drug1 may decrease the effectiveness of oral drug0  certain drug0  drug0  drug0  drug0  drug2  and drug0 .,barbiturates,anticoagulants,TRUE,int
drug1 may decrease the effectiveness of oral drug0  certain drug0  drug0  drug0  drug0  drug0  and drug2 .,barbiturates,beta blockers,TRUE,int
drug0 may decrease the effectiveness of oral drug1  certain drug2  drug0  drug0  drug0  drug0  and drug0 .,contraceptives,antibiotics,FALSE,none
drug0 may decrease the effectiveness of oral drug1  certain drug0  drug0  drug0  drug0  drug0  and drug2 .,contraceptives,beta blockers,FALSE,none
drug0 may decrease the effectiveness of oral drug0  certain drug0  drug0  drug0  drug0  drug1  and drug2 .,anticoagulants,beta blockers,FALSE,none
the occurrence of stupor  muscular rigidity  severe agitation  and elevated temperature has been reported in some patients receiving the combination of drug1 and drug2 .,selegiline,meperidine,TRUE,effect
this is typical of the interaction of drug1 and drug2 .,meperidine,maois,TRUE,int
severe toxicity has also been reported in patients receiving the combination of drug1 and drug2 and drug0 and drug0 .,tricyclic antidepressants,eldepryl,TRUE,effect
severe toxicity has also been reported in patients receiving the combination of drug1 and drug0 and drug2 and drug0 .,tricyclic antidepressants,selective serotonin reuptake inhibitors,FALSE,none
severe toxicity has also been reported in patients receiving the combination of drug1 and drug2 and drug0 and drug0 .,tricyclic antidepressants,eldepryl,FALSE,none
severe toxicity has also been reported in patients receiving the combination of drug0 drug0 and drug1 and drug2 and drug0 .,eldepryl,selective serotonin reuptake inhibitors,FALSE,none
severe toxicity has also been reported in patients receiving the combination of drug0 drug0 and drug2 and drug1 and drug0 .,selective serotonin reuptake inhibitors,eldepryl,TRUE,effect
one case of hypertensive crisis has been reported in a patient taking the recommended doses of drug1 and a drug2 ( drug0 ) .,selegiline,sympathomimetic medication,TRUE,effect
one case of hypertensive crisis has been reported in a patient taking the recommended doses of drug1 and a drug0 ( drug2 ) .,selegiline,ephedrine,TRUE,effect
drug1 : there was a slight increase in the area under the curve ( auc  11 % ) and mean peak drug concentration ( cmax  18 % ) of drug0 with the co-administration of 100 mg drug2 for 10 days .,digoxin,sitagliptin,FALSE,none
drug1 : there was a slight increase in the area under the curve ( auc  11 % ) and mean peak drug concentration ( cmax  18 % ) of drug0 with the co-administration of 100 mg drug2 for 10 days .,digoxin,sitagliptin,TRUE,mechanism
no dosage adjustment of drug1 or drug2 is recommended .,digoxin,januvia,FALSE,none
drug1 and drug2 are incompatible with drug0 solution .,norepinephrine,dobutamine,FALSE,none
drug1 and drug0 are incompatible with drug2 solution .,norepinephrine,sodium bicarbonate,TRUE,int
drug0 and drug1 are incompatible with drug2 solution .,dobutamine,sodium bicarbonate,TRUE,int
the addition of drug1 to parenteral solutions containing drug2 should be avoided  except where compatibility has been previously established .,sodium bicarbonate,calcium,FALSE,none
do not exceed a 5 mg daily dose of drug1 when administered with therapeutic doses of drug2 or other potent cyp3a4 inhibitors .,vesicare,ketoconazole,TRUE,advise
limited published data indicate that drug1 treatment increases cytochrome p450 ( cp450 ) mediated drug2 clearance in man .,gh,antipyrine,TRUE,mechanism
these data suggest that drug1 administration may alter the clearance of compounds known to be metabolized by cp450 liver enzymes ( e.g.  drug2  drug0  drug0  drug0 ) .,gh,corticosteroids,TRUE,mechanism
these data suggest that drug1 administration may alter the clearance of compounds known to be metabolized by cp450 liver enzymes ( e.g.  drug0  drug2  drug0  drug0 ) .,gh,sex steroids,TRUE,mechanism
these data suggest that drug1 administration may alter the clearance of compounds known to be metabolized by cp450 liver enzymes ( e.g.  drug0  drug0  drug2  drug0 ) .,gh,anticonvulsants,TRUE,mechanism
these data suggest that drug1 administration may alter the clearance of compounds known to be metabolized by cp450 liver enzymes ( e.g.  drug0  drug0  drug0  drug2 ) .,gh,cyclosporin,TRUE,mechanism
caution is recommended when administering drug1 with compounds that are metabolized/eliminated predominantly by the ugt1a1 pathway ( e.g . drug2 ) .,nexavar,irinotecan,TRUE,advise
concomitant treatment with drug1 resulted in a 21 % increase in the auc of drug2 .,nexavar,doxorubicin,TRUE,mechanism
caution is recommended when administering drug1 with drug2 .,doxorubicin,nexavar,TRUE,advise
drug1 competitively inhibits the intracellular phosphorylation of drug2 .,zidovudine,stavudine,TRUE,effect
therefore  use of drug1 in combination with drug2 should be avoided .,zidovudine,zerit,TRUE,advise
in vitro data indicate that the phosphorylation of drug1 is also inhibited at relevant concentrations by drug2 and drug0 .,stavudine,doxorubicin,TRUE,effect
in vitro data indicate that the phosphorylation of drug1 is also inhibited at relevant concentrations by drug0 and drug2 .,stavudine,ribavirin,TRUE,effect
in vitro data indicate that the phosphorylation of drug0 is also inhibited at relevant concentrations by drug1 and drug2 .,doxorubicin,ribavirin,FALSE,none
use of drug1 and drug2 -- drug0  drug0  alone or in combination with drug0 and drug0  may cause bleeding complications .,anticoagulants,antiplatelet agents,FALSE,none
use of drug1 and drug0 -- drug2  drug0  alone or in combination with drug0 and drug0  may cause bleeding complications .,anticoagulants,streptase,FALSE,none
use of drug1 and drug0 -- drug0  drug2  alone or in combination with drug0 and drug0  may cause bleeding complications .,anticoagulants,streptokinase,FALSE,none
use of drug1 and drug2 -- drug0  drug0  alone or in combination with drug0 and drug0  may cause bleeding complications .,anticoagulants,antiplatelet agents,FALSE,none
use of drug0 and drug1 -- drug2  drug0  alone or in combination with drug0 and drug0  may cause bleeding complications .,antiplatelet agents,streptase,FALSE,none
use of drug0 and drug1 -- drug0  drug2  alone or in combination with drug0 and drug0  may cause bleeding complications .,antiplatelet agents,streptokinase,FALSE,none
use of drug2 and drug1 -- drug0  drug0  alone or in combination with drug0 and drug0  may cause bleeding complications .,antiplatelet agents,anticoagulants,FALSE,none
use of drug0 and drug2 -- drug1  drug0  alone or in combination with drug0 and drug0  may cause bleeding complications .,streptase,antiplatelet agents,TRUE,effect
use of drug2 and drug0 -- drug1  drug0  alone or in combination with drug0 and drug0  may cause bleeding complications .,streptase,anticoagulants,TRUE,effect
use of drug0 and drug2 -- drug0  drug1  alone or in combination with drug0 and drug0  may cause bleeding complications .,streptokinase,antiplatelet agents,TRUE,effect
use of drug2 and drug0 -- drug0  drug1  alone or in combination with drug0 and drug0  may cause bleeding complications .,streptokinase,anticoagulants,TRUE,effect
use of drug2 and drug1 -- drug0  drug0  alone or in combination with drug0 and drug0  may cause bleeding complications .,antiplatelet agents,anticoagulants,FALSE,none
in the treatment of acute mi  drug1  when not otherwise contraindicated  should be administered with drug2 ( see below ) .,aspirin,streptokinase,FALSE,none
anticoagulation and drug1 after treatment for myocardial infarction -- in the treatment of acute myocardial infarction  the use of drug2 has been shown to reduce the incidence of reinfarction and stroke .,antiplatelets,aspirin,FALSE,none
drug1 has been reported to prolong the elimination half-life of drug2 and may lead to severe bone marrow suppression ;,streptozocin,doxorubicin,TRUE,mechanism
a reduction of the drug1 dosage should be considered in patients receiving drug2 concurrently .,doxorubicin,zanosar,TRUE,advise
the concurrent use of drug1 and drug2 has been reported in one case to result in reduced drug0 cytotoxicity .,streptozocin,phenytoin,TRUE,effect
the concurrent use of drug2 and drug1 has been reported in one case to result in reduced drug0 cytotoxicity .,phenytoin,streptozocin,FALSE,none
concomitant administration of drug1 with other chelation therapy  such as drug2 is not recommended .,chemet,cana 2 edta,TRUE,advise
drug1 may increase the effects of drug2  drug0  and drug0 .,sulfamethizole,barbiturates,TRUE,effect
drug1 may increase the effects of drug0  drug2  and drug0 .,sulfamethizole,tolbutamide,TRUE,effect
drug1 may increase the effects of drug0  drug0  and drug2 .,sulfamethizole,uricosurics,TRUE,effect
drug0 may increase the effects of drug0  drug1  and drug2 .,tolbutamide,uricosurics,FALSE,none
it may also interact with drug1 ( increased thrombocytopenia )  drug2 ( increased nephrotoxicity )  drug0 agents ( increased drug0 response )  drug0 ( increased drug0 effect )  drug0 ( decreased renal excretion of drug0 )  drug0 ( decreased hepatic clearance of drug0 ) .,thiazides,cyclosporine,FALSE,none
it may also interact with drug1 ( increased thrombocytopenia )  drug0 ( increased nephrotoxicity )  drug2 ( increased drug0 response )  drug0 ( increased drug0 effect )  drug0 ( decreased renal excretion of drug0 )  drug0 ( decreased hepatic clearance of drug0 ) .,thiazides,sulfonylurea agents,FALSE,none
it may also interact with drug1 ( increased thrombocytopenia )  drug0 ( increased nephrotoxicity )  drug0 agents ( increased drug0 response )  drug2 ( increased drug0 effect )  drug0 ( decreased renal excretion of drug0 )  drug0 ( decreased hepatic clearance of drug0 ) .,thiazides,warfarin,FALSE,none
it may also interact with drug1 ( increased thrombocytopenia )  drug0 ( increased nephrotoxicity )  drug0 agents ( increased drug0 response )  drug0 ( increased drug0 effect )  drug2 ( decreased renal excretion of drug0 )  drug0 ( decreased hepatic clearance of drug0 ) .,thiazides,methotrexate,FALSE,none
it may also interact with drug1 ( increased thrombocytopenia )  drug0 ( increased nephrotoxicity )  drug0 agents ( increased drug0 response )  drug0 ( increased drug0 effect )  drug2 ( decreased renal excretion of drug0 )  drug0 ( decreased hepatic clearance of drug0 ) .,thiazides,methotrexate,FALSE,none
it may also interact with drug1 ( increased thrombocytopenia )  drug0 ( increased nephrotoxicity )  drug0 agents ( increased drug0 response )  drug0 ( increased drug0 effect )  drug0 ( decreased renal excretion of drug0 )  drug2 ( decreased hepatic clearance of drug0 ) .,thiazides,phenytoin,FALSE,none
it may also interact with drug1 ( increased thrombocytopenia )  drug0 ( increased nephrotoxicity )  drug0 agents ( increased drug0 response )  drug0 ( increased drug0 effect )  drug0 ( decreased renal excretion of drug0 )  drug2 ( decreased hepatic clearance of drug0 ) .,thiazides,phenytoin,FALSE,none
it may also interact with drug0 ( increased thrombocytopenia )  drug1 ( increased nephrotoxicity )  drug2 ( increased drug0 response )  drug0 ( increased drug0 effect )  drug0 ( decreased renal excretion of drug0 )  drug0 ( decreased hepatic clearance of drug0 ) .,cyclosporine,sulfonylurea agents,FALSE,none
it may also interact with drug0 ( increased thrombocytopenia )  drug1 ( increased nephrotoxicity )  drug0 agents ( increased drug0 response )  drug2 ( increased drug0 effect )  drug0 ( decreased renal excretion of drug0 )  drug0 ( decreased hepatic clearance of drug0 ) .,cyclosporine,warfarin,FALSE,none
it may also interact with drug0 ( increased thrombocytopenia )  drug1 ( increased nephrotoxicity )  drug0 agents ( increased drug0 response )  drug0 ( increased drug0 effect )  drug2 ( decreased renal excretion of drug0 )  drug0 ( decreased hepatic clearance of drug0 ) .,cyclosporine,methotrexate,FALSE,none
it may also interact with drug0 ( increased thrombocytopenia )  drug1 ( increased nephrotoxicity )  drug0 agents ( increased drug0 response )  drug0 ( increased drug0 effect )  drug2 ( decreased renal excretion of drug0 )  drug0 ( decreased hepatic clearance of drug0 ) .,cyclosporine,methotrexate,FALSE,none
it may also interact with drug0 ( increased thrombocytopenia )  drug1 ( increased nephrotoxicity )  drug0 agents ( increased drug0 response )  drug0 ( increased drug0 effect )  drug0 ( decreased renal excretion of drug0 )  drug2 ( decreased hepatic clearance of drug0 ) .,cyclosporine,phenytoin,FALSE,none
it may also interact with drug0 ( increased thrombocytopenia )  drug1 ( increased nephrotoxicity )  drug0 agents ( increased drug0 response )  drug0 ( increased drug0 effect )  drug0 ( decreased renal excretion of drug0 )  drug2 ( decreased hepatic clearance of drug0 ) .,cyclosporine,phenytoin,FALSE,none
it may also interact with drug0 ( increased thrombocytopenia )  drug0 ( increased nephrotoxicity )  drug1 ( increased drug0 response )  drug2 ( increased drug0 effect )  drug0 ( decreased renal excretion of drug0 )  drug0 ( decreased hepatic clearance of drug0 ) .,sulfonylurea agents,warfarin,FALSE,none
it may also interact with drug0 ( increased thrombocytopenia )  drug0 ( increased nephrotoxicity )  drug1 ( increased drug0 response )  drug0 ( increased drug0 effect )  drug2 ( decreased renal excretion of drug0 )  drug0 ( decreased hepatic clearance of drug0 ) .,sulfonylurea agents,methotrexate,FALSE,none
it may also interact with drug0 ( increased thrombocytopenia )  drug0 ( increased nephrotoxicity )  drug1 ( increased drug0 response )  drug0 ( increased drug0 effect )  drug2 ( decreased renal excretion of drug0 )  drug0 ( decreased hepatic clearance of drug0 ) .,sulfonylurea agents,methotrexate,FALSE,none
it may also interact with drug0 ( increased thrombocytopenia )  drug0 ( increased nephrotoxicity )  drug1 ( increased drug0 response )  drug0 ( increased drug0 effect )  drug0 ( decreased renal excretion of drug0 )  drug2 ( decreased hepatic clearance of drug0 ) .,sulfonylurea agents,phenytoin,FALSE,none
it may also interact with drug0 ( increased thrombocytopenia )  drug0 ( increased nephrotoxicity )  drug1 ( increased drug0 response )  drug0 ( increased drug0 effect )  drug0 ( decreased renal excretion of drug0 )  drug2 ( decreased hepatic clearance of drug0 ) .,sulfonylurea agents,phenytoin,FALSE,none
it may also interact with drug0 ( increased thrombocytopenia )  drug0 ( increased nephrotoxicity )  drug0 agents ( increased drug0 response )  drug1 ( increased drug0 effect )  drug2 ( decreased renal excretion of drug0 )  drug0 ( decreased hepatic clearance of drug0 ) .,warfarin,methotrexate,FALSE,none
it may also interact with drug0 ( increased thrombocytopenia )  drug0 ( increased nephrotoxicity )  drug0 agents ( increased drug0 response )  drug1 ( increased drug0 effect )  drug2 ( decreased renal excretion of drug0 )  drug0 ( decreased hepatic clearance of drug0 ) .,warfarin,methotrexate,FALSE,none
it may also interact with drug0 ( increased thrombocytopenia )  drug0 ( increased nephrotoxicity )  drug0 agents ( increased drug0 response )  drug1 ( increased drug0 effect )  drug0 ( decreased renal excretion of drug0 )  drug2 ( decreased hepatic clearance of drug0 ) .,warfarin,phenytoin,FALSE,none
it may also interact with drug0 ( increased thrombocytopenia )  drug0 ( increased nephrotoxicity )  drug0 agents ( increased drug0 response )  drug1 ( increased drug0 effect )  drug0 ( decreased renal excretion of drug0 )  drug2 ( decreased hepatic clearance of drug0 ) .,warfarin,phenytoin,FALSE,none
it may also interact with drug0 ( increased thrombocytopenia )  drug0 ( increased nephrotoxicity )  drug0 agents ( increased drug0 response )  drug0 ( increased drug0 effect )  drug1 ( decreased renal excretion of drug0 )  drug2 ( decreased hepatic clearance of drug0 ) .,methotrexate,phenytoin,FALSE,none
it may also interact with drug0 ( increased thrombocytopenia )  drug0 ( increased nephrotoxicity )  drug0 agents ( increased drug0 response )  drug0 ( increased drug0 effect )  drug1 ( decreased renal excretion of drug0 )  drug2 ( decreased hepatic clearance of drug0 ) .,methotrexate,phenytoin,FALSE,none
it may also interact with drug0 ( increased thrombocytopenia )  drug0 ( increased nephrotoxicity )  drug0 agents ( increased drug0 response )  drug0 ( increased drug0 effect )  drug1 ( decreased renal excretion of drug0 )  drug2 ( decreased hepatic clearance of drug0 ) .,methotrexate,phenytoin,FALSE,none
it may also interact with drug0 ( increased thrombocytopenia )  drug0 ( increased nephrotoxicity )  drug0 agents ( increased drug0 response )  drug0 ( increased drug0 effect )  drug1 ( decreased renal excretion of drug0 )  drug2 ( decreased hepatic clearance of drug0 ) .,methotrexate,phenytoin,FALSE,none
in elderly patients concurrently receiving certain drug1  primarily drug2  an increased incidence of thrombopenia with purpura has been reported .,diuretics,thiazides,FALSE,none
it has been reported that drug1 may prolong the prothrombin time in patients who are receiving the drug2 drug0 .,sulfamethoxazole,anticoagulant,FALSE,none
it has been reported that drug1 may prolong the prothrombin time in patients who are receiving the drug0 drug2 .,sulfamethoxazole,warfarin,TRUE,effect
it has been reported that drug0 may prolong the prothrombin time in patients who are receiving the drug1 drug2 .,anticoagulant,warfarin,FALSE,none
drug1 may inhibit the hepatic metabolism of drug2 .,sulfamethoxazole,phenytoin,TRUE,mechanism
at a 1.6-g dose  drug1 produced a slight but significant increase in the half-life of drug2 but did not produce a corresponding decrease in the metabolic clearance rate .,sulfamethoxazole,phenytoin,TRUE,mechanism
drug1 can also displace drug2 from plasma protein-binding sites  thus increasing free drug0 concentrations .,sulfonamides,methotrexate,TRUE,mechanism
drug1 can also displace drug2 from plasma protein-binding sites  thus increasing free drug0 concentrations .,sulfonamides,methotrexate,FALSE,none
reduced absorption of drug1 and drug2 have been reported when those agents were administered concomitantly with drug0 .,folic acid,digoxin,FALSE,none
reduced absorption of drug1 and drug0 have been reported when those agents were administered concomitantly with drug2 .,folic acid,sulfasalazine,TRUE,mechanism
reduced absorption of drug0 and drug1 have been reported when those agents were administered concomitantly with drug2 .,digoxin,sulfasalazine,TRUE,mechanism
daily doses of drug1 2 g ( maximum 3 g ) and weekly doses of drug2 7.5 mg ( maximum 15 mg ) were administered alone or in combination to 310 rheumatoid arthritis patients in two controlled 52-week clinical studies .,sulfasalazine,methotrexate,FALSE,none
drug1 may increase the effects of drug2  drug0  and drug0 .,sulfoxone,barbiturates,TRUE,effect
drug1 may increase the effects of drug0  drug2  and drug0 .,sulfoxone,tolbutamide,TRUE,effect
drug1 may increase the effects of drug0  drug0  and drug2 .,sulfoxone,uricosurics,TRUE,effect
drug0 may increase the effects of drug0  drug1  and drug2 .,tolbutamide,uricosurics,FALSE,none
it may also interact with drug1 ( increased thrombocytopenia )  drug2 ( increased nephrotoxicity )  drug0 agents ( increased drug0 response )  drug0 ( increased drug0 effect )  drug0 ( decreased renal excretion of drug0 )  drug0 ( decreased hepatic clearance of drug0 ) .,thiazides,cyclosporine,FALSE,none
it may also interact with drug1 ( increased thrombocytopenia )  drug0 ( increased nephrotoxicity )  drug2 ( increased drug0 response )  drug0 ( increased drug0 effect )  drug0 ( decreased renal excretion of drug0 )  drug0 ( decreased hepatic clearance of drug0 ) .,thiazides,sulfonylurea agents,FALSE,none
it may also interact with drug1 ( increased thrombocytopenia )  drug0 ( increased nephrotoxicity )  drug0 agents ( increased drug0 response )  drug2 ( increased drug0 effect )  drug0 ( decreased renal excretion of drug0 )  drug0 ( decreased hepatic clearance of drug0 ) .,thiazides,warfarin,FALSE,none
it may also interact with drug1 ( increased thrombocytopenia )  drug0 ( increased nephrotoxicity )  drug0 agents ( increased drug0 response )  drug0 ( increased drug0 effect )  drug2 ( decreased renal excretion of drug0 )  drug0 ( decreased hepatic clearance of drug0 ) .,thiazides,methotrexate,FALSE,none
it may also interact with drug1 ( increased thrombocytopenia )  drug0 ( increased nephrotoxicity )  drug0 agents ( increased drug0 response )  drug0 ( increased drug0 effect )  drug2 ( decreased renal excretion of drug0 )  drug0 ( decreased hepatic clearance of drug0 ) .,thiazides,methotrexate,FALSE,none
it may also interact with drug1 ( increased thrombocytopenia )  drug0 ( increased nephrotoxicity )  drug0 agents ( increased drug0 response )  drug0 ( increased drug0 effect )  drug0 ( decreased renal excretion of drug0 )  drug2 ( decreased hepatic clearance of drug0 ) .,thiazides,phenytoin,FALSE,none
it may also interact with drug1 ( increased thrombocytopenia )  drug0 ( increased nephrotoxicity )  drug0 agents ( increased drug0 response )  drug0 ( increased drug0 effect )  drug0 ( decreased renal excretion of drug0 )  drug2 ( decreased hepatic clearance of drug0 ) .,thiazides,phenytoin,FALSE,none
it may also interact with drug0 ( increased thrombocytopenia )  drug1 ( increased nephrotoxicity )  drug2 ( increased drug0 response )  drug0 ( increased drug0 effect )  drug0 ( decreased renal excretion of drug0 )  drug0 ( decreased hepatic clearance of drug0 ) .,cyclosporine,sulfonylurea agents,FALSE,none
it may also interact with drug0 ( increased thrombocytopenia )  drug1 ( increased nephrotoxicity )  drug0 agents ( increased drug0 response )  drug2 ( increased drug0 effect )  drug0 ( decreased renal excretion of drug0 )  drug0 ( decreased hepatic clearance of drug0 ) .,cyclosporine,warfarin,FALSE,none
it may also interact with drug0 ( increased thrombocytopenia )  drug1 ( increased nephrotoxicity )  drug0 agents ( increased drug0 response )  drug0 ( increased drug0 effect )  drug2 ( decreased renal excretion of drug0 )  drug0 ( decreased hepatic clearance of drug0 ) .,cyclosporine,methotrexate,FALSE,none
it may also interact with drug0 ( increased thrombocytopenia )  drug1 ( increased nephrotoxicity )  drug0 agents ( increased drug0 response )  drug0 ( increased drug0 effect )  drug2 ( decreased renal excretion of drug0 )  drug0 ( decreased hepatic clearance of drug0 ) .,cyclosporine,methotrexate,FALSE,none
it may also interact with drug0 ( increased thrombocytopenia )  drug1 ( increased nephrotoxicity )  drug0 agents ( increased drug0 response )  drug0 ( increased drug0 effect )  drug0 ( decreased renal excretion of drug0 )  drug2 ( decreased hepatic clearance of drug0 ) .,cyclosporine,phenytoin,FALSE,none
it may also interact with drug0 ( increased thrombocytopenia )  drug1 ( increased nephrotoxicity )  drug0 agents ( increased drug0 response )  drug0 ( increased drug0 effect )  drug0 ( decreased renal excretion of drug0 )  drug2 ( decreased hepatic clearance of drug0 ) .,cyclosporine,phenytoin,FALSE,none
it may also interact with drug0 ( increased thrombocytopenia )  drug0 ( increased nephrotoxicity )  drug1 ( increased drug0 response )  drug2 ( increased drug0 effect )  drug0 ( decreased renal excretion of drug0 )  drug0 ( decreased hepatic clearance of drug0 ) .,sulfonylurea agents,warfarin,FALSE,none
it may also interact with drug0 ( increased thrombocytopenia )  drug0 ( increased nephrotoxicity )  drug1 ( increased drug0 response )  drug0 ( increased drug0 effect )  drug2 ( decreased renal excretion of drug0 )  drug0 ( decreased hepatic clearance of drug0 ) .,sulfonylurea agents,methotrexate,FALSE,none
it may also interact with drug0 ( increased thrombocytopenia )  drug0 ( increased nephrotoxicity )  drug1 ( increased drug0 response )  drug0 ( increased drug0 effect )  drug2 ( decreased renal excretion of drug0 )  drug0 ( decreased hepatic clearance of drug0 ) .,sulfonylurea agents,methotrexate,FALSE,none
it may also interact with drug0 ( increased thrombocytopenia )  drug0 ( increased nephrotoxicity )  drug1 ( increased drug0 response )  drug0 ( increased drug0 effect )  drug0 ( decreased renal excretion of drug0 )  drug2 ( decreased hepatic clearance of drug0 ) .,sulfonylurea agents,phenytoin,FALSE,none
it may also interact with drug0 ( increased thrombocytopenia )  drug0 ( increased nephrotoxicity )  drug1 ( increased drug0 response )  drug0 ( increased drug0 effect )  drug0 ( decreased renal excretion of drug0 )  drug2 ( decreased hepatic clearance of drug0 ) .,sulfonylurea agents,phenytoin,FALSE,none
it may also interact with drug0 ( increased thrombocytopenia )  drug0 ( increased nephrotoxicity )  drug0 agents ( increased drug0 response )  drug1 ( increased drug0 effect )  drug2 ( decreased renal excretion of drug0 )  drug0 ( decreased hepatic clearance of drug0 ) .,warfarin,methotrexate,FALSE,none
it may also interact with drug0 ( increased thrombocytopenia )  drug0 ( increased nephrotoxicity )  drug0 agents ( increased drug0 response )  drug1 ( increased drug0 effect )  drug2 ( decreased renal excretion of drug0 )  drug0 ( decreased hepatic clearance of drug0 ) .,warfarin,methotrexate,FALSE,none
it may also interact with drug0 ( increased thrombocytopenia )  drug0 ( increased nephrotoxicity )  drug0 agents ( increased drug0 response )  drug1 ( increased drug0 effect )  drug0 ( decreased renal excretion of drug0 )  drug2 ( decreased hepatic clearance of drug0 ) .,warfarin,phenytoin,FALSE,none
it may also interact with drug0 ( increased thrombocytopenia )  drug0 ( increased nephrotoxicity )  drug0 agents ( increased drug0 response )  drug1 ( increased drug0 effect )  drug0 ( decreased renal excretion of drug0 )  drug2 ( decreased hepatic clearance of drug0 ) .,warfarin,phenytoin,FALSE,none
it may also interact with drug0 ( increased thrombocytopenia )  drug0 ( increased nephrotoxicity )  drug0 agents ( increased drug0 response )  drug0 ( increased drug0 effect )  drug1 ( decreased renal excretion of drug0 )  drug2 ( decreased hepatic clearance of drug0 ) .,methotrexate,phenytoin,FALSE,none
it may also interact with drug0 ( increased thrombocytopenia )  drug0 ( increased nephrotoxicity )  drug0 agents ( increased drug0 response )  drug0 ( increased drug0 effect )  drug1 ( decreased renal excretion of drug0 )  drug2 ( decreased hepatic clearance of drug0 ) .,methotrexate,phenytoin,FALSE,none
it may also interact with drug0 ( increased thrombocytopenia )  drug0 ( increased nephrotoxicity )  drug0 agents ( increased drug0 response )  drug0 ( increased drug0 effect )  drug1 ( decreased renal excretion of drug0 )  drug2 ( decreased hepatic clearance of drug0 ) .,methotrexate,phenytoin,FALSE,none
it may also interact with drug0 ( increased thrombocytopenia )  drug0 ( increased nephrotoxicity )  drug0 agents ( increased drug0 response )  drug0 ( increased drug0 effect )  drug1 ( decreased renal excretion of drug0 )  drug2 ( decreased hepatic clearance of drug0 ) .,methotrexate,phenytoin,FALSE,none
because there is a theoretical basis that these effects may be additive  use of drug1-containing or drug2 ( like drug0 or drug0 ) and drug0 within 24 hours of each other should be avoided .,ergotamine,ergot-type medications,FALSE,none
because there is a theoretical basis that these effects may be additive  use of drug1-containing or drug0 ( like drug2 or drug0 ) and drug0 within 24 hours of each other should be avoided .,ergotamine,dihydroergotamine,FALSE,none
because there is a theoretical basis that these effects may be additive  use of drug1-containing or drug0 ( like drug0 or drug2 ) and drug0 within 24 hours of each other should be avoided .,ergotamine,methysergide,FALSE,none
because there is a theoretical basis that these effects may be additive  use of drug1-containing or drug0 ( like drug0 or drug0 ) and drug2 within 24 hours of each other should be avoided .,ergotamine,sumatriptan,TRUE,advise
because there is a theoretical basis that these effects may be additive  use of drug0-containing or drug1 ( like drug2 or drug0 ) and drug0 within 24 hours of each other should be avoided .,ergot-type medications,dihydroergotamine,FALSE,none
because there is a theoretical basis that these effects may be additive  use of drug0-containing or drug1 ( like drug0 or drug2 ) and drug0 within 24 hours of each other should be avoided .,ergot-type medications,methysergide,FALSE,none
because there is a theoretical basis that these effects may be additive  use of drug0-containing or drug1 ( like drug0 or drug0 ) and drug2 within 24 hours of each other should be avoided .,ergot-type medications,sumatriptan,TRUE,advise
because there is a theoretical basis that these effects may be additive  use of drug0-containing or drug0 ( like drug1 or drug2 ) and drug0 within 24 hours of each other should be avoided .,dihydroergotamine,methysergide,FALSE,none
because there is a theoretical basis that these effects may be additive  use of drug0-containing or drug0 ( like drug1 or drug0 ) and drug2 within 24 hours of each other should be avoided .,dihydroergotamine,sumatriptan,TRUE,advise
because there is a theoretical basis that these effects may be additive  use of drug0-containing or drug0 ( like drug0 or drug1 ) and drug2 within 24 hours of each other should be avoided .,methysergide,sumatriptan,TRUE,advise
drug1 reduce drug2 clearance  significantly increasing systemic exposure .,mao-a inhibitors,sumatriptan,TRUE,mechanism
therefore  the use of drug1 tablets in patients receiving drug2 is contraindicated . drug0 ( drug0 ) ( e.g.  drug0  drug0  drug0  drug0 ) have been reported  rarely  to cause weakness  hyperreflexia  and incoordination when coadministered with drug0 .,sumatriptan succinate,mao-a inhibitors,TRUE,advise
therefore  the use of drug1 tablets in patients receiving drug0 is contraindicated . drug2 ( drug0 ) ( e.g.  drug0  drug0  drug0  drug0 ) have been reported  rarely  to cause weakness  hyperreflexia  and incoordination when coadministered with drug0 .,sumatriptan succinate,selective serotonin reuptake inhibitors,FALSE,none
therefore  the use of drug1 tablets in patients receiving drug0 is contraindicated . drug0 ( drug2 ) ( e.g.  drug0  drug0  drug0  drug0 ) have been reported  rarely  to cause weakness  hyperreflexia  and incoordination when coadministered with drug0 .,sumatriptan succinate,ssris,FALSE,none
therefore  the use of drug1 tablets in patients receiving drug0 is contraindicated . drug0 ( drug0 ) ( e.g.  drug2  drug0  drug0  drug0 ) have been reported  rarely  to cause weakness  hyperreflexia  and incoordination when coadministered with drug0 .,sumatriptan succinate,fluoxetine,FALSE,none
therefore  the use of drug1 tablets in patients receiving drug0 is contraindicated . drug0 ( drug0 ) ( e.g.  drug0  drug2  drug0  drug0 ) have been reported  rarely  to cause weakness  hyperreflexia  and incoordination when coadministered with drug0 .,sumatriptan succinate,fluvoxamine,FALSE,none
therefore  the use of drug1 tablets in patients receiving drug0 is contraindicated . drug0 ( drug0 ) ( e.g.  drug0  drug0  drug2  drug0 ) have been reported  rarely  to cause weakness  hyperreflexia  and incoordination when coadministered with drug0 .,sumatriptan succinate,paroxetine,FALSE,none
therefore  the use of drug1 tablets in patients receiving drug0 is contraindicated . drug0 ( drug0 ) ( e.g.  drug0  drug0  drug0  drug2 ) have been reported  rarely  to cause weakness  hyperreflexia  and incoordination when coadministered with drug0 .,sumatriptan succinate,sertraline,FALSE,none
therefore  the use of drug1 tablets in patients receiving drug0 is contraindicated . drug0 ( drug0 ) ( e.g.  drug0  drug0  drug0  drug0 ) have been reported  rarely  to cause weakness  hyperreflexia  and incoordination when coadministered with drug2 .,sumatriptan succinate,sumatriptan,FALSE,none
therefore  the use of drug0 succinate tablets in patients receiving drug1 is contraindicated . drug2 ( drug0 ) ( e.g.  drug0  drug0  drug0  drug0 ) have been reported  rarely  to cause weakness  hyperreflexia  and incoordination when coadministered with drug0 .,mao-a inhibitors,selective serotonin reuptake inhibitors,FALSE,none
therefore  the use of drug0 succinate tablets in patients receiving drug1 is contraindicated . drug0 ( drug2 ) ( e.g.  drug0  drug0  drug0  drug0 ) have been reported  rarely  to cause weakness  hyperreflexia  and incoordination when coadministered with drug0 .,mao-a inhibitors,ssris,FALSE,none
therefore  the use of drug0 succinate tablets in patients receiving drug1 is contraindicated . drug0 ( drug0 ) ( e.g.  drug2  drug0  drug0  drug0 ) have been reported  rarely  to cause weakness  hyperreflexia  and incoordination when coadministered with drug0 .,mao-a inhibitors,fluoxetine,FALSE,none
therefore  the use of drug0 succinate tablets in patients receiving drug1 is contraindicated . drug0 ( drug0 ) ( e.g.  drug0  drug2  drug0  drug0 ) have been reported  rarely  to cause weakness  hyperreflexia  and incoordination when coadministered with drug0 .,mao-a inhibitors,fluvoxamine,FALSE,none
therefore  the use of drug0 succinate tablets in patients receiving drug1 is contraindicated . drug0 ( drug0 ) ( e.g.  drug0  drug0  drug2  drug0 ) have been reported  rarely  to cause weakness  hyperreflexia  and incoordination when coadministered with drug0 .,mao-a inhibitors,paroxetine,FALSE,none
therefore  the use of drug0 succinate tablets in patients receiving drug1 is contraindicated . drug0 ( drug0 ) ( e.g.  drug0  drug0  drug0  drug2 ) have been reported  rarely  to cause weakness  hyperreflexia  and incoordination when coadministered with drug0 .,mao-a inhibitors,sertraline,FALSE,none
therefore  the use of drug2 succinate tablets in patients receiving drug1 is contraindicated . drug0 ( drug0 ) ( e.g.  drug0  drug0  drug0  drug0 ) have been reported  rarely  to cause weakness  hyperreflexia  and incoordination when coadministered with drug0 .,mao-a inhibitors,sumatriptan,FALSE,none
therefore  the use of drug0 succinate tablets in patients receiving drug0 is contraindicated . drug1 ( drug0 ) ( e.g.  drug2  drug0  drug0  drug0 ) have been reported  rarely  to cause weakness  hyperreflexia  and incoordination when coadministered with drug0 .,selective serotonin reuptake inhibitors,fluoxetine,FALSE,none
therefore  the use of drug0 succinate tablets in patients receiving drug0 is contraindicated . drug1 ( drug0 ) ( e.g.  drug0  drug2  drug0  drug0 ) have been reported  rarely  to cause weakness  hyperreflexia  and incoordination when coadministered with drug0 .,selective serotonin reuptake inhibitors,fluvoxamine,FALSE,none
therefore  the use of drug0 succinate tablets in patients receiving drug0 is contraindicated . drug1 ( drug0 ) ( e.g.  drug0  drug0  drug2  drug0 ) have been reported  rarely  to cause weakness  hyperreflexia  and incoordination when coadministered with drug0 .,selective serotonin reuptake inhibitors,paroxetine,FALSE,none
therefore  the use of drug0 succinate tablets in patients receiving drug0 is contraindicated . drug1 ( drug0 ) ( e.g.  drug0  drug0  drug0  drug2 ) have been reported  rarely  to cause weakness  hyperreflexia  and incoordination when coadministered with drug0 .,selective serotonin reuptake inhibitors,sertraline,FALSE,none
therefore  the use of drug2 succinate tablets in patients receiving drug0 is contraindicated . drug1 ( drug0 ) ( e.g.  drug0  drug0  drug0  drug0 ) have been reported  rarely  to cause weakness  hyperreflexia  and incoordination when coadministered with drug0 .,selective serotonin reuptake inhibitors,sumatriptan,TRUE,effect
therefore  the use of drug0 succinate tablets in patients receiving drug0 is contraindicated . drug0 ( drug1 ) ( e.g.  drug2  drug0  drug0  drug0 ) have been reported  rarely  to cause weakness  hyperreflexia  and incoordination when coadministered with drug0 .,ssris,fluoxetine,FALSE,none
therefore  the use of drug0 succinate tablets in patients receiving drug0 is contraindicated . drug0 ( drug1 ) ( e.g.  drug0  drug2  drug0  drug0 ) have been reported  rarely  to cause weakness  hyperreflexia  and incoordination when coadministered with drug0 .,ssris,fluvoxamine,FALSE,none
therefore  the use of drug0 succinate tablets in patients receiving drug0 is contraindicated . drug0 ( drug1 ) ( e.g.  drug0  drug0  drug2  drug0 ) have been reported  rarely  to cause weakness  hyperreflexia  and incoordination when coadministered with drug0 .,ssris,paroxetine,FALSE,none
therefore  the use of drug0 succinate tablets in patients receiving drug0 is contraindicated . drug0 ( drug1 ) ( e.g.  drug0  drug0  drug0  drug2 ) have been reported  rarely  to cause weakness  hyperreflexia  and incoordination when coadministered with drug0 .,ssris,sertraline,FALSE,none
therefore  the use of drug2 succinate tablets in patients receiving drug0 is contraindicated . drug0 ( drug1 ) ( e.g.  drug0  drug0  drug0  drug0 ) have been reported  rarely  to cause weakness  hyperreflexia  and incoordination when coadministered with drug0 .,ssris,sumatriptan,TRUE,effect
therefore  the use of drug2 succinate tablets in patients receiving drug0 is contraindicated . drug0 ( drug0 ) ( e.g.  drug1  drug0  drug0  drug0 ) have been reported  rarely  to cause weakness  hyperreflexia  and incoordination when coadministered with drug0 .,fluoxetine,sumatriptan,TRUE,effect
therefore  the use of drug2 succinate tablets in patients receiving drug0 is contraindicated . drug0 ( drug0 ) ( e.g.  drug0  drug1  drug0  drug0 ) have been reported  rarely  to cause weakness  hyperreflexia  and incoordination when coadministered with drug0 .,fluvoxamine,sumatriptan,TRUE,effect
therefore  the use of drug2 succinate tablets in patients receiving drug0 is contraindicated . drug0 ( drug0 ) ( e.g.  drug0  drug0  drug1  drug0 ) have been reported  rarely  to cause weakness  hyperreflexia  and incoordination when coadministered with drug0 .,paroxetine,sumatriptan,TRUE,effect
therefore  the use of drug2 succinate tablets in patients receiving drug0 is contraindicated . drug0 ( drug0 ) ( e.g.  drug0  drug0  drug0  drug1 ) have been reported  rarely  to cause weakness  hyperreflexia  and incoordination when coadministered with drug0 .,sertraline,sumatriptan,TRUE,effect
if concomitant treatment with drug1 and an drug2 is clinically warranted  appropriate observation of the patient is advised .,sumatriptan,ssri,TRUE,advise
co-administration of drug1 with strong inhibitors of the cyp3a4 family ( e.g.  drug2  drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0 ) may increases drug0 concentrations .,sutent,ketoconazole,TRUE,mechanism
co-administration of drug1 with strong inhibitors of the cyp3a4 family ( e.g.  drug0  drug2  drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0 ) may increases drug0 concentrations .,sutent,itraconazole,TRUE,mechanism
co-administration of drug1 with strong inhibitors of the cyp3a4 family ( e.g.  drug0  drug0  drug2  drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0 ) may increases drug0 concentrations .,sutent,clarithromycin,TRUE,mechanism
co-administration of drug1 with strong inhibitors of the cyp3a4 family ( e.g.  drug0  drug0  drug0  drug2  drug0  drug0  drug0  drug0  drug0  drug0  drug0 ) may increases drug0 concentrations .,sutent,atazanavir,TRUE,mechanism
co-administration of drug1 with strong inhibitors of the cyp3a4 family ( e.g.  drug0  drug0  drug0  drug0  drug2  drug0  drug0  drug0  drug0  drug0  drug0 ) may increases drug0 concentrations .,sutent,indinavir,TRUE,mechanism
co-administration of drug1 with strong inhibitors of the cyp3a4 family ( e.g.  drug0  drug0  drug0  drug0  drug0  drug2  drug0  drug0  drug0  drug0  drug0 ) may increases drug0 concentrations .,sutent,nefazodone,TRUE,mechanism
co-administration of drug1 with strong inhibitors of the cyp3a4 family ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0  drug2  drug0  drug0  drug0  drug0 ) may increases drug0 concentrations .,sutent,nelfinavir,TRUE,mechanism
co-administration of drug1 with strong inhibitors of the cyp3a4 family ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug2  drug0  drug0  drug0 ) may increases drug0 concentrations .,sutent,ritonavir,TRUE,mechanism
co-administration of drug1 with strong inhibitors of the cyp3a4 family ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug2  drug0  drug0 ) may increases drug0 concentrations .,sutent,saquinavir,TRUE,mechanism
co-administration of drug1 with strong inhibitors of the cyp3a4 family ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug2  drug0 ) may increases drug0 concentrations .,sutent,telithromycin,TRUE,mechanism
co-administration of drug1 with strong inhibitors of the cyp3a4 family ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug2 ) may increases drug0 concentrations .,sutent,voriconizole,TRUE,mechanism
co-administration of drug1 with strong inhibitors of the cyp3a4 family ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0 ) may increases drug2 concentrations .,sutent,sunitinib,FALSE,none
co-administration of drug0 with strong inhibitors of the cyp3a4 family ( e.g.  drug1  drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0 ) may increases drug2 concentrations .,ketoconazole,sunitinib,FALSE,none
co-administration of drug0 with strong inhibitors of the cyp3a4 family ( e.g.  drug0  drug1  drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0 ) may increases drug2 concentrations .,itraconazole,sunitinib,FALSE,none
co-administration of drug0 with strong inhibitors of the cyp3a4 family ( e.g.  drug0  drug0  drug1  drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0 ) may increases drug2 concentrations .,clarithromycin,sunitinib,FALSE,none
co-administration of drug0 with strong inhibitors of the cyp3a4 family ( e.g.  drug0  drug0  drug0  drug1  drug0  drug0  drug0  drug0  drug0  drug0  drug0 ) may increases drug2 concentrations .,atazanavir,sunitinib,FALSE,none
co-administration of drug0 with strong inhibitors of the cyp3a4 family ( e.g.  drug0  drug0  drug0  drug0  drug1  drug0  drug0  drug0  drug0  drug0  drug0 ) may increases drug2 concentrations .,indinavir,sunitinib,FALSE,none
co-administration of drug0 with strong inhibitors of the cyp3a4 family ( e.g.  drug0  drug0  drug0  drug0  drug0  drug1  drug0  drug0  drug0  drug0  drug0 ) may increases drug2 concentrations .,nefazodone,sunitinib,FALSE,none
co-administration of drug0 with strong inhibitors of the cyp3a4 family ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0  drug1  drug0  drug0  drug0  drug0 ) may increases drug2 concentrations .,nelfinavir,sunitinib,FALSE,none
co-administration of drug0 with strong inhibitors of the cyp3a4 family ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug1  drug0  drug0  drug0 ) may increases drug2 concentrations .,ritonavir,sunitinib,FALSE,none
co-administration of drug0 with strong inhibitors of the cyp3a4 family ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug1  drug0  drug0 ) may increases drug2 concentrations .,saquinavir,sunitinib,FALSE,none
co-administration of drug0 with strong inhibitors of the cyp3a4 family ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug1  drug0 ) may increases drug2 concentrations .,telithromycin,sunitinib,FALSE,none
co-administration of drug0 with strong inhibitors of the cyp3a4 family ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug1 ) may increases drug2 concentrations .,voriconizole,sunitinib,FALSE,none
co-administration of drug1 with inducers of the cyp3a4 family ( e.g.  drug2  drug0  drug0  drug0  drug0  drug0  drug0  st. johns wort ) may decrease drug0 concentrations .,sutent,dexamethasone,TRUE,mechanism
co-administration of drug1 with inducers of the cyp3a4 family ( e.g.  drug0  drug2  drug0  drug0  drug0  drug0  drug0  st. johns wort ) may decrease drug0 concentrations .,sutent,phenytoin,TRUE,mechanism
co-administration of drug1 with inducers of the cyp3a4 family ( e.g.  drug0  drug0  drug2  drug0  drug0  drug0  drug0  st. johns wort ) may decrease drug0 concentrations .,sutent,carbamazepine,TRUE,mechanism
co-administration of drug1 with inducers of the cyp3a4 family ( e.g.  drug0  drug0  drug0  drug2  drug0  drug0  drug0  st. johns wort ) may decrease drug0 concentrations .,sutent,rifampin,TRUE,mechanism
co-administration of drug1 with inducers of the cyp3a4 family ( e.g.  drug0  drug0  drug0  drug0  drug2  drug0  drug0  st. johns wort ) may decrease drug0 concentrations .,sutent,rifabutin,TRUE,mechanism
co-administration of drug1 with inducers of the cyp3a4 family ( e.g.  drug0  drug0  drug0  drug0  drug0  drug2  drug0  st. johns wort ) may decrease drug0 concentrations .,sutent,rifapentin,TRUE,mechanism
co-administration of drug1 with inducers of the cyp3a4 family ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0  drug2  st. johns wort ) may decrease drug0 concentrations .,sutent,phenobarbital,TRUE,mechanism
co-administration of drug1 with inducers of the cyp3a4 family ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0  drug0  st. johns wort ) may decrease drug2 concentrations .,sutent,sunitinib,FALSE,none
co-administration of drug0 with inducers of the cyp3a4 family ( e.g.  drug1  drug0  drug0  drug0  drug0  drug0  drug0  st. johns wort ) may decrease drug2 concentrations .,dexamethasone,sunitinib,FALSE,none
co-administration of drug0 with inducers of the cyp3a4 family ( e.g.  drug0  drug1  drug0  drug0  drug0  drug0  drug0  st. johns wort ) may decrease drug2 concentrations .,phenytoin,sunitinib,FALSE,none
co-administration of drug0 with inducers of the cyp3a4 family ( e.g.  drug0  drug0  drug1  drug0  drug0  drug0  drug0  st. johns wort ) may decrease drug2 concentrations .,carbamazepine,sunitinib,FALSE,none
co-administration of drug0 with inducers of the cyp3a4 family ( e.g.  drug0  drug0  drug0  drug1  drug0  drug0  drug0  st. johns wort ) may decrease drug2 concentrations .,rifampin,sunitinib,FALSE,none
co-administration of drug0 with inducers of the cyp3a4 family ( e.g.  drug0  drug0  drug0  drug0  drug1  drug0  drug0  st. johns wort ) may decrease drug2 concentrations .,rifabutin,sunitinib,FALSE,none
co-administration of drug0 with inducers of the cyp3a4 family ( e.g.  drug0  drug0  drug0  drug0  drug0  drug1  drug0  st. johns wort ) may decrease drug2 concentrations .,rifapentin,sunitinib,FALSE,none
co-administration of drug0 with inducers of the cyp3a4 family ( e.g.  drug0  drug0  drug0  drug0  drug0  drug0  drug1  st. johns wort ) may decrease drug2 concentrations .,phenobarbital,sunitinib,FALSE,none
other eye drops or medications such as drug1 ( drug0 ) and drug2 ( drug0  isopto drug0 ) may decrease the effects of drug0 ophthalmic .,acetylcholine chloride,carbachol,FALSE,none
other eye drops or medications such as drug1 ( drug0 ) and drug0 ( drug2  isopto drug0 ) may decrease the effects of drug0 ophthalmic .,acetylcholine chloride,carboptic,FALSE,none
other eye drops or medications such as drug1 ( drug0 ) and drug0 ( drug0  drug2 ) may decrease the effects of drug0 ophthalmic .,acetylcholine chloride,isopto carbachol,FALSE,none
other eye drops or medications such as drug1 ( drug0 ) and drug0 ( drug0  isopto drug0 ) may decrease the effects of drug2 ophthalmic .,acetylcholine chloride,suprofen,TRUE,effect
other eye drops or medications such as drug0 ( drug1 ) and drug2 ( drug0  isopto drug0 ) may decrease the effects of drug0 ophthalmic .,miochol,carbachol,FALSE,none
other eye drops or medications such as drug0 ( drug1 ) and drug0 ( drug2  isopto drug0 ) may decrease the effects of drug0 ophthalmic .,miochol,carboptic,FALSE,none
other eye drops or medications such as drug0 ( drug1 ) and drug0 ( drug0  drug2 ) may decrease the effects of drug0 ophthalmic .,miochol,isopto carbachol,FALSE,none
other eye drops or medications such as drug0 ( drug1 ) and drug0 ( drug0  isopto drug0 ) may decrease the effects of drug2 ophthalmic .,miochol,suprofen,TRUE,effect
other eye drops or medications such as drug0 ( drug0 ) and drug1 ( drug2  isopto drug0 ) may decrease the effects of drug0 ophthalmic .,carbachol,carboptic,FALSE,none
other eye drops or medications such as drug0 ( drug0 ) and drug1 ( drug0  drug2 ) may decrease the effects of drug0 ophthalmic .,carbachol,isopto carbachol,FALSE,none
other eye drops or medications such as drug0 ( drug0 ) and drug1 ( drug0  isopto drug0 ) may decrease the effects of drug2 ophthalmic .,carbachol,suprofen,TRUE,effect
other eye drops or medications such as drug0 ( drug0 ) and drug0 ( drug1  isopto drug0 ) may decrease the effects of drug2 ophthalmic .,carboptic,suprofen,TRUE,effect
other eye drops or medications such as drug0 ( drug0 ) and drug0 ( drug0  drug1 ) may decrease the effects of drug2 ophthalmic .,isopto carbachol,suprofen,TRUE,effect
however  interactions may be expected and drug1 capsules should not be used in combination with other drug2 .,flomax,alpha-adrenergic blocking agents,TRUE,advise
the pharmacokinetic interaction between drug1 and drug2 capsules was investigated .,cimetidine,flomax,FALSE,none
therefore  drug1 capsules should be used with caution in combination with drug2  particularly at doses higher than 0.4 mg .,flomax,cimetidine,TRUE,advise
results from limited in vitro and in vivo drug-drug interaction studies between drug1 and drug2 are inconclusive .,tamsulosin hci,warfarin,FALSE,none
therefore  caution should be exercised with concomitant administration of drug1 and drug2 capsules .,warfarin,flomax,TRUE,advise
administration of drug1 decreases oral clearance of drug2 by about 5 % .,valproic acid,temozolomide,TRUE,mechanism
patients studied in clinical trials of drug1 were routinely treated with drug2 and drug0 .,tnkase,heparin,FALSE,none
patients studied in clinical trials of drug1 were routinely treated with drug0 and drug2 .,tnkase,aspirin,FALSE,none
patients studied in clinical trials of drug0 were routinely treated with drug1 and drug2 .,heparin,aspirin,FALSE,none
drug1 ( such as drug2 and drug0 antagonists ) and drugs that alter platelet function ( such as drug0  drug0  and gp iib/iiia inhibitors ) may increase the risk of bleeding if administered prior to  during  or after drug0 therapy .,anticoagulants,heparin,FALSE,none
drug1 ( such as drug0 and drug2 ) and drugs that alter platelet function ( such as drug0  drug0  and gp iib/iiia inhibitors ) may increase the risk of bleeding if administered prior to  during  or after drug0 therapy .,anticoagulants,vitamin k antagonists,FALSE,none
drug1 ( such as drug0 and drug0 antagonists ) and drugs that alter platelet function ( such as drug2  drug0  and gp iib/iiia inhibitors ) may increase the risk of bleeding if administered prior to  during  or after drug0 therapy .,anticoagulants,acetylsalicylic acid,FALSE,none
drug1 ( such as drug0 and drug0 antagonists ) and drugs that alter platelet function ( such as drug0  drug2  and gp iib/iiia inhibitors ) may increase the risk of bleeding if administered prior to  during  or after drug0 therapy .,anticoagulants,dipyridamole,FALSE,none
drug1 ( such as drug0 and drug0 antagonists ) and drugs that alter platelet function ( such as drug0  drug0  and gp iib/iiia inhibitors ) may increase the risk of bleeding if administered prior to  during  or after drug2 therapy .,anticoagulants,tnkase,TRUE,effect
drug0 ( such as drug1 and drug2 ) and drugs that alter platelet function ( such as drug0  drug0  and gp iib/iiia inhibitors ) may increase the risk of bleeding if administered prior to  during  or after drug0 therapy .,heparin,vitamin k antagonists,FALSE,none
drug0 ( such as drug1 and drug0 antagonists ) and drugs that alter platelet function ( such as drug2  drug0  and gp iib/iiia inhibitors ) may increase the risk of bleeding if administered prior to  during  or after drug0 therapy .,heparin,acetylsalicylic acid,FALSE,none
drug0 ( such as drug1 and drug0 antagonists ) and drugs that alter platelet function ( such as drug0  drug2  and gp iib/iiia inhibitors ) may increase the risk of bleeding if administered prior to  during  or after drug0 therapy .,heparin,dipyridamole,FALSE,none
drug0 ( such as drug1 and drug0 antagonists ) and drugs that alter platelet function ( such as drug0  drug0  and gp iib/iiia inhibitors ) may increase the risk of bleeding if administered prior to  during  or after drug2 therapy .,heparin,tnkase,TRUE,effect
drug0 ( such as drug0 and drug1 ) and drugs that alter platelet function ( such as drug2  drug0  and gp iib/iiia inhibitors ) may increase the risk of bleeding if administered prior to  during  or after drug0 therapy .,vitamin k antagonists,acetylsalicylic acid,FALSE,none
drug0 ( such as drug0 and drug1 ) and drugs that alter platelet function ( such as drug0  drug2  and gp iib/iiia inhibitors ) may increase the risk of bleeding if administered prior to  during  or after drug0 therapy .,vitamin k antagonists,dipyridamole,FALSE,none
drug0 ( such as drug0 and drug1 ) and drugs that alter platelet function ( such as drug0  drug0  and gp iib/iiia inhibitors ) may increase the risk of bleeding if administered prior to  during  or after drug2 therapy .,vitamin k antagonists,tnkase,TRUE,effect
drug0 ( such as drug0 and drug0 antagonists ) and drugs that alter platelet function ( such as drug1  drug0  and gp iib/iiia inhibitors ) may increase the risk of bleeding if administered prior to  during  or after drug2 therapy .,acetylsalicylic acid,tnkase,TRUE,effect
drug0 ( such as drug0 and drug0 antagonists ) and drugs that alter platelet function ( such as drug0  drug1  and gp iib/iiia inhibitors ) may increase the risk of bleeding if administered prior to  during  or after drug2 therapy .,dipyridamole,tnkase,TRUE,effect
in a study in which 34 different drugs were tested  therapeutically relevant concentrations of drug1  sodium drug0 and drug2 displaced protein-bound drug0 in fresh human serum to a small but significant extent .,tolbutamide,sulfamethizole,FALSE,none
in a study in which 34 different drugs were tested  therapeutically relevant concentrations of drug1  sodium drug0 and drug0 displaced protein-bound drug2 in fresh human serum to a small but significant extent .,tolbutamide,teniposide,TRUE,mechanism
in a study in which 34 different drugs were tested  therapeutically relevant concentrations of drug0  drug1 and drug2 displaced protein-bound drug0 in fresh human serum to a small but significant extent .,sodium salicylate,sulfamethizole,FALSE,none
in a study in which 34 different drugs were tested  therapeutically relevant concentrations of drug0  drug1 and drug0 displaced protein-bound drug2 in fresh human serum to a small but significant extent .,sodium salicylate,teniposide,TRUE,mechanism
in a study in which 34 different drugs were tested  therapeutically relevant concentrations of drug0  sodium drug0 and drug1 displaced protein-bound drug2 in fresh human serum to a small but significant extent .,sulfamethizole,teniposide,TRUE,mechanism
therefore  caution should be used in administering drug1 ( drug2 injection ) to patients receiving these other agents .,vumon,teniposide,FALSE,none
there was no change in the plasma kinetics of drug1 when coadministered with drug2 .,teniposide,methotrexate,FALSE,none
an increase in intracellular levels of drug1 was observed in vitro in the presence of drug2 .,methotrexate,teniposide,TRUE,mechanism
in vitro studies with human liver microsomes showed that drug1 does not inhibit the metabolism of drug2  ethinyldrug0  ethoxydrug0  and drug0 .,terbinafine,tolbutamide,FALSE,none
in vitro studies with human liver microsomes showed that drug1 does not inhibit the metabolism of drug0  drug2  ethoxydrug0  and drug0 .,terbinafine,ethinylestradiol,FALSE,none
in vitro studies with human liver microsomes showed that drug1 does not inhibit the metabolism of drug0  ethinyldrug0  drug2  and drug0 .,terbinafine,ethoxycoumarin,FALSE,none
in vitro studies with human liver microsomes showed that drug1 does not inhibit the metabolism of drug0  ethinyldrug0  ethoxydrug0  and drug2 .,terbinafine,cyclosporine,FALSE,none
in vitro studies with human liver microsomes showed that drug0 does not inhibit the metabolism of drug0  ethinyldrug0  drug1  and drug2 .,ethoxycoumarin,cyclosporine,FALSE,none
this may be of clinical relevance for compounds predominantly metabolized by this enzyme  such as drug1  -blockers  drug2 ( drug0 )  and drug0 ( mao-is ) type b  if they have a narrow therapeutic window .,tricyclic antidepressants,selective serotonin reuptake inhibitors,FALSE,none
this may be of clinical relevance for compounds predominantly metabolized by this enzyme  such as drug1  -blockers  drug0 ( drug2 )  and drug0 ( mao-is ) type b  if they have a narrow therapeutic window .,tricyclic antidepressants,ssris,FALSE,none
this may be of clinical relevance for compounds predominantly metabolized by this enzyme  such as drug1  -blockers  drug0 ( drug0 )  and drug0 ( mao-is ) type b  if they have a narrow therapeutic window .,tricyclic antidepressants,monoamine oxidase inhibitors (mao-is) type b,FALSE,none
this may be of clinical relevance for compounds predominantly metabolized by this enzyme  such as drug0 drug0  -blockers  drug1 ( drug0 )  and drug0 ( mao-is ) type b  if they have a narrow therapeutic window .,selective serotonin reuptake inhibitors,monoamine oxidase inhibitors (mao-is) type b,FALSE,none
this may be of clinical relevance for compounds predominantly metabolized by this enzyme  such as drug0 drug0  -blockers  drug0 ( drug1 )  and drug0 ( mao-is ) type b  if they have a narrow therapeutic window .,ssris,monoamine oxidase inhibitors (mao-is) type b,FALSE,none
drug1 decreases the clearance of drug2 by 19 % .,terbinafine,caffeine,TRUE,mechanism
drug1 increases the clearance of drug2 by 15 % .,terbinafine,cyclosporine,TRUE,mechanism
drug1 clearance is increased 100 % by drug2  a cyp450 enzyme inducer  and decreased 33 % by drug0  a cyp450 enzyme inhibitor .,terbinafine,rifampin,TRUE,mechanism
drug1 clearance is increased 100 % by drug0  a cyp450 enzyme inducer  and decreased 33 % by drug2  a cyp450 enzyme inhibitor .,terbinafine,cimetidine,TRUE,mechanism
drug0 clearance is increased 100 % by drug1  a cyp450 enzyme inducer  and decreased 33 % by drug2  a cyp450 enzyme inhibitor .,rifampin,cimetidine,FALSE,none
drug1 clearance is unaffected by drug2 .,terbinafine,cyclosporine,FALSE,none
there is no information available from adequate drug-drug interaction studies with the following classes of drugs : oral drug1  hormone replacement therapies  drug0  drug0  drug0  thiazide drug0  drug0  and drug2 .,contraceptives,calcium channel blockers,FALSE,none
there is no information available from adequate drug-drug interaction studies with the following classes of drugs : oral drug0  hormone replacement therapies  drug1  drug0  drug0  thiazide drug0  drug0  and drug2 .,hypoglycemics,calcium channel blockers,FALSE,none
there is no information available from adequate drug-drug interaction studies with the following classes of drugs : oral drug0  hormone replacement therapies  drug0  drug1  drug0  thiazide drug0  drug0  and drug2 .,theophyllines,calcium channel blockers,FALSE,none
there is no information available from adequate drug-drug interaction studies with the following classes of drugs : oral drug0  hormone replacement therapies  drug0  drug0  drug1  thiazide drug0  drug0  and drug2 .,phenytoins,calcium channel blockers,FALSE,none
there is no information available from adequate drug-drug interaction studies with the following classes of drugs : oral drug0  hormone replacement therapies  drug0  drug0  drug0  thiazide drug0  drug1  and drug2 .,beta blockers,calcium channel blockers,FALSE,none
drug1 : spontaneous adverse reaction reports of patients taking concomitant drug0 with recommended doses of drug2 demonstrate qt interval prolongation and rare serious cardiac events  e.g .,ketoconazole,terfenadine,FALSE,none
drug1 : spontaneous adverse reaction reports of patients taking concomitant drug0 with recommended doses of drug2 demonstrate qt interval prolongation and rare serious cardiac events  e.g .,ketoconazole,terfenadine,TRUE,effect
pharmacokinetic data indicate that drug1 markedly inhibits the metabolism of drug2  resulting in elevated plasma drug0 levels .,ketoconazole,terfenadine,TRUE,mechanism
pharmacokinetic data indicate that drug1 markedly inhibits the metabolism of drug2  resulting in elevated plasma drug0 levels .,ketoconazole,terfenadine,FALSE,none
concomitant administration of drug1 and drug2 is contraindicated .,ketoconazole,terfenadine,TRUE,advise
drug1 : torsades de pointes and elevated parent drug2 levels have been reported during concomitant use of drug0 and drug0 in clinical trials of drug0 and from foreign post-marketing sources .,itraconazole,terfenadine,FALSE,none
drug1 : torsades de pointes and elevated parent drug2 levels have been reported during concomitant use of drug0 and drug0 in clinical trials of drug0 and from foreign post-marketing sources .,itraconazole,terfenadine,FALSE,none
drug2 : torsades de pointes and elevated parent drug1 levels have been reported during concomitant use of drug0 and drug0 in clinical trials of drug0 and from foreign post-marketing sources .,terfenadine,itraconazole,FALSE,none
drug2 : torsades de pointes and elevated parent drug1 levels have been reported during concomitant use of drug0 and drug0 in clinical trials of drug0 and from foreign post-marketing sources .,terfenadine,itraconazole,FALSE,none
drug2 : torsades de pointes and elevated parent drug1 levels have been reported during concomitant use of drug0 and drug0 in clinical trials of drug0 and from foreign post-marketing sources .,terfenadine,itraconazole,TRUE,mechanism
drug2 : torsades de pointes and elevated parent drug1 levels have been reported during concomitant use of drug0 and drug0 in clinical trials of drug0 and from foreign post-marketing sources .,terfenadine,itraconazole,FALSE,none
concomitant administration of drug1 and drug2 is contraindicated .,itraconazole,terfenadine,TRUE,advise
due to the chemical similarity of other drug1 ( including drug2  drug0  and drug0 ) to drug0  and drug0  concomitant use of these products with drug0 is not recommended pending full examination of potential interactions .,azole-type antifungal agents,fluconazole,FALSE,none
due to the chemical similarity of other drug1 ( including drug0  drug2  and drug0 ) to drug0  and drug0  concomitant use of these products with drug0 is not recommended pending full examination of potential interactions .,azole-type antifungal agents,metronidazole,FALSE,none
due to the chemical similarity of other drug1 ( including drug0  drug0  and drug2 ) to drug0  and drug0  concomitant use of these products with drug0 is not recommended pending full examination of potential interactions .,azole-type antifungal agents,miconazole,FALSE,none
due to the chemical similarity of other drug1 ( including drug0  drug0  and drug0 ) to drug2  and drug0  concomitant use of these products with drug0 is not recommended pending full examination of potential interactions .,azole-type antifungal agents,ketoconazole,FALSE,none
due to the chemical similarity of other drug1 ( including drug0  drug0  and drug0 ) to drug0  and drug2  concomitant use of these products with drug0 is not recommended pending full examination of potential interactions .,azole-type antifungal agents,itraconazole,FALSE,none
due to the chemical similarity of other drug1 ( including drug0  drug0  and drug0 ) to drug0  and drug0  concomitant use of these products with drug2 is not recommended pending full examination of potential interactions .,azole-type antifungal agents,terfenadine,TRUE,advise
due to the chemical similarity of other drug0 ( including drug1  drug0  and drug0 ) to drug2  and drug0  concomitant use of these products with drug0 is not recommended pending full examination of potential interactions .,fluconazole,ketoconazole,FALSE,none
due to the chemical similarity of other drug0 ( including drug1  drug0  and drug0 ) to drug0  and drug2  concomitant use of these products with drug0 is not recommended pending full examination of potential interactions .,fluconazole,itraconazole,FALSE,none
due to the chemical similarity of other drug0 ( including drug1  drug0  and drug0 ) to drug0  and drug0  concomitant use of these products with drug2 is not recommended pending full examination of potential interactions .,fluconazole,terfenadine,TRUE,advise
due to the chemical similarity of other drug0 ( including drug0  drug1  and drug2 ) to drug0  and drug0  concomitant use of these products with drug0 is not recommended pending full examination of potential interactions .,metronidazole,miconazole,FALSE,none
due to the chemical similarity of other drug0 ( including drug0  drug1  and drug0 ) to drug2  and drug0  concomitant use of these products with drug0 is not recommended pending full examination of potential interactions .,metronidazole,ketoconazole,FALSE,none
due to the chemical similarity of other drug0 ( including drug0  drug1  and drug0 ) to drug0  and drug2  concomitant use of these products with drug0 is not recommended pending full examination of potential interactions .,metronidazole,itraconazole,FALSE,none
due to the chemical similarity of other drug0 ( including drug0  drug1  and drug0 ) to drug0  and drug0  concomitant use of these products with drug2 is not recommended pending full examination of potential interactions .,metronidazole,terfenadine,TRUE,advise
due to the chemical similarity of other drug0 ( including drug0  drug0  and drug1 ) to drug2  and drug0  concomitant use of these products with drug0 is not recommended pending full examination of potential interactions .,miconazole,ketoconazole,FALSE,none
due to the chemical similarity of other drug0 ( including drug0  drug0  and drug1 ) to drug0  and drug2  concomitant use of these products with drug0 is not recommended pending full examination of potential interactions .,miconazole,itraconazole,FALSE,none
due to the chemical similarity of other drug0 ( including drug0  drug0  and drug1 ) to drug0  and drug0  concomitant use of these products with drug2 is not recommended pending full examination of potential interactions .,miconazole,terfenadine,TRUE,advise
due to the chemical similarity of other drug0 ( including drug0  drug0  and drug0 ) to drug1  and drug2  concomitant use of these products with drug0 is not recommended pending full examination of potential interactions .,ketoconazole,itraconazole,FALSE,none
due to the chemical similarity of other drug0 ( including drug0  drug0  and drug0 ) to drug1  and drug0  concomitant use of these products with drug2 is not recommended pending full examination of potential interactions .,ketoconazole,terfenadine,FALSE,none
due to the chemical similarity of other drug0 ( including drug0  drug0  and drug0 ) to drug0  and drug1  concomitant use of these products with drug2 is not recommended pending full examination of potential interactions .,itraconazole,terfenadine,FALSE,none
drug1 : clinical drug interaction studies indicate that drug2 and drug0 can exert an effect on drug0 metabolism by a mechanism which may be similar to that of drug0  but to a lesser extent .,macrolides,erythromycin,FALSE,none
drug1 : clinical drug interaction studies indicate that drug0 and drug2 can exert an effect on drug0 metabolism by a mechanism which may be similar to that of drug0  but to a lesser extent .,macrolides,clarithromycin,FALSE,none
drug1 : clinical drug interaction studies indicate that drug0 and drug0 can exert an effect on drug2 metabolism by a mechanism which may be similar to that of drug0  but to a lesser extent .,macrolides,terfenadine,FALSE,none
drug1 : clinical drug interaction studies indicate that drug0 and drug0 can exert an effect on drug0 metabolism by a mechanism which may be similar to that of drug2  but to a lesser extent .,macrolides,ketoconazole,FALSE,none
drug0 : clinical drug interaction studies indicate that drug1 and drug2 can exert an effect on drug0 metabolism by a mechanism which may be similar to that of drug0  but to a lesser extent .,erythromycin,clarithromycin,FALSE,none
drug0 : clinical drug interaction studies indicate that drug1 and drug0 can exert an effect on drug2 metabolism by a mechanism which may be similar to that of drug0  but to a lesser extent .,erythromycin,terfenadine,TRUE,mechanism
drug0 : clinical drug interaction studies indicate that drug1 and drug0 can exert an effect on drug0 metabolism by a mechanism which may be similar to that of drug2  but to a lesser extent .,erythromycin,ketoconazole,FALSE,none
drug0 : clinical drug interaction studies indicate that drug0 and drug1 can exert an effect on drug2 metabolism by a mechanism which may be similar to that of drug0  but to a lesser extent .,clarithromycin,terfenadine,TRUE,mechanism
drug0 : clinical drug interaction studies indicate that drug0 and drug1 can exert an effect on drug0 metabolism by a mechanism which may be similar to that of drug2  but to a lesser extent .,clarithromycin,ketoconazole,FALSE,none
drug0 : clinical drug interaction studies indicate that drug0 and drug0 can exert an effect on drug1 metabolism by a mechanism which may be similar to that of drug2  but to a lesser extent .,terfenadine,ketoconazole,FALSE,none
a few spontaneous accounts of qt interval prolongation with ventricular arrhythmia including torsades de pointes  have been reported in patients receiving drug1 or drug2 .,erythromycin,troleandomycin,FALSE,none
concomitant administration of drug1 with drug2  drug0  or drug0 is contraindicated : pending full characterization of potential interactions  concomitant administration of drug0 with other macrolide drug0  including drug0  is not recommended .,terfenadine,clarithromycin,TRUE,advise
concomitant administration of drug1 with drug0  drug2  or drug0 is contraindicated : pending full characterization of potential interactions  concomitant administration of drug0 with other macrolide drug0  including drug0  is not recommended .,terfenadine,erythromycin,TRUE,advise
concomitant administration of drug1 with drug0  drug0  or drug2 is contraindicated : pending full characterization of potential interactions  concomitant administration of drug0 with other macrolide drug0  including drug0  is not recommended .,terfenadine,troleandomycin,TRUE,advise
concomitant administration of drug1 with drug0  drug0  or drug0 is contraindicated : pending full characterization of potential interactions  concomitant administration of drug0 with other drug2  including drug0  is not recommended .,terfenadine,macrolide antibiotics,FALSE,none
concomitant administration of drug1 with drug0  drug0  or drug0 is contraindicated : pending full characterization of potential interactions  concomitant administration of drug0 with other macrolide drug0  including drug2  is not recommended .,terfenadine,azithromycin,FALSE,none
concomitant administration of drug2 with drug1  drug0  or drug0 is contraindicated : pending full characterization of potential interactions  concomitant administration of drug0 with other macrolide drug0  including drug0  is not recommended .,clarithromycin,terfenadine,FALSE,none
concomitant administration of drug0 with drug1  drug0  or drug0 is contraindicated : pending full characterization of potential interactions  concomitant administration of drug0 with other drug2  including drug0  is not recommended .,clarithromycin,macrolide antibiotics,FALSE,none
concomitant administration of drug0 with drug1  drug0  or drug0 is contraindicated : pending full characterization of potential interactions  concomitant administration of drug0 with other macrolide drug0  including drug2  is not recommended .,clarithromycin,azithromycin,FALSE,none
concomitant administration of drug0 with drug0  drug1  or drug2 is contraindicated : pending full characterization of potential interactions  concomitant administration of drug0 with other macrolide drug0  including drug0  is not recommended .,erythromycin,troleandomycin,FALSE,none
concomitant administration of drug2 with drug0  drug1  or drug0 is contraindicated : pending full characterization of potential interactions  concomitant administration of drug0 with other macrolide drug0  including drug0  is not recommended .,erythromycin,terfenadine,FALSE,none
concomitant administration of drug0 with drug0  drug1  or drug0 is contraindicated : pending full characterization of potential interactions  concomitant administration of drug0 with other drug2  including drug0  is not recommended .,erythromycin,macrolide antibiotics,FALSE,none
concomitant administration of drug0 with drug0  drug1  or drug0 is contraindicated : pending full characterization of potential interactions  concomitant administration of drug0 with other macrolide drug0  including drug2  is not recommended .,erythromycin,azithromycin,FALSE,none
concomitant administration of drug2 with drug0  drug0  or drug1 is contraindicated : pending full characterization of potential interactions  concomitant administration of drug0 with other macrolide drug0  including drug0  is not recommended .,troleandomycin,terfenadine,FALSE,none
concomitant administration of drug0 with drug0  drug0  or drug1 is contraindicated : pending full characterization of potential interactions  concomitant administration of drug0 with other drug2  including drug0  is not recommended .,troleandomycin,macrolide antibiotics,FALSE,none
concomitant administration of drug0 with drug0  drug0  or drug1 is contraindicated : pending full characterization of potential interactions  concomitant administration of drug0 with other macrolide drug0  including drug2  is not recommended .,troleandomycin,azithromycin,FALSE,none
concomitant administration of drug1 with drug0  drug0  or drug0 is contraindicated : pending full characterization of potential interactions  concomitant administration of drug0 with other drug2  including drug0  is not recommended .,terfenadine,macrolide antibiotics,TRUE,advise
concomitant administration of drug1 with drug0  drug0  or drug0 is contraindicated : pending full characterization of potential interactions  concomitant administration of drug0 with other macrolide drug0  including drug2  is not recommended .,terfenadine,azithromycin,TRUE,advise
concomitant administration of drug0 with drug0  drug0  or drug0 is contraindicated : pending full characterization of potential interactions  concomitant administration of drug0 with other drug1  including drug2  is not recommended .,macrolide antibiotics,azithromycin,FALSE,none
studies to evaluate potential interactions of drug1 with drug2 are in progress .,terfenadine,azithromycin,FALSE,none
when administered concurrently  drug1 may increase the effects of oral drug2 ;,testolactone,anticoagulants,TRUE,effect
drug1 has been reported to enhance the sedative activity of drug2  drug0  drug0  and drug0 .,thalidomide,barbiturates,TRUE,effect
drug1 has been reported to enhance the sedative activity of drug0  drug2  drug0  and drug0 .,thalidomide,alcohol,FALSE,none
drug1 has been reported to enhance the sedative activity of drug0  drug0  drug2  and drug0 .,thalidomide,chlorpromazine,FALSE,none
drug1 has been reported to enhance the sedative activity of drug0  drug0  drug0  and drug2 .,thalidomide,reserpine,FALSE,none
drug0 has been reported to enhance the sedative activity of drug0  drug0  drug1  and drug2 .,chlorpromazine,reserpine,FALSE,none
oral drug1 : in 10 healthy women  the pharmacokinetic profiles of drug2 and ethinyl drug0 following administration of a single dose containing 1.0 mg of drug0 acetate and 75 g of ethinyl drug0 were studied .,contraceptives,norethindrone,FALSE,none
oral drug1 : in 10 healthy women  the pharmacokinetic profiles of drug0 and drug2 following administration of a single dose containing 1.0 mg of drug0 acetate and 75 g of ethinyl drug0 were studied .,contraceptives,ethinyl estradiol,FALSE,none
oral drug1 : in 10 healthy women  the pharmacokinetic profiles of drug0 and ethinyl drug0 following administration of a single dose containing 1.0 mg of drug2 and 75 g of ethinyl drug0 were studied .,contraceptives,norethindrone acetate,FALSE,none
oral drug1 : in 10 healthy women  the pharmacokinetic profiles of drug0 and drug2 following administration of a single dose containing 1.0 mg of drug0 acetate and 75 g of ethinyl drug0 were studied .,contraceptives,ethinyl estradiol,FALSE,none
oral drug0 : in 10 healthy women  the pharmacokinetic profiles of drug1 and drug2 following administration of a single dose containing 1.0 mg of drug0 acetate and 75 g of ethinyl drug0 were studied .,norethindrone,ethinyl estradiol,FALSE,none
oral drug0 : in 10 healthy women  the pharmacokinetic profiles of drug1 and ethinyl drug0 following administration of a single dose containing 1.0 mg of drug2 and 75 g of ethinyl drug0 were studied .,norethindrone,norethindrone acetate,FALSE,none
oral drug0 : in 10 healthy women  the pharmacokinetic profiles of drug1 and drug2 following administration of a single dose containing 1.0 mg of drug0 acetate and 75 g of ethinyl drug0 were studied .,norethindrone,ethinyl estradiol,FALSE,none
oral drug0 : in 10 healthy women  the pharmacokinetic profiles of drug0 and drug1 following administration of a single dose containing 1.0 mg of drug2 and 75 g of ethinyl drug0 were studied .,ethinyl estradiol,norethindrone acetate,FALSE,none
oral drug0 : in 10 healthy women  the pharmacokinetic profiles of drug0 and drug2 following administration of a single dose containing 1.0 mg of drug1 and 75 g of ethinyl drug0 were studied .,norethindrone acetate,ethinyl estradiol,FALSE,none
important non-drug1 drug interactions drugs that interfere with drug2 : concomitant use of drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug0  or certain herbal supplements such as st .,thalidomide,hormonal contraceptives,FALSE,none
important non-drug1 drug interactions drugs that interfere with hormonal drug0 : concomitant use of drug2  drug0  drug0  drug0  drug0  drug0  drug0  drug0  or certain herbal supplements such as st .,thalidomide,hiv-protease inhibitors,FALSE,none
important non-drug1 drug interactions drugs that interfere with hormonal drug0 : concomitant use of drug0  drug2  drug0  drug0  drug0  drug0  drug0  drug0  or certain herbal supplements such as st .,thalidomide,griseofulvin,FALSE,none
important non-drug1 drug interactions drugs that interfere with hormonal drug0 : concomitant use of drug0  drug0  drug2  drug0  drug0  drug0  drug0  drug0  or certain herbal supplements such as st .,thalidomide,modafinil,FALSE,none
important non-drug1 drug interactions drugs that interfere with hormonal drug0 : concomitant use of drug0  drug0  drug0  drug2  drug0  drug0  drug0  drug0  or certain herbal supplements such as st .,thalidomide,penicillins,FALSE,none
important non-drug1 drug interactions drugs that interfere with hormonal drug0 : concomitant use of drug0  drug0  drug0  drug0  drug2  drug0  drug0  drug0  or certain herbal supplements such as st .,thalidomide,rifampin,FALSE,none
important non-drug1 drug interactions drugs that interfere with hormonal drug0 : concomitant use of drug0  drug0  drug0  drug0  drug0  drug2  drug0  drug0  or certain herbal supplements such as st .,thalidomide,rifabutin,FALSE,none
important non-drug1 drug interactions drugs that interfere with hormonal drug0 : concomitant use of drug0  drug0  drug0  drug0  drug0  drug0  drug2  drug0  or certain herbal supplements such as st .,thalidomide,phenytoin,FALSE,none
important non-drug1 drug interactions drugs that interfere with hormonal drug0 : concomitant use of drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug2  or certain herbal supplements such as st .,thalidomide,carbamazepine,FALSE,none
important non-drug0 drug interactions drugs that interfere with drug1 : concomitant use of drug2  drug0  drug0  drug0  drug0  drug0  drug0  drug0  or certain herbal supplements such as st .,hormonal contraceptives,hiv-protease inhibitors,FALSE,none
important non-drug0 drug interactions drugs that interfere with drug1 : concomitant use of drug0  drug2  drug0  drug0  drug0  drug0  drug0  drug0  or certain herbal supplements such as st .,hormonal contraceptives,griseofulvin,FALSE,none
important non-drug0 drug interactions drugs that interfere with drug1 : concomitant use of drug0  drug0  drug2  drug0  drug0  drug0  drug0  drug0  or certain herbal supplements such as st .,hormonal contraceptives,modafinil,FALSE,none
important non-drug0 drug interactions drugs that interfere with drug1 : concomitant use of drug0  drug0  drug0  drug2  drug0  drug0  drug0  drug0  or certain herbal supplements such as st .,hormonal contraceptives,penicillins,FALSE,none
important non-drug0 drug interactions drugs that interfere with drug1 : concomitant use of drug0  drug0  drug0  drug0  drug2  drug0  drug0  drug0  or certain herbal supplements such as st .,hormonal contraceptives,rifampin,FALSE,none
important non-drug0 drug interactions drugs that interfere with drug1 : concomitant use of drug0  drug0  drug0  drug0  drug0  drug2  drug0  drug0  or certain herbal supplements such as st .,hormonal contraceptives,rifabutin,FALSE,none
important non-drug0 drug interactions drugs that interfere with drug1 : concomitant use of drug0  drug0  drug0  drug0  drug0  drug0  drug2  drug0  or certain herbal supplements such as st .,hormonal contraceptives,phenytoin,FALSE,none
important non-drug0 drug interactions drugs that interfere with drug1 : concomitant use of drug0  drug0  drug0  drug0  drug0  drug0  drug0  drug2  or certain herbal supplements such as st .,hormonal contraceptives,carbamazepine,FALSE,none
drug1 with drug2 may reduce the effectiveness of the contraception and up to one month after discontinuation of these concomitant therapies .,john's wort,hormonal contraceptive agents,TRUE,effect
drug1 may compete with other drugs  such as drug2  for sites of metabolism in the liver  thus elevating the serum levels of such compounds to potentially toxic levels .,thiabendazole,theophylline,TRUE,mechanism
therefore  when concomitant use of drug1 and drug2 is anticipated  it may be necessary to monitor blood levels and/or reduce the dosage of such compounds .,thiabendazole,xanthine derivatives,TRUE,advise
interactions for drug1 ( drug0 ) : drug2  oral drug0  drug0  drug0 antidepressants,vitamin b1,loop diuretics,TRUE,int
interactions for drug1 ( drug0 ) : loop drug0  oral drug2  drug0  drug0 antidepressants,vitamin b1,contraceptives,TRUE,int
interactions for drug1 ( drug0 ) : loop drug0  oral drug0  drug2  drug0 antidepressants,vitamin b1,stavudine,TRUE,int
interactions for drug1 ( drug0 ) : loop drug0  oral drug0  drug0  drug0 antidepressants,vitamin b1,tricyclic antidepressants,TRUE,int
interactions for drug0 ( drug1 ) : drug2  oral drug0  drug0  drug0 antidepressants,thiamine,loop diuretics,TRUE,int
interactions for drug0 ( drug1 ) : loop drug0  oral drug2  drug0  drug0 antidepressants,thiamine,contraceptives,TRUE,int
interactions for drug0 ( drug1 ) : loop drug0  oral drug0  drug2  drug0 antidepressants,thiamine,stavudine,TRUE,int
interactions for drug0 ( drug1 ) : loop drug0  oral drug0  drug0  drug0 antidepressants,thiamine,tricyclic antidepressants,TRUE,int
interactions for drug0 ( drug0 ) : drug1  oral drug2  drug0  drug0 antidepressants,loop diuretics,contraceptives,FALSE,none
interactions for drug0 ( drug0 ) : drug1  oral drug0  drug0  drug0 antidepressants,loop diuretics,tricyclic antidepressants,FALSE,none
interactions for drug0 ( drug0 ) : loop drug0  oral drug1  drug0  drug0 antidepressants,contraceptives,tricyclic antidepressants,FALSE,none
interactions for drug0 ( drug0 ) : loop drug0  oral drug0  drug1  drug0 antidepressants,stavudine,tricyclic antidepressants,FALSE,none
drug1 are capable of potentiating drug2 ( e.g.  drug0  drug0  drug0  drug0  etc . ),phenothiazines,cns depressants,TRUE,effect
drug1 are capable of potentiating drug0 ( e.g.  drug2  drug0  drug0  drug0  etc . ),phenothiazines,barbiturates,TRUE,effect
drug1 are capable of potentiating drug0 ( e.g.  drug0  drug2  drug0  drug0  etc . ),phenothiazines,anesthetics,TRUE,effect
drug1 are capable of potentiating drug0 ( e.g.  drug0  drug0  drug2  drug0  etc . ),phenothiazines,opiates,TRUE,effect
drug1 are capable of potentiating drug0 ( e.g.  drug0  drug0  drug0  drug2  etc . ),phenothiazines,alcohol,TRUE,effect
drug0 are capable of potentiating drug1 ( e.g.  drug2  drug0  drug0  drug0  etc . ),cns depressants,barbiturates,FALSE,none
drug0 are capable of potentiating drug1 ( e.g.  drug0  drug2  drug0  drug0  etc . ),cns depressants,anesthetics,FALSE,none
drug0 are capable of potentiating drug1 ( e.g.  drug0  drug0  drug2  drug0  etc . ),cns depressants,opiates,FALSE,none
drug0 are capable of potentiating drug1 ( e.g.  drug0  drug0  drug0  drug2  etc . ),cns depressants,alcohol,FALSE,none
as well as drug1 and drug2 .,atropine,phosphorous insecticides,FALSE,none
there is usually complete cross-resistance between drug1 ( drug0 ) and drug2 brand drug0 .,purinethol,tabloid,TRUE,effect
there is usually complete cross-resistance between drug1 ( drug0 ) and drug0 brand drug2 .,purinethol,thioguanine,TRUE,effect
there is usually complete cross-resistance between drug0 ( drug1 ) and drug2 brand drug0 .,mercaptopurine,tabloid,TRUE,effect
there is usually complete cross-resistance between drug0 ( drug1 ) and drug0 brand drug2 .,mercaptopurine,thioguanine,TRUE,effect
there is usually complete cross-resistance between drug0 ( drug0 ) and drug1 brand drug2 .,tabloid,thioguanine,FALSE,none
as there is in vitro evidence that drug1 ( e.g.  drug2  drug0  or drug0 ) inhibit the tpmt enzyme  they should be administered with caution to patients receiving concurrent drug0 therapy .,aminosalicylate derivatives,olsalazine,FALSE,none
as there is in vitro evidence that drug1 ( e.g.  drug0  drug2  or drug0 ) inhibit the tpmt enzyme  they should be administered with caution to patients receiving concurrent drug0 therapy .,aminosalicylate derivatives,mesalazine,FALSE,none
as there is in vitro evidence that drug1 ( e.g.  drug0  drug0  or drug2 ) inhibit the tpmt enzyme  they should be administered with caution to patients receiving concurrent drug0 therapy .,aminosalicylate derivatives,sulphasalazine,FALSE,none
as there is in vitro evidence that drug1 ( e.g.  drug0  drug0  or drug0 ) inhibit the tpmt enzyme  they should be administered with caution to patients receiving concurrent drug2 therapy .,aminosalicylate derivatives,thioguanine,TRUE,mechanism
as there is in vitro evidence that drug0 ( e.g.  drug1  drug0  or drug0 ) inhibit the tpmt enzyme  they should be administered with caution to patients receiving concurrent drug2 therapy .,olsalazine,thioguanine,TRUE,mechanism
as there is in vitro evidence that drug0 ( e.g.  drug0  drug1  or drug2 ) inhibit the tpmt enzyme  they should be administered with caution to patients receiving concurrent drug0 therapy .,mesalazine,sulphasalazine,FALSE,none
as there is in vitro evidence that drug0 ( e.g.  drug0  drug1  or drug0 ) inhibit the tpmt enzyme  they should be administered with caution to patients receiving concurrent drug2 therapy .,mesalazine,thioguanine,TRUE,mechanism
as there is in vitro evidence that drug0 ( e.g.  drug0  drug0  or drug1 ) inhibit the tpmt enzyme  they should be administered with caution to patients receiving concurrent drug2 therapy .,sulphasalazine,thioguanine,TRUE,mechanism
caution should be exercised when administering drug1 therapy in combination with other drug2 .,zadaxin,immunomodulating drugs,TRUE,advise
prothrombin time or other suitable anticoagulation test should be monitored if drug1 is administered with drug2 .,tigecycline,warfarin,TRUE,advise
concurrent use of drug1 with oral drug2 may render oral drug0 less effective .,antibacterial drugs,contraceptives,TRUE,effect
concurrent use of drug1 with oral drug2 may render oral drug0 less effective .,antibacterial drugs,contraceptives,FALSE,none
the bioavailability of drug1 is decreased 80 % by drug2  when drug0 and drug0 are administered at the same time  and 60 % by some drug0- or drug0-containing drug0  when administered 1 hour before drug0 .,skelid,calcium,TRUE,mechanism
the bioavailability of drug1 is decreased 80 % by drug2  when drug0 and drug0 are administered at the same time  and 60 % by some drug0- or drug0-containing drug0  when administered 1 hour before drug0 .,skelid,calcium,FALSE,none
the bioavailability of drug1 is decreased 80 % by drug0  when drug0 and drug0 are administered at the same time  and 60 % by some drug2- or drug0-containing drug0  when administered 1 hour before drug0 .,skelid,aluminum,FALSE,none
the bioavailability of drug1 is decreased 80 % by drug0  when drug0 and drug0 are administered at the same time  and 60 % by some drug0- or drug2-containing drug0  when administered 1 hour before drug0 .,skelid,magnesium,FALSE,none
the bioavailability of drug1 is decreased 80 % by drug0  when drug0 and drug0 are administered at the same time  and 60 % by some drug0- or drug0-containing drug2  when administered 1 hour before drug0 .,skelid,antacids,FALSE,none
the bioavailability of drug2 is decreased 80 % by drug1  when drug0 and drug0 are administered at the same time  and 60 % by some drug0- or drug0-containing drug0  when administered 1 hour before drug0 .,calcium,skelid,FALSE,none
the bioavailability of drug0 is decreased 80 % by drug1  when drug0 and drug0 are administered at the same time  and 60 % by some drug2- or drug0-containing drug0  when administered 1 hour before drug0 .,calcium,aluminum,FALSE,none
the bioavailability of drug0 is decreased 80 % by drug1  when drug0 and drug0 are administered at the same time  and 60 % by some drug0- or drug2-containing drug0  when administered 1 hour before drug0 .,calcium,magnesium,FALSE,none
the bioavailability of drug0 is decreased 80 % by drug1  when drug0 and drug0 are administered at the same time  and 60 % by some drug0- or drug0-containing drug2  when administered 1 hour before drug0 .,calcium,antacids,FALSE,none
the bioavailability of drug2 is decreased 80 % by drug1  when drug0 and drug0 are administered at the same time  and 60 % by some drug0- or drug0-containing drug0  when administered 1 hour before drug0 .,calcium,skelid,FALSE,none
the bioavailability of drug2 is decreased 80 % by drug1  when drug0 and drug0 are administered at the same time  and 60 % by some drug0- or drug0-containing drug0  when administered 1 hour before drug0 .,calcium,skelid,FALSE,none
the bioavailability of drug0 is decreased 80 % by drug1  when drug0 and drug0 are administered at the same time  and 60 % by some drug2- or drug0-containing drug0  when administered 1 hour before drug0 .,calcium,aluminum,FALSE,none
the bioavailability of drug0 is decreased 80 % by drug1  when drug0 and drug0 are administered at the same time  and 60 % by some drug0- or drug2-containing drug0  when administered 1 hour before drug0 .,calcium,magnesium,FALSE,none
the bioavailability of drug0 is decreased 80 % by drug1  when drug0 and drug0 are administered at the same time  and 60 % by some drug0- or drug0-containing drug2  when administered 1 hour before drug0 .,calcium,antacids,FALSE,none
the bioavailability of drug2 is decreased 80 % by drug1  when drug0 and drug0 are administered at the same time  and 60 % by some drug0- or drug0-containing drug0  when administered 1 hour before drug0 .,calcium,skelid,FALSE,none
the bioavailability of drug1 is decreased 80 % by drug0  when drug0 and drug0 are administered at the same time  and 60 % by some drug2- or drug0-containing drug0  when administered 1 hour before drug0 .,skelid,aluminum,FALSE,none
the bioavailability of drug1 is decreased 80 % by drug0  when drug0 and drug0 are administered at the same time  and 60 % by some drug0- or drug2-containing drug0  when administered 1 hour before drug0 .,skelid,magnesium,FALSE,none
the bioavailability of drug1 is decreased 80 % by drug0  when drug0 and drug0 are administered at the same time  and 60 % by some drug0- or drug0-containing drug2  when administered 1 hour before drug0 .,skelid,antacids,FALSE,none
the bioavailability of drug0 is decreased 80 % by drug0  when drug0 and drug0 are administered at the same time  and 60 % by some drug1- or drug2-containing drug0  when administered 1 hour before drug0 .,aluminum,magnesium,FALSE,none
the bioavailability of drug0 is decreased 80 % by drug0  when drug0 and drug0 are administered at the same time  and 60 % by some drug1- or drug0-containing drug2  when administered 1 hour before drug0 .,aluminum,antacids,FALSE,none
the bioavailability of drug2 is decreased 80 % by drug0  when drug0 and drug0 are administered at the same time  and 60 % by some drug1- or drug0-containing drug0  when administered 1 hour before drug0 .,aluminum,skelid,TRUE,mechanism
the bioavailability of drug0 is decreased 80 % by drug0  when drug0 and drug0 are administered at the same time  and 60 % by some drug0- or drug1-containing drug2  when administered 1 hour before drug0 .,magnesium,antacids,FALSE,none
the bioavailability of drug2 is decreased 80 % by drug0  when drug0 and drug0 are administered at the same time  and 60 % by some drug0- or drug1-containing drug0  when administered 1 hour before drug0 .,magnesium,skelid,TRUE,mechanism
the bioavailability of drug2 is decreased 80 % by drug0  when drug0 and drug0 are administered at the same time  and 60 % by some drug0- or drug0-containing drug1  when administered 1 hour before drug0 .,antacids,skelid,FALSE,none
drug1 may decrease bioavailability of drug2 by up to 50 % when taken 2 hours after drug0 .,aspirin,skelid,TRUE,mechanism
drug1 may decrease bioavailability of drug2 by up to 50 % when taken 2 hours after drug0 .,aspirin,skelid,FALSE,none
in vitro studies show that drug1 does not displace drug2 from its binding site on protein .,tiludronate,warfarin,FALSE,none
these include drug1  drug0  and oral and inhaled drug2 .,sympathomimetic bronchodilators,steroids,FALSE,none
these include drug0  drug1  and oral and inhaled drug2 .,methylxanthines,steroids,FALSE,none
drug1 has been studied on a background of drug2 and drug0 .,aggrastat,aspirin,FALSE,none
drug1 has been studied on a background of drug0 and drug2 .,aggrastat,heparin,FALSE,none
drug0 has been studied on a background of drug1 and drug2 .,aspirin,heparin,FALSE,none
the use of drug1  in combination with drug2 and drug0  has been associated with an increase in bleeding compared to drug0 and drug0 alone ( see,aggrastat,heparin,TRUE,effect
the use of drug1  in combination with drug0 and drug2  has been associated with an increase in bleeding compared to drug0 and drug0 alone ( see,aggrastat,aspirin,TRUE,effect
the use of drug1  in combination with drug2 and drug0  has been associated with an increase in bleeding compared to drug0 and drug0 alone ( see,aggrastat,heparin,FALSE,none
the use of drug1  in combination with drug0 and drug2  has been associated with an increase in bleeding compared to drug0 and drug0 alone ( see,aggrastat,aspirin,FALSE,none
the use of drug0  in combination with drug1 and drug2  has been associated with an increase in bleeding compared to drug0 and drug0 alone ( see,heparin,aspirin,FALSE,none
the use of drug0  in combination with drug1 and drug2  has been associated with an increase in bleeding compared to drug0 and drug0 alone ( see,heparin,aspirin,FALSE,none
the use of drug0  in combination with drug2 and drug1  has been associated with an increase in bleeding compared to drug0 and drug0 alone ( see,aspirin,heparin,FALSE,none
the use of drug0  in combination with drug1 and drug2  has been associated with an increase in bleeding compared to drug0 and drug0 alone ( see,heparin,aspirin,FALSE,none
in clinical studies of drug1  patients taking drug0 concomitantly with drug2 ( drug0  genentech )  ( beta ) -agonists  inhaled drug0  other drug0  or parenteral drug0 demonstrated adverse experience profiles similar to the study population as a whole .,tobi,dornase alfa,FALSE,none
in clinical studies of drug1  patients taking drug0 concomitantly with drug0 ( drug2  genentech )  ( beta ) -agonists  inhaled drug0  other drug0  or parenteral drug0 demonstrated adverse experience profiles similar to the study population as a whole .,tobi,pulmozyme,FALSE,none
in clinical studies of drug1  patients taking drug0 concomitantly with drug0 ( drug0  genentech )  ( beta ) -agonists  inhaled drug0  other drug0  or parenteral drug0 demonstrated adverse experience profiles similar to the study population as a whole .,tobi,(beta)-agonists,FALSE,none
in clinical studies of drug1  patients taking drug0 concomitantly with drug0 ( drug0  genentech )  ( beta ) -agonists  inhaled drug2  other drug0  or parenteral drug0 demonstrated adverse experience profiles similar to the study population as a whole .,tobi,corticosteroids,FALSE,none
in clinical studies of drug1  patients taking drug0 concomitantly with drug0 ( drug0  genentech )  ( beta ) -agonists  inhaled drug0  other drug2  or parenteral drug0 demonstrated adverse experience profiles similar to the study population as a whole .,tobi,anti-pseudomonal antibiotics,FALSE,none
in clinical studies of drug1  patients taking drug0 concomitantly with drug0 ( drug0  genentech )  ( beta ) -agonists  inhaled drug0  other drug0  or parenteral drug2 demonstrated adverse experience profiles similar to the study population as a whole .,tobi,aminoglycosides,FALSE,none
in clinical studies of drug1  patients taking drug0 concomitantly with drug2 ( drug0  genentech )  ( beta ) -agonists  inhaled drug0  other drug0  or parenteral drug0 demonstrated adverse experience profiles similar to the study population as a whole .,tobi,dornase alfa,TRUE,effect
in clinical studies of drug1  patients taking drug0 concomitantly with drug0 ( drug2  genentech )  ( beta ) -agonists  inhaled drug0  other drug0  or parenteral drug0 demonstrated adverse experience profiles similar to the study population as a whole .,tobi,pulmozyme,TRUE,effect
in clinical studies of drug1  patients taking drug0 concomitantly with drug0 ( drug0  genentech )  ( beta ) -agonists  inhaled drug0  other drug0  or parenteral drug0 demonstrated adverse experience profiles similar to the study population as a whole .,tobi,(beta)-agonists,TRUE,effect
in clinical studies of drug1  patients taking drug0 concomitantly with drug0 ( drug0  genentech )  ( beta ) -agonists  inhaled drug2  other drug0  or parenteral drug0 demonstrated adverse experience profiles similar to the study population as a whole .,tobi,corticosteroids,TRUE,effect
in clinical studies of drug1  patients taking drug0 concomitantly with drug0 ( drug0  genentech )  ( beta ) -agonists  inhaled drug0  other drug2  or parenteral drug0 demonstrated adverse experience profiles similar to the study population as a whole .,tobi,anti-pseudomonal antibiotics,TRUE,effect
in clinical studies of drug1  patients taking drug0 concomitantly with drug0 ( drug0  genentech )  ( beta ) -agonists  inhaled drug0  other drug0  or parenteral drug2 demonstrated adverse experience profiles similar to the study population as a whole .,tobi,aminoglycosides,TRUE,effect
in clinical studies of drug0  patients taking drug0 concomitantly with drug1 ( drug2  genentech )  ( beta ) -agonists  inhaled drug0  other drug0  or parenteral drug0 demonstrated adverse experience profiles similar to the study population as a whole .,dornase alfa,pulmozyme,FALSE,none
in clinical studies of drug0  patients taking drug0 concomitantly with drug1 ( drug0  genentech )  ( beta ) -agonists  inhaled drug0  other drug0  or parenteral drug0 demonstrated adverse experience profiles similar to the study population as a whole .,dornase alfa,(beta)-agonists,FALSE,none
in clinical studies of drug0  patients taking drug0 concomitantly with drug1 ( drug0  genentech )  ( beta ) -agonists  inhaled drug2  other drug0  or parenteral drug0 demonstrated adverse experience profiles similar to the study population as a whole .,dornase alfa,corticosteroids,FALSE,none
in clinical studies of drug0  patients taking drug0 concomitantly with drug1 ( drug0  genentech )  ( beta ) -agonists  inhaled drug0  other drug2  or parenteral drug0 demonstrated adverse experience profiles similar to the study population as a whole .,dornase alfa,anti-pseudomonal antibiotics,FALSE,none
in clinical studies of drug0  patients taking drug0 concomitantly with drug1 ( drug0  genentech )  ( beta ) -agonists  inhaled drug0  other drug0  or parenteral drug2 demonstrated adverse experience profiles similar to the study population as a whole .,dornase alfa,aminoglycosides,FALSE,none
in clinical studies of drug0  patients taking drug0 concomitantly with drug0 ( drug1  genentech )  ( beta ) -agonists  inhaled drug0  other drug0  or parenteral drug0 demonstrated adverse experience profiles similar to the study population as a whole .,pulmozyme,(beta)-agonists,FALSE,none
in clinical studies of drug0  patients taking drug0 concomitantly with drug0 ( drug1  genentech )  ( beta ) -agonists  inhaled drug2  other drug0  or parenteral drug0 demonstrated adverse experience profiles similar to the study population as a whole .,pulmozyme,corticosteroids,FALSE,none
in clinical studies of drug0  patients taking drug0 concomitantly with drug0 ( drug1  genentech )  ( beta ) -agonists  inhaled drug0  other drug2  or parenteral drug0 demonstrated adverse experience profiles similar to the study population as a whole .,pulmozyme,anti-pseudomonal antibiotics,FALSE,none
in clinical studies of drug0  patients taking drug0 concomitantly with drug0 ( drug1  genentech )  ( beta ) -agonists  inhaled drug0  other drug0  or parenteral drug2 demonstrated adverse experience profiles similar to the study population as a whole .,pulmozyme,aminoglycosides,FALSE,none
in clinical studies of drug0  patients taking drug0 concomitantly with drug0 ( drug0  genentech )  ( beta ) -agonists  inhaled drug2  other drug0  or parenteral drug0 demonstrated adverse experience profiles similar to the study population as a whole .,(beta)-agonists,corticosteroids,FALSE,none
in clinical studies of drug0  patients taking drug0 concomitantly with drug0 ( drug0  genentech )  ( beta ) -agonists  inhaled drug0  other drug2  or parenteral drug0 demonstrated adverse experience profiles similar to the study population as a whole .,(beta)-agonists,anti-pseudomonal antibiotics,FALSE,none
in clinical studies of drug0  patients taking drug0 concomitantly with drug0 ( drug0  genentech )  ( beta ) -agonists  inhaled drug0  other drug0  or parenteral drug2 demonstrated adverse experience profiles similar to the study population as a whole .,(beta)-agonists,aminoglycosides,FALSE,none
in clinical studies of drug0  patients taking drug0 concomitantly with drug0 ( drug0  genentech )  ( beta ) -agonists  inhaled drug1  other drug2  or parenteral drug0 demonstrated adverse experience profiles similar to the study population as a whole .,corticosteroids,anti-pseudomonal antibiotics,FALSE,none
in clinical studies of drug0  patients taking drug0 concomitantly with drug0 ( drug0  genentech )  ( beta ) -agonists  inhaled drug1  other drug0  or parenteral drug2 demonstrated adverse experience profiles similar to the study population as a whole .,corticosteroids,aminoglycosides,FALSE,none
in clinical studies of drug0  patients taking drug0 concomitantly with drug0 ( drug0  genentech )  ( beta ) -agonists  inhaled drug0  other drug1  or parenteral drug2 demonstrated adverse experience profiles similar to the study population as a whole .,anti-pseudomonal antibiotics,aminoglycosides,FALSE,none
some drug1 can enhance drug2 toxicity by altering drug0 concentrations in serum and tissue .,diuretics,aminoglycoside,TRUE,effect
some drug1 can enhance drug0 toxicity by altering drug2 concentrations in serum and tissue .,diuretics,antibiotic,FALSE,none
some drug0 can enhance drug1 toxicity by altering drug2 concentrations in serum and tissue .,aminoglycoside,antibiotic,FALSE,none
drug1 should not be administered concomitantly with drug2  drug0  drug0  or drug0 .,tobi,ethacrynic acid,TRUE,advise
drug1 should not be administered concomitantly with drug0  drug2  drug0  or drug0 .,tobi,furosemide,TRUE,advise
drug1 should not be administered concomitantly with drug0  drug0  drug2  or drug0 .,tobi,urea,TRUE,advise
drug1 should not be administered concomitantly with drug0  drug0  drug0  or drug2 .,tobi,mannitol,TRUE,advise
drug0 should not be administered concomitantly with drug0  drug0  drug1  or drug2 .,urea,mannitol,FALSE,none
however  increased prothrombin time and bleeding have been reported in patients on concomitant drug1 and drug2 therapy .,tolectin,warfarin,TRUE,effect
therefore  caution should be exercised when administering drug1 to patients on drug2 .,tolectin,anticoagulants,TRUE,advise
in adult diabetic patients under treatment with either drug1 or drug2 there is no change in the clinical effects of either drug0 or the drug0 agents .,sulfonylureas,insulin,FALSE,none
in adult diabetic patients under treatment with either drug1 or drug0 there is no change in the clinical effects of either drug2 or the drug0 agents .,sulfonylureas,tolectin,FALSE,none
in adult diabetic patients under treatment with either drug1 or drug0 there is no change in the clinical effects of either drug0 or the drug2 .,sulfonylureas,hypoglycemic agents,FALSE,none
in adult diabetic patients under treatment with either drug0 or drug1 there is no change in the clinical effects of either drug2 or the drug0 agents .,insulin,tolectin,FALSE,none
in adult diabetic patients under treatment with either drug0 or drug1 there is no change in the clinical effects of either drug0 or the drug2 .,insulin,hypoglycemic agents,FALSE,none
in adult diabetic patients under treatment with either drug0 or drug0 there is no change in the clinical effects of either drug1 or the drug2 .,tolectin,hypoglycemic agents,FALSE,none
caution should be used if drug1 is administered concomitantly with drug2 .,tolectin,methotrexate,TRUE,advise
drug1 and other drug2 have been reported to reduce the tubular secretion of drug0 in an animal model  possibly enhancing the toxicity of drug0 .,tolectin,nonsteroidal anti-inflammatory drugs,FALSE,none
drug1 and other drug0 have been reported to reduce the tubular secretion of drug2 in an animal model  possibly enhancing the toxicity of drug0 .,tolectin,methotrexate,TRUE,mechanism
drug1 and other drug0 have been reported to reduce the tubular secretion of drug2 in an animal model  possibly enhancing the toxicity of drug0 .,tolectin,methotrexate,FALSE,none
drug0 and other drug1 have been reported to reduce the tubular secretion of drug2 in an animal model  possibly enhancing the toxicity of drug0 .,nonsteroidal anti-inflammatory drugs,methotrexate,TRUE,mechanism
drug0 and other drug1 have been reported to reduce the tubular secretion of drug2 in an animal model  possibly enhancing the toxicity of drug0 .,nonsteroidal anti-inflammatory drugs,methotrexate,FALSE,none
cyp3a4 inhibitors : drug1  an inhibitor of the drug metabolizing enzyme cyp3a4  significantly increased plasma concentrations of drug2 when coadministered to subjects who were poor metabolizers ( see clinical pharmacology  variability in metabolism and drug-drug interactions ) .,ketoconazole,tolterodine,TRUE,mechanism
for patients receiving drug1 or other potent cyp3a4 inhibitors such as other drug2 ( eg  drug0  drug0 ) or macrolide drug0 ( eg  drug0  drug0 ) or drug0 or drug0  the recommended dose of drug0 is 2 mg daily .,ketoconazole,azole antifungals,FALSE,none
for patients receiving drug1 or other potent cyp3a4 inhibitors such as other drug0 ( eg  drug2  drug0 ) or macrolide drug0 ( eg  drug0  drug0 ) or drug0 or drug0  the recommended dose of drug0 is 2 mg daily .,ketoconazole,itraconazole,FALSE,none
for patients receiving drug1 or other potent cyp3a4 inhibitors such as other drug0 ( eg  drug0  drug2 ) or macrolide drug0 ( eg  drug0  drug0 ) or drug0 or drug0  the recommended dose of drug0 is 2 mg daily .,ketoconazole,miconazole,FALSE,none
for patients receiving drug1 or other potent cyp3a4 inhibitors such as other drug0 ( eg  drug0  drug0 ) or drug2 ( eg  drug0  drug0 ) or drug0 or drug0  the recommended dose of drug0 is 2 mg daily .,ketoconazole,macrolide antibiotics,FALSE,none
for patients receiving drug1 or other potent cyp3a4 inhibitors such as other drug0 ( eg  drug0  drug0 ) or macrolide drug0 ( eg  drug2  drug0 ) or drug0 or drug0  the recommended dose of drug0 is 2 mg daily .,ketoconazole,erythromycin,FALSE,none
for patients receiving drug1 or other potent cyp3a4 inhibitors such as other drug0 ( eg  drug0  drug0 ) or macrolide drug0 ( eg  drug0  drug2 ) or drug0 or drug0  the recommended dose of drug0 is 2 mg daily .,ketoconazole,clarithromycin,FALSE,none
for patients receiving drug1 or other potent cyp3a4 inhibitors such as other drug0 ( eg  drug0  drug0 ) or macrolide drug0 ( eg  drug0  drug0 ) or drug2 or drug0  the recommended dose of drug0 is 2 mg daily .,ketoconazole,cyclosporine,FALSE,none
for patients receiving drug1 or other potent cyp3a4 inhibitors such as other drug0 ( eg  drug0  drug0 ) or macrolide drug0 ( eg  drug0  drug0 ) or drug0 or drug2  the recommended dose of drug0 is 2 mg daily .,ketoconazole,vinblastine,FALSE,none
for patients receiving drug1 or other potent cyp3a4 inhibitors such as other drug0 ( eg  drug0  drug0 ) or macrolide drug0 ( eg  drug0  drug0 ) or drug0 or drug0  the recommended dose of drug2 is 2 mg daily .,ketoconazole,detrol la,TRUE,advise
for patients receiving drug0 or other potent cyp3a4 inhibitors such as other drug1 ( eg  drug2  drug0 ) or macrolide drug0 ( eg  drug0  drug0 ) or drug0 or drug0  the recommended dose of drug0 is 2 mg daily .,azole antifungals,itraconazole,FALSE,none
for patients receiving drug0 or other potent cyp3a4 inhibitors such as other drug1 ( eg  drug0  drug2 ) or macrolide drug0 ( eg  drug0  drug0 ) or drug0 or drug0  the recommended dose of drug0 is 2 mg daily .,azole antifungals,miconazole,FALSE,none
for patients receiving drug0 or other potent cyp3a4 inhibitors such as other drug1 ( eg  drug0  drug0 ) or drug2 ( eg  drug0  drug0 ) or drug0 or drug0  the recommended dose of drug0 is 2 mg daily .,azole antifungals,macrolide antibiotics,FALSE,none
for patients receiving drug0 or other potent cyp3a4 inhibitors such as other drug1 ( eg  drug0  drug0 ) or macrolide drug0 ( eg  drug2  drug0 ) or drug0 or drug0  the recommended dose of drug0 is 2 mg daily .,azole antifungals,erythromycin,FALSE,none
for patients receiving drug0 or other potent cyp3a4 inhibitors such as other drug1 ( eg  drug0  drug0 ) or macrolide drug0 ( eg  drug0  drug2 ) or drug0 or drug0  the recommended dose of drug0 is 2 mg daily .,azole antifungals,clarithromycin,FALSE,none
for patients receiving drug0 or other potent cyp3a4 inhibitors such as other drug1 ( eg  drug0  drug0 ) or macrolide drug0 ( eg  drug0  drug0 ) or drug2 or drug0  the recommended dose of drug0 is 2 mg daily .,azole antifungals,cyclosporine,FALSE,none
for patients receiving drug0 or other potent cyp3a4 inhibitors such as other drug1 ( eg  drug0  drug0 ) or macrolide drug0 ( eg  drug0  drug0 ) or drug0 or drug2  the recommended dose of drug0 is 2 mg daily .,azole antifungals,vinblastine,FALSE,none
for patients receiving drug0 or other potent cyp3a4 inhibitors such as other drug1 ( eg  drug0  drug0 ) or macrolide drug0 ( eg  drug0  drug0 ) or drug0 or drug0  the recommended dose of drug2 is 2 mg daily .,azole antifungals,detrol la,TRUE,advise
for patients receiving drug0 or other potent cyp3a4 inhibitors such as other drug0 ( eg  drug1  drug0 ) or drug2 ( eg  drug0  drug0 ) or drug0 or drug0  the recommended dose of drug0 is 2 mg daily .,itraconazole,macrolide antibiotics,FALSE,none
for patients receiving drug0 or other potent cyp3a4 inhibitors such as other drug0 ( eg  drug1  drug0 ) or macrolide drug0 ( eg  drug2  drug0 ) or drug0 or drug0  the recommended dose of drug0 is 2 mg daily .,itraconazole,erythromycin,FALSE,none
for patients receiving drug0 or other potent cyp3a4 inhibitors such as other drug0 ( eg  drug1  drug0 ) or macrolide drug0 ( eg  drug0  drug2 ) or drug0 or drug0  the recommended dose of drug0 is 2 mg daily .,itraconazole,clarithromycin,FALSE,none
for patients receiving drug0 or other potent cyp3a4 inhibitors such as other drug0 ( eg  drug1  drug0 ) or macrolide drug0 ( eg  drug0  drug0 ) or drug2 or drug0  the recommended dose of drug0 is 2 mg daily .,itraconazole,cyclosporine,FALSE,none
for patients receiving drug0 or other potent cyp3a4 inhibitors such as other drug0 ( eg  drug1  drug0 ) or macrolide drug0 ( eg  drug0  drug0 ) or drug0 or drug2  the recommended dose of drug0 is 2 mg daily .,itraconazole,vinblastine,FALSE,none
for patients receiving drug0 or other potent cyp3a4 inhibitors such as other drug0 ( eg  drug1  drug0 ) or macrolide drug0 ( eg  drug0  drug0 ) or drug0 or drug0  the recommended dose of drug2 is 2 mg daily .,itraconazole,detrol la,TRUE,advise
for patients receiving drug0 or other potent cyp3a4 inhibitors such as other drug0 ( eg  drug0  drug1 ) or drug2 ( eg  drug0  drug0 ) or drug0 or drug0  the recommended dose of drug0 is 2 mg daily .,miconazole,macrolide antibiotics,FALSE,none
for patients receiving drug0 or other potent cyp3a4 inhibitors such as other drug0 ( eg  drug0  drug1 ) or macrolide drug0 ( eg  drug2  drug0 ) or drug0 or drug0  the recommended dose of drug0 is 2 mg daily .,miconazole,erythromycin,FALSE,none
for patients receiving drug0 or other potent cyp3a4 inhibitors such as other drug0 ( eg  drug0  drug1 ) or macrolide drug0 ( eg  drug0  drug2 ) or drug0 or drug0  the recommended dose of drug0 is 2 mg daily .,miconazole,clarithromycin,FALSE,none
for patients receiving drug0 or other potent cyp3a4 inhibitors such as other drug0 ( eg  drug0  drug1 ) or macrolide drug0 ( eg  drug0  drug0 ) or drug2 or drug0  the recommended dose of drug0 is 2 mg daily .,miconazole,cyclosporine,FALSE,none
for patients receiving drug0 or other potent cyp3a4 inhibitors such as other drug0 ( eg  drug0  drug1 ) or macrolide drug0 ( eg  drug0  drug0 ) or drug0 or drug2  the recommended dose of drug0 is 2 mg daily .,miconazole,vinblastine,FALSE,none
for patients receiving drug0 or other potent cyp3a4 inhibitors such as other drug0 ( eg  drug0  drug1 ) or macrolide drug0 ( eg  drug0  drug0 ) or drug0 or drug0  the recommended dose of drug2 is 2 mg daily .,miconazole,detrol la,TRUE,advise
for patients receiving drug0 or other potent cyp3a4 inhibitors such as other drug0 ( eg  drug0  drug0 ) or drug1 ( eg  drug2  drug0 ) or drug0 or drug0  the recommended dose of drug0 is 2 mg daily .,macrolide antibiotics,erythromycin,FALSE,none
for patients receiving drug0 or other potent cyp3a4 inhibitors such as other drug0 ( eg  drug0  drug0 ) or drug1 ( eg  drug0  drug2 ) or drug0 or drug0  the recommended dose of drug0 is 2 mg daily .,macrolide antibiotics,clarithromycin,FALSE,none
for patients receiving drug0 or other potent cyp3a4 inhibitors such as other drug0 ( eg  drug0  drug0 ) or drug1 ( eg  drug0  drug0 ) or drug2 or drug0  the recommended dose of drug0 is 2 mg daily .,macrolide antibiotics,cyclosporine,FALSE,none
for patients receiving drug0 or other potent cyp3a4 inhibitors such as other drug0 ( eg  drug0  drug0 ) or drug1 ( eg  drug0  drug0 ) or drug0 or drug2  the recommended dose of drug0 is 2 mg daily .,macrolide antibiotics,vinblastine,FALSE,none
for patients receiving drug0 or other potent cyp3a4 inhibitors such as other drug0 ( eg  drug0  drug0 ) or drug1 ( eg  drug0  drug0 ) or drug0 or drug0  the recommended dose of drug2 is 2 mg daily .,macrolide antibiotics,detrol la,TRUE,advise
for patients receiving drug0 or other potent cyp3a4 inhibitors such as other drug0 ( eg  drug0  drug0 ) or macrolide drug0 ( eg  drug1  drug0 ) or drug2 or drug0  the recommended dose of drug0 is 2 mg daily .,erythromycin,cyclosporine,FALSE,none
for patients receiving drug0 or other potent cyp3a4 inhibitors such as other drug0 ( eg  drug0  drug0 ) or macrolide drug0 ( eg  drug1  drug0 ) or drug0 or drug2  the recommended dose of drug0 is 2 mg daily .,erythromycin,vinblastine,FALSE,none
for patients receiving drug0 or other potent cyp3a4 inhibitors such as other drug0 ( eg  drug0  drug0 ) or macrolide drug0 ( eg  drug1  drug0 ) or drug0 or drug0  the recommended dose of drug2 is 2 mg daily .,erythromycin,detrol la,TRUE,advise
for patients receiving drug0 or other potent cyp3a4 inhibitors such as other drug0 ( eg  drug0  drug0 ) or macrolide drug0 ( eg  drug0  drug1 ) or drug2 or drug0  the recommended dose of drug0 is 2 mg daily .,clarithromycin,cyclosporine,FALSE,none
for patients receiving drug0 or other potent cyp3a4 inhibitors such as other drug0 ( eg  drug0  drug0 ) or macrolide drug0 ( eg  drug0  drug1 ) or drug0 or drug2  the recommended dose of drug0 is 2 mg daily .,clarithromycin,vinblastine,FALSE,none
for patients receiving drug0 or other potent cyp3a4 inhibitors such as other drug0 ( eg  drug0  drug0 ) or macrolide drug0 ( eg  drug0  drug1 ) or drug0 or drug0  the recommended dose of drug2 is 2 mg daily .,clarithromycin,detrol la,TRUE,advise
for patients receiving drug0 or other potent cyp3a4 inhibitors such as other drug0 ( eg  drug0  drug0 ) or macrolide drug0 ( eg  drug0  drug0 ) or drug1 or drug2  the recommended dose of drug0 is 2 mg daily .,cyclosporine,vinblastine,FALSE,none
for patients receiving drug0 or other potent cyp3a4 inhibitors such as other drug0 ( eg  drug0  drug0 ) or macrolide drug0 ( eg  drug0  drug0 ) or drug1 or drug0  the recommended dose of drug2 is 2 mg daily .,cyclosporine,detrol la,TRUE,advise
for patients receiving drug0 or other potent cyp3a4 inhibitors such as other drug0 ( eg  drug0  drug0 ) or macrolide drug0 ( eg  drug0  drug0 ) or drug0 or drug1  the recommended dose of drug2 is 2 mg daily .,vinblastine,detrol la,TRUE,advise
administration of drug1 in combination with drug2 resulted in a two-fold decrease in drug0 clearance in a non-human primate study and in a 1.5-fold increase in drug0 serum levels in clinical studies .,paclitaxel,herceptin,TRUE,mechanism
administration of drug1 in combination with drug2 resulted in a two-fold decrease in drug0 clearance in a non-human primate study and in a 1.5-fold increase in drug0 serum levels in clinical studies .,paclitaxel,herceptin,FALSE,none
administration of drug1 in combination with drug2 resulted in a two-fold decrease in drug0 clearance in a non-human primate study and in a 1.5-fold increase in drug0 serum levels in clinical studies .,paclitaxel,herceptin,FALSE,none
drug1 may interact with drug2 or drug0 ( causing too great a decrease in adrenal function ) .,trilostane,aminoglutethimide,TRUE,int
drug1 may interact with drug0 or drug2 ( causing too great a decrease in adrenal function ) .,trilostane,mitotane,TRUE,int
drug0 may interact with drug1 or drug2 ( causing too great a decrease in adrenal function ) .,aminoglutethimide,mitotane,FALSE,none
drug1 may inhibit the hepatic metabolism of drug2 .,trimethoprim,phenytoin,TRUE,mechanism
drug1  given at a common clinical dosage  increased the drug2 half-life by 51 % and decreased the drug0 metabolic clearance rate by 30 % .,trimethoprim,phenytoin,TRUE,mechanism
drug1  given at a common clinical dosage  increased the drug2 half-life by 51 % and decreased the drug0 metabolic clearance rate by 30 % .,trimethoprim,phenytoin,TRUE,mechanism
agents that might be coadministered with drug1 in aids patients for other indications that could elicit this activity include drug2  drug0  drug0  drug0  and drug0 .,trimetrexate,erythromycin,TRUE,effect
agents that might be coadministered with drug1 in aids patients for other indications that could elicit this activity include drug0  drug2  drug0  drug0  and drug0 .,trimetrexate,rifampin,TRUE,effect
agents that might be coadministered with drug1 in aids patients for other indications that could elicit this activity include drug0  drug0  drug2  drug0  and drug0 .,trimetrexate,rifabutin,TRUE,effect
agents that might be coadministered with drug1 in aids patients for other indications that could elicit this activity include drug0  drug0  drug0  drug2  and drug0 .,trimetrexate,ketoconazole,TRUE,effect
agents that might be coadministered with drug1 in aids patients for other indications that could elicit this activity include drug0  drug0  drug0  drug0  and drug2 .,trimetrexate,fluconazole,TRUE,effect
agents that might be coadministered with drug0 in aids patients for other indications that could elicit this activity include drug0  drug0  drug0  drug1  and drug2 .,ketoconazole,fluconazole,FALSE,none
in vitro perfusion of isolated rat liver has shown that drug1 caused a significant reduction in drug2 metabolism and that drug0 altered the relative concentration of drug0 metabolites possibly by competing for sulfate metabolites .,cimetidine,trimetrexate,TRUE,mechanism
in vitro perfusion of isolated rat liver has shown that drug1 caused a significant reduction in drug0 metabolism and that drug2 altered the relative concentration of drug0 metabolites possibly by competing for sulfate metabolites .,cimetidine,acetaminophen,FALSE,none
in vitro perfusion of isolated rat liver has shown that drug0 caused a significant reduction in drug1 metabolism and that drug2 altered the relative concentration of drug0 metabolites possibly by competing for sulfate metabolites .,trimetrexate,acetaminophen,FALSE,none
based on an in vitro rat liver model  nitrogen substituted drug1 ( drug2  drug0  drug0 ) were potent  non-competitive inhibitors of drug0 metabolism .,imidazole drugs,clotrimazole,FALSE,none
based on an in vitro rat liver model  nitrogen substituted drug1 ( drug0  drug2  drug0 ) were potent  non-competitive inhibitors of drug0 metabolism .,imidazole drugs,ketoconazole,FALSE,none
based on an in vitro rat liver model  nitrogen substituted drug1 ( drug0  drug0  drug2 ) were potent  non-competitive inhibitors of drug0 metabolism .,imidazole drugs,miconazole,FALSE,none
based on an in vitro rat liver model  nitrogen substituted drug1 ( drug0  drug0  drug0 ) were potent  non-competitive inhibitors of drug2 metabolism .,imidazole drugs,trimetrexate,TRUE,mechanism
based on an in vitro rat liver model  nitrogen substituted drug0 ( drug1  drug0  drug0 ) were potent  non-competitive inhibitors of drug2 metabolism .,clotrimazole,trimetrexate,TRUE,mechanism
based on an in vitro rat liver model  nitrogen substituted drug0 ( drug0  drug1  drug0 ) were potent  non-competitive inhibitors of drug2 metabolism .,ketoconazole,trimetrexate,TRUE,mechanism
based on an in vitro rat liver model  nitrogen substituted drug0 ( drug0  drug0  drug1 ) were potent  non-competitive inhibitors of drug2 metabolism .,miconazole,trimetrexate,TRUE,mechanism
drug1 may enhance the sedative effects of drug2 including drug0  drug0  drug0  narcotic drug0  drug0  and drug0 .,triprolidine,central nervous system depressants,TRUE,effect
drug1 may enhance the sedative effects of drug0 including drug2  drug0  drug0  narcotic drug0  drug0  and drug0 .,triprolidine,alcohol,TRUE,effect
drug1 may enhance the sedative effects of drug0 including drug0  drug2  drug0  narcotic drug0  drug0  and drug0 .,triprolidine,barbiturates,TRUE,effect
drug1 may enhance the sedative effects of drug0 including drug0  drug0  drug2  narcotic drug0  drug0  and drug0 .,triprolidine,hypnotics,TRUE,effect
drug1 may enhance the sedative effects of drug0 including drug0  drug0  drug0  drug2  drug0  and drug0 .,triprolidine,narcotic analgesics,TRUE,effect
drug1 may enhance the sedative effects of drug0 including drug0  drug0  drug0  narcotic drug0  drug2  and drug0 .,triprolidine,sedatives,TRUE,effect
drug1 may enhance the sedative effects of drug0 including drug0  drug0  drug0  narcotic drug0  drug0  and drug2 .,triprolidine,tranquillisers,TRUE,effect
drug0 may enhance the sedative effects of drug1 including drug2  drug0  drug0  narcotic drug0  drug0  and drug0 .,central nervous system depressants,alcohol,FALSE,none
drug0 may enhance the sedative effects of drug1 including drug0  drug2  drug0  narcotic drug0  drug0  and drug0 .,central nervous system depressants,barbiturates,FALSE,none
drug0 may enhance the sedative effects of drug1 including drug0  drug0  drug2  narcotic drug0  drug0  and drug0 .,central nervous system depressants,hypnotics,FALSE,none
drug0 may enhance the sedative effects of drug1 including drug0  drug0  drug0  drug2  drug0  and drug0 .,central nervous system depressants,narcotic analgesics,FALSE,none
drug0 may enhance the sedative effects of drug1 including drug0  drug0  drug0  narcotic drug0  drug2  and drug0 .,central nervous system depressants,sedatives,FALSE,none
drug0 may enhance the sedative effects of drug1 including drug0  drug0  drug0  narcotic drug0  drug0  and drug2 .,central nervous system depressants,tranquillisers,FALSE,none
drug0 may enhance the sedative effects of drug0 including drug1  drug0  drug0  narcotic drug0  drug0  and drug2 .,alcohol,tranquillisers,FALSE,none
drug0 may enhance the sedative effects of drug0 including drug0  drug1  drug0  narcotic drug0  drug0  and drug2 .,barbiturates,tranquillisers,FALSE,none
drug0 may enhance the sedative effects of drug0 including drug0  drug0  drug1  narcotic drug0  drug0  and drug2 .,hypnotics,tranquillisers,FALSE,none
drug0 may enhance the sedative effects of drug0 including drug0  drug0  drug0  narcotic drug0  drug1  and drug2 .,sedatives,tranquillisers,FALSE,none
the effects of drug1  such as drug2 and drug0 drug0 may be enhanced by the concomitant administration of drug0 .,anticholinergic drugs,atropine,FALSE,none
the effects of drug1  such as drug0 and drug2 may be enhanced by the concomitant administration of drug0 .,anticholinergic drugs,tricyclic antidepressants,FALSE,none
the effects of drug1  such as drug0 and drug0 drug0 may be enhanced by the concomitant administration of drug2 .,anticholinergic drugs,triprolidine,TRUE,effect
the effects of drug0 drugs  such as drug1 and drug2 may be enhanced by the concomitant administration of drug0 .,atropine,tricyclic antidepressants,FALSE,none
the effects of drug0 drugs  such as drug1 and drug0 drug0 may be enhanced by the concomitant administration of drug2 .,atropine,triprolidine,TRUE,effect
the effects of drug0 drugs  such as drug0 and drug1 may be enhanced by the concomitant administration of drug2 .,tricyclic antidepressants,triprolidine,TRUE,effect
the concomitant use of drug1 with other drug2 that produce dry mouth  constipation  and other drug0 pharmacological effects may increase the frequency and/or severity of such effects .,sanctura,anticholinergic agents,TRUE,effect
concomitant administration of drug1 and drug2 has been associated with erythema and histamine-like flushing and anaphylactoid reactions .,vancomycin,anesthetic agents,TRUE,effect
concurrent and/or sequential systemic or topical use of other potentially neurotoxic and/or nephrotoxic drugs  such as drug0  drug0  drug0  drug0  drug0  drug1  or drug2  when indicated  requires careful monitoring .,viomycin,cisplatin,FALSE,none
a study published in 2002 found that drug1 causes a statistically significant increase in plasma clearance of drug2 .,vigabatrin,carbamazepine,TRUE,mechanism
in 1984  drs rimmer and richens at the university of wales reported that administering drug1 with drug2 lowered the serum drug0 concentration in patients with treatment-resistant epilepsy .,vigabatrin,phenytoin,TRUE,mechanism
in 1984  drs rimmer and richens at the university of wales reported that administering drug1 with drug2 lowered the serum drug0 concentration in patients with treatment-resistant epilepsy .,vigabatrin,phenytoin,FALSE,none
drug1 can interact with the drugs of the following categories : - blood dyscrasia : can cause unpredictable myelotoxicity - bone marrow depressants : can cause a predictable dose-related myelotoxicity - radiation therapy : may cause marrow depression - neurotoxic medications : can cause neurologic toxicity - drug2 : can increase seizure activity - drug0 : may potentiate the replication of the drug0 virus  may increase the side effects of the vaccination  and decrease patient 's response to the drug0 - drug0 : may cause shortness of breath and bronchospasm - drug0 : may decrease patient 's response to the vaccine,vindesine,phenytoin,TRUE,int
drug1 can interact with the drugs of the following categories : - blood dyscrasia : can cause unpredictable myelotoxicity - bone marrow depressants : can cause a predictable dose-related myelotoxicity - radiation therapy : may cause marrow depression - neurotoxic medications : can cause neurologic toxicity - drug0 : can increase seizure activity - drug2 : may potentiate the replication of the drug0 virus  may increase the side effects of the vaccination  and decrease patient 's response to the drug0 - drug0 : may cause shortness of breath and bronchospasm - drug0 : may decrease patient 's response to the vaccine,vindesine,live virus vaccines,TRUE,int
drug1 can interact with the drugs of the following categories : - blood dyscrasia : can cause unpredictable myelotoxicity - bone marrow depressants : can cause a predictable dose-related myelotoxicity - radiation therapy : may cause marrow depression - neurotoxic medications : can cause neurologic toxicity - drug0 : can increase seizure activity - drug0 : may potentiate the replication of the drug2 virus  may increase the side effects of the vaccination  and decrease patient 's response to the drug0 - drug0 : may cause shortness of breath and bronchospasm - drug0 : may decrease patient 's response to the vaccine,vindesine,vaccine,FALSE,none
drug1 can interact with the drugs of the following categories : - blood dyscrasia : can cause unpredictable myelotoxicity - bone marrow depressants : can cause a predictable dose-related myelotoxicity - radiation therapy : may cause marrow depression - neurotoxic medications : can cause neurologic toxicity - drug0 : can increase seizure activity - drug0 : may potentiate the replication of the drug0 virus  may increase the side effects of the vaccination  and decrease patient 's response to the drug0 - drug2 : may cause shortness of breath and bronchospasm - drug0 : may decrease patient 's response to the vaccine,vindesine,mitomycin-c,TRUE,int
drug1 can interact with the drugs of the following categories : - blood dyscrasia : can cause unpredictable myelotoxicity - bone marrow depressants : can cause a predictable dose-related myelotoxicity - radiation therapy : may cause marrow depression - neurotoxic medications : can cause neurologic toxicity - drug0 : can increase seizure activity - drug0 : may potentiate the replication of the drug0 virus  may increase the side effects of the vaccination  and decrease patient 's response to the drug0 - drug0 : may cause shortness of breath and bronchospasm - drug2 : may decrease patient 's response to the vaccine,vindesine,killed virus vaccines,TRUE,int
drug1 can interact with the drugs of the following categories : - blood dyscrasia : can cause unpredictable myelotoxicity - bone marrow depressants : can cause a predictable dose-related myelotoxicity - radiation therapy : may cause marrow depression - neurotoxic medications : can cause neurologic toxicity - drug0 : can increase seizure activity - drug0 : may potentiate the replication of the drug2 virus  may increase the side effects of the vaccination  and decrease patient 's response to the drug0 - drug0 : may cause shortness of breath and bronchospasm - drug0 : may decrease patient 's response to the vaccine,vindesine,vaccine,FALSE,none
drug0 can interact with the drugs of the following categories : - blood dyscrasia : can cause unpredictable myelotoxicity - bone marrow depressants : can cause a predictable dose-related myelotoxicity - radiation therapy : may cause marrow depression - neurotoxic medications : can cause neurologic toxicity - drug1 : can increase seizure activity - drug2 : may potentiate the replication of the drug0 virus  may increase the side effects of the vaccination  and decrease patient 's response to the drug0 - drug0 : may cause shortness of breath and bronchospasm - drug0 : may decrease patient 's response to the vaccine,phenytoin,live virus vaccines,FALSE,none
drug0 can interact with the drugs of the following categories : - blood dyscrasia : can cause unpredictable myelotoxicity - bone marrow depressants : can cause a predictable dose-related myelotoxicity - radiation therapy : may cause marrow depression - neurotoxic medications : can cause neurologic toxicity - drug1 : can increase seizure activity - drug0 : may potentiate the replication of the drug2 virus  may increase the side effects of the vaccination  and decrease patient 's response to the drug0 - drug0 : may cause shortness of breath and bronchospasm - drug0 : may decrease patient 's response to the vaccine,phenytoin,vaccine,FALSE,none
drug0 can interact with the drugs of the following categories : - blood dyscrasia : can cause unpredictable myelotoxicity - bone marrow depressants : can cause a predictable dose-related myelotoxicity - radiation therapy : may cause marrow depression - neurotoxic medications : can cause neurologic toxicity - drug1 : can increase seizure activity - drug0 : may potentiate the replication of the drug0 virus  may increase the side effects of the vaccination  and decrease patient 's response to the drug0 - drug2 : may cause shortness of breath and bronchospasm - drug0 : may decrease patient 's response to the vaccine,phenytoin,mitomycin-c,FALSE,none
drug0 can interact with the drugs of the following categories : - blood dyscrasia : can cause unpredictable myelotoxicity - bone marrow depressants : can cause a predictable dose-related myelotoxicity - radiation therapy : may cause marrow depression - neurotoxic medications : can cause neurologic toxicity - drug1 : can increase seizure activity - drug0 : may potentiate the replication of the drug0 virus  may increase the side effects of the vaccination  and decrease patient 's response to the drug0 - drug0 : may cause shortness of breath and bronchospasm - drug2 : may decrease patient 's response to the vaccine,phenytoin,killed virus vaccines,FALSE,none
drug0 can interact with the drugs of the following categories : - blood dyscrasia : can cause unpredictable myelotoxicity - bone marrow depressants : can cause a predictable dose-related myelotoxicity - radiation therapy : may cause marrow depression - neurotoxic medications : can cause neurologic toxicity - drug1 : can increase seizure activity - drug0 : may potentiate the replication of the drug2 virus  may increase the side effects of the vaccination  and decrease patient 's response to the drug0 - drug0 : may cause shortness of breath and bronchospasm - drug0 : may decrease patient 's response to the vaccine,phenytoin,vaccine,FALSE,none
drug0 can interact with the drugs of the following categories : - blood dyscrasia : can cause unpredictable myelotoxicity - bone marrow depressants : can cause a predictable dose-related myelotoxicity - radiation therapy : may cause marrow depression - neurotoxic medications : can cause neurologic toxicity - drug0 : can increase seizure activity - drug1 : may potentiate the replication of the drug2 virus  may increase the side effects of the vaccination  and decrease patient 's response to the drug0 - drug0 : may cause shortness of breath and bronchospasm - drug0 : may decrease patient 's response to the vaccine,live virus vaccines,vaccine,FALSE,none
drug0 can interact with the drugs of the following categories : - blood dyscrasia : can cause unpredictable myelotoxicity - bone marrow depressants : can cause a predictable dose-related myelotoxicity - radiation therapy : may cause marrow depression - neurotoxic medications : can cause neurologic toxicity - drug0 : can increase seizure activity - drug1 : may potentiate the replication of the drug0 virus  may increase the side effects of the vaccination  and decrease patient 's response to the drug0 - drug2 : may cause shortness of breath and bronchospasm - drug0 : may decrease patient 's response to the vaccine,live virus vaccines,mitomycin-c,FALSE,none
drug0 can interact with the drugs of the following categories : - blood dyscrasia : can cause unpredictable myelotoxicity - bone marrow depressants : can cause a predictable dose-related myelotoxicity - radiation therapy : may cause marrow depression - neurotoxic medications : can cause neurologic toxicity - drug0 : can increase seizure activity - drug1 : may potentiate the replication of the drug0 virus  may increase the side effects of the vaccination  and decrease patient 's response to the drug0 - drug0 : may cause shortness of breath and bronchospasm - drug2 : may decrease patient 's response to the vaccine,live virus vaccines,killed virus vaccines,FALSE,none
drug0 can interact with the drugs of the following categories : - blood dyscrasia : can cause unpredictable myelotoxicity - bone marrow depressants : can cause a predictable dose-related myelotoxicity - radiation therapy : may cause marrow depression - neurotoxic medications : can cause neurologic toxicity - drug0 : can increase seizure activity - drug1 : may potentiate the replication of the drug2 virus  may increase the side effects of the vaccination  and decrease patient 's response to the drug0 - drug0 : may cause shortness of breath and bronchospasm - drug0 : may decrease patient 's response to the vaccine,live virus vaccines,vaccine,FALSE,none
drug0 can interact with the drugs of the following categories : - blood dyscrasia : can cause unpredictable myelotoxicity - bone marrow depressants : can cause a predictable dose-related myelotoxicity - radiation therapy : may cause marrow depression - neurotoxic medications : can cause neurologic toxicity - drug0 : can increase seizure activity - drug0 : may potentiate the replication of the drug1 virus  may increase the side effects of the vaccination  and decrease patient 's response to the drug0 - drug2 : may cause shortness of breath and bronchospasm - drug0 : may decrease patient 's response to the vaccine,vaccine,mitomycin-c,FALSE,none
drug0 can interact with the drugs of the following categories : - blood dyscrasia : can cause unpredictable myelotoxicity - bone marrow depressants : can cause a predictable dose-related myelotoxicity - radiation therapy : may cause marrow depression - neurotoxic medications : can cause neurologic toxicity - drug0 : can increase seizure activity - drug0 : may potentiate the replication of the drug1 virus  may increase the side effects of the vaccination  and decrease patient 's response to the drug0 - drug0 : may cause shortness of breath and bronchospasm - drug2 : may decrease patient 's response to the vaccine,vaccine,killed virus vaccines,FALSE,none
drug0 can interact with the drugs of the following categories : - blood dyscrasia : can cause unpredictable myelotoxicity - bone marrow depressants : can cause a predictable dose-related myelotoxicity - radiation therapy : may cause marrow depression - neurotoxic medications : can cause neurologic toxicity - drug0 : can increase seizure activity - drug0 : may potentiate the replication of the drug0 virus  may increase the side effects of the vaccination  and decrease patient 's response to the drug0 - drug1 : may cause shortness of breath and bronchospasm - drug2 : may decrease patient 's response to the vaccine,mitomycin-c,killed virus vaccines,FALSE,none
drug0 can interact with the drugs of the following categories : - blood dyscrasia : can cause unpredictable myelotoxicity - bone marrow depressants : can cause a predictable dose-related myelotoxicity - radiation therapy : may cause marrow depression - neurotoxic medications : can cause neurologic toxicity - drug0 : can increase seizure activity - drug0 : may potentiate the replication of the drug2 virus  may increase the side effects of the vaccination  and decrease patient 's response to the drug0 - drug1 : may cause shortness of breath and bronchospasm - drug0 : may decrease patient 's response to the vaccine,mitomycin-c,vaccine,FALSE,none
drug0 can interact with the drugs of the following categories : - blood dyscrasia : can cause unpredictable myelotoxicity - bone marrow depressants : can cause a predictable dose-related myelotoxicity - radiation therapy : may cause marrow depression - neurotoxic medications : can cause neurologic toxicity - drug0 : can increase seizure activity - drug0 : may potentiate the replication of the drug2 virus  may increase the side effects of the vaccination  and decrease patient 's response to the drug0 - drug0 : may cause shortness of breath and bronchospasm - drug1 : may decrease patient 's response to the vaccine,killed virus vaccines,vaccine,FALSE,none
drug interactions : women on oral drug1 have shown a significant increase in plasma drug2 levels .,contraceptives,vitamin a,TRUE,mechanism
limited evidence suggests that drug1 may influence the intensity and duration of action of drug2 .,ascorbic acid,bishydroxycoumarin,TRUE,mechanism
drug1 : prolongation of prothrombin time ( pt ) and international normalized ratio ( inr ) were observed in patients receiving drug2 concomitantly with drug0-derivative drug0 .,coumarin-derivative anticoagulants,zolinza,FALSE,none
drug2 : prolongation of prothrombin time ( pt ) and international normalized ratio ( inr ) were observed in patients receiving drug1 concomitantly with drug0-derivative drug0 .,zolinza,coumarin-derivative anticoagulants,TRUE,effect
physicians should carefully monitor pt and inr in patients concurrently administered drug1 and drug2 .,zolinza,coumarin derivatives,TRUE,advise
other drug1 severe thrombocytopenia and gastrointestinal bleeding have been reported with concomitant use of drug2 and other drug0 ( e.g.  drug0 ) .,hdac inhibitors,zolinza,FALSE,none
other drug1 severe thrombocytopenia and gastrointestinal bleeding have been reported with concomitant use of drug0 and other drug0 ( e.g.  drug2 ) .,hdac inhibitors,valproic acid,FALSE,none
other drug2 severe thrombocytopenia and gastrointestinal bleeding have been reported with concomitant use of drug1 and other drug0 ( e.g.  drug0 ) .,zolinza,hdac inhibitors,TRUE,effect
other drug0 severe thrombocytopenia and gastrointestinal bleeding have been reported with concomitant use of drug1 and other drug0 ( e.g.  drug2 ) .,zolinza,valproic acid,TRUE,effect
other drug1 severe thrombocytopenia and gastrointestinal bleeding have been reported with concomitant use of drug0 and other drug0 ( e.g.  drug2 ) .,hdac inhibitors,valproic acid,FALSE,none
drug1 : prolongation of prothrombin time ( pt ) and international normalized ratio ( inr ) were observed in patients receiving drug2 concomitantly with drug0-derivative drug0 .,coumarin-derivative anticoagulants,zolinza,FALSE,none
drug2 : prolongation of prothrombin time ( pt ) and international normalized ratio ( inr ) were observed in patients receiving drug1 concomitantly with drug0-derivative drug0 .,zolinza,coumarin-derivative anticoagulants,TRUE,effect
physicians should carefully monitor pt and inr in patients concurrently administered drug1 and drug2 .,zolinza,coumarin derivatives,TRUE,advise
other drug1 severe thrombocytopenia and gastrointestinal bleeding have been reported with concomitant use of drug2 and other drug0 ( e.g.  drug0 ) .,hdac inhibitors,zolinza,FALSE,none
other drug1 severe thrombocytopenia and gastrointestinal bleeding have been reported with concomitant use of drug0 and other drug0 ( e.g.  drug2 ) .,hdac inhibitors,valproic acid,FALSE,none
other drug2 severe thrombocytopenia and gastrointestinal bleeding have been reported with concomitant use of drug1 and other drug0 ( e.g.  drug0 ) .,zolinza,hdac inhibitors,TRUE,effect
other drug0 severe thrombocytopenia and gastrointestinal bleeding have been reported with concomitant use of drug1 and other drug0 ( e.g.  drug2 ) .,zolinza,valproic acid,TRUE,effect
other drug1 severe thrombocytopenia and gastrointestinal bleeding have been reported with concomitant use of drug0 and other drug0 ( e.g.  drug2 ) .,hdac inhibitors,valproic acid,FALSE,none
in the present study  we tested whether the highly specific metabotropic glutamate receptor 5 antagonist  drug1  reduces dopaminergic and noradrenergic neuronal loss in monkeys rendered parkinsonian by chronic treatment with low doses of drug2 .,"3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine","1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine",FALSE,none
weekly intramuscular drug1 injections ( 0.2-0.5 mg/kg body weight )  in combination with daily administration of drug2 or vehicle  were performed until the development of parkinsonian motor symptoms in either of the two experimental groups ( drug0/drug0 versus drug0/vehicle ) .,"1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine","3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine",FALSE,none
weekly intramuscular drug1 injections ( 0.2-0.5 mg/kg body weight )  in combination with daily administration of drug2 or vehicle  were performed until the development of parkinsonian motor symptoms in either of the two experimental groups ( drug0/drug0 versus drug0/vehicle ) .,"1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine","3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine",FALSE,none
weekly intramuscular drug2 injections ( 0.2-0.5 mg/kg body weight )  in combination with daily administration of drug1 or vehicle  were performed until the development of parkinsonian motor symptoms in either of the two experimental groups ( drug0/drug0 versus drug0/vehicle ) .,"3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine","1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine",FALSE,none
weekly intramuscular drug2 injections ( 0.2-0.5 mg/kg body weight )  in combination with daily administration of drug1 or vehicle  were performed until the development of parkinsonian motor symptoms in either of the two experimental groups ( drug0/drug0 versus drug0/vehicle ) .,"3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine","1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine",FALSE,none
weekly intramuscular drug1 injections ( 0.2-0.5 mg/kg body weight )  in combination with daily administration of drug2 or vehicle  were performed until the development of parkinsonian motor symptoms in either of the two experimental groups ( drug0/drug0 versus drug0/vehicle ) .,"1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine","3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine",FALSE,none
weekly intramuscular drug2 injections ( 0.2-0.5 mg/kg body weight )  in combination with daily administration of drug1 or vehicle  were performed until the development of parkinsonian motor symptoms in either of the two experimental groups ( drug0/drug0 versus drug0/vehicle ) .,"3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine","1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine",FALSE,none
after 21 weeks of drug1 treatment  all drug0/vehicle-treated animals displayed parkinsonian symptoms  whereas none of the drug0/drug2-treated monkeys were significantly affected .,"1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine","3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine",FALSE,none
after 21 weeks of drug1 treatment  all drug0/vehicle-treated animals displayed parkinsonian symptoms  whereas none of the drug0/drug2-treated monkeys were significantly affected .,"1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine","3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine",FALSE,none
after 21 weeks of drug1 treatment  all drug0/vehicle-treated animals displayed parkinsonian symptoms  whereas none of the drug0/drug2-treated monkeys were significantly affected .,"1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine","3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine",TRUE,effect
these behavioural observations were consistent with in vivo positron emission tomography dopamine transporter imaging data  and with post-mortem stereological counts of midbrain dopaminergic neurons  as well as striatal intensity measurements of dopamine transporter and tyrosine hydroxylase immunoreactivity  which were all significantly higher in drug1/drug2-treated animals than in drug0/vehicle-treated monkeys .,"1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine","3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine",TRUE,effect
these behavioural observations were consistent with in vivo positron emission tomography dopamine transporter imaging data  and with post-mortem stereological counts of midbrain dopaminergic neurons  as well as striatal intensity measurements of dopamine transporter and tyrosine hydroxylase immunoreactivity  which were all significantly higher in drug2/drug1-treated animals than in drug0/vehicle-treated monkeys .,"3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine","1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine",FALSE,none
the drug1 treatment also had a significant effect on the drug2-induced loss of drug0 neurons in the locus coeruleus and adjoining a5 and a7 noradrenaline cell groups .,"3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine","1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine",TRUE,effect
in drug1/vehicle-treated animals  almost 40 % loss of tyrosine hydroxylase-positive drug0 neurons was found in locus coeruleus/a5/a7 noradrenaline cell groups  whereas the extent of neuronal loss was lower than 15 % of control values in drug0/drug2-treated monkeys .,"1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine","3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine",FALSE,none
in drug1/vehicle-treated animals  almost 40 % loss of tyrosine hydroxylase-positive drug0 neurons was found in locus coeruleus/a5/a7 noradrenaline cell groups  whereas the extent of neuronal loss was lower than 15 % of control values in drug0/drug2-treated monkeys .,"1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine","3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine",TRUE,effect
our data demonstrate that chronic treatment with the metabotropic glutamate receptor 5 antagonist  drug1  significantly reduces drug2 toxicity towards dopaminergic and noradrenergic cell groups in non-human primates .,"3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine","1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine",TRUE,effect
effect of drug1-mediated cyp3a4 inhibition on clinical pharmacokinetics of drug2 ( drug0 )  an orally active drug0 .,ketoconazole,panobinostat,FALSE,none
effect of drug1-mediated cyp3a4 inhibition on clinical pharmacokinetics of drug0 ( drug2 )  an orally active drug0 .,ketoconazole,lbh589,FALSE,none
effect of drug1-mediated cyp3a4 inhibition on clinical pharmacokinetics of drug0 ( drug0 )  an orally active drug2 .,ketoconazole,histone deacetylase inhibitor,FALSE,none
effect of drug0-mediated cyp3a4 inhibition on clinical pharmacokinetics of drug1 ( drug0 )  an orally active drug2 .,panobinostat,histone deacetylase inhibitor,FALSE,none
effect of drug0-mediated cyp3a4 inhibition on clinical pharmacokinetics of drug0 ( drug1 )  an orally active drug2 .,lbh589,histone deacetylase inhibitor,FALSE,none
this study evaluated the effect of a potent cyp3a inhibitor  drug1  on the pharmacokinetics and safety of drug2 .,ketoconazole,panobinostat,FALSE,none
on day 8  a single drug1 dose was co-administered with drug2 .,panobinostat,ketoconazole,FALSE,none
in the presence of drug1  there was 1.6- and 1.8-fold increase in c ( max ) and auc of drug2  respectively .,ketoconazole,panobinostat,TRUE,mechanism
interaction study of drug1 and drug2 with co-administered drugs .,moxifloxacin,lomefloxacin,FALSE,none
drug1 and drug2 are fluoroquinolone drug0 used in treating urinary and respiratory tract infections .,moxifloxacin,lomefloxacin,FALSE,none
drug1 and drug0 are drug2 used in treating urinary and respiratory tract infections .,moxifloxacin,fluoroquinolone antibiotics,FALSE,none
drug0 and drug1 are drug2 used in treating urinary and respiratory tract infections .,lomefloxacin,fluoroquinolone antibiotics,FALSE,none
being drug1 and drug0 drug2 the interaction study of was carried out with drug0  drug0  drug0 and multi drug0 .,moxifloxacin,fluoroquinolones,FALSE,none
being drug1 and drug0 drug0 the interaction study of was carried out with drug2  drug0  drug0 and multi drug0 .,moxifloxacin,sucralfate,FALSE,none
being drug1 and drug0 drug0 the interaction study of was carried out with drug0  drug2  drug0 and multi drug0 .,moxifloxacin,gelusil,FALSE,none
being drug1 and drug0 drug0 the interaction study of was carried out with drug0  drug0  drug2 and multi drug0 .,moxifloxacin,erythromycin,FALSE,none
being drug1 and drug0 drug0 the interaction study of was carried out with drug0  drug0  drug0 and drug2 .,moxifloxacin,multi minerals,FALSE,none
being drug0 and drug0 drug1 the interaction study of was carried out with drug2  drug0  drug0 and multi drug0 .,fluoroquinolones,sucralfate,FALSE,none
being drug0 and drug0 drug1 the interaction study of was carried out with drug0  drug2  drug0 and multi drug0 .,fluoroquinolones,gelusil,FALSE,none
being drug0 and drug0 drug1 the interaction study of was carried out with drug0  drug0  drug2 and multi drug0 .,fluoroquinolones,erythromycin,FALSE,none
being drug0 and drug0 drug1 the interaction study of was carried out with drug0  drug0  drug0 and drug2 .,fluoroquinolones,multi minerals,FALSE,none
being drug0 and drug0 drug0 the interaction study of was carried out with drug1  drug0  drug0 and drug2 .,sucralfate,multi minerals,FALSE,none
being drug0 and drug0 drug0 the interaction study of was carried out with drug0  drug1  drug0 and drug2 .,gelusil,multi minerals,FALSE,none
being drug0 and drug0 drug0 the interaction study of was carried out with drug0  drug0  drug1 and drug2 .,erythromycin,multi minerals,FALSE,none
the response of drug1 and drug2 after interaction with co-administered drugs at different conditions and temperature were noted using a shimadzu hplc system with pda detector .,moxifloxacin,lomefloxacin,FALSE,none
drug1 and drug2 reacts faster with drug0 and drug0 in acidic media whereas with drug0 in basic media and multi-drug0 in neutral media .,moxifloxacin,lomefloxacin,FALSE,none
drug1 and drug0 reacts faster with drug2 and drug0 in acidic media whereas with drug0 in basic media and multi-drug0 in neutral media .,moxifloxacin,sucralfate,TRUE,mechanism
drug1 and drug0 reacts faster with drug0 and drug2 in acidic media whereas with drug0 in basic media and multi-drug0 in neutral media .,moxifloxacin,gelusil,TRUE,mechanism
drug1 and drug0 reacts faster with drug0 and drug0 in acidic media whereas with drug2 in basic media and multi-drug0 in neutral media .,moxifloxacin,erythromycin,TRUE,mechanism
drug1 and drug0 reacts faster with drug0 and drug0 in acidic media whereas with drug0 in basic media and drug2 in neutral media .,moxifloxacin,multi-minerals,TRUE,mechanism
drug0 and drug1 reacts faster with drug2 and drug0 in acidic media whereas with drug0 in basic media and multi-drug0 in neutral media .,lomefloxacin,sucralfate,TRUE,mechanism
drug0 and drug1 reacts faster with drug0 and drug2 in acidic media whereas with drug0 in basic media and multi-drug0 in neutral media .,lomefloxacin,gelusil,TRUE,mechanism
drug0 and drug1 reacts faster with drug0 and drug0 in acidic media whereas with drug2 in basic media and multi-drug0 in neutral media .,lomefloxacin,erythromycin,TRUE,mechanism
drug0 and drug1 reacts faster with drug0 and drug0 in acidic media whereas with drug0 in basic media and drug2 in neutral media .,lomefloxacin,multi-minerals,TRUE,mechanism
drug0 and drug0 reacts faster with drug1 and drug2 in acidic media whereas with drug0 in basic media and multi-drug0 in neutral media .,sucralfate,gelusil,FALSE,none
drug0 and drug0 reacts faster with drug1 and drug0 in acidic media whereas with drug2 in basic media and multi-drug0 in neutral media .,sucralfate,erythromycin,FALSE,none
drug0 and drug0 reacts faster with drug1 and drug0 in acidic media whereas with drug0 in basic media and drug2 in neutral media .,sucralfate,multi-minerals,FALSE,none
drug0 and drug0 reacts faster with drug0 and drug1 in acidic media whereas with drug2 in basic media and multi-drug0 in neutral media .,gelusil,erythromycin,FALSE,none
drug0 and drug0 reacts faster with drug0 and drug1 in acidic media whereas with drug0 in basic media and drug2 in neutral media .,gelusil,multi-minerals,FALSE,none
drug0 and drug0 reacts faster with drug0 and drug0 in acidic media whereas with drug1 in basic media and drug2 in neutral media .,erythromycin,multi-minerals,FALSE,none
exposure to oral drug1 is unaffected by drug2 but greatly increased by drug0 .,s-ketamine,itraconazole,FALSE,none
exposure to oral drug1 is unaffected by drug0 but greatly increased by drug2 .,s-ketamine,ticlopidine,TRUE,effect
exposure to oral s-drug0 is unaffected by drug1 but greatly increased by drug2 .,itraconazole,ticlopidine,FALSE,none
this study examined drug-drug interactions of oral drug1 with the cytochrome p450 ( cyp ) 2b6 inhibitor drug2 and the cyp3a inhibitor drug0 .,s-ketamine,ticlopidine,FALSE,none
this study examined drug-drug interactions of oral drug1 with the cytochrome p450 ( cyp ) 2b6 inhibitor drug0 and the cyp3a inhibitor drug2 .,s-ketamine,itraconazole,FALSE,none
this study examined drug-drug interactions of oral s-drug0 with the cytochrome p450 ( cyp ) 2b6 inhibitor drug1 and the cyp3a inhibitor drug2 .,ticlopidine,itraconazole,FALSE,none
in this randomized  blinded  crossover study  11 healthy volunteers ingested 0.2 mg/kg drug1 after pretreatments with oral drug2 ( 250 mg twice daily )  drug0 ( 200 mg once daily )  or placebo in 6-day treatment periods at intervals of 4 weeks .,s-ketamine,ticlopidine,FALSE,none
in this randomized  blinded  crossover study  11 healthy volunteers ingested 0.2 mg/kg drug1 after pretreatments with oral drug0 ( 250 mg twice daily )  drug2 ( 200 mg once daily )  or placebo in 6-day treatment periods at intervals of 4 weeks .,s-ketamine,itraconazole,FALSE,none
in this randomized  blinded  crossover study  11 healthy volunteers ingested 0.2 mg/kg s-drug0 after pretreatments with oral drug1 ( 250 mg twice daily )  drug2 ( 200 mg once daily )  or placebo in 6-day treatment periods at intervals of 4 weeks .,ticlopidine,itraconazole,FALSE,none
drug1 treatment increased the mean area under the plasma concentration-time curve extrapolated to infinity ( auc ( 0- ) ) of oral drug2 by 2.4-fold  whereas drug0 treatment did not increase the exposure to s-drug0 .,ticlopidine,ketamine,TRUE,mechanism
drug1 treatment increased the mean area under the plasma concentration-time curve extrapolated to infinity ( auc ( 0- ) ) of oral drug0 by 2.4-fold  whereas drug2 treatment did not increase the exposure to s-drug0 .,ticlopidine,itraconazole,FALSE,none
drug1 treatment increased the mean area under the plasma concentration-time curve extrapolated to infinity ( auc ( 0- ) ) of oral drug0 by 2.4-fold  whereas drug0 treatment did not increase the exposure to drug2 .,ticlopidine,s-ketamine,FALSE,none
drug0 treatment increased the mean area under the plasma concentration-time curve extrapolated to infinity ( auc ( 0- ) ) of oral drug1 by 2.4-fold  whereas drug2 treatment did not increase the exposure to s-drug0 .,ketamine,itraconazole,FALSE,none
drug0 treatment increased the mean area under the plasma concentration-time curve extrapolated to infinity ( auc ( 0- ) ) of oral drug1 by 2.4-fold  whereas drug0 treatment did not increase the exposure to drug2 .,ketamine,s-ketamine,FALSE,none
drug0 treatment increased the mean area under the plasma concentration-time curve extrapolated to infinity ( auc ( 0- ) ) of oral drug0 by 2.4-fold  whereas drug1 treatment did not increase the exposure to drug2 .,itraconazole,s-ketamine,FALSE,none
the ratio of drug1 auc ( 0- ) to drug2 auc ( 0- ) was significantly decreased in the drug0 ( p & lt ; 0.001 ) and drug0 phases ( p = 0.006 ) as compared to placebo .,norketamine,ketamine,FALSE,none
the ratio of drug1 auc ( 0- ) to drug0 auc ( 0- ) was significantly decreased in the drug2 ( p & lt ; 0.001 ) and drug0 phases ( p = 0.006 ) as compared to placebo .,norketamine,ticlopidine,FALSE,none
the ratio of drug1 auc ( 0- ) to drug0 auc ( 0- ) was significantly decreased in the drug0 ( p & lt ; 0.001 ) and drug2 phases ( p = 0.006 ) as compared to placebo .,norketamine,itraconazole,FALSE,none
the ratio of nordrug1 auc ( 0- ) to drug0 auc ( 0- ) was significantly decreased in the drug2 ( p & lt ; 0.001 ) and drug0 phases ( p = 0.006 ) as compared to placebo .,ketamine,ticlopidine,FALSE,none
the ratio of nordrug1 auc ( 0- ) to drug0 auc ( 0- ) was significantly decreased in the drug0 ( p & lt ; 0.001 ) and drug2 phases ( p = 0.006 ) as compared to placebo .,ketamine,itraconazole,FALSE,none
the ratio of nordrug0 auc ( 0- ) to drug0 auc ( 0- ) was significantly decreased in the drug1 ( p & lt ; 0.001 ) and drug2 phases ( p = 0.006 ) as compared to placebo .,ticlopidine,itraconazole,FALSE,none
in the drug1 and drug2 phases  the areas under the effect-time curves ( self-reported drowsiness and performance ) were significantly higher than those in the placebo phase ( p < 0.05 ) .,ticlopidine,itraconazole,FALSE,none
the findings suggest that the dosage of drug1 should be reduced in patients receiving drug2 .,s-ketamine,ticlopidine,TRUE,advise
we also found that bcl-2 was overexpressed in drug1 insensitive cells  and cotreatment with drug0 and drug2  a bcl-2 family inhibitor  synergistically inhibited growth and induced apoptosis of drug0 insensitive mm cells .,dznep,abt-737,FALSE,none
we also found that bcl-2 was overexpressed in drug1 insensitive cells  and cotreatment with drug0 and drug2  a bcl-2 family inhibitor  synergistically inhibited growth and induced apoptosis of drug0 insensitive mm cells .,dznep,abt-737,TRUE,effect
we also found that bcl-2 was overexpressed in drug2 insensitive cells  and cotreatment with drug0 and drug1  a bcl-2 family inhibitor  synergistically inhibited growth and induced apoptosis of drug0 insensitive mm cells .,abt-737,dznep,FALSE,none
in addition  drug1 insensitivity might be associated with overexpression of bcl-2  and the combination of drug2 and drug0 could synergistically induced apoptosis .,dznep,abt-737,FALSE,none
in addition  drug2 insensitivity might be associated with overexpression of bcl-2  and the combination of drug1 and drug0 could synergistically induced apoptosis .,abt-737,dznep,TRUE,effect
drug1 failure in an hiv-positive woman on drug2 therapy resulting in two ectopic pregnancies .,implanon,antiretroviral,TRUE,effect
we present an interesting case of an hiv-positive woman on drug1 therapy having tubal pregnancies on two separate occasions with drug2 in place .,antiretroviral,implanon,TRUE,effect
drug1-drug2 interaction and associated gastrointestinal bleeding risk in a case-control study .,antidepressant,warfarin,FALSE,none
we sought to evaluate whether initiation of an drug1 increases the risk of hospitalization for gastrointestinal bleeding in drug2 users .,antidepressant,warfarin,FALSE,none
drug1 users had an increased odds ratio of gastrointestinal bleeding upon initiation of drug2 ( or = 1.73 [ 95 % ci  1.25-2.38 ] )  drug0 ( or = 1.63 [ 95 % ci  1.11-2.38 ] )  drug0 ( or = 1.64 [ 95 % ci  1.27-2.12 ] )  drug0 ( or = 1.47 [ 95 % ci  1.02-2.11 ] ) .,warfarin,citalopram,TRUE,effect
drug1 users had an increased odds ratio of gastrointestinal bleeding upon initiation of drug0 ( or = 1.73 [ 95 % ci  1.25-2.38 ] )  drug2 ( or = 1.63 [ 95 % ci  1.11-2.38 ] )  drug0 ( or = 1.64 [ 95 % ci  1.27-2.12 ] )  drug0 ( or = 1.47 [ 95 % ci  1.02-2.11 ] ) .,warfarin,fluoxetine,TRUE,effect
drug1 users had an increased odds ratio of gastrointestinal bleeding upon initiation of drug0 ( or = 1.73 [ 95 % ci  1.25-2.38 ] )  drug0 ( or = 1.63 [ 95 % ci  1.11-2.38 ] )  drug2 ( or = 1.64 [ 95 % ci  1.27-2.12 ] )  drug0 ( or = 1.47 [ 95 % ci  1.02-2.11 ] ) .,warfarin,paroxetine,TRUE,effect
drug1 users had an increased odds ratio of gastrointestinal bleeding upon initiation of drug0 ( or = 1.73 [ 95 % ci  1.25-2.38 ] )  drug0 ( or = 1.63 [ 95 % ci  1.11-2.38 ] )  drug0 ( or = 1.64 [ 95 % ci  1.27-2.12 ] )  drug2 ( or = 1.47 [ 95 % ci  1.02-2.11 ] ) .,warfarin,amitriptyline,TRUE,effect
drug0 users had an increased odds ratio of gastrointestinal bleeding upon initiation of drug1 ( or = 1.73 [ 95 % ci  1.25-2.38 ] )  drug2 ( or = 1.63 [ 95 % ci  1.11-2.38 ] )  drug0 ( or = 1.64 [ 95 % ci  1.27-2.12 ] )  drug0 ( or = 1.47 [ 95 % ci  1.02-2.11 ] ) .,citalopram,fluoxetine,FALSE,none
drug0 users had an increased odds ratio of gastrointestinal bleeding upon initiation of drug1 ( or = 1.73 [ 95 % ci  1.25-2.38 ] )  drug0 ( or = 1.63 [ 95 % ci  1.11-2.38 ] )  drug2 ( or = 1.64 [ 95 % ci  1.27-2.12 ] )  drug0 ( or = 1.47 [ 95 % ci  1.02-2.11 ] ) .,citalopram,paroxetine,FALSE,none
drug0 users had an increased odds ratio of gastrointestinal bleeding upon initiation of drug1 ( or = 1.73 [ 95 % ci  1.25-2.38 ] )  drug0 ( or = 1.63 [ 95 % ci  1.11-2.38 ] )  drug0 ( or = 1.64 [ 95 % ci  1.27-2.12 ] )  drug2 ( or = 1.47 [ 95 % ci  1.02-2.11 ] ) .,citalopram,amitriptyline,FALSE,none
drug0 users had an increased odds ratio of gastrointestinal bleeding upon initiation of drug0 ( or = 1.73 [ 95 % ci  1.25-2.38 ] )  drug1 ( or = 1.63 [ 95 % ci  1.11-2.38 ] )  drug2 ( or = 1.64 [ 95 % ci  1.27-2.12 ] )  drug0 ( or = 1.47 [ 95 % ci  1.02-2.11 ] ) .,fluoxetine,paroxetine,FALSE,none
drug0 users had an increased odds ratio of gastrointestinal bleeding upon initiation of drug0 ( or = 1.73 [ 95 % ci  1.25-2.38 ] )  drug1 ( or = 1.63 [ 95 % ci  1.11-2.38 ] )  drug0 ( or = 1.64 [ 95 % ci  1.27-2.12 ] )  drug2 ( or = 1.47 [ 95 % ci  1.02-2.11 ] ) .,fluoxetine,amitriptyline,FALSE,none
drug0 users had an increased odds ratio of gastrointestinal bleeding upon initiation of drug0 ( or = 1.73 [ 95 % ci  1.25-2.38 ] )  drug0 ( or = 1.63 [ 95 % ci  1.11-2.38 ] )  drug1 ( or = 1.64 [ 95 % ci  1.27-2.12 ] )  drug2 ( or = 1.47 [ 95 % ci  1.02-2.11 ] ) .,paroxetine,amitriptyline,FALSE,none
also drug1  which is not believed to interact with drug2  increased the risk of gi bleeding ( or = 1.75 [ 95 % ci  1.30-2.35 ] ) .,mirtazapine,warfarin,TRUE,effect
drug1 users who initiated drug2  drug0  drug0  drug0  or drug0 had an increased risk of hospitalization for gastrointestinal bleeding .,warfarin,citalopram,TRUE,effect
drug1 users who initiated drug0  drug2  drug0  drug0  or drug0 had an increased risk of hospitalization for gastrointestinal bleeding .,warfarin,fluoxetine,TRUE,effect
drug1 users who initiated drug0  drug0  drug2  drug0  or drug0 had an increased risk of hospitalization for gastrointestinal bleeding .,warfarin,paroxetine,TRUE,effect
drug1 users who initiated drug0  drug0  drug0  drug2  or drug0 had an increased risk of hospitalization for gastrointestinal bleeding .,warfarin,amitriptyline,TRUE,effect
drug1 users who initiated drug0  drug0  drug0  drug0  or drug2 had an increased risk of hospitalization for gastrointestinal bleeding .,warfarin,mirtazapine,TRUE,effect
drug0 users who initiated drug0  drug0  drug0  drug1  or drug2 had an increased risk of hospitalization for gastrointestinal bleeding .,amitriptyline,mirtazapine,FALSE,none
drug1 decreased the toxicity of drug2  increased exposure to parent compound  and decreased metabolite levels in a dose-dependent manner .,abt,precocene i,TRUE,effect
of the isoform-specific cyp inhibitors tested for an effect on the drug1 metabolite profile  only drug2 was noticeably effective  indicating a role of cyps 2a6  2c9  2cl9  and 2e1 .,precocene i,tranylcypromine,FALSE,none
with respect to toxicity  the order of cyp inhibitor effectiveness was drug1 > drug2~drug0 > drug0 .,abt,diethyldithiocarbamate,FALSE,none
with respect to toxicity  the order of cyp inhibitor effectiveness was drug1 > drug0~drug2 > drug0 .,abt,tranylcypromine,FALSE,none
with respect to toxicity  the order of cyp inhibitor effectiveness was drug1 > drug0~drug0 > drug2 .,abt,ketoconazole,FALSE,none
with respect to toxicity  the order of cyp inhibitor effectiveness was drug0 > drug1~drug2 > drug0 .,diethyldithiocarbamate,tranylcypromine,FALSE,none
with respect to toxicity  the order of cyp inhibitor effectiveness was drug0 > drug1~drug0 > drug2 .,diethyldithiocarbamate,ketoconazole,FALSE,none
with respect to toxicity  the order of cyp inhibitor effectiveness was drug0 > drug0~drug1 > drug2 .,tranylcypromine,ketoconazole,FALSE,none
drug1 containing cdna encoding enhanced green fluorescent protein ( gfp )  under the control of a chicken -actin promoter  was delivered by intravitreal injection to adult mice in conjunction with enzymes including drug2  drug0  drug0  or drug0 .,aav2,collagenase,FALSE,none
drug1 containing cdna encoding enhanced green fluorescent protein ( gfp )  under the control of a chicken -actin promoter  was delivered by intravitreal injection to adult mice in conjunction with enzymes including drug0  drug2  drug0  or drug0 .,aav2,hyaluronan lyase,FALSE,none
drug1 containing cdna encoding enhanced green fluorescent protein ( gfp )  under the control of a chicken -actin promoter  was delivered by intravitreal injection to adult mice in conjunction with enzymes including drug0  drug0  drug2  or drug0 .,aav2,heparinase iii,FALSE,none
drug1 containing cdna encoding enhanced green fluorescent protein ( gfp )  under the control of a chicken -actin promoter  was delivered by intravitreal injection to adult mice in conjunction with enzymes including drug0  drug0  drug0  or drug2 .,aav2,chondroitin abc lyase,FALSE,none
drug0 containing cdna encoding enhanced green fluorescent protein ( gfp )  under the control of a chicken -actin promoter  was delivered by intravitreal injection to adult mice in conjunction with enzymes including drug0  drug0  drug1  or drug2 .,heparinase iii,chondroitin abc lyase,FALSE,none
the addition of drug1 or drug2 greatly enhanced transduction of the retinal ganglion cell layer and increased the depth of transduction into the outer retina .,heparinase iii,chondroitin abc lyase,FALSE,none
drug1 had a limited effect and drug2 was ineffective .,hyaluronan lyase,collagenase,FALSE,none
electroretinograms survived with higher concentrations of drug1 and drug2 than were required for optimal retinal transduction .,heparinase iii,chondroitin abc lyase,FALSE,none
drug1-mediated retinal transduction is improved by co-injection of drug2 or drug0 .,aav2,heparinase iii,TRUE,effect
drug1-mediated retinal transduction is improved by co-injection of drug0 or drug2 .,aav2,chondroitin abc lyase,TRUE,effect
drug0-mediated retinal transduction is improved by co-injection of drug1 or drug2 .,heparinase iii,chondroitin abc lyase,FALSE,none
prevention of emergence agitation in seven children receiving low-dose drug1 and drug2 total intravenous anesthesia .,ketamine,propofol,FALSE,none
we retrospectively reviewed the records of 7 pediatric oncology patients who received low-dose drug1 in conjunction with drug2 for total intravenous anesthesia ( tiva ) repeatedly for radiation therapy .,ketamine,propofol,FALSE,none
ea signs were observed in all 7 patients in association with drug1 tiva but did not recur in any of 123 subsequent drug0 sessions during which low-dose drug2 was added to drug0 .,propofol,ketamine,FALSE,none
ea signs were observed in all 7 patients in association with drug2 tiva but did not recur in any of 123 subsequent drug0 sessions during which low-dose drug1 was added to drug0 .,ketamine,propofol,FALSE,none
based on this experience  we suggest that low-dose drug1 added to drug2 may be associated with prevention of ea in children with a history of ea with drug0 tiva .,ketamine,propofol,TRUE,effect
based on this experience  we suggest that low-dose drug1 added to drug2 may be associated with prevention of ea in children with a history of ea with drug0 tiva .,ketamine,propofol,FALSE,none
drug1  an drug2  is the standard hormone treatment for breast cancer .,tamoxifen,estrogen antagonist,FALSE,none
drug1 and drug2 reduce the plasma concentration of drug0 by about 50 % .,paroxetine,fluoxetine,FALSE,none
drug1 and drug0 reduce the plasma concentration of drug2 by about 50 % .,paroxetine,endoxifen,TRUE,mechanism
drug0 and drug1 reduce the plasma concentration of drug2 by about 50 % .,fluoxetine,endoxifen,TRUE,mechanism
it is better to avoid prescribing isoenzyme cyp 2d6 inhibitors to women treated with drug1 for breast cancer  especially drug2 such as drug0 and drug0 .,tamoxifen,ssri antidepressants,TRUE,advise
it is better to avoid prescribing isoenzyme cyp 2d6 inhibitors to women treated with drug1 for breast cancer  especially drug0 drug0 such as drug2 and drug0 .,tamoxifen,paroxetine,TRUE,advise
it is better to avoid prescribing isoenzyme cyp 2d6 inhibitors to women treated with drug1 for breast cancer  especially drug0 drug0 such as drug0 and drug2 .,tamoxifen,fluoxetine,TRUE,advise
it is better to avoid prescribing isoenzyme cyp 2d6 inhibitors to women treated with drug0 for breast cancer  especially drug1 such as drug0 and drug2 .,ssri antidepressants,fluoxetine,FALSE,none
it is better to avoid prescribing isoenzyme cyp 2d6 inhibitors to women treated with drug0 for breast cancer  especially drug0 drug0 such as drug1 and drug2 .,paroxetine,fluoxetine,FALSE,none
if in certain cases  an drug1 is considered necessary  it may be advisable to replace drug2 with drug0 .,antidepressant,tamoxifen,TRUE,advise
if in certain cases  an drug1 is considered necessary  it may be advisable to replace drug0 with drug2 .,antidepressant,anastrozole,FALSE,none
if in certain cases  an drug0 is considered necessary  it may be advisable to replace drug1 with drug2 .,tamoxifen,anastrozole,FALSE,none
drug1 locomotor sensitization and conditioned place preference in adolescent male and female rats neonatally treated with drug2 .,amphetamine,quinpirole,FALSE,none
the objective was to analyze the effects of neonatal drug1 treatment on effects of drug2 in adolescent rats using locomotor sensitization and conditioned place preference procedures .,quinpirole,amphetamine,FALSE,none
in female rats  neonatal drug1 treatment enhanced drug2 locomotor sensitization compared with drug0-free controls sensitized to drug0 .,quinpirole,amphetamine,TRUE,effect
in female rats  neonatal drug1 treatment enhanced drug2 locomotor sensitization compared with drug0-free controls sensitized to drug0 .,quinpirole,amphetamine,FALSE,none
in female rats  neonatal drug2 treatment enhanced drug1 locomotor sensitization compared with drug0-free controls sensitized to drug0 .,amphetamine,quinpirole,FALSE,none
in female rats  neonatal drug1 treatment enhanced drug2 locomotor sensitization compared with drug0-free controls sensitized to drug0 .,quinpirole,amphetamine,FALSE,none
male rats demonstrated sensitization to drug1  althoudrug0 this was muted compared with female rats  and were unaffected by neonatal drug2 .,amphetamine,quinpirole,FALSE,none
rats treated with neonatal drug1 enhanced time spent in the drug2-paired context compared with drug0-free controls conditioned with drug0  but only female controls conditioned with drug0 spent more time in the drug-paired context compared with saline-treated controls .,quinpirole,amphetamine,FALSE,none
rats treated with neonatal drug1 enhanced time spent in the drug2-paired context compared with drug0-free controls conditioned with drug0  but only female controls conditioned with drug0 spent more time in the drug-paired context compared with saline-treated controls .,quinpirole,amphetamine,FALSE,none
rats treated with neonatal drug1 enhanced time spent in the drug2-paired context compared with drug0-free controls conditioned with drug0  but only female controls conditioned with drug0 spent more time in the drug-paired context compared with saline-treated controls .,quinpirole,amphetamine,FALSE,none
rats treated with neonatal drug2 enhanced time spent in the drug1-paired context compared with drug0-free controls conditioned with drug0  but only female controls conditioned with drug0 spent more time in the drug-paired context compared with saline-treated controls .,amphetamine,quinpirole,FALSE,none
rats treated with neonatal drug1 enhanced time spent in the drug2-paired context compared with drug0-free controls conditioned with drug0  but only female controls conditioned with drug0 spent more time in the drug-paired context compared with saline-treated controls .,quinpirole,amphetamine,FALSE,none
rats treated with neonatal drug1 enhanced time spent in the drug2-paired context compared with drug0-free controls conditioned with drug0  but only female controls conditioned with drug0 spent more time in the drug-paired context compared with saline-treated controls .,quinpirole,amphetamine,FALSE,none
in vivo cyp3a activity is significantly lower in drug1-treated as compared with drug2-treated renal allograft recipients .,cyclosporine,tacrolimus,FALSE,none
in vitro studies have identified drug1 and drug2 as cyp3a inhibitors .,cyclosporine,tacrolimus,FALSE,none
systemic and apparent oral drug1 clearance were 24 % ( 269 73 vs. 354 102 ml/min  p = 0.022 ) and 31 % ( 479 190 vs. 688 265 ml/min  p = 0.013 )  respectively  lower in drug2-treated patients ( n = 20 ) than in matched drug0-treated patients ( n = 20 ) .,midazolam,cyclosporine,TRUE,mechanism
systemic and apparent oral drug1 clearance were 24 % ( 269 73 vs. 354 102 ml/min  p = 0.022 ) and 31 % ( 479 190 vs. 688 265 ml/min  p = 0.013 )  respectively  lower in drug0-treated patients ( n = 20 ) than in matched drug2-treated patients ( n = 20 ) .,midazolam,tacrolimus,FALSE,none
systemic and apparent oral drug0 clearance were 24 % ( 269 73 vs. 354 102 ml/min  p = 0.022 ) and 31 % ( 479 190 vs. 688 265 ml/min  p = 0.013 )  respectively  lower in drug1-treated patients ( n = 20 ) than in matched drug2-treated patients ( n = 20 ) .,cyclosporine,tacrolimus,FALSE,none
the latter displayed drug1 clearances similar to those in two larger cohorts of nonmatched drug2-treated patients ( n = 58 and n = 80 ) and to those receiving a drug0-free regimen ( n = 6 ) .,midazolam,tacrolimus,FALSE,none
the latter displayed drug1 clearances similar to those in two larger cohorts of nonmatched drug0-treated patients ( n = 58 and n = 80 ) and to those receiving a drug2-free regimen ( n = 6 ) .,midazolam,calcineurin inhibitor,FALSE,none
the latter displayed drug0 clearances similar to those in two larger cohorts of nonmatched drug1-treated patients ( n = 58 and n = 80 ) and to those receiving a drug2-free regimen ( n = 6 ) .,tacrolimus,calcineurin inhibitor,FALSE,none
this implies that in vivo hepatic and first-pass cyp3a activities are significantly lower in patients receiving drug1 than in those receiving drug2  indicating that  at the doses generally used in clinical practice  drug0 is the stronger of the two with respect to cyp3a inhibition .,cyclosporine,tacrolimus,FALSE,none
this implies that in vivo hepatic and first-pass cyp3a activities are significantly lower in patients receiving drug2 than in those receiving drug1  indicating that  at the doses generally used in clinical practice  drug0 is the stronger of the two with respect to cyp3a inhibition .,tacrolimus,cyclosporine,FALSE,none
improved parathyroid hormone control by drug1 is associated with reduction in drug2 requirement in patients with end-stage renal disease .,cinacalcet,darbepoetin,FALSE,none
medical treatment with drug1 is effective in reducing plasma parathyroid hormone ( pth ) levels  but its effect on drug2 dosing is unknown .,cinacalcet,darbepoetin,FALSE,none
the primary objective of the study was to ascertain the difference in drug1 responsiveness before and after 12 months of drug2 therapy .,darbepoetin,cinacalcet,FALSE,none
reduction of pth by drug1 is associated with a decrease in drug2 requirement .,cinacalcet,darbepoetin,TRUE,effect
interaction of drug1 with different drug2 is antagonistic in breast but not in other cancer cells .,celecoxib,anti-cancer drugs,TRUE,effect
this study investigates the ability of drug1 to sensitize cells from different origins to several drug2 .,cyclooxygenase-2 inhibitors,chemotherapeutic agents,FALSE,none
the sensitivity  cell cycle  apoptosis and dna damage of five different cancer cell lines ( hela  hct116  hepg2  mcf7 and u251 ) to drug1  drug0  drug0 and drug2 drug0 following different incubation schedules were analyzed .,5-fu,etoposide,FALSE,none
the sensitivity  cell cycle  apoptosis and dna damage of five different cancer cell lines ( hela  hct116  hepg2  mcf7 and u251 ) to drug1  drug0  drug0 and drug0 drug2 following different incubation schedules were analyzed .,5-fu,celecoxib,FALSE,none
the sensitivity  cell cycle  apoptosis and dna damage of five different cancer cell lines ( hela  hct116  hepg2  mcf7 and u251 ) to drug0  drug1  drug0 and drug2 drug0 following different incubation schedules were analyzed .,cisplatin,etoposide,FALSE,none
the sensitivity  cell cycle  apoptosis and dna damage of five different cancer cell lines ( hela  hct116  hepg2  mcf7 and u251 ) to drug0  drug1  drug0 and drug0 drug2 following different incubation schedules were analyzed .,cisplatin,celecoxib,FALSE,none
the sensitivity  cell cycle  apoptosis and dna damage of five different cancer cell lines ( hela  hct116  hepg2  mcf7 and u251 ) to drug0  drug0  drug1 and drug2 drug0 following different incubation schedules were analyzed .,doxorubicin,etoposide,FALSE,none
the sensitivity  cell cycle  apoptosis and dna damage of five different cancer cell lines ( hela  hct116  hepg2  mcf7 and u251 ) to drug0  drug0  drug1 and drug0 drug2 following different incubation schedules were analyzed .,doxorubicin,celecoxib,FALSE,none
the sensitivity  cell cycle  apoptosis and dna damage of five different cancer cell lines ( hela  hct116  hepg2  mcf7 and u251 ) to drug0  drug0  drug0 and drug1 drug2 following different incubation schedules were analyzed .,etoposide,celecoxib,FALSE,none
we found antagonism between drug1 and the four drugs in the breast cancer cells mcf7 following all incubation schedules and between drug0 and drug2 in all cell lines except for two combinations in hct116 cells .,celecoxib,doxorubicin,FALSE,none
we found antagonism between drug1 and the four drugs in the breast cancer cells mcf7 following all incubation schedules and between drug0 and drug2 in all cell lines except for two combinations in hct116 cells .,celecoxib,doxorubicin,TRUE,effect
[ interaction between drug1 and drug2 ] .,clopidogrel,proton pump inhibitors,FALSE,none
the drug interaction between drug1 and drug2 has been the subject of much study in recent years .,proton pump inhibitors,clopidogrel,FALSE,none
contradictory results regarding the effect of drug1 on platelet reactivity and on clinical outcome in drug2-treated patients have been reported in literature .,proton pump inhibitors,clopidogrel,FALSE,none
concomitant use of drug1 and drug2 was found to decrease the exposure ( auc ) to drug0 's active metabolite by 50 % and to sharply increase platelet reactivity  as a result of inhibition by drug0 of cyp2c19  a cytochrome p450 ( cyp ) enzyme .,omeprazole,clopidogrel,TRUE,mechanism
concomitant use of drug2 and drug1 was found to decrease the exposure ( auc ) to drug0 's active metabolite by 50 % and to sharply increase platelet reactivity  as a result of inhibition by drug0 of cyp2c19  a cytochrome p450 ( cyp ) enzyme .,clopidogrel,omeprazole,FALSE,none
drug1 has a much weaker effect on drug2 's pharmacokinetics and on platelet reactivity during concomitant use .,pantoprazole,clopidogrel,TRUE,mechanism
the influence of the other drug1 when used simultaneously with drug2 has not yet been investigated in adequately randomized studies .,proton pump inhibitors,clopidogrel,FALSE,none
regulatory agencies state that the combination of drug1 and the cyp2c19 inhibitors drug2 and drug0 should be avoided .,clopidogrel,omeprazole,TRUE,advise
regulatory agencies state that the combination of drug1 and the cyp2c19 inhibitors drug0 and drug2 should be avoided .,clopidogrel,esomeprazole,TRUE,advise
regulatory agencies state that the combination of drug0 and the cyp2c19 inhibitors drug1 and drug2 should be avoided .,omeprazole,esomeprazole,FALSE,none
to date  there is no conclusive evidence of a clinically-relevant interaction between any of the drug1 and drug2 .,proton pump inhibitors,clopidogrel,FALSE,none
in vitro activity of drug1 combined with drug2 against clinical isolates of drug0-resistant staphylococcus aureus .,minocycline,fosfomycin,FALSE,none
in vitro activity of drug1 combined with drug0 against clinical isolates of drug2-resistant staphylococcus aureus .,minocycline,methicillin,FALSE,none
in vitro activity of drug0 combined with drug1 against clinical isolates of drug2-resistant staphylococcus aureus .,fosfomycin,methicillin,FALSE,none
this study aimed to evaluate the in vitro activity of drug1 combined with drug2 against isolates of drug0-resistant staphylococcus aureus ( mrsa ) .,minocycline,fosfomycin,FALSE,none
this study aimed to evaluate the in vitro activity of drug1 combined with drug0 against isolates of drug2-resistant staphylococcus aureus ( mrsa ) .,minocycline,methicillin,FALSE,none
this study aimed to evaluate the in vitro activity of drug0 combined with drug1 against isolates of drug2-resistant staphylococcus aureus ( mrsa ) .,fosfomycin,methicillin,FALSE,none
the susceptibility results for drug1 and drug2 were interpreted according to the most relevant criteria .,minocycline,fosfomycin,FALSE,none
the combination of drug1 and drug2 can be synergistic against mrsa .,minocycline,fosfomycin,TRUE,effect
the authors report the case of an infant with confirmed congenital hypothyroidism on drug1 who experienced a possible drug interaction with drug2 .,levothyroxine,simeticone,TRUE,int
questioning revealed the child was taking drug1 drops before feeds while on drug2 .,infacol,levothyroxine,FALSE,none
drug1 does not inhibit the absorption of 5 milligrams of nonheme or drug0 at doses less than 800 milligrams in nonpregnant women .,calcium,nonheme iron,FALSE,none
drug1 does not inhibit the absorption of 5 milligrams of nonheme or drug2 at doses less than 800 milligrams in nonpregnant women .,calcium,heme iron,FALSE,none
drug0 does not inhibit the absorption of 5 milligrams of nonheme or drug2 at doses less than 800 milligrams in nonpregnant women .,nonheme iron,heme iron,FALSE,none
drug1 is the only known component in the diet that may affect absorption of both nonheme and drug0 .,calcium,nonheme iron,TRUE,mechanism
drug1 is the only known component in the diet that may affect absorption of both nonheme and drug2 .,calcium,heme iron,TRUE,mechanism
drug0 is the only known component in the diet that may affect absorption of both nonheme and drug2 .,nonheme iron,heme iron,FALSE,none
however  the evidence for a drug1 effect on drug2 absorption mainly comes from studies that did not isolate the effect of drug0 from that of other dietary components  because it was detected in single-meal studies .,calcium,iron,TRUE,mechanism
however  the evidence for a drug2 effect on drug1 absorption mainly comes from studies that did not isolate the effect of drug0 from that of other dietary components  because it was detected in single-meal studies .,iron,calcium,FALSE,none
our objective was to establish potential effects of drug1 on absorption of nonheme and drug0 and the dose response for this effect in the absence of a meal .,calcium,nonheme iron,FALSE,none
our objective was to establish potential effects of drug1 on absorption of nonheme and drug2 and the dose response for this effect in the absence of a meal .,calcium,heme iron,FALSE,none
our objective was to establish potential effects of drug0 on absorption of nonheme and drug2 and the dose response for this effect in the absence of a meal .,nonheme iron,heme iron,FALSE,none
we evaluated the effects of drug1 doses between 200 and 1500 mg on absorption of 5 mg drug2 ( as drug0 ) .,calcium,nonheme iron,FALSE,none
we evaluated the effects of drug1 doses between 200 and 1500 mg on absorption of 5 mg nondrug0 ( as drug2 ) .,calcium,ferrous sulfate,FALSE,none
we evaluated the effects of drug0 doses between 200 and 1500 mg on absorption of 5 mg drug1 ( as drug2 ) .,nonheme iron,ferrous sulfate,FALSE,none
we also evaluated the effects of drug1 doses between 200 and 800 mg on absorption of 5 mg drug2 [ as concentrated rbc ( crbc ) ] .,calcium,heme iron,FALSE,none
drug1 was administered as drug2 in all studies and drug0 were ingested on an empty stomach .,calcium,calcium chloride,FALSE,none
drug1 was administered as drug0 chloride in all studies and drug2 were ingested on an empty stomach .,calcium,minerals,FALSE,none
drug0 was administered as drug1 in all studies and drug2 were ingested on an empty stomach .,calcium chloride,minerals,FALSE,none
drug1 doses 1000 mg diminished drug2 absorption by an average of 49.6 % .,calcium,nonheme iron,TRUE,mechanism
a drug1 dose of 800 mg diminished absorption of 5 mg drug2 by 37.7 % .,calcium,heme iron,TRUE,mechanism
in conclusion  we demonstrated an isolated effect of drug1 ( as chloride ) on absorption of 5 mg of drug0 provided as nonheme ( as sulfate ) and heme ( as crbc ) drug0 .,calcium,nonheme iron,TRUE,mechanism
in conclusion  we demonstrated an isolated effect of drug1 ( as chloride ) on absorption of 5 mg of drug0 provided as nonheme ( as sulfate ) and heme ( as crbc ) drug0 .,calcium,heme iron,TRUE,mechanism
in conclusion  we demonstrated an isolated effect of drug0 ( as chloride ) on absorption of 5 mg of drug0 provided as nonheme ( as sulfate ) and heme ( as crbc ) drug0 .,nonheme iron,heme iron,FALSE,none
synergistic interaction between drug1 and drug2 is sequence dependent in human non-small lung cancer with egfr tkis-resistant mutation .,sunitinib,docetaxel,TRUE,int
this study was aimed to investigate the efficacy of single use of drug1 and that of concurrent or sequential administration of drug0 and drug2 in nsclc cell lines that are resistant to egfr tkis .,sunitinib,docetaxel,FALSE,none
this study was aimed to investigate the efficacy of single use of drug1 and that of concurrent or sequential administration of drug0 and drug2 in nsclc cell lines that are resistant to egfr tkis .,sunitinib,docetaxel,FALSE,none
nsclc cell lines with egfr t790m mutation and k-ras mutation were exposed to either drug1 or drug2 or both based on various sequential administrations .,sunitinib,docetaxel,FALSE,none
drug1 exhibited dose-dependent growth inhibition in nsclc cell lines and arrested cell cycle at g1 phase  whereas drug2 arrested at s phase .,sunitinib,docetaxel,FALSE,none
althoudrug0 single or concurrent use of drug1 and drug2 has some anti-proliferative effects  the sequential administrations of both drugs remarkably enhanced anti-tumor activity .,sunitinib,docetaxel,TRUE,effect
when cells were exposed to drug1 followed by drug2  synergism was observed .,docetaxel,sunitinib,TRUE,effect
the molecular basis of this synergism is that the signaling pathways that were initially activated by drug1 exposure were efficiently suppressed by the subsequent exposure to drug2 .,docetaxel,sunitinib,TRUE,effect
drug1 as a single agent exhibits anti-proliferative effects in vitro in nsclc cell lines with egfr t790m and k-ras mutations but the sequential administration of drug2 followed by drug0 is superior to drug0 followed by drug0 and concurrent administration .,sunitinib,docetaxel,FALSE,none
drug1 as a single agent exhibits anti-proliferative effects in vitro in nsclc cell lines with egfr t790m and k-ras mutations but the sequential administration of drug2 followed by drug0 is superior to drug0 followed by drug0 and concurrent administration .,sunitinib,docetaxel,FALSE,none
drug2 as a single agent exhibits anti-proliferative effects in vitro in nsclc cell lines with egfr t790m and k-ras mutations but the sequential administration of drug1 followed by drug0 is superior to drug0 followed by drug0 and concurrent administration .,docetaxel,sunitinib,TRUE,effect
drug2 as a single agent exhibits anti-proliferative effects in vitro in nsclc cell lines with egfr t790m and k-ras mutations but the sequential administration of drug1 followed by drug0 is superior to drug0 followed by drug0 and concurrent administration .,docetaxel,sunitinib,FALSE,none
drug1 as a single agent exhibits anti-proliferative effects in vitro in nsclc cell lines with egfr t790m and k-ras mutations but the sequential administration of drug2 followed by drug0 is superior to drug0 followed by drug0 and concurrent administration .,sunitinib,docetaxel,FALSE,none
drug1 as a single agent exhibits anti-proliferative effects in vitro in nsclc cell lines with egfr t790m and k-ras mutations but the sequential administration of drug2 followed by drug0 is superior to drug0 followed by drug0 and concurrent administration .,sunitinib,docetaxel,FALSE,none
distinct synergistic action of drug1 and drug2 against pseudomonas aeruginosa .,piperacillin,methylglyoxal,FALSE,none
results revealed that the strains were resistant to many drugs at hidrug0 levels  only drug1  drug0  drug0 and drug2 showed resistances at comparatively lower levels .,piperacillin,ciprofloxacin,FALSE,none
results revealed that the strains were resistant to many drugs at hidrug0 levels  only drug0  drug1  drug0 and drug2 showed resistances at comparatively lower levels .,carbenicillin,ciprofloxacin,FALSE,none
results revealed that the strains were resistant to many drugs at hidrug0 levels  only drug0  drug0  drug1 and drug2 showed resistances at comparatively lower levels .,amikacin,ciprofloxacin,FALSE,none
distinct and statistically significant synergism was observed between drug1 and drug2 by disc diffusion tests when compared with their individual effects .,methylglyoxal,piperacillin,TRUE,effect
synergism was also noted when drug1 was combined with drug2 and drug0 .,methylglyoxal,carbenicillin,TRUE,effect
synergism was also noted when drug1 was combined with drug0 and drug2 .,methylglyoxal,amikacin,TRUE,effect
synergism was also noted when drug0 was combined with drug1 and drug2 .,carbenicillin,amikacin,FALSE,none
protective effect of drug1 and drug2 against the acute toxicity of diepoxybutane to human lymphocytes .,acetyl-l-carnitine,alpha lipoic acid,FALSE,none
( ii ) drug1 elicits a significant protective effect on deb induced toxicity  which was potentiated by drug2 .,acetyl-l-carnitine,alpha-lipoic acid,TRUE,effect
[ influence of drug1 and drug2 on drug0-evoked behavior violations in c57bl/6 mice ] .,hemantane,doxycycline,FALSE,none
the effects of drug1 drug2 [ ( 2-adamantyl ) hexamethylenimine ] ( 10 mg/kg  p . o . ),anti-parkinsonian drug,hemantane,FALSE,none
the effects of drug1 drug0 [ ( 2-adamantyl ) hexamethylenimine ] ( 10 mg/kg  p . o . ),anti-parkinsonian drug,(2-adamantyl)hexamethylenimine,FALSE,none
the effects of drug0 drug1 [ ( 2-adamantyl ) hexamethylenimine ] ( 10 mg/kg  p . o . ),hemantane,(2-adamantyl)hexamethylenimine,FALSE,none
and/or drug1 drug2 ( 100 mg/kg  p . o . )  as well as that of neurotoxin drug0 ( drug0 ) ( 4 x 20 mg/kg  i. p . ),antibiotic drug,doxycycline,FALSE,none
and/or drug1 drug0 ( 100 mg/kg  p . o . )  as well as that of neurotoxin drug2 ( drug0 ) ( 4 x 20 mg/kg  i. p . ),antibiotic drug,"1-methyl-4-phenyl-1,2,3,4-tetrahydropyridine",FALSE,none
and/or drug1 drug0 ( 100 mg/kg  p . o . )  as well as that of neurotoxin drug0 ( drug2 ) ( 4 x 20 mg/kg  i. p . ),antibiotic drug,mptp,FALSE,none
and/or drug0 drug drug1 ( 100 mg/kg  p . o . )  as well as that of neurotoxin drug2 ( drug0 ) ( 4 x 20 mg/kg  i. p . ),doxycycline,"1-methyl-4-phenyl-1,2,3,4-tetrahydropyridine",FALSE,none
and/or drug0 drug drug1 ( 100 mg/kg  p . o . )  as well as that of neurotoxin drug0 ( drug2 ) ( 4 x 20 mg/kg  i. p . ),doxycycline,mptp,FALSE,none
acute administration of drug1 or drug2 failed to influence locomotion in mice  while their combination normalized motor activity .,hemantane,doxycycline,TRUE,effect
the role of p27 ( kip1 ) in drug1-enhanced drug2 cytotoxicity in human ovarian cancer cells .,dasatinib,paclitaxel,TRUE,effect
the effect of drug1  an inhibitor of src and abl kinases  on drug2 sensitivity was measured in ovarian cancer cells and hey xenografts .,dasatinib,paclitaxel,FALSE,none
the roles of p27 ( kip1 )  bcl-2  and cdk1 in apoptosis induced by drug1 and drug2 were assessed using a terminal deoxynucleotidyl transferase-mediated dutp nick-end labeling ( tunel ) assay  sirna knockdown of gene expression  transfection with bcl-2 and cdk1 expression vectors  and flow cytometry .,dasatinib,paclitaxel,FALSE,none
hey cells treated with drug1 plus drug2 formed fewer colonies than did cells treated with either agent alone .,dasatinib,paclitaxel,TRUE,effect
treatment of hey xenograft-bearing mice with drug1 plus drug2 inhibited tumor growth more than treatment with either agent alone ( average tumor volume per mouse  drug0 + drug0 vs drug0 : 0.28 vs. 0.81 cm3  difference = 0.53 cm3  95 % confidence interval [ ci ] = 0.44 to 0.62 cm3  p = .014 ) ;,dasatinib,paclitaxel,TRUE,effect
treatment of hey xenograft-bearing mice with drug1 plus drug2 inhibited tumor growth more than treatment with either agent alone ( average tumor volume per mouse  drug0 + drug0 vs drug0 : 0.28 vs. 0.81 cm3  difference = 0.53 cm3  95 % confidence interval [ ci ] = 0.44 to 0.62 cm3  p = .014 ) ;,dasatinib,paclitaxel,FALSE,none
treatment of hey xenograft-bearing mice with drug1 plus drug2 inhibited tumor growth more than treatment with either agent alone ( average tumor volume per mouse  drug0 + drug0 vs drug0 : 0.28 vs. 0.81 cm3  difference = 0.53 cm3  95 % confidence interval [ ci ] = 0.44 to 0.62 cm3  p = .014 ) ;,dasatinib,paclitaxel,FALSE,none
treatment of hey xenograft-bearing mice with drug2 plus drug1 inhibited tumor growth more than treatment with either agent alone ( average tumor volume per mouse  drug0 + drug0 vs drug0 : 0.28 vs. 0.81 cm3  difference = 0.53 cm3  95 % confidence interval [ ci ] = 0.44 to 0.62 cm3  p = .014 ) ;,paclitaxel,dasatinib,FALSE,none
treatment of hey xenograft-bearing mice with drug1 plus drug2 inhibited tumor growth more than treatment with either agent alone ( average tumor volume per mouse  drug0 + drug0 vs drug0 : 0.28 vs. 0.81 cm3  difference = 0.53 cm3  95 % confidence interval [ ci ] = 0.44 to 0.62 cm3  p = .014 ) ;,dasatinib,paclitaxel,FALSE,none
treatment of hey xenograft-bearing mice with drug1 plus drug2 inhibited tumor growth more than treatment with either agent alone ( average tumor volume per mouse  drug0 + drug0 vs drug0 : 0.28 vs. 0.81 cm3  difference = 0.53 cm3  95 % confidence interval [ ci ] = 0.44 to 0.62 cm3  p = .014 ) ;,dasatinib,paclitaxel,FALSE,none
drug1 + drug2 vs .,dasatinib,paclitaxel,FALSE,none
the sirna knockdown of p27 ( kip1 ) decreased drug1- and drug2-induced apoptosis compared with a negative control sirna ( sub-g1 fraction  control sirna vs. p27 ( kip1 ) sirna : 42.5 % vs. 20.1 %  difference = 22.4 %  95 % ci = 20.1 % to 24.7 %  p = .017 ) .,dasatinib,paclitaxel,FALSE,none
studies with forced expression and sirna knockdown of bcl-2 and cdk1 suggest that drug1-mediated induction of p27 ( kip1 ) enhanced drug2-induced apoptosis by negatively regulating bcl-2 and cdk1 expression .,dasatinib,paclitaxel,TRUE,effect
inhibition of src family and abl kinases with either sirnas or drug1 enhances drug2 sensitivity of ovarian cancer cells throudrug0 p27 ( kip1 ) -mediated suppression of bcl-2 and cdk1 expression .,dasatinib,paclitaxel,TRUE,effect
phase i trial of drug1 and drug2 in patients with relapsed multiple myeloma : evidence for drug0-drug0 interaction via p-glycoprotein .,lenalidomide,cci-779,FALSE,none
phase i trial of drug1 and drug2 in patients with relapsed multiple myeloma : evidence for drug0-drug0 interaction via p-glycoprotein .,lenalidomide,cci-779,FALSE,none
phase i trial of drug2 and drug1 in patients with relapsed multiple myeloma : evidence for drug0-drug0 interaction via p-glycoprotein .,cci-779,lenalidomide,FALSE,none
phase i trial of drug1 and drug2 in patients with relapsed multiple myeloma : evidence for drug0-drug0 interaction via p-glycoprotein .,lenalidomide,cci-779,FALSE,none
the preclinical combination of drug1 with the mtor inhibitor drug2 has displayed synergy in vitro and represents a novel combination in mm .,lenalidomide,cci-779,TRUE,effect
enhancement of humoral immune responses to inactivated newcastle disease and drug1 by oral administration of drug2 in chickens .,avian influenza vaccines,ginseng stem-and-leaf saponins,FALSE,none
the objective of this study was to evaluate the effect of oral administration of drug1 ( drug0 ) on the humoral immune responses of chickens to inactivated nd and ai vaccines .,ginseng stem-and-leaf saponins,inactivated nd vaccines,FALSE,none
the objective of this study was to evaluate the effect of oral administration of drug1 ( drug0 ) on the humoral immune responses of chickens to inactivated nd and ai vaccines .,ginseng stem-and-leaf saponins,inactivated ai vaccines,FALSE,none
the objective of this study was to evaluate the effect of oral administration of drug0 ( drug1 ) on the humoral immune responses of chickens to inactivated nd and ai vaccines .,gsls,inactivated nd vaccines,FALSE,none
the objective of this study was to evaluate the effect of oral administration of drug0 ( drug1 ) on the humoral immune responses of chickens to inactivated nd and ai vaccines .,gsls,inactivated ai vaccines,FALSE,none
the objective of this study was to evaluate the effect of oral administration of drug0 ( drug0 ) on the humoral immune responses of chickens to inactivated nd and ai vaccines .,inactivated nd vaccines,inactivated ai vaccines,FALSE,none
in experiment 1  oral administration of drug1 at a dose of 5 mg/kg of bw for 7 d on the immune response in chickens intramuscularly injected with drug2 was evaluated .,gsls,inactivated nd vaccine,FALSE,none
in experiment 2  the same regimen of drug1 was administered to chickens inoculated with drug2  and an enhanced serum antibody response to ai vaccination was also observed .,gsls,inactivated ai vaccines,TRUE,effect
interaction of drug1 and drug2  in vitro and in vivo  in human a375 melanoma cells .,dacarbazine,imexon,FALSE,none
we evaluated mechanisms of interaction between the alkyating agent drug1 ( drug0 ) and the pro-oxidant  drug2  in the human a375 melanoma cell line .,dacarbazine,imexon,FALSE,none
we evaluated mechanisms of interaction between the alkyating agent drug0 ( drug1 ) and the pro-oxidant  drug2  in the human a375 melanoma cell line .,dtic,imexon,FALSE,none
the effect of drug1 and drug2  alone and in combination  was evaluated for growth inhibition ( mtt )  radiolabeled drug uptake  cellular thiol content ( hplc )  and dna strand breaks ( comet assay ) .,dtic,imexon,FALSE,none
there was a > 75 % reduction in cellular glutathione and cysteine with drug1 but not drug2 .,imexon,dtic,FALSE,none
drug1 and drug2 show additive effects in vitro but not in vivo in human a375 melanoma cells .,imexon,dacarbazine,TRUE,effect
drug1 enhances drug2-mediated antibody-dependent cellular cytotoxicity by up-regulation of cell surface her2 expression .,lapatinib,herceptin,TRUE,effect
althoudrug0 it was previously reported that drug1 combined with drug2 improved the progression-free survival rate compared with drug0 alone for patients with drug0-refractory her2-positive metastatic breast cancer  the mechanism is purported to be an antiproliferative effect relating to the synergism of these two agents .,lapatinib,herceptin,TRUE,effect
althoudrug0 it was previously reported that drug1 combined with drug2 improved the progression-free survival rate compared with drug0 alone for patients with drug0-refractory her2-positive metastatic breast cancer  the mechanism is purported to be an antiproliferative effect relating to the synergism of these two agents .,lapatinib,herceptin,FALSE,none
althoudrug0 it was previously reported that drug2 combined with drug1 improved the progression-free survival rate compared with drug0 alone for patients with drug0-refractory her2-positive metastatic breast cancer  the mechanism is purported to be an antiproliferative effect relating to the synergism of these two agents .,herceptin,lapatinib,FALSE,none
althoudrug0 it was previously reported that drug1 combined with drug2 improved the progression-free survival rate compared with drug0 alone for patients with drug0-refractory her2-positive metastatic breast cancer  the mechanism is purported to be an antiproliferative effect relating to the synergism of these two agents .,lapatinib,herceptin,FALSE,none
we evaluated how drug1 interacts with drug2 in her2-positive breast cancer  with a particular focus on drug0-mediated antibody-dependent cellular cytotoxicity ( adcc ) .,lapatinib,herceptin,FALSE,none
we evaluated how drug1 interacts with drug2 in her2-positive breast cancer  with a particular focus on drug0-mediated antibody-dependent cellular cytotoxicity ( adcc ) .,lapatinib,herceptin,FALSE,none
in an in vitro assay  drug1 induced her2 expression at the cell surface of her2-positive breast cancer cell lines  leading to the enhancement of drug2-mediated adcc .,lapatinib,herceptin,TRUE,effect
furthermore  we present a case report in which a second drug1 treatment following drug2 resulted in the marked shrinkage of multiple metastatic tumors in her2-positive breast cancer .,herceptin,lapatinib,TRUE,effect
drug1 may have the potential to convert drug2-refractory to drug0-sensitive tumors in her2-positive breast cancer by up-regulation of the cell surface expression of her2 .,lapatinib,herceptin,FALSE,none
drug1 may have the potential to convert drug2-refractory to drug0-sensitive tumors in her2-positive breast cancer by up-regulation of the cell surface expression of her2 .,lapatinib,herceptin,FALSE,none
we elucidated the expression of hb-egf in t-all cell lines  and evaluated the effect of drug1 on these cells alone or in combination with drug2 .,crm197,anticancer agent,FALSE,none
drug1 induced apoptosis  and furthermore  the combination of drug0 plus drug2 enhanced cytotoxicity in a t-all cell line .,crm197,doxorubicin,FALSE,none
drug1 induced apoptosis  and furthermore  the combination of drug0 plus drug2 enhanced cytotoxicity in a t-all cell line .,crm197,doxorubicin,TRUE,effect
drug1 enhances the antinociceptive effect of drug2 in mice .,ephedrine,dexmedetomidine,TRUE,effect
the purpose of this study was to evaluate whether the psychostimulant drug drug1 has any effect on drug2-induced antinociception and locomotor inhibitor activity in mice in acute application .,ephedrine,dexmedetomidine,FALSE,none
saline + saline  drug1 ( 10 mg/kg ) + saline  saline + drug2 ( 15 g/kg ) and drug0 ( 10 mg/kg ) + drug0 ( 15 g/kg )  intraperitoneally  30 min before hot plate or holed open field tests .,ephedrine,dexmedetomidine,FALSE,none
saline + saline  drug1 ( 10 mg/kg ) + saline  saline + drug2 ( 15 g/kg ) and drug0 ( 10 mg/kg ) + drug0 ( 15 g/kg )  intraperitoneally  30 min before hot plate or holed open field tests .,ephedrine,dexmedetomidine,FALSE,none
saline + saline  drug2 ( 10 mg/kg ) + saline  saline + drug1 ( 15 g/kg ) and drug0 ( 10 mg/kg ) + drug0 ( 15 g/kg )  intraperitoneally  30 min before hot plate or holed open field tests .,dexmedetomidine,ephedrine,FALSE,none
saline + saline  drug1 ( 10 mg/kg ) + saline  saline + drug2 ( 15 g/kg ) and drug0 ( 10 mg/kg ) + drug0 ( 15 g/kg )  intraperitoneally  30 min before hot plate or holed open field tests .,ephedrine,dexmedetomidine,FALSE,none
in the hot plate test in mice  co-administration of 15 g/kg drug1 with 10 mg/kg drug2 intraperitoneally not only enhanced  but also prolonged the duration of antinociception induced by drug0 .,dexmedetomidine,ephedrine,TRUE,effect
in the hot plate test in mice  co-administration of 15 g/kg drug2 with 10 mg/kg drug1 intraperitoneally not only enhanced  but also prolonged the duration of antinociception induced by drug0 .,ephedrine,dexmedetomidine,FALSE,none
at the same time  the locomotor inhibitory effect of drug1 was counteracted by drug2 .,dexmedetomidine,ephedrine,TRUE,effect
we concluded that the combined administration of drug1 with drug2 may have beneficial effects in the treatment of pain without causing sedation  which limits the use of drug0 as an drug0 in humans .,dexmedetomidine,ephedrine,TRUE,effect
we concluded that the combined administration of drug1 with drug0 may have beneficial effects in the treatment of pain without causing sedation  which limits the use of drug0 as an drug2 in humans .,dexmedetomidine,analgesic,FALSE,none
we concluded that the combined administration of drug2 with drug1 may have beneficial effects in the treatment of pain without causing sedation  which limits the use of drug0 as an drug0 in humans .,ephedrine,dexmedetomidine,FALSE,none
we concluded that the combined administration of drug0 with drug1 may have beneficial effects in the treatment of pain without causing sedation  which limits the use of drug0 as an drug2 in humans .,ephedrine,analgesic,FALSE,none
we concluded that the combined administration of drug1 with drug0 may have beneficial effects in the treatment of pain without causing sedation  which limits the use of drug0 as an drug2 in humans .,dexmedetomidine,analgesic,FALSE,none
[ efficacy of fixed combination drug1/drug2 in hospitalized patients with hypertensive disease ],amlodipine,valsartan,FALSE,none
efficacy and tolerability of fixed drug1/drug2 combination was studied in 86 patients with hypertensive disease hospitalized in departments of general internal medicine or cardiology .,amlodipine,valsartan,FALSE,none
all patients had indications for drug0 therapy and were randomized either to fixed combination drug1/drug2 ( n=43 ) or to therapy which corresponded to the hospital formulary ( n=43 ) .,amlodipine,valsartan,FALSE,none
rate of achievement of target bp with fixed combination drug1/drug2 ( 93 % ) was comparable with that on traditional therapy ( 90 % ) .,amlodipine,valsartan,FALSE,none
but the use of fixed combination drug1/drug2 compared with traditional therapy was associated with lower clinical and self measured bp  quicker achievement of target bp ( 5.8+/-2.3 and 9.2+/-1.8 days  respectively  0.05 )  lesser number of drug0 drugs ( 2.5+/-0.6 and 3.0+/-0.9 days  respectively )  lower rate of concealed inefficacy of treatment ( 12 and 31 %  respectively  0.05 ) .,amlodipine,valsartan,TRUE,effect
but the use of fixed combination drug1/drug0 compared with traditional therapy was associated with lower clinical and self measured bp  quicker achievement of target bp ( 5.8+/-2.3 and 9.2+/-1.8 days  respectively  0.05 )  lesser number of drug2 ( 2.5+/-0.6 and 3.0+/-0.9 days  respectively )  lower rate of concealed inefficacy of treatment ( 12 and 31 %  respectively  0.05 ) .,amlodipine,antihypertensive drugs,FALSE,none
but the use of fixed combination drug0/drug1 compared with traditional therapy was associated with lower clinical and self measured bp  quicker achievement of target bp ( 5.8+/-2.3 and 9.2+/-1.8 days  respectively  0.05 )  lesser number of drug2 ( 2.5+/-0.6 and 3.0+/-0.9 days  respectively )  lower rate of concealed inefficacy of treatment ( 12 and 31 %  respectively  0.05 ) .,valsartan,antihypertensive drugs,FALSE,none
we have demonstrated appropriateness of inhospital administration of fixed drug1/drug2 combination as an approach allowing to achieve target bp in shorter time  with the use of fewer drug0 drugs  and diminishing concealed inefficacy of treatment .,amlodipine,valsartan,TRUE,effect
we have demonstrated appropriateness of inhospital administration of fixed drug1/drug0 combination as an approach allowing to achieve target bp in shorter time  with the use of fewer drug2  and diminishing concealed inefficacy of treatment .,amlodipine,antihypertensive drugs,FALSE,none
we have demonstrated appropriateness of inhospital administration of fixed drug0/drug1 combination as an approach allowing to achieve target bp in shorter time  with the use of fewer drug2  and diminishing concealed inefficacy of treatment .,valsartan,antihypertensive drugs,FALSE,none
drug1 ( drug0 ) -- better than drug2 ( drug0 ),ticagrelor,clopidogrel,FALSE,none
drug1 ( drug0 ) -- better than drug0 ( drug2 ),ticagrelor,plavix,FALSE,none
drug0 ( drug1 ) -- better than drug2 ( drug0 ),brilinta,clopidogrel,FALSE,none
drug0 ( drug1 ) -- better than drug0 ( drug2 ),brilinta,plavix,FALSE,none
the fda has approved drug1 ( drug2-astrazeneca )  an oral drug0  for use with low-dose drug0 to reduce the rate of thrombotic cardiovascular events in patients with acute coronary syndrome ( acs ) .,ticagrelor,brilinta,FALSE,none
the fda has approved drug1 ( drug0-astrazeneca )  an oral drug2  for use with low-dose drug0 to reduce the rate of thrombotic cardiovascular events in patients with acute coronary syndrome ( acs ) .,ticagrelor,antiplatelet drug,FALSE,none
the fda has approved drug1 ( drug0-astrazeneca )  an oral drug0  for use with low-dose drug2 to reduce the rate of thrombotic cardiovascular events in patients with acute coronary syndrome ( acs ) .,ticagrelor,aspirin,TRUE,effect
the fda has approved drug0 ( drug1-astrazeneca )  an oral drug2  for use with low-dose drug0 to reduce the rate of thrombotic cardiovascular events in patients with acute coronary syndrome ( acs ) .,brilinta,antiplatelet drug,FALSE,none
the fda has approved drug0 ( drug1-astrazeneca )  an oral drug0  for use with low-dose drug2 to reduce the rate of thrombotic cardiovascular events in patients with acute coronary syndrome ( acs ) .,brilinta,aspirin,TRUE,effect
the fda has approved drug0 ( drug0-astrazeneca )  an oral drug1  for use with low-dose drug2 to reduce the rate of thrombotic cardiovascular events in patients with acute coronary syndrome ( acs ) .,antiplatelet drug,aspirin,FALSE,none
it will compete with drug1 ( drug0 ) and drug2 ( drug0 ) for such use .,clopidogrel,prasugrel,FALSE,none
it will compete with drug1 ( drug0 ) and drug0 ( drug2 ) for such use .,clopidogrel,effient,FALSE,none
it will compete with drug0 ( drug1 ) and drug2 ( drug0 ) for such use .,plavix,prasugrel,FALSE,none
it will compete with drug0 ( drug1 ) and drug0 ( drug2 ) for such use .,plavix,effient,FALSE,none
influence of drug1 on drug2 induced antinociception and its pharmacokinetics .,piperine,ibuprofen,FALSE,none
in the present study drug1 ( 10 mg/kg ) significantly increased the dose-dependent antinociceptive activity of drug2 evaluated by both drug0 writhing and formalin test  when it was administered with drug0 .,piperine,ibuprofen,TRUE,effect
in the present study drug1 ( 10 mg/kg ) significantly increased the dose-dependent antinociceptive activity of drug0 evaluated by both drug2 writhing and formalin test  when it was administered with drug0 .,piperine,acetic acid,FALSE,none
in the present study drug1 ( 10 mg/kg ) significantly increased the dose-dependent antinociceptive activity of drug2 evaluated by both drug0 writhing and formalin test  when it was administered with drug0 .,piperine,ibuprofen,FALSE,none
in the present study drug0 ( 10 mg/kg ) significantly increased the dose-dependent antinociceptive activity of drug1 evaluated by both drug2 writhing and formalin test  when it was administered with drug0 .,ibuprofen,acetic acid,FALSE,none
in the present study drug0 ( 10 mg/kg ) significantly increased the dose-dependent antinociceptive activity of drug2 evaluated by both drug1 writhing and formalin test  when it was administered with drug0 .,acetic acid,ibuprofen,FALSE,none
drug1 plasma concentration was also increased when it was administered with drug2 .,ibuprofen,piperine,TRUE,mechanism
the synergistic antinociception activity of drug1 when administered with drug2 can be attributed to increased plasma concentration of drug0 .,ibuprofen,piperine,TRUE,mechanism
the synergistic antinociception activity of drug2 when administered with drug1 can be attributed to increased plasma concentration of drug0 .,piperine,ibuprofen,FALSE,none
from this study it can be concluded that drug1 can be used as a bioenhancer along with drug2 .,piperine,ibuprofen,TRUE,effect